{
  "meta": {
    "title": "Aiims_Nov_2019_2019_11_17",
    "url": "https://brainandscalpel.vercel.app/aiims-nov-2019-2019-11-17-f6d18020.html",
    "scrapedAt": "2025-11-29T18:15:44.218Z"
  },
  "questions": [
    {
      "id": 50000,
      "choices": [
        {
          "id": 200000,
          "text": "<p><span style=\"font-size:12.0pt;\">Colles’ fracture</span></p>"
        },
        {
          "id": 200001,
          "text": "<p><span style=\"font-size:12.0pt;\">Smith’s fracture</span></p>"
        },
        {
          "id": 200002,
          "text": "<p><span style=\"font-size:12.0pt;\">Monteggia fracture</span></p>"
        },
        {
          "id": 200003,
          "text": "<p><span style=\"font-size:12.0pt;\">Galeazzi fracture</span></p>"
        }
      ],
      "text": "<p style=\"text-align:justify;\"><span style=\"font-size:12.0pt;\">A child presented with pain in the forearm following a trauma. The radiograph of the forearm reveal the findings as shown. What is the most likely diagnosis?(AIIMS NOV 2019)</span></p><p style=\"text-align:justify;\"> </p><p style=\"text-align:justify;\"><img src=\"https://cerebellum-web-static.s3.amazonaws.com/media/public/images/2024/01/17/picture12_kDdooyp.jpg\" alt=\"\" width=\"250\" height=\"253\"></p><p><img src=\"https://cerebellum-web-static.s3.amazonaws.com/media/public/images/2024/01/17/picture12_kDdooyp.jpg\" alt=\"Question Image\"></p>",
      "unique_key": "Q9900656",
      "question_audio": null,
      "question_video": null,
      "map_id": 34560758,
      "difficulty_level": "intermediate",
      "subjects_id": [],
      "solution": "<p><span style=\"font-size:12.0pt;\"><strong>Ans. D) Galeazzi fracture</strong></span></p><p> </p><p><span style=\"font-size:12.0pt;\"><strong><u>Explanation:</u></strong></span></p><p> </p><p><span style=\"font-size:12.0pt;\"><strong>GALEAZZI FRACTURE-DISLOCATION</strong></span></p><p> </p><ul><li><span style=\"font-size:12.0pt;\">Fracture of distal third of radius with dislocation of the distal radioulnar joint, along with damage to interosseous membrane and triangular fibrocartilage complex</span></li><li><span style=\"font-size:12.0pt;\">A treatment regimen of closed reduction and cast immobilization has a high rate of unsatisfactory results.</span></li><li><span style=\"font-size:12.0pt;\">Open reduction and internal fixation with plate is the treatment of choice in adult.</span></li></ul><p> </p><p><span style=\"font-size:12.0pt;\"><img src=\"https://cerebellum-web-static.s3.amazonaws.com/media/public/images/2024/01/17/picture13_gzmSza3.jpg\" alt=\"\" width=\"300\" height=\"376\"></span></p><p> </p><p><span style=\"font-size:12.0pt;\"><strong>Monteggia and Galeazzi Fractures:</strong></span></p><p> </p><p><span style=\"font-size:12.0pt;\"><strong><img src=\"https://cerebellum-web-static.s3.amazonaws.com/media/public/images/2024/01/17/screenshot-2024-01-17-154720.jpg\" alt=\"\" width=\"1000\" height=\"643\"></strong></span></p><p> </p><p><span style=\"font-size:12.0pt;\"><strong><u>Explanation:</u></strong></span></p><p> </p><p style=\"text-align:justify;\"><span style=\"font-size:12.0pt;\"><strong>Option A. Colle’s fracture. </strong>Colles’s fracture is fracture of lower end of radius at its corti-cocancellous junction mostly occurring in post-menopausal osteoporotic elderly women, as a result of fall on outstretched hand, with wrist in extension. It is one of the most common fractures in elderly. Most Colles fractures can be successfully treated nonoperatively, and cast (hand-shaking cast) is applied on opposite forces to displacement. Complications include finger stiffness (most common), malunion (2nd most common) leading to dinner fork deformity. Colles’s fracture is the commonest cause of Sudeck's dystrophy in upper limb.</span></p><p> </p><p style=\"text-align:center;\"><span style=\"font-size:12.0pt;\"><img src=\"https://cerebellum-web-static.s3.amazonaws.com/media/public/images/2024/01/17/picture14.jpg\" alt=\"\" width=\"300\" height=\"378\"></span></p><p style=\"text-align:center;\"><span style=\"font-size:12.0pt;\"><strong>Dinner fork deformity</strong></span></p><p style=\"text-align:center;\"> </p><p> </p><p><img src=\"https://cerebellum-web-static.s3.amazonaws.com/media/public/images/2024/01/17/whatsapp-image-2024-01-17-at-41614-pm.jpeg\" alt=\"\" width=\"800\" height=\"484\"></p><p style=\"text-align:center;\"><span style=\"font-size:12.0pt;\"><strong>Reduction and application of Hand-shaking cast</strong></span></p><p> </p><p style=\"text-align:justify;\"><span style=\"font-size:12.0pt;\"><strong>Option B. Smith’s fracture</strong>. A Smith fracture is a break to the end of the radius. The end part of the bone, which forms part of the wrist joint, is displaced or angled in the direction of the palm of the hand. Often, this injury occurs by a fall to the back of a flexed wrist but can occur in any fall to an outstretched hand. Smith fracture is treated by close reduction and immobilization in long arm (above elbow) cast with forearm in supination and wrist in extension (dorsiflexion).</span></p><p> </p><p><img src=\"https://cerebellum-web-static.s3.amazonaws.com/media/public/images/2024/01/17/picture16.jpg\" alt=\"\" width=\"300\" height=\"304\"></p><p> </p><p style=\"text-align:justify;\"><span style=\"font-size:12.0pt;\"><strong>Option C. Monteggia fracture. </strong>Fractures between the proximal third of the ulna and the base of olecranon combined with dislocation of the proximal radioulnar joint. The clue to successful treatment is to restore the length of the fractured ulna; only then can the dislocated joint be fully reduced and remain stable. In adults, treatment is reduction and fixation. In children, treatment is reduction and cast application. Posterior interosseous nerve has been most commonly injured nerve in association with Monteggia fracture dislocation because it takes a turn around radial head and is injured with its dislocation. This causes paralysis of thumb and finger extensors.</span></p><p> </p><p><img src=\"https://cerebellum-web-static.s3.amazonaws.com/media/public/images/2024/01/17/picture17.jpg\" alt=\"\" width=\"300\" height=\"300\"></p><p> </p><p><span style=\"font-size:12.0pt;\"><strong><u>Educational objective:</u></strong></span></p><p> </p><ul><li><span style=\"font-size:12.0pt;\">The given image in the question reveals a Galeazzi fracture of the forearm.</span></li></ul><p><img src=\"https://cerebellum-web-static.s3.amazonaws.com/media/public/images/2024/01/17/picture13_gzmSza3.jpg\" alt=\"Solution Image\"></p>",
      "correct_choice_id": 200003,
      "solution_audio": null,
      "solution_video": null,
      "audio_explanation_heading": null,
      "video_explanation_heading": null,
      "solution_media_position": "bottom",
      "tags": [],
      "explanation_video": null,
      "question_images": [],
      "explanation_images": []
    },
    {
      "id": 50001,
      "choices": [
        {
          "id": 200004,
          "text": "<p><span style=\"font-size:12.0pt;\">Contraindicated if platelet count <40,000</span></p>"
        },
        {
          "id": 200005,
          "text": "<p><span style=\"font-size:12.0pt;\">Breath holding is required</span></p>"
        },
        {
          "id": 200006,
          "text": "<p><span style=\"font-size:12.0pt;\">Procedure can be done in both lateral & prone position</span></p>"
        },
        {
          "id": 200007,
          "text": "<p><span style=\"font-size:12.0pt;\">Diagnosing an infiltrative or granulomatous disease</span></p>"
        }
      ],
      "text": "<p><span style=\"font-size:12.0pt;\">Which of the following is not true regarding the procedure done using the instrument given in the image below?</span><span style=\"font-size:11pt;\"> </span><span style=\"font-size:12.0pt;\">(AIIMS NOV 2019)</span></p><p> </p><p><span style=\"font-size:12.0pt;\"><img src=\"https://cerebellum-web-static.s3.amazonaws.com/media/public/images/2023/04/12/956.jpg\" alt=\"\" width=\"300\" height=\"200\"></span></p><p><img src=\"https://cerebellum-web-static.s3.amazonaws.com/media/public/images/2023/04/12/956.jpg\" alt=\"Question Image\"></p>",
      "unique_key": "Q4260164",
      "question_audio": null,
      "question_video": null,
      "map_id": 34508658,
      "difficulty_level": "intermediate",
      "subjects_id": [],
      "solution": "<p><span style=\"font-size:12.0pt;\"><strong>Ans. A) Contraindicated if platelet count <40,000</strong></span></p><p> </p><p><span style=\"font-size:12.0pt;\">The image shows a <strong>bone marrow biopsy needle. </strong>Thrombocytopenia is not a contraindication, and platelet transfusion can be performed if clinically warranted prior to the procedure, commonly performed if platelet counts are below 20,000 cells/microliter.</span></p><p> </p><p><span style=\"font-size:12.0pt;\"><img src=\"https://cerebellum-web-static.s3.amazonaws.com/media/public/images/2023/04/12/957.jpg\" alt=\"\" width=\"500\" height=\"490\"></span></p><p> </p><p><span style=\"font-size:12.0pt;\"><strong><u>Indications of bone marrow biopsy:</u></strong></span></p><p> </p><ul><li><span style=\"font-size:12.0pt;\">Evaluation of unexplained anemia, leukopenia, thrombocytopenia, pancytopenia</span></li><li><span style=\"font-size:12.0pt;\">Evaluation of polycythemia, thrombocytosis, leukocytosis</span></li><li><span style=\"font-size:12.0pt;\">Diagnosis and staging of lymphoma or solid tumors</span></li><li><span style=\"font-size:12.0pt;\">Diagnosis and evaluation of plasma cell disorders and leukemias</span></li><li><span style=\"font-size:12.0pt;\">Evaluation of suspected infiltrative and storage diseases</span></li><li><span style=\"font-size:12.0pt;\">Evaluation of fever of unknown origin, suspected mycobacterial, fungal, or parasitic infections, or granulomatous diseases</span></li></ul><p> </p><p><span style=\"font-size:12.0pt;\"><strong><u>Contraindications of bone marrow biopsy</u></strong><u>:</u></span></p><p> </p><ul><li><span style=\"font-size:12.0pt;\">Severe hemophilia</span></li><li><span style=\"font-size:12.0pt;\">Severe disseminated intravascular coagulopathy</span></li><li><span style=\"font-size:12.0pt;\">Severe bleeding disorders</span></li></ul><p> </p><p><span style=\"font-size:12.0pt;\"><strong><u>Procedure for bone marrow biopsy:</u></strong></span></p><p> </p><p><span style=\"font-size:12.0pt;\"><strong>Prone or lateral position </strong>is chosen for the procedure. <strong>Posterior superior iliac spine is identified</strong>. After disinfection and local anesthesia, the patient is asked to inhale slowly through the nose and exhale slowly through the mouth to relieve anxiety. The needle is inserted and rotated on its axis.</span></p><p> </p><p><span style=\"font-size:12.0pt;\">On reaching the desired depth, the stylet is removed and needle is advanced. The needle is rotated in the opposite direction to loosen the specimen. It is then withdrawn using the same rotational movement.</span></p><p> </p><p><span style=\"font-size:12.0pt;\"><strong>Other Options:</strong></span></p><p> </p><p><span style=\"font-size:12.0pt;\"><strong>Option B. Breath holding is required</strong>: This is true for minimizing patient movement during the procedure.</span></p><p> </p><p><span style=\"font-size:12.0pt;\"><strong>Option C. Procedure can be done in both lateral & prone position</strong>: This is true and allows for flexibility depending on the patient's condition and biopsy site.</span></p><p> </p><p><span style=\"font-size:12.0pt;\"><strong>Option D. Diagnosing an infiltrative or granulomatous disease</strong>: This is true and one of the key indications for bone marrow biopsy.</span></p><p> </p><p><span style=\"font-size:12.0pt;\"><strong>Educational Objective:</strong></span></p><p> </p><p><span style=\"font-size:12.0pt;\">A platelet count of <40,000 is <strong>not</strong> an absolute contraindication for bone marrow biopsy, as platelet transfusion can be performed to mitigate bleeding risk.</span></p><p> </p><p><span style=\"font-size:12.0pt;\"><strong>Source - </strong></span><a href=\"https://www.ncbi.nlm.nih.gov/books/NBK559232/\"><span style=\"font-size:12.0pt;\"><strong><u>https://www.ncbi.nlm.nih.gov/books/NBK559232/</u></strong></span></a></p><p><img src=\"https://cerebellum-web-static.s3.amazonaws.com/media/public/images/2023/04/12/957.jpg\" alt=\"Solution Image\"></p>",
      "correct_choice_id": 200004,
      "solution_audio": null,
      "solution_video": null,
      "audio_explanation_heading": null,
      "video_explanation_heading": null,
      "solution_media_position": "bottom",
      "tags": [],
      "explanation_video": null,
      "question_images": [],
      "explanation_images": []
    },
    {
      "id": 50002,
      "choices": [
        {
          "id": 200008,
          "text": "<p><span style=\"font-size:12.0pt;\">Loss of sensation of the nail of index finger</span></p>"
        },
        {
          "id": 200009,
          "text": "<p><span style=\"font-size:12.0pt;\">Hypothenar muscles wasting</span></p>"
        },
        {
          "id": 200010,
          "text": "<p><span style=\"font-size:12.0pt;\">Loss of sensation at the tip of radial tubercle</span></p>"
        },
        {
          "id": 200011,
          "text": "<p><span style=\"font-size:12.0pt;\">Loss of sensation of the 4th interdigital cleft</span></p>"
        }
      ],
      "text": "<p><span style=\"font-size:12.0pt;\">Lesion of the structure marked '11' causes: (</span><span style=\"background-color:rgb(255,255,255);color:rgb(111,126,149);font-size:14px;\">AIIMS Nov 2019)</span></p><p> </p><p><img src=\"https://cerebellum-web-static.s3.amazonaws.com/media/public/images/2023/11/10/19.jpg\" alt=\"\" width=\"250\" height=\"321\"></p><p><img src=\"https://cerebellum-web-static.s3.amazonaws.com/media/public/images/2023/11/10/19.jpg\" alt=\"Question Image\"></p>",
      "unique_key": "Q6969170",
      "question_audio": null,
      "question_video": null,
      "map_id": 34498639,
      "difficulty_level": "intermediate",
      "subjects_id": [],
      "solution": "<p><span style=\"font-size:12.0pt;\"><strong>Ans. A. Loss of sensation of the nail of index finger</strong></span></p><p> </p><p><span style=\"font-size:12.0pt;\">The structure marked 11 in the diagram is median nerve in the cubital fossa. A lesion of the median nerve causes loss of sensation of the nail of the index finger.</span></p><p> </p><p><span style=\"font-size:12.0pt;\">Anterior view of the right cubital fossa. The structures marked in the given image are:</span></p><p> </p><ol><li><span style=\"font-size:12.0pt;\">Branch of the median nerve to the brachialis muscle</span></li><li><span style=\"font-size:12.0pt;\">Biceps brachii muscle</span></li><li><span style=\"font-size:12.0pt;\">Brachialis muscle</span></li><li><span style=\"font-size:12.0pt;\">Lateral cutaneous nerve of fore arm</span></li><li><span style=\"font-size:12.0pt;\">Superficial branch of the radial nerve</span></li><li><span style=\"font-size:12.0pt;\">Brachioradialis muscle</span></li><li><span style=\"font-size:12.0pt;\">Flexor carpi ulnaris muscle</span></li><li><span style=\"font-size:12.0pt;\">Pronator teres muscle</span></li><li><span style=\"font-size:12.0pt;\">Brachial artery</span></li><li><span style=\"font-size:12.0pt;\">Medial cutaneous nerve of forearm</span></li><li><span style=\"font-size:12.0pt;\">Median nerve.</span></li></ol><p> </p><p><span style=\"font-size:12.0pt;\"><img src=\"https://cerebellum-web-static.s3.amazonaws.com/media/public/images/2023/05/03/ia-73.jpg\" alt=\"\" width=\"500\" height=\"396\"></span></p><p> </p><p><span style=\"font-size:12.0pt;\"><strong>Median nerve cutaneous supply:</strong></span></p><p> </p><ul><li><span style=\"font-size:12.0pt;\">Lateral 2/3rd of the palm by superficial cutaneous branch</span></li><li><span style=\"font-size:12.0pt;\">Lateral 3½ fingers (palmar aspect and dorsal aspect of nailbeds) by palmar digital nerves</span></li></ul><p> </p><p><span style=\"font-size:12.0pt;\"><strong>Cubital fossa boundaries</strong></span></p><p> </p><ul><li><span style=\"font-size:12.0pt;\">An essential point of transition between the arm and the forearm is the cubital fossa. It is a triangle depression produced between two forearm muscles that is anterior to the elbow joint:</span></li><li><span style=\"font-size:12.0pt;\">the brachioradialis muscle originating from the lateral supraepicondylar ridge of the humerus;</span></li><li><span style=\"font-size:12.0pt;\">the pronator teres muscle originating from the medial epicondyle of the humerus</span></li></ul><p> </p><p><span style=\"font-size:12.0pt;\"><strong>Contents of cubital fossa</strong>: (From medial to lateral) - \"MBBS\"</span></p><p> </p><ul><li><span style=\"font-size:12.0pt;\">Median nerve</span></li><li><span style=\"font-size:12.0pt;\">Brachial artery</span></li><li><span style=\"font-size:12.0pt;\">Biceps brachi tendon</span></li><li><span style=\"font-size:12.0pt;\">Superficial branch of radial nerve</span></li></ul><p> </p><p><span style=\"font-size:12.0pt;\"><img src=\"https://cerebellum-web-static.s3.amazonaws.com/media/public/images/2023/05/03/ia-74.jpg\" alt=\"\" width=\"500\" height=\"258\"></span></p><p> </p><p><span style=\"font-size:12.0pt;\"><strong>Other Options:</strong></span></p><p> </p><p><span style=\"font-size:12pt;\"><strong>Option B.</strong> </span><span style=\"font-size:12.0pt;\"><strong>Hypothenar muscles wasting:</strong> The hypothenar muscles are primarily innervated by the ulnar nerve, not the median nerve. Therefore, injury to the median nerve would not directly result in the wasting of these muscles.</span></p><p> </p><p><span style=\"font-size:12.0pt;\"><strong>Option C</strong>. <strong>Loss of sensation at the tip of the radial tubercle:</strong> The radial tubercle refers to the styloid process of the radius, which is not typically innervated by the median nerve. Sensory loss in this area is more likely associated with a different nerve, such as the radial nerve.</span></p><p> </p><p><span style=\"font-size:12.0pt;\"><strong>Option D</strong>. <strong>Loss of sensation of the 4th interdigital cleft:</strong> The median nerve supplies sensory fibers to the radial half of the ring finger, so an injury to the median nerve could result in sensory loss in the 4th interdigital cleft (between the ring finger and the little finger).</span></p><p> </p><p><span style=\"font-size:12.0pt;\"><strong>Educational Objective:</strong></span></p><p> </p><p><span style=\"font-size:12.0pt;\">The median nerve supplies sensory fibers to the palmar aspect of the thumb, index finger, middle finger, and the radial half of the ring finger. This means that an injury to the median nerve can lead to sensory loss in these areas, including the nail of the index finger.</span></p><p><img src=\"https://cerebellum-web-static.s3.amazonaws.com/media/public/images/2023/05/03/ia-73.jpg\" alt=\"Solution Image\"></p>",
      "correct_choice_id": 200008,
      "solution_audio": null,
      "solution_video": null,
      "audio_explanation_heading": null,
      "video_explanation_heading": null,
      "solution_media_position": "bottom",
      "tags": [],
      "explanation_video": null,
      "question_images": [],
      "explanation_images": []
    },
    {
      "id": 50003,
      "choices": [
        {
          "id": 200012,
          "text": "<p><span style=\"font-size:12.0pt;\">A child < 2 years</span></p>"
        },
        {
          "id": 200013,
          "text": "<p><span style=\"font-size:12.0pt;\">A patient with sickle cell disease</span></p>"
        },
        {
          "id": 200014,
          "text": "<p><span style=\"font-size:12.0pt;\">A patient with cystic fibrosis</span></p>"
        },
        {
          "id": 200015,
          "text": "<p><span style=\"font-size:12.0pt;\">A patient with recurrent otitis media</span></p>"
        }
      ],
      "text": "<p><span style=\"font-size:12.0pt;\">A new vaccine has been developed to target the 23 serotypes of <i>Streptococcus pneumoniae</i>. This polysaccharide vaccine promises to reduce the morbidity and mortality associated with pneumococcal infections, particularly in certain high-risk groups. Which of the following patient groups would most likely derive the most benefit from this vaccine? (AIIMS NOV 2019)</span></p>",
      "unique_key": "Q6638846",
      "question_audio": null,
      "question_video": null,
      "map_id": 34030951,
      "difficulty_level": "intermediate",
      "subjects_id": [],
      "solution": "<p><span style=\"font-size:12.0pt;\"><strong>Ans. B) A patient with sickle cell disease </strong></span></p><p> </p><ul><li><span style=\"font-size:12.0pt;\">The polysaccharide vaccine targeting Streptococcus pneumoniae (PPSV-23) provides the greatest advantages to individuals with sickle cell disease.</span></li><li><span style=\"font-size:12.0pt;\">Streptococcus pneumoniae is a bacteria enveloped in a protective layer that the spleen recognizes and eliminates.</span></li><li><span style=\"font-size:12.0pt;\">However, in the case of sickle cell disease, the distorted shape of red blood cells obstructs the spleen's blood vessels, leading to damage.</span></li><li><span style=\"font-size:12.0pt;\">This compromised spleen function, known as hyposplenism, raises the susceptibility to pneumococcal infections.</span></li><li><span style=\"font-size:12.0pt;\">Consequently, sickle cell patients receive the pneumococcal vaccine (PPSV-23) as a preventive measure, aimed at diminishing this vulnerability.</span></li></ul><p> </p><p><span style=\"font-size:12.0pt;\"><strong>Other Options:</strong></span></p><p> </p><p><span style=\"font-size:12.0pt;\"><strong>Option A. A child < 2 years: </strong>Polysaccharide vaccines are not effective in children under 2 years old due to their immature immune systems. Conjugate vaccines are preferred for this age group.</span></p><p> </p><p><span style=\"font-size:12.0pt;\"><strong>Option C. A patient with cystic fibrosis: </strong>While at risk for lung infections, cystic fibrosis patients benefit more from vaccines targeting typical respiratory pathogens, and their spleen function is usually normal.</span></p><p> </p><p><span style=\"font-size:12.0pt;\"><strong>Option D. A patient with recurrent otitis media: </strong>This condition is typically managed with other interventions, and the need for a polysaccharide vaccine is less critical.</span></p><p> </p><p><span style=\"font-size:12.0pt;\"><strong>Educational Objective:</strong></span></p><p> </p><ul><li><span style=\"font-size:12.0pt;\">The PPSV-23 vaccine is most beneficial for patients with sickle cell disease due to their increased susceptibility to pneumococcal infections caused by compromised spleen function.</span></li></ul>",
      "correct_choice_id": 200013,
      "solution_audio": null,
      "solution_video": null,
      "audio_explanation_heading": null,
      "video_explanation_heading": null,
      "solution_media_position": "bottom",
      "tags": [],
      "explanation_video": null,
      "question_images": [],
      "explanation_images": []
    },
    {
      "id": 50004,
      "choices": [
        {
          "id": 200016,
          "text": "<p><span style=\"font-size:12pt;\">Keratinocytes</span></p>"
        },
        {
          "id": 200017,
          "text": "<p><span style=\"font-size:12pt;\">Merkel cells</span></p>"
        },
        {
          "id": 200018,
          "text": "<p><span style=\"font-size:12pt;\">Melanocytes</span></p>"
        },
        {
          "id": 200019,
          "text": "<p><span style=\"font-size:12pt;\">Langerhans cells</span></p>"
        }
      ],
      "text": "<p><span style=\"font-size:12.0pt;\">Which cells are not present in the layer marked as D? (</span>AIIMS Nov 2019)</p><p> </p><p><span style=\"font-size:12.0pt;\"><img src=\"https://cerebellum-web-static.s3.amazonaws.com/media/public/images/2023/08/19/untitled-13534_QMQ2Xbb.jpg\" alt=\"\" width=\"300\" height=\"294\"></span></p><p><img src=\"https://cerebellum-web-static.s3.amazonaws.com/media/public/images/2023/08/19/untitled-13534_QMQ2Xbb.jpg\" alt=\"Question Image\"></p>",
      "unique_key": "Q4869341",
      "question_audio": null,
      "question_video": null,
      "map_id": 34587465,
      "difficulty_level": "intermediate",
      "subjects_id": [],
      "solution": "<p><span style=\"font-size:12pt;\"><strong>Ans. D) Langerhans cells</strong></span></p><p> </p><ul><li><span style=\"font-size:12pt;\">The layer marked as D is <strong>stratum basale</strong>.</span></li><li><span style=\"font-size:12pt;\"><strong>Langerhan's cells </strong>are not present in stratum basale.</span></li><li><span style=\"font-size:12pt;\">Langerhan's cells are predominantly present in <strong>stratum spinosum.</strong></span></li><li><span style=\"font-size:12pt;\"><strong>Keratinocytes, Merkel cells & Melanocytes are all seen in Stratum Basale.</strong></span></li></ul><p> </p><p><span style=\"font-size:12pt;\"><strong>Other Options:</strong></span></p><p> </p><p><span style=\"font-size:12pt;\"><strong>Option A. Keratinocytes</strong>: Keratinocytes are the most prevalent cells in the<strong> </strong>epidermis and are definitely found in the <strong>stratum basale.</strong> They are responsible for the production of <strong>keratin,</strong> a key structural protein in the skin.</span></p><p> </p><p><span style=\"font-size:12pt;\"><strong>Option B. Merkel cells</strong>: Merkel cells are <strong>mechanoreceptor cells</strong> that are present in the <strong>basal layer</strong> of the epidermis. They are involved in the sensation of light touch.</span></p><p> </p><p><span style=\"font-size:12pt;\"><strong>Option C. Melanocytes</strong>: Melanocytes are also present in the <strong>stratum basale</strong>. These cells produce <strong>melanin</strong>, the pigment that gives skin its <strong>color</strong> and provides protection against <strong>UV radiation.</strong></span></p><p> </p><p><span style=\"font-size:12pt;\"><strong>Educational Objective:</strong></span></p><p> </p><p><img src=\"https://cerebellum-web-static.s3.amazonaws.com/media/public/images/2023/11/27/screenshot-2023-11-27-124309.jpg\" alt=\"\" width=\"1000\" height=\"586\"></p><p> </p><p><img src=\"https://cerebellum-web-static.s3.amazonaws.com/media/public/images/2023/11/27/screenshot-2023-11-27-124434.jpg\" alt=\"\" width=\"1000\" height=\"389\"></p><p> </p><p><span style=\"font-size:12pt;\"><strong>Ref - Rooks textbook of dermatology- 9<sup>th</sup> Edition: Volume 1 Chapter 2, Page no 2.4</strong></span></p><p><img src=\"https://cerebellum-web-static.s3.amazonaws.com/media/public/images/2023/11/27/screenshot-2023-11-27-124309.jpg\" alt=\"Solution Image\"></p>",
      "correct_choice_id": 200019,
      "solution_audio": null,
      "solution_video": null,
      "audio_explanation_heading": null,
      "video_explanation_heading": null,
      "solution_media_position": "bottom",
      "tags": [],
      "explanation_video": null,
      "question_images": [],
      "explanation_images": []
    },
    {
      "id": 50005,
      "choices": [
        {
          "id": 200020,
          "text": "<p><span style=\"font-size:12.0pt;\">Vertebral artery</span></p>"
        },
        {
          "id": 200021,
          "text": "<p><span style=\"font-size:12.0pt;\">Internal carotid artery</span></p>"
        },
        {
          "id": 200022,
          "text": "<p><span style=\"font-size:12.0pt;\">Anterior cerebral artery</span></p>"
        },
        {
          "id": 200023,
          "text": "<p><span style=\"font-size:12.0pt;\">Middle cerebral artery</span></p>"
        }
      ],
      "text": "<p><span style=\"font-size:12.0pt;\">The blood supply to the structure marked in the image is by? (</span>AIIMS Nov 2019)</p><p> </p><p><span style=\"font-size:12.0pt;\"><img src=\"https://cerebellum-web-static.s3.amazonaws.com/media/public/images/2023/05/03/ia-78.jpg\" alt=\"\" width=\"300\" height=\"247\"></span></p><p><img src=\"https://cerebellum-web-static.s3.amazonaws.com/media/public/images/2023/05/03/ia-78.jpg\" alt=\"Question Image\"></p>",
      "unique_key": "Q1221964",
      "question_audio": null,
      "question_video": null,
      "map_id": 34542306,
      "difficulty_level": "intermediate",
      "subjects_id": [],
      "solution": "<p><span style=\"font-size:12.0pt;\"><strong>Ans. C. Anterior cerebral artery</strong></span></p><p> </p><p><span style=\"font-size:12.0pt;\"><strong>Explanation:</strong></span></p><p> </p><p><span style=\"font-size:12.0pt;\">The marked structure is fornix which is supplied by the anterior cerebral artery.</span></p><p> </p><p><span style=\"font-size:12.0pt;\">The optic chiasma, lamina terminalis, hypothalamus, para-olfactory regions, and cingulate gyrus are all supplied by the anteromedial central branches of the anterior cerebral artery in addition to the fornix.</span></p><p> </p><p><span style=\"font-size:12.0pt;\">The fornix is a C-shaped bundle of nerve fibers in the brain that plays a crucial role in memory and cognitive functions. It is supplied by</span></p><p> </p><ol><li><span style=\"font-size:12.0pt;\"><strong>Anterior Cerebral Artery (ACA):</strong> The ACA is one of the major arteries of the Circle of Willis and is responsible for supplying blood to the frontal lobes of the brain, including the anterior part of the fornix.</span></li><li><span style=\"font-size:12.0pt;\"><strong>Posterior Cerebral Artery (PCA):</strong> The PCA is another major artery of the Circle of Willis, and its branches supply blood to the posterior part of the fornix.</span></li><li><span style=\"font-size:12.0pt;\"><strong>Anterior Choroidal Artery:</strong> This artery arises from the internal carotid artery and supplies blood to the choroid plexus in the lateral and third ventricles of the brain. It also sends branches to the fornix, particularly the inferior part.</span></li><li><span style=\"font-size:12.0pt;\"><strong>Septal Branches:</strong> The fornix also receives blood supply from septal branches, which originate from the anterior cerebral arteries. Top of Form</span></li></ol><p> </p><p><span style=\"font-size:12.0pt;\"><strong>Educational Objective:</strong></span></p><p> </p><p> </p><p><span style=\"font-size:12.0pt;\"><img src=\"https://cerebellum-web-static.s3.amazonaws.com/media/public/images/2023/05/03/ia-79.jpg\" alt=\"\" width=\"500\" height=\"213\"></span></p><p><img src=\"https://cerebellum-web-static.s3.amazonaws.com/media/public/images/2023/05/03/ia-79.jpg\" alt=\"Solution Image\"></p>",
      "correct_choice_id": 200022,
      "solution_audio": null,
      "solution_video": null,
      "audio_explanation_heading": null,
      "video_explanation_heading": null,
      "solution_media_position": "bottom",
      "tags": [],
      "explanation_video": null,
      "question_images": [],
      "explanation_images": []
    },
    {
      "id": 50006,
      "choices": [
        {
          "id": 200024,
          "text": "<p><span style=\"font-size:12.0pt;\">Base excision</span></p>"
        },
        {
          "id": 200025,
          "text": "<p><span style=\"font-size:12.0pt;\">Non- Homologous End Joining</span></p>"
        },
        {
          "id": 200026,
          "text": "<p><span style=\"font-size:12.0pt;\">Homologous End Joining</span></p>"
        },
        {
          "id": 200027,
          "text": "<p><span style=\"font-size:12.0pt;\">Mismatch repair</span></p>"
        }
      ],
      "text": "<p><span style=\"font-size:12.0pt;\">By which mechanism does gene repair occur when mediated by CRISPR-Cas9?(</span>AIIMS Nov 2019)</p>",
      "unique_key": "Q7926032",
      "question_audio": null,
      "question_video": null,
      "map_id": 34222104,
      "difficulty_level": "intermediate",
      "subjects_id": [],
      "solution": "<p><span style=\"font-size:12.0pt;\"><strong>Ans. B) Non-Homologous End joining</strong></span></p><p> </p><p><span style=\"font-size:12.0pt;\"><strong>Common repair mechanism in mammalian cells.</strong></span></p><p> </p><ul><li><span style=\"font-size:12.0pt;\"><strong>Error-prone: </strong>It can introduce insertions or deletions (indels) at the cut site.</span></li><li><span style=\"font-size:12.0pt;\">This mechanism is frequently used in CRISPR-Cas9 to disrupt gene function (gene knock-out).</span></li></ul><p> </p><p><span style=\"font-size:12.0pt;\">Many clustered regularly interspaced short palindromic repeats (CRISPR)-CRISPR-associated protein 9 (Cas9)-based genome editing technologies <strong>take advantage of Cas nucleases to induce DNA double-strand breaks (DSBs) at desired locations within a genome</strong>. Further processing of the DSBs by the cellular DSB repair machinery is then necessary <strong>to introduce desired mutations, sequence insertions, or gene deletions.</strong></span></p><p> </p><p><span style=\"font-size:12.0pt;\"><strong>Other Options:</strong></span></p><p> </p><p><span style=\"font-size:12pt;\"><strong>Option A.</strong> </span><span style=\"font-size:12.0pt;\"><strong>Base excision:</strong> This repair mechanism corrects single-base lesions that do not significantly distort the DNA helix, typically involving the removal of damaged bases by glycosylases followed by endonuclease action.</span></p><p> </p><p><span style=\"font-size:12pt;\"><strong>Option C.</strong> </span><span style=\"font-size:12.0pt;\"><strong>Homologous End Joining:</strong> This term is not commonly used in the context of DSB repair. The correct term would be Homologous Recombination (HR), which is an accurate repair mechanism but not the predominant one in CRISPR-Cas9-mediated repairs.</span></p><p> </p><p><span style=\"font-size:12pt;\"><strong>Option D.</strong> </span><span style=\"font-size:12.0pt;\"><strong>Mismatch repair:</strong> This mechanism corrects base-pair mismatches and small insertion/deletion loops formed during DNA replication and recombination, but it is not primarily involved in repairing DSBs.</span></p><p> </p><p><span style=\"font-size:12.0pt;\"><strong>Educational Objective:</strong></span></p><p> </p><p><span style=\"font-size:12.0pt;\">CRISPR-Cas9 mediated gene repair primarily occurs through Non-Homologous End Joining (NHEJ), an error-prone repair process that ligates broken DNA ends together, often resulting in small insertions or deletions at the repair site.</span></p>",
      "correct_choice_id": 200025,
      "solution_audio": null,
      "solution_video": null,
      "audio_explanation_heading": null,
      "video_explanation_heading": null,
      "solution_media_position": "bottom",
      "tags": [],
      "explanation_video": null,
      "question_images": [],
      "explanation_images": []
    },
    {
      "id": 50007,
      "choices": [
        {
          "id": 200028,
          "text": "<p><span style=\"font-size:12.0pt;\">Glutamate</span></p>"
        },
        {
          "id": 200029,
          "text": "<p><span style=\"font-size:12.0pt;\">Phenylbutyrate</span></p>"
        },
        {
          "id": 200030,
          "text": "<p><span style=\"font-size:12.0pt;\">Isoleucine</span></p>"
        },
        {
          "id": 200031,
          "text": "<p><span style=\"font-size:12.0pt;\">L-carnitine</span></p>"
        }
      ],
      "text": "<p><span style=\"font-size:12.0pt;\">In urea cycle disorders, which of the following can be used to reduce the levels of ammonia?</span></p>",
      "unique_key": "Q7788147",
      "question_audio": null,
      "question_video": null,
      "map_id": 34127637,
      "difficulty_level": "intermediate",
      "subjects_id": [],
      "solution": "<p><span style=\"font-size:12.0pt;\"><strong>Ans. B) Phenylbutyrate</strong></span></p><p><span style=\"font-size:10.5pt;\"><strong> </strong></span></p><p><span style=\"font-size:12.0pt;\">In urea cycle disorders ammonia cannot be converted to urea, but alternatively can be converted to glutamine and glycine. <strong>Ammonia scavengers phenylbutyrate and sodium benzoate react with glutamine and glycine and consequently remove excess of ammonia. Phenylglutamine and hippurate are excreted in urine.</strong></span></p><p> </p><p><span style=\"font-size:12.0pt;\"><strong>Other Options:</strong></span></p><p> </p><p><span style=\"font-size:12pt;\"><strong>Option A.</strong> </span><span style=\"font-size:12.0pt;\"><strong>Glutamate:</strong> While glutamate can bind ammonia to form glutamine, it does not directly reduce ammonia levels through excretion.</span></p><p> </p><p><span style=\"font-size:12.0pt;\"><strong>Option C. Isoleucine:</strong> An amino acid that does not have a role in reducing ammonia levels in urea cycle disorders.</span></p><p> </p><p><span style=\"font-size:12.0pt;\"><strong>Option D. L-carnitine:</strong> Involved in the transport of fatty acids into mitochondria for beta-oxidation, but it does not play a role in reducing ammonia levels.</span></p><p> </p><p><span style=\"font-size:12.0pt;\"><strong>Educational Objective:</strong></span></p><p><span style=\"font-size:10.5pt;\"><strong> </strong></span></p><p><span style=\"font-size:12.0pt;\">Phenylbutyrate is used in urea cycle disorders to reduce ammonia levels by converting ammonia into phenylacetylglutamine, which is then excreted in the urine.</span></p>",
      "correct_choice_id": 200029,
      "solution_audio": null,
      "solution_video": null,
      "audio_explanation_heading": null,
      "video_explanation_heading": null,
      "solution_media_position": "bottom",
      "tags": [],
      "explanation_video": null,
      "question_images": [],
      "explanation_images": []
    },
    {
      "id": 50008,
      "choices": [
        {
          "id": 200032,
          "text": "<p><span style=\"font-size:12.0pt;\">Malignant melanoma</span></p>"
        },
        {
          "id": 200033,
          "text": "<p><span style=\"font-size:12.0pt;\">ВСС</span></p>"
        },
        {
          "id": 200034,
          "text": "<p><span style=\"font-size:12.0pt;\">SCC</span></p>"
        },
        {
          "id": 200035,
          "text": "<p><span style=\"font-size:12.0pt;\">Actinic keratosis</span></p>"
        }
      ],
      "text": "<p><span style=\"font-size:12.0pt;\">ABCDE rule is seen in:</span> <span style=\"font-size:12.0pt;\">(AIIMS NOV 2019)</span></p>",
      "unique_key": "Q3780355",
      "question_audio": null,
      "question_video": null,
      "map_id": 34015245,
      "difficulty_level": "intermediate",
      "subjects_id": [],
      "solution": "<p><span style=\"font-size:12.0pt;\"><strong>Ans. A) Malignant melanoma</strong></span></p><p> </p><p><span style=\"font-size:12.0pt;\">ABCDE rule applies to malignant melanoma.</span></p><p> </p><p><span style=\"font-size:12.0pt;\"><strong>Educational Objective:</strong></span></p><p> </p><p><span style=\"font-size:12.0pt;\">ABCDE rule for the clinical evaluation of malignant melanoma:</span></p><p> </p><p><span style=\"font-size:12.0pt;\"><strong>A - Asymmetry</strong>: One half of the mole does not match the other half.</span></p><p> </p><p><span style=\"font-size:12.0pt;\"><strong>B - Border irregularity</strong>: The edges of the mole are irregular, ragged, or blurred.</span></p><p> </p><p><span style=\"font-size:12.0pt;\"><strong>C - Color variation</strong>: The mole has different shades of color, such as black, brown, tan, or red.</span></p><p> </p><p><span style=\"font-size:12.0pt;\"><strong>D - Diameter</strong>: The mole is larger than 6 millimeters or has grown in size.</span></p><p> </p><p><span style=\"font-size:12.0pt;\"><strong>E - Evolution</strong>: The mole has changed in size, shape, or color, or has started to bleed, itch, or crust over.</span></p>",
      "correct_choice_id": 200032,
      "solution_audio": null,
      "solution_video": null,
      "audio_explanation_heading": null,
      "video_explanation_heading": null,
      "solution_media_position": "bottom",
      "tags": [],
      "explanation_video": null,
      "question_images": [],
      "explanation_images": []
    },
    {
      "id": 50009,
      "choices": [
        {
          "id": 200036,
          "text": "<p><span style=\"font-size:12.0pt;\">Macular ischemia</span></p>"
        },
        {
          "id": 200037,
          "text": "<p><span style=\"font-size:12.0pt;\">﻿﻿﻿Macular edema</span></p>"
        },
        {
          "id": 200038,
          "text": "<p><span style=\"font-size:12.0pt;\">﻿﻿﻿Submacular haemorrhage</span></p>"
        },
        {
          "id": 200039,
          "text": "<p><span style=\"font-size:12.0pt;\">﻿﻿﻿Premacular haemorrhage</span></p>"
        }
      ],
      "text": "<p><span style=\"font-size:12.0pt;\">A patient with a history of diabetes and hypertension underwent fundus fluorescein angiography (FFA) to evaluate his decreasing vision. The FFA yields an image as shown below. The given FFA is characteristic of which of the following? (</span>AIIMS Nov 2019)</p><p> </p><p><span style=\"font-size:12.0pt;\"><img src=\"https://cerebellum-web-static.s3.amazonaws.com/media/public/images/2023/04/29/picture1_lGMMpSl.jpg\" alt=\"\" width=\"300\" height=\"242\"></span></p><p><img src=\"https://cerebellum-web-static.s3.amazonaws.com/media/public/images/2023/04/29/picture1_lGMMpSl.jpg\" alt=\"Question Image\"></p>",
      "unique_key": "Q9827534",
      "question_audio": null,
      "question_video": null,
      "map_id": 34196594,
      "difficulty_level": "intermediate",
      "subjects_id": [],
      "solution": "<p><span style=\"font-size:12.0pt;\"><strong>Ans. A) Macular ischemia</strong></span></p><p> </p><ul><li><span style=\"font-size:12.0pt;\">The FFA image shows features suggestive of macular ischemia (see the images below).</span></li><li><span style=\"font-size:12.0pt;\">The image below shows pinpoint areas of hyper fluorescence and areas of fluorescein leakage in the disc region and elsewhere.</span></li></ul><p> </p><p><span style=\"font-size:12.0pt;\"><img src=\"https://cerebellum-web-static.s3.amazonaws.com/media/public/images/2023/10/07/untitled-320.jpg\" alt=\"\" width=\"400\" height=\"155\"></span></p><p> </p><ul><li><span style=\"font-size:12.0pt;\">The FFA is showing enlarged fovea avascular zone arrow (white arrow), and capillary non-perfused areas (blue arrow).</span></li><li><span style=\"font-size:12.0pt;\">Both of which are suggestive of macular ischemia which when combined with the history of diabetes in this patient points towards diabetic macular ischemia.</span></li></ul><p> </p><p><span style=\"font-size:12.0pt;\"><img src=\"https://cerebellum-web-static.s3.amazonaws.com/media/public/images/2023/10/07/untitled-319.jpg\" alt=\"\" width=\"900\" height=\"369\"></span></p><p> </p><p><span style=\"font-size:12.0pt;\"><strong>Other Options:</strong></span></p><p> </p><p><span style=\"font-size:12.0pt;\"><strong>Option B. Macular edema</strong>: shows the characteristic petaloid appearance.</span></p><p> </p><p><span style=\"font-size:12.0pt;\"><strong>Option C. Submacular/subretinal hemorrhage</strong>: obscure the choroidal dye visualization in the corresponding area, appearing similar to capillary non-perfusion but spreads across vascular zones without a defined pattern. The retinal vessels overlying the area would, however, be visualized.</span></p><p> </p><p><span style=\"font-size:12.0pt;\"><strong>Option D. Premacular hemorrhage/ vitreous hemorrhage</strong>: obscure the visualization of even retinal vasculature and would appear as a region of hypo fluorescence with no retinal vasculature visualization.</span></p><p> </p><p><span style=\"font-size:12.0pt;\"><strong>Educational Objective:</strong></span></p><p> </p><p><span style=\"font-size:12.0pt;\">Macular ischemia in diabetic patients can be identified in FFA images by an enlarged foveal avascular zone and visible areas of capillary non-perfusion, key indicators of decreased vascular supply to the macula.</span></p><p><img src=\"https://cerebellum-web-static.s3.amazonaws.com/media/public/images/2023/10/07/untitled-320.jpg\" alt=\"Solution Image\"></p>",
      "correct_choice_id": 200036,
      "solution_audio": null,
      "solution_video": null,
      "audio_explanation_heading": null,
      "video_explanation_heading": null,
      "solution_media_position": "bottom",
      "tags": [],
      "explanation_video": null,
      "question_images": [],
      "explanation_images": []
    },
    {
      "id": 50010,
      "choices": [
        {
          "id": 200040,
          "text": "<p><span style=\"font-size:12.0pt;\">Collagen</span></p>"
        },
        {
          "id": 200041,
          "text": "<p><span style=\"font-size:12.0pt;\">Mucin</span></p>"
        },
        {
          "id": 200042,
          "text": "<p><span style=\"font-size:12.0pt;\">Albumin</span></p>"
        },
        {
          "id": 200043,
          "text": "<p><span style=\"font-size:12.0pt;\">Immunoglobulin</span></p>"
        }
      ],
      "text": "<p><span style=\"font-size:12.0pt;\">Which of the following has protective as well as lubricating property? (</span>AIIMS Nov 2019)</p>",
      "unique_key": "Q7017451",
      "question_audio": null,
      "question_video": null,
      "map_id": 34639690,
      "difficulty_level": "intermediate",
      "subjects_id": [],
      "solution": "<p><span style=\"font-size:12.0pt;\"><strong>Ans. B) Mucin</strong></span></p><p> </p><p><span style=\"font-size:12.0pt;\">Mucins form a <strong>protective barrier on epithelial surfaces</strong>. They are also found in secretions of the gastrointestinal, respiratory and urogenital tract. They also have <strong>lubricating properties</strong>.</span></p><p> </p><p><span style=\"font-size:12.0pt;\"><strong>Functions of Mucin:</strong></span></p><ol><li><span style=\"font-size:12.0pt;\">Membrane-bound mucins participate in various cell-cell interactions.</span></li><li><span style=\"font-size:12.0pt;\">Protective barrier on epithelial surfaces.</span></li><li><span style=\"font-size:12.0pt;\">Lubricating properties.</span></li><li><span style=\"font-size:12.0pt;\">\"Mask\" certain surface antigens.</span></li><li><span style=\"font-size:12.0pt;\">Mucins also carry cancer-specific peptide and carbohydrate epitopes.</span></li></ol><p> </p><p><span style=\"font-size:12.0pt;\"><strong>Salient features of Mucin:</strong></span></p><ol style=\"list-style-type:upper-roman;\"><li><span style=\"font-size:12.0pt;\"><strong>Found in secretions</strong> of the gastrointestinal, respiratory, and reproductive tracts and also in membranes of various cells.</span></li><li><span style=\"font-size:12.0pt;\">Exhibit <strong>high content of O-glycan chains</strong>, usually containing NeuAc.</span></li><li><span style=\"font-size:12.0pt;\">Contain repeating amino acid sequences <strong>rich in serine, threonine, and proline</strong>.</span></li><li><span style=\"font-size:12.0pt;\">Extended structure contributes to their <strong>high viscoelasticity</strong>.</span></li></ol><p> </p><p><span style=\"font-size:12.0pt;\"><strong>Other Options:</strong></span></p><p> </p><p><span style=\"font-size:12.0pt;\"><strong>Option A. Collagen:</strong> Collagen provides structural support and strength to tissues but does not have significant lubricating properties.</span></p><p> </p><p><span style=\"font-size:12pt;\"><strong>Option C.</strong> </span><span style=\"font-size:12.0pt;\"><strong>Albumin:</strong> Albumin is a major plasma protein involved in maintaining osmotic pressure and transporting various substances but does not have lubricating properties.</span></p><p> </p><p><span style=\"font-size:12.0pt;\"><strong>Option D. Immunoglobulin:</strong> Immunoglobulins are antibodies that play a crucial role in immune response but do not provide lubrication.</span></p><p> </p><p><span style=\"font-size:12.0pt;\"><strong>Educational Objective:</strong></span></p><p><span style=\"font-size:10.5pt;\"><strong> </strong></span></p><p><span style=\"font-size:12.0pt;\">Mucins have both protective and lubricating properties, forming a barrier on epithelial surfaces and reducing friction in various body tracts. They are essential for maintaining the integrity and function of mucosal surfaces.</span></p>",
      "correct_choice_id": 200041,
      "solution_audio": null,
      "solution_video": null,
      "audio_explanation_heading": null,
      "video_explanation_heading": null,
      "solution_media_position": "bottom",
      "tags": [],
      "explanation_video": null,
      "question_images": [],
      "explanation_images": []
    },
    {
      "id": 50011,
      "choices": [
        {
          "id": 200044,
          "text": "<p><span style=\"font-size:12.0pt;\">Congenital</span></p>"
        },
        {
          "id": 200045,
          "text": "<p><span style=\"font-size:12.0pt;\">Idiopathic</span></p>"
        },
        {
          "id": 200046,
          "text": "<p><span style=\"font-size:12.0pt;\">Neuromuscular</span></p>"
        },
        {
          "id": 200047,
          "text": "<p><span style=\"font-size:12.0pt;\">Neurofibromatosis</span></p>"
        }
      ],
      "text": "<p style=\"text-align:justify;\"><span style=\"font-size:12.0pt;\">A patient presents with scoliosis. X-ray shown below. Identify the likely cause:(AIIMS NOV 2019)</span></p><p style=\"text-align:justify;\"> </p><p style=\"text-align:justify;\"><span style=\"font-size:12.0pt;\"><img src=\"https://cerebellum-web-static.s3.amazonaws.com/media/public/images/2024/01/17/picture18.jpg\" alt=\"\" width=\"300\" height=\"291\"></span></p><p style=\"margin-left:0;\"> </p><p><img src=\"https://cerebellum-web-static.s3.amazonaws.com/media/public/images/2024/01/17/picture18.jpg\" alt=\"Question Image\"></p>",
      "unique_key": "Q6394666",
      "question_audio": null,
      "question_video": null,
      "map_id": 34805680,
      "difficulty_level": "intermediate",
      "subjects_id": [],
      "solution": "<p><span style=\"font-size:12.0pt;\"><strong>Ans. A) Congenital</strong></span></p><p> </p><p><span style=\"font-size:12.0pt;\"><strong>Explanation:</strong></span></p><p> </p><p><span style=\"font-size:12.0pt;\"><strong>SCOLIOSIS</strong></span></p><p> </p><ul><li><span style=\"font-size:12.0pt;\">Scoliosis is characterized by <strong>lateral curvature of the spine associated with rotation of the involved vertebrae</strong>.</span></li><li><span style=\"font-size:12.0pt;\"><strong>There are four main categories of scoliosis:</strong></span><span style=\"font-size:11pt;\"> </span><ol><li><span style=\"font-size:12.0pt;\"><strong>Idiopathic: </strong>Idiopathic scoliosis accounts for around 80% of cases. It is more common in girls and typically develops around 10-12 years of age but can occur earlier. There is a genetic component, but the etiology is multifactorial.</span></li><li><span style=\"font-size:12.0pt;\"><strong>Congenital: </strong>Congenital scoliosis accounts for 5-7% of cases and is a result of vertebral abnormalities due to a failure of formation or segmentation of the affected vertebrae.</span></li><li><span style=\"font-size:12.0pt;\"><strong>Neuromuscular </strong>(associated with a neurological or muscular disease)</span></li><li><span style=\"font-size:12.0pt;\"><strong>Syndromic </strong>(associated with a known syndrome)</span></li></ol></li></ul><p> </p><p><span style=\"font-size:12.0pt;\"><strong>CONGENITAL SCOLIOSIS</strong></span></p><p> </p><ul><li><span style=\"font-size:12.0pt;\">Congenital scoliosis is the most frequent congenital deformity of the spine.</span></li><li><span style=\"font-size:12.0pt;\">Congenital curvatures are due to anomalous development of the vertebrae (failure of formation and/or segmentation).</span></li><li><span style=\"font-size:12.0pt;\">In most cases, congenital scolioses are non-hereditary.</span></li><li><span style=\"font-size:12.0pt;\">It is believed to be related to an insult to the fetus during spine embryological development (between the 5<sup>th</sup>-8<sup>th</sup> week of gestation).</span></li><li><span style=\"font-size:12.0pt;\">25% of curves are non-progressive, 25% mildly progressive and 50% highly progressive and will require treatment.</span></li><li><span style=\"font-size:12.0pt;\">The mainstay of treatment is either observation or surgery.</span></li><li><span style=\"font-size:12.0pt;\">The rigidity of the curve is assessed, and the rib hump measured.</span></li><li><span style=\"font-size:12.0pt;\">Associated malformations must be looked for clinically: look for foot or leg asymmetry, craniofacial malformation, a Klippel-Feil web neck, and cardiac and urinary malformations.</span></li><li><span style=\"font-size:12.0pt;\">Full-body-width Postero-anterior (PA) and lateral X-rays are essential.</span></li><li><span style=\"font-size:12.0pt;\">After 1 year of age, X-rays should be taken standing, with the legs in extension and the pelvis level, to compensate for any leg length discrepancy.</span></li><li><span style=\"font-size:12.0pt;\">The Cobb angle will be measured.</span></li><li><span style=\"font-size:12.0pt;\">CT scans shows a bony bar.</span></li><li><span style=\"font-size:12.0pt;\">Congenital scoliosis can be classified into defect of formation or defect of segmentation:</span><ul style=\"list-style-type:circle;\"><li><span style=\"font-size:12.0pt;\">Fully segmented hemivertebra (two growth plates) with a contralateral bar</span></li><li><span style=\"font-size:12.0pt;\">Unilateral unsegmented bar</span></li><li><span style=\"font-size:12.0pt;\">Two consecutives fully segmented hemivertebrae</span></li><li><span style=\"font-size:12.0pt;\">Fully segmented hemivertebra</span></li><li><span style=\"font-size:12.0pt;\">Semi segmented hemivertebra</span></li><li><span style=\"font-size:12.0pt;\">Wedge vertebra (partial failure of formation)</span></li><li><span style=\"font-size:12.0pt;\">Incarcerated hemivertebra (smaller and induce little deformity as the hemivertebra sits in a non-growing block; the alignment of the pedicles usually remains straight)</span></li></ul></li></ul><p> </p><p><span style=\"font-size:12.0pt;\"><img src=\"https://cerebellum-web-static.s3.amazonaws.com/media/public/images/2024/01/17/picture19.jpg\" alt=\"\" width=\"600\" height=\"225\"></span></p><p> </p><ul><li><span style=\"font-size:12.0pt;\"><strong>Treatment:</strong></span><ul><li><span style=\"font-size:12.0pt;\">Treatment consists of either observation of the curve or surgery, or, rarely, bracing.</span></li><li><span style=\"font-size:12.0pt;\">Observation should be applied only for non-progressive curves with a balanced spine.</span></li><li><span style=\"font-size:12.0pt;\">Bracing is inefficient in congenital scoliosis. It may be indicated for long flexible curves or to control the compensatory lumbar curve or help rebalancing the spine, or it may be used after an operation, for instance, until the fusion is solid.</span></li><li><span style=\"font-size:12.0pt;\">Surgery is the mainstay of care.</span></li><li><span style=\"font-size:12.0pt;\"><strong>Prophylactic surgery: </strong> surgery that will prevent further worsening or allow progressive correction over time. These operations are in situ fusion and hemi epiphysiodesis.</span></li><li><span style=\"font-size:12.0pt;\">In situ fusion can be done with a single posterior fusion, with or without instrumentation or with an anterior fusion, or a 360° fusion.</span></li></ul></li></ul><p> </p><p><span style=\"font-size:12.0pt;\"><img src=\"https://cerebellum-web-static.s3.amazonaws.com/media/public/images/2024/01/17/picture20_rZDtczB.jpg\" alt=\"\" width=\"400\" height=\"316\"></span></p><p> </p><ul><li><span style=\"font-size:12.0pt;\">Hemiepiphysiodesis tends to achieve progressive correction over time, taking advantage of the intact growth plates on the concave side of the deformity<strong>.</strong>  It has to be done ideally before the age of 5 to take advantage of the growth potential of the spine to allow a progressive correction of the deformity. It should not be carried out if there is a kyphosis component to the deformity.</span></li></ul><p> </p><p><span style=\"font-size:12.0pt;\"><strong>Other Options:</strong></span></p><p> </p><p style=\"text-align:justify;\"><span style=\"font-size:12.0pt;\"><strong>Option B. Idiopathic</strong>. Idiopathic scoliosis accounts for around 80% of cases. It is more common in girls and typically develops around 10-12 years of age, but can occur earlier. There is a genetic component, but the etiology is multifactorial. <strong>It is grouped by age. </strong>In children age 3 and younger, it is called infantile scoliosis. In age 4-10, it is called juvenile scoliosis. In age >10, it is called adolescent scoliosis. Structural curve becomes more prominent on forward bending (Adams test) as opposed to postural scoliosis. Compensatory curve due to limb length discrepancy or sciatic list (due to disc prolapsed) disappear on sitting.  Postural scoliosis disappears on forward bending.</span></p><p> </p><p style=\"text-align:justify;\"><span style=\"font-size:12.0pt;\"><strong>Option C. Neuromuscular</strong>. This type is caused by a nervous system problem such as <strong>cerebral palsy, muscular dystrophy, </strong>spina bifida, and <strong>polio. </strong>It may present at any age; and in many cases progresses relentlessly, particularly in patients with more severe neurologic and systemic involvement. Progressive deformity may limit mobility and seating status, and may be associated with primary or secondary effects on cardiopulmonary function over time. Management includes observation, non-operative interventions such as bracing, specialized seating systems, and surgery.</span></p><p> </p><p style=\"text-align:justify;\"><span style=\"font-size:12.0pt;\"><strong>Option D. Neurofibromatosis</strong>. It is hereditary, hamartomatous disorder, that affects central and peripheral nervous system, skeletal, skin and deeper soft tissue. It is one of the commonest single gene disorder affecting the skeletal system. Clinical presentation includes-<strong>cafe au lait spots </strong>(most common feature) axillary, and inguinal freckling (2nd m.c), cutaneous neurofibromas, plexiform neurofibromas (~5% are premalignant), Lisch nodule on iris, veruccous hyperplasia (thickened overgrown valvety soft skin), elephantiasis (pachy- dermatocele), optic glioma, skeletal abnormalities (scoliosis, congenital pseudoarthrosis of tibia, hemihypertrophy) and cognitive deficits (learning disability).</span></p><p> </p><p><span style=\"font-size:12.0pt;\"><strong>Educational Objective:</strong></span></p><p> </p><p><span style=\"font-size:12.0pt;\">The given image in the question shows hemivertebra and block vertebra, which are characteristic of congenital type of scoliosis.</span></p><p><img src=\"https://cerebellum-web-static.s3.amazonaws.com/media/public/images/2024/01/17/picture19.jpg\" alt=\"Solution Image\"></p>",
      "correct_choice_id": 200044,
      "solution_audio": null,
      "solution_video": null,
      "audio_explanation_heading": null,
      "video_explanation_heading": null,
      "solution_media_position": "bottom",
      "tags": [],
      "explanation_video": null,
      "question_images": [],
      "explanation_images": []
    },
    {
      "id": 50012,
      "choices": [
        {
          "id": 200048,
          "text": "<p><span style=\"font-size:12.0pt;\">Virus shedding is present before symptoms begins</span></p>"
        },
        {
          "id": 200049,
          "text": "<p><span style=\"font-size:12.0pt;\">5-12 years is a high-risk group</span></p>"
        },
        {
          "id": 200050,
          "text": "<p><span style=\"font-size:12.0pt;\">Aquatic birds act as reservoir</span></p>"
        },
        {
          "id": 200051,
          "text": "<p><span style=\"font-size:12.0pt;\">Secondary attack rate is 5-15%</span></p>"
        }
      ],
      "text": "<p><span style=\"font-size:12.0pt;\">Which of the following is false about influenza? (INICET NOV 2019)</span></p>",
      "unique_key": "Q6823211",
      "question_audio": null,
      "question_video": null,
      "map_id": 34379699,
      "difficulty_level": "intermediate",
      "subjects_id": [],
      "solution": "<p><span style=\"font-size:12.0pt;\"><strong>Ans. B) 5-12 years is a high-risk group</strong></span></p><p> </p><p><span style=\"font-size:12.0pt;\">People at greater risk of severe disease or complications when infected are:</span></p><p> </p><ol style=\"list-style-type:lower-alpha;\"><li><span style=\"font-size:12.0pt;\">pregnant women</span></li><li><span style=\"font-size:12.0pt;\">Children under 59 months</span></li><li><span style=\"font-size:12.0pt;\">Elderly</span></li><li><span style=\"font-size:12.0pt;\">Individuals with chronic medical conditions (such as chronic cardiac, pulmonary, renal, metabolic, neurodevelopmental, liver or hematologic diseases)</span></li><li><span style=\"font-size:12.0pt;\">Individuals with immunosuppressive conditions (such as HIV/AIDS, receiving chemotherapy or steroids, or malignancy).</span></li><li><span style=\"font-size:12.0pt;\">Health care workers are at high risk acquiring influenza virus infection due to increased exposure to the patients and risk further spread particularly to vulnerable individuals.</span></li></ol><p> </p><p><span style=\"font-size:12.0pt;\">Mode of transmission – <strong>droplet infection</strong></span></p><p> </p><p><span style=\"font-size:12.0pt;\">Incubation period – <strong>1 to 4 days</strong></span></p><p> </p><p><span style=\"font-size:12.0pt;\"><strong>Contagious period</strong> - About one day before developing any symptoms and up to seven days after the symptoms resolve.</span></p><p> </p><p><span style=\"font-size:12.0pt;\">Birds, especially <strong>aquatic birds act as reservoirs</strong> of influenza viruses. Avian influenza or bird flu refers to the disease caused by infection with avian (bird) influenza (flu) Type A viruses.</span></p><p> </p><p><span style=\"font-size:12.0pt;\"><u>The secondary attack rate (SAR</u>), defined as the probability that an infection occurs among susceptible people within a specific group (i.e., household or close contacts), can provide an indication of how social interactions relate to transmission risk. <strong>It is 5- 15% for influenza</strong>.</span></p><p> </p><p><span style=\"font-size:12.0pt;\"><strong>Other Options:</strong></span></p><p> </p><p><span style=\"font-size:12.0pt;\"><strong>Option A. Virus shedding is present before symptoms begin:</strong> This is true. Influenza can be contagious before symptoms appear, which contributes to its rapid spread.</span></p><p> </p><p><span style=\"font-size:12.0pt;\"><strong>Option C. Aquatic birds act as a reservoir:</strong> This is true. Birds, especially aquatic birds, act as reservoirs of influenza viruses. Avian influenza, or bird flu, refers to the disease caused by infection with avian (bird) influenza (flu) Type A viruses.</span></p><p> </p><p><span style=\"font-size:12.0pt;\"><strong>Option D. Secondary attack rate is 5-15%:</strong> This is true. The secondary attack rate (SAR) for influenza, defined as the probability that an infection occurs among susceptible people within a specific group (e.g., household or close contacts), is typically between 5-15%.</span></p><p> </p><p><span style=\"font-size:12.0pt;\"><strong>Educational Objective:</strong></span></p><p> </p><p><span style=\"font-size:12.0pt;\">Children under 5 years, pregnant women, the elderly, individuals with chronic medical conditions or immunosuppressive conditions, and health care workers are at greater risk of severe disease or complications from influenza. The 5-12 years age group is not specifically categorized as high-risk for severe disease from influenza.</span></p>",
      "correct_choice_id": 200049,
      "solution_audio": null,
      "solution_video": null,
      "audio_explanation_heading": null,
      "video_explanation_heading": null,
      "solution_media_position": "bottom",
      "tags": [],
      "explanation_video": null,
      "question_images": [],
      "explanation_images": []
    },
    {
      "id": 50013,
      "choices": [
        {
          "id": 200052,
          "text": "<p><span style=\"font-size:12.0pt;\">Viral Myositis</span></p>"
        },
        {
          "id": 200053,
          "text": "<p><span style=\"font-size:12.0pt;\">Duchenne</span></p>"
        },
        {
          "id": 200054,
          "text": "<p><span style=\"font-size:12.0pt;\">GBS</span></p>"
        },
        {
          "id": 200055,
          "text": "<p><span style=\"font-size:12.0pt;\">Dermatomyositis</span></p>"
        }
      ],
      "text": "<p><span style=\"font-size:12.0pt;\">A 7-year-old child presents with leg pain. She had fever and cough 3 days prior. Currently, there is pain on palpation of the calf muscles. Reflexes and other clinical examinations are normal. Lab test reveals CK levels of 2000 IU. What is the likely diagnosis? (AIIMS NOV 2019)</span></p>",
      "unique_key": "Q9145431",
      "question_audio": null,
      "question_video": null,
      "map_id": 34852919,
      "difficulty_level": "intermediate",
      "subjects_id": [],
      "solution": "<p><span style=\"font-size:12.0pt;\"><strong>Ans. A) Viral myositis</strong></span></p><p> </p><p><span style=\"font-size:12.0pt;\">The clinical presentation described is most consistent with <strong>viral myositis</strong>. Viral myositis is an inflammation of the muscles caused by viral infection, often following an upper respiratory tract illness. The condition is characterized by the following features:</span></p><p> </p><ul><li><span style=\"font-size:12.0pt;\"><strong>Recent viral illness:</strong> The history of fever and cough 3 days prior suggests a preceding viral infection, which is a common trigger for viral myositis.</span></li><li><span style=\"font-size:12.0pt;\"><strong>Leg pain and muscle tenderness:</strong> Viral myositis often presents with significant muscle soreness, especially in the calf muscles, leading to pain on palpation.</span></li><li><span style=\"font-size:12.0pt;\"><strong>Elevated creatine kinase (CK) levels:</strong> The CK level of 2000 IU indicates muscle injury or inflammation, which is consistent with viral myositis.</span></li><li><span style=\"font-size:12.0pt;\"><strong>Normal reflexes and neurological examination:</strong> This helps differentiate viral myositis from other conditions like Guillain-Barré Syndrome (GBS) or Duchenne muscular dystrophy, which would typically present with abnormal reflexes or progressive muscle weakness.</span></li></ul><p> </p><p><span style=\"font-size:12.0pt;\"><strong>Influenza</strong> is a common viral cause of myositis, particularly in children. The muscle pain typically begins 1-7 days after the onset of the viral illness and may lead to difficulty walking, often with a characteristic toe-walking gait due to involvement of the gastrocnemius-soleus muscles.</span></p><p> </p><p><span style=\"font-size:12.0pt;\"><strong>Other Options:</strong></span></p><p> </p><p><span style=\"font-size:12.0pt;\"><strong>Option B. Duchenne:</strong> Duchenne muscular dystrophy is a genetic disorder characterized by progressive muscle degeneration and weakness, typically presenting with proximal muscle weakness, calf pseudohypertrophy, and elevated CK levels. However, it does not present acutely following a viral illness and usually starts earlier in life.</span></p><p> </p><p><span style=\"font-size:12.0pt;\"><strong>Option C. GBS (Guillain-Barré Syndrome):</strong> GBS is an autoimmune condition that causes ascending paralysis, starting with weakness in the legs. Reflexes are usually diminished or absent in GBS, unlike the normal reflexes observed in this case.</span></p><p> </p><p><span style=\"font-size:12.0pt;\"><strong>Option D. Dermatomyositis:</strong> Dermatomyositis is an inflammatory muscle disease characterized by muscle weakness and a distinctive skin rash. It usually presents with chronic, progressive weakness rather than acute pain following a viral illness.</span></p><p> </p><p><span style=\"font-size:12.0pt;\"><strong>Educational Objective:</strong></span></p><p> </p><p><span style=\"font-size:12.0pt;\">Viral myositis is characterized by muscle pain, especially in the calves, following a viral infection, with elevated CK levels and normal reflexes, distinguishing it from other neuromuscular conditions.</span></p>",
      "correct_choice_id": 200052,
      "solution_audio": null,
      "solution_video": null,
      "audio_explanation_heading": null,
      "video_explanation_heading": null,
      "solution_media_position": "bottom",
      "tags": [],
      "explanation_video": null,
      "question_images": [],
      "explanation_images": []
    },
    {
      "id": 50014,
      "choices": [
        {
          "id": 200056,
          "text": "<p><span style=\"font-size:12pt;\">Melasma</span></p>"
        },
        {
          "id": 200057,
          "text": "<p><span style=\"font-size:12pt;\">Fixed drug eruption</span></p>"
        },
        {
          "id": 200058,
          "text": "<p><span style=\"font-size:12pt;\">Lichen planus</span></p>"
        },
        {
          "id": 200059,
          "text": "<p><span style=\"font-size:12pt;\">Chikungunya</span></p>"
        }
      ],
      "text": "<p><span style=\"font-size:12.0pt;\">The patient developed pigmentation on the nose after experiencing fever and joint pain, which appeared shortly after taking NSAIDs as shown below. What would be the likely diagnosis in this case? (</span><span style=\"background-color:rgb(255,255,255);color:rgb(111,126,149);font-size:14px;\">AIIMS Nov 2019)</span></p><p> </p><p><img src=\"https://cerebellum-web-static.s3.amazonaws.com/media/public/images/2023/08/19/untitled-13541.jpg\" alt=\"\" width=\"400\" height=\"155\"></p><p><img src=\"https://cerebellum-web-static.s3.amazonaws.com/media/public/images/2023/08/19/untitled-13541.jpg\" alt=\"Question Image\"></p>",
      "unique_key": "Q6652251",
      "question_audio": null,
      "question_video": null,
      "map_id": 34264863,
      "difficulty_level": "intermediate",
      "subjects_id": [],
      "solution": "<p><span style=\"font-size:12pt;\"><strong>Ans. D) Chikungunya</strong></span></p><p> </p><ul><li><span style=\"font-size:12pt;\">The patient's medical history is indicative of a potential diagnosis of <strong>Chikungunya (CKG)</strong> infection.</span></li><li><span style=\"font-size:12pt;\">Chikungunya is a <strong>mosquito-borne viral</strong> illness presenting with <strong>fever, joint pain,</strong> and potential rash.</span></li></ul><p> </p><p><img src=\"https://cerebellum-web-static.s3.amazonaws.com/media/public/images/2024/06/18/screenshot-2024-06-18-131002.png\" alt=\"\" width=\"300\" height=\"227\"></p><p> </p><p><span style=\"font-size:12pt;\"><strong>Fig: Nose pigmentation</strong></span></p><p> </p><p><span style=\"font-size:12pt;\"><strong>IMAGE DEPICTING CHIK SIGN</strong></span></p><p> </p><ul><li><span style=\"font-size:12pt;\">It can cause skin <strong>hyperpigmentation</strong>, especially on the <strong>nose and cheeks</strong>, known as the <strong>\"Chik sign.\"</strong></span></li><li><span style=\"font-size:12pt;\">The \"Chik sign\" is <strong>distinctive to Chikungunya</strong> and is not usually seen with other viral infections.</span></li><li><span style=\"font-size:12pt;\">The <strong>nose</strong> pigmentation may last <strong>three to six months</strong> post-infection, aiding in <strong>clinical and retrospective diagnosis</strong>.</span></li><li><span style=\"font-size:12pt;\">This pigmentation pattern serves as a <strong>clinical marker</strong> for Chikungunya infection.</span></li></ul><p> </p><p><span style=\"font-size:12pt;\"><strong>Other Options:</strong></span></p><p> </p><p><span style=\"font-size:12pt;\"><strong>Option A. Melasma</strong>:</span></p><p> </p><p><span style=\"font-size:12pt;\">Typically presents as <strong>symmetric brown</strong> patches on the face, especially the <strong>cheeks, bridge of the nose, forehead, chin, and above the upper lip</strong> as shown in the image below.</span></p><p> </p><p><span style=\"font-size:12pt;\"><img src=\"https://cerebellum-web-static.s3.amazonaws.com/media/public/images/2024/06/18/screenshot-2024-06-18-131147.png\" alt=\"\" width=\"300\" height=\"200\"></span></p><p> </p><p><span style=\"font-size:12pt;\">It is often triggered by <strong>sun exposure</strong> or <strong>hormonal changes</strong>, such as <strong>pregnancy</strong> or use of <strong>oral contraceptives</strong>.</span></p><p> </p><p><span style=\"font-size:12pt;\"><strong>Option B. Fixed drug eruption (FDE)</strong>:</span></p><p> </p><ul><li><span style=\"font-size:12pt;\">It is a type of <strong>allergic</strong> reaction to <strong>medications</strong>. It presents as well-demarcated, round, or oval patches of <strong>redness a</strong>nd s<strong>welling</strong> that can later become <strong>brown</strong>.</span></li><li><span style=\"font-size:12pt;\">However, FDEs are typically r<strong>ecurrent</strong> in the <strong>same location</strong> when the offending <strong>drug is taken again</strong>, and the presentation isn't specifically associated with the symptoms described.</span></li></ul><p> </p><p><span style=\"font-size:12pt;\"><strong>Option C. Lichen planus:</strong></span></p><p> </p><ul><li><span style=\"font-size:12pt;\">Lichen planus is an <strong>inflammatory</strong> condition that affects the <strong>skin and mucous</strong> membranes, presenting as <strong>itchy, purple, polygonal, flat-topped papules</strong>.</span></li><li><span style=\"font-size:12pt;\">It is <strong>not</strong> usually <strong>associated</strong> with the intake of <strong>NSAIDs</strong> and the subsequent appearance of <strong>pigmented lesions</strong> in the described manner.</span></li></ul><p> </p><p><span style=\"font-size:12pt;\"><strong>Educational Objective:</strong></span></p><p> </p><p><span style=\"font-size:12pt;\">In the context of <strong>fever, body ache, and joint pain</strong>, followed by the development of <strong>brownish pigmentation</strong> on the nose, <strong>Chikungunya</strong> is the probable diagnosis, as it can present with persistent <strong>joint pain</strong> and <strong>hyperpigmentation,</strong> particularly in regions where the virus is <strong>endemic.</strong></span></p><p><img src=\"https://cerebellum-web-static.s3.amazonaws.com/media/public/images/2024/06/18/screenshot-2024-06-18-131002.png\" alt=\"Solution Image\"></p>",
      "correct_choice_id": 200059,
      "solution_audio": null,
      "solution_video": null,
      "audio_explanation_heading": null,
      "video_explanation_heading": null,
      "solution_media_position": "bottom",
      "tags": [],
      "explanation_video": null,
      "question_images": [],
      "explanation_images": []
    },
    {
      "id": 50015,
      "choices": [
        {
          "id": 200060,
          "text": "<p><span style=\"font-size:12.0pt;\">Right coronary artery</span></p>"
        },
        {
          "id": 200061,
          "text": "<p><span style=\"font-size:12.0pt;\">Anterior interventricular artery</span></p>"
        },
        {
          "id": 200062,
          "text": "<p><span style=\"font-size:12.0pt;\">Marginal artery</span></p>"
        },
        {
          "id": 200063,
          "text": "<p><span style=\"font-size:12.0pt;\">Diagonal artery</span></p>"
        }
      ],
      "text": "<p><span style=\"font-size:12.0pt;\">All of the following supply the structure marked ‘E’ except? (</span>AIIMS Nov 2019)</p><p> </p><p><span style=\"font-size:12.0pt;\"><img src=\"https://cerebellum-web-static.s3.amazonaws.com/media/public/images/2023/11/10/21.jpg\" alt=\"\" width=\"300\" height=\"199\"></span></p><p><img src=\"https://cerebellum-web-static.s3.amazonaws.com/media/public/images/2023/11/10/21.jpg\" alt=\"Question Image\"></p>",
      "unique_key": "Q4449865",
      "question_audio": null,
      "question_video": null,
      "map_id": 34196857,
      "difficulty_level": "intermediate",
      "subjects_id": [],
      "solution": "<p><span style=\"font-size:12.0pt;\"><strong>Ans. D. Diagonal artery</strong></span></p><p> </p><p><span style=\"font-size:12.0pt;\">The right ventricle is the marked object. The diagonal arterial supply does not reach it.</span></p><p> </p><p><span style=\"font-size:12.0pt;\">The anterior interventricular artery, which supplies the left ventricle, has a branch called the diagonal artery. Between 30 to 50 percent of the population has this.</span></p><p> </p><p><span style=\"font-size:12.0pt;\">The right coronary artery and its branches, including the marginal artery, provide the right ventricle with the majority of its blood.</span></p><p> </p><p><span style=\"font-size:12.0pt;\">One or two anterior right ventricular branches emerge from the anterior interventricular artery.</span></p><p> </p><p><span style=\"font-size:12.0pt;\"><img src=\"https://cerebellum-web-static.s3.amazonaws.com/media/public/images/2023/05/03/ia-84.jpg\" alt=\"\" width=\"500\" height=\"446\"></span></p><p> </p><p><span style=\"font-size:12.0pt;\"><strong>Other Options:</strong></span></p><p> </p><p><span style=\"font-size:12.0pt;\"><strong>Option A. Right coronary artery: </strong>This is correct in terms of not being an exception. The right coronary artery primarily supplies the right atrium and the right ventricle, including the structure marked as 'E', which is the right ventricle.</span></p><p> </p><p><span style=\"font-size:12.0pt;\"><strong>Option B. Anterior interventricular artery:</strong> This artery primarily supplies the interventricular septum and the anterior walls of both ventricles. Although it predominantly serves the left ventricle, it also sends branches such as the anterior right ventricular branches that can reach the right ventricle.</span></p><p> </p><p><span style=\"font-size:12.0pt;\"><strong>Option C. Marginal artery:</strong> This artery, a branch of the right coronary artery, specifically supplies the right ventricle, which is the structure marked as 'E'.</span></p><p> </p><p><span style=\"font-size:12.0pt;\"><strong>Educational Objective:</strong></span></p><p> </p><p><span style=\"font-size:12.0pt;\">Understanding the vascular supply of the heart is crucial, especially in clinical settings dealing with coronary artery disease. The right ventricle is primarily supplied by the right coronary artery and its branches, including the marginal artery. The diagonal artery, a branch of the left coronary system (specifically the anterior interventricular artery), mainly supplies the left ventricle and does not contribute significantly to the blood supply of the right ventricle.</span></p><p><img src=\"https://cerebellum-web-static.s3.amazonaws.com/media/public/images/2023/05/03/ia-84.jpg\" alt=\"Solution Image\"></p>",
      "correct_choice_id": 200063,
      "solution_audio": null,
      "solution_video": null,
      "audio_explanation_heading": null,
      "video_explanation_heading": null,
      "solution_media_position": "bottom",
      "tags": [],
      "explanation_video": null,
      "question_images": [],
      "explanation_images": []
    },
    {
      "id": 50016,
      "choices": [
        {
          "id": 200064,
          "text": "<p style=\"margin-right:3px\"><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span style=\"font-size:12.0pt\">Involves degranulation of mast cells</span></span></span></p>"
        },
        {
          "id": 200065,
          "text": "<p style=\"margin-right:3px\"><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span style=\"font-size:12.0pt\">IgE mediated</span></span></span></p>"
        },
        {
          "id": 200066,
          "text": "<p style=\"margin-right:3px\"><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span style=\"font-size:12.0pt\">Can occur on first exposure</span></span></span></p>"
        },
        {
          "id": 200067,
          "text": "<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span style=\"font-size:12.0pt\">Most commonly caused by NSAIDs</span></span></span></p>"
        }
      ],
      "text": "<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span style=\"font-size:12.0pt\">True about anaphylactoid reaction are all except: </span></span></span><span style=\"font-size:12.0pt\"><span style=\"font-family:\"Calibri\",sans-serif\">(AIIMS NOV 2019)</span></span></p>",
      "unique_key": "Q7447858",
      "question_audio": null,
      "question_video": null,
      "map_id": 34649745,
      "difficulty_level": "intermediate",
      "subjects_id": [],
      "solution": "<p style=\"margin-right:3px\"><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\">Ans. B) IgE mediated</span></strong></span></span></p>\r\n\r\n<p style=\"margin-right:3px\"> </p>\r\n\r\n<ul>\r\n\t<li><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\">Anaphylactoid reactions are defined as those reactions that produce the same clinical picture with anaphylaxis but are <strong>not IgE mediated</strong>, occur through a <strong>direct nonimmune-mediated release of mediators from mast cells</strong> and/or basophils or result from direct complement activation.</span></span></span></li>\r\n\t<li><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\">Unlike the classic anaphylaxis which occurs on re-exposure to the allergen, the anaphylactoid reaction can occur even on the first exposure</span></strong><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\">. The most common agents that can cause an anaphylactoid reaction include NSAIDs and radiocontrast media.</span></span></span></li>\r\n</ul>\r\n\r\n<p style=\"margin-right:3px\"> </p>\r\n\r\n<p style=\"margin-right:3px\"><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\">According to World allergy organization (WAO) anaphylaxis guidance 2020</span></span></span></p>\r\n\r\n<p style=\"margin-right:3px\"> </p>\r\n\r\n<p style=\"margin-right:3px\"><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\">IgE-mediated anaphylaxis</span></strong><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\"> is considered the classic and most frequent mechanism. In this type, anaphylaxis is triggered by the interaction of an allergen (usually a protein) interacting with the allergen-specific IgE/high-affinity receptor (FcεRI) complex expressed on effector cells, predominantly mast cells and basophils. This initiates intracellular signaling resulting in the release of preformed and de novo synthesis of mediators.</span></span></span></p>\r\n\r\n<p style=\"margin-right:3px\"> </p>\r\n\r\n<p style=\"margin-right:3px\"><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\">Non–IgE-mediated anaphylaxis</span></strong><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\"> may be immunologic or non-immunologic</span></span></span></p>\r\n\r\n<p style=\"margin-right:3px\"> </p>\r\n\r\n<ul>\r\n\t<li><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\">Non-IgE-mediated immunologic mechanisms may involve the activation of pathways such as the complement system (anaphylatoxins, C3a, and C5a), the contact and coagulation system activation or immunoglobulin G (IgG)- mediated anaphylaxis. </span></span></span></li>\r\n\t<li><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\">Non-immunologic mechanisms have been described for some drugs (opioids). Ethanol and physical factors, such as exercise, may be involved in triggering anaphylaxis through mechanisms which are not fully elucidated. Mast cells may be activated through receptors by certain drugs such as neuromuscular blocking agents and fluoroquinolones.</span></span></span></li>\r\n</ul>\r\n\r\n<p style=\"margin-right:3px\"> </p>\r\n\r\n<p style=\"margin-right:3px\"><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span style=\"font-size:12.0pt\">Other Options:</span></strong></span></span></p>\r\n\r\n<p style=\"margin-right:3px\"> </p>\r\n\r\n<p style=\"margin-right:3px\"><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\">Option A. Involves degranulation of mast cells:</span></strong><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\"> This is true for both anaphylaxis and anaphylactoid reactions, where mast cells release histamine and other mediators, leading to the symptoms.</span></span></span></p>\r\n\r\n<p style=\"margin-right:3px\"> </p>\r\n\r\n<p style=\"margin-right:3px\"><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\">Option C. Can occur on first exposure:</span></strong><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\"> This is true for anaphylactoid reactions, as they do not require prior exposure or sensitization to the allergen.</span></span></span></p>\r\n\r\n<p style=\"margin-right:3px\"> </p>\r\n\r\n<p style=\"margin-right:3px\"><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\">Option D. Most commonly caused by NSAIDs:</span></strong><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\"> This is true. NSAIDs are a common cause of anaphylactoid reactions, which can occur without prior exposure.</span></span></span></p>\r\n\r\n<p style=\"margin-right:3px\"> </p>\r\n\r\n<p style=\"margin-right:3px\"><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span style=\"font-size:12.0pt\">Educational Objective:</span></strong></span></span></p>\r\n\r\n<p style=\"margin-right:3px\"> </p>\r\n\r\n<p style=\"margin-right:3px\"><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\">Anaphylactoid reactions are not <strong>IgE-mediated</strong> and can occur on first exposure to the triggering substance, with NSAIDs being one of the common causes.</span></span></span></p>",
      "correct_choice_id": 200065,
      "solution_audio": null,
      "solution_video": null,
      "audio_explanation_heading": null,
      "video_explanation_heading": null,
      "solution_media_position": "bottom",
      "tags": [],
      "explanation_video": null,
      "question_images": [],
      "explanation_images": []
    },
    {
      "id": 50017,
      "choices": [
        {
          "id": 200068,
          "text": "<p><span style=\"font-size:12.0pt;\">Pudendal nerve</span></p>"
        },
        {
          "id": 200069,
          "text": "<p><span style=\"font-size:12.0pt;\">Sciatic nerve</span></p>"
        },
        {
          "id": 200070,
          "text": "<p><span style=\"font-size:12.0pt;\">Obturator nerve</span></p>"
        },
        {
          "id": 200071,
          "text": "<p><span style=\"font-size:12.0pt;\">Femoral nerve</span></p>"
        }
      ],
      "text": "<p><span style=\"font-size:12.0pt;\">Which of the following structures given below is related to the structure highlighted green in image? (</span>AIIMS Nov 2019)</p><p> </p><p style=\"text-align:justify;\"><span style=\"font-size:12.0pt;\"><img src=\"https://cerebellum-web-static.s3.amazonaws.com/media/public/images/2023/05/03/ia-65.jpg\" alt=\"\" width=\"250\" height=\"259\"></span></p><p><img src=\"https://cerebellum-web-static.s3.amazonaws.com/media/public/images/2023/05/03/ia-65.jpg\" alt=\"Question Image\"></p>",
      "unique_key": "Q9369281",
      "question_audio": null,
      "question_video": null,
      "map_id": 34863511,
      "difficulty_level": "intermediate",
      "subjects_id": [],
      "solution": "<p><span style=\"font-size:12.0pt;\"><strong>Ans. A. Pudendal nerve</strong></span></p><p> </p><p><span style=\"font-size:12.0pt;\"><strong>Explanation:</strong></span></p><p> </p><p><span style=\"font-size:12.0pt;\">The structure marked in green is the ischial spine and the pudendal nerve is related to it.</span></p><p> </p><p><span style=\"font-size:12.0pt;\">The ischial spine is a bony projection from the posterior part of the ischium in the pelvis</span></p><p> </p><p><span style=\"font-size:12.0pt;\">The pudendal nerve originates from the sacral plexus S2-S4. It exits out of the pelvis by passing through the greater sciatic foramen. It then enters the perineum below the pelvic floor by passing around the ischial spine. The ischial spine is used as a landmark for pudendal nerve block.</span></p><p> </p><p><span style=\"font-size:12.0pt;\"><img src=\"https://cerebellum-web-static.s3.amazonaws.com/media/public/images/2023/05/03/ia-66.jpg\" alt=\"\" width=\"500\" height=\"378\"></span></p><p> </p><ol><li><span style=\"font-size:12.0pt;\">Sensory function: The pudendal nerve provides sensation to the external genitalia, perineum, and anus.</span></li><li><span style=\"font-size:12.0pt;\">Motor function: The pudendal nerve also supplies motor function to the pelvic floor muscles, including the external anal sphincter, bulbospongiosus muscle, and ischiocavernosus muscle.</span></li><li><span style=\"font-size:12.0pt;\">Sexual function: The pudendal nerve plays a crucial role in sexual function by supplying motor and sensory innervation to the genital organs.</span></li><li><span style=\"font-size:12.0pt;\">Urinary and fecal continence: The pudendal nerve is involved in maintaining urinary and fecal continence by controlling the external anal sphincter muscle. Damage to the pudendal nerve can lead to incontinence, which is the loss of control over urinary or fecal elimination.Top of Form</span></li></ol><p> </p><p> </p><p><span style=\"font-size:12.0pt;\"><strong>Other Options:</strong></span></p><p> </p><p><span style=\"font-size:12.0pt;\"><strong>Option B. Sciatic nerve:</strong> The sciatic nerve is the largest nerve in the body and originates from the sacral plexus (L4-S3). It exits the pelvis through the greater sciatic foramen, below the piriformis muscle. While it is near the ischial spine, it descends posteriorly down the thigh, dividing into the tibial and common fibular (peroneal) nerves. It provides motor and sensory innervation to the posterior thigh and most of the leg and foot. Its relation to the ischial spine is less clinically significant than the pudendal nerve's.</span></p><p> </p><p><span style=\"font-size:12.0pt;\"><strong>Option C. Obturator nerve:</strong> The obturator nerve arises from the lumbar plexus (L2-L4). It exits the pelvis through the obturator foramen and provides sensory and motor innervation to the medial thigh. In terms of its relationship to the ischial spine, it is anatomically distinct, as it courses more anteriorly in the pelvis, and it doesn't have significant clinical associations with the ischial spine.</span></p><p> </p><p><span style=\"font-size:12.0pt;\"><strong>Option D. Femoral nerve:</strong> The femoral nerve also originates from the lumbar plexus (L2-L4). It descends through the psoas muscle and enters the thigh beneath the inguinal ligament. It provides motor innervation to the anterior thigh muscles and sensory innervation to the anterior thigh and medial leg. The femoral nerve's course is anterior in the pelvis, and it doesn't have a direct relationship or significant clinical association with the ischial spine.</span></p><p> </p><p><span style=\"font-size:12.0pt;\"><strong>Educational Objective:</strong></span></p><p> </p><p><span style=\"font-size:12.0pt;\">The pudendal nerve arises from the sacral plexus (S2-S4 nerve roots). It exits the pelvis through the greater sciatic foramen, just inferior to the piriformis muscle. It then courses around the ischial spine and re-enters the pelvis through the lesser sciatic foramen. The pudendal nerve provides sensory and motor innervation to the perineal region and external genitalia. Due to its proximity to the ischial spine, the pudendal nerve can be blocked for pain relief during childbirth and certain surgical procedures in the perineal region.</span></p><p><img src=\"https://cerebellum-web-static.s3.amazonaws.com/media/public/images/2023/05/03/ia-66.jpg\" alt=\"Solution Image\"></p>",
      "correct_choice_id": 200068,
      "solution_audio": null,
      "solution_video": null,
      "audio_explanation_heading": null,
      "video_explanation_heading": null,
      "solution_media_position": "bottom",
      "tags": [],
      "explanation_video": null,
      "question_images": [],
      "explanation_images": []
    },
    {
      "id": 50018,
      "choices": [
        {
          "id": 200072,
          "text": "<p><span style=\"font-size:12.0pt;\">Oculomotor nerve</span></p>"
        },
        {
          "id": 200073,
          "text": "<p><span style=\"font-size:12.0pt;\">Trochlear nerve</span></p>"
        },
        {
          "id": 200074,
          "text": "<p><span style=\"font-size:12.0pt;\">Trigeminal nerve</span></p>"
        },
        {
          "id": 200075,
          "text": "<p><span style=\"font-size:12.0pt;\">Abducens nerve</span></p>"
        }
      ],
      "text": "<p><span style=\"font-size:12.0pt;\">What is the nerve supply of the structure marked by red arrow in the image below? (</span>AIIMS Nov 2019)</p><p> </p><p><img src=\"https://cerebellum-web-static.s3.amazonaws.com/media/public/images/2023/11/10/22.jpg\" alt=\"\" width=\"300\" height=\"253\"></p><p><img src=\"https://cerebellum-web-static.s3.amazonaws.com/media/public/images/2023/11/10/22.jpg\" alt=\"Question Image\"></p>",
      "unique_key": "Q3788958",
      "question_audio": null,
      "question_video": null,
      "map_id": 34219063,
      "difficulty_level": "intermediate",
      "subjects_id": [],
      "solution": "<p><span style=\"font-size:12.0pt;\"><strong>Ans. B. Trochlear nerve</strong></span></p><p> </p><p><span style=\"font-size:12.0pt;\"><strong>Explanation:</strong></span></p><p> </p><p><span style=\"font-size:12.0pt;\">The structure marked in the image is the superior oblique muscle. It is innervated by the trochlear nerve.</span></p><p> </p><p><img src=\"https://cerebellum-web-static.s3.amazonaws.com/media/public/images/2023/11/10/23.jpg\" alt=\"\" width=\"500\" height=\"354\"></p><p> </p><p><span style=\"font-size:12.0pt;\">There are seven extraocular muscles present in the eye. They are:</span></p><p> </p><ul><li><span style=\"font-size:12.0pt;\">Levator palpebrae superioris - Which elevates the upper eyelids</span></li><li><span style=\"font-size:12.0pt;\">Four recti muscles - Superior, inferior, medial, and lateral recti</span></li><li><span style=\"font-size:12.0pt;\">Two obliques - Superior and inferior oblique</span></li></ul><p> </p><p><span style=\"font-size:12.0pt;\">The muscles originate from the back of the orbit in a common tendinous ring called the annulus of Zinn and are inserted into the sclera.</span></p><p> </p><p><span style=\"font-size:12.0pt;\"><strong>All the extraocular muscles are innervated by the oculomotor (III) except Superior Oblique (Trochlear nerve, IV) and Lateral rectus (Abducens, VI)</strong></span></p><p> </p><p><span style=\"font-size:12.0pt;\"><strong>Other Options:</strong></span></p><p> </p><p><span style=\"font-size:12.0pt;\"><strong>Option A. Oculomotor nerve:</strong> This nerve innervates most of the extraocular muscles except for the superior oblique and the lateral rectus. It does not innervate the structure marked in the image, which is the superior oblique muscle.</span></p><p> </p><p><span style=\"font-size:12.0pt;\"><strong>Option C. Trigeminal nerve:</strong> This nerve primarily provides sensory innervation to the face and does not innervate any of the extraocular muscles, including the superior oblique.</span></p><p> </p><p><span style=\"font-size:12.0pt;\"><strong>Option D. Abducens nerve:</strong> This nerve innervates the lateral rectus muscle only, which abducts the eye. It does not innervate the superior oblique muscle.</span></p><p> </p><p><span style=\"font-size:12.0pt;\"><strong>Educational Objective:</strong></span></p><p> </p><p><span style=\"font-size:12.0pt;\">The superior oblique muscle, is uniquely innervated by the trochlear nerve (cranial nerve IV), which is the only cranial nerve that exits the brainstem dorsally. This muscle functions to depress, abduct, and internally rotate the eyeball, and it is the only extraocular muscle innervated by the trochlear nerve. Remembering this specific innervation is crucial for diagnosing and managing ocular motility disorders.</span></p><p><img src=\"https://cerebellum-web-static.s3.amazonaws.com/media/public/images/2023/11/10/23.jpg\" alt=\"Solution Image\"></p>",
      "correct_choice_id": 200073,
      "solution_audio": null,
      "solution_video": null,
      "audio_explanation_heading": null,
      "video_explanation_heading": null,
      "solution_media_position": "bottom",
      "tags": [],
      "explanation_video": null,
      "question_images": [],
      "explanation_images": []
    },
    {
      "id": 50019,
      "choices": [
        {
          "id": 200076,
          "text": "<p><span style=\"font-size:12.0pt;\">b → c → d → a</span></p>"
        },
        {
          "id": 200077,
          "text": "<p><span style=\"font-size:12.0pt;\">c → d → a → b</span></p>"
        },
        {
          "id": 200078,
          "text": "<p><span style=\"font-size:12.0pt;\">a → c → b → d</span></p>"
        },
        {
          "id": 200079,
          "text": "<p><span style=\"font-size:12.0pt;\">b → d → a → c</span></p>"
        }
      ],
      "text": "<p><span style=\"font-size:12.0pt;\">Steps of surgery of DDH in a child < 2 years:(AIIMS NOV 2019)</span></p><p> </p><ol style=\"list-style-type:lower-alpha;\"><li><span style=\"font-size:12.0pt;\">Capsulotomy</span></li><li><span style=\"font-size:12.0pt;\">Femoral osteotomy</span></li><li><span style=\"font-size:12.0pt;\">Identification of true acetabulum using round ligament</span></li><li><span style=\"font-size:12.0pt;\">Placing the head back into acetabulum</span></li></ol>",
      "unique_key": "Q1559269",
      "question_audio": null,
      "question_video": null,
      "map_id": 34990569,
      "difficulty_level": "intermediate",
      "subjects_id": [],
      "solution": "<p><span style=\"color:black;font-size:14.0pt;\"><strong>Ans. C) a → c → b → d</strong></span></p><p> </p><p><span style=\"color:black;font-size:14.0pt;\"><strong>DEVELOPMENTAL DYSPLASIA OF HIP (DDH)</strong></span></p><p> </p><ul style=\"list-style-type:disc;\"><li><span style=\"color:black;font-size:14.0pt;\">This is a spontaneous dislocation of the hip occurring before, during or shortly after birth.</span></li><li><span style=\"color:black;font-size:14.0pt;\">DDH is failure of maintenance of femoral head due to malformations of acetabulum or femur.</span></li><li><span style=\"color:black;font-size:14.0pt;\">More common in girls usually seen on left side.</span></li></ul><p> </p><p><span style=\"color:black;font-size:14.0pt;\"><img src=\"https://cerebellum-web-static.s3.amazonaws.com/media/public/Screenshot%202025-08-11%20165051.jpeg\" width=\"795\" height=\"454\"></span></p><p> </p><p><span style=\"color:black;font-size:14.0pt;\"><img src=\"https://cerebellum-web-static.s3.amazonaws.com/media/public/Screenshot%202025-08-11%20165112.jpeg\" width=\"763\" height=\"442\"></span></p><p> </p><p><span style=\"color:black;font-size:14.0pt;\"><img src=\"https://cerebellum-web-static.s3.amazonaws.com/media/public/Screenshot%202025-08-11%20165126.jpeg\" width=\"786\" height=\"394\"></span></p><p> </p><ul style=\"list-style-type:square;\"><li><p><span style=\"color:black;font-size:14.0pt;\"><strong>Treatment:</strong></span></p><ul style=\"list-style-type:circle;\"><li><span style=\"color:black;font-size:14.0pt;\"><strong>Surgical approach:</strong> </span><ul style=\"list-style-type:square;\"><li><span style=\"color:black;font-size:14.0pt;\">The aim in DDH is to place the head of femur in acetabulum. </span></li><li><span style=\"color:black;font-size:14.0pt;\">Open the joint, identify the acetabulum, cut and rotate the femur and place the head in acetabulum.</span></li></ul></li><li><span style=\"color:black;font-size:14.0pt;\"><strong>Surgical procedure:</strong></span><ul style=\"list-style-type:square;\"><li><span style=\"color:black;font-size:14.0pt;\">Percutaneous adductor tenotomy is performed in all patients prior to open reduction. </span></li><li><span style=\"color:black;font-size:14.0pt;\">The hip joint is approached superficially between sartorius and tensor fascia lata. </span></li><li><span style=\"color:black;font-size:14.0pt;\">The sartorius is detached from anterior superior iliac spine to improve exposure. </span></li><li><span style=\"color:black;font-size:14.0pt;\">The anteromedial capsule is incised to remove the obstacle to reduction. </span></li><li><span style=\"color:black;font-size:14.0pt;\">The femoral head is identified and ligamentum teres is cut and traced to the acetabulum. </span></li><li><span style=\"color:black;font-size:14.0pt;\">The psoas tendon is identified and tenotomy is done to improve access to the acetabulum. </span></li><li><span style=\"color:black;font-size:14.0pt;\">The acetabular labrum is identified and care is taken to keep it intact and undamaged. </span></li><li><span style=\"color:black;font-size:14.0pt;\">The transverse acetabular ligament is identified and incised to remove the inferior obstacle to reduction. </span></li><li><span style=\"color:black;font-size:14.0pt;\">The acetabulum is cleared of fibrocartilaginous tissue and femoral head is reduced into the acetabulum. </span></li></ul></li></ul><p> </p></li></ul><p><span style=\"color:black;font-size:14.0pt;\"><strong>Educational Objective:</strong></span></p><p> </p><p><span style=\"color:black;font-size:14.0pt;\">The correct order of surgical procedure for DDH in a child < 2 years of age is: </span><br><br><span style=\"color:black;font-size:14.0pt;\">Capsulotomy</span></p><p><span style=\"color:black;font-size:14.0pt;\">↓</span></p><p><span style=\"color:black;font-size:14.0pt;\">Identification of true acetabulum using round ligament</span></p><p><span style=\"color:black;font-size:14.0pt;\">↓</span></p><p><span style=\"color:black;font-size:14.0pt;\">Femoral osteotomy</span></p><p><span style=\"color:black;font-size:14.0pt;\">↓</span></p><p><span style=\"color:black;font-size:14.0pt;\">Placing the head back into acetabulum</span></p><p><img src=\"https://cerebellum-web-static.s3.amazonaws.com/media/public/Screenshot%202025-08-11%20165051.jpeg\" alt=\"Solution Image\"></p>",
      "correct_choice_id": 200078,
      "solution_audio": null,
      "solution_video": null,
      "audio_explanation_heading": null,
      "video_explanation_heading": null,
      "solution_media_position": "bottom",
      "tags": [],
      "explanation_video": null,
      "question_images": [],
      "explanation_images": []
    },
    {
      "id": 50020,
      "choices": [
        {
          "id": 200080,
          "text": "<p><span style=\"font-size:11pt\"><span style=\"font-family:Arial,sans-serif\"><span dir=\"ltr\" lang=\"EN\" style=\"font-size:12.0pt\"><span style=\"font-family:\"Calibri\",sans-serif\">Dexamethasone</span></span></span></span></p>"
        },
        {
          "id": 200081,
          "text": "<p><span style=\"font-size:11pt\"><span style=\"font-family:Arial,sans-serif\"><span dir=\"ltr\" lang=\"EN\" style=\"font-size:12.0pt\"><span style=\"font-family:\"Calibri\",sans-serif\">Chloroquine</span></span></span></span></p>"
        },
        {
          "id": 200082,
          "text": "<p><span style=\"font-size:11pt\"><span style=\"font-family:Arial,sans-serif\"><span dir=\"ltr\" lang=\"EN\" style=\"font-size:12.0pt\"><span style=\"font-family:\"Calibri\",sans-serif\">Hydroxychloroquine</span></span></span></span></p>"
        },
        {
          "id": 200083,
          "text": "<p><span style=\"font-size:11pt\"><span style=\"font-family:Arial,sans-serif\"><span dir=\"ltr\" lang=\"EN\" style=\"font-size:12.0pt\"><span style=\"font-family:\"Calibri\",sans-serif\">Ketoconazole</span></span></span></span></p>"
        }
      ],
      "text": "<p><span dir=\"ltr\" lang=\"EN\" style=\"font-size:12.0pt\"><span style=\"font-family:\"Calibri\",sans-serif\">Which of the following is used in the treatment of hypercalcemia due to Vitamin D toxicity?</span></span><span dir=\"ltr\" lang=\"EN\" style=\"font-size:12.0pt\"><span style=\"font-family:\"Aptos\",sans-serif\"> (AIIMS NOV 2019)</span></span></p>",
      "unique_key": "Q7062033",
      "question_audio": null,
      "question_video": null,
      "map_id": 34806640,
      "difficulty_level": "intermediate",
      "subjects_id": [],
      "solution": "<p><span style=\"font-size:11pt\"><span style=\"font-family:Arial,sans-serif\"><strong><span dir=\"ltr\" lang=\"EN\" style=\"font-size:12.0pt\"><span style=\"font-family:\"Calibri\",sans-serif\">Ans. A) </span></span></strong><strong><span dir=\"ltr\" lang=\"EN\" style=\"font-size:12.0pt\"><span style=\"font-family:\"Calibri\",sans-serif\">Dexamethasone</span></span></strong></span></span></p>\r\n\r\n<p> </p>\r\n\r\n<p><span style=\"font-size:12pt\"><span style=\"font-family:\"Times New Roman\",serif\"><span style=\"font-family:\"Calibri\",sans-serif\">Dexamethasone is utilized in the treatment of hypercalcemia, particularly when induced by Vitamin D toxicity. This corticosteroid helps reduce calcium absorption from the intestine and increase calcium excretion, effectively lowering serum calcium levels.</span></span></span></p>\r\n\r\n<p> </p>\r\n\r\n<p><strong><span dir=\"ltr\" lang=\"EN\" style=\"font-size:11.0pt\"><span style=\"font-family:\"Calibri\",sans-serif\">Other Options:</span></span></strong></p>\r\n\r\n<p> </p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Arial,sans-serif\"><strong><span dir=\"ltr\" lang=\"EN\" style=\"font-size:12.0pt\"><span style=\"font-family:\"Calibri\",sans-serif\">Option B. Chloroquine: </span></span></strong><span dir=\"ltr\" lang=\"EN\" style=\"font-size:12.0pt\"><span style=\"font-family:\"Calibri\",sans-serif\">Used primarily as an antimalarial and in autoimmune diseases, it does not play a role in managing hypercalcemia.</span></span></span></span></p>\r\n\r\n<p> </p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Arial,sans-serif\"><strong><span dir=\"ltr\" lang=\"EN\" style=\"font-size:12.0pt\"><span style=\"font-family:\"Calibri\",sans-serif\">Option C. Hydroxychloroquine: </span></span></strong><span dir=\"ltr\" lang=\"EN\" style=\"font-size:12.0pt\"><span style=\"font-family:\"Calibri\",sans-serif\">Similar to chloroquine, used for autoimmune disorders but not for hypercalcemia.</span></span></span></span></p>\r\n\r\n<p> </p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Arial,sans-serif\"><strong><span dir=\"ltr\" lang=\"EN\" style=\"font-size:12.0pt\"><span style=\"font-family:\"Calibri\",sans-serif\">Option D. Ketoconazole: </span></span></strong><span dir=\"ltr\" lang=\"EN\" style=\"font-size:12.0pt\"><span style=\"font-family:\"Calibri\",sans-serif\">An antifungal medication that can reduce corticosteroid production but is not specifically used to treat hypercalcemia caused by Vitamin D toxicity</span></span></span></span></p>\r\n\r\n<p> </p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Arial,sans-serif\"><strong><span dir=\"ltr\" lang=\"EN\" style=\"font-size:12.0pt\"><span style=\"font-family:\"Calibri\",sans-serif\">Educational Objective</span></span></strong><span dir=\"ltr\" lang=\"EN\" style=\"font-size:12.0pt\"><span style=\"font-family:\"Calibri\",sans-serif\">:</span></span></span></span></p>\r\n\r\n<p> </p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Arial,sans-serif\"><span dir=\"ltr\" lang=\"EN\" style=\"font-size:12.0pt\"><span style=\"font-family:\"Calibri\",sans-serif\">Dexamethasone, Bisphosphonates, IV fluids, Loop diuretics, Calcitonin are used in the management of Hypercalcemia.</span></span></span></span></p>\r\n\r\n<p> </p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Arial,sans-serif\"><strong><span dir=\"ltr\" lang=\"EN\" style=\"font-size:12.0pt\"><span style=\"font-family:\"Calibri\",sans-serif\">Reference - (Harrison/Endocrinology/Hypercalcemia)</span></span></strong></span></span></p>",
      "correct_choice_id": 200080,
      "solution_audio": null,
      "solution_video": null,
      "audio_explanation_heading": null,
      "video_explanation_heading": null,
      "solution_media_position": "bottom",
      "tags": [],
      "explanation_video": null,
      "question_images": [],
      "explanation_images": []
    },
    {
      "id": 50021,
      "choices": [
        {
          "id": 200084,
          "text": "<p><span style=\"font-size:12.0pt;\">A-3, B-4, C-5, D-1</span></p>"
        },
        {
          "id": 200085,
          "text": "<p><span style=\"font-size:12.0pt;\">A-1, B-2, C-3, D-4</span></p>"
        },
        {
          "id": 200086,
          "text": "<p><span style=\"font-size:12.0pt;\">A-2, B-1, C-3, D-4</span></p>"
        },
        {
          "id": 200087,
          "text": "<p><span style=\"font-size:12.0pt;\">A-4, B-3, C-1, D-2</span></p>"
        }
      ],
      "text": "<p><span style=\"font-size:12.0pt;\">Match the following:(AIIMS NOV 2019)</span></p><p> </p><p><span style=\"font-size:12.0pt;\"><img src=\"https://cerebellum-web-static.s3.amazonaws.com/media/public/images/2024/01/17/screenshot-2024-01-17-154252_CK2hyZl.jpg\" alt=\"\" width=\"1000\" height=\"275\"></span></p><p><img src=\"https://cerebellum-web-static.s3.amazonaws.com/media/public/images/2024/01/17/screenshot-2024-01-17-154252_CK2hyZl.jpg\" alt=\"Question Image\"></p>",
      "unique_key": "Q3732643",
      "question_audio": null,
      "question_video": null,
      "map_id": 34496338,
      "difficulty_level": "intermediate",
      "subjects_id": [],
      "solution": "<p><span style=\"font-size:12.0pt;\"><strong>Ans. A) A-3, B-4, C-5, D-1</strong></span></p><p> </p><p><span style=\"font-size:12.0pt;\"><strong><u>Explanation:</u></strong></span></p><p> </p><p><span style=\"font-size:12.0pt;\"><strong>A. Madelung deformity </strong>involves distal radius.<strong>  </strong>It<strong> </strong>is the volar translation of the wrist. It is seen associated with Turner Syndrome.</span></p><p> </p><p><span style=\"color:#231f20;font-size:12.0pt;\"><img src=\"https://cerebellum-web-static.s3.amazonaws.com/media/public/images/2023/08/18/whatsapp-image-2023-06-12-at-190121011010201026_page_68_page_112.jpg\" alt=\"\" width=\"400\" height=\"280\"></span></p><p> </p><p><span style=\"font-size:12.0pt;\"><strong>B. Haglund deformity </strong>is the bony prominence over calcaneum and the overlying retrocalcaneal bursitis.</span></p><p> </p><p><span style=\"color:#231f20;font-size:12.0pt;\"><img src=\"https://cerebellum-web-static.s3.amazonaws.com/media/public/images/2023/08/18/whatsapp-image-2023-06-12-at-190121011010201026_page_68_page_113.jpg\" alt=\"\" width=\"300\" height=\"329\"></span></p><p> </p><p><span style=\"font-size:12.0pt;\"><strong>C. Buttonhole deformity </strong>is the abnormal extension at distal interphalangeal joint and flexion at proximal interphalangeal joint and is seen with Rheumatoid arthritis.</span></p><p> </p><p><img src=\"https://cerebellum-web-static.s3.amazonaws.com/media/public/images/2023/08/18/whatsapp-image-2023-06-12-at-190121011010201026_page_68_page_114.jpg\" alt=\"\" width=\"300\" height=\"225\"></p><p> </p><p><span style=\"font-size:12.0pt;\"><strong>D. Gunstock deformity </strong>is seen in Cubitus varus. It is a complication frequently seen after untreated supracondylar fracture of humerus.</span></p><p> </p><p><span style=\"color:#231f20;font-size:12.0pt;\"><img src=\"https://cerebellum-web-static.s3.amazonaws.com/media/public/images/2023/08/18/whatsapp-image-2023-06-12-at-190121011010201026_page_68_page_115.jpg\" alt=\"\" width=\"300\" height=\"246\"></span></p><p> </p><p><span style=\"font-size:12.0pt;\"><strong>Educational Objective:</strong></span></p><p> </p><p><span style=\"font-size:12.0pt;\"><strong><u><img src=\"https://cerebellum-web-static.s3.amazonaws.com/media/public/images/2024/01/17/screenshot-2024-01-17-154530.jpg\" alt=\"\" width=\"1000\" height=\"277\"></u></strong></span></p><p><img src=\"https://cerebellum-web-static.s3.amazonaws.com/media/public/images/2023/08/18/whatsapp-image-2023-06-12-at-190121011010201026_page_68_page_112.jpg\" alt=\"Solution Image\"></p>",
      "correct_choice_id": 200084,
      "solution_audio": null,
      "solution_video": null,
      "audio_explanation_heading": null,
      "video_explanation_heading": null,
      "solution_media_position": "bottom",
      "tags": [],
      "explanation_video": null,
      "question_images": [],
      "explanation_images": []
    },
    {
      "id": 50022,
      "choices": [
        {
          "id": 200088,
          "text": "<p style=\"margin-right:3px\"><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span dir=\"ltr\" lang=\"PT-BR\" style=\"font-size:12.0pt\">Apoptosis</span></span></span></p>"
        },
        {
          "id": 200089,
          "text": "<p style=\"margin-right:3px\"><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span dir=\"ltr\" lang=\"PT-BR\" style=\"font-size:12.0pt\">Necrosis</span></span></span></p>"
        },
        {
          "id": 200090,
          "text": "<p style=\"margin-right:3px\"><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span dir=\"ltr\" lang=\"PT-BR\" style=\"font-size:12.0pt\">Necroptosis</span></span></span></p>"
        },
        {
          "id": 200091,
          "text": "<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span style=\"font-size:12.0pt\">Pyroptosis</span></span></span></p>"
        }
      ],
      "text": "<p><span style=\"font-size:12.0pt\"><span style=\"font-family:\"Calibri\",sans-serif\">Both intrinsic and extrinsic pathways are seen in: (AIIMS NOV 2019)</span></span></p>",
      "unique_key": "Q3937694",
      "question_audio": null,
      "question_video": null,
      "map_id": 34618466,
      "difficulty_level": "intermediate",
      "subjects_id": [],
      "solution": "<p style=\"margin-right:3px\"><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\">Ans. A) Apoptosis</span></strong></span></span></p>\r\n\r\n<p style=\"margin-right:3px\"> </p>\r\n\r\n<p style=\"margin-right:3px\"><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\">Intrinsic and extrinsic pathways are both seen in apoptosis.</span></span></span></p>\r\n\r\n<p style=\"margin-right:3px\"> </p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\"><img alt=\"\" src=\"https://cerebellum-web-static.s3.amazonaws.com/media/public/images/2023/04/12/952.jpg\" style=\"height:319px; width:600px\" /></span></span></span></p>\r\n\r\n<p> </p>\r\n\r\n<p> </p>\r\n\r\n<p style=\"margin-right:3px\"><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span style=\"font-size:12.0pt\">Other Options:</span></strong></span></span></p>\r\n\r\n<p style=\"margin-right:3px\"> </p>\r\n\r\n<p style=\"margin-right:3px\"><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\">Option B. Necrosis</span></strong><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\">: Necrosis is a form of traumatic cell death that results from acute cellular injury. It is characterized by uncontrolled cell lysis, inflammation, and the release of intracellular contents into the extracellular space. Necrosis does not involve the intrinsic or extrinsic pathways seen in apoptosis.</span></span></span></p>\r\n\r\n<p style=\"margin-right:3px\"> </p>\r\n\r\n<p style=\"margin-right:3px\"><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\">Option C. Necroptosis</span></strong><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\">: Necroptosis is a programmed form of necrosis that is caspase-independent but involves the receptor-interacting protein kinases (RIPK1 and RIPK3). It is similar to necrosis but is regulated and has distinct signaling pathways that do not include the intrinsic or extrinsic apoptotic pathways.</span></span></span></p>\r\n\r\n<p style=\"margin-right:3px\"> </p>\r\n\r\n<p style=\"margin-right:3px\"><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\">Option D. Pyroptosis</span></strong><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\">: Pyroptosis is a form of programmed cell death associated with inflammation, typically involving caspase-1, which processes pro-inflammatory cytokines. It does not involve the intrinsic or extrinsic apoptotic pathways.</span></span></span></p>\r\n\r\n<p style=\"margin-right:3px\"> </p>\r\n\r\n<p style=\"margin-right:3px\"><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span style=\"font-size:12.0pt\">Educational Objective:</span></strong></span></span></p>\r\n\r\n<p style=\"margin-right:3px\"> </p>\r\n\r\n<p style=\"margin-right:3px\"><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\">Apoptosis is characterized by both intrinsic and extrinsic pathways, which lead to programmed cell death in a controlled and regulated manner.</span></span></span></p><p><img src=\"https://cerebellum-web-static.s3.amazonaws.com/media/public/images/2023/04/12/952.jpg\" alt=\"Solution Image\"></p>",
      "correct_choice_id": 200088,
      "solution_audio": null,
      "solution_video": null,
      "audio_explanation_heading": null,
      "video_explanation_heading": null,
      "solution_media_position": "bottom",
      "tags": [],
      "explanation_video": null,
      "question_images": [],
      "explanation_images": []
    },
    {
      "id": 50023,
      "choices": [
        {
          "id": 200092,
          "text": "<p><span style=\"font-size:12pt;\">Immediate C- section</span></p>"
        },
        {
          "id": 200093,
          "text": "<p><span style=\"font-size:12pt;\">Dexamethasone for fetal lung maturity</span></p>"
        },
        {
          "id": 200094,
          "text": "<p><span style=\"font-size:12pt;\">Induction - vaginal delivery</span></p>"
        },
        {
          "id": 200095,
          "text": "<p><span style=\"font-size:12pt;\">MgSO4 IV</span></p>"
        }
      ],
      "text": "<p><span style=\"font-size:12.0pt;\">A 33-week multigravida woman presents with epigastric pain, headache, visual symptoms, proteinuria: 3+. The next step of management would be? </span>(INICET NOV 2019)</p>",
      "unique_key": "Q9807743",
      "question_audio": null,
      "question_video": null,
      "map_id": 34116769,
      "difficulty_level": "intermediate",
      "subjects_id": [],
      "solution": "<p><span style=\"font-size:12pt;\"><strong>Ans. D) MgSO4 IV</strong></span></p><p> </p><p><span style=\"font-size:12pt;\">In the scenario of imminent eclampsia, neuro-prophylaxis with Magnesium Sulfate (MgSO4) is recommended. Imminent eclampsia is characterized by symptoms such as severe headaches, visual disturbances, epigastric pain, and hyperreflexia, indicating that the woman is at high risk of developing seizures (eclampsia). MgSO4 is effective in preventing seizures in women with severe pre-eclampsia and imminent eclampsia, as supported by the Magpie Trial, which is the largest comparative study demonstrating its efficacy.</span></p><p> </p><p><span style=\"font-size:12pt;\">The Magpie Trial (MgSO4 for Prevention of Eclampsia) showed that MgSO4 prophylaxis in women with severe pre-eclampsia effectively prevented the development of eclampsia, making it the standard of care for neuro-prophylaxis in such cases.</span></p><p> </p><p><span style=\"font-size:12pt;\"><strong>Other Options:</strong></span></p><p> </p><p><span style=\"font-size:12pt;\"><strong>Option A. Dexamethasone:</strong> Dexamethasone is an antenatal steroid used to enhance fetal lung maturation in pregnancies less than 34+6 weeks. It is administered in doses of 6 mg every 12 hours for a total of four doses. However, it is not used for neuro-prophylaxis in imminent eclampsia.</span></p><p> </p><p><span style=\"font-size:12pt;\"><strong>Option B. Betamethasone:</strong> Betamethasone, like dexamethasone, is also an antenatal steroid given to enhance fetal lung maturation in pregnancies less than 34+6 weeks. The typical regimen is 12 mg administered 24 hours apart for two doses. It is not used for neuro-prophylaxis in imminent eclampsia.</span></p><p> </p><p><span style=\"font-size:12pt;\"><strong>Option D. LSCS:</strong> The mode of delivery, whether vaginal or Lower Segment Cesarean Section (LSCS), will depend on the status of the cervical os and other obstetric indications. LSCS is not a prophylactic measure for preventing eclampsia.</span></p><p> </p><p><span style=\"font-size:12pt;\"><strong>Educational Objective:</strong></span></p><p> </p><p><span style=\"font-size:12pt;\">MgSO4 is recommended for neuro-prophylaxis in women with severe or imminent eclampsia to prevent seizures.</span></p><p> </p><p><span style=\"font-size:12pt;\"><strong>Ref: William’s textbook of obstetrics 26<sup>th</sup> edition pg 1840</strong></span></p>",
      "correct_choice_id": 200095,
      "solution_audio": null,
      "solution_video": null,
      "audio_explanation_heading": null,
      "video_explanation_heading": null,
      "solution_media_position": "bottom",
      "tags": [],
      "explanation_video": null,
      "question_images": [],
      "explanation_images": []
    },
    {
      "id": 50024,
      "choices": [
        {
          "id": 200096,
          "text": "<p><span style=\"font-size:12.0pt;\">Insertion</span></p>"
        },
        {
          "id": 200097,
          "text": "<p><span style=\"font-size:12.0pt;\">Deletion</span></p>"
        },
        {
          "id": 200098,
          "text": "<p><span style=\"font-size:12.0pt;\">Point mutation</span></p>"
        },
        {
          "id": 200099,
          "text": "<p><span style=\"font-size:12.0pt;\">Frameshift mutations</span></p>"
        }
      ],
      "text": "<p><span style=\"font-size:12.0pt;\">What type of mutation is seen in sickle cell anemia? (</span>AIIMS Nov 2019)</p>",
      "unique_key": "Q5667825",
      "question_audio": null,
      "question_video": null,
      "map_id": 34859558,
      "difficulty_level": "intermediate",
      "subjects_id": [],
      "solution": "<p><span style=\"font-size:12.0pt;\"><strong>Ans. C) Point mutations</strong></span></p><p><span style=\"font-size:10.5pt;\"><strong> </strong></span></p><p><span style=\"font-size:12.0pt;\">Sickle cell anemia is caused due to a <strong>point mutation in B globin gene wherein adenine is replaced with thymine in the 6<sup>th</sup> codon of DNA sequence</strong>. Thus, <strong>the glutamic acid in the 6th position of beta chain of HbA is changed to valine in HbS</strong>. This single amino acid substitution leads to polymerization of hemoglobin molecules inside RBCs. This causes a distortion of cell into sickle shape.</span></p><p> </p><p><span style=\"font-size:12.0pt;\"><strong>Other Options:</strong></span></p><p> </p><p><span style=\"font-size:12pt;\"><strong>Option A.</strong> </span><span style=\"font-size:12.0pt;\"><strong>Insertion:</strong> An insertion mutation involves the addition of one or more nucleotide base pairs into the DNA sequence. This type of mutation is not responsible for sickle cell anemia.</span></p><p> </p><p><span style=\"font-size:12pt;\"><strong>Option B.</strong> </span><span style=\"font-size:12.0pt;\"><strong>Deletion: </strong>A deletion mutation involves the removal of one or more nucleotide base pairs from the DNA sequence. This type of mutation is not responsible for sickle cell anemia.</span></p><p> </p><p><span style=\"font-size:12pt;\"><strong>Option D.</strong> </span><span style=\"font-size:12.0pt;\"><strong>Frameshift mutation: </strong>A frameshift mutation is caused by insertions or deletions of a number of nucleotides that are not divisible by three, resulting in a shift in the reading frame of the codons in the DNA sequence. This type of mutation is not responsible for sickle cell anemia.</span></p><p> </p><p><span style=\"font-size:12.0pt;\"><strong>Educational Objective</strong></span></p><p> </p><p><img src=\"https://cerebellum-web-static.s3.amazonaws.com/media/public/images/2024/06/07/screenshot-2024-06-07-120128.jpg\" alt=\"\" width=\"1000\" height=\"337\"></p><p><img src=\"https://cerebellum-web-static.s3.amazonaws.com/media/public/images/2024/06/07/screenshot-2024-06-07-120128.jpg\" alt=\"Solution Image\"></p>",
      "correct_choice_id": 200098,
      "solution_audio": null,
      "solution_video": null,
      "audio_explanation_heading": null,
      "video_explanation_heading": null,
      "solution_media_position": "bottom",
      "tags": [],
      "explanation_video": null,
      "question_images": [],
      "explanation_images": []
    },
    {
      "id": 50025,
      "choices": [
        {
          "id": 200100,
          "text": "<p><span style=\"font-size:12.0pt;\">Romovac</span></p>"
        },
        {
          "id": 200101,
          "text": "<p><span style=\"font-size:12.0pt;\">Jackson-Pratt drain</span></p>"
        },
        {
          "id": 200102,
          "text": "<p><span style=\"font-size:12.0pt;\">Minivac</span></p>"
        },
        {
          "id": 200103,
          "text": "<p><span style=\"font-size:12.0pt;\">Corrugated drain</span></p>"
        }
      ],
      "text": "<p><span style=\"font-size:12.0pt;\">The instrument given in the image is:</span> <span style=\"font-size:12.0pt;\">(AIIMS NOV 2019)</span></p><p> </p><p><span style=\"font-size:12.0pt;\"><img src=\"https://cerebellum-web-static.s3.amazonaws.com/media/public/images/2023/05/06/untitled-664.jpg\" alt=\"\" width=\"400\" height=\"301\"></span></p><p><img src=\"https://cerebellum-web-static.s3.amazonaws.com/media/public/images/2023/05/06/untitled-664.jpg\" alt=\"Question Image\"></p>",
      "unique_key": "Q1697239",
      "question_audio": null,
      "question_video": null,
      "map_id": 34577218,
      "difficulty_level": "intermediate",
      "subjects_id": [],
      "solution": "<p><span style=\"font-size:12.0pt;\"><strong>Ans. B) Jackson-Pratt drain</strong></span></p><p> </p><p><span style=\"font-size:12.0pt;\">The image displays a Jackson-Pratt (JP) drain, which is a type of closed drainage system used in post-surgical procedures. This device comprises a flexible bulb connected to tubing, creating negative pressure to gently suction fluid from the wound or surgical site. The bulb can be compressed and then sealed to initiate suction, allowing controlled drainage and reducing the risk of infection.</span></p><p> </p><p><span style=\"font-size:12.0pt;\"><strong>Other Options:</strong></span></p><p> </p><p><span style=\"font-size:12pt;\"><strong>Option A.</strong> </span><span style=\"font-size:12.0pt;\"><strong>Romovac drain</strong>: Romovac drains are commonly used after various surgical procedures, including abdominal surgeries, breast surgeries, orthopedic surgeries, and others. They are also utilized in the treatment of abscesses and some types of traumatic injuries. They are a closed drainage system.</span></p><p> </p><p><span style=\"font-size:12.0pt;\"><img src=\"https://cerebellum-web-static.s3.amazonaws.com/media/public/images/2023/05/06/untitled-665.jpg\" alt=\"\" width=\"306\" height=\"307\"></span></p><p> </p><p><span style=\"font-size:12.0pt;\"><strong>Option C. Minivac drain – (Mini in size)</strong>: A closed suction <i><strong>drain</strong></i> is placed under your skin during surgery. This <i><strong>drain</strong></i> removes any blood or other fluids that might build up in this area.</span></p><p> </p><p><span style=\"font-size:12.0pt;\"><img src=\"https://cerebellum-web-static.s3.amazonaws.com/media/public/images/2023/05/06/untitled-667.jpg\" alt=\"\" width=\"190\" height=\"281\"></span></p><p> </p><p><span style=\"font-size:12.0pt;\"><strong>Option D. Corrugated drain</strong>: Corrugated drains are intended for open passive drainage, used in situations where wounds must be kept open. They are placed directly into the wounds left to heal by secondary intent. </span></p><p> </p><p><span style=\"font-size:12.0pt;\"><img src=\"https://cerebellum-web-static.s3.amazonaws.com/media/public/images/2023/05/06/untitled-668.jpg\" alt=\"\" width=\"222\" height=\"131\"></span></p><p> </p><p><span style=\"font-size:12.0pt;\"><strong>Educational Objective : </strong></span></p><p> </p><p><span style=\"font-size:12.0pt;\">The Jackson-Pratt drain is a closed drainage system that uses gentle suction to remove fluids from surgical sites, helping prevent fluid accumulation and reducing infection risk.</span></p><p><img src=\"https://cerebellum-web-static.s3.amazonaws.com/media/public/images/2023/05/06/untitled-665.jpg\" alt=\"Solution Image\"></p>",
      "correct_choice_id": 200101,
      "solution_audio": null,
      "solution_video": null,
      "audio_explanation_heading": null,
      "video_explanation_heading": null,
      "solution_media_position": "bottom",
      "tags": [],
      "explanation_video": null,
      "question_images": [],
      "explanation_images": []
    },
    {
      "id": 50026,
      "choices": [
        {
          "id": 200104,
          "text": "<p><span style=\"font-size:12.0pt;\">2nd Dorsal interossei</span></p>"
        },
        {
          "id": 200105,
          "text": "<p><span style=\"font-size:12.0pt;\">Lumbricals</span></p>"
        },
        {
          "id": 200106,
          "text": "<p><span style=\"font-size:12.0pt;\">Extensor digitorum</span></p>"
        },
        {
          "id": 200107,
          "text": "<p><span style=\"font-size:12.0pt;\">2nd Palmar interossei</span></p>"
        }
      ],
      "text": "<p><span style=\"font-size:12.0pt;\">All of the following form the marked structure except? (</span><span style=\"background-color:rgb(255,255,255);color:rgb(111,126,149);font-size:14px;\">AIIMS Nov 2019)</span></p><p> </p><p><span style=\"font-size:12.0pt;\"><img src=\"https://cerebellum-web-static.s3.amazonaws.com/media/public/images/2023/11/10/18.jpg\" alt=\"\" width=\"300\" height=\"327\"></span></p><p><img src=\"https://cerebellum-web-static.s3.amazonaws.com/media/public/images/2023/11/10/18.jpg\" alt=\"Question Image\"></p>",
      "unique_key": "Q6773528",
      "question_audio": null,
      "question_video": null,
      "map_id": 34080385,
      "difficulty_level": "intermediate",
      "subjects_id": [],
      "solution": "<p><span style=\"font-size:12.0pt;\"><strong>Ans. D. 2nd Palmar interossei</strong></span></p><p> </p><p><span style=\"font-size:12.0pt;\">The dorsal digital extension of the middle finger is the structure indicated in the picture. The middle finger's dorsal digital extension is not aided by the palmar interossei because they do not attach to the middle finger.</span></p><p> </p><p><span style=\"font-size:12.0pt;\">The palmar interossei muscles are also located between the metacarpal bones but are found on the palmar side of the hand. Their primary function is to adduct the fingers. Unlike the dorsal interossei, the palmar interossei insert only into the bases of the proximal phalanges and do not extend to the dorsal digital expansion. Therefore, the 2nd palmar interosseous does not contribute to the dorsal digital expansion.</span></p><p> </p><p><span style=\"font-size:12.0pt;\">Extensor hoods, also known as \"dorsal digital expansions,\" are formed when the tendons of the extensor digitorum and extensor pollicis longus muscles cross over the dorsal aspect of the digits and extend over the proximal phalanges. These hoods are connected by the tendons of the extensor digiti minimi, extensor indicis, and extensor pollicis brevis muscles.</span></p><p> </p><p><img src=\"https://cerebellum-web-static.s3.amazonaws.com/media/public/images/2023/05/03/ia-68.jpg\" alt=\"\" width=\"500\" height=\"214\"></p><p> </p><p><img src=\"https://cerebellum-web-static.s3.amazonaws.com/media/public/images/2023/05/03/ia-69.jpg\" alt=\"\" width=\"500\" height=\"474\"></p><p> </p><p><span style=\"font-size:12.0pt;\">The dorsal digital expansion, also known as the extensor hood or extensor expansion, is a complex aponeurotic structure found on the dorsal aspect of each finger. It serves as the insertion point for certain tendons and allows the extensor tendons to provide extension at all three finger joints.</span></p><p> </p><p><span style=\"font-size:12.0pt;\"><strong>Other Options:</strong></span></p><p> </p><p><span style=\"font-size:12.0pt;\"><strong>Option A. 2nd Dorsal interossei:</strong> The dorsal interossei muscles are located between the metacarpal bones and are primarily responsible for the abduction of the fingers. There are four dorsal interossei in the hand. The tendons of the dorsal interossei insert into the bases of the proximal phalanges and into the dorsal digital expansion. Therefore, the 2nd dorsal interosseous does contribute to the dorsal digital expansion.</span></p><p> </p><p><span style=\"font-size:12.0pt;\"><strong>Option B. Lumbricals:</strong> The lumbricals are four small muscles in the hand that arise from the flexor digitorum profundus tendons. Their primary function is to flex the metacarpophalangeal joints and extend the interphalangeal joints. The tendons of the lumbricals insert into the dorsal digital expansion on the radial sides of the fingers. Hence, lumbricals do contribute to the dorsal digital expansion.</span></p><p> </p><p><span style=\"font-size:12.0pt;\"><strong>Option C. Extensor digitorum:</strong> The extensor digitorum muscle originates from the lateral epicondyle of the humerus. It extends down the forearm and sends tendons to the fingers. These tendons attach to the dorsal digital expansion and primarily facilitate the extension of the fingers. Thus, the extensor digitorum directly contributes to the formation of the dorsal digital expansion.</span></p><p> </p><p><span style=\"font-size:12.0pt;\"><strong>Educational Objective:</strong></span></p><p> </p><p><span style=\"font-size:12.0pt;\">The dorsal digital expansion plays a key role in extending the finger joints and is formed by the integration of tendons from several muscles, excluding the 2nd Palmar interossei, which primarily functions in adduction and does not extend to the dorsal side of the fingers.</span></p><p><img src=\"https://cerebellum-web-static.s3.amazonaws.com/media/public/images/2023/05/03/ia-68.jpg\" alt=\"Solution Image\"></p>",
      "correct_choice_id": 200107,
      "solution_audio": null,
      "solution_video": null,
      "audio_explanation_heading": null,
      "video_explanation_heading": null,
      "solution_media_position": "bottom",
      "tags": [],
      "explanation_video": null,
      "question_images": [],
      "explanation_images": []
    },
    {
      "id": 50027,
      "choices": [
        {
          "id": 200108,
          "text": "<p><span style=\"font-size:12.0pt;\">Nucleus ambiguous</span></p>"
        },
        {
          "id": 200109,
          "text": "<p><span style=\"font-size:12.0pt;\">Rostral-ventro lateral medulla</span></p>"
        },
        {
          "id": 200110,
          "text": "<p><span style=\"font-size:12.0pt;\">Nucleus Tractus Solitarius</span></p>"
        },
        {
          "id": 200111,
          "text": "<p><span style=\"font-size:12.0pt;\">Caudal ventrolateral medulla</span></p>"
        }
      ],
      "text": "<p><span style=\"font-size:12.0pt;\">Where do afferent fibers from baroreceptors primarily project for blood pressure control? (</span>AIIMS Nov 2019)</p>",
      "unique_key": "Q1315699",
      "question_audio": null,
      "question_video": null,
      "map_id": 34339203,
      "difficulty_level": "intermediate",
      "subjects_id": [],
      "solution": "<p><span style=\"font-size:12.0pt;\"><strong>Ans. C) Nucleus Tractus Solitarius</strong></span></p><p> </p><p><span style=\"font-size:12.0pt;\">Afferent fiber for blood pressure control goes to the Nucleus Tractus Solitarius (NTS).</span></p><p> </p><p><span style=\"font-size:12.0pt;\">The afferent fibers from baroreceptors for blood pressure control primarily project to the Nucleus Tractus Solitarius (NTS). The NTS is located in the medulla oblongata, which is part of the brainstem. It serves as the primary site for integrating and processing information related to blood pressure regulation.</span></p><p> </p><p><span style=\"font-size:12.0pt;\">The baroreceptors are specialized sensory receptors located in the walls of certain blood vessels, particularly in the carotid sinus and aortic arch. These receptors detect changes in blood pressure and relay this information via afferent (sensory) nerve fibers. The afferent fibers from the baroreceptors transmit signals to the NTS, where they are integrated and contribute to the regulation of blood pressure.</span></p><p> </p><p><span style=\"font-size:12.0pt;\"><img src=\"https://cerebellum-web-static.s3.amazonaws.com/media/public/images/2023/04/05/aiims-physio-nov-2018-03_uoyP3dK.jpg\" alt=\"\" width=\"800\" height=\"386\"></span></p><p> </p><p><span style=\"font-size:12.0pt;\"><strong>Other Options:</strong></span></p><p> </p><p><span style=\"font-size:12.0pt;\"><strong>Option A. Nucleus ambiguous:</strong> Incorrect. This nucleus is involved in controlling the muscles of the pharynx, larynx, and soft palate.</span></p><p> </p><p><span style=\"font-size:12.0pt;\"><strong>Option B. Rostral-ventrolateral medulla:</strong> Incorrect. This area is involved in the regulation of sympathetic outflow but does not receive direct input from baroreceptor afferents.</span></p><p> </p><p><span style=\"font-size:12.0pt;\"><strong>Option D. Caudal ventrolateral medulla:</strong> Incorrect. This area is involved in regulating blood pressure but is not the primary projection site for baroreceptor afferents.</span></p><p> </p><p><span style=\"font-size:12.0pt;\"><strong>Educational Objective:</strong></span></p><p> </p><p><span style=\"font-size:12.0pt;\">Afferent fibers from baroreceptors project to the Nucleus Tractus Solitarius (NTS) in the medulla oblongata, where they integrate and process information related to blood pressure regulation.</span></p><p><img src=\"https://cerebellum-web-static.s3.amazonaws.com/media/public/images/2023/04/05/aiims-physio-nov-2018-03_uoyP3dK.jpg\" alt=\"Solution Image\"></p>",
      "correct_choice_id": 200110,
      "solution_audio": null,
      "solution_video": null,
      "audio_explanation_heading": null,
      "video_explanation_heading": null,
      "solution_media_position": "bottom",
      "tags": [],
      "explanation_video": null,
      "question_images": [],
      "explanation_images": []
    },
    {
      "id": 50028,
      "choices": [
        {
          "id": 200112,
          "text": "<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\">Magistrate</span></span></span></p>"
        },
        {
          "id": 200113,
          "text": "<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\">Police</span></span></span></p>"
        },
        {
          "id": 200114,
          "text": "<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\">Child Welfare Committee</span></span></span></p>"
        },
        {
          "id": 200115,
          "text": "<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\">Parents</span></span></span></p>"
        }
      ],
      "text": "<p style=\"text-align:justify\"><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\"><span style=\"font-family:\"Calibri\",sans-serif\">A young girl refuses to go to Mathematics class everyday citing abnormal excuses. It was discovered by the principal that the mathematics teacher was touching her genitalia inappropriately. The duty of the principal is to report this to?(AIIMS NOV 2019)</span></span></p>",
      "unique_key": "Q4747295",
      "question_audio": null,
      "question_video": null,
      "map_id": 34772146,
      "difficulty_level": "intermediate",
      "subjects_id": [],
      "solution": "<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\">Ans. B. Police</span></strong> </span></span></p>\r\n\r\n<p> </p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\">Explanation:</span></strong> </span></span></p>\r\n\r\n<p> </p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\">Under the Protection of Children from Sexual Offences (POCSO) Act, the principal should refer to Section 19 which states that “Any person who has apprehension that an offence under this Act is likely to be committed or has knowledge that such an offence has been committed shall provide such information to the Special Juvenile Police Unit or the local police.”</span></span></span></p>\r\n\r\n<p> </p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><u><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\">Other options </span></u></strong></span></span></p>\r\n\r\n<p> </p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\">Option A) Magistrate, Option C) child welfare committee, Option D) Parents: </span></strong><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\">According to POCSO Act, Article 19, the immediate duty is to inform the police when there is knowledge or apprehension of a child being sexually abused. Others can be informed later.</span></span></span></p>\r\n\r\n<p> </p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><u><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\">Educational Objective</span></u></strong></span></span></p>\r\n\r\n<p> </p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\">POCSO Act Provisions</span></strong></span></span></p>\r\n\r\n<p> </p>\r\n\r\n<ul>\r\n\t<li><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\">Section 19 of the Act makes it mandatory for any person including the child to approach the police in case of an apprehension that an offence under the Act is likely to be committed or \"has the knowledge\" that such an act has been committed.</span></span></span></li>\r\n</ul>\r\n\r\n<p style=\"margin-left:24px\"> </p>\r\n\r\n<p><span style=\"font-size:9pt\"><span style=\"font-family:Helvetica,sans-serif\"> <span style=\"font-size:12.0pt\"><span style=\"font-family:\"Calibri\",sans-serif\">The POCSO act defines a child as any person below eighteen years of age. It defines various forms of sexual offenses which include:</span></span></span></span></p>\r\n\r\n<p> </p>\r\n\r\n<ul style=\"list-style-type:circle\">\r\n\t<li><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span style=\"font-size:12.0pt\">﻿﻿﻿Sexual harassment - Threatening</span></span></span></li>\r\n\t<li><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span style=\"font-size:12.0pt\">﻿﻿﻿Sexual assault - Any act with sexual intent that involves physical contact without penetration.</span></span></span></li>\r\n\t<li><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span style=\"font-size:12.0pt\">﻿﻿﻿Aggravated sexual assault - Similar to sexual assault along with the criteria explained under the term aggravated</span></span></span></li>\r\n\t<li><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span style=\"font-size:12.0pt\">﻿﻿﻿Penetrative sexual assault - An act with sexual intent that involves physical penetration of the penis or any object into the vagina, mouth, urethra, or anus.</span></span></span></li>\r\n\t<li><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span style=\"font-size:12.0pt\">﻿﻿﻿Aggravated penetrative sexual assault - Similar to penetrative sexual assault along with the criteria explained under the term aggravated</span></span></span></li>\r\n\t<li><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span style=\"font-size:12.0pt\">﻿﻿﻿Pornography</span></span></span></li>\r\n</ul>",
      "correct_choice_id": 200113,
      "solution_audio": null,
      "solution_video": null,
      "audio_explanation_heading": null,
      "video_explanation_heading": null,
      "solution_media_position": "bottom",
      "tags": [],
      "explanation_video": null,
      "question_images": [],
      "explanation_images": []
    },
    {
      "id": 50029,
      "choices": [
        {
          "id": 200116,
          "text": "<p><span style=\"font-size:12.0pt;\">It inhibits proteus swarming</span></p>"
        },
        {
          "id": 200117,
          "text": "<p><span style=\"font-size:12.0pt;\">It promotes the growth of candida, streptococcus and staphylococcus</span></p>"
        },
        {
          "id": 200118,
          "text": "<p><span style=\"font-size:12.0pt;\">It differentiates between lactose-fermenting and non-lactose fermenting bacteria</span></p>"
        },
        {
          "id": 200119,
          "text": "<p><span style=\"font-size:12.0pt;\">It promotes the growth of pseudomonas</span></p>"
        }
      ],
      "text": "<p><span style=\"font-size:12.0pt;\">The CLED medium is preferred over other media for the culture of organisms in case of UTI because: (INICET NOV 2019)</span></p>",
      "unique_key": "Q8406176",
      "question_audio": null,
      "question_video": null,
      "map_id": 34979597,
      "difficulty_level": "intermediate",
      "subjects_id": [],
      "solution": "<p><span style=\"font-size:12.0pt;\"><strong>Ans. A. It inhibits proteus swarming</strong></span></p><p> </p><p><span style=\"font-size:12.0pt;\">Cystine-Lactose-Electrolyte-Deficient (CLED) medium is a differential medium used for the isolation and enumeration of bacteria from urine. The medium supports the growth of all urinary potential pathogens and provides distinct colony morphology. <strong>It supports the growth of urinary pathogens </strong>and contaminants and gives good colonial differentiation without the spread of Proteus species due to <u>its lack of electrolytes</u>.</span></p><p> </p><p><span style=\"font-size:12.0pt;\">Proteus species are a common cause of UTI and produce swarming on ordinary medias leading to difficult isolation of other important urinary pathogens</span></p><p> </p><p><span style=\"font-size:12.0pt;\">Bromothymol blue is the indicator used in the agar, it changes to yellow in case of acid production during fermentation of lactose or changes to deep blue in case of alkalinization. Lactose-positive bacteria build yellow colonies. Bacteria which decarboxylate L-cystine cause an alkaline reaction and build deep blue colonies.</span></p><p> </p><p><span style=\"font-size:12.0pt;\"><strong>Other options:</strong></span></p><p> </p><p><span style=\"font-size:12.0pt;\"><strong>Option B: It promotes the growth of candida, streptococcus and staphylococcus. </strong>CLED media does not specifically promote the growth of candida, streptococcus and staphylococcus.</span><br> </p><p> </p><p><span style=\"font-size:12.0pt;\"><strong>Option C. It differentiates between lactose-fermenting and non-lactose fermenting bacteria:</strong> This is also true for CLED medium but not the reason why it is specifically used for urinary pathogens. Bromothymol blue is the indicator used in the agar, changing to yellow in case of acid production during lactose fermentation or to deep blue in case of alkalinization. Lactose-positive bacteria form yellow colonies, while bacteria that decarboxylate L-cystine cause an alkaline reaction and form deep blue colonies.</span></p><p> </p><p><span style=\"font-size:12.0pt;\"><strong>Option D. It promotes the growth of Pseudomonas:</strong> While Pseudomonas can grow on CLED medium, it is not specifically promoted by this medium compared to the growth of Candida, Streptococcus, and Staphylococcus</span></p><p> </p><p><span style=\"font-size:12.0pt;\"><strong>Educational Objective:</strong></span></p><p> </p><p><span style=\"font-size:12.0pt;\">Cystine-Lactose-Electrolyte-Deficient (CLED) medium is a differential medium used for the isolation and enumeration of bacteria from urine. The medium supports the growth of all urinary potential pathogens and provides distinct colony morphology. It supports the growth of urinary pathogens and contaminants and gives good colonial differentiation without the spread of Proteus species due to its lack of electrolytes.</span></p>",
      "correct_choice_id": 200116,
      "solution_audio": null,
      "solution_video": null,
      "audio_explanation_heading": null,
      "video_explanation_heading": null,
      "solution_media_position": "bottom",
      "tags": [],
      "explanation_video": null,
      "question_images": [],
      "explanation_images": []
    },
    {
      "id": 50030,
      "choices": [
        {
          "id": 200120,
          "text": "<p><span style=\"font-size:12.0pt;\">Acute infection</span></p>"
        },
        {
          "id": 200121,
          "text": "<p><span style=\"font-size:12.0pt;\">Fatty liver</span></p>"
        },
        {
          "id": 200122,
          "text": "<p><span style=\"font-size:12.0pt;\">Gradual withdrawal of alcohol</span></p>"
        },
        {
          "id": 200123,
          "text": "<p><span style=\"font-size:12.0pt;\">Small doses of regular consumption of alcohol</span></p>"
        }
      ],
      "text": "<p style=\"text-align:justify;\"><span style=\"font-size:12.0pt;\">A 48-year-old male presents to the ER with confusion and shaking of the entire body. He has a history of excessive alcohol consumption. What is the cause of delirium tremens in an alcoholic? (</span>AIIMS Nov 2019)</p>",
      "unique_key": "Q7273842",
      "question_audio": null,
      "question_video": null,
      "map_id": 34913146,
      "difficulty_level": "intermediate",
      "subjects_id": [],
      "solution": "<p><span style=\"font-size:12.0pt;\"><strong>Ans. A) Acute infection</strong></span></p><p> </p><p><span style=\"font-size:12.0pt;\">Delirium tremens is primarily caused by abrupt alcohol cessation in chronic users.</span></p><p> </p><p><span style=\"font-size:12.0pt;\">Acute infections can exacerbate or precipitate its onset.</span></p><p> </p><p><span style=\"font-size:12.0pt;\"><strong>Other Options:</strong></span></p><p> </p><p><span style=\"font-size:12.0pt;\"><strong>Option B. Fatty liver:</strong> Fatty liver doesn't directly precipitate DT.</span></p><p> </p><p><span style=\"font-size:12.0pt;\"><strong>Option C. Gradual withdrawal of alcohol:</strong> Gradual withdrawal typically avoids DT.</span></p><p> </p><p><span style=\"font-size:12.0pt;\"><strong>Option D. Small doses of regular consumption of alcohol: </strong>Regular small doses wouldn't lead to abrupt cessation symptoms.</span></p><p> </p><p><span style=\"font-size:12.0pt;\"><strong>Educational Objective: </strong></span></p><p> </p><p><span style=\"color:#374151;font-size:12.0pt;\">Alcohol withdrawal delirium (DTs) typically presents 48-72 hours after the last drink and is characterized by disturbances of consciousness, disorientation to time, place, and person, hallucinations (especially visual), agitation, coarse tremors and autonomic hyperactivity. Risk factors include surgery, infections or other medical conditions. It is a medical emergency requiring prompt intervention. Treatment includes intravenous lorazepam or diazepam with thiamine supplementation to prevent Wernicke encephalopathy.</span></p><p> </p><p><span style=\"font-size:12.0pt;\"><strong>Reference: Shorter Oxford Textbook of Psychiatry, 7th edition, Page No 572-573.</strong></span></p>",
      "correct_choice_id": 200120,
      "solution_audio": null,
      "solution_video": null,
      "audio_explanation_heading": null,
      "video_explanation_heading": null,
      "solution_media_position": "bottom",
      "tags": [],
      "explanation_video": null,
      "question_images": [],
      "explanation_images": []
    },
    {
      "id": 50031,
      "choices": [
        {
          "id": 200124,
          "text": "<p><span style=\"font-size:12.0pt;\">Respiratory rate ≥22/min</span></p>"
        },
        {
          "id": 200125,
          "text": "<p><span style=\"font-size:12.0pt;\">Systolic BP < 100 mm Hg</span></p>"
        },
        {
          "id": 200126,
          "text": "<p><span style=\"font-size:12.0pt;\">Altered mental status</span></p>"
        },
        {
          "id": 200127,
          "text": "<p><span style=\"font-size:12.0pt;\">Bilateral absent pupillary reflex</span></p>"
        }
      ],
      "text": "<p><span style=\"font-size:12.0pt;\">Identify which of these is not a component of qSOFA? (AIIMS NOV 2019)</span></p>",
      "unique_key": "Q1165063",
      "question_audio": null,
      "question_video": null,
      "map_id": 34510720,
      "difficulty_level": "intermediate",
      "subjects_id": [],
      "solution": "<p><span style=\"font-size:12.0pt;\"><strong>Ans. D) Bilateral absent pupillary reflex</strong></span></p><p> </p><p><span style=\"font-size:12.0pt;\">qSOFA stands for Quick Sequential Organ Failure Assessment. It is a simplified bedside clinical tool used to quickly assess the risk of organ failure and sepsis in patients. qSOFA includes three Clinical criteria:</span></p><p> </p><ol><li><span style=\"font-size:12.0pt;\">Respiratory Rate ≥ 22/min: A respiratory rate of 22 or higher per minute suggests abnormal breathing and is one of the criteria in qSOFA.</span></li><li><span style=\"font-size:12.0pt;\">Altered Mental Status: Altered mental status, such as confusion or disorientation, is also a component of qSOFA. It reflects the patient's neurological status and helps in evaluating the severity of illness.</span></li><li><span style=\"font-size:12.0pt;\">Systolic Blood Pressure < 100 mm Hg: A systolic blood pressure (BP) less than 100 mm Hg indicates poor perfusion and is another parameter in qSOFA.</span></li></ol><p> </p><p><span style=\"font-size:12.0pt;\">Derangement in 2 or 3 components carries high mortality.</span></p><p> </p><p><span style=\"font-size:12.0pt;\"><strong>Option D: Bilateral absent pupillary reflex</strong>: Not a component of qSOFA. The qSOFA score does not include any criteria related to pupillary reflexes. Bilateral absent pupillary reflex is more relevant to assessing brainstem function or neurological assessment rather than organ failure related to sepsis</span></p><p> </p><p><span style=\"font-size:12.0pt;\"><strong>Educational Objective: </strong></span></p><p> </p><p><span style=\"font-size:12.0pt;\">qSOFA includes three criteria for assessing sepsis risk: respiratory rate ≥ 22/min, systolic BP < 100 mm Hg, and altered mental status. It does not include pupillary reflex assessment.</span></p>",
      "correct_choice_id": 200127,
      "solution_audio": null,
      "solution_video": null,
      "audio_explanation_heading": null,
      "video_explanation_heading": null,
      "solution_media_position": "bottom",
      "tags": [],
      "explanation_video": null,
      "question_images": [],
      "explanation_images": []
    },
    {
      "id": 50032,
      "choices": [
        {
          "id": 200128,
          "text": "<p><span style=\"font-size:12.0pt;\">Kills extracellular bacteria by granulysin and perforin</span></p>"
        },
        {
          "id": 200129,
          "text": "<p><span style=\"font-size:12.0pt;\">Need antigen processing and presentation for it recognition</span></p>"
        },
        {
          "id": 200130,
          "text": "<p><span style=\"font-size:12.0pt;\">Direct killing of infected macrophages</span></p>"
        },
        {
          "id": 200131,
          "text": "<p><span style=\"font-size:12.0pt;\">Provide protection against mycobacteria</span></p>"
        }
      ],
      "text": "<p><span style=\"font-size:12.0pt;\">Which of the following about γδ T-cells is incorrect? (AIIMS NOV 2019)</span></p>",
      "unique_key": "Q1922199",
      "question_audio": null,
      "question_video": null,
      "map_id": 34039330,
      "difficulty_level": "intermediate",
      "subjects_id": [],
      "solution": "<p><span style=\"font-size:12.0pt;\"><strong>Ans. B) Need antigen processing and presentation for it recognition</strong></span></p><p> </p><p><span style=\"font-size:12.0pt;\"><strong>γδ T-cells do not need antigen processing and presentation for its recognition</strong>.</span></p><p> </p><p><span style=\"font-size:12.0pt;\">There are two types of T cells: γδ T-cells and αβ T-cells.</span></p><p> </p><ul><li><span style=\"font-size:12.0pt;\">The functions of γδ T-cells:</span><ul><li><span style=\"font-size:12.0pt;\">Provide protection <strong>against mycobacteria</strong> by direct killing of infected macrophages</span></li><li><span style=\"font-size:12.0pt;\">Kills <strong>extracellular bacteria</strong> by granulysin and perforin</span></li><li><span style=\"font-size:12.0pt;\">Plays a role in maintaining self-tolerance</span></li><li><span style=\"font-size:12.0pt;\">Capable of recognizing and lying diverse cancers in an <strong>MHC-unrestricted manner</strong></span></li></ul></li><li><span style=\"font-size:12.0pt;\">The <strong>αβ TCR recognizes peptide antigens that are displayed by major histocompatibility complex (MHC. molecules on the surfaces of antigen-presenting cells (APCs)</strong>. By limiting the specificity of T cells for peptides displayed by cell surface MHC molecules, <strong>called MHC restriction</strong>, the immune system ensures that T cells see only cell-associated antigens (e.g., those derived from microbes in cells).</span></li></ul><p> </p><p><span style=\"font-size:12.0pt;\"><strong>Other Options:</strong></span></p><p> </p><p><span style=\"font-size:12.0pt;\"><strong>Option A. Kills extracellular bacteria by granulysin and perforin</strong>: This is correct and one of the key functions of γδ T-cells.</span></p><p> </p><p><span style=\"font-size:12.0pt;\"><strong>Option C. Direct killing of infected macrophages</strong>: This is correct, as γδ T-cells can directly target and kill infected cells.</span></p><p> </p><p><span style=\"font-size:12.0pt;\"><strong>Option D. Provide protection against mycobacteria</strong>: This is correct; γδ T-cells play an important role in defense against mycobacterial infections.</span></p><p> </p><p><span style=\"font-size:12.0pt;\"><strong>Educational Objective:</strong></span></p><p> </p><p><span style=\"font-size:12.0pt;\"><strong>γδ T-cells do not require antigen processing and presentation</strong> by MHC molecules for their recognition, unlike αβ T-cells, making them unique in their ability to directly recognize and respond to a variety of antigens.</span></p><p> </p><p><span style=\"font-size:12.0pt;\"><strong>Ref: Robbins and Cotrans Pathologic basis of disease 8<sup>th</sup> edition pg 352-353</strong></span></p>",
      "correct_choice_id": 200129,
      "solution_audio": null,
      "solution_video": null,
      "audio_explanation_heading": null,
      "video_explanation_heading": null,
      "solution_media_position": "bottom",
      "tags": [],
      "explanation_video": null,
      "question_images": [],
      "explanation_images": []
    },
    {
      "id": 50033,
      "choices": [
        {
          "id": 200132,
          "text": "<p style=\"margin-right:3px\"><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span style=\"font-size:12.0pt\">Platelets</span></span></span></p>"
        },
        {
          "id": 200133,
          "text": "<p style=\"margin-right:3px\"><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span style=\"font-size:12.0pt\">Lymphocytes</span></span></span></p>"
        },
        {
          "id": 200134,
          "text": "<p style=\"margin-right:3px\"><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span style=\"font-size:12.0pt\">Macrophages</span></span></span></p>"
        },
        {
          "id": 200135,
          "text": "<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span style=\"font-size:12.0pt\">Endothelial cells</span></span></span></p>"
        }
      ],
      "text": "<p><span style=\"font-size:12.0pt\"><span style=\"font-family:\"Calibri\",sans-serif\">Which of the following is the major source of plasma von-Willebrand factor? (AIIMS NOV 2019)</span></span></p>",
      "unique_key": "Q6675680",
      "question_audio": null,
      "question_video": null,
      "map_id": 34827933,
      "difficulty_level": "intermediate",
      "subjects_id": [],
      "solution": "<p style=\"margin-right:3px\"><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\">Ans. D) Endothelial cells</span></strong></span></span></p>\r\n\r\n<p style=\"margin-right:3px\"> </p>\r\n\r\n<p style=\"margin-right:3px\"><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\">vWF is made in endothelial cells and megakaryocytes</span></strong><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\">. vWF is also present in the subendothelial matrix of normal blood vessels and the α-granules of platelets. Following endothelial injury, exposure of subendothelial vWF causes adhesion of platelets, primarily via the glycoprotein lb (GpIB) platelet receptor.</span></span></span></p>\r\n\r\n<p style=\"margin-right:3px\"> </p>\r\n\r\n<ul>\r\n\t<li><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\">Endothelial cells</span></strong><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\"> are responsible for producing and secreting the majority of plasma vWF. They synthesize vWF and store it in Weibel-Palade bodies, specialized storage granules in the endothelial cells. Upon vascular injury, vWF is released into the bloodstream, where it binds to platelets and subendothelial structures, facilitating the formation of a platelet plug.</span></span></span></li>\r\n\t<li><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\">Additionally, <strong>megakaryocytes</strong> synthesize vWF, which is stored in the alpha granules of platelets and released during platelet activation.</span></span></span></li>\r\n</ul>\r\n\r\n<p style=\"margin-right:3px\"> </p>\r\n\r\n<p style=\"margin-right:3px\"><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span style=\"font-size:12.0pt\">Other Options:</span></strong></span></span></p>\r\n\r\n<p style=\"margin-right:3px\"> </p>\r\n\r\n<p style=\"margin-right:3px\"><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span style=\"font-size:12.0pt\">Option </span></strong><strong><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\">A. Platelets:</span></strong><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\"> While platelets contain vWF in their alpha granules and release it upon activation, they are not the major source of plasma vWF. Instead, their vWF contributes to local hemostasis at the site of injury.</span></span></span></p>\r\n\r\n<p style=\"margin-right:3px\"> </p>\r\n\r\n<p style=\"margin-right:3px\"><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span style=\"font-size:12.0pt\">Option </span></strong><strong><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\">B. Lymphocytes:</span></strong><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\"> Lymphocytes are a type of white blood cell involved in the immune response and do not produce or release vWF.</span></span></span></p>\r\n\r\n<p style=\"margin-right:3px\"> </p>\r\n\r\n<p style=\"margin-right:3px\"><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span style=\"font-size:12.0pt\">Option </span></strong><strong><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\">C. Macrophages:</span></strong><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\"> Macrophages are involved in phagocytosis and the immune response, but they do not produce vWF.</span></span></span></p>\r\n\r\n<p style=\"margin-right:3px\"> </p>\r\n\r\n<p style=\"margin-right:3px\"><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span style=\"font-size:12.0pt\">Educational Objective:</span></strong></span></span></p>\r\n\r\n<p style=\"margin-right:3px\"> </p>\r\n\r\n<p style=\"margin-right:3px\"><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\">The major source of plasma von Willebrand factor (vWF) is <strong>endothelial cells</strong>, which release vWF into the bloodstream upon vascular injury to facilitate platelet adhesion.</span></span></span></p>\r\n\r\n<p style=\"margin-right:3px\"> </p>\r\n\r\n<p style=\"margin-right:3px\"><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\">Ref: Robbins and Cotrans pathologic basis of disease 8<sup>th</sup> edition pg 1253</span></strong></span></span></p>",
      "correct_choice_id": 200135,
      "solution_audio": null,
      "solution_video": null,
      "audio_explanation_heading": null,
      "video_explanation_heading": null,
      "solution_media_position": "bottom",
      "tags": [],
      "explanation_video": null,
      "question_images": [],
      "explanation_images": []
    },
    {
      "id": 50034,
      "choices": [
        {
          "id": 200136,
          "text": "<p><span style=\"font-size:12.0pt;\">Endometriosis</span></p>"
        },
        {
          "id": 200137,
          "text": "<p><span style=\"font-size:12.0pt;\">Male infertility</span></p>"
        },
        {
          "id": 200138,
          "text": "<p><span style=\"font-size:12.0pt;\">Central precocious puberty</span></p>"
        },
        {
          "id": 200139,
          "text": "<p><span style=\"font-size:12.0pt;\">Prostate cancer</span></p>"
        }
      ],
      "text": "<p style=\"text-align:justify;\"><span style=\"color:#333333;font-size:12pt;\">Non-pulsatile dose of GnRH agonist is used in all of the following conditions except? (AIIMS NOV 2019)</span></p>",
      "unique_key": "Q8119985",
      "question_audio": null,
      "question_video": null,
      "map_id": 34106071,
      "difficulty_level": "intermediate",
      "subjects_id": [],
      "solution": "<p><span style=\"color:#333333;font-size:12pt;\"><strong>Ans. B. Male infertility</strong></span></p><p> </p><p><span style=\"color:#333333;font-size:12pt;\">Pulsatile exposure to GnRH induces FSH/LH secretion while sustained exposure de-sensitizes the receptors resulting in decrease in secretion of gonadotropins. Therefore, non-pulsatile (continuous) GnRH agonists are given when we want to decrease the sex hormones.</span></p><p> </p><p><span style=\"color:#333333;font-size:12pt;\"><strong>Indications:-</strong></span></p><p> </p><ul><li><span style=\"color:#333333;font-size:12pt;\"> Prostatic carcinoma</span></li><li><span style=\"color:#333333;font-size:12pt;\"> Endometriosis</span></li><li><span style=\"color:#333333;font-size:12pt;\"> Precocious puberty</span></li><li><span style=\"color:#333333;font-size:12pt;\"> Fibroid</span></li></ul><p> </p><p><span style=\"color:#333333;font-size:12pt;\">But in case of male infertility, more testosterone is required to induce spermatogenesis, so GnRH agonists are given in pulsatile manner.</span></p><p> </p><p><span style=\"font-size:12.0pt;\"><strong>Other Options:</strong></span></p><p> </p><p><span style=\"font-size:12.0pt;\"><strong>Option A. Endometriosis: </strong>In endometriosis, continuous GnRH agonists are used to lower estrogen levels, which helps reduce the growth of endometrial tissue and alleviate symptoms.</span></p><p> </p><p><span style=\"font-size:12.0pt;\"><strong>Option C. Central precocious puberty</strong></span><span style=\"font-size:12pt;\"><strong>:</strong></span><span style=\"font-size:14px;\"><strong> </strong></span><span style=\"font-size:12pt;\">Continuous GnRH agonists are used to decrease sex hormone levels, thereby delaying early onset puberty.</span></p><p> </p><p><span style=\"font-size:12.0pt;\"><strong>Option D. Prostate cancer: </strong>Continuous GnRH agonists reduce testosterone levels, which helps in managing prostate cancer by slowing down the growth of cancer cells.</span></p><p> </p><p><span style=\"font-size:12.0pt;\"><strong>Educational Objective:</strong></span></p><p> </p><p><span style=\"font-size:12.0pt;\">Non-pulsatile (continuous) GnRH agonists are used to decrease sex hormone levels in conditions such as endometriosis, central precocious puberty, and prostate cancer. In male infertility, pulsatile GnRH agonists are used to increase testosterone and induce spermatogenesis.</span></p><p> </p><p><span style=\"color:#333333;font-size:12pt;\"><strong>Reference: KDT 8th/. 262,263</strong></span></p>",
      "correct_choice_id": 200137,
      "solution_audio": null,
      "solution_video": null,
      "audio_explanation_heading": null,
      "video_explanation_heading": null,
      "solution_media_position": "bottom",
      "tags": [],
      "explanation_video": null,
      "question_images": [],
      "explanation_images": []
    },
    {
      "id": 50035,
      "choices": [
        {
          "id": 200140,
          "text": "<p><span style=\"font-size:12.0pt;\">Autoimmune adrenalitis</span></p>"
        },
        {
          "id": 200141,
          "text": "<p><span style=\"font-size:12.0pt;\">Hypernephroma</span></p>"
        },
        {
          "id": 200142,
          "text": "<p><span style=\"font-size:12.0pt;\">Adrenocortical carcinoma</span></p>"
        },
        {
          "id": 200143,
          "text": "<p><span style=\"font-size:12.0pt;\">Medullary carcinoma thyroid</span></p>"
        }
      ],
      "text": "<p><span style=\"font-size:12.0pt;\">Addison's disease is commonly associated with: (AIIMS NOV 2019)</span></p>",
      "unique_key": "Q2536562",
      "question_audio": null,
      "question_video": null,
      "map_id": 34442558,
      "difficulty_level": "intermediate",
      "subjects_id": [],
      "solution": "<p><span style=\"font-size:12.0pt;\"><strong>Ans. A) Autoimmune adrenalitis</strong></span></p><p> </p><p><span style=\"font-size:12pt;\">Addison's disease, primarily characterized by adrenal insufficiency, is most commonly associated with autoimmune adrenalitis. In this condition, the body's immune system attacks the adrenal cortex, leading to a decrease in the production of steroid hormones such as cortisol and aldosterone.</span></p><p> </p><p><span style=\"font-size:12pt;\"><strong>Other Options:</strong></span></p><p> </p><p><span style=\"font-size:12.0pt;\"><strong>Option B. Hypernephroma: </strong>Also known as renal cell carcinoma, hypernephroma is a type of kidney cancer and has no direct link to the adrenal function or Addison's disease.</span></p><p> </p><p><span style=\"font-size:12.0pt;\"><strong>Option C. Adrenocortical carcinoma: </strong>This is a cancer of the adrenal cortex but typically leads to excessive hormone production, associated more with Cushing's syndrome rather than Addison's disease, where there is hormone deficiency.</span></p><p> </p><p><span style=\"font-size:12.0pt;\"><strong>Option D. Medullary carcinoma of the thyroid: </strong>This type of cancer is associated with the thyroid gland and is related to multiple endocrine neoplasia type 2 (MEN2) syndrome but not directly linked to Addison's disease.</span></p><p> </p><p><span style=\"font-size:12.0pt;\"><strong>Educational Objective</strong>:</span></p><p> </p><p><span style=\"font-size:11.0pt;\">Addison's disease is most commonly caused by autoimmune adrenalitis, where the immune system mistakenly attacks the adrenal glands, leading to insufficient production of vital hormones.</span></p>",
      "correct_choice_id": 200140,
      "solution_audio": null,
      "solution_video": null,
      "audio_explanation_heading": null,
      "video_explanation_heading": null,
      "solution_media_position": "bottom",
      "tags": [],
      "explanation_video": null,
      "question_images": [],
      "explanation_images": []
    },
    {
      "id": 50036,
      "choices": [
        {
          "id": 200144,
          "text": "<p><span style=\"font-size:12.0pt;\">Increase in cAMP</span></p>"
        },
        {
          "id": 200145,
          "text": "<p><span style=\"font-size:12.0pt;\">Increase in cGMP</span></p>"
        },
        {
          "id": 200146,
          "text": "<p><span style=\"font-size:12.0pt;\">ADP ribosylation of EF2</span></p>"
        },
        {
          "id": 200147,
          "text": "<p><span style=\"font-size:12.0pt;\">RNA glycosidase</span></p>"
        }
      ],
      "text": "<p><span style=\"font-size:12.0pt;\">The toxin produced by the organisms shown below acts via? (INICET NOV 2019)</span></p><p> </p><p><img src=\"https://cerebellum-web-static.s3.amazonaws.com/media/public/images/2024/07/03/screenshot-2024-07-03-143517.png\" alt=\"\" width=\"300\" height=\"104\"></p><p><img src=\"https://cerebellum-web-static.s3.amazonaws.com/media/public/images/2024/07/03/screenshot-2024-07-03-143517.png\" alt=\"Question Image\"></p>",
      "unique_key": "Q3668125",
      "question_audio": null,
      "question_video": null,
      "map_id": 34068050,
      "difficulty_level": "intermediate",
      "subjects_id": [],
      "solution": "<p><span style=\"font-size:12.0pt;\"><strong>Ans. C) ADP ribosylation of EF2</strong></span></p><p> </p><p><span style=\"font-size:12.0pt;\">The given image shows <strong>gram-positive rods with club-shaped ends</strong>, beaded appearance, and a <strong>Chinese-letter pattern</strong> of arrangement indicative of Corynebacterium diphtheria.</span></p><p> </p><p><span style=\"font-size:12.0pt;\"><img src=\"https://cerebellum-web-static.s3.amazonaws.com/media/public/images/2024/07/01/screenshot-2024-07-01-110733.png\" alt=\"\" width=\"500\" height=\"438\"></span></p><p> </p><p><span style=\"font-size:12.0pt;\"><strong>Diphtheria toxin functions by selectively ADP-ribosylating ribosomal elongation factor, EF-2, attenuating protein synthesis </strong>and leading to cell death within a matter of hours. DT is a highly potent toxin. It is <strong>bacteriophage </strong>mediated.</span></p><p> </p><p><span style=\"font-size:12.0pt;\"><strong>NOTE: Pseudomonas </strong>toxin also inhibits protein synthesis by ADP ribosylation of EF2.</span></p><p> </p><p><span style=\"font-size:12.0pt;\"><img src=\"https://cerebellum-web-static.s3.amazonaws.com/media/public/images/2024/07/01/screenshot-2024-07-01-110821.png\" alt=\"\" width=\"600\" height=\"321\"></span></p><p> </p><p><span style=\"font-size:12.0pt;\"><strong>Other options:</strong></span></p><p> </p><p><span style=\"font-size:12.0pt;\"><strong>Option A. Increase in cAMP:</strong> This mechanism is typically associated with toxins such as cholera toxin and pertussis toxin, which lead to an increase in intracellular cyclic AMP (cAMP) by ADP-ribosylating G proteins, but not involved in the action of diphtheria toxin.</span></p><p> </p><p><span style=\"font-size:12.0pt;\"><strong>Option B. Increase in cGMP:</strong> This mechanism is not relevant to diphtheria toxin but is associated with certain bacterial toxins like heat-stable enterotoxin (ST) produced by E. coli, which increases cyclic GMP (cGMP) levels.</span></p><p> </p><p><span style=\"font-size:12.0pt;\"><strong>Option D. RNA glycosidase:</strong> This mechanism refers to Shiga toxin and ricin, which inhibit protein synthesis by enzymatically removing adenine from rRNA, but it is not the mode of action for diphtheria toxin.</span></p><p> </p><p><span style=\"font-size:12.0pt;\"><strong>Educational Objective:</strong></span></p><p> </p><p><span style=\"font-size:12.0pt;\">Diphtheria toxin acts by ADP-ribosylating elongation factor 2 (EF-2), thereby inhibiting protein synthesis and leading to cell death.</span></p><p><img src=\"https://cerebellum-web-static.s3.amazonaws.com/media/public/images/2024/07/01/screenshot-2024-07-01-110733.png\" alt=\"Solution Image\"></p>",
      "correct_choice_id": 200146,
      "solution_audio": null,
      "solution_video": null,
      "audio_explanation_heading": null,
      "video_explanation_heading": null,
      "solution_media_position": "bottom",
      "tags": [],
      "explanation_video": null,
      "question_images": [],
      "explanation_images": []
    },
    {
      "id": 50037,
      "choices": [
        {
          "id": 200148,
          "text": "<p><span style=\"font-size:11pt\"><span style=\"font-family:Arial,sans-serif\"><span dir=\"ltr\" lang=\"EN\" style=\"font-size:12.0pt\"><span style=\"font-family:\"Calibri\",sans-serif\">Repeat Inj. adenosine 6 mg</span></span></span></span></p>"
        },
        {
          "id": 200149,
          "text": "<p><span style=\"font-size:11pt\"><span style=\"font-family:Arial,sans-serif\"><span dir=\"ltr\" lang=\"EN\" style=\"font-size:12.0pt\"><span style=\"font-family:\"Calibri\",sans-serif\">Synchronized cardioversion</span></span></span></span></p>"
        },
        {
          "id": 200150,
          "text": "<p><span style=\"font-size:11pt\"><span style=\"font-family:Arial,sans-serif\"><span dir=\"ltr\" lang=\"EN\" style=\"font-size:12.0pt\"><span style=\"font-family:\"Calibri\",sans-serif\">Inj. amiodarone 300 mg</span></span></span></span></p>"
        },
        {
          "id": 200151,
          "text": "<p><span style=\"font-size:11pt\"><span style=\"font-family:Arial,sans-serif\"><span dir=\"ltr\" lang=\"EN\" style=\"font-size:12.0pt\"><span style=\"font-family:\"Calibri\",sans-serif\">DC cardioversion</span></span></span></span></p>"
        }
      ],
      "text": "<p><span dir=\"ltr\" lang=\"EN\" style=\"font-size:12.0pt\"><span style=\"font-family:\"Calibri\",sans-serif\">The ECG of a patient who presented to the ER is as given below. The patient was already given a carotid massage and IV Adenosine but the BP is currently 60/30 mm Hg. What is the next best step of management? (AIIMS NOV 2019)</span></span></p>\r\n\r\n<p> </p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Arial,sans-serif\"><span dir=\"ltr\" lang=\"EN\" style=\"font-size:12.0pt\"><span style=\"font-family:\"Calibri\",sans-serif\"><img alt=\"\" src=\"https://cerebellum-web-static.s3.amazonaws.com/media/public/images/2023/04/27/nm97.jpg\" style=\"height:296px; width:700px\" /></span></span></span></span></p><p><img src=\"https://cerebellum-web-static.s3.amazonaws.com/media/public/images/2023/04/27/nm97.jpg\" alt=\"Question Image\"></p>",
      "unique_key": "Q8109594",
      "question_audio": null,
      "question_video": null,
      "map_id": 34276083,
      "difficulty_level": "intermediate",
      "subjects_id": [],
      "solution": "<p><span style=\"font-size:11pt\"><span style=\"font-family:Arial,sans-serif\"><strong><span dir=\"ltr\" lang=\"EN\" style=\"font-size:12.0pt\"><span style=\"font-family:\"Calibri\",sans-serif\">Ans. B) </span></span></strong><strong><span dir=\"ltr\" lang=\"EN\" style=\"font-size:12.0pt\"><span style=\"font-family:\"Calibri\",sans-serif\">Synchronized Cardioversion</span></span></strong></span></span></p>\r\n\r\n<p> </p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Arial,sans-serif\"><span dir=\"ltr\" lang=\"EN\" style=\"font-size:12.0pt\"><span style=\"font-family:\"Calibri\",sans-serif\">Any hemodynamically unstable rhythm, requires synchronized cardioversion (Shock delivered in sync with R wave to prevent R-on T phenomenon). </span></span></span></span></p>\r\n\r\n<p> </p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Arial,sans-serif\"><strong><span dir=\"ltr\" lang=\"EN\" style=\"font-size:12.0pt\"><span style=\"font-family:\"Calibri\",sans-serif\">Synchronized Cardioversion </span></span></strong><span dir=\"ltr\" lang=\"EN\" style=\"font-size:12.0pt\"><span style=\"font-family:\"Calibri\",sans-serif\">is the correct choice for a hemodynamically unstable patient, as it is intended to restore normal heart rhythm without causing further cardiac risks. Synchronization ensures that the shock is delivered at a safe point in the QRS complex to prevent the induction of ventricular fibrillation.</span></span></span></span></p>\r\n\r\n<p> </p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Arial,sans-serif\"><strong><span dir=\"ltr\" lang=\"EN\" style=\"font-size:12.0pt\"><span style=\"font-family:\"Calibri\",sans-serif\">Other Options:</span></span></strong></span></span></p>\r\n\r\n<p> </p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Arial,sans-serif\"><strong><span dir=\"ltr\" lang=\"EN\" style=\"font-size:12.0pt\"><span style=\"font-family:\"Calibri\",sans-serif\">Option A. </span></span></strong><span dir=\"ltr\" lang=\"EN\" style=\"font-size:12.0pt\"><span style=\"font-family:\"Calibri\",sans-serif\">Maximum of 30mg of adenosine can be tried if patient is <em>Hemodynamically Stable</em></span></span></span></span></p>\r\n\r\n<p> </p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Arial,sans-serif\"><strong><span dir=\"ltr\" lang=\"EN\" style=\"font-size:12.0pt\"><span style=\"font-family:\"Calibri\",sans-serif\">Option C. </span></span></strong><span dir=\"ltr\" lang=\"EN\" style=\"font-size:12.0pt\"><span style=\"font-family:\"Calibri\",sans-serif\">Amiodarone is used in the treatment of chronic arrhythmias and rarely for acute treatment of SVT</span></span></span></span></p>\r\n\r\n<p> </p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Arial,sans-serif\"><span dir=\"ltr\" lang=\"EN\" style=\"font-size:12pt\"><span style=\"font-family:Calibri,sans-serif\"><strong>Option D.</strong> </span></span><span dir=\"ltr\" lang=\"EN\" style=\"font-size:12.0pt\"><span style=\"font-family:\"Calibri\",sans-serif\"><strong><span style=\"font-family:\"Calibri\",sans-serif\">DC cardioversion </span></strong>technically refers to the same treatment as synchronized cardioversion in the context of unstable rhythms but the lack of specification about synchronization could imply a risk if not properly timed.</span></span></span></span></p>\r\n\r\n<p> </p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Arial,sans-serif\"><span dir=\"ltr\" lang=\"EN\" style=\"font-size:12.0pt\"><span style=\"font-family:\"Calibri\",sans-serif\">Synchronised cardioversion avoid possibility of R on T phenomenon.</span></span></span></span></p>\r\n\r\n<p> </p>\r\n\r\n<p><img alt=\"\" src=\"https://cerebellum-web-static.s3.amazonaws.com/media/public/images/2024/09/11/screenshot-2024-09-11-112319.png\" style=\"height:445px; width:1000px\" /></p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Arial,sans-serif\"><span dir=\"ltr\" lang=\"EN\" style=\"font-size:12.0pt\"><span style=\"font-family:\"Calibri\",sans-serif\"><img alt=\"\" src=\"https://cerebellum-web-static.s3.amazonaws.com/media/public/images/2023/04/27/nm118.jpg\" style=\"height:364px; width:700px\" /></span></span></span></span></p>\r\n\r\n<p> </p>\r\n\r\n<p> </p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Arial,sans-serif\"><strong><span dir=\"ltr\" lang=\"EN\" style=\"font-size:12.0pt\"><span style=\"font-family:\"Calibri\",sans-serif\">Educational Objective:</span></span></strong></span></span></p>\r\n\r\n<p> </p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Arial,sans-serif\"><span dir=\"ltr\" lang=\"EN\" style=\"font-size:12.0pt\"><span style=\"font-family:\"Calibri\",sans-serif\">In cases of hemodynamically unstable tachyarrhythmias where initial pharmacological interventions fail, synchronized cardioversion should be promptly employed to stabilize the patient. This technique is crucial for preventing progression to more severe complications such as cardiac arrest.</span></span></span></span></p><p><img src=\"https://cerebellum-web-static.s3.amazonaws.com/media/public/images/2024/09/11/screenshot-2024-09-11-112319.png\" alt=\"Solution Image\"></p>",
      "correct_choice_id": 200149,
      "solution_audio": null,
      "solution_video": null,
      "audio_explanation_heading": null,
      "video_explanation_heading": null,
      "solution_media_position": "bottom",
      "tags": [],
      "explanation_video": null,
      "question_images": [],
      "explanation_images": []
    },
    {
      "id": 50038,
      "choices": [
        {
          "id": 200152,
          "text": "<p><span style=\"font-size:12.0pt;\">Washing hands with soap and water</span></p>"
        },
        {
          "id": 200153,
          "text": "<p><span style=\"font-size:12.0pt;\">Administration of tenofovir monotherapy</span></p>"
        },
        {
          "id": 200154,
          "text": "<p><span style=\"font-size:12.0pt;\">Measure baseline viral markers of health care worker immediately</span></p>"
        },
        {
          "id": 200155,
          "text": "<p><span style=\"font-size:12.0pt;\">Measure viral markers after 6 weeks</span></p>"
        }
      ],
      "text": "<p><span style=\"font-size:12.0pt;\">During a busy day at the outpatient clinic, a nurse accidentally sustains a needle stick injury while drawing blood from a patient known to have HIV. She asks for guidance on immediate management steps to mitigate her risk of acquiring the infection. Which of the following recommendations would NOT be appropriate? (AIIMS NOV 2019)</span></p>",
      "unique_key": "Q8565699",
      "question_audio": null,
      "question_video": null,
      "map_id": 34551936,
      "difficulty_level": "intermediate",
      "subjects_id": [],
      "solution": "<p><span style=\"font-size:12.0pt;\"><strong>Ans. B) Administration of tenofovir monotherapy</strong></span></p><p> </p><ul><li><span style=\"font-size:12.0pt;\">Triple drug PEP regimens are now the recommended regimens for all exposures owing to the safety and tolerability of new HIV drugs. Tenofovir 300mg + Lamivudine 300mg + Dolutegravir 50mg is recommended for HIV post-exposure prophylaxis (PEP), not monotherapy.</span></li><li><span style=\"font-size:12.0pt;\">Post-exposure prophylaxis for HIV consists of a comprehensive set of services to prevent infection developing in an exposed person, including first aid care; counselling and risk assessment; HIV testing and counselling; and, depending on the risk assessment, the short term (28 days) provision of antiretroviral drugs, with support and follow-up.</span></li></ul><p> </p><p><span style=\"font-size:12.0pt;\"><strong>Other Options:</strong></span></p><p> </p><p><span style=\"font-size:12.0pt;\"><strong>Option A. Washing hands with soap and water: </strong>This is an appropriate initial step.</span></p><p> </p><p><span style=\"font-size:12.0pt;\"><strong>Option C. Measure baseline viral markers of health care worker immediately: </strong>This is necessary to establish the baseline and monitor for any seroconversion.</span></p><p> </p><p><span style=\"font-size:12.0pt;\"><strong>Option D. Measure viral markers after 6 weeks: </strong>Follow-up testing is crucial to detect any potential infection.</span></p><p> </p><p><span style=\"font-size:12.0pt;\"><strong>Educational Objective:</strong></span></p><p> </p><ul><li><span style=\"font-size:12.0pt;\">For needle stick injuries involving HIV exposure, a triple drug regimen for post-exposure prophylaxis is recommended, not monotherapy.</span></li><li><span style=\"font-size:12.0pt;\">Immediate washing, baseline viral markers, and follow-up testing are also critical components of the management protocol.</span></li></ul>",
      "correct_choice_id": 200153,
      "solution_audio": null,
      "solution_video": null,
      "audio_explanation_heading": null,
      "video_explanation_heading": null,
      "solution_media_position": "bottom",
      "tags": [],
      "explanation_video": null,
      "question_images": [],
      "explanation_images": []
    },
    {
      "id": 50039,
      "choices": [
        {
          "id": 200156,
          "text": "<p><span style=\"font-size:12.0pt;\">Metabolic alkalosis</span></p>"
        },
        {
          "id": 200157,
          "text": "<p><span style=\"font-size:12.0pt;\">Metabolic acidosis</span></p>"
        },
        {
          "id": 200158,
          "text": "<p><span style=\"font-size:12.0pt;\">Respiratory alkalosis</span></p>"
        },
        {
          "id": 200159,
          "text": "<p><span style=\"font-size:12.0pt;\">Respiratory acidosis</span></p>"
        }
      ],
      "text": "<p><span style=\"font-size:12.0pt;\">A patient of hemophilia received multiple blood transfusions. Which of the following metabolic abnormalities can be seen in a patient? (AIIMS NOV 2019)</span></p>",
      "unique_key": "Q8311300",
      "question_audio": null,
      "question_video": null,
      "map_id": 34012822,
      "difficulty_level": "intermediate",
      "subjects_id": [],
      "solution": "<p><span style=\"font-size:12.0pt;\"><strong>Ans. A) Metabolic Alkalosis</strong></span></p><p> </p><p><span style=\"font-size:12.0pt;\">Metabolic alkalosis in a patient who received multiple blood transfusions arises primarily from the metabolism of citrate, used as a preservative in stored blood products.</span></p><p> </p><p><span style=\"font-size:12.0pt;\">Massive transfusion (MT) is defined as the replacement by transfusion of <i>10 units of pRBCs </i>in 24 hours or more than <i>4 units of pRBCs</i> in one hour.</span></p><p> </p><p><span style=\"font-size:12.0pt;\">Excess citrate preservative gets converted to bicarbonate causing Metabolic alkalosis</span></p><p> </p><p><span style=\"font-size:12.0pt;\"><strong>Other Options:</strong></span></p><p> </p><p><span style=\"font-size:12.0pt;\"><strong>Option B. Metabolic Acidosis: </strong>This condition would typically result from an accumulation of acids or loss of bicarbonate, which is not a direct consequence of blood transfusion.</span></p><p> </p><p><span style=\"font-size:12.0pt;\"><strong>Option C. Respiratory Alkalosis: </strong>Would involve hyperventilation leading to decreased carbon dioxide levels, unrelated to transfusion effects.</span></p><p> </p><p><span style=\"font-size:12.0pt;\"><strong>Option D. Respiratory Acidosis: </strong>Involves hypoventilation increasing carbon dioxide levels, which is also unrelated to the effects of blood transfusions.</span></p><p> </p><p><span style=\"font-size:12.0pt;\"><strong>Educational Objective:</strong></span></p><p> </p><p><span style=\"font-size:12.0pt;\">Metabolic alkalosis is a potential complication of multiple or massive blood transfusions due to the metabolism of citrate preservative into bicarbonate, emphasizing the importance of monitoring electrolytes and acid-base balance during such procedures.</span></p><p> </p><p><span style=\"font-size:12.0pt;\"><strong>Additional Information</strong></span></p><p> </p><p><img src=\"https://cerebellum-web-static.s3.amazonaws.com/media/public/images/2024/09/11/whatsapp-image-2024-09-11-at-101953-am.jpeg\" alt=\"\" width=\"1000\" height=\"1171\"><img src=\"https://cerebellum-web-static.s3.amazonaws.com/media/public/images/2024/09/11/whatsapp-image-2024-09-11-at-101953-am-1.jpeg\" alt=\"\" width=\"1000\" height=\"694\"></p><p> </p><p><span style=\"font-size:12.0pt;\"><strong><u>Delayed complications: </u></strong>GVHD, PTP, Infections</span></p><p><img src=\"https://cerebellum-web-static.s3.amazonaws.com/media/public/images/2024/09/11/whatsapp-image-2024-09-11-at-101953-am.jpeg\" alt=\"Solution Image\"></p>",
      "correct_choice_id": 200156,
      "solution_audio": null,
      "solution_video": null,
      "audio_explanation_heading": null,
      "video_explanation_heading": null,
      "solution_media_position": "bottom",
      "tags": [],
      "explanation_video": null,
      "question_images": [],
      "explanation_images": []
    },
    {
      "id": 50040,
      "choices": [
        {
          "id": 200160,
          "text": "<p><span style=\"font-size:12.0pt;\">Veress needle</span></p>"
        },
        {
          "id": 200161,
          "text": "<p><span style=\"font-size:12.0pt;\">Morris' needle</span></p>"
        },
        {
          "id": 200162,
          "text": "<p><span style=\"font-size:12.0pt;\">Yankauer suction tip</span></p>"
        },
        {
          "id": 200163,
          "text": "<p><span style=\"font-size:12.0pt;\">Von Graefe needle</span></p>"
        }
      ],
      "text": "<p><span style=\"font-size:12.0pt;\">Identify the instrument shown below used in laparoscopic surgeries?</span> <span style=\"font-size:12.0pt;\">(AIIMS NOV 2019)</span></p><p> </p><p><span style=\"font-size:12.0pt;\"><img src=\"https://cerebellum-web-static.s3.amazonaws.com/media/public/images/2023/05/06/untitled-660.jpg\" alt=\"\" width=\"334\" height=\"191\"></span></p><p><img src=\"https://cerebellum-web-static.s3.amazonaws.com/media/public/images/2023/05/06/untitled-660.jpg\" alt=\"Question Image\"></p>",
      "unique_key": "Q7874192",
      "question_audio": null,
      "question_video": null,
      "map_id": 34808452,
      "difficulty_level": "intermediate",
      "subjects_id": [],
      "solution": "<p><span style=\"font-size:12.0pt;\"><strong>Ans. A) Veress needle</strong></span></p><p> </p><p><span style=\"font-size:12.0pt;\">The instrument in the image is Veress Needle.</span></p><p> </p><p><span style=\"font-size:12.0pt;\">The Veress needle is a surgical instrument used to create pneumoperitoneum in laparoscopic surgeries. It consists of a long, slender needle with a sharp, pointed tip and a hollow center. The needle is attached to a handle and a valve that controls the flow of gas into the abdominal cavity.</span></p><p> </p><p><span style=\"font-size:12.0pt;\">The Veress needle is inserted into the abdominal cavity through a small incision, usually in the umbilicus (closed technique). The surgeon first lifts the abdominal wall away from the underlying organs and tissues, then inserts the Veress needle at a 45-degree angle to the skin and advances it until it reaches the abdominal cavity. The valve is then opened to allow gas (usually carbon dioxide) to flow into the abdominal cavity, creating a space for the laparoscope and other instruments.</span></p><p> </p><p><span style=\"font-size:12.0pt;\"><strong>Other Options:</strong></span></p><p> </p><p><span style=\"font-size:12.0pt;\"><strong>Option B. Morris' needle</strong>: This is not commonly used for pneumoperitoneum or laparoscopic access.</span></p><p> </p><p><span style=\"font-size:12.0pt;\"><strong>Option C. Yankauer suction tip</strong>: This is a suction instrument used to clear surgical sites of blood and fluids, not for gas insufflation.</span></p><p> </p><p><span style=\"font-size:12.0pt;\"><strong>Option D. Von Graefe needle</strong>: Primarily used in ophthalmic procedures, unrelated to laparoscopic surgery.</span></p><p> </p><p><span style=\"font-size:12.0pt;\"><strong>Educational Objective:</strong></span></p><p> </p><p><span style=\"font-size:12.0pt;\">The use of the Veress needle helps to minimize the risk of injury to surrounding organs and tissues during laparoscopic procedures. It is typically used at the beginning of the procedure, after which the laparoscope and other instruments are inserted through separate ports or trocars placed in the abdomen. The Veress needle is then removed and the incision closed.</span></p>",
      "correct_choice_id": 200160,
      "solution_audio": null,
      "solution_video": null,
      "audio_explanation_heading": null,
      "video_explanation_heading": null,
      "solution_media_position": "bottom",
      "tags": [],
      "explanation_video": null,
      "question_images": [],
      "explanation_images": []
    },
    {
      "id": 50041,
      "choices": [
        {
          "id": 200164,
          "text": "<p><span style=\"font-size:11pt\"><span style=\"font-family:Arial,sans-serif\"><span dir=\"ltr\" lang=\"EN\" style=\"font-size:12.0pt\"><span style=\"font-family:\"Calibri\",sans-serif\">Normal ABG</span></span></span></span></p>"
        },
        {
          "id": 200165,
          "text": "<p><span style=\"font-size:11pt\"><span style=\"font-family:Arial,sans-serif\"><span dir=\"ltr\" lang=\"EN\" style=\"font-size:12.0pt\"><span style=\"font-family:\"Calibri\",sans-serif\">Normal anion gap, metabolic acidosis</span></span></span></span></p>"
        },
        {
          "id": 200166,
          "text": "<p><span style=\"font-size:11pt\"><span style=\"font-family:Arial,sans-serif\"><span dir=\"ltr\" lang=\"EN\" style=\"font-size:12.0pt\"><span style=\"font-family:\"Calibri\",sans-serif\">High anion gap metabolic acidosis with metabolic alkalosis</span></span></span></span></p>"
        },
        {
          "id": 200167,
          "text": "<p><span style=\"font-size:11pt\"><span style=\"font-family:Arial,sans-serif\"><span dir=\"ltr\" lang=\"EN\" style=\"font-size:12.0pt\"><span style=\"font-family:\"Calibri\",sans-serif\">High anion gap metabolic alkalosis with normal metabolic acidosis</span></span></span></span></p>"
        }
      ],
      "text": "<p><span dir=\"ltr\" lang=\"EN\" style=\"font-size:12.0pt\"><span style=\"font-family:\"Calibri\",sans-serif\">A patient with renal failure develops vomiting in ICU. ABG analysis showed pH - 7.4, Na+ = 145 mEq/L, Cl- = 100 mEq/L, HC03- = 24mEq/L, PaC02 = 40 mmHg. What is the likely metabolic abnormality?</span></span><span dir=\"ltr\" lang=\"EN\" style=\"font-size:12.0pt\"><span style=\"font-family:\"Aptos\",sans-serif\"> (AIIMS NOV 2019)</span></span></p>",
      "unique_key": "Q2172049",
      "question_audio": null,
      "question_video": null,
      "map_id": 34067942,
      "difficulty_level": "intermediate",
      "subjects_id": [],
      "solution": "<p><span style=\"font-size:11pt\"><span style=\"font-family:Arial,sans-serif\"><strong><span dir=\"ltr\" lang=\"EN\" style=\"font-size:12.0pt\"><span style=\"font-family:\"Calibri\",sans-serif\">Ans. C) </span></span></strong><strong><span dir=\"ltr\" lang=\"EN\" style=\"font-size:12.0pt\"><span style=\"font-family:\"Calibri\",sans-serif\">High anion gap metabolic acidosis with metabolic alkalosis</span></span></strong></span></span></p>\r\n\r\n<p> </p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Arial,sans-serif\"><span dir=\"ltr\" lang=\"EN\" style=\"font-size:12.0pt\"><span style=\"font-family:\"Calibri\",sans-serif\">Clinical history of renal failure should hint towards possibility of preexisting metabolic acidosis. Important in MCQs to always calculate AG even if ABG appears normal.</span></span></span></span></p>\r\n\r\n<p> </p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Arial,sans-serif\"><span dir=\"ltr\" lang=\"EN\" style=\"font-size:12.0pt\"><span style=\"font-family:\"Calibri\",sans-serif\">AG: 145-(100+24) = 21 (Normal ~12)</span></span></span></span></p>\r\n\r\n<p> </p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Arial,sans-serif\"><span dir=\"ltr\" lang=\"EN\" style=\"font-size:12.0pt\"><span style=\"font-family:\"Calibri\",sans-serif\">Excess unmeasured anion(H) combines with HCO3 thereby reducing the HCO3 proportionately. </span></span></span></span></p>\r\n\r\n<p> </p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Arial,sans-serif\"><span dir=\"ltr\" lang=\"EN\" style=\"font-size:12.0pt\"><span style=\"font-family:\"Calibri\",sans-serif\">Hence Delta ratio i.e., ΔAG(AG-12) /ΔHCO3(24-HCO3) = >2.</span></span></span></span></p>\r\n\r\n<p> </p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Arial,sans-serif\"><span dir=\"ltr\" lang=\"EN\" style=\"font-size:12.0pt\"><span style=\"font-family:\"Calibri\",sans-serif\">Value >2 indicate coexisting Metabolic alkalosis</span></span></span></span></p>\r\n\r\n<p> </p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Arial,sans-serif\"><strong><span dir=\"ltr\" lang=\"EN\" style=\"font-size:12.0pt\"><span style=\"font-family:\"Calibri\",sans-serif\">Other Options:</span></span></strong></span></span></p>\r\n\r\n<p> </p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Arial,sans-serif\"><strong><span dir=\"ltr\" lang=\"EN\" style=\"font-size:12.0pt\"><span style=\"font-family:\"Calibri\",sans-serif\">Option A. Normal ABG: </span></span></strong><span dir=\"ltr\" lang=\"EN\" style=\"font-size:12.0pt\"><span style=\"font-family:\"Calibri\",sans-serif\">The pH is indeed normal, but the underlying disturbances (as reflected by an increased anion gap) indicate that the system is not normal.</span></span></span></span></p>\r\n\r\n<p> </p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Arial,sans-serif\"><strong><span dir=\"ltr\" lang=\"EN\" style=\"font-size:12.0pt\"><span style=\"font-family:\"Calibri\",sans-serif\">Option B. Normal anion gap, metabolic acidosis: </span></span></strong><span dir=\"ltr\" lang=\"EN\" style=\"font-size:12.0pt\"><span style=\"font-family:\"Calibri\",sans-serif\">The anion gap is increased, ruling out normal anion gap acidosis.</span></span></span></span></p>\r\n\r\n<p> </p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Arial,sans-serif\"><strong><span dir=\"ltr\" lang=\"EN\" style=\"font-size:12.0pt\"><span style=\"font-family:\"Calibri\",sans-serif\">Option D. High anion gap metabolic alkalosis with normal metabolic acidosis: </span></span></strong><span dir=\"ltr\" lang=\"EN\" style=\"font-size:12.0pt\"><span style=\"font-family:\"Calibri\",sans-serif\">This choice incorrectly identifies the nature of acid-base disturbances, confusing the interpretation and relationship between anion gap and bicarbonate levels.</span></span></span></span></p>\r\n\r\n<p> </p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Arial,sans-serif\"><strong><span dir=\"ltr\" lang=\"EN\" style=\"font-size:12.0pt\"><span style=\"font-family:\"Calibri\",sans-serif\">Educational Objective</span></span></strong><span dir=\"ltr\" lang=\"EN\" style=\"font-size:12.0pt\"><span style=\"font-family:\"Calibri\",sans-serif\">:</span></span></span></span></p>\r\n\r\n<p> </p>\r\n\r\n<p><span dir=\"ltr\" lang=\"EN\" style=\"font-size:11.0pt\"><span style=\"font-family:\"Calibri\",sans-serif\">In patients with renal failure and symptoms like vomiting, it's crucial to evaluate both the anion gap and changes in bicarbonate to identify complex acid-base disturbances such as the coexistence of high anion gap metabolic acidosis with metabolic alkalosis.</span></span></p>",
      "correct_choice_id": 200166,
      "solution_audio": null,
      "solution_video": null,
      "audio_explanation_heading": null,
      "video_explanation_heading": null,
      "solution_media_position": "bottom",
      "tags": [],
      "explanation_video": null,
      "question_images": [],
      "explanation_images": []
    },
    {
      "id": 50042,
      "choices": [
        {
          "id": 200168,
          "text": "<p><span style=\"font-size:12.0pt;\">Observe the patient for 2 hours post meal</span></p>"
        },
        {
          "id": 200169,
          "text": "<p><span style=\"font-size:12.0pt;\">Ask the psychiatrist to prescribe anti-anxiety medication</span></p>"
        },
        {
          "id": 200170,
          "text": "<p><span style=\"font-size:12.0pt;\">Increase the calories from 1500 to 2000 in her diet</span></p>"
        },
        {
          "id": 200171,
          "text": "<p><span style=\"font-size:12.0pt;\">Increase water intake</span></p>"
        }
      ],
      "text": "<p style=\"text-align:justify;\"><span style=\"font-size:12.0pt;\">A patient of anorexia nervosa was eating all her meals according to the prescribed diet chart but there is no change in her weight after 1 week. Which of the following needs to be done? (</span>AIIMS Nov 2019)</p>",
      "unique_key": "Q6933925",
      "question_audio": null,
      "question_video": null,
      "map_id": 34566988,
      "difficulty_level": "intermediate",
      "subjects_id": [],
      "solution": "<p><span style=\"font-size:12.0pt;\"><strong>Ans. A) Observe the patient for 2 hours post meal</strong></span></p><p> </p><p><span style=\"font-size:12.0pt;\">A lack of weight gain in an anorexia nervosa patient adhering to a diet can suggest surreptitious purging behaviors:</span></p><p> </p><p><span style=\"font-size:12.0pt;\">Observe the patient for 2 hours post meal: This helps in ensuring the patient isn't purging post-meal.</span></p><p> </p><p><span style=\"font-size:12.0pt;\"><strong>Other Options:</strong></span></p><p> </p><p><span style=\"font-size:12.0pt;\"><strong>Option B. Anti-anxiety medication: </strong>Anxiety is common in anorexia but doesn't directly address potential purging.</span></p><p> </p><p><span style=\"font-size:12.0pt;\"><strong>Option C. Increase calories: </strong>Confirm proper consumption and retention before adjusting calories.</span></p><p> </p><p><span style=\"font-size:12.0pt;\"><strong>Option D. Increase water intake:</strong> This won't address the primary concern and may introduce other issues.</span></p><p> </p><p><span style=\"font-size:12.0pt;\"><strong>Educational Objective: </strong></span></p><p> </p><p><span style=\"color:#374151;font-size:12.0pt;\">In patients with anorexia nervosa who are not gaining weight despite adherence to a meal plan, it's important to first rule out surreptitious purging behaviors. Observing the patient post-meal can help ensure that they are not engaging in behaviors like vomiting or excessive exercise after eating.</span></p><p> </p><p><span style=\"color:#374151;font-size:12.0pt;\"><strong>Reference: Shorter Oxford Textbook of Psychiatry, 7th edition, Page No 320.</strong></span></p>",
      "correct_choice_id": 200168,
      "solution_audio": null,
      "solution_video": null,
      "audio_explanation_heading": null,
      "video_explanation_heading": null,
      "solution_media_position": "bottom",
      "tags": [],
      "explanation_video": null,
      "question_images": [],
      "explanation_images": []
    },
    {
      "id": 50043,
      "choices": [
        {
          "id": 200172,
          "text": "<p><span style=\"font-size:12.0pt;\">Direct observation with a structured checklist</span></p>"
        },
        {
          "id": 200173,
          "text": "<p><span style=\"font-size:12.0pt;\">Closed circuit camera surveillance</span></p>"
        },
        {
          "id": 200174,
          "text": "<p><span style=\"font-size:12.0pt;\">In-depth interview with the patient</span></p>"
        },
        {
          "id": 200175,
          "text": "<p><span style=\"font-size:12.0pt;\">In-depth interview with the healthcare provider</span></p>"
        }
      ],
      "text": "<p><span style=\"font-size:12.0pt;\">A newly established hospital aims to maintain the highest standards of care and ensure patient safety by standardizing injection practices among health workers. They seek a reliable method for real-time assessment of these practices. Which of the following would be the most appropriate method to monitor the injection practices of health workers? (AIIMS NOV 2019)</span></p>",
      "unique_key": "Q1160945",
      "question_audio": null,
      "question_video": null,
      "map_id": 34407038,
      "difficulty_level": "intermediate",
      "subjects_id": [],
      "solution": "<p><span style=\"font-size:12.0pt;\"><strong>Ans. A) Direct observation with a structured checklist</strong></span></p><p> </p><ul><li><span style=\"font-size:12.0pt;\">The most effective approach for assessing the injection practices of healthcare workers is through direct observation using a structured checklist.</span></li><li><span style=\"font-size:12.0pt;\">This method allows for real-time, accurate assessment of adherence to aseptic techniques and best practices.</span></li><li><span style=\"font-size:12.0pt;\">A structured checklist ensures all critical steps are monitored and recorded systematically.</span></li></ul><p> </p><p><span style=\"font-size:12.0pt;\"><strong>Other Options:</strong></span></p><p> </p><p><span style=\"font-size:12.0pt;\"><strong>Option B. Closed circuit camera surveillance: </strong>While it may offer some insights, it lacks the detail and real-time assessment provided by direct observation.</span></p><p> </p><p><span style=\"font-size:12.0pt;\"><strong>Option C. In-depth interview with the patient: </strong>Patients may not have the expertise to accurately comment on the technical aspects of injection practices.</span></p><p> </p><p><span style=\"font-size:12.0pt;\"><strong>Option D. In-depth interview with the healthcare provider: </strong>This relies on self-reporting, which may be biased and not always accurate.</span></p><p> </p><p><span style=\"font-size:12.0pt;\"><strong>Educational Objective:</strong></span></p><p> </p><ul><li><span style=\"font-size:12.0pt;\">The most effective approach for assessing the injection practices of healthcare workers is through direct observation using a structured checklist.</span></li></ul><p> </p><p><img src=\"https://cerebellum-web-static.s3.amazonaws.com/media/public/images/2024/09/21/screenshot-2024-09-21-104556.png\" alt=\"\" width=\"1000\" height=\"874\"></p><p><img src=\"https://cerebellum-web-static.s3.amazonaws.com/media/public/images/2024/09/21/screenshot-2024-09-21-104556.png\" alt=\"Solution Image\"></p>",
      "correct_choice_id": 200172,
      "solution_audio": null,
      "solution_video": null,
      "audio_explanation_heading": null,
      "video_explanation_heading": null,
      "solution_media_position": "bottom",
      "tags": [],
      "explanation_video": null,
      "question_images": [],
      "explanation_images": []
    },
    {
      "id": 50044,
      "choices": [
        {
          "id": 200176,
          "text": "<p><span style=\"font-size:12.0pt;\">Both assertion and reason are true and the reason is the correct explanation of the assertion.</span></p>"
        },
        {
          "id": 200177,
          "text": "<p><span style=\"font-size:12.0pt;\">Both the assertion and reason are true statements, but the reason is not the correct explanation of the assertion.</span></p>"
        },
        {
          "id": 200178,
          "text": "<p><span style=\"font-size:12.0pt;\">Assertion is true but the reason is false.</span></p>"
        },
        {
          "id": 200179,
          "text": "<p><span style=\"font-size:12.0pt;\">Assertion is false but the reason is true.</span></p>"
        }
      ],
      "text": "<p><span style=\"font-size:16px;\"><strong>Assertion</strong>: Ultrasonography is the primary imaging modality for the screening and diagnosis of IVH and parenchymal hemorrhage in neonates.</span></p><p> </p><p><span style=\"font-size:16px;\"><strong>Reason</strong>: The posterior fontanelle offers a good acoustic window for imaging using USG.</span></p>",
      "unique_key": "Q9177600",
      "question_audio": null,
      "question_video": null,
      "map_id": 34582694,
      "difficulty_level": "intermediate",
      "subjects_id": [],
      "solution": "<p><span style=\"font-size:16px;\"><strong>Ans. C) Assertion is true but the reason is false.</strong></span></p><p> </p><p><span style=\"font-size:16px;\">Ultrasonography (USG) is indeed the primary imaging modality for screening and diagnosing intraventricular hemorrhage (IVH) and parenchymal hemorrhage in neonates. This is because USG is non-invasive, quick, safe, and can be easily performed at the bedside, which is ideal for neonates in a critical care setting.</span></p><p> </p><p><span style=\"font-size:16px;\">The assertion is correct, but the reason given is incorrect. The appropriate acoustic window for imaging IVH and other intracranial structures in neonates is the anterior fontanelle, not the posterior fontanelle. The anterior fontanelle provides a larger and more accessible window, which is optimal for visualizing the brain structures in detail.</span></p><p> </p><p><span style=\"font-size:16px;\">Neonates at high risk for IVH, such as those with a gestational age below 32 weeks or a birth weight under 1500 grams, should undergo routine screening. Additionally, more mature preterm infants (32-34 weeks) should also be considered for screening if they experience complications postnatally, such as shock, unexplained anemia, or severe respiratory distress requiring mechanical ventilation.</span></p><p> </p><p><span style=\"font-size:16px;\"><strong>Educational Objective:</strong></span></p><p> </p><p><span style=\"font-size:16px;\">The anterior fontanelle, not the posterior, is the primary acoustic window used in ultrasonography for imaging intracranial structures in neonates.</span></p>",
      "correct_choice_id": 200178,
      "solution_audio": null,
      "solution_video": null,
      "audio_explanation_heading": null,
      "video_explanation_heading": null,
      "solution_media_position": "bottom",
      "tags": [],
      "explanation_video": null,
      "question_images": [],
      "explanation_images": []
    },
    {
      "id": 50045,
      "choices": [
        {
          "id": 200180,
          "text": "<p><span style=\"font-size:12.0pt;\">Roots</span></p>"
        },
        {
          "id": 200181,
          "text": "<p><span style=\"font-size:12.0pt;\">Cords</span></p>"
        },
        {
          "id": 200182,
          "text": "<p><span style=\"font-size:12.0pt;\">Trunks</span></p>"
        },
        {
          "id": 200183,
          "text": "<p><span style=\"font-size:12.0pt;\">Divisions</span></p>"
        }
      ],
      "text": "<p><span style=\"font-size:12.0pt;\">Which of the following structures of brachial plexus do not give branches? (</span>AIIMS Nov 2019)</p>",
      "unique_key": "Q5254194",
      "question_audio": null,
      "question_video": null,
      "map_id": 34364532,
      "difficulty_level": "intermediate",
      "subjects_id": [],
      "solution": "<p><span style=\"font-size:12.0pt;\"><strong>Ans. D. Divisions</strong></span></p><p> </p><p><span style=\"font-size:12.0pt;\"><strong>Explanation:</strong></span></p><p> </p><p><span style=\"font-size:12.0pt;\">The divisions in the brachial plexus do not give any branches.</span></p><p> </p><p><span style=\"font-size:12.0pt;\">However, the roots, trunks, and cords of the brachial plexus give out direct branches.</span></p><p> </p><p><span style=\"font-size:12.0pt;\">The brachial plexus is a complex network of nerves that originates from the ventral rami of the fifth cervical to the first thoracic spinal nerves (C5-T1). The brachial plexus is typically organized into five stages: roots, trunks, divisions, cords, and terminal branches.</span></p><p> </p><p><span style=\"font-size:12.0pt;\"><strong>Other Options:</strong></span></p><p> </p><p><span style=\"font-size:12.0pt;\"><strong>Option A. Roots:</strong> The roots of the brachial plexus are the five ventral rami (C5-T1) that serve as the origin of the brachial plexus. These roots give off several branches:</span></p><p> </p><ul><li><span style=\"font-size:12.0pt;\">C5 root can contribute to the dorsal scapular nerve.</span></li><li><span style=\"font-size:12.0pt;\">C5 and C6 roots together give rise to the upper trunk, but before they merge, they can give off the nerve to the subclavius muscle (from C5 and C6).</span></li><li><span style=\"font-size:12.0pt;\">C8 and T1 roots can contribute to the long thoracic nerve along with C7 root.</span></li></ul><p> </p><p><span style=\"font-size:12.0pt;\"><strong>Option B. Cords:</strong> The cords are named based on their position relative to the axillary artery: lateral, medial, and posterior cords.</span></p><p> </p><ul><li><span style=\"font-size:12.0pt;\">The lateral cord gives branches like the lateral pectoral nerve.</span></li><li><span style=\"font-size:12.0pt;\">The medial cord gives branches like the medial pectoral, medial cutaneous nerve of arm, and medial cutaneous nerve of forearm.</span></li><li><span style=\"font-size:12.0pt;\">The posterior cord provides branches like the upper subscapular, thoracodorsal, and lower subscapular nerves.</span></li></ul><p> </p><p><span style=\"font-size:12.0pt;\"><strong>Option C. Trunks:</strong> There are three trunks in the brachial plexus: upper, middle, and lower.</span></p><p> </p><ul><li><span style=\"font-size:12.0pt;\">The upper trunk is formed by the union of C5 and C6 roots and gives off the suprascapular nerve and the nerve to the omohyoid muscle.</span></li><li><span style=\"font-size:12.0pt;\">The middle and lower trunks usually do not give any significant branches.</span></li></ul><p> </p><p><span style=\"font-size:12.0pt;\"><strong>Educational Objective:</strong></span></p><p> </p><p><span style=\"font-size:12.0pt;\">Each trunk divides into two divisions: an anterior division and a posterior division. The divisions do not provide any branches.</span></p><p> </p><p><span style=\"font-size:12.0pt;\"><img src=\"https://cerebellum-web-static.s3.amazonaws.com/media/public/images/2024/05/16/screenshot-2024-05-16-174639.JPG\" alt=\"\" width=\"500\" height=\"389\"></span></p><p><img src=\"https://cerebellum-web-static.s3.amazonaws.com/media/public/images/2024/05/16/screenshot-2024-05-16-174639.JPG\" alt=\"Solution Image\"></p>",
      "correct_choice_id": 200183,
      "solution_audio": null,
      "solution_video": null,
      "audio_explanation_heading": null,
      "video_explanation_heading": null,
      "solution_media_position": "bottom",
      "tags": [],
      "explanation_video": null,
      "question_images": [],
      "explanation_images": []
    },
    {
      "id": 50046,
      "choices": [
        {
          "id": 200184,
          "text": "<p><span style=\"font-size:12.0pt;\">Cardiac tamponade</span></p>"
        },
        {
          "id": 200185,
          "text": "<p><span style=\"font-size:12.0pt;\">Restrictive cardiomyopathy</span></p>"
        },
        {
          "id": 200186,
          "text": "<p><span style=\"font-size:12.0pt;\">Constrictive pericarditis</span></p>"
        },
        {
          "id": 200187,
          "text": "<p><span style=\"font-size:12.0pt;\">Tricuspid regurgitation</span></p>"
        }
      ],
      "text": "<p><span style=\"font-size:12.0pt;\">Deep y descent in Jugular Venous Pressure (JVP) is seen in all of the following conditions except: (AIIMS NOV 2019)</span></p>",
      "unique_key": "Q5786172",
      "question_audio": null,
      "question_video": null,
      "map_id": 34001982,
      "difficulty_level": "intermediate",
      "subjects_id": [],
      "solution": "<p><span style=\"font-size:12.0pt;\"><strong>Ans. A) Cardiac Tamponade</strong></span></p><p> </p><p><span style=\"font-size:12.0pt;\">Deep y descent in JVP (Jugular venous pressure) is a characteristic finding in several conditions that affect the filling of the right ventricle. These conditions include constrictive pericarditis, restrictive cardiomyopathy, and tricuspid regurgitation.</span></p><p> </p><p><span style=\"font-size:12.0pt;\">Cardiac tamponade, as it is associated with a blunted y descent in JVP rather than a deep y descent. In cardiac tamponade, the pericardial fluid accumulation restricts cardiac filling, leading to a decrease in the amplitude of the y descent.</span></p><p> </p><p><span style=\"font-size:12.0pt;\"><strong>Other Options:</strong></span></p><p> </p><p><span style=\"font-size:12.0pt;\"><strong>Option B. Restrictive cardiomyopathy: </strong>This condition can cause a deep y descent due to the stiff ventricular walls allowing rapid passive filling only during early diastole.</span></p><p> </p><p><span style=\"font-size:12.0pt;\"><strong>Option C. Constrictive pericarditis: </strong>Similar to restrictive cardiomyopathy, constrictive pericarditis also shows a rapid early diastolic filling as the rigid pericardium constricts ventricular filling in late diastole, leading to a pronounced y descent.</span></p><p> </p><p><span style=\"font-size:12.0pt;\"><strong>Option D. Tricuspid regurgitation: </strong>In tricuspid regurgitation, right atrial emptying occurs without the normal resistance posed by a competent tricuspid valve, often resulting in a prominent y descent.</span></p><p> </p><p><span style=\"font-size:12.0pt;\"><strong>Educational Objective</strong>:</span></p><p> </p><p><span style=\"font-size:12pt;\">In cardiac tamponade, the presence of fluid in the pericardial space restricts all phases of cardiac filling, leading to a blunted or absent y descent, differentiating it from conditions where a deep y descent is observed.</span></p>",
      "correct_choice_id": 200184,
      "solution_audio": null,
      "solution_video": null,
      "audio_explanation_heading": null,
      "video_explanation_heading": null,
      "solution_media_position": "bottom",
      "tags": [],
      "explanation_video": null,
      "question_images": [],
      "explanation_images": []
    },
    {
      "id": 50047,
      "choices": [
        {
          "id": 200188,
          "text": "<p><span style=\"font-size:12.0pt;\">1-b, 2-c, 3-a, 4-d</span></p>"
        },
        {
          "id": 200189,
          "text": "<p><span style=\"font-size:12.0pt;\">1-c, 2-b, 3-d, 4-a</span></p>"
        },
        {
          "id": 200190,
          "text": "<p><span style=\"font-size:12.0pt;\">1-a, 2-d, 3-c, 4-b</span></p>"
        },
        {
          "id": 200191,
          "text": "<p><span style=\"font-size:12.0pt;\">1-d, 2-a, 3-b, 4-c</span></p>"
        }
      ],
      "text": "<p><span style=\"font-size:16px;\">Match the items in Column A with their correct description in Column B: </span></p><p> </p><p><span style=\"font-size:16px;\"><strong>Column A:</strong></span></p><p><span style=\"font-size:16px;\">1. Primary survey</span></p><p><span style=\"font-size:16px;\">2. Secondary survey</span></p><p><span style=\"font-size:16px;\">3. Definitive care</span></p><p><span style=\"font-size:16px;\">4. Resuscitation</span></p><p> </p><p><span style=\"font-size:16px;\"><strong>Column B:</strong></span><br><span style=\"font-size:16px;\">a. Make a management plan</span><br><span style=\"font-size:16px;\">b. Identify what can cause death</span><br><span style=\"font-size:16px;\">c. Identify other injuries</span><br><span style=\"font-size:16px;\">d. Treat what can cause death</span></p>",
      "unique_key": "Q3617266",
      "question_audio": null,
      "question_video": null,
      "map_id": 34485104,
      "difficulty_level": "intermediate",
      "subjects_id": [],
      "solution": "<p><span style=\"font-size:16px;\"><strong>Ans. A)  1-b, 2-c, 3-a, 4-d</strong></span></p><p><br><span style=\"font-size:16px;\">The steps outlined are part of the Advanced Trauma Life Support (ATLS) protocol, designed to assess and manage trauma patients systematically.</span></p><p> </p><ul style=\"list-style-type:disc;\"><li><span style=\"font-size:16px;\"><strong>Primary Survey</strong> involves the ABCDE approach (Airway, Breathing, Circulation, Disability, Exposure), focusing on identifying and treating immediate life-threatening issues. It emphasizes identifying what can cause death.</span></li><li><span style=\"font-size:16px;\"><strong>Secondary Survey</strong> is a thorough head-to-toe evaluation after initial stabilization. This step is intended to identify other injuries that may not be immediately life-threatening.</span></li><li><span style=\"font-size:16px;\"><strong>Definitive Care</strong> involves creating a comprehensive treatment plan based on findings from the primary and secondary surveys, hence making a management plan.</span></li><li><span style=\"font-size:16px;\"><strong>Resuscitation</strong> is simultaneous with the primary survey to stabilize vital signs and provide essential interventions, focusing on treating what can cause death immediately, such as hemorrhage control and airway support.</span></li></ul><p> </p><p><span style=\"font-size:16px;\"><strong>Educational Objective:</strong></span></p><p> </p><p><span style=\"font-size:16px;\">ATLS protocol steps emphasize a structured approach for trauma assessment, prioritizing immediate life-threatening conditions first, followed by a comprehensive examination and a definitive management plan.</span></p><p> </p><ol><li><span style=\"font-size:16px;\">Primary survey -<strong> Identify what can cause death</strong></span></li><li><span style=\"font-size:16px;\">Secondary survey -<strong> Identify other injuries</strong></span></li><li><span style=\"font-size:16px;\">Definitive care - <strong>Make a management plan</strong></span></li><li><span style=\"font-size:16px;\">Resuscitation - <strong>Treat what can cause death</strong></span></li></ol>",
      "correct_choice_id": 200188,
      "solution_audio": null,
      "solution_video": null,
      "audio_explanation_heading": null,
      "video_explanation_heading": null,
      "solution_media_position": "bottom",
      "tags": [],
      "explanation_video": null,
      "question_images": [],
      "explanation_images": []
    },
    {
      "id": 50048,
      "choices": [
        {
          "id": 200192,
          "text": "<p><span style=\"font-size:12.0pt;\">1-B, 2-D, 3-A, 4-C</span></p>"
        },
        {
          "id": 200193,
          "text": "<p><span style=\"font-size:12.0pt;\">1-A, 2-B, 3-C, 4-D</span></p>"
        },
        {
          "id": 200194,
          "text": "<p><span style=\"font-size:12.0pt;\">1-C, 2-A, 3-D, 4-B</span></p>"
        },
        {
          "id": 200195,
          "text": "<p><span style=\"font-size:12.0pt;\">1-D, 2-C, 3-B, 4-A</span></p>"
        }
      ],
      "text": "<p><span style=\"font-size:12.0pt;\">Match the snakes with the corresponding images: </span></p><p> </p><p style=\"text-align:justify;\"><span style=\"font-size:12.0pt;\"><strong>Column A:</strong></span></p><p><span style=\"font-size:12.0pt;\">1. Cobra</span></p><p><span style=\"font-size:12.0pt;\">2. Viper</span></p><p><span style=\"font-size:12.0pt;\">3. Python</span></p><p style=\"text-align:justify;\"><span style=\"font-size:12.0pt;\">4. Krait</span></p><p style=\"text-align:justify;\"> </p><p style=\"text-align:justify;\"><span style=\"font-size:12.0pt;\"><strong>Column B:</strong></span></p><p style=\"text-align:justify;\"><span style=\"font-size:12.0pt;\"><strong><img src=\"https://cerebellum-web-static.s3.amazonaws.com/media/public/Screenshot%202024-11-12%20123247.jpg\" width=\"685\" height=\"582\"></strong></span></p><p><img src=\"https://cerebellum-web-static.s3.amazonaws.com/media/public/Screenshot%202024-11-12%20123247.jpg\" alt=\"Question Image\"></p>",
      "unique_key": "Q9471355",
      "question_audio": null,
      "question_video": null,
      "map_id": 34930482,
      "difficulty_level": "intermediate",
      "subjects_id": [],
      "solution": "<p><span style=\"font-size:16px;\"><strong>Ans. A) 1-B, 2-D, 3-A, 4-C</strong></span></p><p><br><span style=\"font-size:16px;\">The correct matches between Column A (snakes) and Column B (images) are based on identifying features unique to each snake:</span></p><p> </p><ol><li><span style=\"font-size:16px;\"><strong>Cobra (1 - B)</strong>: The cobra is identified by its hood and characteristic spectacle mark. In the images, Image B shows a hooded snake with this mark, which is typical of cobras.</span></li><li><span style=\"font-size:16px;\"><strong>Viper (2 - D)</strong>: Vipers usually have thick bodies and distinctive diamond or blotched patterns. Image D shows a snake with diamond-shaped patterns on its body, which aligns with the viper's appearance.</span></li><li><span style=\"font-size:16px;\"><strong>Python (3 - A)</strong>: Pythons are generally large and thick-bodied, with irregular circular markings. Image A displays these features, which are characteristic of pythons.</span></li><li><span style=\"font-size:16px;\"><strong>Krait (4 - C)</strong>: Kraits are slender snakes with alternating bands. Image C shows a snake with white bands on a darker body, which matches the appearance of a krait.</span></li></ol><p> </p><p><span style=\"font-size:16px;\"><strong>Educational Objective:</strong></span></p><p> </p><ul style=\"list-style-type:disc;\"><li><span style=\"font-size:16px;\"><strong>Cobra</strong> - Hooded with spectacle mark</span></li><li><span style=\"font-size:16px;\"><strong>Viper</strong> - Diamond-shaped spots</span></li><li><span style=\"font-size:16px;\"><strong>Python</strong> - Thick and large</span></li><li><span style=\"font-size:16px;\"><strong>Krait</strong> - White bands on body</span></li></ul>",
      "correct_choice_id": 200192,
      "solution_audio": null,
      "solution_video": null,
      "audio_explanation_heading": null,
      "video_explanation_heading": null,
      "solution_media_position": "bottom",
      "tags": [],
      "explanation_video": null,
      "question_images": [],
      "explanation_images": []
    },
    {
      "id": 50049,
      "choices": [
        {
          "id": 200196,
          "text": "<p><span style=\"font-size:12.0pt;\">Alport syndrome</span></p>"
        },
        {
          "id": 200197,
          "text": "<p><span style=\"font-size:12.0pt;\">Goodpasture syndrome</span></p>"
        },
        {
          "id": 200198,
          "text": "<p><span style=\"font-size:12.0pt;\">IgA nephropathy</span></p>"
        },
        {
          "id": 200199,
          "text": "<p><span style=\"font-size:12.0pt;\">PSGN</span></p>"
        }
      ],
      "text": "<p><span style=\"font-size:12.0pt;\">An 8-year-old boy with sensorineural hearing loss and eye defects presents to the OPD with hematuria. His renal biopsy on light microscopy was normal. Family history reveals the maternal uncle had Gr 5 CKD and is undergoing dialysis. Which of the following would be the probable diagnosis? (AIIMS NOV 2019)</span></p>",
      "unique_key": "Q9451585",
      "question_audio": null,
      "question_video": null,
      "map_id": 34232215,
      "difficulty_level": "intermediate",
      "subjects_id": [],
      "solution": "<p><span style=\"font-size:12.0pt;\"><strong>Ans. A) Alport syndrome.</strong></span></p><p> </p><p><img src=\"https://cerebellum-web-static.s3.amazonaws.com/media/public/images/2024/09/17/screenshot-2024-09-17-141312.png\" alt=\"\" width=\"1000\" height=\"549\"></p><p> </p><p><img src=\"https://cerebellum-web-static.s3.amazonaws.com/media/public/images/2023/04/13/108.jpg\" alt=\"\" width=\"491\" height=\"366\"></p><p> </p><p><span style=\"font-size:12.0pt;\">A, Alport syndrome (EM), Note the presence of both the characteristic “basket- weave” change (asterisks) and thinning of the GBM (arrows).</span></p><p> </p><p><span style=\"font-size:12.0pt;\"><strong>Other Options:</strong></span></p><p> </p><p><span style=\"font-size:12.0pt;\"><strong>Option B. Goodpasture syndrome</strong>: Goodpasture syndrome is an immune-mediated disease characterised by antibodies against the alpha-3 chain of GBM type IV collagen; it is not hereditary, and light microscopy reveals extracapillary growth with crescents and necrosis.</span></p><p> </p><p><span style=\"font-size:12pt;\"><strong>Option C.</strong></span><span style=\"font-size:14px;\"><strong> </strong></span><span style=\"font-size:12.0pt;\"><strong>IgA nephropathy</strong></span><span style=\"font-size:12pt;\">: In IgA nephropathy, light microscopy would demonstrate focal mesangial proliferative glomerulonephritis and mesangial widening.</span></p><p> </p><p><span style=\"font-size:12.0pt;\"><strong>Option D.</strong></span><span style=\"font-size:10.5pt;\"><strong> </strong></span><span style=\"font-size:12.0pt;\"><strong>PSGN</strong>:  In PSGN, light microscopy would reveal diffuse endocapillary proliferation with concomitant leukocytic infiltration in LM.</span></p><p> </p><p><span style=\"font-size:12.0pt;\"><strong>Educational Objective:</strong></span></p><p> </p><p><span style=\"font-size:12pt;\">Alport syndrome is a genetic disorder characterized by hematuria, sensorineural hearing loss, and ocular abnormalities, with characteristic findings on electron microscopy, including a \"basket-weave\" appearance of the glomerular basement membrane.</span></p><p><img src=\"https://cerebellum-web-static.s3.amazonaws.com/media/public/images/2024/09/17/screenshot-2024-09-17-141312.png\" alt=\"Solution Image\"></p>",
      "correct_choice_id": 200196,
      "solution_audio": null,
      "solution_video": null,
      "audio_explanation_heading": null,
      "video_explanation_heading": null,
      "solution_media_position": "bottom",
      "tags": [],
      "explanation_video": null,
      "question_images": [],
      "explanation_images": []
    },
    {
      "id": 50050,
      "choices": [
        {
          "id": 200200,
          "text": "<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\">Neostigmine</span></span></span></p>"
        },
        {
          "id": 200201,
          "text": "<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\">Atropine</span></span></span></p>"
        },
        {
          "id": 200202,
          "text": "<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\">Flumazenil</span></span></span></p>"
        },
        {
          "id": 200203,
          "text": "<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\">Physostigmine</span></span></span></p>"
        }
      ],
      "text": "<p style=\"text-align:justify\"><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\"><span style=\"font-family:\"Calibri\",sans-serif\">A patient presented to emergency with overdose some drug. There were increased salivation and increased bronchial secretions. On examination, blood pressure was 88/60 mmHg. RBC esterase level is 50. What should be the treatment of this person?</span></span>(AIIMS NOV 2019)</p>",
      "unique_key": "Q3258555",
      "question_audio": null,
      "question_video": null,
      "map_id": 34045785,
      "difficulty_level": "intermediate",
      "subjects_id": [],
      "solution": "<p><span style=\"font-size:12pt\"><span style=\"font-family:\"Liberation Serif\",serif\"><strong><span dir=\"ltr\" lang=\"EN-US\" style=\"font-family:\"Calibri\",sans-serif\"><span style=\"color:#333333\">Ans. B. Atropine</span></span></strong></span></span></p>\r\n\r\n<p> </p>\r\n\r\n<ul>\r\n\t<li><span style=\"font-size:12pt\"><span style=\"font-family:\"Liberation Serif\",serif\"><span dir=\"ltr\" lang=\"EN-US\" style=\"font-family:\"Calibri\",sans-serif\"><span style=\"color:#333333\">Low esterase levels are suggestive of overdose of some drug which acts by inhibiting acetyl choline esterase like organophosphate poisoning.</span></span></span></span></li>\r\n\t<li><span style=\"font-size:12pt\"><span style=\"font-family:\"Liberation Serif\",serif\"><span dir=\"ltr\" lang=\"EN-US\" style=\"font-family:\"Calibri\",sans-serif\"><span style=\"color:#333333\">Inhibition of choline esterase results in increased amount of Ach at synapse, so poisoning or overdose results in cholinergic symptoms like salivation, lacrimation, urination, emesis, increased bronchial secretions, and reduction in blood pressure.<br />\r\n\tSo treatment of choice is Atropine.</span></span></span></span></li>\r\n\t<li><span style=\"font-size:12pt\"><span style=\"font-family:\"Liberation Serif\",serif\"><span dir=\"ltr\" lang=\"EN-US\" style=\"font-family:\"Calibri\",sans-serif\"><span style=\"color:#333333\">Atropine - It is highly effective in counter-acting the muscarinic symptoms, but higher doses are required to antagonize the central effects. It does not reverse peripheral muscular paralysis which is a nicotinic action. All cases of anti-ChE (carbamate or organophosphate) poisoning must be promptly treated with atropine 2 mg i.v. repeated every 10 min till dryness of mouth or other signs of atropinization appear (upto 200 mg has been administered in a day). Continued treatment with maintenance doses may be required for 1-2 weeks.</span></span></span></span></li>\r\n</ul>\r\n\r\n<h3> </h3>\r\n\r\n<h3><span style=\"font-size:13.5pt\"><span style=\"font-family:\"Times New Roman\",serif\"><strong><span style=\"font-size:12.0pt\"><span style=\"font-family:\"Calibri\",sans-serif\">Other Options:</span></span></strong></span></span></h3>\r\n\r\n<p> </p>\r\n\r\n<p><span style=\"font-size:12pt\"><span style=\"font-family:\"Times New Roman\",serif\"><strong><span style=\"font-family:\"Calibri\",sans-serif\">Option <strong><span style=\"font-family:\"Calibri\",sans-serif\">A. Neostigmine: </span></strong></span></strong><span style=\"font-family:\"Calibri\",sans-serif\">Neostigmine is incorrect as it is an acetylcholine esterase inhibitor, which would worsen the cholinergic symptoms by increasing acetylcholine levels further.</span></span></span></p>\r\n\r\n<p> </p>\r\n\r\n<p><span style=\"font-size:12pt\"><span style=\"font-family:\"Times New Roman\",serif\"><strong><span style=\"font-family:\"Calibri\",sans-serif\">Option <strong><span style=\"font-family:\"Calibri\",sans-serif\">C. Flumazenil: </span></strong></span></strong><span style=\"font-family:\"Calibri\",sans-serif\">Flumazenil is incorrect because it is an antidote for benzodiazepine overdose, not for organophosphate poisoning. It works by antagonizing the effects of benzodiazepines on the central nervous system.</span></span></span></p>\r\n\r\n<p> </p>\r\n\r\n<p><span style=\"font-size:12pt\"><span style=\"font-family:\"Times New Roman\",serif\"><strong><span style=\"font-family:\"Calibri\",sans-serif\">Option <strong><span style=\"font-family:\"Calibri\",sans-serif\">D. Physostigmine: </span></strong></span></strong><span style=\"font-family:\"Calibri\",sans-serif\">Physostigmine is incorrect as it is also an acetylcholine esterase inhibitor, which would exacerbate the </span></span></span><span style=\"font-size:12pt\"><span style=\"font-family:\"Times New Roman\",serif\"><span style=\"font-family:\"Calibri\",sans-serif\">symptoms of cholinergic overdose. Additionally, it is used to treat atropine poisoning, not organophosphate poisoning.</span></span></span></p>\r\n\r\n<p> </p>\r\n\r\n<p><span style=\"font-size:12pt\"><span style=\"font-family:\"Times New Roman\",serif\"><strong><span style=\"font-family:\"Calibri\",sans-serif\">Educational objective:</span></strong></span></span></p>\r\n\r\n<p> </p>\r\n\r\n<p><span style=\"font-size:12pt\"><span style=\"font-family:\"Times New Roman\",serif\"><span style=\"font-family:\"Calibri\",sans-serif\">In cases of organophosphate poisoning, which presents with cholinergic symptoms and low RBC esterase levels, the treatment of choice is atropine, administered intravenously until signs of atropinization appear.</span></span></span></p>\r\n\r\n<p> </p>\r\n\r\n<p><span style=\"font-size:12pt\"><span style=\"font-family:\"Liberation Serif\",serif\"><strong><span dir=\"ltr\" lang=\"EN-US\" style=\"font-family:\"Calibri\",sans-serif\"><span style=\"color:#333333\">Reference: KDT 8th/122</span></span></strong></span></span></p>",
      "correct_choice_id": 200201,
      "solution_audio": null,
      "solution_video": null,
      "audio_explanation_heading": null,
      "video_explanation_heading": null,
      "solution_media_position": "bottom",
      "tags": [],
      "explanation_video": null,
      "question_images": [],
      "explanation_images": []
    },
    {
      "id": 50051,
      "choices": [
        {
          "id": 200204,
          "text": "<p><span style=\"font-size:12.0pt;\">Botulinum</span></p>"
        },
        {
          "id": 200205,
          "text": "<p><span style=\"font-size:12.0pt;\">Tetanus</span></p>"
        },
        {
          "id": 200206,
          "text": "<p><span style=\"font-size:12.0pt;\">Diphtheria</span></p>"
        },
        {
          "id": 200207,
          "text": "<p><span style=\"font-size:12.0pt;\">Pertussis</span></p>"
        }
      ],
      "text": "<p><span style=\"font-size:12.0pt;\">Which toxin acts via the mechanism depicted in the image below? (INICET NOV 2019)</span></p><p> </p><p><img src=\"https://cerebellum-web-static.s3.amazonaws.com/media/public/images/2024/07/01/screenshot-2024-07-01-110223.png\" alt=\"\" width=\"500\" height=\"348\"></p><p><img src=\"https://cerebellum-web-static.s3.amazonaws.com/media/public/images/2024/07/01/screenshot-2024-07-01-110223.png\" alt=\"Question Image\"></p>",
      "unique_key": "Q8223886",
      "question_audio": null,
      "question_video": null,
      "map_id": 34429225,
      "difficulty_level": "intermediate",
      "subjects_id": [],
      "solution": "<p><span style=\"font-size:12.0pt;\"><strong>Ans. A) Botulinum</strong></span></p><p> </p><p><span style=\"font-size:12.0pt;\">The image given above depicts the mechanism of action of botulinum toxin.</span></p><p> </p><p><span style=\"font-size:12.0pt;\">Clostridium botulinum is <u>non-invasive</u>. Its pathogenesis is due to the production of powerful neurotoxin ‘botulinum toxin’ (BoNT). It produces <strong>flaccid paralysis</strong>. There are 7 serological types of botulinum neurotoxin labeled as types A, B, C [C1 C2], D, E, F, and G. Human botulism is caused mainly by types A, B, E and F (rarely).</span></p><p> </p><p><span style=\"font-size:12.0pt;\">After entry (either <strong>ingested, inhaled, or produced </strong>in a wound), botulinum toxin is transported via the <u>blood to peripheral cholinergic nerve terminals</u>. The most common nerve terminal sites are neuromuscular junctions, postganglionic parasympathetic nerve endings, and peripheral ganglia. <strong>It does not affect the CNS.</strong></span></p><p> </p><p><span style=\"font-size:12.0pt;\">Botulinum toxin causes <strong>proteolysis of snare proteins</strong> that are required for the excocytosis of acetylcholine vesicles, thereby <strong>preventing the release of acetylcholine (Ach) at the peripheral nerve endings, including neuromuscular junctions (presynaptic inhibition</strong>). This results in a lack of stimulus to the muscle fibers, irreversible relaxation of the muscles to presynaptic inhibition of neuronal, and flaccid paralysis.</span></p><p> </p><p><img src=\"https://cerebellum-web-static.s3.amazonaws.com/media/public/images/2024/07/01/screenshot-2024-07-01-110414.png\" alt=\"\" width=\"500\" height=\"227\"></p><p> </p><p><span style=\"font-size:12.0pt;\"><strong>Other options:</strong></span></p><p> </p><p><span style=\"font-size:12.0pt;\"><strong>Option B. Tetanus:</strong> Tetanus toxin (produced by Clostridium tetani) acts by inhibiting neurotransmitter release in the central nervous system by cleaving synaptobrevin, another SNARE protein, but it causes spastic paralysis rather than flaccid paralysis.</span></p><p> </p><p><span style=\"font-size:12.0pt;\"><strong>Option C. Diphtheria:</strong> Diphtheria toxin (produced by Corynebacterium diphtheriae) inhibits protein synthesis in host cells by ADP-ribosylation of elongation factor-2 (EF-2), which is a completely different mechanism from that of botulinum toxin.</span></p><p> </p><p><span style=\"font-size:12.0pt;\"><strong>Option D. Pertussis:</strong> Pertussis toxin (produced by Bordetella pertussis) modifies the signaling of G-protein coupled receptors by ADP-ribosylating the Gi protein, thereby affecting cellular communication but not directly impacting acetylcholine release at neuromuscular junctions.</span></p><p> </p><p><span style=\"font-size:12.0pt;\"><strong>Educational Objective:</strong></span></p><p> </p><p><span style=\"font-size:12.0pt;\">Botulinum toxin causes flaccid paralysis by preventing the release of acetylcholine at peripheral nerve endings through the proteolysis of SNARE proteins necessary for acetylcholine vesicle exocytosis.</span></p><p><img src=\"https://cerebellum-web-static.s3.amazonaws.com/media/public/images/2024/07/01/screenshot-2024-07-01-110414.png\" alt=\"Solution Image\"></p>",
      "correct_choice_id": 200204,
      "solution_audio": null,
      "solution_video": null,
      "audio_explanation_heading": null,
      "video_explanation_heading": null,
      "solution_media_position": "bottom",
      "tags": [],
      "explanation_video": null,
      "question_images": [],
      "explanation_images": []
    },
    {
      "id": 50052,
      "choices": [
        {
          "id": 200208,
          "text": "<p><span style=\"font-size:12.0pt;\">150-200 ml</span></p>"
        },
        {
          "id": 200209,
          "text": "<p><span style=\"font-size:12.0pt;\">500-600 ml</span></p>"
        },
        {
          "id": 200210,
          "text": "<p><span style=\"font-size:12.0pt;\">200-350 ml</span></p>"
        },
        {
          "id": 200211,
          "text": "<p><span style=\"font-size:12.0pt;\">350-400 ml</span></p>"
        }
      ],
      "text": "<p><span style=\"font-size:12.0pt;\">You are an intern and want to determine the quantity of IV fluids needed for a patient. How much amount of transient loss/insensible loss per day would you account for in your calculations? (</span>AIIMS Nov 2019)</p>",
      "unique_key": "Q8049917",
      "question_audio": null,
      "question_video": null,
      "map_id": 34380736,
      "difficulty_level": "intermediate",
      "subjects_id": [],
      "solution": "<p><span style=\"font-size:12.0pt;\"><strong>Ans. B) 500-600 ml</strong></span></p><p> </p><p><span style=\"font-size:12.0pt;\">Some of the water losses cannot be precisely regulated. For example, there is a continuous loss of water by evaporation from the respiratory tract and diffusion through the skin, which together account for about 500-600 ml/day of water loss under normal conditions. This is termed insensible water loss because we are not consciously aware of it.</span></p><p> </p><p><span style=\"font-size:12.0pt;\"><strong>Educational Objective:</strong></span></p><p> </p><p><span style=\"font-size:12.0pt;\">When calculating the quantity of IV fluids needed for a patient, it is essential to account for approximately 500-600 ml/day of insensible water loss due to evaporation from the respiratory tract and diffusion through the skin.</span></p>",
      "correct_choice_id": 200209,
      "solution_audio": null,
      "solution_video": null,
      "audio_explanation_heading": null,
      "video_explanation_heading": null,
      "solution_media_position": "bottom",
      "tags": [],
      "explanation_video": null,
      "question_images": [],
      "explanation_images": []
    },
    {
      "id": 50053,
      "choices": [
        {
          "id": 200212,
          "text": "<p><span style=\"font-size:12.0pt;\">Downregulation of aquaporin 2 production</span></p>"
        },
        {
          "id": 200213,
          "text": "<p><span style=\"font-size:12.0pt;\">Increase in urine osmolarity</span></p>"
        },
        {
          "id": 200214,
          "text": "<p><span style=\"font-size:12.0pt;\">Decrease in ADH secretion</span></p>"
        },
        {
          "id": 200215,
          "text": "<p><span style=\"font-size:12.0pt;\">Upregulation of aquaporin 2 production</span></p>"
        }
      ],
      "text": "<p><span style=\"font-size:12.0pt;\">\"Vasopressin escape\" in SIADH results due to: (</span>AIIMS Nov 2019)</p>",
      "unique_key": "Q2227579",
      "question_audio": null,
      "question_video": null,
      "map_id": 34917534,
      "difficulty_level": "intermediate",
      "subjects_id": [],
      "solution": "<p><span style=\"font-size:12.0pt;\"><strong>Ans. A) Downregulation of aquaporin 2 production</strong></span></p><p> </p><p><span style=\"font-size:12.0pt;\">Vasopressin escape in SIADH (Syndrome of inappropriate ADH secretion) results due to downregulation of aquaporin 2 production.</span></p><p> </p><p><span style=\"font-size:12.0pt;\">Downregulation of aquaporin-2 receptors occurs due to prolonged exposure to elevated vasopressin levels resulting in excessive reabsorption of water, despite high serum ADH levels, thus maintaining euvolemia and preventing excessive dilutional hyponatremia in SIADH. This is called as vasopressin escape.</span></p><p> </p><p><span style=\"font-size:12.0pt;\"><strong>Other Options:</strong></span></p><p> </p><p><span style=\"font-size:12pt;\"><strong>Option</strong> </span><span style=\"font-size:12.0pt;\"><strong>B. Increase in urine osmolarity:</strong> Incorrect. Vasopressin escape does not result in an increase in urine osmolarity. Instead, it is characterized by the body's ability to excrete free water to prevent hyponatremia.</span></p><p> </p><p><span style=\"font-size:12.0pt;\"><strong>Option C. Decrease in ADH secretion:</strong> Incorrect. Vasopressin escape occurs despite high levels of ADH, not due to a decrease in ADH secretion.</span></p><p> </p><p><span style=\"font-size:12pt;\"><strong>Option</strong> </span><span style=\"font-size:12.0pt;\"><strong>D. Upregulation of aquaporin 2 production:</strong> Incorrect. The condition involves the downregulation, not upregulation, of aquaporin 2 production.</span></p><p> </p><p><span style=\"font-size:12.0pt;\"><strong>Educational Objective:</strong></span></p><p> </p><p><span style=\"font-size:12.0pt;\"><strong>Syndrome of inappropriate anti-diuretic hormone (SIADH): Pathogenesis and clinical findings</strong></span></p><p> </p><p><span style=\"font-size:12.0pt;\"><strong><img src=\"https://cerebellum-web-static.s3.amazonaws.com/media/public/images/2023/06/29/aiims-physio-nov-2019-02.jpg\" alt=\"\" width=\"900\" height=\"714\"></strong></span></p><p><img src=\"https://cerebellum-web-static.s3.amazonaws.com/media/public/images/2023/06/29/aiims-physio-nov-2019-02.jpg\" alt=\"Solution Image\"></p>",
      "correct_choice_id": 200212,
      "solution_audio": null,
      "solution_video": null,
      "audio_explanation_heading": null,
      "video_explanation_heading": null,
      "solution_media_position": "bottom",
      "tags": [],
      "explanation_video": null,
      "question_images": [],
      "explanation_images": []
    },
    {
      "id": 50054,
      "choices": [
        {
          "id": 200216,
          "text": "<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\">Marbling</span></span></span></p>"
        },
        {
          "id": 200217,
          "text": "<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\">Algor mortis</span></span></span></p>"
        },
        {
          "id": 200218,
          "text": "<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\">Rigor mortis</span></span></span></p>"
        },
        {
          "id": 200219,
          "text": "<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\">Post mortem lividity</span></span></span></p>"
        }
      ],
      "text": "<p><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\"><span style=\"font-family:\"Calibri\",sans-serif\">The postmortem change seen in the image below corresponds to which of the following?(AIIMS NOV 2019)</span></span></p>\r\n\r\n<p> </p>\r\n\r\n<p><img alt=\"\" src=\"https://cerebellum-web-static.s3.amazonaws.com/media/public/images/2024/06/11/screenshot-2024-06-11-174551.png\" style=\"height:183px; width:300px\" /></p><p><img src=\"https://cerebellum-web-static.s3.amazonaws.com/media/public/images/2024/06/11/screenshot-2024-06-11-174551.png\" alt=\"Question Image\"></p>",
      "unique_key": "Q4070376",
      "question_audio": null,
      "question_video": null,
      "map_id": 34767053,
      "difficulty_level": "intermediate",
      "subjects_id": [],
      "solution": "<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\">Ans. A. Marbling</span></strong> </span></span></p>\r\n\r\n<p> </p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\"><span style=\"color:black\">Explanation:</span></span></strong><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\"><span style=\"color:black\"> In the above picture superficial veins are visible on the dead body which is characteristic of <strong>Marbling. </strong></span></span><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\">Hydrogen sulphides gas produced by decomposing tissues combine with Hb to form sulph-meth-haemoglobin. This sulph-meth-haemoglobin stains the tissues and vessels producing a greenish black color called marbling.</span></span></span></p>\r\n\r\n<p> </p>\r\n\r\n<p> </p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><u><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\">Other options </span></u></strong></span></span></p>\r\n\r\n<p> </p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\">Option B) Algor mortis: </span></strong><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\">Algor mortis refers to the postmortem cooling of the body. After death, the body temperature gradually decreases until it reaches the ambient temperature hence this option is incorrect.</span></span></span></p>\r\n\r\n<p> </p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\">Option C) Rigor mortis: </span></strong><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\">Rigor mortis is the stiffening of muscles that occurs after death due to ATP depletion in the muscles.</span></span></span></p>\r\n\r\n<p> </p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\">Option D)</span></strong><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\"> <strong>Post mortem lividity </strong>is a passive process of blood accumulating within the blood vessels in the dependent parts of the body as a result of gravity, causing a discoloration of the skin that varies from pink to dark purplish. The pale looking areas on the skin are the pressure areas. The below image of PM Lividity</span> </span></span></p>\r\n\r\n<p style=\"text-align:justify\"> </p>\r\n\r\n<p style=\"text-align:justify\"><img alt=\"\" src=\"https://cerebellum-web-static.s3.amazonaws.com/media/public/images/2024/06/11/screenshot-2024-06-11-174634.png\" style=\"height:177px; width:300px\" /></p>\r\n\r\n<p style=\"text-align:justify\"> </p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><u><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\">Educational Objective </span></u></strong></span></span></p>\r\n\r\n<p> </p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\">Marbling</span></strong></span></span></p>\r\n\r\n<p> </p>\r\n\r\n<ol>\r\n\t<li><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\">Marbling is a characteristic color change <strong>occurring in Putrefaction </strong>in which the <strong>superficial veins become visible on the skin</strong> due to staining by Hemoglobin or sulphmethhaemoglobin</span></span></span></li>\r\n\t<li><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\">Mechanism of color change in putrefaction: </span></span></span></li>\r\n</ol>\r\n\r\n<ol style=\"list-style-type:lower-roman\">\r\n\t<li><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\">Direct staining by Hemoglobin (Hb):</span></strong><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\"> Lyses of RBCs occur in putrefaction which releases the Hb. This Hb itself stains the tissues and vessels producing a reddish brown coloration which later becomes greenish black.</span></span></span></li>\r\n\t<li><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\">Staining by Sulph-meth-haemoglobin:</span></strong><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\"> Hydrogen sulphides gas produced by decomposing tissues combine with Hb to form sulph-meth-haemoglobin. This sulph-meth-haemoglobin stains the tissues and vessels producing a greenish black color.</span></span></span></li>\r\n</ol>\r\n\r\n<ol start=\"3\">\r\n\t<li><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\">This greenish black staining of superficial veins appears as prominent lines on the skin called Marbling </span></span></span></li>\r\n\t<li><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\">Marbling is distinctly appreciable in the superficial veins of abdomen, shoulders, chest and inguinal region.</span></span></span></li>\r\n\t<li><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\">Marbling starts in 24 hours and becomes prominent in about 36–48 hours after death in summer</span></span></span></li>\r\n</ol><p><img src=\"https://cerebellum-web-static.s3.amazonaws.com/media/public/images/2024/06/11/screenshot-2024-06-11-174634.png\" alt=\"Solution Image\"></p>",
      "correct_choice_id": 200216,
      "solution_audio": null,
      "solution_video": null,
      "audio_explanation_heading": null,
      "video_explanation_heading": null,
      "solution_media_position": "bottom",
      "tags": [],
      "explanation_video": null,
      "question_images": [],
      "explanation_images": []
    },
    {
      "id": 50055,
      "choices": [
        {
          "id": 200220,
          "text": "<p><span style=\"font-size:12.0pt;\">Gastrinoma</span></p>"
        },
        {
          "id": 200221,
          "text": "<p><span style=\"font-size:12.0pt;\">Somatostatinoma</span></p>"
        },
        {
          "id": 200222,
          "text": "<p><span style=\"font-size:12.0pt;\">Insulinoma</span></p>"
        },
        {
          "id": 200223,
          "text": "<p><span style=\"font-size:12.0pt;\">VIPoma</span></p>"
        }
      ],
      "text": "<p><span style=\"font-size:12.0pt;\">Out of the options given below the most common pancreatic neuroendocrine tumor (PNET) is:</span> <span style=\"font-size:12.0pt;\">(AIIMS NOV 2019)</span></p>",
      "unique_key": "Q9283567",
      "question_audio": null,
      "question_video": null,
      "map_id": 34245926,
      "difficulty_level": "intermediate",
      "subjects_id": [],
      "solution": "<p><span style=\"font-size:12.0pt;\"><strong>Ans. C) Insulinoma</strong></span></p><p> </p><p><span style=\"font-size:12.0pt;\">Most common type of PNET seen is: Insulinoma</span></p><p> </p><p><span style=\"font-size:12.0pt;\">Insulinomas are the most common type of PNETs. They produce excess insulin, leading to hypoglycemia (low blood sugar) in affected individuals. Insulinomas are typically benign and occur more frequently than other types of PNETs.</span></p><p> </p><p><span style=\"font-size:12.0pt;\"><strong>Other Options:</strong></span></p><p> </p><p><span style=\"font-size:12pt;\"><strong>Option A.</strong> </span><span style=\"font-size:12.0pt;\"><strong>Gastrinoma</strong>: Gastrinoma is a type of PNET that produces excess gastrin hormone. It is associated with a condition called Zollinger-Ellison syndrome. Gastrinomas are relatively less common than insulinomas.</span></p><p> </p><p><span style=\"font-size:12pt;\"><strong>Option</strong> </span><span style=\"font-size:12.0pt;\"><strong>B</strong>. <strong>Somatostatinoma</strong>: Somatostatinomas are rare PNETs that produce excess somatostatin hormone. They can occur in the pancreas or other parts of the digestive system. They are less common than insulinomas.</span></p><p> </p><p><span style=\"font-size:12pt;\"><strong>Option</strong> </span><span style=\"font-size:12.0pt;\"><strong>D.</strong> <strong>VIPoma</strong>: VIPomas, also known as Verner-Morrison syndrome or pancreatic cholera, are PNETs that produce vasoactive intestinal peptide (VIP). These tumors are relatively rare compared to insulinomas.</span></p><p> </p><p><span style=\"font-size:12.0pt;\"><strong>Educational Objective:</strong></span></p><p> </p><ul><li><span style=\"font-size:12.0pt;\">PNETs are a rare type of pancreatic tumor that originate from neuroendocrine cells in the pancreas.</span></li><li><span style=\"font-size:12.0pt;\">PNETs are classified as either functioning or non-functioning based on their ability to produce hormones.</span></li><li><span style=\"font-size:12.0pt;\">Diagnosis of PNETs typically involves imaging studies such as CT or MRI, as well as biopsy or blood tests to measure hormone levels.</span></li><li><span style=\"font-size:12.0pt;\">Treatment options for PNETs may include surgery, chemotherapy, or radiation therapy, depending on the size, location, and type of tumor.</span></li></ul><p> </p><p><span style=\"font-size:12.0pt;\"><strong>Insulinoma:</strong></span></p><p> </p><ul><li><span style=\"font-size:12.0pt;\">The investigation of choice for insulinoma 72-hour fasting glucose and serum insulin levels.</span></li><li><span style=\"font-size:12.0pt;\">Medical management:</span><ul><li><span style=\"font-size:12.0pt;\">Octreotide</span></li></ul></li><li><span style=\"font-size:12.0pt;\">Surgical management - Enucleation</span></li></ul>",
      "correct_choice_id": 200222,
      "solution_audio": null,
      "solution_video": null,
      "audio_explanation_heading": null,
      "video_explanation_heading": null,
      "solution_media_position": "bottom",
      "tags": [],
      "explanation_video": null,
      "question_images": [],
      "explanation_images": []
    },
    {
      "id": 50056,
      "choices": [
        {
          "id": 200224,
          "text": "<p><span style=\"font-size:12pt\"><span style=\"font-family:\"Times New Roman\",serif\"><span style=\"font-family:\"Calibri\",sans-serif\">6 to 10 weeks</span></span></span></p>"
        },
        {
          "id": 200225,
          "text": "<p><span style=\"font-size:12pt\"><span style=\"font-family:\"Times New Roman\",serif\"><span style=\"font-family:\"Calibri\",sans-serif\">8 to 12 weeks</span></span></span></p>"
        },
        {
          "id": 200226,
          "text": "<p><span style=\"font-size:12pt\"><span style=\"font-family:\"Times New Roman\",serif\"><span style=\"font-family:\"Calibri\",sans-serif\">13 to 20 weeks</span></span></span></p>"
        },
        {
          "id": 200227,
          "text": "<p><span style=\"font-size:12pt\"><span style=\"font-family:\"Times New Roman\",serif\"><span style=\"font-family:\"Calibri\",sans-serif\">20 to 28 weeks</span></span></span></p>"
        }
      ],
      "text": "<p><span style=\"font-size:12.0pt\"><span style=\"font-family:\"Calibri\",sans-serif\">The risk of fetal varicella syndrome is maximum when the mother is infected between: </span></span>(INICET NOV 2019)</p>",
      "unique_key": "Q8380749",
      "question_audio": null,
      "question_video": null,
      "map_id": 34416594,
      "difficulty_level": "intermediate",
      "subjects_id": [],
      "solution": "<p><span style=\"font-size:12pt\"><span style=\"font-family:\"Times New Roman\",serif\"><strong><span style=\"font-family:\"Calibri\",sans-serif\">Ans. C) 13 to 20 weeks</span></strong></span></span></p>\r\n\r\n<p> </p>\r\n\r\n<p><span style=\"font-size:12pt\"><span style=\"font-family:\"Times New Roman\",serif\"><strong><span style=\"font-family:\"Calibri\",sans-serif\">Explanation:</span></strong> </span></span></p>\r\n\r\n<p> </p>\r\n\r\n<p><span style=\"font-size:12pt\"><span style=\"font-family:\"Times New Roman\",serif\"><span style=\"font-family:\"Calibri\",sans-serif\">Varicella Zoster Virus (VZV) is a double-stranded DNA virus that is primarily acquired in childhood and causes chickenpox. The virus is transmitted through direct contact with an infected individual. Nonimmune pregnant women who come into close contact with a patient with chickenpox are at risk of contracting the infection.</span></span></span></p>\r\n\r\n<p> </p>\r\n\r\n<p><span style=\"font-size:12pt\"><span style=\"font-family:\"Times New Roman\",serif\"><span style=\"font-family:\"Calibri\",sans-serif\">If a pregnant woman contracts chickenpox, particularly early in pregnancy, there is a risk of congenital varicella syndrome in the fetus. The highest risk period for the development of congenital varicella syndrome is between 13 and 20 weeks of gestation.</span></span></span></p>\r\n\r\n<p> </p>\r\n\r\n<p><span style=\"font-size:12pt\"><span style=\"font-family:\"Times New Roman\",serif\"><span style=\"font-family:\"Calibri\",sans-serif\">Congenital varicella syndrome includes the following features:</span></span></span></p>\r\n\r\n<p> </p>\r\n\r\n<ul>\r\n\t<li><span style=\"font-size:12pt\"><span style=\"font-family:\"Times New Roman\",serif\"><span style=\"font-family:\"Calibri\",sans-serif\">Chorioretinitis</span></span></span></li>\r\n\t<li><span style=\"font-size:12pt\"><span style=\"font-family:\"Times New Roman\",serif\"><span style=\"font-family:\"Calibri\",sans-serif\">Microphthalmia</span></span></span></li>\r\n\t<li><span style=\"font-size:12pt\"><span style=\"font-family:\"Times New Roman\",serif\"><span style=\"font-family:\"Calibri\",sans-serif\">Cerebral cortical atrophy</span></span></span></li>\r\n\t<li><span style=\"font-size:12pt\"><span style=\"font-family:\"Times New Roman\",serif\"><span style=\"font-family:\"Calibri\",sans-serif\">Fetal growth restriction</span></span></span></li>\r\n\t<li><span style=\"font-size:12pt\"><span style=\"font-family:\"Times New Roman\",serif\"><span style=\"font-family:\"Calibri\",sans-serif\">Hydronephrosis</span></span></span></li>\r\n\t<li><span style=\"font-size:12pt\"><span style=\"font-family:\"Times New Roman\",serif\"><span style=\"font-family:\"Calibri\",sans-serif\">Limb hypoplasia</span></span></span></li>\r\n\t<li><span style=\"font-size:12pt\"><span style=\"font-family:\"Times New Roman\",serif\"><span style=\"font-family:\"Calibri\",sans-serif\">Cicatricial skin lesions</span></span></span></li>\r\n</ul>\r\n\r\n<p> </p>\r\n\r\n<p><span style=\"font-size:12pt\"><span style=\"font-family:\"Times New Roman\",serif\"><span style=\"font-family:\"Calibri\",sans-serif\">If the fetus or neonate is exposed to active VZV infection just before or during delivery (less than 5 days before and up to 2 days after delivery), there is a significant risk of disseminated disease and CNS involvement in the neonate, with a mortality rate of approximately 30%. In such cases, administration of VZIG (Varicella-Zoster Immune Globulin) is recommended.</span></span></span></p>\r\n\r\n<p> </p>\r\n\r\n<p><span style=\"font-size:12pt\"><span style=\"font-family:\"Times New Roman\",serif\"><strong><span style=\"font-family:\"Calibri\",sans-serif\">Educational Objective:</span></strong> </span></span></p>\r\n\r\n<p> </p>\r\n\r\n<p><span style=\"font-size:12pt\"><span style=\"font-family:\"Times New Roman\",serif\"><span style=\"font-family:\"Calibri\",sans-serif\">The highest risk period for the development of congenital varicella syndrome in a fetus is when the mother is infected with Varicella Zoster Virus between 13 and 20 weeks of gestation.</span></span></span></p>\r\n\r\n<p> </p>\r\n\r\n<p><span style=\"font-size:12pt\"><span style=\"font-family:\"Times New Roman\",serif\"><strong><span style=\"font-family:\"Calibri\",sans-serif\">Ref: William’s textbook of obstetrics 26<sup>th</sup> edition pg 3085</span></strong></span></span></p>",
      "correct_choice_id": 200226,
      "solution_audio": null,
      "solution_video": null,
      "audio_explanation_heading": null,
      "video_explanation_heading": null,
      "solution_media_position": "bottom",
      "tags": [],
      "explanation_video": null,
      "question_images": [],
      "explanation_images": []
    },
    {
      "id": 50057,
      "choices": [
        {
          "id": 200228,
          "text": "<p><span style=\"font-size:12.0pt;\">Tumor more than 4 cm</span></p>"
        },
        {
          "id": 200229,
          "text": "<p><span style=\"font-size:12.0pt;\">Inflammatory breast cancer</span></p>"
        },
        {
          "id": 200230,
          "text": "<p><span style=\"font-size:12.0pt;\">Chest wall involvement</span></p>"
        },
        {
          "id": 200231,
          "text": "<p><span style=\"font-size:12.0pt;\">Skin involvement</span></p>"
        }
      ],
      "text": "<p><span style=\"font-size:12.0pt;\">Locally advanced breast cancer can be defined as all except? (AIIMS NOV 2019)</span></p>",
      "unique_key": "Q9421594",
      "question_audio": null,
      "question_video": null,
      "map_id": 34026633,
      "difficulty_level": "intermediate",
      "subjects_id": [],
      "solution": "<p><span style=\"font-size:12.0pt;\"><strong>Ans. A) Tumor more than 4 cm</strong></span></p><p> </p><p><span style=\"font-size:12.0pt;\">While a tumor size larger than 4 cm is indicative of a relatively large tumor, it alone does not define locally advanced breast cancer. Locally advanced breast cancer typically involves not only tumor size but also the extent of its spread to nearby structures.</span></p><p> </p><p><span style=\"font-size:12.0pt;\"><strong>Other Options:</strong></span></p><p> </p><p><span style=\"font-size:12.0pt;\"><strong>Option B. Inflammatory breast cancer</strong>:<strong> </strong>Inflammatory breast cancer is an aggressive subtype of breast cancer characterized by redness, swelling, and warmth in the breast. It is considered an advanced stage of breast cancer.</span></p><p> </p><p><span style=\"font-size:12.0pt;\"><strong>Option C. Chest wall involvement</strong>:<strong> </strong>Locally advanced breast cancer is often defined by its involvement of the chest wall. This means that the cancer has spread beyond the breast tissue and may affect the underlying muscles and structures of the chest wall.</span></p><p> </p><p><span style=\"font-size:12pt;\"><strong>Option</strong> </span><span style=\"font-size:12.0pt;\"><strong>D. Skin involvement</strong>: Skin involvement, such as changes in the appearance of the skin over the breast like peau’d orange or ulceration, can be a feature of locally advanced breast cancer.</span></p><p> </p><p><span style=\"font-size:12.0pt;\"><strong>Educational Objective:</strong></span></p><p> </p><p><span style=\"font-size:12.0pt;\">Tumor more than 5 cm, not 4 is classified as LABC.</span></p><p> </p><p><span style=\"font-size:12.0pt;\">Locally advanced breast cancer (LABC) includes: (Mnemonic – CUBE N2)</span></p><p> </p><p><span style=\"font-size:12.0pt;\">C - Chest wall invasion</span></p><p> </p><p><span style=\"font-size:12.0pt;\">U - Ulceration of skin</span></p><p> </p><p><span style=\"font-size:12.0pt;\">B - Both (chest wall invasion and ulceration of skin)</span></p><p> </p><p><span style=\"font-size:12.0pt;\">E - E(I)nflammatory carcinoma</span></p><p> </p><p><span style=\"font-size:12.0pt;\">N2 - fixed axillary lymph nodes</span></p>",
      "correct_choice_id": 200228,
      "solution_audio": null,
      "solution_video": null,
      "audio_explanation_heading": null,
      "video_explanation_heading": null,
      "solution_media_position": "bottom",
      "tags": [],
      "explanation_video": null,
      "question_images": [],
      "explanation_images": []
    },
    {
      "id": 50058,
      "choices": [
        {
          "id": 200232,
          "text": "<p><span style=\"font-size:12.0pt;\">Carries negative charge</span></p>"
        },
        {
          "id": 200233,
          "text": "<p><span style=\"font-size:12.0pt;\">Chondroitin sulfate is a proteoglycan</span></p>"
        },
        {
          "id": 200234,
          "text": "<p><span style=\"font-size:12.0pt;\">Made of amino acids and sugars</span></p>"
        },
        {
          "id": 200235,
          "text": "<p><span style=\"font-size:12.0pt;\">Holds less water</span></p>"
        }
      ],
      "text": "<p><span style=\"font-size:12.0pt;\">Which of the following is NOT true about proteoglycans?</span></p>",
      "unique_key": "Q7327258",
      "question_audio": null,
      "question_video": null,
      "map_id": 34790137,
      "difficulty_level": "intermediate",
      "subjects_id": [],
      "solution": "<p><span style=\"font-size:12.0pt;\"><strong>Ans. D) Holds less water</strong></span></p><p> </p><p><span style=\"font-size:12.0pt;\"><strong>Proteoglycans are widely distributed complex molecules having glycosaminoglycans (GAG) and proteins</strong>. The GAGs containing repeating disaccharide units are covalently bound to the peptide chain to form proteoglycans. Acetylated amino groups, sulfate and carboxyl groups are also generally present. <strong>Because of the presence of these charged groups, they attract water molecules and so they produce viscous solutions.</strong></span></p><p> </p><p><span style=\"font-size:12.0pt;\">Chondroitin sulfate It is present in ground substance of connective tissues widely distributed in cartilage, bone, tendons, cornea and skin. It is composed of repeating units of glucuronic acid → beta-1,3-N-acetyl galactosamine sulphate → beta-1, 4 and so on. It is a glycosaminoglycan bound to a protein; hence it is a proteoglycan.</span></p><p> </p><p><span style=\"font-size:12.0pt;\"><strong>Other Options:</strong></span></p><p> </p><p><span style=\"font-size:12.0pt;\"><strong>Option A. Carries Negative Charge:</strong> Proteoglycans carry negative charges due to the presence of sulfate and carboxyl groups on the GAG chains. These negatively charged groups attract positively charged ions and water molecules.</span></p><p style=\"margin-left:24px;\"> </p><p><span style=\"font-size:12.0pt;\"><strong>Option B. Chondroitin Sulfate is a Proteoglycan:</strong> Chondroitin sulfate is a type of GAG that, when attached to a core protein, forms a proteoglycan. It is widely distributed in cartilage, bone, tendons, cornea, and skin.</span></p><p> </p><p><span style=\"font-size:12.0pt;\"><strong>Option C. Made of Amino Acids and Sugars:</strong> Proteoglycans are made up of a protein core (composed of amino acids) and one or more GAG chains (composed of sugars).</span></p><p> </p><p><span style=\"font-size:12.0pt;\"><strong>Educational Objective:</strong></span></p><p><span style=\"font-size:10.5pt;\"><strong> </strong></span></p><p><span style=\"font-size:12.0pt;\">Proteoglycans are complex molecules made of amino acids and sugars, carrying negative charges and holding a significant amount of water due to their hydrophilic nature. Chondroitin sulfate, a type of GAG, forms proteoglycans when bound to a protein.</span></p>",
      "correct_choice_id": 200235,
      "solution_audio": null,
      "solution_video": null,
      "audio_explanation_heading": null,
      "video_explanation_heading": null,
      "solution_media_position": "bottom",
      "tags": [],
      "explanation_video": null,
      "question_images": [],
      "explanation_images": []
    },
    {
      "id": 50059,
      "choices": [
        {
          "id": 200236,
          "text": "<p><span style=\"font-size:12.0pt;\">Stomach</span></p>"
        },
        {
          "id": 200237,
          "text": "<p><span style=\"font-size:12.0pt;\">Spleen</span></p>"
        },
        {
          "id": 200238,
          "text": "<p><span style=\"font-size:12.0pt;\">2nd part of duodenum</span></p>"
        },
        {
          "id": 200239,
          "text": "<p><span style=\"font-size:12.0pt;\">Pancreas</span></p>"
        }
      ],
      "text": "<p><span style=\"font-size:12.0pt;\">Which of the following is related to the marked area in the image? (</span><span style=\"background-color:rgb(255,255,255);color:rgb(111,126,149);font-size:14px;\">AIIMS Nov 2019)</span></p><p> </p><p><span style=\"font-size:12.0pt;\"><img src=\"https://cerebellum-web-static.s3.amazonaws.com/media/public/images/2023/05/03/ia-75.jpg\" alt=\"\" width=\"260\" height=\"341\"></span></p><p><img src=\"https://cerebellum-web-static.s3.amazonaws.com/media/public/images/2023/05/03/ia-75.jpg\" alt=\"Question Image\"></p>",
      "unique_key": "Q5363938",
      "question_audio": null,
      "question_video": null,
      "map_id": 34187469,
      "difficulty_level": "intermediate",
      "subjects_id": [],
      "solution": "<p><span style=\"font-size:12.0pt;\"><strong>Ans. A. Stomach</strong></span></p><p> </p><p><span style=\"font-size:12.0pt;\">The marked area in the image of the left kidney is related to the stomach.</span></p><p> </p><p><span style=\"font-size:12.0pt;\"><img src=\"https://cerebellum-web-static.s3.amazonaws.com/media/public/images/2023/05/03/ia-76.jpg\" alt=\"\" width=\"500\" height=\"205\"></span></p><p> </p><p><span style=\"font-size:12.0pt;\"><strong>The diagram shows the anterior relation of kidney:</strong></span></p><p> </p><p><span style=\"font-size:12.0pt;\"><img src=\"https://cerebellum-web-static.s3.amazonaws.com/media/public/images/2023/05/03/ia-77.jpg\" alt=\"\" width=\"500\" height=\"213\"></span></p><p> </p><p><span style=\"font-size:12.0pt;\">The anterior relations of the left kidney involve various structures, including the stomach, spleen, and pancreas.</span></p><p> </p><p><span style=\"font-size:12.0pt;\"><strong>Other Options:</strong></span></p><p> </p><p><span style=\"font-size:12.0pt;\"><strong>Option B</strong>. <strong>Spleen:</strong> The spleen is typically located more to the left side of the abdomen, and it is not a direct anterior relation of the left kidney. However, there may be some variability in the position of the spleen, and in some individuals, a small part of the spleen might be located anterior to the left kidney.</span></p><p> </p><p><span style=\"font-size:12.0pt;\"><strong>Option C</strong>. <strong>2nd part of duodenum:</strong> The second part of the duodenum runs horizontally and is situated anterior to the right kidney, it has no relation to the left kidney. This part of the duodenum is part of the foregut and is involved in the digestion and absorption of nutrients.</span></p><p> </p><p><span style=\"font-size:12.0pt;\"><strong>Option D</strong>. <strong>Pancreas:</strong> Pancreas in general is related to the left kidney but below the level of relation with stomach. </span></p><p> </p><p><span style=\"font-size:12.0pt;\"><strong>Educational Objective:</strong></span></p><p> </p><p><span style=\"font-size:12.0pt;\">The stomach is located anterior to the left kidney. The part of the stomach that lies in close proximity to the left kidney is the lesser curvature, specifically the anterior aspect of the stomach. The left kidney is situated posterior to this portion of the stomach.</span></p><p><img src=\"https://cerebellum-web-static.s3.amazonaws.com/media/public/images/2023/05/03/ia-76.jpg\" alt=\"Solution Image\"></p>",
      "correct_choice_id": 200236,
      "solution_audio": null,
      "solution_video": null,
      "audio_explanation_heading": null,
      "video_explanation_heading": null,
      "solution_media_position": "bottom",
      "tags": [],
      "explanation_video": null,
      "question_images": [],
      "explanation_images": []
    },
    {
      "id": 50060,
      "choices": [
        {
          "id": 200240,
          "text": "<p><span style=\"font-size:11pt\"><span style=\"font-family:Aptos,sans-serif\"><span style=\"font-size:12.0pt\"><span style=\"font-family:\"Calibri\",sans-serif\">197</span></span></span></span></p>"
        },
        {
          "id": 200241,
          "text": "<p><span style=\"font-size:11pt\"><span style=\"font-family:Aptos,sans-serif\"><span style=\"font-size:12.0pt\"><span style=\"font-family:\"Calibri\",sans-serif\">392</span></span></span></span></p>"
        },
        {
          "id": 200242,
          "text": "<p><span style=\"font-size:11pt\"><span style=\"font-family:Aptos,sans-serif\"><span style=\"font-size:12.0pt\"><span style=\"font-family:\"Calibri\",sans-serif\">225</span></span></span></span></p>"
        },
        {
          "id": 200243,
          "text": "<p><span style=\"font-size:11pt\"><span style=\"font-family:Aptos,sans-serif\"><span style=\"font-size:12.0pt\"><span style=\"font-family:\"Calibri\",sans-serif\">344</span></span></span></span></p>"
        }
      ],
      "text": "<p><span style=\"font-size:12.0pt\"><span style=\"font-family:\"Calibri\",sans-serif\">A community with a population of 20,000 documented 456 births in a year, of which 56 were stillbirths. The total number of deaths in the community for that year was 247, including 56 deaths within the first 28 days of life and 34 additional deaths after 28 days but before completing the first year of life. What is the infant mortality rate (IMR) for this community? (AIIMS NOV 2019)</span></span></p>",
      "unique_key": "Q4761258",
      "question_audio": null,
      "question_video": null,
      "map_id": 34144230,
      "difficulty_level": "intermediate",
      "subjects_id": [],
      "solution": "<p><span style=\"font-size:11pt\"><span style=\"font-family:Aptos,sans-serif\"><strong><span style=\"font-size:12.0pt\"><span style=\"font-family:\"Calibri\",sans-serif\">Ans. C) 225</span></span></strong></span></span></p>\r\n\r\n<p> </p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span dir=\"ltr\" lang=\"FR\" style=\"font-size:12.0pt\"><img alt=\"\" src=\"https://cerebellum-web-static.s3.amazonaws.com/media/public/images/2023/10/25/screenshot-2023-10-25-161612.jpg\" style=\"height:64px; width:500px\" /></span></strong></span></span></p>\r\n\r\n<p> </p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Aptos,sans-serif\"><strong><span style=\"font-size:12.0pt\"><span style=\"font-family:\"Calibri\",sans-serif\">In the given question,</span></span></strong><span style=\"font-size:12.0pt\"><span style=\"font-family:\"Calibri\",sans-serif\"> out of total 456 births, 56 were dead born. </span></span></span></span></p>\r\n\r\n<p> </p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Aptos,sans-serif\"><span style=\"font-size:12.0pt\"><span style=\"font-family:\"Calibri\",sans-serif\">Therefore, the number of live births= 456-56 = 400.</span></span></span></span></p>\r\n\r\n<p> </p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Aptos,sans-serif\"><span style=\"font-size:12.0pt\"><span style=\"font-family:\"Calibri\",sans-serif\">In the same year, it is given that the number of deaths before 28 days is 56, and the number of deaths after 28 days but before 1 year is 34.</span></span></span></span></p>\r\n\r\n<p> </p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Aptos,sans-serif\"><span style=\"font-size:12.0pt\"><span style=\"font-family:\"Calibri\",sans-serif\">Hence, the total number of deaths of children < 1 year is 56 + 34 = 90</span></span></span></span></p>\r\n\r\n<p> </p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Aptos,sans-serif\"><span style=\"font-size:12.0pt\"><span style=\"font-family:\"Calibri\",sans-serif\">IMR = (90x1000)/400 = 900/4 = 225</span></span></span></span></p>\r\n\r\n<p> </p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Aptos,sans-serif\"><span style=\"font-size:12.0pt\"><span style=\"font-family:\"Calibri\",sans-serif\">Hence, the IMR is 225 per 1000 live births.</span></span></span></span></p>\r\n\r\n<p> </p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Aptos,sans-serif\"><strong><span style=\"font-size:12.0pt\"><span style=\"font-family:\"Calibri\",sans-serif\">INFANT MORTALITY RATE</span></span></strong></span></span></p>\r\n\r\n<p> </p>\r\n\r\n<ul>\r\n\t<li><span style=\"font-size:11pt\"><span style=\"font-family:Aptos,sans-serif\"><span style=\"font-size:12.0pt\"><span style=\"font-family:\"Calibri\",sans-serif\">It is the number of deaths per 1000 live births of children under one year of age. It is the most sensitive indicator of availability and utilization of health care services in a country. Is most important indicator of health status of a community, level of living and effectiveness of MCH services in general. </span></span></span></span></li>\r\n\t<li><span style=\"font-size:11pt\"><span style=\"font-family:Aptos,sans-serif\"><span style=\"font-size:12.0pt\"><span style=\"font-family:\"Calibri\",sans-serif\">IMR is among ‘the best predictors of state failure’</span></span></span></span></li>\r\n\t<li><span style=\"font-size:11pt\"><span style=\"font-family:Aptos,sans-serif\"><span style=\"font-size:12.0pt\"><span style=\"font-family:\"Calibri\",sans-serif\">It is a rate.</span></span></span></span></li>\r\n\t<li><span style=\"font-size:11pt\"><span style=\"font-family:Aptos,sans-serif\"><span style=\"font-size:12.0pt\"><span style=\"font-family:\"Calibri\",sans-serif\">IMR of India (2023): 26.6 per 1000 live births; </span></span></span></span></li>\r\n\t<li><span style=\"font-size:11pt\"><span style=\"font-family:Aptos,sans-serif\"><span style=\"font-size:12.0pt\"><span style=\"font-family:\"Calibri\",sans-serif\">IMR of India - 35 per 1000 live births (NFHS-5 2019-21,); </span></span></span></span><span style=\"font-size:11pt\"><span style=\"font-family:Aptos,sans-serif\"><span style=\"font-size:12.0pt\"><span style=\"font-family:\"Calibri\",sans-serif\">28 per 1000 Live births (SRS, May 2022)</span></span></span></span></li>\r\n\t<li><span style=\"font-size:11pt\"><span style=\"font-family:Aptos,sans-serif\"><span style=\"font-size:12.0pt\"><span style=\"font-family:\"Calibri\",sans-serif\">Is the second best indicator of socio-economic development of a country: Ultimate solution for lowering IMR lies in socio-economic development [Best indicator is U5MR]</span></span></span></span></li>\r\n</ul>\r\n\r\n<p> </p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Aptos,sans-serif\"><strong><span style=\"font-size:12.0pt\"><span style=\"font-family:\"Calibri\",sans-serif\">Educational Objective: </span></span></strong></span></span></p>\r\n\r\n<p> </p>\r\n\r\n<ul>\r\n\t<li><span style=\"font-size:11pt\"><span style=\"font-family:Aptos,sans-serif\"><span style=\"font-size:12.0pt\"><span style=\"font-family:\"Calibri\",sans-serif\">The Infant Mortality Rate (IMR) for the community, calculated as the number of infant deaths per 1000 live births. </span></span></span></span></li>\r\n\t<li><span style=\"font-size:11pt\"><span style=\"font-family:Aptos,sans-serif\"><span style=\"font-size:12.0pt\"><span style=\"font-family:\"Calibri\",sans-serif\">This rate serves as a crucial indicator of the health status and effectiveness of maternal and child health services in the community.</span></span></span></span></li>\r\n</ul>\r\n\r\n<p> </p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Aptos,sans-serif\"><strong><span style=\"font-size:12.0pt\"><span style=\"font-family:\"Calibri\",sans-serif\">NOTE - UNICEF considers U5MR or CMR as ‘single best indicator of socio-economic development and well-being’ (even better than IMR)</span></span></strong></span></span></p><p><img src=\"https://cerebellum-web-static.s3.amazonaws.com/media/public/images/2023/10/25/screenshot-2023-10-25-161612.jpg\" alt=\"Solution Image\"></p>",
      "correct_choice_id": 200242,
      "solution_audio": null,
      "solution_video": null,
      "audio_explanation_heading": null,
      "video_explanation_heading": null,
      "solution_media_position": "bottom",
      "tags": [],
      "explanation_video": null,
      "question_images": [],
      "explanation_images": []
    },
    {
      "id": 50061,
      "choices": [
        {
          "id": 200244,
          "text": "<p><span style=\"font-size:12.0pt;\">Post-neonatal period death</span></p>"
        },
        {
          "id": 200245,
          "text": "<p><span style=\"font-size:12.0pt;\">Early neonatal death of fetus > 1000 g</span></p>"
        },
        {
          "id": 200246,
          "text": "<p><span style=\"font-size:12.0pt;\">Stillbirth of fetus < 500 g</span></p>"
        },
        {
          "id": 200247,
          "text": "<p><span style=\"font-size:12.0pt;\">Abortion after 16 weeks</span></p>"
        }
      ],
      "text": "<p><span style=\"font-size:12.0pt;\">To accurately calculate the perinatal mortality rate, which of the following should specifically be considered as part of the numerator? (AIIMS NOV 2019)</span></p>",
      "unique_key": "Q5151788",
      "question_audio": null,
      "question_video": null,
      "map_id": 34139161,
      "difficulty_level": "intermediate",
      "subjects_id": [],
      "solution": "<p><span style=\"font-size:12.0pt;\"><strong>Ans. B) Early neonatal death of fetus > 1000 g </strong></span></p><p> </p><p><span style=\"font-size:12.0pt;\">Perinatal Mortality Rate (PNMR)</span></p><p> </p><ul><li><span style=\"font-size:12.0pt;\">It includes both late fetal deaths (stillbirths) and early neonatal deaths.</span></li></ul><p> </p><p><span style=\"font-size:12.0pt;\"><img src=\"https://cerebellum-web-static.s3.amazonaws.com/media/public/images/2023/10/25/picture8555.jpg\" alt=\"\" width=\"700\" height=\"82\"></span></p><p> </p><ul><li><span style=\"font-size:12.0pt;\">Perinatal period is from 28 weeks period of gestation to 7th completed days of life (But the WHO definition of perinatal period is from 22 completed weeks gestation to 7th completed days of life).</span></li><li><span style=\"font-size:12.0pt;\">PNMR is a major marker to assess the quality of health care delivery; PNMR is a” Yardstick of Obstetric and Pediatric care before and around the time of birth”</span></li><li><span style=\"font-size:12.0pt;\">P List (ICD 10): 100 causes of perinatal mortality and morbidity</span></li><li><span style=\"font-size:12.0pt;\">PNMR of India (2022) - 18 per 1000 LB (SRS, September 2022)</span></li></ul><p> </p><p><span style=\"font-size:12.0pt;\"><strong>Educational Objective:</strong></span></p><p> </p><ul><li><span style=\"font-size:12.0pt;\">Perinatal mortality rate includes late fetal deaths (stillbirths) and early neonatal deaths, focusing on the period from 28 weeks of gestation to 7 days after birth.</span></li></ul><p><img src=\"https://cerebellum-web-static.s3.amazonaws.com/media/public/images/2023/10/25/picture8555.jpg\" alt=\"Solution Image\"></p>",
      "correct_choice_id": 200245,
      "solution_audio": null,
      "solution_video": null,
      "audio_explanation_heading": null,
      "video_explanation_heading": null,
      "solution_media_position": "bottom",
      "tags": [],
      "explanation_video": null,
      "question_images": [],
      "explanation_images": []
    },
    {
      "id": 50062,
      "choices": [
        {
          "id": 200248,
          "text": "<p><span style=\"font-size:12.0pt;\">Both Assertion and Reason are correct statements and the Reason is the correct explanation for the Assertion.</span></p>"
        },
        {
          "id": 200249,
          "text": "<p><span style=\"font-size:12.0pt;\">Both Assertion and Reason are correct statements, but the Reason is not the correct explanation for the Assertion.</span></p>"
        },
        {
          "id": 200250,
          "text": "<p><span style=\"font-size:12.0pt;\">The assertion is correct statement, but the Reason is an incorrect statement.</span></p>"
        },
        {
          "id": 200251,
          "text": "<p><span style=\"font-size:12.0pt;\">The assertion is a incorrect statement, but the Reason is a correct statement.</span></p>"
        }
      ],
      "text": "<p><span style=\"font-size:16px;\"><strong>Assertion</strong>: A patient comatose due to stroke in the past few hours should be intubated.</span></p><p> </p><p><span style=\"font-size:16px;\"><strong>Reason</strong>: Following a stroke, there are high chances of a patient having sleep apnea. </span></p>",
      "unique_key": "Q8390386",
      "question_audio": null,
      "question_video": null,
      "map_id": 34876086,
      "difficulty_level": "intermediate",
      "subjects_id": [],
      "solution": "<p><span style=\"font-size:16px;\"><strong>Ans. C) The assertion is correct statement, but the Reason is an incorrect statement.</strong></span></p><p> </p><p><span style=\"font-size:16px;\">A patient who is comatose due to a recent stroke should indeed be intubated due to the increased risk of aspiration pneumonia. Stroke can impair swallowing reflexes and gag reflexes, which heightens the risk of aspiration and subsequent respiratory complications. This need for intubation is directly related to the prevention of aspiration, not to sleep apnea.</span></p><p> </p><p><span style=\"font-size:16px;\">The Reason provided in the statement is incorrect because, although sleep apnea can occur in some stroke patients, it is not a common acute complication requiring immediate intervention. The primary concern in an unconscious stroke patient is the risk of aspiration, not sleep apnea. Thus, the assertion is true, but the reason is false.</span></p><p> </p><p><span style=\"font-size:16px;\"><strong>Educational Objective:</strong></span></p><p> </p><p><span style=\"font-size:16px;\">In cases of comatose stroke patients, intubation is indicated primarily to prevent aspiration pneumonia due to compromised protective reflexes, not due to concerns about sleep apnea.</span></p>",
      "correct_choice_id": 200250,
      "solution_audio": null,
      "solution_video": null,
      "audio_explanation_heading": null,
      "video_explanation_heading": null,
      "solution_media_position": "bottom",
      "tags": [],
      "explanation_video": null,
      "question_images": [],
      "explanation_images": []
    },
    {
      "id": 50063,
      "choices": [
        {
          "id": 200252,
          "text": "<p><span style=\"font-size:12.0pt;\">Ferroportin</span></p>"
        },
        {
          "id": 200253,
          "text": "<p><span style=\"font-size:12.0pt;\">Divalent metal transporter 1</span></p>"
        },
        {
          "id": 200254,
          "text": "<p><span style=\"font-size:12.0pt;\">Divalent metal transporter 2</span></p>"
        },
        {
          "id": 200255,
          "text": "<p><span style=\"font-size:12.0pt;\">Haptocorrin</span></p>"
        }
      ],
      "text": "<p><span style=\"font-size:12.0pt;\">Which transporter is required for the transport of iron into the enterocyte? (AIIMS NOV 2019)</span></p>",
      "unique_key": "Q9163431",
      "question_audio": null,
      "question_video": null,
      "map_id": 34376989,
      "difficulty_level": "intermediate",
      "subjects_id": [],
      "solution": "<p><span style=\"font-size:12.0pt;\"><strong>Ans. B) Divalent metal transporter 1</strong></span></p><p> </p><p><span style=\"font-size:12.0pt;\"><strong>DMT1 (divalent metal transporter 1) is required for the transport of iron into the enterocyte.</strong></span></p><p> </p><p><span style=\"font-size:12.0pt;\">Luminal nonheme iron is mostly in the Fe [3] + (ferric state and is reduced to Fe [2] + (ferrous) iron by ferrireductases, such as b cytochromes and STEAP3. Fe [2] + iron is then transported across the apical membrane by divalent metal transporter 1 (DMT1).</span></p><p> </p><p><span style=\"font-size:12.0pt;\">Fe [2] + iron destined for the circulation, is transported from the cytoplasm across the basolateral enterocyte membrane by ferroportin. This process is coupled to the oxidation of Fe [2] + iron to Fe [3] + iron, which is carried out by the iron oxidases hephaestin and ceruloplasmin.</span></p><p> </p><p><img src=\"https://cerebellum-web-static.s3.amazonaws.com/media/public/images/2023/04/12/959.jpg\" alt=\"\" width=\"703\" height=\"451\"></p><p> </p><p><span style=\"font-size:12.0pt;\"><strong>Other Options:</strong></span></p><p> </p><p><span style=\"font-size:12.0pt;\"><strong>Option A. Ferroportin:</strong> Ferroportin is not involved in the initial transport of iron into the enterocyte. Instead, it is responsible for exporting iron from the enterocyte into the bloodstream. Ferroportin also works in tandem with hephaestin to ensure that Fe²⁺ iron is oxidized to Fe³⁺ before being released into circulation.</span></p><p> </p><p><span style=\"font-size:12.0pt;\"><strong>Option C. Divalent metal transporter 2:</strong> There is no known transporter named \"Divalent metal transporter 2\" involved in iron absorption or transport within enterocytes. This option is incorrect and may be a distractor or incorrect reference.</span></p><p> </p><p><span style=\"font-size:12.0pt;\"><strong>Option D. Haptocorrin:</strong> Haptocorrin is a protein that binds vitamin B12 (cobalamin) in the stomach, protecting it from degradation. It is not involved in iron transport or metabolism, making this option incorrect in the context of iron absorption.</span></p><p> </p><p><span style=\"font-size:12.0pt;\"><strong>Educational Objective:</strong></span></p><p> </p><p><span style=\"font-size:12.0pt;\">Divalent metal transporter 1 (DMT1) is critical for the transport of Fe²⁺ iron across the apical membrane of enterocytes, facilitating iron absorption in the gut.</span></p><p> </p><p><span style=\"font-size:12.0pt;\"><strong>Ref: Robbins and Cotrans pathologic basis of disease 8th edition Pg 1230</strong></span></p><p><img src=\"https://cerebellum-web-static.s3.amazonaws.com/media/public/images/2023/04/12/959.jpg\" alt=\"Solution Image\"></p>",
      "correct_choice_id": 200253,
      "solution_audio": null,
      "solution_video": null,
      "audio_explanation_heading": null,
      "video_explanation_heading": null,
      "solution_media_position": "bottom",
      "tags": [],
      "explanation_video": null,
      "question_images": [],
      "explanation_images": []
    },
    {
      "id": 50064,
      "choices": [
        {
          "id": 200256,
          "text": "<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\">1-C, 2-A, 3-B, 4-E</span></span></span></p>"
        },
        {
          "id": 200257,
          "text": "<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\">1-D, 2-A, 3-E, 4-B</span></span></span></p>"
        },
        {
          "id": 200258,
          "text": "<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\">1-C, 2-A, 3-D, 4-E</span></span></span></p>"
        },
        {
          "id": 200259,
          "text": "<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\">1-C, 2-A, 3-B, 4-D</span></span></span></p>"
        }
      ],
      "text": "<p style=\"text-align:justify\"><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\"><span style=\"font-family:\"Calibri\",sans-serif\"><span style=\"color:#333333\">Drug with mechanism of action are given in two columns. Which of the following is the correct match?</span></span></span>(AIIMS NOV 2019)</p>\r\n\r\n<p> </p>\r\n\r\n<p><img alt=\"\" src=\"https://cerebellum-web-static.s3.amazonaws.com/media/public/images/2024/07/20/screenshot-2024-07-20-124051.png\" style=\"height:296px; width:1000px\" /></p><p><img src=\"https://cerebellum-web-static.s3.amazonaws.com/media/public/images/2024/07/20/screenshot-2024-07-20-124051.png\" alt=\"Question Image\"></p>",
      "unique_key": "Q6189405",
      "question_audio": null,
      "question_video": null,
      "map_id": 34055930,
      "difficulty_level": "intermediate",
      "subjects_id": [],
      "solution": "<p><span style=\"font-size:12pt\"><span style=\"font-family:\"Liberation Serif\",serif\"><strong><span dir=\"ltr\" lang=\"EN-US\" style=\"font-family:\"Calibri\",sans-serif\"><span style=\"color:#333333\">Ans. A. 1-C, 2-A, 3-B, 4-E</span></span></strong></span></span></p>\r\n\r\n<p> </p>\r\n\r\n<p style=\"text-align:left\"><span style=\"font-size:10.5pt\"><span style=\"font-family:Calibri,sans-serif\"><span style=\"font-size:12.0pt\">The correct matches between the drugs and their mechanisms of action are as follows:</span></span></span></p>\r\n\r\n<ol>\r\n\t<li style=\"text-align:left\"><span style=\"font-size:10.5pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span style=\"font-size:12.0pt\">Omalizumab - Anti-IgE (1-C)</span></strong></span></span>\r\n\r\n\t<ul>\r\n\t\t<li style=\"text-align:left\"><span style=\"font-size:10.5pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span style=\"font-size:12.0pt\">Indication</span></strong><span style=\"font-size:12.0pt\">: Omalizumab is used in the treatment of bronchial asthma. It works by binding to IgE, which plays a key role in allergic reactions.</span></span></span></li>\r\n\t</ul>\r\n\t</li>\r\n\t<li style=\"text-align:left\"><span style=\"font-size:10.5pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span style=\"font-size:12.0pt\">Itolizumab - Anti-CD 6 (2-A)</span></strong></span></span>\r\n\t<ul>\r\n\t\t<li style=\"text-align:left\"><span style=\"font-size:10.5pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span style=\"font-size:12.0pt\">Indication</span></strong><span style=\"font-size:12.0pt\">: Itolizumab is a new drug used for psoriasis. It targets CD6, a molecule involved in T-cell activation.</span></span></span></li>\r\n\t</ul>\r\n\t</li>\r\n\t<li style=\"text-align:left\"><span style=\"font-size:10.5pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span style=\"font-size:12.0pt\">Daclizumab - Anti-CD 25 (3-B)</span></strong></span></span>\r\n\t<ul>\r\n\t\t<li style=\"text-align:left\"><span style=\"font-size:10.5pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span style=\"font-size:12.0pt\">Indication</span></strong><span style=\"font-size:12.0pt\">: Daclizumab acts as an IL-2 receptor antagonist by binding to CD25, which is part of the IL-2 receptor. It is used as an immunosuppressant.</span></span></span></li>\r\n\t</ul>\r\n\t</li>\r\n\t<li style=\"text-align:left\"><span style=\"font-size:10.5pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span style=\"font-size:12.0pt\">Belimumab - Anti-B lymphocyte stimulator (BlyS) (4-E)</span></strong></span></span>\r\n\t<ul>\r\n\t\t<li style=\"text-align:left\"><span style=\"font-size:10.5pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span style=\"font-size:12.0pt\">Indication</span></strong><span style=\"font-size:12.0pt\">: Belimumab is used for the treatment of systemic lupus erythematosus (SLE). It inhibits B-lymphocyte stimulator, which is involved in the survival of B cells.</span></span></span></li>\r\n\t</ul>\r\n\t</li>\r\n</ol>\r\n\r\n<p> </p>\r\n\r\n<p><span style=\"font-size:12pt\"><span style=\"font-family:\"Liberation Serif\",serif\"><strong><span dir=\"ltr\" lang=\"EN-US\" style=\"font-family:\"Calibri\",sans-serif\">Educational objective:</span></strong></span></span></p>\r\n\r\n<p> </p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\"><img alt=\"\" src=\"https://cerebellum-web-static.s3.amazonaws.com/media/public/images/2023/12/20/screenshot-2023-12-20-101044.jpg\" style=\"height:355px; width:1000px\" /></span></strong></span></span></p>\r\n\r\n<p> </p>\r\n\r\n<p><span style=\"font-size:12pt\"><span style=\"font-family:\"Liberation Serif\",serif\"><strong><span dir=\"ltr\" lang=\"EN-US\" style=\"font-family:\"Calibri\",sans-serif\"><span style=\"color:#333333\">Reference: KDT 8<sup>TH</sup>/251-52,943</span></span></strong></span></span></p><p><img src=\"https://cerebellum-web-static.s3.amazonaws.com/media/public/images/2023/12/20/screenshot-2023-12-20-101044.jpg\" alt=\"Solution Image\"></p>",
      "correct_choice_id": 200256,
      "solution_audio": null,
      "solution_video": null,
      "audio_explanation_heading": null,
      "video_explanation_heading": null,
      "solution_media_position": "bottom",
      "tags": [],
      "explanation_video": null,
      "question_images": [],
      "explanation_images": []
    },
    {
      "id": 50065,
      "choices": [
        {
          "id": 200260,
          "text": "<p><span style=\"font-size:12.0pt;\">Binding of ATP</span></p>"
        },
        {
          "id": 200261,
          "text": "<p><span style=\"font-size:12.0pt;\">﻿﻿﻿Entry of calcium into sarcoplasmic reticulum</span></p>"
        },
        {
          "id": 200262,
          "text": "<p><span style=\"font-size:12.0pt;\">﻿﻿﻿Change in troponin C configuration</span></p>"
        },
        {
          "id": 200263,
          "text": "<p><span style=\"font-size:12.0pt;\">﻿﻿﻿Release of ADP and Pi</span></p>"
        }
      ],
      "text": "<p><span style=\"font-size:12.0pt;\">Myosin head detaches from actin by which of the following mechanism? (</span>AIIMS Nov 2019)</p>",
      "unique_key": "Q3305636",
      "question_audio": null,
      "question_video": null,
      "map_id": 34403775,
      "difficulty_level": "intermediate",
      "subjects_id": [],
      "solution": "<p><span style=\"font-size:12.0pt;\"><strong>Ans. A) Binding of ATP</strong></span></p><p> </p><p><span style=\"font-size:12.0pt;\">Binding of ATP on the free site of myosin leads to the detachment of myosin head from the thin filament.</span></p><p> </p><p><span style=\"font-size:12.0pt;\"><img src=\"https://cerebellum-web-static.s3.amazonaws.com/media/public/images/2023/04/05/aiims-physio-nov-2019-04.jpg\" alt=\"\" width=\"1200\" height=\"592\"></span></p><p> </p><p><span style=\"font-size:12.0pt;\">Energy for movement of myosin head (power stroke) is obtained by breakdown of adenosine triphosphate (ATP) into adenosine diphosphate (ADP) and inorganic phosphate (Pi). Head of myosin has a site for ATP and itself can act as the enzyme ATPase and catalyse the breakdown of ATP.</span></p><p> </p><p><span style=\"font-size:12.0pt;\">Even before the onset of contraction, an ATP molecule binds with myosin head.</span></p><p><span style=\"font-size:12.0pt;\">When tropomyosin moves to expose the active sites, the head is attached to the active site. Now ATPase cleaves ATP into ADP and Pi, which remains in head itself. The energy released during this process is utilized for contraction.</span></p><p> </p><p><span style=\"font-size:12.0pt;\"><strong>Other Options:</strong></span></p><p> </p><p><span style=\"font-size:12pt;\"><strong>Option</strong> </span><span style=\"font-size:12.0pt;\"><strong>B. Entry of calcium into sarcoplasmic reticulum:</strong> Incorrect. The entry of calcium into the sarcoplasmic reticulum helps in muscle relaxation but does not directly cause the detachment of the myosin head from actin.</span></p><p> </p><p><span style=\"font-size:12pt;\"><strong>Option</strong> </span><span style=\"font-size:12.0pt;\"><strong>C. Change in troponin C configuration:</strong> Incorrect. The change in troponin C configuration exposes the active sites on actin for myosin binding but does not cause detachment.</span></p><p> </p><p><span style=\"font-size:12pt;\"><strong>Option</strong> </span><span style=\"font-size:12.0pt;\"><strong>D. Release of ADP and Pi:</strong> Incorrect. The release of ADP and Pi occurs after the power stroke but does not cause the detachment of the myosin head.</span></p><p> </p><p><span style=\"font-size:12.0pt;\"><strong>Educational Objective:</strong></span></p><p> </p><p><span style=\"font-size:12.0pt;\">The detachment of the myosin head from actin is caused by the binding of ATP to the myosin head, which is a critical step in the muscle contraction and relaxation cycle.</span></p><p><img src=\"https://cerebellum-web-static.s3.amazonaws.com/media/public/images/2023/04/05/aiims-physio-nov-2019-04.jpg\" alt=\"Solution Image\"></p>",
      "correct_choice_id": 200260,
      "solution_audio": null,
      "solution_video": null,
      "audio_explanation_heading": null,
      "video_explanation_heading": null,
      "solution_media_position": "bottom",
      "tags": [],
      "explanation_video": null,
      "question_images": [],
      "explanation_images": []
    },
    {
      "id": 50066,
      "choices": [
        {
          "id": 200264,
          "text": "<p><span style=\"font-size:12.0pt;\">Phenylalanine</span></p>"
        },
        {
          "id": 200265,
          "text": "<p><span style=\"font-size:12.0pt;\">﻿﻿﻿Tryptophan</span></p>"
        },
        {
          "id": 200266,
          "text": "<p><span style=\"font-size:12.0pt;\">﻿﻿﻿Glutamine</span></p>"
        },
        {
          "id": 200267,
          "text": "<p><span style=\"font-size:12.0pt;\">﻿﻿﻿Arginine</span></p>"
        }
      ],
      "text": "<p><span style=\"font-size:12.0pt;\">Which of the following is deficient in a patient with features as shown below?</span></p><p> </p><p><span style=\"font-size:12.0pt;\"><img src=\"https://cerebellum-web-static.s3.amazonaws.com/media/public/images/2023/03/29/untitled-229.jpg\" alt=\"\" width=\"396\" height=\"347\"></span></p><p><img src=\"https://cerebellum-web-static.s3.amazonaws.com/media/public/images/2023/03/29/untitled-229.jpg\" alt=\"Question Image\"></p>",
      "unique_key": "Q1572558",
      "question_audio": null,
      "question_video": null,
      "map_id": 34558126,
      "difficulty_level": "intermediate",
      "subjects_id": [],
      "solution": "<p><span style=\"font-size:12.0pt;\"><strong>Ans. B) Tryptophan</strong></span></p><p> </p><p><span style=\"font-size:12.0pt;\">The Casal collar or <strong>Casal necklace</strong> is a clinical sign in which there is an <strong>erythematous pigmented skin rash</strong><u> </u>in the distribution of a broad collar (<strong>dermatomes C3 and C4)</strong>. It is <strong>seen in patients with pellagra, as a result of niacin (vitamin B3) deficiency or tryptophan deficiency.</strong></span></p><p> </p><p><span style=\"font-size:12.0pt;\">Deficiency of niacin leads to the clinical condition called pellagra. Pellagra is an Italian word, meaning <strong>“rough skin</strong>”. Pellagra is caused by the deficiency of Tryptophan as well as Niacin. Pellagra is seen <strong>more in women; this may be because tryptophan metabolism is inhibited by estrogen metabolites.</strong></span></p><p> </p><p><span style=\"font-size:12.0pt;\"><strong>The symptoms of pellagra are (3 Ds):</strong></span></p><p> </p><ol style=\"list-style-type:lower-alpha;\"><li><span style=\"font-size:12.0pt;\"><strong>Dermatitis</strong>: In early stages, bright red erythema occurs, especially in the feet, ankles and face. Increased pigmentation around the neck is known as Casal necklace. The dermatitis is <strong>precipitated by exposure to sunlight</strong></span></li><li><span style=\"font-size:12.0pt;\"><strong>Diarrhea:</strong> The diarrhea may be <strong>mild or severe with blood and mucus</strong>. This may lead to weight loss. Nausea and vomiting may also be present.</span></li><li><span style=\"font-size:12.0pt;\"><strong>Dementia</strong>: It is frequently seen in chronic cases.</span></li></ol><p> </p><p><span style=\"font-size:12.0pt;\"><strong>Delirium is common in acute Pellagra</strong>. Irritability, inability to concentrate and poor memory are more common in mild cases. <strong>Ataxia, and spasticity</strong> are also seen.</span></p><p> </p><p><span style=\"font-size:12.0pt;\"><strong>Other Options:</strong></span></p><p><span style=\"font-size:10.5pt;\"> </span></p><p><span style=\"font-size:12.0pt;\"><strong>Option.  </strong>A. <strong>Phenylalanine, </strong>C. <strong>Glutamine:</strong> and D. <strong>Arginine:</strong> Deficiency of these amino acids are not associated with pellagra.</span></p><p> </p><p><span style=\"font-size:12.0pt;\"><strong>Educational Objective</strong></span></p><p> </p><p><span style=\"font-size:12.0pt;\"><strong>Pellagra can occur due to:</strong></span></p><p> </p><ul><li><span style=\"font-size:12.0pt;\">﻿﻿<strong>Vitamin B3 (Niacin) deficiency</strong></span></li><li><span style=\"font-size:12.0pt;\"><strong>﻿﻿Tryptophan deficiency:</strong> Niacin is synthetised from tryptophan</span></li><li><span style=\"font-size:12.0pt;\"><strong>Deficient synthesis: </strong>Kynureninase, an important enzyme in the pathway of tryptophan, is pyridoxal phosphate dependent. So, conversion of tryptophan to niacin is not possible in pyridoxal deficiency.</span></li><li><span style=\"font-size:12.0pt;\"><strong>Isoniazid (INH):</strong> It is an anti-tubercular drug, which inhibits pyridoxal phosphate formation. Hence, there is block in conversion of tryptophan to NAD.</span></li><li><span style=\"font-size:12.0pt;\"><strong>Hartnup disease:</strong> Tryptophan absorption from intestine is defective in this congenital disease. Moreover, tryptophan is excreted in urine in large quantities. This leads to lack of tryptophan and consequently deficiency of nicotinamide.</span></li><li><span style=\"font-size:12.0pt;\"><strong>Carcinoid syndrome:</strong> The tumor utilizes major portion of available tryptophan for synthesis of serotonin; so, tryptophan is unavailable.</span></li></ul>",
      "correct_choice_id": 200265,
      "solution_audio": null,
      "solution_video": null,
      "audio_explanation_heading": null,
      "video_explanation_heading": null,
      "solution_media_position": "bottom",
      "tags": [],
      "explanation_video": null,
      "question_images": [],
      "explanation_images": []
    },
    {
      "id": 50067,
      "choices": [
        {
          "id": 200268,
          "text": "<p><span style=\"font-size:12pt\"><span style=\"font-family:\"Liberation Serif\",serif\"><span dir=\"ltr\" lang=\"EN-US\" style=\"font-family:\"Calibri\",sans-serif\">All are true</span></span></span></p>"
        },
        {
          "id": 200269,
          "text": "<p><span style=\"font-size:12pt\"><span style=\"font-family:\"Liberation Serif\",serif\"><span dir=\"ltr\" lang=\"EN-US\" style=\"font-family:\"Calibri\",sans-serif\">A, B and C only</span></span></span></p>"
        },
        {
          "id": 200270,
          "text": "<p><span style=\"font-size:12pt\"><span style=\"font-family:\"Liberation Serif\",serif\"><span dir=\"ltr\" lang=\"EN-US\" style=\"font-family:\"Calibri\",sans-serif\">A, C, and E only</span></span></span></p>"
        },
        {
          "id": 200271,
          "text": "<p><span style=\"font-size:12pt\"><span style=\"font-family:\"Liberation Serif\",serif\"><span dir=\"ltr\" lang=\"EN-US\" style=\"font-family:\"Calibri\",sans-serif\">A, B, D and E</span></span></span></p>"
        }
      ],
      "text": "<p><span style=\"font-size:12pt\"><span style=\"font-family:\"Liberation Serif\",serif\"><span dir=\"ltr\" lang=\"EN-US\" style=\"font-family:\"Calibri\",sans-serif\"><span style=\"color:#333333\">Which of the following statements regarding foscarnet are True? </span></span></span></span></p>\r\n\r\n<p> </p>\r\n\r\n<ol style=\"list-style-type:upper-alpha\">\r\n\t<li><span style=\"font-size:12pt\"><span style=\"font-family:\"Liberation Serif\",serif\"><span dir=\"ltr\" lang=\"EN-US\" style=\"font-family:\"Calibri\",sans-serif\"><span style=\"color:#333333\">It is used for resistant CMV infections</span></span></span></span></li>\r\n\t<li><span style=\"font-size:12pt\"><span style=\"font-family:\"Liberation Serif\",serif\"><span dir=\"ltr\" lang=\"EN-US\" style=\"font-family:\"Calibri\",sans-serif\"><span style=\"color:#333333\">Renal toxicity is seen </span></span></span></span></li>\r\n\t<li><span style=\"font-size:12pt\"><span style=\"font-family:\"Liberation Serif\",serif\"><span dir=\"ltr\" lang=\"EN-US\" style=\"font-family:\"Calibri\",sans-serif\"><span style=\"color:#333333\">It is activated by viral thymidine kinase </span></span></span></span></li>\r\n\t<li><span style=\"font-size:12pt\"><span style=\"font-family:\"Liberation Serif\",serif\"><span dir=\"ltr\" lang=\"EN-US\" style=\"font-family:\"Calibri\",sans-serif\"><span style=\"color:#333333\">Regular monitoring of serum electrolytes is required </span></span></span></span></li>\r\n\t<li><span style=\"font-size:12pt\"><span style=\"font-family:\"Liberation Serif\",serif\"><span dir=\"ltr\" lang=\"EN-US\" style=\"font-family:\"Calibri\",sans-serif\"><span style=\"color:#333333\">It can cause genital ulceration </span></span></span></span></li>\r\n</ol>",
      "unique_key": "Q7572174",
      "question_audio": null,
      "question_video": null,
      "map_id": 34717971,
      "difficulty_level": "intermediate",
      "subjects_id": [],
      "solution": "<p><span style=\"font-size:12pt\"><span style=\"font-family:\"Liberation Serif\",serif\"><strong><span dir=\"ltr\" lang=\"EN-US\" style=\"font-family:\"Calibri\",sans-serif\"><span style=\"color:#333333\">Ans. D. A, B, D and E</span></span></strong></span></span></p>\r\n\r\n<p> </p>\r\n\r\n<p><span style=\"font-size:12pt\"><span style=\"font-family:\"Times New Roman\",serif\"><strong><span style=\"font-family:\"Calibri\",sans-serif\">Foscarnet</span></strong><span style=\"font-family:\"Calibri\",sans-serif\"> is an antiviral medication used primarily for the treatment of cytomegalovirus (CMV) and other herpesvirus infections, particularly when the viruses are resistant to other treatments like ganciclovir and acyclovir.</span></span></span></p>\r\n\r\n<p> </p>\r\n\r\n<p><span style=\"font-size:12pt\"><span style=\"font-family:\"Times New Roman\",serif\"><strong><span style=\"font-family:\"Calibri\",sans-serif\">Statements:</span></strong></span></span></p>\r\n\r\n<p> </p>\r\n\r\n<p><span style=\"font-size:12pt\"><span style=\"font-family:\"Times New Roman\",serif\"><strong><span style=\"font-family:\"Calibri\",sans-serif\">A. It is used for resistant CMV infections</span></strong></span></span></p>\r\n\r\n<p> </p>\r\n\r\n<p><span style=\"font-size:12pt\"><span style=\"font-family:\"Times New Roman\",serif\"><span style=\"font-family:\"Calibri\",sans-serif\">This is true. Foscarnet is effective against CMV, including strains that are resistant to ganciclovir.</span></span></span></p>\r\n\r\n<p> </p>\r\n\r\n<p><span style=\"font-size:12pt\"><span style=\"font-family:\"Times New Roman\",serif\"><strong><span style=\"font-family:\"Calibri\",sans-serif\">B. Renal toxicity is seen</span></strong></span></span></p>\r\n\r\n<p> </p>\r\n\r\n<p><span style=\"font-size:12pt\"><span style=\"font-family:\"Times New Roman\",serif\"><span style=\"font-family:\"Calibri\",sans-serif\">This is true. Renal toxicity is a significant adverse effect of foscarnet, which can lead to acute renal failure and other renal complications.</span></span></span></p>\r\n\r\n<p> </p>\r\n\r\n<p><span style=\"font-size:12pt\"><span style=\"font-family:\"Times New Roman\",serif\"><strong><span style=\"font-family:\"Calibri\",sans-serif\">D. Regular monitoring of serum electrolytes is required</span></strong></span></span></p>\r\n\r\n<p> </p>\r\n\r\n<p><span style=\"font-size:12pt\"><span style=\"font-family:\"Times New Roman\",serif\"><span style=\"font-family:\"Calibri\",sans-serif\">This is true. Due to its potential to cause electrolyte imbalances, particularly hypocalcemia, regular monitoring of serum electrolytes is necessary during foscarnet therapy.</span></span></span></p>\r\n\r\n<p> </p>\r\n\r\n<p><span style=\"font-size:12pt\"><span style=\"font-family:\"Times New Roman\",serif\"><strong><span style=\"font-family:\"Calibri\",sans-serif\">E. It can cause genital ulceration</span></strong></span></span></p>\r\n\r\n<p> </p>\r\n\r\n<p><span style=\"font-size:12pt\"><span style=\"font-family:\"Times New Roman\",serif\"><span style=\"font-family:\"Calibri\",sans-serif\">This is true. Genital ulceration is one of the potential side effects of foscarnet.</span></span></span></p>\r\n\r\n<p> </p>\r\n\r\n<p><span style=\"font-size:12pt\"><span style=\"font-family:\"Times New Roman\",serif\"><strong><span style=\"font-family:\"Calibri\",sans-serif\">Other Options:</span></strong></span></span></p>\r\n\r\n<p> </p>\r\n\r\n<p><span style=\"font-size:12pt\"><span style=\"font-family:\"Times New Roman\",serif\"><strong><span style=\"font-family:\"Calibri\",sans-serif\">Option <strong><span style=\"font-family:\"Calibri\",sans-serif\">C. It is activated by viral thymidine kinase: </span></strong></span></strong><span style=\"font-family:\"Calibri\",sans-serif\">This is false. Foscarnet does not require activation by viral thymidine kinase. Unlike acyclovir and ganciclovir, foscarnet directly inhibits viral DNA polymerase, RNA polymerase, and HIV reverse transcriptase without needing to be phosphorylated by viral enzymes.</span></span></span></p>\r\n\r\n<p> </p>\r\n\r\n<p><span style=\"font-size:12pt\"><span style=\"font-family:\"Times New Roman\",serif\"><strong><span style=\"font-family:\"Calibri\",sans-serif\">Educational objective:</span></strong></span></span></p>\r\n\r\n<p> </p>\r\n\r\n<ul>\r\n\t<li><span style=\"font-size:12pt\"><span style=\"font-family:\"Liberation Serif\",serif\"><span dir=\"ltr\" lang=\"EN-US\" style=\"font-family:\"Calibri\",sans-serif\"><span style=\"color:#333333\">Drug of choice for herpes simplex virus and varicella zoster virus infection is acyclovir.</span></span></span></span></li>\r\n\t<li><span style=\"font-size:12pt\"><span style=\"font-family:\"Liberation Serif\",serif\"><span dir=\"ltr\" lang=\"EN-US\" style=\"font-family:\"Calibri\",sans-serif\"><span style=\"color:#333333\">Drug of choice for cytomegalovirus is ganciclovir.</span></span></span></span></li>\r\n\t<li><span style=\"font-size:12pt\"><span style=\"font-family:\"Liberation Serif\",serif\"><span dir=\"ltr\" lang=\"EN-US\" style=\"font-family:\"Calibri\",sans-serif\"><span style=\"color:#333333\">Both acyclovir and ganciclovir are pro-drugs and require activation by kinases.</span></span></span></span></li>\r\n</ul>\r\n\r\n<p> </p>\r\n\r\n<p><span style=\"font-size:12pt\"><span style=\"font-family:\"Liberation Serif\",serif\"><strong><span dir=\"ltr\" lang=\"EN-US\" style=\"font-family:\"Calibri\",sans-serif\"><span style=\"color:#333333\">FOSCARNET</span></span></strong></span></span></p>\r\n\r\n<p> </p>\r\n\r\n<ul>\r\n\t<li><span style=\"font-size:12pt\"><span style=\"font-family:\"Liberation Serif\",serif\"><span dir=\"ltr\" lang=\"EN-US\" style=\"font-family:\"Calibri\",sans-serif\"><span style=\"color:#333333\">It is a simple straight chain phosphonate.</span></span></span></span></li>\r\n\t<li><span style=\"font-size:12pt\"><span style=\"font-family:\"Liberation Serif\",serif\"><span dir=\"ltr\" lang=\"EN-US\" style=\"font-family:\"Calibri\",sans-serif\"><span style=\"color:#333333\">It does not require activation by kinases.</span></span></span></span></li>\r\n\t<li><span style=\"font-size:12pt\"><span style=\"font-family:\"Liberation Serif\",serif\"><span dir=\"ltr\" lang=\"EN-US\" style=\"font-family:\"Calibri\",sans-serif\"><span style=\"color:#333333\">It is active against H. simplex (including strains resistant to acyclovir), CMV (including ganciclovir-resistant ones) and other herpes group viruses.</span></span></span></span></li>\r\n\t<li><span style=\"font-size:12pt\"><span style=\"font-family:\"Liberation Serif\",serif\"><span dir=\"ltr\" lang=\"EN-US\" style=\"font-family:\"Calibri\",sans-serif\"><span style=\"color:#333333\">Oral absorption is poor. Its t½ is 4–8 hours, and it is not metabolized by liver.</span></span></span></span></li>\r\n\t<li><span style=\"font-size:12pt\"><span style=\"font-family:\"Liberation Serif\",serif\"><span dir=\"ltr\" lang=\"EN-US\" style=\"font-family:\"Calibri\",sans-serif\"><span style=\"color:#333333\">Toxicity of foscarnet is high. It damages kidney and produces a renal diabetes like condition; acute <strong>renal failure</strong> can also occur. Anemia, phlebitis, tremors, convulsions, <strong>genital ulceration</strong> and other neurological as well as constitutional symptoms due to <strong>hypocalcemia</strong> are frequent.</span></span></span></span></li>\r\n\t<li><span style=\"font-size:12pt\"><span style=\"font-family:\"Liberation Serif\",serif\"><span dir=\"ltr\" lang=\"EN-US\" style=\"font-family:\"Calibri\",sans-serif\"><span style=\"color:#333333\">It is administered by i.v. infusion</span></span></span></span><br />\r\n\t </li>\r\n</ul>\r\n\r\n<p><span style=\"font-size:12pt\"><span style=\"font-family:\"Liberation Serif\",serif\"><strong><span dir=\"ltr\" lang=\"EN-US\" style=\"font-family:\"Calibri\",sans-serif\"><span style=\"color:#333333\">Reference: KDT 8<sup>th</sup>/852, 853</span></span></strong></span></span></p>",
      "correct_choice_id": 200271,
      "solution_audio": null,
      "solution_video": null,
      "audio_explanation_heading": null,
      "video_explanation_heading": null,
      "solution_media_position": "bottom",
      "tags": [],
      "explanation_video": null,
      "question_images": [],
      "explanation_images": []
    },
    {
      "id": 50068,
      "choices": [
        {
          "id": 200272,
          "text": "<p><span style=\"font-size:12.0pt;\">Atypical pneumonia</span></p>"
        },
        {
          "id": 200273,
          "text": "<p><span style=\"font-size:12.0pt;\">Lung abscess</span></p>"
        },
        {
          "id": 200274,
          "text": "<p><span style=\"font-size:12.0pt;\">Hemorrhagic mediastinitis</span></p>"
        },
        {
          "id": 200275,
          "text": "<p><span style=\"font-size:12.0pt;\">Broncho pulmonary pneumonia</span></p>"
        }
      ],
      "text": "<p><span style=\"font-size:12.0pt;\">What is the most common presentation of inhalational anthrax? (AIIMS NOV 2019)</span></p>",
      "unique_key": "Q6170016",
      "question_audio": null,
      "question_video": null,
      "map_id": 34407770,
      "difficulty_level": "intermediate",
      "subjects_id": [],
      "solution": "<p><span style=\"font-size:12.0pt;\"><strong>Ans. C) Hemorrhagic mediastinitis</strong></span></p><p> </p><p><span style=\"font-size:12.0pt;\">Inhalational of anthrax spores (<5 microns) are phagocytosed by alveolar macrophages, carried to local mediastinal lymph nodes releasing toxins causing hemorrhagic mediastinitis</span></p><p> </p><p><span style=\"font-size:12.0pt;\">It is category A bioterrorism agent along with plague, botulism</span></p><p> </p><p><span style=\"font-size:12.0pt;\">Treatment recommended with IV antibiotics (Ciprofloxacin+Clindamycin)</span></p><p> </p><p><span style=\"font-size:12.0pt;\"><strong>Other Options:</strong></span></p><p> </p><p><span style=\"font-size:12.0pt;\"><strong>Option A. Atypical pneumonia</strong> occurs in Chlamydia, Mycoplasma, Legionella pneumonia causing interstitial infiltrates</span></p><p> </p><p><span style=\"font-size:12.0pt;\"><strong>Option B. Lung abscess</strong> is seen as complication of infection with anaerobes, complication of pneumonia, atypical organisms like burkholderia, Infective endocarditis with septic embolism</span></p><p> </p><p><span style=\"font-size:12.0pt;\"><strong>Option D. Bronchopneumonia occurs due to pneumococcus</strong>, H.influenza etc.</span></p><p> </p><p><span style=\"font-size:12.0pt;\"><strong>Educational Objective:</strong></span></p><p> </p><p><span style=\"font-size:12.0pt;\">Hemorrhagic mediastinitis is the hallmark presentation of inhalational anthrax, indicating a severe systemic infection that requires immediate medical attention and aggressive antibiotic therapy. Awareness of this presentation is crucial, particularly in contexts involving potential exposure to anthrax spores, such as bioterrorism.</span></p>",
      "correct_choice_id": 200274,
      "solution_audio": null,
      "solution_video": null,
      "audio_explanation_heading": null,
      "video_explanation_heading": null,
      "solution_media_position": "bottom",
      "tags": [],
      "explanation_video": null,
      "question_images": [],
      "explanation_images": []
    },
    {
      "id": 50069,
      "choices": [
        {
          "id": 200276,
          "text": "<p><span style=\"font-size:12pt;\">Kit 6/Yellow</span></p>"
        },
        {
          "id": 200277,
          "text": "<p><span style=\"font-size:12pt;\">Kit 2/green</span></p>"
        },
        {
          "id": 200278,
          "text": "<p><span style=\"font-size:12pt;\">Kit 3/white</span></p>"
        },
        {
          "id": 200279,
          "text": "<p><span style=\"font-size:12pt;\">Kit 1/grey</span></p>"
        }
      ],
      "text": "<p><span style=\"font-size:12.0pt;\">In a 25-year-old man who visited a primary health center with complaints as shown in the image below, 5 days after engaging in unprotected sexual intercourse. The patient experienced painful ulcers upon palpation, and there was suppurative inguinal lymphadenopathy on the right side. Additionally, the patient has no history of drug allergy. What specific kit will be used for managing this sexually transmitted disease? (</span>AIIMS Nov 2019)</p><p style=\"text-align:justify;\"> </p><p><span style=\"font-size:12.0pt;\"><img src=\"https://cerebellum-web-static.s3.amazonaws.com/media/public/images/2023/04/12/2_Py1ZGSh.jpg\" alt=\"\" width=\"200\" height=\"301\"></span></p><p><img src=\"https://cerebellum-web-static.s3.amazonaws.com/media/public/images/2023/04/12/2_Py1ZGSh.jpg\" alt=\"Question Image\"></p>",
      "unique_key": "Q7089468",
      "question_audio": null,
      "question_video": null,
      "map_id": 34902303,
      "difficulty_level": "intermediate",
      "subjects_id": [],
      "solution": "<p><span style=\"font-size:12pt;\"><strong>Ans. C) Kit 3/white</strong></span></p><p> </p><p><span style=\"font-size:12pt;\">The clinical image and findings presented above are consistent with <strong>chancroid</strong>, a sexually transmitted disease.</span></p><p> </p><p><span style=\"font-size:12pt;\"><strong>Chancroid:</strong></span></p><p> </p><ul><li><span style=\"font-size:12pt;\">The causative agent responsible for chancroid is <strong>Haemophilus ducreyi</strong>.</span></li><li><span style=\"font-size:12pt;\">The incubation period typically ranges from 3 to 10 days.</span></li><li><span style=\"font-size:12pt;\">It is characterized by the presence of <strong>painful and deep ulcers,</strong> along with <strong>tender lymphadenopathy</strong>. The recommended kit for managing this condition is Kit 3/White.</span></li><li><span style=\"font-size:12pt;\">Initially, a painful papule appears, which later transforms into a <strong>painful, non-indurated ulcer with undermined edges</strong>, often accompanied by central necrosis.</span></li><li><span style=\"font-size:12pt;\">Autoinoculation may lead to the presence of <strong>\"kissing ulcers.\"</strong></span></li><li><span style=\"font-size:12pt;\">The disease is also associated with <strong>painful lymphadenopathy</strong>, which can progress to form suppurating sinuses and <strong>buboes</strong>.</span></li><li><span style=\"font-size:12pt;\">When the patient presents with both genital ulcers and inguinal lymphadenopathy (bubo), it is referred to as <strong>concomitant genital ulcer as shown below.</strong></span></li></ul><p><img src=\"https://cerebellum-web-static.s3.amazonaws.com/media/public/images/2023/11/27/picture8.jpg\" alt=\"\" width=\"300\" height=\"241\"></p><p> </p><p><span style=\"font-size:12pt;\"><strong>Chancroid </strong>showing <strong>Concomitant genital ulcer</strong>: Small <strong>soft ulcer</strong> on the internal surface of the <strong>prepuce</strong> with <strong>painful,</strong> fluctuant <strong>inguinal adenitis (bubo).</strong></span></p><p style=\"margin-left:24px;\"> </p><p><span style=\"font-size:12pt;\"><strong>NACO KIT 3 / White color KIT</strong></span></p><p> </p><p><span style=\"font-size:12pt;\"><strong>Kit 3/white consists of:</strong></span></p><p> </p><ol><li><span style=\"font-size:12pt;\"><strong>Tablet Azithromycin 1gm single dose</strong>, which is used for the treatment of chancroid.</span></li><li><span style=\"font-size:12pt;\"><strong>Injection Benzathine Penicillin 2.4 Million IU</strong> deep IM stat, which is used for syphilis.</span></li></ol><p> </p><p><span style=\"font-size:12.0pt;\"><img src=\"https://cerebellum-web-static.s3.amazonaws.com/media/public/images/2023/08/19/untitled-13539.jpg\" alt=\"\" width=\"400\" height=\"339\"></span></p><p> </p><ul><li><span style=\"font-size:12pt;\"><strong>Concomitant genital ulcer </strong>is seen associated with Chancroid, but <strong>absent in LGV.</strong></span></li><li><span style=\"font-size:12pt;\">First line treatment for Chancroid is <strong>azithromycin </strong>1g orally as a single dose or ceftriaxone 250 mg IM as a single dose.</span></li></ul><p> </p><p><span style=\"font-size:12pt;\"><strong>The second-line options for chancroid are as follows:</strong></span></p><p> </p><ul><li><span style=\"font-size:12pt;\">Ciprofloxacin 500 mg orally twice a day for 3 days (OR)</span></li><li><span style=\"font-size:12pt;\">Erythromycin base 500 mg orally four times a day for 7 days</span></li></ul><p> </p><p><span style=\"font-size:12pt;\"><strong>Differentiating features between Herpes genitalis & Chancroid:</strong></span></p><p> </p><p><img src=\"https://cerebellum-web-static.s3.amazonaws.com/media/public/images/2023/08/19/untitled-13540_WqInQ3d.jpg\" alt=\"\" width=\"1000\" height=\"702\"></p><p> </p><p><span style=\"font-size:12pt;\"><strong>Other KITs:</strong></span></p><p> </p><p><span style=\"font-size:12pt;\"><i><strong><img src=\"https://cerebellum-web-static.s3.amazonaws.com/media/public/images/2023/11/27/picture9.jpg\" alt=\"\" width=\"1000\" height=\"377\"></strong></i></span></p><p> </p><p><img src=\"https://cerebellum-web-static.s3.amazonaws.com/media/public/images/2023/11/27/picture10.jpg\" alt=\"\" width=\"400\" height=\"227\"></p><p> </p><p><img src=\"https://cerebellum-web-static.s3.amazonaws.com/media/public/images/2023/11/27/picture11.jpg\" alt=\"\" width=\"400\" height=\"227\"></p><p> </p><p><img src=\"https://cerebellum-web-static.s3.amazonaws.com/media/public/images/2023/11/27/picture12.jpg\" alt=\"\" width=\"400\" height=\"214\"></p><p> </p><p><img src=\"https://cerebellum-web-static.s3.amazonaws.com/media/public/images/2023/11/27/picture13.jpg\" alt=\"\" width=\"400\" height=\"228\"></p><p> </p><p><img src=\"https://cerebellum-web-static.s3.amazonaws.com/media/public/images/2023/11/27/picture14.jpg\" alt=\"\" width=\"400\" height=\"232\"></p><p> </p><p><img src=\"https://cerebellum-web-static.s3.amazonaws.com/media/public/images/2023/11/27/picture15.jpg\" alt=\"\" width=\"400\" height=\"236\"></p><p> </p><p><span style=\"font-size:12pt;\"><strong>Educational Objective:</strong></span></p><p> </p><ul><li><span style=\"font-size:12pt;\">When managing a patient presenting with <strong>painful genital ulcers</strong> and <strong>suppurative lymphadenopathy (Bubo)</strong>, the primary consideration is to treat for <strong>chancroid</strong> which is a STI, typically with a kit containing appropriate antibiotics.</span></li></ul><p> </p><p><span style=\"font-size:12pt;\"><strong>Kit 3/white consists of:</strong></span></p><p> </p><ol><li><span style=\"font-size:12pt;\">Tablet Azithromycin, which is used for the treatment of chancroid.</span></li><li><span style=\"font-size:12pt;\">Injection Benzathine Penicillin, which is used for syphilis.</span></li></ol><p> </p><p><span style=\"font-size:12pt;\"><strong>Ref - Rook's Textbook of Dermatology - Volume II - 9th Edition, Chapter 30 Page no 30.21</strong></span></p><p><span style=\"font-size:12pt;\"><strong>Online Resource</strong></span></p><p><a href=\"https://www.uptodate.com/contents/chancroid?source=search_result&search=chancroid&selectedTitle=1~47\"><span style=\"font-size:12pt;\"><strong>https://www.uptodate.com/contents/chancroid?source=search_result HYPERLINK \"https://www.uptodate.com/contents/chancroid?source=search_result&search=chancroid&selectedTitle=1~47\"& HYPERLINK \"https://www.uptodate.com/contents/chancroid?source=search_result</strong></span></a></p><p><img src=\"https://cerebellum-web-static.s3.amazonaws.com/media/public/images/2023/11/27/picture8.jpg\" alt=\"Solution Image\"></p>",
      "correct_choice_id": 200278,
      "solution_audio": null,
      "solution_video": null,
      "audio_explanation_heading": null,
      "video_explanation_heading": null,
      "solution_media_position": "bottom",
      "tags": [],
      "explanation_video": null,
      "question_images": [],
      "explanation_images": []
    },
    {
      "id": 50070,
      "choices": [
        {
          "id": 200280,
          "text": "<p><span style=\"font-size:12.0pt;\">Organophosphates</span></p>"
        },
        {
          "id": 200281,
          "text": "<p><span style=\"font-size:12.0pt;\">Belladonna</span></p>"
        },
        {
          "id": 200282,
          "text": "<p><span style=\"font-size:12.0pt;\">Morphine</span></p>"
        },
        {
          "id": 200283,
          "text": "<p><span style=\"font-size:12.0pt;\">Pilocarpine</span></p>"
        }
      ],
      "text": "<p><span style=\"color:#333333;font-size:12pt;\">All of the following can cause miosis except</span></p>",
      "unique_key": "Q6149965",
      "question_audio": null,
      "question_video": null,
      "map_id": 34890435,
      "difficulty_level": "intermediate",
      "subjects_id": [],
      "solution": "<p><span style=\"color:#333333;font-size:12pt;\"><strong>Ans. B. Belladonna</strong></span></p><p> </p><p><span style=\"color:#333333;font-size:12pt;\">Belladonna is plant (Atropa belladonna) from which atropine (Anticholinergic drug) is obtained. It causes mydriasis not miosis.</span></p><p> </p><h3><span style=\"font-size:12.0pt;\"><strong>Other Options:</strong></span></h3><p> </p><p><span style=\"font-size:12pt;\"><strong>Option A. Organophosphates: </strong>Organophosphates cause miosis by inhibiting acetylcholinesterase, which increases acetylcholine levels, resulting in overstimulation of muscarinic receptors.</span></p><p> </p><p><span style=\"font-size:12pt;\"><strong>Option C. Morphine: </strong>Morphine induces miosis by stimulating the parasympathetic nervous system through opioid receptors, leading to pupil constriction.</span></p><p> </p><p><span style=\"font-size:12pt;\"><strong>Option D. Pilocarpine: </strong>Pilocarpine is a cholinergic drug that causes miosis by directly activating muscarinic receptors in the eye.</span></p><p> </p><p><span style=\"color:#333333;font-size:12pt;\"><strong>Educational objective:</strong></span></p><p> </p><p><span style=\"color:#333333;font-size:12pt;\"><strong>Miosis or pin point pupil is caused by:-</strong></span></p><p> </p><ul><li><span style=\"color:#333333;font-size:12pt;\">Organophosphate poisoning</span></li><li><span style=\"color:#333333;font-size:12pt;\">Opioids like morphine</span></li><li><span style=\"color:#333333;font-size:12pt;\">Phenol poisoning</span></li><li><span style=\"color:#333333;font-size:12pt;\">Pontine hemorrhage</span></li><li><span style=\"color:#333333;font-size:12pt;\">Cholinergic drugs like pilocarpine</span></li></ul><p> </p><p><span style=\"color:#333333;font-size:12pt;\"><strong>Reference: KDT 8<sup>th</sup>/115,122,127,499</strong></span></p>",
      "correct_choice_id": 200281,
      "solution_audio": null,
      "solution_video": null,
      "audio_explanation_heading": null,
      "video_explanation_heading": null,
      "solution_media_position": "bottom",
      "tags": [],
      "explanation_video": null,
      "question_images": [],
      "explanation_images": []
    },
    {
      "id": 50071,
      "choices": [
        {
          "id": 200284,
          "text": "<p><span style=\"font-size:12.0pt;\">Anti-HBc Ab</span></p>"
        },
        {
          "id": 200285,
          "text": "<p><span style=\"font-size:12.0pt;\">Anti-HBe Ab</span></p>"
        },
        {
          "id": 200286,
          "text": "<p><span style=\"font-size:12.0pt;\">Anti-HBs Ab</span></p>"
        },
        {
          "id": 200287,
          "text": "<p><span style=\"font-size:12.0pt;\">HBsAg</span></p>"
        }
      ],
      "text": "<p><span style=\"font-size:12.0pt;\">Patient affected with acute hepatitis B infection has currently come for follow up. Identify the serological marker marked in the image? (AIIMS NOV 2019)</span></p><p> </p><p><span style=\"font-size:12.0pt;\"><img src=\"https://cerebellum-web-static.s3.amazonaws.com/media/public/images/2023/04/27/nm121.jpg\" alt=\"\" width=\"500\" height=\"247\"></span></p><p><img src=\"https://cerebellum-web-static.s3.amazonaws.com/media/public/images/2023/04/27/nm121.jpg\" alt=\"Question Image\"></p>",
      "unique_key": "Q3841804",
      "question_audio": null,
      "question_video": null,
      "map_id": 34764070,
      "difficulty_level": "intermediate",
      "subjects_id": [],
      "solution": "<p><span style=\"font-size:12.0pt;\"><strong>Ans. A) Anti-HBc Ab</strong></span></p><p> </p><p><span style=\"font-size:12.0pt;\">Anti Hbc Ab are produced against Hepatitis B infection. IgM is produced early and IgG later. Production of antibodies(A) is seen to correspond to gradual reduction of surface, envelop antigens.</span></p><p> </p><p><span style=\"font-size:12.0pt;\"><img src=\"https://cerebellum-web-static.s3.amazonaws.com/media/public/images/2023/04/27/nm122.jpg\" alt=\"\" width=\"700\" height=\"317\"></span></p><p> </p><p><span style=\"font-size:12.0pt;\">Person recovering from acute infection may have negative anti HbS levels with low HbsAg levels. This is called window period where there is a lag between development of antiHbS and HbsAg levels.</span></p><p> </p><p><span style=\"font-size:12.0pt;\"><strong>Other Options:</strong></span></p><p> </p><p><span style=\"font-size:12.0pt;\"><strong>Option B. Anti-HBe Ab: </strong>These antibodies against the hepatitis B e antigen generally signify lower levels of viral replication. They are not represented at the marked point in the graph.</span></p><p> </p><p><span style=\"font-size:12.0pt;\"><strong>Option C. Anti-HBs Ab: </strong>These antibodies indicate recovery and immunity and typically appear after the disappearance of HBsAg, which occurs later than the timeframe shown for the marked serological marker.</span></p><p> </p><p><span style=\"font-size:12.0pt;\"><strong>Option D. HBsAg:</strong> This is the earliest detectable viral antigen to appear in the blood following infection but declines as Anti-HBc Ab and later Anti-HBs appear.</span></p><p> </p><p><span style=\"font-size:12.0pt;\"><strong>Educational Objective</strong>:</span></p><p> </p><p><span style=\"font-size:11.0pt;\">Anti-HBc antibodies are crucial in diagnosing hepatitis B infection, as they appear early after exposure and persist throughout the infection. They are typically seen during the \"window period\" when HBsAg starts to wane and before Anti-HBs becomes detectable, indicating the body's initial immune response to the infection.</span></p><p> </p><p><span style=\"font-size:12.0pt;\"><strong>Reference - Harrison 21E/Hepatology/Viral hepatitis/ chap 339/</strong></span></p><p><img src=\"https://cerebellum-web-static.s3.amazonaws.com/media/public/images/2023/04/27/nm122.jpg\" alt=\"Solution Image\"></p>",
      "correct_choice_id": 200284,
      "solution_audio": null,
      "solution_video": null,
      "audio_explanation_heading": null,
      "video_explanation_heading": null,
      "solution_media_position": "bottom",
      "tags": [],
      "explanation_video": null,
      "question_images": [],
      "explanation_images": []
    },
    {
      "id": 50072,
      "choices": [
        {
          "id": 200288,
          "text": "<p><span style=\"font-size:12pt\"><span style=\"font-family:\"Liberation Serif\",serif\"><span dir=\"ltr\" lang=\"EN-US\" style=\"font-family:\"Calibri\",sans-serif\"><span style=\"color:#333333\">Radical cure of Plasmodium vivax</span></span></span></span></p>"
        },
        {
          "id": 200289,
          "text": "<p><span style=\"font-size:12pt\"><span style=\"font-family:\"Liberation Serif\",serif\"><span dir=\"ltr\" lang=\"EN-US\" style=\"font-family:\"Calibri\",sans-serif\"><span style=\"color:#333333\">Prophylaxis of malaria in pregnancy</span></span></span></span></p>"
        },
        {
          "id": 200290,
          "text": "<p><span style=\"font-size:12pt\"><span style=\"font-family:\"Liberation Serif\",serif\"><span dir=\"ltr\" lang=\"EN-US\" style=\"font-family:\"Calibri\",sans-serif\"><span style=\"color:#333333\">Treatment of severe falciparum malaria</span></span></span></span></p>"
        },
        {
          "id": 200291,
          "text": "<p><span style=\"font-size:12pt\"><span style=\"font-family:\"Liberation Serif\",serif\"><span dir=\"ltr\" lang=\"EN-US\" style=\"font-family:\"Calibri\",sans-serif\"><span style=\"color:#333333\">Treatment of endemic malaria in children < 2 years</span></span></span></span></p>"
        }
      ],
      "text": "<p style=\"text-align:justify\"><span style=\"font-size:12pt\"><span style=\"font-family:\"Liberation Serif\",serif\"><span dir=\"ltr\" lang=\"EN-US\" style=\"font-family:\"Calibri\",sans-serif\"><span style=\"color:#333333\">W</span></span><span dir=\"ltr\" lang=\"EN-US\" style=\"font-family:\"Calibri\",sans-serif\"><span style=\"color:#333333\">hich of the following is clinical use of tafenoquine? (</span></span></span></span>AIIMS Nov 2019</p>",
      "unique_key": "Q4206482",
      "question_audio": null,
      "question_video": null,
      "map_id": 34313836,
      "difficulty_level": "intermediate",
      "subjects_id": [],
      "solution": "<p><span style=\"font-size:12pt\"><span style=\"font-family:\"Liberation Serif\",serif\"><strong><span dir=\"ltr\" lang=\"EN-US\" style=\"font-family:\"Calibri\",sans-serif\"><span style=\"color:#333333\">Ans. A. Radical cure of Plasmodium vivax</span></span></strong></span></span></p>\r\n\r\n<p> </p>\r\n\r\n<p><span style=\"font-size:12pt\"><span style=\"font-family:\"Liberation Serif\",serif\"><strong><span dir=\"ltr\" lang=\"EN-US\" style=\"font-family:\"Calibri\",sans-serif\"><span style=\"color:#333333\">Radical cure –</span></span></strong><span dir=\"ltr\" lang=\"EN-US\" style=\"font-family:\"Calibri\",sans-serif\"><span style=\"color:#333333\"> Several patients of P. vivax malaria relapse due to persistence of exo-erythrocytic stage. Drugs which attack this stage (hypnozooites) given together with a clinical curative achieve total eradication of the parasite from the patient's body.</span></span></span></span></p>\r\n\r\n<p> </p>\r\n\r\n<p><span style=\"font-size:12pt\"><span style=\"font-family:\"Liberation Serif\",serif\"><strong><span dir=\"ltr\" lang=\"EN-US\" style=\"font-family:\"Calibri\",sans-serif\"><span style=\"color:#333333\">Drug of choice for radical cure of vivax and ovale malaria is:</span></span></strong></span></span></p>\r\n\r\n<p> </p>\r\n\r\n<ul>\r\n\t<li><span style=\"font-size:12pt\"><span style=\"font-family:\"Liberation Serif\",serif\"><span dir=\"ltr\" lang=\"EN-US\" style=\"font-family:\"Calibri\",sans-serif\"><span style=\"color:#333333\">Primaquine 15 mg daily for 14 days</span></span></span></span></li>\r\n\t<li><span style=\"font-size:12pt\"><span style=\"font-family:\"Liberation Serif\",serif\"><span dir=\"ltr\" lang=\"EN-US\" style=\"font-family:\"Calibri\",sans-serif\"><span style=\"color:#333333\">Tafenoquine is a new long-acting exo-erythrocytic schizontocidal drug. It has been developed as a single dose radical cure for vivax malaria.</span></span></span></span></li>\r\n</ul>\r\n\r\n<h3> </h3>\r\n\r\n<h3><span style=\"font-size:13.5pt\"><span style=\"font-family:\"Times New Roman\",serif\"><strong><span style=\"font-size:12.0pt\"><span style=\"font-family:\"Calibri\",sans-serif\">Other Options:</span></span></strong></span></span></h3>\r\n\r\n<p> </p>\r\n\r\n<p><span style=\"font-size:12pt\"><span style=\"font-family:\"Times New Roman\",serif\"><strong><span style=\"font-family:\"Calibri\",sans-serif\">Option <strong><span style=\"font-family:\"Calibri\",sans-serif\">B. Prophylaxis of malaria in pregnancy: </span></strong></span></strong><span style=\"font-family:\"Calibri\",sans-serif\">Tafenoquine is not recommended for malaria prophylaxis in pregnancy due to its potential for causing hemolysis in individuals with glucose-6-phosphate dehydrogenase (G6PD) deficiency. Pregnant women are typically advised to use other antimalarial drugs for prophylaxis.</span></span></span></p>\r\n\r\n<p> </p>\r\n\r\n<p><span style=\"font-size:12pt\"><span style=\"font-family:\"Times New Roman\",serif\"><strong><span style=\"font-family:\"Calibri\",sans-serif\">Option <strong><span style=\"font-family:\"Calibri\",sans-serif\">C. Treatment of severe falciparum malaria: </span></strong></span></strong><span style=\"font-family:\"Calibri\",sans-serif\">The treatment of severe falciparum malaria typically involves intravenous administration of drugs like artesunate or quinine, rather than tafenoquine. Tafenoquine is not used in this context.</span></span></span></p>\r\n\r\n<p> </p>\r\n\r\n<p><span style=\"font-size:12pt\"><span style=\"font-family:\"Times New Roman\",serif\"><strong><span style=\"font-family:\"Calibri\",sans-serif\">Option <strong><span style=\"font-family:\"Calibri\",sans-serif\">D. Treatment of endemic malaria in children < 2 years: </span></strong></span></strong><span style=\"font-family:\"Calibri\",sans-serif\">Tafenoquine is not recommended for use in children under 2 years of age. The safety and efficacy of tafenoquine in this age group have not been established, and alternative antimalarial therapies are preferred for young children.</span></span></span></p>\r\n\r\n<p> </p>\r\n\r\n<p><span style=\"font-size:12pt\"><span style=\"font-family:\"Times New Roman\",serif\"><strong><span style=\"font-family:\"Calibri\",sans-serif\">Educational objective:</span></strong></span></span></p>\r\n\r\n<p> </p>\r\n\r\n<p><span style=\"font-size:12pt\"><span style=\"font-family:\"Times New Roman\",serif\"><span style=\"font-family:\"Calibri\",sans-serif\">Tafenoquine is used for the radical cure of Plasmodium vivax malaria due to its long-acting effects against the exo-erythrocytic stage of the parasite, helping to prevent relapses.</span></span></span></p>\r\n\r\n<p> </p>\r\n\r\n<p><span style=\"font-size:12pt\"><span style=\"font-family:\"Liberation Serif\",serif\"><strong><span dir=\"ltr\" lang=\"EN-US\" style=\"font-family:\"Calibri\",sans-serif\"><span style=\"color:#333333\">Reference: KDT 8th/. 878</span></span></strong></span></span></p>",
      "correct_choice_id": 200288,
      "solution_audio": null,
      "solution_video": null,
      "audio_explanation_heading": null,
      "video_explanation_heading": null,
      "solution_media_position": "bottom",
      "tags": [],
      "explanation_video": null,
      "question_images": [],
      "explanation_images": []
    },
    {
      "id": 50073,
      "choices": [
        {
          "id": 200292,
          "text": "<p style=\"text-align:left\"><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\">Mannitol</span></span></span></p>"
        },
        {
          "id": 200293,
          "text": "<p style=\"text-align:left\"><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\">Methazolamide</span></span></span></p>"
        },
        {
          "id": 200294,
          "text": "<p style=\"text-align:left\"><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\">Clonidine</span></span></span></p>"
        },
        {
          "id": 200295,
          "text": "<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\">Dexamethasone</span></span></span></p>"
        }
      ],
      "text": "<p style=\"text-align:left\"><span style=\"font-size:12pt\"><span style=\"font-family:\"Liberation Serif\",serif\"><span dir=\"ltr\" lang=\"EN-US\" style=\"font-family:\"Calibri\",sans-serif\"><span style=\"color:#333333\">A</span></span><span dir=\"ltr\" lang=\"EN-US\" style=\"font-family:\"Calibri\",sans-serif\"><span style=\"color:#333333\">ll of the following can be used to decreased intraocular pressure in glaucoma except? (</span></span></span></span><span dir=\"ltr\" lang=\"EN-IN\" style=\"font-size:11.0pt\"><span style=\"font-family:\"Calibri\",sans-serif\">AIIMS NOV 2019)</span></span></p>",
      "unique_key": "Q9558143",
      "question_audio": null,
      "question_video": null,
      "map_id": 34500721,
      "difficulty_level": "intermediate",
      "subjects_id": [],
      "solution": "<p><span style=\"font-size:12pt\"><span style=\"font-family:\"Liberation Serif\",serif\"><strong><span dir=\"ltr\" lang=\"EN-US\" style=\"font-family:\"Calibri\",sans-serif\"><span style=\"color:#333333\">Ans. D. Dexamethasone</span></span></strong></span></span></p>\r\n\r\n<p> </p>\r\n\r\n<p><span style=\"font-size:12pt\"><span style=\"font-family:\"Times New Roman\",serif\"><strong><span style=\"font-family:\"Calibri\",sans-serif\">Dexamethasone</span></strong><span style=\"font-family:\"Calibri\",sans-serif\"> is a corticosteroid. Corticosteroids are contraindicated in glaucoma because they can lead to an increase in intraocular pressure (IOP). This rise in IOP can exacerbate glaucoma and potentially cause further damage to the optic nerve.</span></span></span></p>\r\n\r\n<p> </p>\r\n\r\n<p><span style=\"font-size:12pt\"><span style=\"font-family:\"Times New Roman\",serif\"><strong><span style=\"font-family:\"Calibri\",sans-serif\">Other Options:</span></strong></span></span></p>\r\n\r\n<p> </p>\r\n\r\n<p><span style=\"font-size:12pt\"><span style=\"font-family:\"Times New Roman\",serif\"><strong><span style=\"font-family:\"Calibri\",sans-serif\">Option <strong><span style=\"font-family:\"Calibri\",sans-serif\">A. Mannitol: </span></strong></span></strong><span style=\"font-family:\"Calibri\",sans-serif\">Mannitol is an osmotic diuretic and is the drug of choice for acute congestive glaucoma when administered intravenously. It decreases IOP by creating an osmotic gradient, which helps to draw fluid out of the eye, thereby reducing congestion.</span></span></span></p>\r\n\r\n<p> </p>\r\n\r\n<p><span style=\"font-size:12pt\"><span style=\"font-family:\"Times New Roman\",serif\"><strong><span style=\"font-family:\"Calibri\",sans-serif\">Option <strong><span style=\"font-family:\"Calibri\",sans-serif\">B. Methazolamide: </span></strong></span></strong><span style=\"font-family:\"Calibri\",sans-serif\">Methazolamide is a carbonic anhydrase inhibitor. It decreases the production of aqueous humor in the eye, which in turn reduces intraocular pressure. Carbonic anhydrase inhibitors are effective in managing glaucoma.</span></span></span></p>\r\n\r\n<p> </p>\r\n\r\n<p><span style=\"font-size:12pt\"><span style=\"font-family:\"Times New Roman\",serif\"><strong><span style=\"font-family:\"Calibri\",sans-serif\">Option <strong><span style=\"font-family:\"Calibri\",sans-serif\">C. Clonidine: </span></strong></span></strong><span style=\"font-family:\"Calibri\",sans-serif\">Clonidine is an alpha-2 adrenergic agonist. It decreases intraocular pressure by reducing aqueous humor production and increasing uveoscleral outflow. Alpha-2 agonists are commonly used in the treatment of glaucoma.</span></span></span></p>\r\n\r\n<p><span style=\"font-size:12pt\"><span style=\"font-family:\"Liberation Serif\",serif\">  </span></span></p>\r\n\r\n<p><span style=\"font-size:12pt\"><span style=\"font-family:\"Liberation Serif\",serif\"><strong><span dir=\"ltr\" lang=\"EN-US\" style=\"font-family:\"Calibri\",sans-serif\"><span style=\"color:#333333\">Educational Objective:</span></span></strong></span></span></p>\r\n\r\n<p> </p>\r\n\r\n<p><img alt=\"\" src=\"https://cerebellum-web-static.s3.amazonaws.com/media/public/images/2024/07/20/screenshot-2024-07-20-122430.png\" style=\"height:284px; width:1000px\" /></p>\r\n\r\n<p> </p>\r\n\r\n<p><span style=\"font-size:12pt\"><span style=\"font-family:\"Liberation Serif\",serif\"><strong><span dir=\"ltr\" lang=\"EN-US\" style=\"font-family:\"Calibri\",sans-serif\">Note </span></strong><span dir=\"ltr\" lang=\"EN-US\" style=\"font-family:\"Calibri\",sans-serif\">- Dexamethasone is contraindicated in glaucoma</span></span></span></p>\r\n\r\n<p> </p>\r\n\r\n<p><span style=\"font-size:12pt\"><span style=\"font-family:\"Liberation Serif\",serif\"><strong><span dir=\"ltr\" lang=\"EN-US\" style=\"font-family:\"Calibri\",sans-serif\"><span style=\"color:#333333\">Reference: KDT 8<sup>th</sup>/ 318, 167, 170</span></span></strong></span></span></p><p><img src=\"https://cerebellum-web-static.s3.amazonaws.com/media/public/images/2024/07/20/screenshot-2024-07-20-122430.png\" alt=\"Solution Image\"></p>",
      "correct_choice_id": 200295,
      "solution_audio": null,
      "solution_video": null,
      "audio_explanation_heading": null,
      "video_explanation_heading": null,
      "solution_media_position": "bottom",
      "tags": [],
      "explanation_video": null,
      "question_images": [],
      "explanation_images": []
    },
    {
      "id": 50074,
      "choices": [
        {
          "id": 200296,
          "text": "<p><span style=\"font-size:12.0pt;\">Toxoplasma</span></p>"
        },
        {
          "id": 200297,
          "text": "<p><span style=\"font-size:12.0pt;\">Plasmodium</span></p>"
        },
        {
          "id": 200298,
          "text": "<p><span style=\"font-size:12.0pt;\">Babesia</span></p>"
        },
        {
          "id": 200299,
          "text": "<p><span style=\"font-size:12.0pt;\">Leishmania</span></p>"
        }
      ],
      "text": "<p><span style=\"font-size:12.0pt;\">All of the following can be seen intracellularly in hepatocytes except: (INICET NOV 2019)</span></p>",
      "unique_key": "Q6097199",
      "question_audio": null,
      "question_video": null,
      "map_id": 34771346,
      "difficulty_level": "intermediate",
      "subjects_id": [],
      "solution": "<p><span style=\"font-size:12.0pt;\"><strong>Ans. C) Babesia</strong></span></p><p> </p><p><span style=\"font-size:12.0pt;\"><strong>Babesia is not an intracellular parasite of hepatocytes. It is an intra-erythrocytic parasite.</strong></span></p><p> </p><p><span style=\"font-size:12.0pt;\"><strong>Other Options:</strong></span></p><p> </p><p><span style=\"font-size:12.0pt;\"><strong>Option A. Toxoplasma:</strong> Toxoplasma gondii can infect hepatocytes as part of its lifecycle.</span></p><p> </p><p><span style=\"font-size:12.0pt;\"><strong>Option B. Plasmodium:</strong> The liver stage (hepatic schizogony) of Plasmodium involves hepatocytes.</span></p><p> </p><p><span style=\"font-size:12.0pt;\"><strong>Option D. Leishmania:</strong> Leishmania species infect macrophages, which can reside in the liver, leading to intracellular infection in hepatocytes indirectly.</span></p><p> </p><p><span style=\"font-size:12.0pt;\"><strong>Educational Objective:</strong></span></p><p> </p><p><span style=\"font-size:12.0pt;\">Obligate intracellular parasites-</span></p><p> </p><ul><li><span style=\"font-size:12.0pt;\">Trypanosoma cruzi</span></li><li><span style=\"font-size:12.0pt;\">Leishmania spp.</span></li><li><span style=\"font-size:12.0pt;\">Plasmodium spp.</span></li><li><span style=\"font-size:12.0pt;\">Babesia spp. -> RBC</span></li><li><span style=\"font-size:12.0pt;\">Toxoplasma gondii</span></li><li><span style=\"font-size:12.0pt;\">Microsporidia</span></li></ul>",
      "correct_choice_id": 200298,
      "solution_audio": null,
      "solution_video": null,
      "audio_explanation_heading": null,
      "video_explanation_heading": null,
      "solution_media_position": "bottom",
      "tags": [],
      "explanation_video": null,
      "question_images": [],
      "explanation_images": []
    },
    {
      "id": 50075,
      "choices": [
        {
          "id": 200300,
          "text": "<p><span style=\"font-size:12.0pt;\">Potassium channel blocker</span></p>"
        },
        {
          "id": 200301,
          "text": "<p><span style=\"font-size:12.0pt;\">Sodium channel blocker</span></p>"
        },
        {
          "id": 200302,
          "text": "<p><span style=\"font-size:12.0pt;\">Calcium channel blocker</span></p>"
        },
        {
          "id": 200303,
          "text": "<p><span style=\"font-size:12.0pt;\">Chlorine channel blocker</span></p>"
        }
      ],
      "text": "<p><span style=\"font-size:16px;\">Which of the following actions leads to an increase in acetylcholine (ACh) release from the presynaptic neuron?</span></p>",
      "unique_key": "Q4357776",
      "question_audio": null,
      "question_video": null,
      "map_id": 34221722,
      "difficulty_level": "intermediate",
      "subjects_id": [],
      "solution": "<p><span style=\"font-size:16px;\"><strong>Ans. A) Potassium channel blocker</strong></span></p><p> </p><p><span style=\"font-size:16px;\">Potassium channel blockers increase acetylcholine (ACh) release from the presynaptic neuron. Blocking potassium channels prolongs depolarization of the neuron, which enhances the influx of calcium through voltage-gated calcium channels. This increased calcium entry then promotes greater ACh release at the neuromuscular junction.</span></p><p> </p><p><span style=\"font-size:16px;\">Aminopyridines, which are potassium channel blockers, are used in the treatment of Lambert-Eaton myasthenic syndrome to improve muscle strength by increasing ACh release.</span></p><p> </p><p><span style=\"font-size:16px;\"><strong>Other Options:</strong></span></p><p> </p><p><span style=\"font-size:16px;\"><strong>Option B. Sodium channel blocker:</strong> Blocking sodium channels would reduce neuronal depolarization, thus decreasing calcium entry and subsequently reducing ACh release.</span></p><p> </p><p><span style=\"font-size:16px;\"><strong>Option C. Calcium channel blocker:</strong> Blocking calcium channels would directly prevent calcium influx, leading to a decrease in ACh release from the presynaptic neuron.</span></p><p> </p><p><span style=\"font-size:16px;\"><strong>Option D. Chlorine channel blocker:</strong> Chlorine (chloride) channels do not directly affect ACh release. Chloride ions typically stabilize the membrane potential, so blocking them would not specifically increase ACh release.</span></p><p> </p><p><span style=\"font-size:16px;\"><strong>Educational Objective:</strong> </span></p><p> </p><p><span style=\"font-size:16px;\">Potassium channel blockers enhance acetylcholine release by prolonging neuronal depolarization and increasing calcium influx at the presynaptic terminal.</span></p>",
      "correct_choice_id": 200300,
      "solution_audio": null,
      "solution_video": null,
      "audio_explanation_heading": null,
      "video_explanation_heading": null,
      "solution_media_position": "bottom",
      "tags": [],
      "explanation_video": null,
      "question_images": [],
      "explanation_images": []
    },
    {
      "id": 50076,
      "choices": [
        {
          "id": 200304,
          "text": "<p><span style=\"font-size:12.0pt;\">Endocardial cushions</span></p>"
        },
        {
          "id": 200305,
          "text": "<p><span style=\"font-size:12.0pt;\">Septum primum</span></p>"
        },
        {
          "id": 200306,
          "text": "<p><span style=\"font-size:12.0pt;\">Left venous valve</span></p>"
        },
        {
          "id": 200307,
          "text": "<p><span style=\"font-size:12.0pt;\">Bulbous venosus</span></p>"
        }
      ],
      "text": "<p><span style=\"font-size:12.0pt;\">Marked structure is derived from the?</span></p><p> </p><p><span style=\"font-size:12.0pt;\"><img src=\"https://cerebellum-web-static.s3.amazonaws.com/media/public/images/2023/05/03/ia-80.jpg\" alt=\"\" width=\"300\" height=\"300\"></span></p><p><img src=\"https://cerebellum-web-static.s3.amazonaws.com/media/public/images/2023/05/03/ia-80.jpg\" alt=\"Question Image\"></p>",
      "unique_key": "Q2380194",
      "question_audio": null,
      "question_video": null,
      "map_id": 34002176,
      "difficulty_level": "intermediate",
      "subjects_id": [],
      "solution": "<p><span style=\"font-size:12.0pt;\"><strong>Ans. A. Endocardial cushions</strong></span></p><p> </p><p><span style=\"font-size:12.0pt;\"><strong>Explanation:</strong></span></p><p> </p><p><span style=\"font-size:12.0pt;\">The interventricular septum's membranous portion is the indicated structure. It comes from the endocardial cushions.</span></p><p> </p><p><span style=\"font-size:12.0pt;\"><img src=\"https://cerebellum-web-static.s3.amazonaws.com/media/public/images/2023/05/03/ia-81.jpg\" alt=\"\" width=\"500\" height=\"375\"></span></p><p> </p><ul><li><span style=\"font-size:12.0pt;\">Endocardial cushions are soft tissue masses that protrude in the atrioventricular and conotruncal regions.</span><ul><li><span style=\"font-size:12.0pt;\">Atrioventricular cushions are derived from overlying endocardial cells.</span></li><li><span style=\"font-size:12.0pt;\">The conotruncal cushions are derived from the neural crest cells.</span></li></ul></li></ul><p> </p><p><span style=\"color:black;font-size:12.0pt;\"><strong>Other Options :</strong></span></p><p> </p><p><span style=\"color:black;font-size:12.0pt;\"><strong>Option B. Septum primum:</strong> The septum primum is involved in the development of the atrial septum, not the interventricular septum. It forms a temporary structure in the embryonic heart that helps separate the atria.</span></p><p> </p><p><span style=\"color:black;font-size:12.0pt;\"><strong>Option C. Left venous valve:</strong> The left venous valve is not directly involved in the formation of the interventricular septum. It is a structure found within the embryonic heart that helps direct oxygenated blood from the left atrium into the left ventricle.</span></p><p> </p><p><span style=\"color:black;font-size:12.0pt;\"><strong>Option D. Bulbous venosus:</strong> The bulbous venosus is an embryonic structure that contributes to the formation of the smooth part of the right ventricle. It is not associated with the development of the interventricular septum.</span></p><p> </p><p><span style=\"font-size:12.0pt;\"><img src=\"https://cerebellum-web-static.s3.amazonaws.com/media/public/images/2023/05/03/ia-82.jpg\" alt=\"\" width=\"500\" height=\"320\"></span></p><p> </p><p><span style=\"font-size:12.0pt;\">Cardiac abnormalities, such as ASs, VSDs, and anomalies affecting the major arteries, can be caused by errors in the creation of the endocardial cushion (transposition of the great vessels, common truncus arterious, and tetralogy of Fallot).</span></p><p> </p><p><span style=\"font-size:12.0pt;\"><strong>Educational Objective:</strong></span></p><p> </p><p><span style=\"font-size:12.0pt;\">Endocardial cushions contribute to the formation of:</span></p><p> </p><ol><li><span style=\"font-size:12.0pt;\">Atrial septa</span></li><li><span style=\"font-size:12.0pt;\">Ventricular septa (membranous portion)</span></li><li><span style=\"font-size:12.0pt;\">Atrioventricular canals</span></li><li><span style=\"font-size:12.0pt;\">Atrioventricular valves</span></li></ol><p> </p><p><span style=\"font-size:12.0pt;\">The membranous portion of the interventricular septum develops from the endocardial cushions.</span></p><p><img src=\"https://cerebellum-web-static.s3.amazonaws.com/media/public/images/2023/05/03/ia-81.jpg\" alt=\"Solution Image\"></p>",
      "correct_choice_id": 200304,
      "solution_audio": null,
      "solution_video": null,
      "audio_explanation_heading": null,
      "video_explanation_heading": null,
      "solution_media_position": "bottom",
      "tags": [],
      "explanation_video": null,
      "question_images": [],
      "explanation_images": []
    },
    {
      "id": 50077,
      "choices": [
        {
          "id": 200308,
          "text": "<p><span style=\"font-size:12.0pt;\">Immediately</span></p>"
        },
        {
          "id": 200309,
          "text": "<p><span style=\"font-size:12.0pt;\">Before his 50th birthday</span></p>"
        },
        {
          "id": 200310,
          "text": "<p><span style=\"font-size:12.0pt;\">After his 50th birthday</span></p>"
        },
        {
          "id": 200311,
          "text": "<p><span style=\"font-size:12.0pt;\">When he complains of decrease in vision</span></p>"
        }
      ],
      "text": "<p><span style=\"font-size:12.0pt;\">A person is diagnosed to have diabetes on his 45th birthday. When will you recommend a dilated fundus examination for him? (</span>AIIMS Nov 2019)</p>",
      "unique_key": "Q6983334",
      "question_audio": null,
      "question_video": null,
      "map_id": 34174479,
      "difficulty_level": "intermediate",
      "subjects_id": [],
      "solution": "<p><span style=\"font-size:12.0pt;\"><strong>Ans. A) Immediately</strong></span></p><p> </p><p><span style=\"font-size:12.0pt;\">Immediate dilated fundus examination is recommended for individuals diagnosed with type 2 diabetes, as early detection of diabetic retinopathy is crucial for preventing vision loss. Screening at diagnosis is essential because diabetic retinopathy can be asymptomatic in its early stages, yet still pose a risk of significant damage.</span></p><p> </p><p><span style=\"font-size:12.0pt;\"><strong>Other Options:</strong></span></p><p> </p><p><span style=\"font-size:12.0pt;\"><strong>Option B. Before his 50th birthday:</strong> While this is within five years of diagnosis, immediate examination is preferred for immediate intervention and management.</span></p><p> </p><p><span style=\"font-size:12.0pt;\"><strong>Option C. After his 50th birthday:</strong> Delaying the examination could lead to unnoticed progression of diabetic retinopathy and potentially irreversible damage.</span></p><p> </p><p><span style=\"font-size:12.0pt;\"><strong>Option D. When he complains of decrease in vision:</strong> Waiting for symptoms such as decreased vision can result in delayed diagnosis of diabetic retinopathy, at which point some damage may be irreversible.</span></p><p> </p><p><span style=\"font-size:12.0pt;\"><strong>Educational Objective:</strong></span></p><p> </p><p><img src=\"https://cerebellum-web-static.s3.amazonaws.com/media/public/images/2023/10/07/untitled-318_5qo6oBy.jpg\" alt=\"\" width=\"900\" height=\"175\"></p><p><img src=\"https://cerebellum-web-static.s3.amazonaws.com/media/public/images/2023/10/07/untitled-318_5qo6oBy.jpg\" alt=\"Solution Image\"></p>",
      "correct_choice_id": 200308,
      "solution_audio": null,
      "solution_video": null,
      "audio_explanation_heading": null,
      "video_explanation_heading": null,
      "solution_media_position": "bottom",
      "tags": [],
      "explanation_video": null,
      "question_images": [],
      "explanation_images": []
    },
    {
      "id": 50078,
      "choices": [
        {
          "id": 200312,
          "text": "<p><span style=\"font-size:12.0pt;\">2 drug therapy for 6 months</span></p>"
        },
        {
          "id": 200313,
          "text": "<p><span style=\"font-size:12.0pt;\">3 drug therapy for 12 months</span></p>"
        },
        {
          "id": 200314,
          "text": "<p><span style=\"font-size:12.0pt;\">2 drug therapy for 12 months</span></p>"
        },
        {
          "id": 200315,
          "text": "<p><span style=\"font-size:12.0pt;\">3 drug therapy for 6 months</span></p>"
        }
      ],
      "text": "<p><span style=\"font-size:12.0pt;\">A 24-year-old man presents with 2-3 hypopigmented, slightly raised patches on his forearm with reduced sensation for 4 months. He is diagnosed with paucibacillary leprosy. What is the recommended treatment regimen? (AIIMS NOV 2019)</span></p>",
      "unique_key": "Q7725409",
      "question_audio": null,
      "question_video": null,
      "map_id": 34076028,
      "difficulty_level": "intermediate",
      "subjects_id": [],
      "solution": "<p><span style=\"font-size:12.0pt;\"><strong>Ans. A) 2 drug therapy for 6 months</strong></span></p><p> </p><ul><li><span style=\"font-size:12.0pt;\">The treatment regimen for paucibacillary leprosy involves a 6-month course of drug therapy with 2 drugs (Dapsone, Rifampicin).</span></li><li><span style=\"font-size:12.0pt;\">Diagnosis of leprosy under NLEP: It is currently based on clinical grounds (revised case definition) - </span></li></ul><p> </p><p><span style=\"font-size:12.0pt;\"><strong>Paucibacillary (PB) case</strong>: A case of leprosy with 1 to 5 skin lesions, without demonstrated presence of bacilli in a skin smear;</span></p><p> </p><p><span style=\"font-size:12.0pt;\"><strong>Multibacillary (MB) case</strong>: A case of leprosy with more than five skin lesions; or with nerve involvement (pure neuritis, or any number of skin lesions and neuritis); or with the demonstrated presence of bacilli in a slit-skin smear, irrespective of the number of skin lesions.</span></p><p> </p><p><span style=\"font-size:12.0pt;\"><strong>Educational Objective:</strong></span></p><p> </p><p><span style=\"font-size:12.0pt;\"><img src=\"https://cerebellum-web-static.s3.amazonaws.com/media/public/images/2023/10/25/screenshot-2023-10-25-174718.jpg\" alt=\"\" width=\"800\" height=\"251\"></span></p><p> </p><p><span style=\"font-size:12.0pt;\"><img src=\"https://cerebellum-web-static.s3.amazonaws.com/media/public/images/2023/10/25/33333.jpg\" alt=\"\" width=\"250\" height=\"250\"></span></p><p> </p><p><span style=\"font-size:12.0pt;\"><strong>MDT blister pack Colour</strong></span></p><p> </p><p><span style=\"font-size:12.0pt;\">PBL adult - Green color</span></p><p> </p><p><span style=\"font-size:12.0pt;\">MBL adult - Red color</span></p><p> </p><p><span style=\"font-size:12.0pt;\">PBL child - Blue color</span></p><p> </p><p><span style=\"font-size:12.0pt;\">MBL child - Yellow colour </span></p><p><img src=\"https://cerebellum-web-static.s3.amazonaws.com/media/public/images/2023/10/25/screenshot-2023-10-25-174718.jpg\" alt=\"Solution Image\"></p>",
      "correct_choice_id": 200312,
      "solution_audio": null,
      "solution_video": null,
      "audio_explanation_heading": null,
      "video_explanation_heading": null,
      "solution_media_position": "bottom",
      "tags": [],
      "explanation_video": null,
      "question_images": [],
      "explanation_images": []
    },
    {
      "id": 50079,
      "choices": [
        {
          "id": 200316,
          "text": "<p>C, D and E</p>"
        },
        {
          "id": 200317,
          "text": "<p>A, B and C</p>"
        },
        {
          "id": 200318,
          "text": "<p>A, C and D</p>"
        },
        {
          "id": 200319,
          "text": "<p>B and D only</p>"
        }
      ],
      "text": "<p><span style=\"color:#333333;\">Which of the following is True regarding drugs used for viral infections?</span></p><p> </p><ol style=\"list-style-type:upper-alpha;\"><li><span style=\"color:#333333;\">Treatment of HCV with ribavirin is considered better than sofosbuvir</span></li><li><span style=\"color:#333333;\">Ombitasvir is inhibitor of proteins synthesis</span></li><li><span style=\"color:#333333;\">Imiquimod is used for Condyloma acuminata</span></li><li><span style=\"color:#333333;\">Simprevir inhibits protease of hepatitis C</span></li><li><span style=\"color:#333333;\">Oseltamivir is used for swine flu</span></li></ol>",
      "unique_key": "Q2716566",
      "question_audio": null,
      "question_video": null,
      "map_id": 34571998,
      "difficulty_level": "intermediate",
      "subjects_id": [],
      "solution": "<p><span style=\"color:#333333;\"><strong>Ans. A. C, D and E</strong></span></p><p> </p><p><strong>C. Imiquimod is used for Condyloma acuminata: </strong>This statement is true. Imiquimod is an immunomodulator used for the treatment of various viral warts, including condyloma acuminata (genital warts).</p><p> </p><p><strong>D. Simprevir inhibits protease of hepatitis C: </strong>This statement is true. Simprevir is a protease inhibitor used in the treatment of HCV, which works by inhibiting the NS3/4A protease enzyme necessary for viral replication.</p><p> </p><p><strong>E. Oseltamivir is used for swine flu: </strong>This statement is true. Oseltamivir is an antiviral medication effective against influenza A (including H5N1 and H1N1, commonly known as swine flu) and influenza B.</p><p> </p><p><strong>Other Options:</strong></p><p> </p><p><strong>Option A. Treatment of HCV with ribavirin is considered better than sofosbuvir: </strong>This statement is false. Ribavirin, when used for the treatment of Hepatitis C Virus (HCV), must be combined with injectable interferons, which have significant adverse effects. Sofosbuvir, a newer oral drug that inhibits the NS5B RNA polymerase, is preferred over ribavirin due to its better efficacy and fewer side effects.</p><p> </p><p><strong>Option B. Ombitasvir is an inhibitor of protein synthesis: </strong>This statement is false. Ombitasvir is an NS5A inhibitor, meaning it acts by inhibiting viral RNA replication and assembly of the hepatitis C virus (HCV), not protein synthesis.</p><p> </p><p><strong>Educational Objective:</strong></p><p> </p><p>Sofosbuvir is preferred over ribavirin for HCV treatment due to better efficacy, ombitasvir is an NS5A inhibitor, imiquimod is used for condyloma acuminata, simprevir inhibits HCV protease, and oseltamivir is used for swine flu.</p><p> </p><p><img src=\"https://cerebellum-web-static.s3.amazonaws.com/media/public/images/2023/12/20/screenshot-2023-12-20-100220.jpg\" alt=\"\" width=\"1000\" height=\"462\"></p><p> </p><p><strong>Reference: KDT 8th/. 853,856,858</strong></p><p><img src=\"https://cerebellum-web-static.s3.amazonaws.com/media/public/images/2023/12/20/screenshot-2023-12-20-100220.jpg\" alt=\"Solution Image\"></p>",
      "correct_choice_id": 200316,
      "solution_audio": null,
      "solution_video": null,
      "audio_explanation_heading": null,
      "video_explanation_heading": null,
      "solution_media_position": "bottom",
      "tags": [],
      "explanation_video": null,
      "question_images": [],
      "explanation_images": []
    },
    {
      "id": 50080,
      "choices": [
        {
          "id": 200320,
          "text": "<p><span style=\"font-size:12.0pt;\">In CPR</span></p>"
        },
        {
          "id": 200321,
          "text": "<p><span style=\"font-size:12.0pt;\">To know about apnea</span></p>"
        },
        {
          "id": 200322,
          "text": "<p><span style=\"font-size:12.0pt;\">In neonatal resuscitation</span></p>"
        },
        {
          "id": 200323,
          "text": "<p><span style=\"font-size:12.0pt;\">Measure central cyanosis</span></p>"
        }
      ],
      "text": "<p><span style=\"font-size:12.0pt;\">The following device shown attached to the baby is used in all except: (AIIMS NOV 2019)</span></p><p> </p><p><span style=\"font-size:12.0pt;\"><img src=\"https://cerebellum-web-static.s3.amazonaws.com/media/public/images/2023/04/13/109.jpg\" alt=\"\" width=\"400\" height=\"179\"></span></p><p><img src=\"https://cerebellum-web-static.s3.amazonaws.com/media/public/images/2023/04/13/109.jpg\" alt=\"Question Image\"></p>",
      "unique_key": "Q8980016",
      "question_audio": null,
      "question_video": null,
      "map_id": 34245149,
      "difficulty_level": "intermediate",
      "subjects_id": [],
      "solution": "<p><span style=\"font-size:12.0pt;\"><strong>Ans. D) Measure central cyanosis.</strong></span></p><p> </p><p><span style=\"font-size:12.0pt;\">The device shown in the image is a <strong>pulse oximeter</strong>. A pulse oximeter is commonly used to measure the oxygen saturation (SpO2) of the blood and monitor heart rate. While it is useful in many clinical settings, including neonatal care, it is <strong>not</strong> reliable for detecting central cyanosis.</span></p><p> </p><p><span style=\"font-size:12.0pt;\"><strong>Cyanosis </strong>is a clinical sign that appears when there is at least 5 g/dL of deoxygenated hemoglobin in the blood. A pulse oximeter measures oxygen saturation but does not directly assess the color changes in the skin or mucous membranes, which are crucial for identifying cyanosis. Moreover, in conditions like severe anemia, a patient might have a low oxygen saturation without appearing cyanosed.</span></p><p> </p><p><span style=\"font-size:12.0pt;\">However, <strong>measuring central cyanosis </strong>requires clinical observation and is not reliably detected by a pulse oximeter. Therefore, a pulse oximeter is not used to measure central cyanosis.</span></p><p> </p><p><span style=\"font-size:12.0pt;\"><strong>Other Options:</strong></span></p><p> </p><p><span style=\"font-size:12.0pt;\"><strong>Uses of a Pulse Oximeter:</strong></span></p><p> </p><p><span style=\"font-size:12.0pt;\"><strong>Option A. In CPR:</strong> Pulse oximeters are used to monitor oxygenation and the effectiveness of chest compressions and ventilation during cardiopulmonary resuscitation.</span></p><p> </p><p><span style=\"font-size:12.0pt;\"><strong>Option B. To know about apnea:</strong> Pulse oximeters can indicate apnea by detecting bradycardia and desaturation episodes.</span></p><p> </p><p><span style=\"font-size:12.0pt;\"><strong>Option C. In neonatal resuscitation:</strong> Pulse oximeters are vital for assessing the newborn's oxygenation status during resuscitation and adjusting oxygen therapy as needed.</span></p><p> </p><p><span style=\"font-size:12.0pt;\"><strong>Educational Objective:</strong></span></p><p> </p><p><span style=\"font-size:12.0pt;\">A pulse oximeter is useful in various neonatal and resuscitation settings to monitor oxygen saturation and heart rate, but it is not reliable for detecting central cyanosis.</span></p>",
      "correct_choice_id": 200323,
      "solution_audio": null,
      "solution_video": null,
      "audio_explanation_heading": null,
      "video_explanation_heading": null,
      "solution_media_position": "bottom",
      "tags": [],
      "explanation_video": null,
      "question_images": [],
      "explanation_images": []
    },
    {
      "id": 50081,
      "choices": [
        {
          "id": 200324,
          "text": "<p style=\"margin-right:3px\"><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span style=\"font-size:12.0pt\">BTK</span></span></span></p>"
        },
        {
          "id": 200325,
          "text": "<p style=\"margin-right:3px\"><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span style=\"font-size:12.0pt\">JAK-3</span></span></span></p>"
        },
        {
          "id": 200326,
          "text": "<p style=\"margin-right:3px\"><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span style=\"font-size:12.0pt\">RAG1</span></span></span></p>"
        },
        {
          "id": 200327,
          "text": "<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span style=\"font-size:12.0pt\">IL-7Ra</span></span></span></p>"
        }
      ],
      "text": "<p><span style=\"font-size:12.0pt\"><span style=\"font-family:\"Calibri\",sans-serif\">Which gene is not involved in SCID? (AIIMS NOV 2019)</span></span></p>",
      "unique_key": "Q1186970",
      "question_audio": null,
      "question_video": null,
      "map_id": 34770754,
      "difficulty_level": "intermediate",
      "subjects_id": [],
      "solution": "<p style=\"margin-right:3px\"><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\">Ans. A) BTK</span></strong></span></span></p>\r\n\r\n<p style=\"margin-right:3px\"> </p>\r\n\r\n<p style=\"margin-right:3px\"><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\">BTK mutation causes X-linked agammaglobulinemia and not SCID </span></strong><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\">(severe combined immunodeficiency).</span></span></span></p>\r\n\r\n<p style=\"margin-right:3px\"> </p>\r\n\r\n<p style=\"margin-right:3px\"><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\">Other Options:</span></strong></span></span></p>\r\n\r\n<p style=\"margin-right:3px\"> </p>\r\n\r\n<p style=\"margin-right:3px\"><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\">Severe combined immunodeficiency is a defect in both humoral and cell-mediated immune responses.</span></strong><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\"> In this condition, the following genes are involved:</span></span></span></p>\r\n\r\n<p style=\"margin-right:3px\"> </p>\r\n\r\n<p style=\"margin-right:3px\"><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\">Option B. JAK3</span></strong><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\">: Mutations in the JAK3 gene are associated with an autosomal recessive form of SCID. JAK3 is essential for the signaling pathways of multiple cytokine receptors, including IL-2, IL-4, IL-7, IL-9, IL-15, and IL-21, which are crucial for lymphocyte development and function.</span></span></span></p>\r\n\r\n<p style=\"margin-right:3px\"> </p>\r\n\r\n<p style=\"margin-right:3px\"><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\">Option C.  RAG1</span></strong><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\">: The RAG1 gene, along with RAG2, is crucial for V(D)J recombination, which is necessary for the generation of diverse antigen receptors on B cells and T cells. Mutations in RAG1 can lead to SCID due to the inability to produce functional B and T cells.</span></span></span></p>\r\n\r\n<p style=\"margin-right:3px\"> </p>\r\n\r\n<p style=\"margin-right:3px\"><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\">Option D. IL-7Ra</span></strong><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\">: The IL-7 receptor alpha chain (IL-7Ra) is important for T-cell development. Mutations in IL-7Ra can lead to a T- B+ NK+ form of SCID, where T cells are absent or non-functional, but B cells and natural killer cells are present.</span></span></span></p>\r\n\r\n<p style=\"margin-right:3px\"> </p>\r\n\r\n<p style=\"margin-right:3px\"><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\">Persons with SCID are extremely susceptible to recurrent, severe infections by a wide range of pathogens, including:</span></span></span></p>\r\n\r\n<p style=\"margin-right:3px\"> </p>\r\n\r\n<ul>\r\n\t<li><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span dir=\"ltr\" lang=\"PT-BR\" style=\"font-size:12.0pt\">Candida albicans</span></span></span></li>\r\n\t<li><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span dir=\"ltr\" lang=\"PT-BR\" style=\"font-size:12.0pt\">Pneumocystis jiroveci</span></span></span></li>\r\n\t<li><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span dir=\"ltr\" lang=\"PT-BR\" style=\"font-size:12.0pt\">Pseudomonas</span></span></span></li>\r\n\t<li><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span dir=\"ltr\" lang=\"PT-BR\" style=\"font-size:12.0pt\">Cytomegalovirus</span></span></span></li>\r\n\t<li><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\">Varicella</span></span></span></li>\r\n</ul>\r\n\r\n<p style=\"margin-right:3px\"> </p>\r\n\r\n<p style=\"margin-right:3px\"><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\">Educational Objective:</span></strong></span></span></p>\r\n\r\n<p style=\"margin-right:3px\"> </p>\r\n\r\n<p style=\"margin-right:3px\"><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span style=\"font-size:12.0pt\">SCID is caused by mutations in several different genes</span></span></span></p>\r\n\r\n<p style=\"margin-right:3px\"> </p>\r\n\r\n<ul>\r\n\t<li><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\">JAK3</span></strong></span></span></li>\r\n\t<li><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\">RAG1</span></strong></span></span></li>\r\n\t<li><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><em><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\">IL-7Ra</span></em></strong></span></span></li>\r\n</ul>\r\n\r\n<p style=\"margin-right:3px\"> </p>\r\n\r\n<p style=\"margin-right:3px\"><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\">Ref: Robbins and Cotrans pathologic basis of disease, 8<sup>th</sup> edition, Pg 438-439</span></strong></span></span></p>",
      "correct_choice_id": 200324,
      "solution_audio": null,
      "solution_video": null,
      "audio_explanation_heading": null,
      "video_explanation_heading": null,
      "solution_media_position": "bottom",
      "tags": [],
      "explanation_video": null,
      "question_images": [],
      "explanation_images": []
    },
    {
      "id": 50082,
      "choices": [
        {
          "id": 200328,
          "text": "<p><span style=\"font-size:12.0pt;\">Inguinal exploration</span></p>"
        },
        {
          "id": 200329,
          "text": "<p><span style=\"font-size:12.0pt;\">Abdominal exploration</span></p>"
        },
        {
          "id": 200330,
          "text": "<p><span style=\"font-size:12.0pt;\">Scrotal exploration</span></p>"
        },
        {
          "id": 200331,
          "text": "<p><span style=\"font-size:12.0pt;\">Nothing to be done</span></p>"
        }
      ],
      "text": "<p><span style=\"font-size:12.0pt;\">A 5-year-old male child is found to have a unilateral undescended testis on the right side during a routine physical exam. A diagnostic laparoscopy is performed, which reveals blind-ending testicular vessels and vas deferens on the right side. What is the next step in the management of this patient? (AIIMS NOV 2019)</span></p>",
      "unique_key": "Q3492805",
      "question_audio": null,
      "question_video": null,
      "map_id": 34830104,
      "difficulty_level": "intermediate",
      "subjects_id": [],
      "solution": "<p><span style=\"font-size:12.0pt;\"><strong>Ans. D) Nothing to be done</strong></span></p><p> </p><p><span style=\"font-size:12.0pt;\">Blind-ending vas deferens and testicular vessels imply anorchism or testicular agenesis. In such cases, no further exploration is required.</span></p><p> </p><p><span style=\"font-size:12.0pt;\">When diagnostic laparoscopy reveals blind-ending testicular vessels, it indicates the absence or nonviable nature of the testis. In such cases, there is no surgical intervention required because there is no viable testis to locate or bring down. The appropriate management approach is to monitor the patient and provide counseling regarding the absence of the testis.</span></p><p> </p><p><span style=\"font-size:12.0pt;\"><strong>Other Options:</strong></span></p><p> </p><p><span style=\"font-size:12pt;\"><strong>Option A.</strong> </span><span style=\"font-size:12.0pt;\"><strong>Inguinal exploration</strong>: Inguinal exploration involves surgical exploration of the inguinal canal to locate and bring down an undescended testis. However, in this case, the diagnostic laparoscopy has already revealed blind-ending testicular vessels on the right side. This finding indicates that the testis is absent or nonviable, and no further surgical exploration is needed.</span></p><p> </p><p><span style=\"font-size:12.0pt;\"><strong>Option B</strong>. <strong>Abdominal exploration</strong>: Abdominal exploration is typically performed when an undescended testis is suspected to be located within the abdominal cavity. However, in this case, the laparoscopy has confirmed the absence of a viable testis on the right side.</span></p><p> </p><p><span style=\"font-size:12.0pt;\"><strong>Option C</strong>. <strong>Scrotal exploration</strong>: Scrotal exploration involves surgical exploration of the scrotum to locate and bring down an undescended testis. However, in this case, the laparoscopy findings have already established the absence of a viable testis on the right side, making scrotal exploration unnecessary.</span></p><p> </p><p><span style=\"font-size:12.0pt;\"><strong>Educational Objective:</strong></span></p><p> </p><p><span style=\"font-size:12.0pt;\">A unilateral undescended testis refers to a condition in which only one of the testes has not descended into the scrotum, while the other testis has descended normally. This condition is relatively common in male infants and can occur on either the right or left side.</span></p><p> </p><p><span style=\"font-size:12.0pt;\">Here are some key points about unilateral undescended testis:</span></p><p> </p><ol><li><span style=\"font-size:12.0pt;\"><strong>Incidence: </strong>It is one of the most common congenital anomalies in male infants, with the majority of cases involving the left testis.</span></li><li><span style=\"font-size:12.0pt;\"><strong>Diagnosis: </strong>Unilateral undescended testis is typically diagnosed during a physical examination, such as a routine well-baby check or pediatric evaluation.</span></li><li><span style=\"font-size:12.0pt;\"><strong>Management: </strong>The management of unilateral undescended testis may vary based on the age of the child and the specific circumstances. In many cases, the testis will descend into the scrotum on its own within the first few months of life. If the testis has not descended by the age of 6 months, treatment options may include hormone therapy to stimulate descent or surgical intervention (orchidopexy) to bring the testis down into the scrotum.</span></li><li><span style=\"font-size:12.0pt;\"><strong>Importance of Treatment: </strong>The goal of treatment is to ensure that the undescended testis is properly positioned in the scrotum. This is important for several reasons, including the potential impact on fertility and the increased risk of testicular cancer in undescended testes if left untreated.</span></li></ol>",
      "correct_choice_id": 200331,
      "solution_audio": null,
      "solution_video": null,
      "audio_explanation_heading": null,
      "video_explanation_heading": null,
      "solution_media_position": "bottom",
      "tags": [],
      "explanation_video": null,
      "question_images": [],
      "explanation_images": []
    },
    {
      "id": 50083,
      "choices": [
        {
          "id": 200332,
          "text": "<p><span style=\"font-size:12.0pt;\">Nausea</span></p>"
        },
        {
          "id": 200333,
          "text": "<p><span style=\"font-size:12.0pt;\">Vivid dreams</span></p>"
        },
        {
          "id": 200334,
          "text": "<p><span style=\"font-size:12.0pt;\">Anorgasmia</span></p>"
        },
        {
          "id": 200335,
          "text": "<p><span style=\"font-size:12.0pt;\">Sialorrhea</span></p>"
        }
      ],
      "text": "<p style=\"text-align:justify;\"><span style=\"font-size:12.0pt;\">A patient was prescribed escitalopram. Which of the following adverse effect is the least likely?</span></p>",
      "unique_key": "Q3339852",
      "question_audio": null,
      "question_video": null,
      "map_id": 34382997,
      "difficulty_level": "intermediate",
      "subjects_id": [],
      "solution": "<p><span style=\"font-size:12.0pt;\"><strong>Ans. D) Sialorrhea</strong></span></p><p> </p><p><span style=\"font-size:12.0pt;\">Sialorrhea is not typically associated with SSRIs. They are more likely to cause dry mouth. Sialorrhea is a common side effect of clozapine.</span></p><p> </p><p><span style=\"font-size:12.0pt;\"><strong>Other Options:</strong></span></p><p> </p><p><span style=\"font-size:12.0pt;\">Escitalopram is a selective serotonin reuptake inhibitor (SSRI). Among the options:</span></p><p> </p><p><span style=\"font-size:12.0pt;\"><strong>Option A. Nausea: </strong>Nausea is a common side effect of SSRIs.</span></p><p> </p><p><span style=\"font-size:12.0pt;\"><strong>Option B. Vivid dreams:</strong> Vivid dreams can occasionally be reported but are not the most common side effect.</span></p><p> </p><p><span style=\"font-size:12.0pt;\"><strong>Option C. Anorgasmia:</strong> Anorgasmia or other sexual side effects are also commonly associated with SSRIs.</span></p><p> </p><p><span style=\"font-size:12.0pt;\"><strong>Educational Objective: </strong></span></p><p> </p><p><span style=\"font-size:12.0pt;\">Side effects of SSRIs include:</span></p><p> </p><ul><li><span style=\"font-size:12.0pt;\">Most common: Nausea</span></li><li><span style=\"font-size:12.0pt;\">Most common long-term side effects: Sexual dysfunction including delayed orgasm, poor erection and low libido.</span></li><li><span style=\"font-size:12.0pt;\">CNS side effects- Paradoxical anxiety, sedation, vivid dreams, sweating, seizures, EPSE etc.</span></li><li><span style=\"font-size:12.0pt;\">QTc prolongation</span></li><li><span style=\"font-size:12.0pt;\">Weight gain</span></li></ul><p> </p><p><span style=\"font-size:12.0pt;\"><strong>Reference: Kaplan & Sadock’s Comprehensive Textbook of Psychiatry, 10th edition, Page No 3156-3158</strong></span></p>",
      "correct_choice_id": 200335,
      "solution_audio": null,
      "solution_video": null,
      "audio_explanation_heading": null,
      "video_explanation_heading": null,
      "solution_media_position": "bottom",
      "tags": [],
      "explanation_video": null,
      "question_images": [],
      "explanation_images": []
    },
    {
      "id": 50084,
      "choices": [
        {
          "id": 200336,
          "text": "<p><span style=\"font-size:12.0pt;\">Kyasanur forest disease virus</span></p>"
        },
        {
          "id": 200337,
          "text": "<p><span style=\"font-size:12.0pt;\">Orientia tsutsugamushi</span></p>"
        },
        {
          "id": 200338,
          "text": "<p><span style=\"font-size:12.0pt;\">Chandipura virus</span></p>"
        },
        {
          "id": 200339,
          "text": "<p><span style=\"font-size:12.0pt;\">Anaplasma phagocytophilia</span></p>"
        }
      ],
      "text": "<p><span style=\"font-size:12.0pt;\">A patient presents with flu-like symptoms after a camping trip and multiple insect bites. You suspect a vector-borne illness. Which pathogen is likely if the vector is a Trombiculid mite? (AIIMS NOV 2019)</span></p><p> </p><p><img src=\"https://cerebellum-web-static.s3.amazonaws.com/media/public/images/2023/04/23/ip42.jpg\" alt=\"\" width=\"300\" height=\"278\"></p><p><img src=\"https://cerebellum-web-static.s3.amazonaws.com/media/public/images/2023/04/23/ip42.jpg\" alt=\"Question Image\"></p>",
      "unique_key": "Q2843949",
      "question_audio": null,
      "question_video": null,
      "map_id": 34876792,
      "difficulty_level": "intermediate",
      "subjects_id": [],
      "solution": "<p><span style=\"font-size:12.0pt;\"><strong>Ans. B) Orientia tsutsugamushi</strong></span></p><p> </p><ul><li><span style=\"font-size:12.0pt;\">Above given image depicts Trombiculid mite, which transmits Orientia tsutsugamushi. It causes scrub typhus disease in humans.</span></li></ul><p> </p><p><span style=\"font-size:12.0pt;\"><img src=\"https://cerebellum-web-static.s3.amazonaws.com/media/public/images/2023/10/25/picture5666.jpg\" alt=\"\" width=\"600\" height=\"663\"></span></p><p> </p><ul><li><span style=\"font-size:12.0pt;\">Life cycle of Trombiculid mite with transovarial transmission</span></li></ul><p> </p><p><span style=\"font-size:12.0pt;\"><strong>Other Options: </strong></span></p><p> </p><p><span style=\"font-size:12pt;\"><strong>Option A.</strong> </span><span style=\"font-size:12.0pt;\"><strong>Kyasanur forest disease virus:</strong> Kyasanur forest disease virus is transmitted by hard tick</span></p><p> </p><p><img src=\"https://cerebellum-web-static.s3.amazonaws.com/media/public/images/2024/01/03/image.png\" width=\"283\" height=\"292\"></p><p> </p><p><span style=\"font-size:12.0pt;\"><strong>Option C. Chandipura virus: </strong>Chandipura virus is an Arbovirus transmitted by Sand fly (Phlebotomus)</span></p><p> </p><p><span style=\"font-size:12.0pt;\"><img src=\"https://cerebellum-web-static.s3.amazonaws.com/media/public/images/2023/10/25/picture7666.jpg\" alt=\"\" width=\"300\" height=\"284\"></span></p><p> </p><p><span style=\"font-size:12.0pt;\"><strong>Option D. Anaplasma phagocytophilia: </strong>Anaplasma phagocytophilia (formerly Ehrlichia phagocytophilum) is a Gram-negative bacterium that causes an acute febrile illness known as anaplasmosis.</span></p><p> </p><p><span style=\"font-size:12.0pt;\"><strong>Educational Objective:</strong></span></p><p> </p><ul><li><span style=\"font-size:12.0pt;\">Orientia tsutsugamushi, transmitted by Trombiculid mites, causes scrub typhus.</span></li></ul><p><img src=\"https://cerebellum-web-static.s3.amazonaws.com/media/public/images/2023/10/25/picture5666.jpg\" alt=\"Solution Image\"></p>",
      "correct_choice_id": 200337,
      "solution_audio": null,
      "solution_video": null,
      "audio_explanation_heading": null,
      "video_explanation_heading": null,
      "solution_media_position": "bottom",
      "tags": [],
      "explanation_video": null,
      "question_images": [],
      "explanation_images": []
    },
    {
      "id": 50085,
      "choices": [
        {
          "id": 200340,
          "text": "<p><span style=\"font-size:12.0pt;\">Low volume, high calories</span></p>"
        },
        {
          "id": 200341,
          "text": "<p><span style=\"font-size:12.0pt;\">High volume, low calories</span></p>"
        },
        {
          "id": 200342,
          "text": "<p><span style=\"font-size:12.0pt;\">High volume, high calories</span></p>"
        },
        {
          "id": 200343,
          "text": "<p><span style=\"font-size:12.0pt;\">Low volume, low calories</span></p>"
        }
      ],
      "text": "<p><span style=\"font-size:12.0pt;\">A 65-year-old male with a history of hypertension and diabetes, recently diagnosed with end-stage renal disease (stage 5) and on hemodialysis, seeks dietary advice. Which of the following characterizes the ideal renal feed for him? (AIIMS NOV 2019)</span></p>",
      "unique_key": "Q5283533",
      "question_audio": null,
      "question_video": null,
      "map_id": 34634840,
      "difficulty_level": "intermediate",
      "subjects_id": [],
      "solution": "<p><span style=\"font-size:12.0pt;\"><strong>Ans. A) Low volume, high calories</strong></span></p><p> </p><ul><li><span style=\"font-size:12.0pt;\">An ideal diet for a patient with end-stage renal disease should consist of low volume but high calorie intake. The patient's dietary choices can significantly impact the advancement of kidney disease and its associated complications. Opting for a diet that is low in volume is recommended to prevent:</span><ul><li><span style=\"font-size:12.0pt;\">Sodium and volume overload</span></li><li><span style=\"font-size:12.0pt;\">Hyperkalemia</span></li><li><span style=\"font-size:12.0pt;\">Hyperphosphatemia</span></li><li><span style=\"font-size:12.0pt;\">Accumulation of toxic metabolites of protein degradation</span></li></ul></li><li><span style=\"font-size:12.0pt;\">Opting for a high-calorie diet is recommended for the potential malnutrition and wasting risks observed in individuals with End-Stage Renal Disease (ESRD).</span></li></ul><p> </p><p><span style=\"font-size:12.0pt;\"><strong>Other Options:</strong></span></p><p> </p><p><span style=\"font-size:12.0pt;\"><strong>Option B. High volume, low calories: </strong>This could lead to volume overload and insufficient caloric intake.</span></p><p> </p><p><span style=\"font-size:12.0pt;\"><strong>Option C. High volume, high calories: </strong>High volume can cause fluid overload issues.</span></p><p> </p><p><span style=\"font-size:12.0pt;\"><strong>Option D. Low volume, low calories: </strong>Insufficient calories can exacerbate malnutrition and wasting.</span></p><p> </p><p><span style=\"font-size:12.0pt;\"><strong>Educational Objective:</strong></span></p><p> </p><ul><li><span style=\"font-size:12.0pt;\">An ideal diet for patients with end-stage renal disease should be low in volume to manage fluid balance and high in calories to prevent malnutrition and wasting.</span></li></ul>",
      "correct_choice_id": 200340,
      "solution_audio": null,
      "solution_video": null,
      "audio_explanation_heading": null,
      "video_explanation_heading": null,
      "solution_media_position": "bottom",
      "tags": [],
      "explanation_video": null,
      "question_images": [],
      "explanation_images": []
    },
    {
      "id": 50086,
      "choices": [
        {
          "id": 200344,
          "text": "<p><span style=\"font-size:16px;\">Both Assertion and Reason are true, and the Reason is the correct explanation for the Assertion.</span></p>"
        },
        {
          "id": 200345,
          "text": "<p><span style=\"font-size:16px;\">Both Assertion and Reason are true, but the Reason is not the correct explanation for the Assertion.</span></p>"
        },
        {
          "id": 200346,
          "text": "<p><span style=\"font-size:16px;\">The Assertion is true, but the Reason is false.</span></p>"
        },
        {
          "id": 200347,
          "text": "<p><span style=\"font-size:16px;\">Both Assertion and Reason are false.</span></p>"
        }
      ],
      "text": "<p><span style=\"font-size:16px;\"><strong>Assertion (A):</strong> Malathion is used as an ultra-low volume fogger during epidemics.</span></p><p><br><span style=\"font-size:16px;\"><strong>Reason (R):</strong> Ultra-low volume foggers have no residual effects. </span></p>",
      "unique_key": "Q2828444",
      "question_audio": null,
      "question_video": null,
      "map_id": 34377717,
      "difficulty_level": "intermediate",
      "subjects_id": [],
      "solution": "<p><span style=\"font-size:16px;\"><strong>Ans. C) The Assertion is true, but the Reason is false.</strong></span></p><p> </p><p><span style=\"font-size:16px;\">Malathion is indeed used as an ultra-low volume (ULV) fogger during epidemics, particularly for vector control, as it helps control mosquito populations effectively. However, the statement in the Reason is incorrect. Ultra-low volume foggers, including Malathion, can leave residual effects. Malathion has residual action that lasts up to approximately 3 months, which makes it useful in epidemic control for an extended period.</span></p><p> </p><p><span style=\"font-size:16px;\"><strong>Educational Objective:</strong></span></p><p> </p><p><span style=\"font-size:16px;\">Malathion is preferred as an ultra-low volume fogger due to its low toxicity among organophosphates, but it does have residual effects lasting up to 3 months.</span></p>",
      "correct_choice_id": 200346,
      "solution_audio": null,
      "solution_video": null,
      "audio_explanation_heading": null,
      "video_explanation_heading": null,
      "solution_media_position": "bottom",
      "tags": [],
      "explanation_video": null,
      "question_images": [],
      "explanation_images": []
    },
    {
      "id": 50087,
      "choices": [
        {
          "id": 200348,
          "text": "<p><span style=\"font-size:12.0pt;\">Meningitis prophylaxis in exposed contacts/relatives</span></p>"
        },
        {
          "id": 200349,
          "text": "<p><span style=\"font-size:12.0pt;\">Hand washing</span></p>"
        },
        {
          "id": 200350,
          "text": "<p><span style=\"font-size:12.0pt;\">Vaccination</span></p>"
        },
        {
          "id": 200351,
          "text": "<p><span style=\"font-size:12.0pt;\">Adding iron to wheat flour</span></p>"
        }
      ],
      "text": "<p><span style=\"font-size:12.0pt;\">A 28-year-old public health nurse is attending a seminar on primary prevention strategies. She needs to identify interventions that fall under specific protection, a subset of primary prevention. Which of the following interventions does NOT come under the primary level of prevention for specific protection? (AIIMS NOV 2019)</span></p>",
      "unique_key": "Q4390370",
      "question_audio": null,
      "question_video": null,
      "map_id": 34071203,
      "difficulty_level": "intermediate",
      "subjects_id": [],
      "solution": "<p><span style=\"font-size:12.0pt;\"><strong>Ans. B) Hand washing</strong></span></p><p> </p><ul><li><span style=\"font-size:12.0pt;\">Specific protection mode of disease prevention: Is a Primary level of disease prevention (applied when risk factors are present in environment but disease has not yet taken place).</span></li><li><span style=\"font-size:12.0pt;\">Risk factors are already present but disease is prevented from occurring by using a specific modality. Ex - Vaccines & Vit A supplementation under NIS, chemoprophylaxis, IFA supplementation, contraception, ITN, etc</span></li><li><span style=\"font-size:12.0pt;\">Handwashing fall within the category of primary prevention as a Health Promotion measure, not specific protection, as it is not a protective measures targeted at any particular disease.</span></li></ul><p> </p><p><span style=\"font-size:12.0pt;\"><strong>Other Options:</strong></span></p><p> </p><p><span style=\"font-size:12.0pt;\"><strong>Option A. Meningitis prophylaxis in exposed contacts/relatives: </strong>This is a form of specific protection, aimed at preventing the onset of meningitis in those exposed to the infection.</span></p><p> </p><p><span style=\"font-size:12.0pt;\"><strong>Option C. Vaccination: </strong>Vaccination is a classic example of specific protection, preventing the occurrence of specific diseases.</span></p><p> </p><p><span style=\"font-size:12.0pt;\"><strong>Option D. Adding iron to wheat flour: </strong>This is a specific protection measure to prevent iron deficiency anemia in the population by fortifying commonly consumed food products.</span></p><p> </p><p><span style=\"font-size:12.0pt;\"><strong>Educational Objective:</strong></span></p><p> </p><ul><li><span style=\"font-size:12.0pt;\">Hand washing is a health promotion measure and does not fall under specific protection in primary prevention strategies.</span></li><li><span style=\"font-size:12.0pt;\">Note - Chinese Medicine is the Pioneer in concept of ‘Specific protection by vaccine’</span></li></ul>",
      "correct_choice_id": 200349,
      "solution_audio": null,
      "solution_video": null,
      "audio_explanation_heading": null,
      "video_explanation_heading": null,
      "solution_media_position": "bottom",
      "tags": [],
      "explanation_video": null,
      "question_images": [],
      "explanation_images": []
    },
    {
      "id": 50088,
      "choices": [
        {
          "id": 200352,
          "text": "<p><span style=\"font-size:12pt\"><span style=\"font-family:\"Times New Roman\",serif\"><span style=\"font-family:\"Calibri\",sans-serif\">Hot flashes</span></span></span></p>"
        },
        {
          "id": 200353,
          "text": "<p><span style=\"font-size:12pt\"><span style=\"font-family:\"Times New Roman\",serif\"><span style=\"font-family:\"Calibri\",sans-serif\">CAD Prophylaxis</span></span></span></p>"
        },
        {
          "id": 200354,
          "text": "<p><span style=\"font-size:12pt\"><span style=\"font-family:\"Times New Roman\",serif\"><span style=\"font-family:\"Calibri\",sans-serif\">Osteoporosis</span></span></span></p>"
        },
        {
          "id": 200355,
          "text": "<p><span style=\"font-size:12pt\"><span style=\"font-family:\"Times New Roman\",serif\"><span style=\"font-family:\"Calibri\",sans-serif\">Premature menopause</span></span></span></p>"
        }
      ],
      "text": "<p><span style=\"font-size:12pt\"><span style=\"font-family:\"Times New Roman\",serif\"><span style=\"font-family:\"Calibri\",sans-serif\">Hormone Replacement Therapy is not indicated for: </span></span></span>(INICET NOV 2019)</p>",
      "unique_key": "Q7924331",
      "question_audio": null,
      "question_video": null,
      "map_id": 34060082,
      "difficulty_level": "intermediate",
      "subjects_id": [],
      "solution": "<p><span style=\"font-size:12pt\"><span style=\"font-family:\"Times New Roman\",serif\"><strong><span style=\"font-family:\"Calibri\",sans-serif\">Ans. B) CAD Prophylaxis</span></strong></span></span></p>\r\n\r\n<p> </p>\r\n\r\n<p><span style=\"font-size:12pt\"><span style=\"font-family:\"Times New Roman\",serif\"><strong><span style=\"font-family:\"Calibri\",sans-serif\">Explanation:</span></strong> </span></span></p>\r\n\r\n<p> </p>\r\n\r\n<p><span style=\"font-size:12pt\"><span style=\"font-family:\"Times New Roman\",serif\"><span style=\"font-family:\"Calibri\",sans-serif\">Hormone Replacement Therapy (HRT) is not recommended for the prophylaxis of coronary artery disease (CAD). Although there was some belief in the past that HRT might provide cardiovascular benefits, extensive research has shown that HRT does not prevent CAD and may, in fact, increase the risk of certain cardiovascular events in some women.</span></span></span></p>\r\n\r\n<p> </p>\r\n\r\n<p><span style=\"font-size:12pt\"><span style=\"font-family:\"Times New Roman\",serif\"><span style=\"font-family:\"Calibri\",sans-serif\">HRT is primarily indicated for the management of symptoms associated with menopause and for certain therapeutic and prophylactic uses:</span></span></span></p>\r\n\r\n<p> </p>\r\n\r\n<p><span style=\"font-size:12pt\"><span style=\"font-family:\"Times New Roman\",serif\"><strong><span style=\"font-family:\"Calibri\",sans-serif\">Therapeutic Indications:</span></strong></span></span></p>\r\n\r\n<p> </p>\r\n\r\n<ul>\r\n\t<li><span style=\"font-size:12pt\"><span style=\"font-family:\"Times New Roman\",serif\"><span style=\"font-family:\"Calibri\",sans-serif\">Gonadal dysgenesis in adolescents</span></span></span></li>\r\n\t<li><span style=\"font-size:12pt\"><span style=\"font-family:\"Times New Roman\",serif\"><span style=\"font-family:\"Calibri\",sans-serif\">Premature ovarian failure</span></span></span></li>\r\n\t<li><span style=\"font-size:12pt\"><span style=\"font-family:\"Times New Roman\",serif\"><span style=\"font-family:\"Calibri\",sans-serif\">Hot flashes (vasomotor symptoms)</span></span></span></li>\r\n\t<li><span style=\"font-size:12pt\"><span style=\"font-family:\"Times New Roman\",serif\"><span style=\"font-family:\"Calibri\",sans-serif\">Vaginal dryness</span></span></span></li>\r\n</ul>\r\n\r\n<p> </p>\r\n\r\n<p><span style=\"font-size:12pt\"><span style=\"font-family:\"Times New Roman\",serif\"><strong><span style=\"font-family:\"Calibri\",sans-serif\">Prophylactic Indications:</span></strong></span></span></p>\r\n\r\n<p> </p>\r\n\r\n<ul>\r\n\t<li><span style=\"font-size:12pt\"><span style=\"font-family:\"Times New Roman\",serif\"><span style=\"font-family:\"Calibri\",sans-serif\">Prevention of osteoporosis in postmenopausal women</span></span></span></li>\r\n</ul>\r\n\r\n<p> </p>\r\n\r\n<p><span style=\"font-size:12pt\"><span style=\"font-family:\"Times New Roman\",serif\"><strong><span style=\"font-family:\"Calibri\",sans-serif\">Risks of HRT:</span></strong></span></span></p>\r\n\r\n<p> </p>\r\n\r\n<ul>\r\n\t<li><span style=\"font-size:12pt\"><span style=\"font-family:\"Times New Roman\",serif\"><span style=\"font-family:\"Calibri\",sans-serif\">Increased risk of endometrial cancer (particularly with unopposed estrogen in women with an intact uterus)</span></span></span></li>\r\n\t<li><span style=\"font-size:12pt\"><span style=\"font-family:\"Times New Roman\",serif\"><span style=\"font-family:\"Calibri\",sans-serif\">Increased risk of breast cancer</span></span></span></li>\r\n\t<li><span style=\"font-size:12pt\"><span style=\"font-family:\"Times New Roman\",serif\"><span style=\"font-family:\"Calibri\",sans-serif\">Increased risk of ovarian cancer</span></span></span></li>\r\n\t<li><span style=\"font-size:12pt\"><span style=\"font-family:\"Times New Roman\",serif\"><span style=\"font-family:\"Calibri\",sans-serif\">Increased risk of thromboembolism</span></span></span></li>\r\n\t<li><span style=\"font-size:12pt\"><span style=\"font-family:\"Times New Roman\",serif\"><span style=\"font-family:\"Calibri\",sans-serif\">Possible adverse effects on lipid profiles</span></span></span></li>\r\n\t<li><span style=\"font-size:12pt\"><span style=\"font-family:\"Times New Roman\",serif\"><span style=\"font-family:\"Calibri\",sans-serif\">Increased risk of gallstones and liver dysfunction</span></span></span></li>\r\n</ul>\r\n\r\n<p> </p>\r\n\r\n<p><span style=\"font-size:12pt\"><span style=\"font-family:\"Times New Roman\",serif\"><strong><span style=\"font-family:\"Calibri\",sans-serif\">Other options:</span></strong></span></span></p>\r\n\r\n<p> </p>\r\n\r\n<p><span style=\"font-size:12pt\"><span style=\"font-family:\"Times New Roman\",serif\"><strong><span style=\"font-family:\"Calibri\",sans-serif\">Option A. Hot flashes:</span></strong><span style=\"font-family:\"Calibri\",sans-serif\"> HRT is widely used to manage hot flashes and other vasomotor symptoms associated with menopause. It is one of the most effective treatments for these symptoms.</span></span></span></p>\r\n\r\n<p> </p>\r\n\r\n<p><span style=\"font-size:12pt\"><span style=\"font-family:\"Times New Roman\",serif\"><strong><span style=\"font-family:\"Calibri\",sans-serif\">Option C. Osteoporosis:</span></strong><span style=\"font-family:\"Calibri\",sans-serif\"> HRT is used prophylactically to prevent osteoporosis in postmenopausal women by maintaining bone density and reducing the risk of fractures.</span></span></span></p>\r\n\r\n<p> </p>\r\n\r\n<p><span style=\"font-size:12pt\"><span style=\"font-family:\"Times New Roman\",serif\"><strong><span style=\"font-family:\"Calibri\",sans-serif\">Option D. Premature menopause:</span></strong><span style=\"font-family:\"Calibri\",sans-serif\"> Women experiencing premature menopause or premature ovarian failure can benefit from HRT to manage symptoms and reduce the long-term risks associated with early loss of estrogen, including osteoporosis.</span></span></span></p>\r\n\r\n<p> </p>\r\n\r\n<p><span style=\"font-size:12pt\"><span style=\"font-family:\"Times New Roman\",serif\"><strong><span style=\"font-family:\"Calibri\",sans-serif\">Educational Objective:</span></strong> </span></span></p>\r\n\r\n<p> </p>\r\n\r\n<p><span style=\"font-size:12pt\"><span style=\"font-family:\"Times New Roman\",serif\"><span style=\"font-family:\"Calibri\",sans-serif\">Hormone Replacement Therapy (HRT) is not indicated for the prophylaxis of coronary artery disease (CAD).</span></span></span></p>\r\n\r\n<p> </p>\r\n\r\n<p><span style=\"font-size:12pt\"><span style=\"font-family:\"Times New Roman\",serif\"><strong><span style=\"font-family:\"Calibri\",sans-serif\">Ref: Dutta’s textbook of gynecology 6<sup>th</sup> edition pg 61,62</span></strong></span></span></p>",
      "correct_choice_id": 200353,
      "solution_audio": null,
      "solution_video": null,
      "audio_explanation_heading": null,
      "video_explanation_heading": null,
      "solution_media_position": "bottom",
      "tags": [],
      "explanation_video": null,
      "question_images": [],
      "explanation_images": []
    },
    {
      "id": 50089,
      "choices": [
        {
          "id": 200356,
          "text": "<p style=\"text-align:left\"><span style=\"font-size:10.5pt\"><span style=\"font-family:Calibri,sans-serif\"><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\">Glutamine replaced by asparagine</span></span></span></p>"
        },
        {
          "id": 200357,
          "text": "<p style=\"text-align:left\"><span style=\"font-size:10.5pt\"><span style=\"font-family:Calibri,sans-serif\"><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\">Glutamine replaced by alanine</span></span></span></p>"
        },
        {
          "id": 200358,
          "text": "<p style=\"text-align:left\"><span style=\"font-size:10.5pt\"><span style=\"font-family:Calibri,sans-serif\"><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\">Glutamine replaced by glutamate</span></span></span></p>"
        },
        {
          "id": 200359,
          "text": "<p style=\"text-align:left\"><span style=\"font-size:10.5pt\"><span style=\"font-family:Calibri,sans-serif\"><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\">Glutamine replaced by arginine</span></span></span></p>"
        }
      ],
      "text": "<p style=\"text-align:left\"><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\"><span style=\"font-family:\"Calibri\",sans-serif\">Which of the following would have no effect on the function of the protein product? (</span></span>AIIMS Nov 2019)</p>",
      "unique_key": "Q2431167",
      "question_audio": null,
      "question_video": null,
      "map_id": 34917504,
      "difficulty_level": "intermediate",
      "subjects_id": [],
      "solution": "<p style=\"text-align:left\"><span style=\"font-size:10.5pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\">Ans. A) Glutamine replaced by asparagine </span></strong></span></span></p>\r\n\r\n<p style=\"text-align:left\"> </p>\r\n\r\n<p style=\"text-align:left\"><span style=\"font-size:10.5pt\"><span style=\"font-family:Calibri,sans-serif\"><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\">Amino acid replacement is a change from one amino acid to a different amino acid in a protein due to point mutation in the corresponding DNA sequence. It is caused by nonsynonymous missense mutation which changes the codon sequence to code other amino acid instead of the original.</span></span></span></p>\r\n\r\n<p style=\"text-align:left\"> </p>\r\n\r\n<p style=\"text-align:left\"><span style=\"font-size:10.5pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\">Usually, amino acids are thus classified into two types:</span></strong></span></span></p>\r\n\r\n<p style=\"text-align:left\"> </p>\r\n\r\n<ol style=\"list-style-type:lower-alpha\">\r\n\t<li style=\"text-align:left\"><span style=\"font-size:10.5pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\">Conservative replacement</span></strong><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\"> - an amino acid is <strong>exchanged into another that has similar properties</strong>. This type of replacement is expected to rarely result in dysfunction in the corresponding protein. </span></span></span></li>\r\n</ol>\r\n\r\n<p style=\"text-align:left\"><span style=\"font-size:10.5pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\">For example, leucine and isoleucine are both aliphatic, branched hydrophobes. Similarly, aspartic acid and glutamic acid are both small, negatively charged residues.</span></strong></span></span></p>\r\n\r\n<p style=\"text-align:left\"> </p>\r\n\r\n<ol start=\"2\" style=\"list-style-type:lower-alpha\">\r\n\t<li style=\"text-align:left\"><span style=\"font-size:10.5pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\">Radical replacement</span></strong><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\"> - an amino acid is exchanged into another with different properties. This can lead to changes in protein structure or function, which can cause potentially lead to changes in phenotype, sometimes pathogenic. </span></span></span></li>\r\n</ol>\r\n\r\n<p style=\"margin-left:24px; text-align:left\"> </p>\r\n\r\n<p style=\"text-align:left\"><span style=\"font-size:10.5pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\">Example - Sickle cell anemia, due to a mutation in beta globin where at position 6 glutamic acid (negatively charged) is exchanged with valine (not charged).</span></strong></span></span></p>\r\n\r\n<p style=\"text-align:left\"> </p>\r\n\r\n<p style=\"text-align:left\"><span style=\"font-size:10.5pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span style=\"font-size:12.0pt\">Other Options:</span></strong> </span></span></p>\r\n\r\n<p style=\"text-align:left\"> </p>\r\n\r\n<p style=\"text-align:left\"><span style=\"font-size:10.5pt\"><span style=\"font-family:Calibri,sans-serif\"><span style=\"font-size:12pt\"><strong>Option B.</strong> </span><span style=\"font-size:12.0pt\"><strong>Glutamine replaced by alanine:</strong> Glutamine is a polar, uncharged amino acid, while alanine is a nonpolar, aliphatic amino acid. This radical replacement could affect the protein's structure or function.</span></span></span></p>\r\n\r\n<p style=\"text-align:left\"> </p>\r\n\r\n<p style=\"text-align:left\"><span style=\"font-size:10.5pt\"><span style=\"font-family:Calibri,sans-serif\"><span style=\"font-size:12pt\"><strong>Option C.</strong> </span><span style=\"font-size:12.0pt\"><strong>Glutamine replaced by glutamate:</strong> Glutamine is a polar, uncharged amino acid, while glutamate is a polar, negatively charged amino acid. Although they are similar in size, the difference in charge makes this a radical replacement, potentially affecting protein function.</span></span></span></p>\r\n\r\n<p style=\"text-align:left\"> </p>\r\n\r\n<p style=\"text-align:left\"><span style=\"font-size:10.5pt\"><span style=\"font-family:Calibri,sans-serif\"><span style=\"font-size:12pt\"><strong>Option D.</strong> </span><span style=\"font-size:12.0pt\"><strong>Glutamine replaced by arginine:</strong> Glutamine is a polar, uncharged amino acid, while arginine is a polar, positively charged amino acid. This radical replacement could significantly alter the protein's structure or function.</span></span></span></p>\r\n\r\n<p style=\"text-align:left\"> </p>\r\n\r\n<p style=\"text-align:left\"><span style=\"font-size:10.5pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span style=\"font-size:12.0pt\">Educational Objective </span></strong></span></span></p>\r\n\r\n<p style=\"text-align:left\"> </p>\r\n\r\n<p style=\"text-align:left\"><span style=\"font-size:12.0pt\"><span style=\"font-family:\"Calibri\",sans-serif\">Conservative replacements, such as replacing glutamine with asparagine, typically do not affect the protein's function because the substituted amino acids have similar properties. Radical replacements, involving amino acids with different properties, are more likely to impact protein function.</span></span></p>",
      "correct_choice_id": 200356,
      "solution_audio": null,
      "solution_video": null,
      "audio_explanation_heading": null,
      "video_explanation_heading": null,
      "solution_media_position": "bottom",
      "tags": [],
      "explanation_video": null,
      "question_images": [],
      "explanation_images": []
    },
    {
      "id": 50090,
      "choices": [
        {
          "id": 200360,
          "text": "<p><span style=\"font-size:12pt;\">Pox virus</span></p>"
        },
        {
          "id": 200361,
          "text": "<p><span style=\"font-size:12pt;\">Coxsackievirus</span></p>"
        },
        {
          "id": 200362,
          "text": "<p><span style=\"font-size:12pt;\">HHV-7</span></p>"
        },
        {
          "id": 200363,
          "text": "<p><span style=\"font-size:12pt;\">Parvovirus</span></p>"
        }
      ],
      "text": "<p><span style=\"font-size:12pt;\">Which causative agent is responsible for the 4-year-old boy's condition, characterized by painful mouth sores, a rash on the hands, and fever as shown below? (</span>AIIMS Nov 2019)</p><p> </p><p><img src=\"https://cerebellum-web-static.s3.amazonaws.com/media/public/images/2024/06/18/screenshot-2024-06-18-125720.png\" alt=\"\" width=\"400\" height=\"130\"></p><p> </p><p><img src=\"https://cerebellum-web-static.s3.amazonaws.com/media/public/images/2024/06/18/screenshot-2024-06-18-125720.png\" alt=\"Question Image\"></p>",
      "unique_key": "Q6869626",
      "question_audio": null,
      "question_video": null,
      "map_id": 34646945,
      "difficulty_level": "intermediate",
      "subjects_id": [],
      "solution": "<p><span style=\"font-size:12pt;\"><strong>Ans. B) Coxsackievirus</strong></span></p><p> </p><p><span style=\"font-size:12pt;\">The above scenario is suggestive of hand-foot-and-mouth disease. It is most commonly caused by <strong>coxsackievirus A16 (CV-A16).CV‐A6 and EV71</strong> are also other important causative organisms.</span></p><p> </p><ul><li><span style=\"font-size:12pt;\"><strong>Age group commonly affected: </strong>Children.</span></li><li><span style=\"font-size:12pt;\"><strong>Spread: </strong>Droplets / fecal contamination.</span></li><li><span style=\"font-size:12pt;\"><strong>Incubation period: </strong>7 days.</span></li><li><span style=\"font-size:12pt;\"><strong>Clinical features:</strong> In children, the onset is with a <strong>low‐grade fever, sore throat and malaise</strong> but in adults, a painful stomatitis is an early feature. </span><ul><li><span style=\"font-size:12pt;\">Blisters in the mouth soon break down to superficial ulcers.</span></li><li><span style=\"font-size:12pt;\">Children are more likely than adults to develop <strong>flaccid greyish 2–5 mm oval vesicles</strong> on the palms and slightly less frequently on the soles.</span></li></ul></li><li><span style=\"font-size:12pt;\">They fade after 2–3 days. Infection can be subclinical.</span></li><li><span style=\"font-size:12pt;\">Only symptomatic treatment is given.</span></li></ul><p> </p><p><span style=\"font-size:12pt;\"><strong>Other Options:</strong></span></p><p> </p><p><span style=\"font-size:12pt;\"><strong>Option A. Pox virus:</strong></span></p><p> </p><ul><li><span style=\"font-size:12pt;\">Poxviruses cause diseases such as <strong>smallpox</strong> and <strong>molluscum contagiosum</strong>, which have very different clinical presentations from HFMD.</span></li><li><span style=\"font-size:12pt;\"><strong>Smallpox</strong>, which has been <strong>eradicated</strong>, presented with a characteristic <strong>vesicular and pustular</strong> rash and <strong>high mortality</strong>.</span></li><li><span style=\"font-size:12pt;\"><strong>Molluscum contagiosum </strong>is characterized by firm, painless, <strong>umbilicated papules</strong>, not the presentation seen in the images provided.</span></li></ul><p> </p><p><span style=\"font-size:12pt;\"><strong>Option C. HHV-7 (Human Herpesvirus-7):</strong></span></p><p> </p><ul><li><span style=\"font-size:12pt;\">HHV-7 is associated with <strong>roseola</strong>, a viral infection characterized by a <strong>high fever and a rash</strong>.</span></li><li><span style=\"font-size:12pt;\">HHV 7 is also associated with Pityriasis rosea.</span></li><li><span style=\"font-size:12pt;\">However, it does not typically cause painful mouth sores or a rash on the hands.</span></li></ul><p> </p><p><span style=\"font-size:12pt;\"><strong>Option D. Parvovirus</strong>: Parvovirus <strong>B19</strong> can cause a condition called <strong>fifth disease</strong>, which may result in a <strong>rash on the face classically described as slapped cheek appearance as shown in the below image</strong></span></p><p> </p><p><span style=\"font-size:12pt;\"><i><strong><img src=\"https://cerebellum-web-static.s3.amazonaws.com/media/public/images/2023/11/27/picture7.jpg\" alt=\"\" width=\"600\" height=\"185\"></strong></i></span></p><p> </p><p><span style=\"font-size:12pt;\">but <strong>parvo virus</strong> not known for causing painful mouth sores or a rash on the hands. Additionally, fifth disease is more common in children between <strong>5 and 15 years old</strong>, so it is less likely in a 4-year-old.</span></p><p> </p><p><span style=\"font-size:12pt;\"><strong>Educational Objective:</strong></span></p><p> </p><p><span style=\"font-size:12pt;\">The clinical presentation of <strong>fever, painful oral sores</strong>, and a <strong>vesicular rash</strong> on the <strong>hands and feet</strong> in a young <strong>child</strong> is characteristic of <strong>Hand, Foot, and Mouth Disease</strong>, which is <strong>most commonly</strong> caused by <strong>Coxsackievirus.</strong></span></p><p> </p><p><img src=\"https://cerebellum-web-static.s3.amazonaws.com/media/public/images/2024/06/18/screenshot-2024-06-18-130109.png\" alt=\"\" width=\"1000\" height=\"709\"></p><p> </p><p><span style=\"font-size:12pt;\"><strong>Ref - Rook's Textbook of Dermatology -9th Edition, Chapter 25 Page no 25.81, chapter 117, Page no 117.6</strong></span></p><p><span style=\"font-size:12pt;\"><strong>Fitzpatrick’s dermatology, 9<sup>th</sup> edition, Page no 1591</strong></span></p><p><img src=\"https://cerebellum-web-static.s3.amazonaws.com/media/public/images/2023/11/27/picture7.jpg\" alt=\"Solution Image\"></p>",
      "correct_choice_id": 200361,
      "solution_audio": null,
      "solution_video": null,
      "audio_explanation_heading": null,
      "video_explanation_heading": null,
      "solution_media_position": "bottom",
      "tags": [],
      "explanation_video": null,
      "question_images": [],
      "explanation_images": []
    },
    {
      "id": 50091,
      "choices": [
        {
          "id": 200364,
          "text": "<p style=\"margin-right:3px\"><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span style=\"font-size:12.0pt\">Promoter insertion</span></span></span></p>"
        },
        {
          "id": 200365,
          "text": "<p style=\"margin-right:3px\"><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span style=\"font-size:12.0pt\">Enhancer deletion</span></span></span></p>"
        },
        {
          "id": 200366,
          "text": "<p style=\"margin-right:3px\"><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span style=\"font-size:12.0pt\">Gene amplification</span></span></span></p>"
        },
        {
          "id": 200367,
          "text": "<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span style=\"font-size:12.0pt\">Point mutation</span></span></span></p>"
        }
      ],
      "text": "<p><span style=\"font-size:12.0pt\"><span style=\"font-family:\"Calibri\",sans-serif\">The mutations/changes that convert proto-oncogene to oncogene include all except: (AIIMS NOV 2019)</span></span></p>",
      "unique_key": "Q4051210",
      "question_audio": null,
      "question_video": null,
      "map_id": 34710783,
      "difficulty_level": "intermediate",
      "subjects_id": [],
      "solution": "<p style=\"margin-right:3px\"><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\">Ans. B) Enhancer deletion</span></strong></span></span></p>\r\n\r\n<p style=\"margin-right:3px\"> </p>\r\n\r\n<p style=\"margin-right:3px\"><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\">Enhancer deletion does not convert a proto-oncogene to an oncogene. </span><span style=\"font-size:12.0pt\">On the contrary, deletion of an enhancer would likely reduce the expression of the gene, potentially reducing its oncogenic potential, rather than increasing it.</span></span></span></p>\r\n\r\n<p style=\"margin-right:3px\"> </p>\r\n\r\n<p style=\"margin-right:3px\"><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\">Selected oncogenes, Their Mode of Activation, and Associated Human Tumors</span></strong></span></span></p>\r\n\r\n<p style=\"margin-right:3px\"> </p>\r\n\r\n<p style=\"margin-right:3px\"><img alt=\"\" src=\"https://cerebellum-web-static.s3.amazonaws.com/media/public/images/2024/09/06/screenshot-2024-09-06-104500_7dqf6dT.png\" style=\"height:961px; width:1000px\" /></p>\r\n\r\n<p style=\"margin-right:3px\"><img alt=\"\" src=\"https://cerebellum-web-static.s3.amazonaws.com/media/public/images/2024/09/05/screenshot-2024-09-05-180427.png\" style=\"height:287px; width:1000px\" /></p>\r\n\r\n<p style=\"margin-right:3px\"> </p>\r\n\r\n<p style=\"margin-right:3px\"><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\">Other Options: </span></strong></span></span></p>\r\n\r\n<p style=\"margin-right:3px\"> </p>\r\n\r\n<p style=\"margin-right:3px\"><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span style=\"font-size:12.0pt\">Option </span></strong><strong><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\">A. Promoter insertion</span></strong><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\">: Can convert a proto-oncogene to an oncogene by increasing gene transcription.</span></span></span></p>\r\n\r\n<p style=\"margin-right:3px\"> </p>\r\n\r\n<p style=\"margin-right:3px\"><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span style=\"font-size:12.0pt\">Option </span></strong><strong><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\">C. Gene amplification</span></strong><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\">: Leads to an increased number of gene copies, enhancing gene product levels, and contributing to oncogenesis.</span></span></span></p>\r\n\r\n<p style=\"margin-right:3px\"> </p>\r\n\r\n<p style=\"margin-right:3px\"><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span style=\"font-size:12.0pt\">Option </span></strong><strong><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\">D. Point mutation</span></strong><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\">: A common mechanism for converting proto-oncogenes to oncogenes by altering the protein product to make it constitutively active.</span></span></span></p>\r\n\r\n<p style=\"margin-right:3px\"> </p>\r\n\r\n<p style=\"margin-right:3px\"><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\">Educational Objective: </span></strong></span></span></p>\r\n\r\n<p style=\"margin-right:3px\"> </p>\r\n\r\n<p style=\"margin-right:3px\"><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\">Transformation of proto-oncogene (i.e., normal cell proliferation gene) to oncogenes (i.e., cancer cell proliferation gene) may occur by three mechanisms:</span></span></span></p>\r\n\r\n<p style=\"margin-right:3px\"> </p>\r\n\r\n<ol style=\"list-style-type:lower-roman\">\r\n\t<li><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\">Point mutations</span></strong><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\"> i.e., an alteration of a single base in the DNA chain. Eg:- RAS oncogene carried in many human tumors such as bladder cancer, pancreatic adenocarcinoma, cholangiocarcinoma. Point mutations, deletions, or insertions in the promoter region of a proto-oncogene that led to increased transcription.  </span></span></span></li>\r\n\t<li><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\">Chromosomal translocations</span></strong><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\"> i.e., transfer of a portion of one chromosome carrying protooncogene to another chromosome and making it independent of growth controls.  Eg :- Philadelphia chromosome seen in 95% cases of chronic myelogenous leukemia in which c-ABL protooncogene on chromosome 9 is translocated to chromosome 22.</span></span></span></li>\r\n\t<li><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\">Gene amplification</span></strong><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\"> i.e., increasing the number of copies of DNA sequence in protooncogene leading to increased mDNA and thus increased or overexpressed gene product. Eg:- Neuroblastoma having n-MYC HSR region,  ERB-B1 in breast and ovarian cancer. </span></span></span></li>\r\n</ol>\r\n\r\n<p style=\"margin-right:3px\"> </p>\r\n\r\n<p style=\"margin-right:3px\"><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\">Ref: Robbins and Cotran Pathologic basis of disease, 8<sup>th</sup> edition, Pg no. 549-551</span></strong></span></span></p><p><img src=\"https://cerebellum-web-static.s3.amazonaws.com/media/public/images/2024/09/06/screenshot-2024-09-06-104500_7dqf6dT.png\" alt=\"Solution Image\"></p>",
      "correct_choice_id": 200365,
      "solution_audio": null,
      "solution_video": null,
      "audio_explanation_heading": null,
      "video_explanation_heading": null,
      "solution_media_position": "bottom",
      "tags": [],
      "explanation_video": null,
      "question_images": [],
      "explanation_images": []
    },
    {
      "id": 50092,
      "choices": [
        {
          "id": 200368,
          "text": "<p><span style=\"font-size:12.0pt;\">a, b, c are correct</span></p>"
        },
        {
          "id": 200369,
          "text": "<p><span style=\"font-size:12.0pt;\">a and c are correct</span></p>"
        },
        {
          "id": 200370,
          "text": "<p><span style=\"font-size:12.0pt;\">b and d are correct</span></p>"
        },
        {
          "id": 200371,
          "text": "<p><span style=\"font-size:12.0pt;\">a, b, c, d are correct</span></p>"
        }
      ],
      "text": "<p><span style=\"font-size:12.0pt;\">Which of the following statements are correct regarding investigation of malignant bone tumors? (AIIMS NOV 2019)</span></p><p> </p><ol style=\"list-style-type:lower-alpha;\"><li><span style=\"font-size:12.0pt;\">Always done by transverse incision.</span></li><li><span style=\"font-size:12.0pt;\">Sample should be taken from 2 different planes.</span></li><li><span style=\"font-size:12.0pt;\">Sample should be taken before any radiological investigations.</span></li><li><span style=\"font-size:12.0pt;\">Sample should be taken from periphery and not from necrotic centre.</span></li></ol>",
      "unique_key": "Q8587295",
      "question_audio": null,
      "question_video": null,
      "map_id": 34563118,
      "difficulty_level": "intermediate",
      "subjects_id": [],
      "solution": "<p><span style=\"font-size:12.0pt;\"><strong>Ans. C) b and d are correct</strong></span></p><p> </p><ul><li><span style=\"font-size:12.0pt;\">Longitudinal incision is given for bone biopsy.</span></li><li><span style=\"font-size:12.0pt;\">Sample should be taken from 2 different planes.</span></li><li><span style=\"font-size:12.0pt;\">Radiological investigations are usually done before the biopsy.</span></li><li><span style=\"font-size:12.0pt;\">It is better to take tissue at the periphery of the lesion, where there are viable cells. On the contrary, necrosis and so nondiagnostic tissue are usually present within the tumor. </span></li></ul><p> </p><p><span style=\"font-size:12.0pt;\"><strong>SIMPLE BONE CYST</strong></span></p><p> </p><ul><li><span style=\"font-size:12.0pt;\">Simple bone cysts are a <strong>common pseudotumor of bone</strong> and the <strong>most frequent cause of pathologic fractures</strong> <strong>in children</strong>.</span></li><li><span style=\"font-size:12.0pt;\">Bone cysts usually affect patients between 5 and 15 years of age and occur more often in boys than in girls (2:1).</span></li><li><span style=\"font-size:12.0pt;\">They are found in the proximal humerus in 50% of cases and in the upper femur in 25%. The calcaneus and pelvis are also uniquely common locations.</span></li><li><span style=\"font-size:12.0pt;\"><strong>Patients are asymptomatic until a pathologic fracture occurs</strong>.</span></li><li><span style=\"font-size:12.0pt;\"><strong>Radiographs </strong>typically show a <strong>solitary cyst that is centrally located in the metaphyseal area</strong> and has marked thinning of the adjacent cortical bone and a pseudoloculated appearance.</span></li><li><span style=\"font-size:12.0pt;\">If there is associated fracture, radiographs may show the characteristic <strong>“fallen leaf” sign</strong>.</span></li><li><span style=\"font-size:12.0pt;\">In weight-bearing bones, such as the proximal femur, lesions should be treated aggressively.</span></li><li><span style=\"font-size:12.0pt;\"><strong>Management:</strong></span><ul><li><span style=\"font-size:12.0pt;\">Initial management usually involves aspiration/injection with either bone marrow or corticosteroid.</span></li><li><span style=\"font-size:12.0pt;\">The injections are carried out with bone biopsy needles and are repeated three to five times at intervals of 2 to 3 months, depending on the radiographic response.</span></li><li><span style=\"font-size:12.0pt;\">Curettage and bone grafting may also be an effective modality.</span></li></ul></li></ul><p> </p><p><span style=\"font-size:12.0pt;\"><strong>OSTEOID OSTEOMA</strong></span></p><p> </p><ul><li><span style=\"font-size:12.0pt;\">The <strong>most common benign osteoid-forming tumor</strong> is the osteoid osteoma, accounting for 10% of all benign bone tumors.</span></li><li><span style=\"font-size:12.0pt;\">It is more common in males than in females with a peak incidence in the second decade of life.</span></li><li><span style=\"font-size:12.0pt;\">Although it may be present in almost any bone, the proximal femur is the most common location.</span></li><li><span style=\"font-size:12.0pt;\"><strong>Dull, aching, nocturnal pain is characteristic, and  it is commonly relieved entirely by nonsteroidal anti-inflammatory drugs (NSAIDs)</strong> secondary to a high concentration of prostaglandins in the nidus.</span></li><li><span style=\"font-size:12.0pt;\"><strong>Radiographic Feature:</strong></span><ul><li><span style=\"font-size:12.0pt;\"><strong>Central, lytic nidus usually 1 cm or less in diameter</strong>. The more common cortically-based lesion exhibits extensive reactive sclerosis, creating a fusiform bulge on the bone surface. If the nidus is close to, or actually in, a joint, as in a femoral neck lesion, the resulting reactive synovitis may mimic a pyarthrosis or rheumatoid arthritis.</span></li><li><span style=\"font-size:12.0pt;\"><strong>Technetium bone scans are invariably positive</strong>.</span></li><li><span style=\"font-size:12.0pt;\">A CT scan is recommended to better anatomically locate the nidus and confirm the diagnosis.</span></li><li><span style=\"font-size:12.0pt;\">In the spine, the typical location for an osteoid osteoma is in the posterior elements.</span></li></ul></li><li><span style=\"font-size:12.0pt;\"><strong>Management:</strong></span><ul><li><span style=\"font-size:12.0pt;\">Many cases of osteoid osteoma are stage 1 lesions and can be treated symptomatically with aspirin or NSAIDs until they spontaneously resolve.</span></li><li><span style=\"font-size:12.0pt;\">If the patient fails such treatment, intervention is warranted.</span></li><li><span style=\"font-size:12.0pt;\">CT-guided radiofrequency ablation has emerged as the preferred treatment modality in many cases.</span></li><li><span style=\"font-size:12.0pt;\">If open surgical excision is undertaken, the entire nidus must be eradicated.</span></li></ul></li></ul><p> </p><p><span style=\"font-size:12.0pt;\"><strong>GIANT-CELL TUMOR (OSTEOCLASTOMA)</strong></span></p><p> </p><ul><li><span style=\"font-size:12.0pt;\">It is bone lesion of uncertain origin, most commonly seen in distal femur, proximal tibia, proximal humerus and distal radius.</span></li><li><span style=\"font-size:12.0pt;\">Most commonly seen in 20-40 years of age, after epiphyseal fusion.</span></li><li><span style=\"font-size:12.0pt;\"><strong>Histology</strong>: </span><ul style=\"list-style-type:circle;\"><li><span style=\"font-size:12.0pt;\">Multinucleated giant cells are seen on a background of stromal cells with little or no visible intercellular tissue.</span></li><li><span style=\"font-size:12.0pt;\">The osteoclast giant cells are the malignant cells, which induce the proliferation of mononuclear macrophage-lineage cells, hence the dividing cell population is the mononuclear cells which form the matrix.</span></li></ul></li><li><span style=\"font-size:12.0pt;\"><strong>Clinical Features:</strong></span><ul style=\"list-style-type:circle;\"><li><span style=\"font-size:12.0pt;\">Most commonly presents with pain, with or without swelling</span></li><li><span style=\"font-size:12.0pt;\">Pathological fracture occurs in 10–15% of cases</span></li><li><span style=\"font-size:12.0pt;\">Pulmonary metastasis occurs in 4% of cases, but they usually regress spontaneously.</span></li></ul></li><li><span style=\"font-size:12.0pt;\"><strong>Radiological features:</strong></span><ul style=\"list-style-type:circle;\"><li><span style=\"font-size:12.0pt;\"><strong>Eccentric lytic lesion at epiphyseal region</strong>, bounded by subchondral bone plate, with <strong>soap bubble appearance.</strong></span></li><li><span style=\"font-size:12.0pt;\">Biopsy is necessary for confirming the diagnosis.</span></li></ul></li><li><span style=\"font-size:12.0pt;\"><strong>Treatment:</strong></span><ul><li><span style=\"font-size:12.0pt;\"><strong>Curettage and ‘stripping’ of the cavity</strong>, followed by swabbing with hydrogen peroxide or by the application of liquid nitrogen.</span></li><li><span style=\"font-size:12.0pt;\">More aggressive tumors and recurrent lesions: <strong>Excision followed by bone grafting</strong>.</span></li></ul></li></ul><p> </p><p><span style=\"font-size:12.0pt;\"><strong>OSTEOSARCOMA</strong></span></p><p> </p><ul><li><span style=\"font-size:12.0pt;\">The classic form of osteosarcoma is typically seen in patients in their second or third decade, with a peak in the adolescent growth spurt.</span></li><li><span style=\"font-size:12.0pt;\">Incidence is <strong>Males > Females</strong> and is found in the metaphyseal areas of long bones, with 50% of lesions about the knee joint.</span></li><li><span style=\"font-size:12.0pt;\">The <strong>distal femur is the most common site</strong>, followed by the proximal tibia and then the proximal humerus.</span></li><li><span style=\"font-size:12.0pt;\"><strong>Radiographic Findings:</strong></span><ul><li><span style=\"font-size:12.0pt;\">Permeated lytic destruction of metaphyseal bone, with eventual cortical breakthrough into the subperiosteal space and <strong>subsequent formation of a Codman triangle</strong> at the diaphyseal end of the tumor.</span></li><li><span style=\"font-size:12.0pt;\">As the tumor continues to push its way into the extracortical soft tissue, a typical <strong>sunburst pattern of neoplastic bone</strong> may be seen outside the involved bone.</span></li></ul></li><li><span style=\"font-size:12.0pt;\"><strong>Management:</strong></span><ul><li><span style=\"font-size:12.0pt;\">With the combination of <strong>chemotherapy and surgical treatment</strong>, the prognosis for <strong>5-year survival is 70-80%.</strong></span></li><li><span style=\"font-size:12.0pt;\">The drugs commonly used today include <strong>high-dose methotrexate, doxorubicin, cisplatin, and ifosfamide.</strong></span></li><li><span style=\"font-size:12.0pt;\">In osteosarcoma of the extremities, limb-sparing surgery with wide resection of the tumor is the standard approach.</span></li><li><span style=\"font-size:12.0pt;\">Amputation is reserved for the exceptional or recurrent case.</span></li></ul></li></ul><p> </p><p><span style=\"font-size:12.0pt;\"><strong>Educational Objective </strong>:</span></p><p> </p><ul><li><span style=\"font-size:12.0pt;\">Longitudinal incision is given for bone biopsy.</span></li><li><span style=\"font-size:12.0pt;\">Sample should be taken from 2 different planes.</span></li><li><span style=\"font-size:12.0pt;\">Radiological investigations are usually done before the biopsy.</span></li><li><span style=\"font-size:12.0pt;\">It is better to take tissue at the periphery of the lesion, where there are viable cells. On the contrary, necrosis and so nondiagnostic tissue are usually present within the tumor. </span></li></ul>",
      "correct_choice_id": 200370,
      "solution_audio": null,
      "solution_video": null,
      "audio_explanation_heading": null,
      "video_explanation_heading": null,
      "solution_media_position": "bottom",
      "tags": [],
      "explanation_video": null,
      "question_images": [],
      "explanation_images": []
    },
    {
      "id": 50093,
      "choices": [
        {
          "id": 200372,
          "text": "<p><span style=\"font-size:12.0pt;\">Facial nerve palsy</span></p>"
        },
        {
          "id": 200373,
          "text": "<p><span style=\"font-size:12.0pt;\">Masticator space abscess</span></p>"
        },
        {
          "id": 200374,
          "text": "<p><span style=\"font-size:12.0pt;\">Plexiform neurofibromatosis</span></p>"
        },
        {
          "id": 200375,
          "text": "<p><span style=\"font-size:12.0pt;\">Fibrous dysplasia</span></p>"
        }
      ],
      "text": "<p><span style=\"font-size:12.0pt;\">Identify the clinical diagnosis: (AIIMS NOV 2019)</span></p><p> </p><p><span style=\"font-size:12.0pt;\"><img src=\"https://cerebellum-web-static.s3.amazonaws.com/media/public/images/2023/04/27/nm119.jpg\" alt=\"\" width=\"365\" height=\"390\"></span></p><p><img src=\"https://cerebellum-web-static.s3.amazonaws.com/media/public/images/2023/04/27/nm119.jpg\" alt=\"Question Image\"></p>",
      "unique_key": "Q2535585",
      "question_audio": null,
      "question_video": null,
      "map_id": 34750670,
      "difficulty_level": "intermediate",
      "subjects_id": [],
      "solution": "<p><span style=\"font-size:12.0pt;\"><strong>Ans. C) Plexiform neurofibromatosis</strong></span></p><p> </p><p><span style=\"font-size:12.0pt;\">Plexiform neurofibroma is seen in patients with NF1 commonly in the craniomaxillofacial region. Malignant transformation to MPNST (Malignant peripheral nerve sheath tumor) occurs in 3-16% patients and is the cause of mortality.</span></p><p> </p><p><span style=\"font-size:12.0pt;\">The mass typically appears as a \"bag of worms\" due to the involvement of multiple nerve branches.</span></p><p> </p><p><span style=\"font-size:12.0pt;\">Treatment is mainly surgical resection of the tumor</span></p><p> </p><p><span style=\"font-size:12.0pt;\"><strong>Other Options:</strong></span></p><p> </p><p><span style=\"font-size:12.0pt;\"><strong>Option</strong></span><span style=\"font-size:11pt;\"> </span><span style=\"font-size:12.0pt;\"><strong>A</strong>.<strong> Facial nerve palsy: </strong>This condition typically presents with asymmetrical facial movement and weakness but does not cause mass-like growths.</span></p><p> </p><p><span style=\"font-size:12.0pt;\"><strong>Option</strong></span><span style=\"font-size:11pt;\"> </span><span style=\"font-size:12.0pt;\"><strong>B</strong>.<strong> Masticator space abscess: </strong>Characterized by swelling and pain, usually due to an infection, which would not cause the extensive, benign proliferative growth seen in the image.</span></p><p> </p><p><span style=\"font-size:12.0pt;\"><strong>Option</strong></span><span style=\"font-size:11pt;\"> </span><span style=\"font-size:12.0pt;\"><strong>D. Fibrous dysplasia: </strong>While it can cause bone deformity and asymmetry, it does not manifest as a soft, extensive mass typically seen in neurofibromatosis.</span></p><p> </p><p><span style=\"font-size:12.0pt;\"><strong>Educational Objective:</strong></span></p><p> </p><p><span style=\"font-size:12.0pt;\">Plexiform neurofibromatosis should be suspected in patients with extensive, soft, non-tender, and irregularly contoured masses along nerve pathways, particularly in those known to have or suspected of having NF1. Surgical resection can be considered for symptomatic relief or cosmetic reasons, though complete removal is often challenging due to the nature of the growth</span></p>",
      "correct_choice_id": 200374,
      "solution_audio": null,
      "solution_video": null,
      "audio_explanation_heading": null,
      "video_explanation_heading": null,
      "solution_media_position": "bottom",
      "tags": [],
      "explanation_video": null,
      "question_images": [],
      "explanation_images": []
    },
    {
      "id": 50094,
      "choices": [
        {
          "id": 200376,
          "text": "<p><span style=\"font-size:12.0pt;\">RML consolidation</span></p>"
        },
        {
          "id": 200377,
          "text": "<p><span style=\"font-size:12.0pt;\">RLL consolidation</span></p>"
        },
        {
          "id": 200378,
          "text": "<p style=\"text-align:justify;\"><span style=\"font-size:12.0pt;\">RUL consolidation</span></p>"
        },
        {
          "id": 200379,
          "text": "<p><span style=\"font-size:12.0pt;\">Pericardial effusion</span></p>"
        }
      ],
      "text": "<p><span style=\"font-size:12.0pt;\">A 28-year-old man presents with the history of cough for one week. He also gives a history of hemoptysis for 1 month and fever for 4 days. The X-ray is given below. What is the diagnosis? (AIIMS NOV 2019)</span></p><p style=\"text-align:justify;\"> </p><p style=\"text-align:justify;\"><span style=\"font-size:12.0pt;\"><img src=\"https://cerebellum-web-static.s3.amazonaws.com/media/public/images/2024/05/27/screenshot-2024-05-27-092839.jpg\" alt=\"\" width=\"300\" height=\"351\"></span></p><p><img src=\"https://cerebellum-web-static.s3.amazonaws.com/media/public/images/2024/05/27/screenshot-2024-05-27-092839.jpg\" alt=\"Question Image\"></p>",
      "unique_key": "Q4008991",
      "question_audio": null,
      "question_video": null,
      "map_id": 34398736,
      "difficulty_level": "intermediate",
      "subjects_id": [],
      "solution": "<p><span style=\"font-size:12.0pt;\"><strong>Ans. A. RML consolidation</strong></span></p><p> </p><p><span style=\"font-size:12.0pt;\"><strong>Explanation:</strong></span></p><p><span style=\"font-size:10.5pt;\"><strong> </strong></span></p><p><span style=\"font-size:12.0pt;\">The X-ray shown above indicates consolidation due to presence of opacities in the right middle lobe silhouetting the right heart border along with the history of fever, cough and hemoptysis.</span></p><p> </p><p><span style=\"font-size:12.0pt;\"><strong>Silhouette sign</strong></span></p><p> </p><p><span style=\"font-size:12.0pt;\"><strong><img src=\"https://cerebellum-web-static.s3.amazonaws.com/media/public/images/2024/05/27/screenshot-2024-05-27-092925.jpg\" alt=\"\" width=\"500\" height=\"251\"></strong></span></p><p> </p><ul><li><span style=\"font-size:12.0pt;\">When the markings of heart are not visible – silhouette sign positive – localized to middle lobe /lingula</span></li><li><span style=\"font-size:12.0pt;\">When the markings of heart are visible – silhouette sign negative – localized to lower lobe.</span></li></ul><p> </p><p><span style=\"font-size:12.0pt;\"><strong>Other Options:</strong></span></p><p> </p><p><span style=\"font-size:12.0pt;\"><strong>Option B. RLL consolidation:</strong> Typically presents with obscuration of the right hemidiaphragm on X-ray, not the heart border.</span></p><p> </p><p><span style=\"font-size:12.0pt;\"><strong>Option C. RUL consolidation:</strong> Would more commonly show opacities in the upper right lung without affecting the silhouette of the heart.</span></p><p> </p><p><span style=\"font-size:12.0pt;\"><strong>Option D. Pericardial effusion:</strong> Would generally show an enlarged cardiac silhouette (\"water bottle\" sign), which is not evident in this image.</span></p><p> </p><p><span style=\"font-size:12.0pt;\"><strong>Educational Objective :</strong></span></p><p> </p><p><span style=\"font-size:12.0pt;\">RML consolidation can be diagnosed when there is obscuration of the right heart border due to lung opacities in the middle lobe, accompanied by clinical symptoms of respiratory infection.</span></p><p><img src=\"https://cerebellum-web-static.s3.amazonaws.com/media/public/images/2024/05/27/screenshot-2024-05-27-092925.jpg\" alt=\"Solution Image\"></p>",
      "correct_choice_id": 200376,
      "solution_audio": null,
      "solution_video": null,
      "audio_explanation_heading": null,
      "video_explanation_heading": null,
      "solution_media_position": "bottom",
      "tags": [],
      "explanation_video": null,
      "question_images": [],
      "explanation_images": []
    },
    {
      "id": 50095,
      "choices": [
        {
          "id": 200380,
          "text": "<p><span style=\"font-size:12.0pt;\">10</span></p>"
        },
        {
          "id": 200381,
          "text": "<p><span style=\"font-size:12.0pt;\">7</span></p>"
        },
        {
          "id": 200382,
          "text": "<p><span style=\"font-size:12.0pt;\">8</span></p>"
        },
        {
          "id": 200383,
          "text": "<p><span style=\"font-size:12.0pt;\">9</span></p>"
        }
      ],
      "text": "<p><span style=\"font-size:12.0pt;\">A preterm infant in the NICU was observed to have marked nasal flare, distinct xiphoid retractions, minimal intercostal retractions, and inspiratory lag with an audible grunt without a stethoscope. What would be the Silverman Anderson score? (AIIMS NOV 2019)</span></p>",
      "unique_key": "Q5175575",
      "question_audio": null,
      "question_video": null,
      "map_id": 34868060,
      "difficulty_level": "intermediate",
      "subjects_id": [],
      "solution": "<p><span style=\"font-size:12.0pt;\"><strong>Ans. C) 8</strong></span></p><p> </p><p><span style=\"font-size:12.0pt;\">The <strong>Silverman-Anderson score</strong> is a clinical scoring system used to assess the degree of respiratory distress in neonates, particularly those with hyaline membrane disease (HMD) or other forms of respiratory distress syndrome (RDS). The score ranges from 0 to 10, with higher scores indicating more severe respiratory distress.</span></p><p> </p><p><span style=\"font-size:12.0pt;\">The score is based on five parameters, each scored from 0 to 2:</span></p><p> </p><p><span style=\"font-size:12.0pt;\"><strong>1. Nasal Flaring:</strong></span></p><ul style=\"list-style-type:circle;\"><li><span style=\"font-size:12.0pt;\">0: None</span></li><li><span style=\"font-size:12.0pt;\">1: Minimal</span></li><li><span style=\"font-size:12.0pt;\">2: Marked</span></li></ul><p> </p><p><span style=\"font-size:12.0pt;\">In this case, the infant has <strong>marked nasal flaring</strong> (score = 2).</span></p><p> </p><p><span style=\"font-size:12.0pt;\"><strong>2. Xiphoid Retractions (Substernal Retractions):</strong></span></p><ul style=\"list-style-type:circle;\"><li><span style=\"font-size:12.0pt;\">0: None</span></li><li><span style=\"font-size:12.0pt;\">1: Minimal</span></li><li><span style=\"font-size:12.0pt;\">2: Distinct</span></li></ul><p> </p><p><span style=\"font-size:12.0pt;\">The infant has <strong>distinct xiphoid retractions</strong> (score = 2).</span></p><p> </p><p><span style=\"font-size:12.0pt;\"><strong>3. Intercostal Retractions:</strong></span></p><ul style=\"list-style-type:circle;\"><li><span style=\"font-size:12.0pt;\">0: None</span></li><li><span style=\"font-size:12.0pt;\">1: Minimal</span></li><li><span style=\"font-size:12.0pt;\">2: Marked</span></li></ul><p> </p><p><span style=\"font-size:12.0pt;\">The infant has <strong>minimal intercostal retractions</strong> (score = 1).</span></p><p> </p><p><span style=\"font-size:12.0pt;\"><strong>4. Chest Movement (Synchrony of Chest and Abdomen):</strong></span></p><ul style=\"list-style-type:circle;\"><li><span style=\"font-size:12.0pt;\">0: Synchrony</span></li><li><span style=\"font-size:12.0pt;\">1: Lag on inspiration</span></li><li><span style=\"font-size:12.0pt;\">2: See-saw movement</span></li></ul><p> </p><p><span style=\"font-size:12.0pt;\">The infant has <strong>inspiratory lag</strong> (score = 1).</span></p><p> </p><p><span style=\"font-size:12.0pt;\"><strong>5. Grunting:</strong></span></p><ul style=\"list-style-type:circle;\"><li><span style=\"font-size:12.0pt;\">0: None</span></li><li><span style=\"font-size:12.0pt;\">1: Audible with stethoscope</span></li><li><span style=\"font-size:12.0pt;\">2: Audible without stethoscope</span></li></ul><p> </p><p><span style=\"font-size:12.0pt;\">The infant has an <strong>audible grunt</strong> (score = 2).</span></p><p> </p><p><span style=\"font-size:12.0pt;\"><strong>Calculation:</strong></span></p><p> </p><ul><li><span style=\"font-size:12.0pt;\">Nasal Flaring: 2</span></li><li><span style=\"font-size:12.0pt;\">Xiphoid Retractions: 2</span></li><li><span style=\"font-size:12.0pt;\">Intercostal Retractions: 1</span></li><li><span style=\"font-size:12.0pt;\">Chest Movement: 1</span></li><li><span style=\"font-size:12.0pt;\">Grunting: 2</span></li></ul><p> </p><p><span style=\"font-size:12.0pt;\"><strong>Total Score = 2 + 2 + 1 + 1 + 2 = 8</strong></span></p><p> </p><p><span style=\"font-size:12.0pt;\">The correct <strong>Silverman-Anderson score</strong> for this infant would be <strong>8</strong>.</span></p><p> </p><p><span style=\"font-size:12.0pt;\"><strong>Educational Objective:</strong></span></p><p> </p><p><span style=\"font-size:12.0pt;\">The Silverman-Anderson score is used to assess the severity of respiratory distress in neonates, with a score of 8 indicating significant distress requiring close monitoring and possibly intervention.</span></p>",
      "correct_choice_id": 200382,
      "solution_audio": null,
      "solution_video": null,
      "audio_explanation_heading": null,
      "video_explanation_heading": null,
      "solution_media_position": "bottom",
      "tags": [],
      "explanation_video": null,
      "question_images": [],
      "explanation_images": []
    },
    {
      "id": 50096,
      "choices": [
        {
          "id": 200384,
          "text": "<p><span style=\"font-size:12.0pt;\">Negative pressure wound therapy</span></p>"
        },
        {
          "id": 200385,
          "text": "<p><span style=\"font-size:12.0pt;\">Positive pressure wound therapy</span></p>"
        },
        {
          "id": 200386,
          "text": "<p><span style=\"font-size:12.0pt;\">Foam therapy</span></p>"
        },
        {
          "id": 200387,
          "text": "<p><span style=\"font-size:12.0pt;\">Sponge therapy</span></p>"
        }
      ],
      "text": "<p><span style=\"font-size:12.0pt;\">A patient presents with a large, deep wound and the healthcare provider decides to use a specific wound-healing procedure. What is the principle behind the wound-healing procedure shown in the image below?</span><span style=\"font-size:11pt;\"> </span><span style=\"font-size:12.0pt;\">(AIIMS NOV 2019)</span></p><p> </p><p><span style=\"font-size:12.0pt;\"><img src=\"https://cerebellum-web-static.s3.amazonaws.com/media/public/images/2023/05/06/untitled-661.jpg\" alt=\"\" width=\"300\" height=\"229\"></span></p><p><img src=\"https://cerebellum-web-static.s3.amazonaws.com/media/public/images/2023/05/06/untitled-661.jpg\" alt=\"Question Image\"></p>",
      "unique_key": "Q1208632",
      "question_audio": null,
      "question_video": null,
      "map_id": 34787947,
      "difficulty_level": "intermediate",
      "subjects_id": [],
      "solution": "<p><span style=\"font-size:12.0pt;\"><strong>Ans. A) Negative pressure wound therapy</strong></span></p><p> </p><p><span style=\"font-size:12.0pt;\">Negative pressure wound therapy, also known as vacuum-assisted closure (VAC) therapy, involves the application of negative pressure to a wound using a sealed dressing connected to a vacuum pump.</span></p><p> </p><ul><li><span style=\"font-size:12.0pt;\">This therapy helps in wound healing by several mechanisms: it removes excess fluid and infectious materials from the wound, improves blood flow to the area, reduces edema (swelling), and promotes the formation of granulation tissue.</span></li><li><span style=\"font-size:12.0pt;\">It is often used for large, deep wounds, chronic wounds, and complex surgical wounds to accelerate the healing process.</span></li></ul><p> </p><p><span style=\"font-size:12.0pt;\"><strong>Educational Objective:  </strong></span></p><p> </p><p><span style=\"font-size:12.0pt;\">VAC therapy = vacuum assisted closure therapy</span></p><p> </p><ol><li><span style=\"font-size:12.0pt;\"><strong>Mechanism of action: </strong>VAC therapy involves the application of negative pressure (-125 mm of hg) to a wound to promote wound healing. The negative pressure removes excess fluid and promotes the formation of granulation tissue and new blood vessels.</span></li><li><span style=\"font-size:12.0pt;\"><strong>Indications: </strong>VAC therapy is commonly used for the management of complex wounds, such as diabetic foot ulcers, pressure ulcers, and surgical wounds. It can also be used to manage wounds with high risk of infection.</span></li><li><span style=\"font-size:12.0pt;\"><strong>Procedure: </strong>VAC therapy involves placing a foam dressing over the wound and covering it with an adhesive film. A tube is then inserted through the film and connected to a vacuum pump, which applies negative pressure to the wound. The pressure can be adjusted to provide the optimal level of tension for the specific wound.</span></li></ol>",
      "correct_choice_id": 200384,
      "solution_audio": null,
      "solution_video": null,
      "audio_explanation_heading": null,
      "video_explanation_heading": null,
      "solution_media_position": "bottom",
      "tags": [],
      "explanation_video": null,
      "question_images": [],
      "explanation_images": []
    },
    {
      "id": 50097,
      "choices": [
        {
          "id": 200388,
          "text": "<p><span style=\"font-size:12.0pt;\">4</span></p>"
        },
        {
          "id": 200389,
          "text": "<p><span style=\"font-size:12.0pt;\">3</span></p>"
        },
        {
          "id": 200390,
          "text": "<p><span style=\"font-size:12.0pt;\">2</span></p>"
        },
        {
          "id": 200391,
          "text": "<p><span style=\"font-size:12.0pt;\">1</span></p>"
        }
      ],
      "text": "<p><span style=\"font-size:12.0pt;\">Stage the bedsore in the following image: </span>(AIIMS NOV 2019)</p><p> </p><p><span style=\"font-size:12.0pt;\"><img src=\"https://cerebellum-web-static.s3.amazonaws.com/media/public/images/2023/05/06/untitled-662.jpg\" alt=\"\" width=\"300\" height=\"225\"></span></p><p><img src=\"https://cerebellum-web-static.s3.amazonaws.com/media/public/images/2023/05/06/untitled-662.jpg\" alt=\"Question Image\"></p>",
      "unique_key": "Q7840886",
      "question_audio": null,
      "question_video": null,
      "map_id": 34360180,
      "difficulty_level": "intermediate",
      "subjects_id": [],
      "solution": "<p><span style=\"font-size:12.0pt;\"><strong>Ans. A) 4</strong></span></p><p> </p><p><span style=\"font-size:12.0pt;\">The image depicts a Stage 4 pressure ulcer (bedsore), which is characterized by deep tissue loss that exposes underlying structures such as muscle, bone, or supporting tissues. Stage 4 is the most severe form of pressure ulcer, often showing significant tissue necrosis, deep crater formation, and the possibility of undermining or tunneling under the skin.</span></p><p> </p><p><span style=\"font-size:12.0pt;\"><img src=\"https://cerebellum-web-static.s3.amazonaws.com/media/public/images/2023/11/20/screenshot-2023-11-20-161307.png\" alt=\"\" width=\"1000\" height=\"596\"></span></p><p> </p><p><span style=\"font-size:12.0pt;\"><strong>Educational Objective</strong>: </span></p><p> </p><p><span style=\"font-size:12.0pt;\">Stage 4 pressure ulcers are characterized by full-thickness tissue loss with visible muscle, bone, or supporting structures, making them the most severe and challenging to manage.</span></p><p><img src=\"https://cerebellum-web-static.s3.amazonaws.com/media/public/images/2023/11/20/screenshot-2023-11-20-161307.png\" alt=\"Solution Image\"></p>",
      "correct_choice_id": 200388,
      "solution_audio": null,
      "solution_video": null,
      "audio_explanation_heading": null,
      "video_explanation_heading": null,
      "solution_media_position": "bottom",
      "tags": [],
      "explanation_video": null,
      "question_images": [],
      "explanation_images": []
    },
    {
      "id": 50098,
      "choices": [
        {
          "id": 200392,
          "text": "<p><span style=\"font-size:12.0pt;\">Serotonin and nor-adrenaline reuptake inhibition</span></p>"
        },
        {
          "id": 200393,
          "text": "<p><span style=\"font-size:12.0pt;\">Anticholinergic</span></p>"
        },
        {
          "id": 200394,
          "text": "<p><span style=\"font-size:12.0pt;\">Antihistaminic</span></p>"
        },
        {
          "id": 200395,
          "text": "<p><span style=\"font-size:12.0pt;\">Serotonin and dopamine reuptake inhibition</span></p>"
        }
      ],
      "text": "<p style=\"text-align:justify;\"><span style=\"color:#333333;font-size:12pt;\">Like all the opioids, tramadol acts as an analgesic drug by stimulating mu opioid receptors. Apart from this, the additional analgesic mechanism of tramadol is? (AIIMS NOV 2019)</span></p>",
      "unique_key": "Q7093716",
      "question_audio": null,
      "question_video": null,
      "map_id": 34990316,
      "difficulty_level": "intermediate",
      "subjects_id": [],
      "solution": "<p><span style=\"color:#333333;font-size:12pt;\"><strong>Ans. A. Serotonin and nor-adrenaline reuptake inhibition</strong></span></p><p> </p><p><span style=\"font-size:12pt;\">Tramadol is an atypical opioid analgesic that not only acts by stimulating mu opioid receptors, like other opioids, but also has an additional mechanism of action. This dual mechanism contributes to its analgesic effect.</span></p><p> </p><ul><li><span style=\"font-size:12pt;\"><strong>Mu Opioid Receptor Agonism</strong>: Tramadol binds to mu opioid receptors, which are part of the body's endogenous pain relief system. Activation of these receptors leads to pain relief.</span></li><li><span style=\"font-size:12pt;\"><strong>Serotonin and Noradrenaline Reuptake Inhibition</strong>: Unlike typical opioids, tramadol also inhibits the reuptake of serotonin (5-HT) and noradrenaline (NA). This increases the levels of these neurotransmitters in the synaptic cleft, enhancing their action. This mechanism activates the monoaminergic descending inhibitory pathways in the spinal cord, which further contributes to pain relief.</span></li></ul><p> </p><p><span style=\"font-size:12pt;\">Due to its unique mechanism, tramadol's analgesic action is only partially reversed by naloxone, an opioid antagonist, indicating that non-opioid mechanisms also play a significant role in its pain-relieving effects.</span></p><p> </p><p><span style=\"font-size:12.0pt;\"><strong>Other Options:</strong></span></p><p> </p><p><span style=\"font-size:12pt;\"><strong>Option B. Anticholinergic: </strong>Tramadol does not have anticholinergic properties. Anticholinergic drugs block the action of acetylcholine in the brain and are not related to the analgesic mechanism of tramadol.</span></p><p> </p><p><span style=\"font-size:12pt;\"><strong>Option C. Antihistaminic: </strong>Tramadol does not act as an antihistamine. Antihistamines are used primarily to treat allergic reactions and have no significant role in pain relief through histamine receptor antagonism.</span></p><p> </p><p><span style=\"font-size:12pt;\"><strong>Option D. Serotonin and dopamine reuptake inhibition: </strong>While tramadol does inhibit serotonin reuptake, it does not inhibit dopamine reuptake significantly. Its main additional mechanism of analgesia is through the inhibition of serotonin and noradrenaline reuptake.</span></p><p> </p><p><span style=\"font-size:12pt;\"><strong>Educational Objective:</strong></span></p><p> </p><p><span style=\"font-size:12pt;\">Tramadol provides pain relief not only through mu opioid receptor agonism but also by inhibiting the reuptake of serotonin and noradrenaline, thereby activating the descending inhibitory pain pathways in the spinal cord.</span></p><p> </p><p><span style=\"color:#333333;font-size:12pt;\"><strong>Reference: KDT 8th/504</strong></span></p>",
      "correct_choice_id": 200392,
      "solution_audio": null,
      "solution_video": null,
      "audio_explanation_heading": null,
      "video_explanation_heading": null,
      "solution_media_position": "bottom",
      "tags": [],
      "explanation_video": null,
      "question_images": [],
      "explanation_images": []
    },
    {
      "id": 50099,
      "choices": [
        {
          "id": 200396,
          "text": "<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\">Residual from barrel of gun</span></span></span></p>"
        },
        {
          "id": 200397,
          "text": "<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\">Blackening</span></span></span></p>"
        },
        {
          "id": 200398,
          "text": "<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\">Gutter fracture of skull</span></span></span></p>"
        },
        {
          "id": 200399,
          "text": "<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\">Tattooing</span></span></span></p>"
        }
      ],
      "text": "<p><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\"><span style=\"font-family:\"Calibri\",sans-serif\">What is bullet wipe? (</span></span>AIIMS Nov 2019)</p>",
      "unique_key": "Q2908196",
      "question_audio": null,
      "question_video": null,
      "map_id": 34001950,
      "difficulty_level": "intermediate",
      "subjects_id": [],
      "solution": "<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\">Ans. A. Residual from barrel of gun</span></strong> </span></span></p>\r\n\r\n<p> </p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\">Explanation:</span></strong> </span></span></p>\r\n\r\n<p> </p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\">A \"bullet wipe\" is a gray or black ring around an entrance bullet hole. The ring is formed by bullet lubricant, byproducts of propellant, traces of bullet metal, and residue in the gun barrel from previous use. It is caused due to residue from barrel of the gun. </span></span></span></p>\r\n\r\n<p> </p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><u><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\">Other options </span></u></strong></span></span></p>\r\n\r\n<p> </p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\">Option B) Blackening: </span></strong><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\">It occurs due to combustion (smoke) produced by burning of gun powder when a firearm is fired. </span></span></span></p>\r\n\r\n<p> </p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\">Option C) Gutter fracture of skull: </span></strong><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\">It occurs due to a bullet passing adjacent to the skull</span></span></span></p>\r\n\r\n<p> </p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\">Option D) Tattooing: </span></strong><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\">It occurs due to unburnt gun powder particles which gets deposited around the firearm wound.</span></span></span></p>\r\n\r\n<p> </p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><u><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\">Educational Objective </span></u></strong></span></span></p>\r\n\r\n<p> </p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\">Bullet Wipe (Grease/Dirt Collar)</span></strong></span></span></p>\r\n\r\n<p> </p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\">• Black/gray ring around gunshot wound.</span></span></span></p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\">• Composition includes bullet lubrication, paraffin, lead, barrel debris, and gun oil.</span></span></span></p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\">• Wider side of the ring indicates the direction of fire.</span></span></span></p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\">• More noticeable in shots from freshly oiled weapons.</span></span></span></p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\">• It  is dark in the center, fading towards the periphery.</span></span></span></p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\">• Prominent in clothing, termed as ‘bullet wipe.’</span></span></span></p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\">• It serve as proof of an entry wound in forensic analysis.</span></span></span></p>",
      "correct_choice_id": 200396,
      "solution_audio": null,
      "solution_video": null,
      "audio_explanation_heading": null,
      "video_explanation_heading": null,
      "solution_media_position": "bottom",
      "tags": [],
      "explanation_video": null,
      "question_images": [],
      "explanation_images": []
    },
    {
      "id": 50100,
      "choices": [
        {
          "id": 200400,
          "text": "<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\">Heroin</span></span></span></p>"
        },
        {
          "id": 200401,
          "text": "<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\">Morphine</span></span></span></p>"
        },
        {
          "id": 200402,
          "text": "<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\">Malathion</span></span></span></p>"
        },
        {
          "id": 200403,
          "text": "<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\">Belladona</span></span></span></p>"
        }
      ],
      "text": "<p style=\"text-align:justify\"><span style=\"font-size:12.0pt\"><span style=\"font-family:\"Calibri\",sans-serif\">A 28-year-old male arrives in the emergency department after being exposed to an unidentified toxic substance given to him by a friend. His symptoms include dry mouth, urinary retention, and constipation. During the examination, his pulse rate is recorded at 140 beats per minute, and his pupils are observed to be dilated. Which substance is the most likely cause of these symptoms? (</span></span>AIIMS Nov 2019)</p>",
      "unique_key": "Q6755749",
      "question_audio": null,
      "question_video": null,
      "map_id": 34366317,
      "difficulty_level": "intermediate",
      "subjects_id": [],
      "solution": "<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\">Ans. D. Belladona</span></strong> </span></span></p>\r\n\r\n<p> </p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\">The symptoms described, including dry mouth, urinary retention, constipation, increased heart rate, and dilated pupils, are consistent with anticholinergic toxicity. Belladonna, contains tropane alkaloids with anticholinergic effects. Features of belladonna are same as that of Datura, and both belong to Solanaceae family.</span></span></span></p>\r\n\r\n<p> </p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\">Other options </span></strong></span></span></p>\r\n\r\n<p> </p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\">Option A) Heroin: </span></strong><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\">It is an Opioid (CNS depressant) and have symptoms such as sedation, coma, decreased vitas (respiratory depression, low BP, low Heart rate, low temperature), and miosis. Whereas in the question there is high pulse rate, and dilated pupils. </span></span></span></p>\r\n\r\n<p> </p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\">Option B) Morphine: </span></strong><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\">is also an Opioid, and will have similar features as that of heroin. </span></span></span></p>\r\n\r\n<p> </p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\">Option C) Malathion: </span></strong><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\">is an organophosphate insecticide. It will have cholinergic symptoms, like <strong>D</strong>iarrhea, <strong>u</strong>rination excessive, <strong>m</strong>iosis, <strong>b</strong>radycardia, <strong>e</strong>mesis, <strong>l</strong>achrymation, and <strong>s</strong>alivation (Mnemonic DUMBELS). These are exactly opposite of those mentioned in question.</span></span></span></p>\r\n\r\n<p> </p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\">Educational Objective</span></strong></span></span></p>\r\n\r\n<p> </p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span style=\"font-size:12.0pt\">Atropa Belladona</span></strong></span></span></p>\r\n\r\n<p> </p>\r\n\r\n<ul>\r\n\t<li style=\"text-align:justify\"><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span style=\"font-size:12.0pt\">Solanaceae family: </span></strong><span style=\"font-size:12.0pt\">Datura stramonium, Atropa belladonna (deadly nightshade) and Hyoscyamus Niger (henbane) all belong to same family Solanaceae </span></span></span></li>\r\n\t<li style=\"text-align:justify\"><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span style=\"font-size:12.0pt\">Anticholinergic alkaloids: </span></strong><span style=\"font-size:12.0pt\">All of these plants have similar alkaloids, and all of these alkaloids have anticholinergic properties. </span></span></span></li>\r\n\t<li style=\"text-align:justify\"><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span style=\"font-size:12.0pt\"><strong>Active Principles: </strong>Examples of important active principles found in these alkaloids are </span><span style=\"font-size:12.0pt\">Atropine, Hyoscine (scopolamine), Hyoscyamine.</span></span></span></li>\r\n</ul>\r\n\r\n<ul>\r\n\t<li style=\"text-align:justify\"><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span style=\"font-size:12.0pt\">Sign and symptoms: </span></strong><span style=\"font-size:12.0pt\">All of these have similar anticholinergic sign and symptoms. So, Atropa belladonna will also have features same as that of Datura: </span><span style=\"font-size:12.0pt\">Dry hot skin, Dilatated pupils, Diplopia, Dry mouth, Decreased Body Secretions, Dysphagia, Dysarthria, Drunken gait, Delirium</span></span></span></li>\r\n</ul>\r\n\r\n<ul>\r\n\t<li style=\"text-align:justify\"><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span style=\"font-size:12.0pt\">Treatment is Physostigmine</span></span></span></li>\r\n\t<li style=\"text-align:justify\"><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span style=\"font-size:12.0pt\">Atropa Belladona have black berries as shown below:</span></strong></span></span></li>\r\n</ul>\r\n\r\n<p style=\"text-align:justify\"> </p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span style=\"font-size:12.0pt\"><img alt=\"\" src=\"https://cerebellum-web-static.s3.amazonaws.com/media/public/images/2024/06/11/screenshot-2024-06-11-174955.png\" style=\"height:267px; width:400px\" /></span></strong></span></span></p><p><img src=\"https://cerebellum-web-static.s3.amazonaws.com/media/public/images/2024/06/11/screenshot-2024-06-11-174955.png\" alt=\"Solution Image\"></p>",
      "correct_choice_id": 200403,
      "solution_audio": null,
      "solution_video": null,
      "audio_explanation_heading": null,
      "video_explanation_heading": null,
      "solution_media_position": "bottom",
      "tags": [],
      "explanation_video": null,
      "question_images": [],
      "explanation_images": []
    },
    {
      "id": 50101,
      "choices": [
        {
          "id": 200404,
          "text": "<p><span style=\"font-size:12.0pt;\">Poly A tail</span></p>"
        },
        {
          "id": 200405,
          "text": "<p><span style=\"font-size:12.0pt;\">tRNA</span></p>"
        },
        {
          "id": 200406,
          "text": "<p><span style=\"font-size:12.0pt;\">Guanyl Cap</span></p>"
        },
        {
          "id": 200407,
          "text": "<p><span style=\"font-size:12.0pt;\">Shine-Dalgarno Sequence</span></p>"
        }
      ],
      "text": "<p><span style=\"font-size:12.0pt;\">The attachment of Eukaryotic mRNA to the ribosome is mediated through?</span></p>",
      "unique_key": "Q9800970",
      "question_audio": null,
      "question_video": null,
      "map_id": 34670348,
      "difficulty_level": "intermediate",
      "subjects_id": [],
      "solution": "<p><span style=\"font-size:12.0pt;\"><strong>Ans. C) Guanyl cap</strong></span></p><p> </p><p><span style=\"font-size:12.0pt;\">In eukaryotic cells, the attachment of mRNA to the ribosome is facilitated by the presence of a 5' cap structure, specifically an N7-methylguanosine (m7G) cap, also known as the guanyl cap. This cap is essential for several functions, including the initiation of translation.</span></p><p> </p><p><span style=\"font-size:12.0pt;\"><strong>Functions of the Guanyl Cap:</strong></span></p><p> </p><ol><li><span style=\"font-size:12.0pt;\"><strong>Initiation of Translation:</strong> The 5' cap is recognized by the eukaryotic initiation factors (eIFs), particularly eIF4E, which is a part of the eIF4F complex. This recognition is crucial for the recruitment of the ribosome to the mRNA.</span></li><li><span style=\"font-size:12.0pt;\"><strong>Protection:</strong> The cap structure protects the mRNA from degradation by 5' to 3' exonucleases.</span></li><li><span style=\"font-size:12.0pt;\"><strong>Splicing and Export:</strong> The cap structure also plays roles in pre-mRNA splicing, polyadenylation, and the export of mRNA from the nucleus to the cytoplasm.</span></li></ol><p> </p><p><span style=\"font-size:12.0pt;\"><strong>Other Options:</strong></span></p><p> </p><p><span style=\"font-size:12pt;\"><strong>Option A.</strong> </span><span style=\"font-size:12.0pt;\"><strong>Poly A tail:</strong> The polyadenylation (poly A tail) at the 3' end of mRNA enhances stability and facilitates the export of mRNA from the nucleus. It also aids in the regulation of translation but does not directly mediate ribosome attachment.</span></p><p> </p><p><span style=\"font-size:12pt;\"><strong>Option B.</strong> </span><span style=\"font-size:12.0pt;\"><strong>tRNA:</strong> Transfer RNA (tRNA) is involved in the translation process by bringing amino acids to the ribosome during protein synthesis, but it does not mediate the attachment of mRNA to the ribosome.</span></p><p> </p><p><span style=\"font-size:12pt;\"><strong>Option D.</strong> </span><span style=\"font-size:12.0pt;\"><strong>Shine-Dalgarno Sequence:</strong> The Shine-Dalgarno sequence is a ribosomal binding site found in prokaryotic mRNA. It helps in the alignment of the ribosome with the start codon, but it is not present in eukaryotic mRNA.</span></p><p> </p><p><span style=\"font-size:12.0pt;\"><strong>Educational Objective:</strong></span></p><p><span style=\"font-size:10.5pt;\"><strong> </strong></span></p><p><span style=\"font-size:12.0pt;\">The attachment of eukaryotic mRNA to the ribosome is mediated through the 5' guanyl cap, which plays a crucial role in the initiation of translation, protection of mRNA, and its processing and export from the nucleus.</span></p>",
      "correct_choice_id": 200406,
      "solution_audio": null,
      "solution_video": null,
      "audio_explanation_heading": null,
      "video_explanation_heading": null,
      "solution_media_position": "bottom",
      "tags": [],
      "explanation_video": null,
      "question_images": [],
      "explanation_images": []
    },
    {
      "id": 50102,
      "choices": [
        {
          "id": 200408,
          "text": "<p><span style=\"font-size:12.0pt;\">1:10000 I.V. - 10 ml</span></p>"
        },
        {
          "id": 200409,
          "text": "<p><span style=\"font-size:12.0pt;\">1:1000 I.M. - 0.5 ml</span></p>"
        },
        {
          "id": 200410,
          "text": "<p><span style=\"font-size:12.0pt;\">1:1000 I.M. - 1 ml</span></p>"
        },
        {
          "id": 200411,
          "text": "<p><span style=\"font-size:12.0pt;\">1:1000 I.V. - 0.5 ml</span></p>"
        }
      ],
      "text": "<p style=\"text-align:justify;\"><span style=\"font-size:12.0pt;\">What dose of epinephrine is used in anaphylactic shock? (AIIMS NOV 2019)</span></p>",
      "unique_key": "Q6455419",
      "question_audio": null,
      "question_video": null,
      "map_id": 34027184,
      "difficulty_level": "intermediate",
      "subjects_id": [],
      "solution": "<p><span style=\"font-size:12.0pt;\"><strong>Ans. B. 1:1000 I.M. - 0.5 ml</strong></span></p><p> </p><p><span style=\"font-size:12.0pt;\">Epinephrine (1:1000 solution) 0.5 ml via intramuscular route is preferred in the treatment of anaphylactic shock.</span></p><p> </p><p><span style=\"font-size:12.0pt;\"><strong>Educational Objective:</strong></span></p><p> </p><p><span style=\"font-size:12.0pt;\"><img src=\"https://cerebellum-web-static.s3.amazonaws.com/media/public/images/2023/12/20/screenshot-2023-12-20-103204.jpg\" alt=\"\" width=\"1000\" height=\"398\"></span></p><p><img src=\"https://cerebellum-web-static.s3.amazonaws.com/media/public/images/2023/12/20/screenshot-2023-12-20-103204.jpg\" alt=\"Solution Image\"></p>",
      "correct_choice_id": 200409,
      "solution_audio": null,
      "solution_video": null,
      "audio_explanation_heading": null,
      "video_explanation_heading": null,
      "solution_media_position": "bottom",
      "tags": [],
      "explanation_video": null,
      "question_images": [],
      "explanation_images": []
    },
    {
      "id": 50103,
      "choices": [
        {
          "id": 200412,
          "text": "<p><span style=\"font-size:12.0pt;\">The first step in the management of PPH is the uterine massage</span></p>"
        },
        {
          "id": 200413,
          "text": "<p><span style=\"font-size:12.0pt;\">IV methyl ergometrine is routinely administered for all patients</span></p>"
        },
        {
          "id": 200414,
          "text": "<p><span style=\"font-size:12.0pt;\">The B-Lynch suture is done if all medical methods fail</span></p>"
        },
        {
          "id": 200415,
          "text": "<p><span style=\"font-size:12.0pt;\">Manual removal of the placenta is done if there are retained products</span></p>"
        }
      ],
      "text": "<p><span style=\"font-size:16px;\">Which of the following statements is incorrect regarding the management of Atonic Postpartum Hemorrhage (PPH)?</span></p>",
      "unique_key": "Q5120778",
      "question_audio": null,
      "question_video": null,
      "map_id": 34221258,
      "difficulty_level": "intermediate",
      "subjects_id": [],
      "solution": "<p><span style=\"font-size:16px;\"><strong>Ans. B) IV methyl ergometrine is routinely administered for all patients</strong></span></p><p><br><span style=\"font-size:16px;\">The use of <strong>IV methyl ergometrine</strong> is not routine for all patients with PPH. If oxytocin, the preferred first-line medication, is unavailable or if bleeding persists despite oxytocin administration, ergometrine or a fixed-dose combination of oxytocin-ergometrine can be offered as a second-line treatment. Routine management prioritizes oxytocin over ergometrine alone or other combinations due to its effectiveness and safety profile.</span></p><p> </p><p><span style=\"font-size:16px;\"><strong>Other Options:</strong></span></p><p> </p><p><span style=\"font-size:16px;\"><strong>Option A. The first step in the management of PPH is the uterine massage:</strong> This statement is correct. Uterine massage is indeed the initial step in managing PPH as it stimulates uterine contraction, which helps control bleeding.</span></p><p> </p><p><span style=\"font-size:16px;\"><strong>Option C. The B-Lynch suture is done if all medical methods fail:</strong> This is also correct. The B-Lynch suture is a surgical technique used to control hemorrhage when medical management is insufficient. It involves placing vertical brace sutures that compress the uterine walls, thereby reducing bleeding.</span></p><p> </p><p><span style=\"font-size:16px;\"><strong>Option D. Manual removal of the placenta is done if there are retained products:</strong> This statement is correct as well. When there are retained placental products, manual removal is necessary. The procedure involves one hand stabilizing the fundus and the other hand sweeping side to side within the uterine cavity until the placenta detaches and can be removed.</span></p><p> </p><p><span style=\"font-size:16px;\"><strong>Educational Objective:</strong></span></p><p> </p><p><span style=\"font-size:16px;\">IV methyl ergometrine is not routinely used in all patients for PPH management; oxytocin is preferred as the first-line treatment.</span></p>",
      "correct_choice_id": 200413,
      "solution_audio": null,
      "solution_video": null,
      "audio_explanation_heading": null,
      "video_explanation_heading": null,
      "solution_media_position": "bottom",
      "tags": [],
      "explanation_video": null,
      "question_images": [],
      "explanation_images": []
    },
    {
      "id": 50104,
      "choices": [
        {
          "id": 200416,
          "text": "<p><span style=\"font-size:12.0pt;\">1-2%</span></p>"
        },
        {
          "id": 200417,
          "text": "<p><span style=\"font-size:12.0pt;\">3%</span></p>"
        },
        {
          "id": 200418,
          "text": "<p><span style=\"font-size:12.0pt;\">13-20%</span></p>"
        },
        {
          "id": 200419,
          "text": "<p><span style=\"font-size:12.0pt;\">20-30%</span></p>"
        }
      ],
      "text": "<p><span style=\"font-size:12.0pt;\">A 45-year-old female patient undergoes surgery for a clean-contaminated wound after receiving prophylactic antibiotics. What is the expected rate of surgical site infection in this patient?</span> <span style=\"font-size:12.0pt;\">(AIIMS NOV 2019)</span></p>",
      "unique_key": "Q5157571",
      "question_audio": null,
      "question_video": null,
      "map_id": 34760458,
      "difficulty_level": "intermediate",
      "subjects_id": [],
      "solution": "<p><span style=\"font-size:12.0pt;\"><strong>Ans. B) 3%</strong></span></p><p> </p><p><span style=\"font-size:12.0pt;\">After the administration of prophylactic antibiotics, the anticipated rate of surgical site infection in a patient with a clean contaminated wound is 3%.</span></p><p> </p><p><span style=\"font-size:12.0pt;\">This is a reasonable estimate for the expected rate of SSI in clean-contaminated surgical wounds. These wounds have a controlled level of contamination, and prophylactic antibiotics are given to reduce the risk of infection.</span></p><p> </p><p><span style=\"font-size:12.0pt;\"><strong>Other Options:</strong></span></p><p> </p><p><span style=\"font-size:12pt;\"><strong>Option</strong> </span><span style=\"font-size:12.0pt;\"><strong>A. 1-2%</strong>: This range represents a lower infection rate, which is more commonly associated with surgeries in clean wounds.</span></p><p> </p><p><span style=\"font-size:12.0pt;\"><strong>Option C. 13-20%</strong>: This range is much higher and is more typical for surgeries in contaminated or dirty wounds, where the risk of infection is significantly elevated.</span></p><p> </p><p><span style=\"font-size:12pt;\"><strong>Option</strong> </span><span style=\"font-size:12.0pt;\"><strong>D. 20-30%</strong>: This range represents a very high infection rate and is more characteristic of surgeries performed in dirty or heavily contaminated wounds. It would be unusual to expect such a high infection rate in a clean-contaminated surgical case with prophylactic antibiotics.</span></p><p> </p><p><span style=\"font-size:12.0pt;\"><strong>Educational Objective:</strong></span></p><p> </p><p><span style=\"font-size:12.0pt;\">A surgical site infection (SSI) is an infection that occurs at or near a surgical incision or operative site after surgery. SSIs can range from mild to severe and can affect the skin and underlying tissues, including muscles and organs. These infections are a common complication of surgery and can lead to various health problems if not treated promptly.</span></p><p> </p><p><span style=\"font-size:12.0pt;\">Key characteristics and considerations related to surgical site infections (SSIs) include:</span></p><p> </p><ol><li><span style=\"font-size:12.0pt;\"><strong>Classification:</strong></span><ul style=\"list-style-type:disc;\"><li><span style=\"font-size:12.0pt;\">SSIs are classified into three main categories based on the timing of onset:</span></li><li><span style=\"font-size:12.0pt;\">Superficial Incisional SSI: Infection occurs within 30 days after the operation and involves only the skin and subcutaneous tissues at the incision site.</span></li><li><span style=\"font-size:12.0pt;\">Deep Incisional SSI: Infection also occurs within 30 days after the operation but involves deeper tissues, such as muscles and fascia, at the incision site.</span></li><li><span style=\"font-size:12.0pt;\">Organ/Space SSI: Infection can occur within 30 or 90 days after the operation and affects any part of the body other than the incision area. This can include infections within the abdominal or chest cavities.</span><br> </li></ul></li><li><span style=\"font-size:12.0pt;\"><strong>Signs and Symptoms:</strong></span><ul style=\"list-style-type:disc;\"><li><span style=\"font-size:12.0pt;\">The symptoms of an SSI may include redness, warmth, swelling, pain, and discharge at or near the surgical site.</span></li><li><span style=\"font-size:12.0pt;\">Systemic symptoms like fever, chills, and malaise can also occur if the infection is severe or has spread.</span><br> </li></ul></li><li><span style=\"font-size:12.0pt;\"><strong>Prevention:</strong></span><ul style=\"list-style-type:disc;\"><li><span style=\"font-size:12.0pt;\">Preventive measures are crucial in reducing the risk of SSIs. These measures include:</span><ul style=\"list-style-type:disc;\"><li><span style=\"font-size:12.0pt;\">Preoperative antibiotic prophylaxis</span></li><li><span style=\"font-size:12.0pt;\">Proper hand hygiene and sterile techniques during surgery</span></li><li><span style=\"font-size:12.0pt;\">Maintaining a clean surgical environment</span></li><li><span style=\"font-size:12.0pt;\">Adequate skin preparation before incision</span></li><li><span style=\"font-size:12.0pt;\">Proper wound care and postoperative monitoring</span><br> </li></ul></li></ul></li><li><span style=\"font-size:12.0pt;\"><strong>Treatment:</strong></span><ul style=\"list-style-type:disc;\"><li><span style=\"font-size:12.0pt;\">Treatment of an SSI typically involves antibiotics to target the specific bacteria causing the infection.</span></li><li><span style=\"font-size:12.0pt;\">In some cases, additional interventions may be necessary, such as wound drainage, debridement (removal of infected tissue), or, rarely, reoperation.</span><br> </li></ul></li><li><span style=\"font-size:12.0pt;\"><strong>Complications:</strong></span><ul style=\"list-style-type:disc;\"><li><span style=\"font-size:12.0pt;\">If left untreated or not managed appropriately, SSIs can lead to more serious complications, such as abscess formation, cellulitis, tissue necrosis, and the spread of infection to other parts of the body.</span></li></ul></li></ol><p> </p><p><span style=\"font-size:12.0pt;\"><img src=\"https://cerebellum-web-static.s3.amazonaws.com/media/public/images/2023/11/20/screenshot-2023-11-20-154011.png\" alt=\"\" width=\"1000\" height=\"526\"></span></p><p><img src=\"https://cerebellum-web-static.s3.amazonaws.com/media/public/images/2023/11/20/screenshot-2023-11-20-154011.png\" alt=\"Solution Image\"></p>",
      "correct_choice_id": 200417,
      "solution_audio": null,
      "solution_video": null,
      "audio_explanation_heading": null,
      "video_explanation_heading": null,
      "solution_media_position": "bottom",
      "tags": [],
      "explanation_video": null,
      "question_images": [],
      "explanation_images": []
    },
    {
      "id": 50105,
      "choices": [
        {
          "id": 200420,
          "text": "<p>2</p>"
        },
        {
          "id": 200421,
          "text": "<p>3</p>"
        },
        {
          "id": 200422,
          "text": "<p>4</p>"
        },
        {
          "id": 200423,
          "text": "<p>5</p>"
        }
      ],
      "text": "<p style=\"text-align:justify;\"><span style=\"font-size:12.0pt;\">A patient says that he feels that there is something wrong with him mentally and it is because of the summer season. How much would he score on the insight scale? (</span>AIIMS Nov 2019)</p>",
      "unique_key": "Q8186558",
      "question_audio": null,
      "question_video": null,
      "map_id": 34868857,
      "difficulty_level": "intermediate",
      "subjects_id": [],
      "solution": "<p><span style=\"font-size:12.0pt;\"><strong>Ans. B) 3</strong></span></p><p> </p><p><span style=\"font-size:12.0pt;\">The insight scale is graded from 1 to 5. In this scenario, the patient recognizes that there's something wrong with him mentally, which signifies some level of insight. However, he attributes it to the summer season, an external factor. This corresponds to a score of 3, which is recognition of a mental illness but blaming it on external causes.</span></p><p> </p><p><span style=\"font-size:12.0pt;\"><strong>Educational Objective: </strong></span></p><p> </p><p><span style=\"font-size:12.0pt;\">Insight is graded from 1 to 5.</span></p><p> </p><p><img src=\"https://cerebellum-web-static.s3.amazonaws.com/media/public/Screenshot%202024-11-12%20155759.jpg\" width=\"1085\" height=\"715\"></p><p> </p><p><span style=\"color:#374151;font-size:12.0pt;\"><strong>Reference: Kaplan & Sadock’s Comprehensive Textbook of Psychiatry, 10th edition, Page No 967.</strong></span></p><p><img src=\"https://cerebellum-web-static.s3.amazonaws.com/media/public/Screenshot%202024-11-12%20155759.jpg\" alt=\"Solution Image\"></p>",
      "correct_choice_id": 200421,
      "solution_audio": null,
      "solution_video": null,
      "audio_explanation_heading": null,
      "video_explanation_heading": null,
      "solution_media_position": "bottom",
      "tags": [],
      "explanation_video": null,
      "question_images": [],
      "explanation_images": []
    },
    {
      "id": 50106,
      "choices": [
        {
          "id": 200424,
          "text": "<p><span style=\"font-size:12.0pt;\">VIA</span></p>"
        },
        {
          "id": 200425,
          "text": "<p><span style=\"font-size:12.0pt;\">VILI</span></p>"
        },
        {
          "id": 200426,
          "text": "<p><span style=\"font-size:12.0pt;\">PAP smear</span></p>"
        },
        {
          "id": 200427,
          "text": "<p><span style=\"font-size:12.0pt;\">Colposcopy</span></p>"
        }
      ],
      "text": "<p><span style=\"font-size:12.0pt;\">The instrument shown in the image is used for which of the following procedures? </span></p><p> </p><p><span style=\"font-size:12.0pt;\"><img src=\"https://cerebellum-web-static.s3.amazonaws.com/media/public/Screenshot%202024-11-12%20123118.jpg\" width=\"447\" height=\"340\"></span></p><p><img src=\"https://cerebellum-web-static.s3.amazonaws.com/media/public/Screenshot%202024-11-12%20123118.jpg\" alt=\"Question Image\"></p>",
      "unique_key": "Q6330806",
      "question_audio": null,
      "question_video": null,
      "map_id": 34150807,
      "difficulty_level": "intermediate",
      "subjects_id": [],
      "solution": "<p><span style=\"font-size:12.0pt;\"><strong>Ans. C) PAP smear</strong></span></p><p><br><span style=\"font-size:12.0pt;\">The instrument shown in the image is an Ayre's spatula, which is used in the preparation of a PAP smear. The PAP smear, or Papanicolaou test, is a screening method for detecting precancerous or cancerous changes in the cervical cells.</span></p><p> </p><p><span style=\"font-size:12.0pt;\">During the procedure, the Ayre's spatula is used to scrape cells from the squamocolumnar junction of the cervix by rotating it around the cervix. The collected cells are then spread onto a glass slide and fixed in a solution of 95% ethyl alcohol and ether. After 30 minutes, the slide is air-dried and stained using the Pap stain or a quick stain method, making the cells visible under a microscope for examination.</span></p><p> </p><p><span style=\"font-size:12.0pt;\"><strong>Prerequisites for PAP smear testing:</strong></span></p><p> </p><ul style=\"list-style-type:disc;\"><li><span style=\"font-size:12.0pt;\">Performed before any vaginal examination.</span></li><li><span style=\"font-size:12.0pt;\">Avoid using lubricants.</span></li><li><span style=\"font-size:12.0pt;\">Should not be conducted during menstruation; ideally done around ovulation.</span></li><li><span style=\"font-size:12.0pt;\">The patient should refrain from intercourse 24 hours before the test.</span></li></ul><p> </p><p><span style=\"font-size:12.0pt;\"><strong>Screening Guidelines for PAP Smear:</strong></span></p><p> </p><ul style=\"list-style-type:disc;\"><li><span style=\"font-size:12.0pt;\"><strong>Initiation:</strong> Screening should begin at 21 years of age, regardless of the first sexual intercourse.</span></li><li><span style=\"font-size:12.0pt;\"><strong>Ages 21-29:</strong> PAP test every 3 years.</span></li><li><span style=\"font-size:12.0pt;\"><strong>Ages 30-65:</strong> Co-testing with PAP and HPV every 5 years or PAP alone every 3 years.</span></li><li><span style=\"font-size:12.0pt;\"><strong>Over 65:</strong> Screening can be stopped unless there is a history of abnormal PAP, which may require extended screening up to 75 years.</span></li><li><span style=\"font-size:12.0pt;\"><strong>HIV+ Women:</strong> Annual screening until three consecutive negative results, then every 3 years for life.</span></li></ul><p> </p><p><span style=\"font-size:12.0pt;\"><strong>Other Options:</strong></span></p><p> </p><p><span style=\"font-size:12.0pt;\"><strong>Option A. VIA (Visual Inspection with Acetic Acid):</strong> VIA is a cervical screening test where acetic acid is applied to the cervix, causing precancerous areas to turn white. No Ayre's spatula is required for this test.</span></p><p> </p><p><span style=\"font-size:12.0pt;\"><strong>Option B. VILI (Visual Inspection with Lugol’s Iodine):</strong> VILI uses Lugol’s iodine for cervical screening. Iodine turns healthy cells brown, while abnormal areas remain unstained. This does not require the use of Ayre's spatula.</span></p><p> </p><p><span style=\"font-size:12.0pt;\"><strong>Option D. Colposcopy:</strong> This is a diagnostic procedure where a colposcope (a magnifying device) is used to closely examine the cervix for abnormalities. The Ayre’s spatula is not used in colposcopy.</span></p><p> </p><p><span style=\"font-size:12.0pt;\"><strong>Educational Objective:</strong></span></p><p><br><span style=\"font-size:12.0pt;\">Ayre’s spatula is a key tool used in PAP smear tests, which is a primary screening method for cervical cancer.</span></p>",
      "correct_choice_id": 200426,
      "solution_audio": null,
      "solution_video": null,
      "audio_explanation_heading": null,
      "video_explanation_heading": null,
      "solution_media_position": "bottom",
      "tags": [],
      "explanation_video": null,
      "question_images": [],
      "explanation_images": []
    },
    {
      "id": 50107,
      "choices": [
        {
          "id": 200428,
          "text": "<p><span style=\"font-size:12.0pt;\">Platelet transfusion</span></p>"
        },
        {
          "id": 200429,
          "text": "<p><span style=\"font-size:12.0pt;\">Arrange PRBC</span></p>"
        },
        {
          "id": 200430,
          "text": "<p><span style=\"font-size:12.0pt;\">IV Octreotide</span></p>"
        },
        {
          "id": 200431,
          "text": "<p><span style=\"font-size:12.0pt;\">Urgent Endoscopy</span></p>"
        }
      ],
      "text": "<p><span style=\"font-size:12.0pt;\">A 45-year-old male patient with a history of liver cirrhosis presents to the emergency room with active variceal bleeding. Which of the following interventions is not typically performed in this situation?</span><span style=\"font-size:11pt;\"> </span><span style=\"font-size:12.0pt;\">(AIIMS NOV 2019)</span></p>",
      "unique_key": "Q3168663",
      "question_audio": null,
      "question_video": null,
      "map_id": 34149570,
      "difficulty_level": "intermediate",
      "subjects_id": [],
      "solution": "<p><span style=\"font-size:12.0pt;\"><strong>Ans. A) Platelet transfusion</strong></span></p><p> </p><ul><li><span style=\"font-size:12.0pt;\">Platelet transfusion is not typically performed as an immediate intervention for variceal bleeding. Platelets are responsible for blood clotting, but variceal bleeding is primarily caused by the rupture of dilated blood vessels (varices) in the esophagus or stomach, which is related to portal hypertension.</span></li><li><span style=\"font-size:12.0pt;\">Platelet transfusions are usually considered when a patient with liver cirrhosis has significant thrombocytopenia (low platelet count) or when there is an underlying bleeding disorder. However, they are not the primary treatment for variceal bleeding.</span></li></ul><p> </p><p><span style=\"font-size:12.0pt;\"><strong>Other Options:</strong></span></p><p> </p><p><span style=\"font-size:12pt;\"><strong>Option B.</strong> </span><span style=\"font-size:12.0pt;\"><strong>Arrange PRBC (packed red blood cell) transfusion</strong>: PRBC transfusion is often necessary to replace lost blood and stabilize the patient's hemodynamic status. Active variceal bleeding can lead to significant blood loss, and transfusion of red blood cells is a crucial part of resuscitation.</span></p><p> </p><p><span style=\"font-size:12.0pt;\"><strong>Option C. IV Octreotide</strong>: IV Octreotide is commonly administered in cases of active variceal bleeding. Octreotide is a medication that helps reduce portal pressure by constricting blood vessels, including those in the varices. This can help control the bleeding until more definitive treatment, such as endoscopy or interventional radiology procedures, can be performed.</span></p><p> </p><p><span style=\"font-size:12.0pt;\"><strong>Option D. Urgent Endoscopy</strong>: Urgent endoscopy, typically performed within 12-24 hours, is a critical intervention in the management of variceal bleeding. During endoscopy, a gastroenterologist can identify the source of bleeding and perform interventions such as band ligation or sclerotherapy to stop the bleeding.</span></p><p> </p><p><span style=\"font-size:12.0pt;\"><strong>Educational Objective:</strong></span></p><p> </p><p><span style=\"font-size:12.0pt;\">Management of variceal bleeding:</span></p><p> </p><ul><li><span style=\"font-size:12.0pt;\">Initial resuscitation: The first step in the management of variceal bleeding is to stabilize the patient with aggressive resuscitation measures, including airway management, fluid and blood product resuscitation, and correction of coagulopathy.</span></li><li><span style=\"font-size:12.0pt;\">Endoscopy: Early endoscopy allows for the identification of the bleeding site and the application of endoscopic therapies such as band ligation or sclerotherapy.</span></li><li><span style=\"font-size:12.0pt;\">Pharmacological therapy: Vasopressin and its analogs (such as terlipressin) are commonly used in the management of variceal bleeding to decrease portal pressure and reduce the risk of re-bleeding.</span></li><li><span style=\"font-size:12.0pt;\">Antibiotics: Prophylactic antibiotics are recommended in patients with variceal bleeding to reduce the risk of bacterial infections, such as spontaneous bacterial peritonitis.</span></li><li><span style=\"font-size:12.0pt;\">Transjugular intrahepatic portosystemic shunt (TIPS): In patients with recurrent bleeding despite endoscopic and pharmacological therapy, TIPS may be considered to reduce portal pressure and prevent further bleeding.</span></li><li><span style=\"font-size:12.0pt;\">Surgery: In rare cases, surgical intervention may be necessary to control variceal bleeding, particularly in patients with refractory bleeding or severe liver disease.</span></li></ul>",
      "correct_choice_id": 200428,
      "solution_audio": null,
      "solution_video": null,
      "audio_explanation_heading": null,
      "video_explanation_heading": null,
      "solution_media_position": "bottom",
      "tags": [],
      "explanation_video": null,
      "question_images": [],
      "explanation_images": []
    },
    {
      "id": 50108,
      "choices": [
        {
          "id": 200432,
          "text": "<p><span style=\"font-size:12.0pt;\">Gaze dependent nystagmus</span></p>"
        },
        {
          "id": 200433,
          "text": "<p><span style=\"font-size:12.0pt;\">Positive Fistula test</span></p>"
        },
        {
          "id": 200434,
          "text": "<p><span style=\"font-size:12.0pt;\">Sensorineural hearing loss</span></p>"
        },
        {
          "id": 200435,
          "text": "<p><span style=\"font-size:12.0pt;\">Positive Tullio's phenomenon</span></p>"
        }
      ],
      "text": "<p><span style=\"font-size:12.0pt;\">Which of these characteristics is not linked to superior semicircular canal dehiscence syndrome?(AIIMS NOV 2018)</span></p>",
      "unique_key": "Q1227617",
      "question_audio": null,
      "question_video": null,
      "map_id": 34351176,
      "difficulty_level": "intermediate",
      "subjects_id": [],
      "solution": "<p><span style=\"font-size:12.0pt;\"><strong>Ans. C) Sensorineural hearing loss</strong></span></p><p> </p><ul><li><span style=\"font-size:12.0pt;\">Conductive hearing loss is seen in superior semicircular canal dehiscence syndrome (SSCDS).</span></li><li><span style=\"font-size:12.0pt;\">“Third window” mechanism due to SCD and enlarged vestibular aqueduct. Schematic representations illustrate inner ear volume velocity with arrows -</span><ol style=\"list-style-type:upper-latin;\"><li><span style=\"font-size:12.0pt;\">Normal anatomy allows volume velocity across the cochlear partition from the oval to the round window (two windows).</span></li><li><span style=\"font-size:12.0pt;\">Air conducted sound stimulation results in volume velocity from the stapes to be shunted toward the SCD (third window) and away from the cochlea, resulting in increased air-conduction thresholds at low frequencies and/or sound-induced vertigo (Tullio's phenomenon). Positive static pressure in the middle-ear cavity may result in ampullofugal fluid motion exciting the ampulla, resulting in nystagmus (Hennebert sign) and oscillopsia/vertigo.</span></li><li><span style=\"font-size:12.0pt;\">Elevated intracranial pressure from Valsalva against closed glottis (e.g., straining, heaving lifting) may result in ampullopetal endolymphatic fluid motion, inhibition of the ampulla, also leading to nystagmus (Hennebert sign) and oscillopsia/vertigo.</span></li><li><span style=\"font-size:12.0pt;\">Enlarged vestibular aqueduct (EVA) can also act as a third window, shunting volume velocity away from the cochlear partition and toward the widened vestibular aqueduct.</span></li></ol></li></ul><p> </p><p><span style=\"font-size:12.0pt;\">Gaze-evoked tinnitus or hyperacusis may also be seen.</span></p><p> </p><p><img src=\"https://cerebellum-web-static.s3.amazonaws.com/media/public/images/2024/06/19/screenshot-2024-06-19-174717.png\" alt=\"\" width=\"600\" height=\"559\"></p><p> </p><ul><li><span style=\"font-size:12.0pt;\">High-resolution CT is the gold standard for identification of SSCD</span></li><li><span style=\"font-size:12.0pt;\">Cervical VEMP sensitivity and specificity for diagnosing SSCDS ranges from 80% to 100%</span></li><li><span style=\"font-size:12.0pt;\">Surgery is indicated only if symptoms are severe and disabling. Otherwise managed conservatively with medication.</span></li></ul><p> </p><p><span style=\"font-size:12.0pt;\"><strong>Other Options:</strong></span></p><p> </p><p><span style=\"font-size:12.0pt;\"><strong>Option A. Gaze dependent nystagmus:</strong> This can occur in SSCDS due to the abnormal transmission of fluid pressure waves through the \"third window\" created by the dehiscence, affecting the balance organs in the inner ear.</span></p><p> </p><p><span style=\"font-size:12.0pt;\"><strong>Option B. Positive Fistula test:</strong> This test, which involves applying pressure to the ear canal, can produce eye movements (nystagmus) or vertigo in cases of SSCDS due to the abnormal transmission of pressure to the inner ear.</span></p><p> </p><p><span style=\"font-size:12.0pt;\"><strong>Option D. Positive Tullio's phenomenon: </strong>This refers to sound-induced vertigo or nystagmus, which is a hallmark of SSCDS. The phenomenon occurs because sound vibrations lead to abnormal fluid dynamics in the inner ear due to the dehiscence.</span></p><p> </p><p><span style=\"font-size:12.0pt;\"><strong>Educational Objective:</strong></span></p><p> </p><p><span style=\"font-size:12.0pt;\">In SSCDS, conductive hearing loss is typical due to the additional pathway for sound and pressure transmission created by the dehiscence, not sensorineural hearing loss, which involves damage to the hair cells in the cochlea or the auditory nerve. Understanding these distinct characteristics helps in accurately diagnosing and managing the condition.</span></p><p> </p><p><span style=\"font-size:12.0pt;\"><strong>Ref - Scott Brown 8<sup>th</sup> edition, volume 2, Page no. 843-847</strong></span></p><p><img src=\"https://cerebellum-web-static.s3.amazonaws.com/media/public/images/2024/06/19/screenshot-2024-06-19-174717.png\" alt=\"Solution Image\"></p>",
      "correct_choice_id": 200434,
      "solution_audio": null,
      "solution_video": null,
      "audio_explanation_heading": null,
      "video_explanation_heading": null,
      "solution_media_position": "bottom",
      "tags": [],
      "explanation_video": null,
      "question_images": [],
      "explanation_images": []
    },
    {
      "id": 50109,
      "choices": [
        {
          "id": 200436,
          "text": "<p><span style=\"font-size:12.0pt;\">No treatment</span></p>"
        },
        {
          "id": 200437,
          "text": "<p><span style=\"font-size:12.0pt;\">2 doses of vaccine on Day 0 & 3</span></p>"
        },
        {
          "id": 200438,
          "text": "<p><span style=\"font-size:12.0pt;\">5 doses of vaccine with Immunoglobulin</span></p>"
        },
        {
          "id": 200439,
          "text": "<p><span style=\"font-size:12.0pt;\">5 doses of vaccine</span></p>"
        }
      ],
      "text": "<p><span style=\"font-size:12.0pt;\">A 5-year-old boy, previously vaccinated against rabies a year ago, was bitten by his vaccinated family pet dog on the toe, resulting in a bleeding wound. What is the most appropriate next step in the management of this child? (AIIMS NOV 2019)</span></p>",
      "unique_key": "Q8753497",
      "question_audio": null,
      "question_video": null,
      "map_id": 34261332,
      "difficulty_level": "intermediate",
      "subjects_id": [],
      "solution": "<p><span style=\"font-size:12.0pt;\"><strong>Ans. B) 2 doses of vaccine on Day 0 & 3</strong></span></p><p> </p><ul><li><span style=\"font-size:12.0pt;\">The patient should receive 2 doses of vaccine on days 0 & 3 as he has already received a prior course of post-exposure prophylaxis (PEP) > 3 months ago.</span></li></ul><p> </p><p><span style=\"font-size:12.0pt;\"><img src=\"https://cerebellum-web-static.s3.amazonaws.com/media/public/images/2023/10/25/screenshot-2023-10-25-174245.jpg\" alt=\"\" width=\"1000\" height=\"512\"></span></p><p> </p><p><span style=\"font-size:12.0pt;\"><strong>Educational Objective:</strong></span></p><p> </p><ul><li><span style=\"font-size:12.0pt;\">For a previously vaccinated individual bitten by a potentially rabid animal, the appropriate post-exposure prophylaxis is to administer 2 booster doses of the rabies vaccine on days 0 and 3.</span></li></ul><p> </p><p><span style=\"font-size:12.0pt;\"><img src=\"https://cerebellum-web-static.s3.amazonaws.com/media/public/images/2023/10/25/screenshot-2023-10-25-174320.jpg\" alt=\"\" width=\"1000\" height=\"442\"></span></p><p><img src=\"https://cerebellum-web-static.s3.amazonaws.com/media/public/images/2023/10/25/screenshot-2023-10-25-174245.jpg\" alt=\"Solution Image\"></p>",
      "correct_choice_id": 200437,
      "solution_audio": null,
      "solution_video": null,
      "audio_explanation_heading": null,
      "video_explanation_heading": null,
      "solution_media_position": "bottom",
      "tags": [],
      "explanation_video": null,
      "question_images": [],
      "explanation_images": []
    },
    {
      "id": 50110,
      "choices": [
        {
          "id": 200440,
          "text": "<p><span style=\"font-size:12.0pt;\">Oral</span></p>"
        },
        {
          "id": 200441,
          "text": "<p><span style=\"font-size:12.0pt;\">Rectal</span></p>"
        },
        {
          "id": 200442,
          "text": "<p><span style=\"font-size:12.0pt;\">Infrared tympanic thermometer</span></p>"
        },
        {
          "id": 200443,
          "text": "<p><span style=\"font-size:12.0pt;\">Axillary</span></p>"
        }
      ],
      "text": "<p><span style=\"font-size:12.0pt;\">A soldier posted in Siachen is brought to you in the ER. In order to rule out hypothermia, how do you best measure his temperature? (</span>AIIMS Nov 2019)</p>",
      "unique_key": "Q7737628",
      "question_audio": null,
      "question_video": null,
      "map_id": 34001135,
      "difficulty_level": "intermediate",
      "subjects_id": [],
      "solution": "<p><span style=\"font-size:12.0pt;\"><strong>Ans. B) Rectal</strong></span></p><p> </p><p><span style=\"font-size:12.0pt;\">In the given clinical scenario measuring rectal temperature would be preferred over other methods in a case of suspected hypothermia, especially in a soldier posted in Siachen where the ambient temperature can be extremely low. Rectal temperature is considered the most accurate method for measuring core body temperature because it reflects the temperature of the body's core organs.</span></p><p> </p><p><span style=\"font-size:12.0pt;\"><strong>Other Options:</strong></span></p><p> </p><p><span style=\"font-size:12pt;\"><strong>Option</strong> </span><span style=\"font-size:12.0pt;\"><strong>A. Oral:</strong> Incorrect. Oral temperature measurements can be influenced by ambient temperature and recent oral intake, making them less reliable in extreme conditions.</span></p><p> </p><p><span style=\"font-size:12.0pt;\"><strong>Option C. Infrared tympanic thermometer:</strong> Incorrect. While it measures the temperature of the eardrum, which can represent core body temperature, it may not be reliable if not inserted adequately or if there is earwax obstruction.</span></p><p> </p><p><span style=\"font-size:12.0pt;\"><strong>Option D. Axillary:</strong> Incorrect. Axillary temperature measurements are less accurate and can be significantly influenced by environmental factors, making them unreliable in cold environments.</span></p><p> </p><p><span style=\"font-size:12.0pt;\"><strong>Educational Objective:</strong></span></p><p> </p><p><span style=\"font-size:12.0pt;\">For accurate measurement of core body temperature in cases of suspected hypothermia, rectal temperature is the preferred method, especially in extreme environmental conditions like those in Siachen.</span></p>",
      "correct_choice_id": 200441,
      "solution_audio": null,
      "solution_video": null,
      "audio_explanation_heading": null,
      "video_explanation_heading": null,
      "solution_media_position": "bottom",
      "tags": [],
      "explanation_video": null,
      "question_images": [],
      "explanation_images": []
    },
    {
      "id": 50111,
      "choices": [
        {
          "id": 200444,
          "text": "<p><span style=\"font-size:12.0pt;\">Superior laryngeal nerve injury</span></p>"
        },
        {
          "id": 200445,
          "text": "<p><span style=\"font-size:12.0pt;\">Glossopharyngeal nerve injury</span></p>"
        },
        {
          "id": 200446,
          "text": "<p><span style=\"font-size:12.0pt;\">Recurrent laryngeal nerve injury</span></p>"
        },
        {
          "id": 200447,
          "text": "<p><span style=\"font-size:12.0pt;\">High vagal injury</span></p>"
        }
      ],
      "text": "<p><span style=\"font-size:12.0pt;\">Following a surgical procedure on the lateral aspect of the skull base, the patient experiences postoperative aspiration. However, there is no alteration in the patient's voice. What could be the explanation for this?(</span>AIIMS Nov 2019)</p>",
      "unique_key": "Q5850306",
      "question_audio": null,
      "question_video": null,
      "map_id": 34592494,
      "difficulty_level": "intermediate",
      "subjects_id": [],
      "solution": "<p><span style=\"font-size:12.0pt;\"><strong>Ans. A) Superior laryngeal nerve injury</strong></span></p><p> </p><ul><li><span style=\"font-size:12.0pt;\">The patient has an injury to the superior laryngeal nerve (SLN).</span></li><li><span style=\"font-size:12.0pt;\">SLN motor supply – cricothyroid muscle → when affected causes change in voice only in high pitch</span></li><li><span style=\"font-size:12.0pt;\">SLN sensory supply – Above level of vocal cords → when affected can cause aspiration.</span></li><li><span style=\"font-size:12.0pt;\">Glossopharyngeal nerve doesn't provide either sensory or motor supply to the larynx so its lesion will not cause aspiration.</span></li><li><span style=\"font-size:12.0pt;\">RLN supplies all the intrinsic muscles of the larynx except cricothyroid > when affected will cause change in voice.</span></li><li><span style=\"font-size:12.0pt;\">A high vagal injury will affect both SLN and RLN, hence can also be ruled out.</span></li></ul><p> </p><p><img src=\"https://cerebellum-web-static.s3.amazonaws.com/media/public/images/2023/08/29/whatsapp-image-2023-08-29-at-165318.jpeg\" alt=\"\" width=\"700\" height=\"306\"></p><p> </p><p><span style=\"font-size:12.0pt;\"><strong>Other Options:</strong></span></p><p> </p><p><span style=\"font-size:12.0pt;\"><strong>Option B. Glossopharyngeal nerve injury:</strong> This nerve does not primarily provide sensory or motor innervation to the larynx; its involvement would not typically result in aspiration.</span></p><p> </p><p><span style=\"font-size:12.0pt;\"><strong>Option C. Recurrent laryngeal nerve injury:</strong> Injury to this nerve would more likely affect the voice since it innervates all intrinsic muscles of the larynx except the cricothyroid. It would lead to vocal cord paralysis.</span></p><p> </p><p><span style=\"font-size:12.0pt;\"><strong>Option D. High vagal injury:</strong> An injury here would affect both the SLN and the recurrent laryngeal nerve, likely causing symptoms in both voice and swallowing mechanisms.</span></p><p> </p><p><span style=\"font-size:12.0pt;\"><strong>Educational Objective:</strong></span></p><p> </p><p><span style=\"font-size:12.0pt;\">Injury to the superior laryngeal nerve, particularly its internal branch, is a plausible explanation for the patient's aspiration post-surgery, especially when there is no accompanying change in voice quality. This suggests that the sensory function above the vocal cords is compromised, increasing the risk of aspiration without necessarily affecting voice modulation handled by the external laryngeal nerve.</span></p><p><img src=\"https://cerebellum-web-static.s3.amazonaws.com/media/public/images/2023/08/29/whatsapp-image-2023-08-29-at-165318.jpeg\" alt=\"Solution Image\"></p>",
      "correct_choice_id": 200444,
      "solution_audio": null,
      "solution_video": null,
      "audio_explanation_heading": null,
      "video_explanation_heading": null,
      "solution_media_position": "bottom",
      "tags": [],
      "explanation_video": null,
      "question_images": [],
      "explanation_images": []
    },
    {
      "id": 50112,
      "choices": [
        {
          "id": 200448,
          "text": "<p><span style=\"font-size:12.0pt;\">Catalase and oxidase positive</span></p>"
        },
        {
          "id": 200449,
          "text": "<p><span style=\"font-size:12.0pt;\">Pili is a virulence factor</span></p>"
        },
        {
          "id": 200450,
          "text": "<p><span style=\"font-size:12.0pt;\">Obligate intracellular organism</span></p>"
        },
        {
          "id": 200451,
          "text": "<p><span style=\"font-size:12.0pt;\">Shows twitching motility</span></p>"
        }
      ],
      "text": "<p><span style=\"font-size:12.0pt;\">A 25-year-old man presents with a history of urethral discharge for the last three days. A gram stain smear of the discharge is shown below. All of the following are true regarding the likely etiology except: (INICET NOV 2019)</span></p><p> </p><p><span style=\"font-size:12.0pt;\"><img src=\"https://cerebellum-web-static.s3.amazonaws.com/media/public/images/2023/03/30/untitled-277.jpg\" alt=\"\" width=\"614\" height=\"295\"></span></p><p><img src=\"https://cerebellum-web-static.s3.amazonaws.com/media/public/images/2023/03/30/untitled-277.jpg\" alt=\"Question Image\"></p>",
      "unique_key": "Q9342444",
      "question_audio": null,
      "question_video": null,
      "map_id": 34812753,
      "difficulty_level": "intermediate",
      "subjects_id": [],
      "solution": "<p><span style=\"font-size:12.0pt;\"><strong>Ans. C) Obligate intracellular organism</strong></span></p><p> </p><p><span style=\"font-size:12.0pt;\">Neisseria is <strong>not an obligate intracellular</strong> organism, it <strong>can also occur extracellularly</strong> i.e, it is a facultative intracellular organism.</span></p><p> </p><p><span style=\"font-size:12.0pt;\">Neisseria gonorrhoeae is an <strong>obligate human pathogen</strong> and is the etiological agent of gonorrhea.</span></p><p> </p><p><span style=\"font-size:12.0pt;\">Habitat –</span></p><p> </p><ul><li><span style=\"font-size:12.0pt;\">Human is only the natural host.</span></li><li><span style=\"font-size:12.0pt;\">Found in human urogenital tract.</span></li><li><span style=\"font-size:12.0pt;\">Rectal carriage in healthy individuals.</span></li><li><span style=\"font-size:12.0pt;\">Typically seen in pus cells (intracellular)</span></li><li><span style=\"font-size:12.0pt;\">Found intracellularly in polymorphonuclear leukocytes, or a specific category of white blood cells with varying shapes of nuclei.</span></li></ul><p> </p><p><span style=\"font-size:12.0pt;\"><strong>Other options:</strong></span></p><p> </p><p><span style=\"font-size:12.0pt;\"><strong>Option A. Catalase and oxidase positive:</strong> This is true for Neisseria gonorrhoeae, which tests positive for both catalase and oxidase enzymes.</span></p><p> </p><p><span style=\"font-size:12.0pt;\"><strong>Option B. Pili is a virulence factor:</strong> Neisseria gonorrhoeae has pili on its surface, which are essential for its virulence, aiding in attachment and colonization.</span></p><p> </p><p><span style=\"font-size:12.0pt;\"><strong>Option D. Shows twitching motility:</strong> Neisseria gonorrhoeae exhibits twitching motility, a type of bacterial movement.</span></p><p> </p><p><span style=\"font-size:12.0pt;\"><strong>Educational Objective</strong></span></p><p> </p><p><span style=\"font-size:12.0pt;\">Morphology of Neisseria Gonorrhea -</span></p><p> </p><ul><li><span style=\"font-size:12.0pt;\"><strong>Gram –ve</strong> cocci</span></li><li><span style=\"font-size:12.0pt;\">Shape is spherical</span></li><li><span style=\"font-size:12.0pt;\"><strong>Coffee bean shaped diplococcic</strong></span></li><li><span style=\"font-size:12.0pt;\">Usually seen <strong>in pairs</strong> with <strong>adjacent sides flattened</strong></span></li><li><span style=\"font-size:12.0pt;\">LPS has highly branched basal <strong>oligosaccharide</strong> structure</span></li><li><span style=\"font-size:12.0pt;\">Contains fimbriae</span></li><li><span style=\"font-size:12.0pt;\"><strong>Possess pili</strong> on the surface</span></li><li><span style=\"font-size:12.0pt;\"><strong>Motile (Twitching motility</strong>)</span></li><li><span style=\"font-size:12.0pt;\"><strong>Non-capsulated</strong></span></li><li><span style=\"font-size:12.0pt;\">Non-sporing</span></li></ul><p> </p><p><span style=\"font-size:12.0pt;\">It is <strong>catalase and oxidase positive.</strong></span></p>",
      "correct_choice_id": 200450,
      "solution_audio": null,
      "solution_video": null,
      "audio_explanation_heading": null,
      "video_explanation_heading": null,
      "solution_media_position": "bottom",
      "tags": [],
      "explanation_video": null,
      "question_images": [],
      "explanation_images": []
    },
    {
      "id": 50113,
      "choices": [
        {
          "id": 200452,
          "text": "<p><span style=\"font-size:12.0pt;\">a, b, c are correct</span></p>"
        },
        {
          "id": 200453,
          "text": "<p><span style=\"font-size:12.0pt;\">a and c are correct</span></p>"
        },
        {
          "id": 200454,
          "text": "<p><span style=\"font-size:12.0pt;\">b and d are correct</span></p>"
        },
        {
          "id": 200455,
          "text": "<p><span style=\"font-size:12.0pt;\">a, b, c, d are correct</span></p>"
        }
      ],
      "text": "<p><span style=\"font-size:12.0pt;\">Evaluate the following statements with respect to CTEV.(AIIMS NOV 2019)</span></p><p> </p><ol style=\"list-style-type:lower-alpha;\"><li><span style=\"font-size:12.0pt;\">50% cases are in males and are bilateral</span></li><li><span style=\"font-size:12.0pt;\">Forefoot is adducted and supinated</span></li><li><span style=\"font-size:12.0pt;\">With Ponsetti technique, correction is up to 90%</span></li><li><span style=\"font-size:12.0pt;\">Equinus should be corrected first</span></li></ol>",
      "unique_key": "Q6286538",
      "question_audio": null,
      "question_video": null,
      "map_id": 34671512,
      "difficulty_level": "intermediate",
      "subjects_id": [],
      "solution": "<p style=\"text-align:justify;\"><span style=\"color:black;font-size:16px;\"><strong>Ans. A. a, b, c are correct</strong></span></p><p style=\"text-align:justify;\"> </p><ul style=\"list-style-type:disc;\"><li><p style=\"text-align:justify;\"><span style=\"color:black;font-size:16px;\"><strong>CTEV is a congenital foot deformity characterized by several components:</strong></span></p><ul><li><p style=\"text-align:justify;\"><span style=\"color:black;font-size:16px;\"><strong>Cavus: </strong>High arch</span></p></li><li><p style=\"text-align:justify;\"><span style=\"color:black;font-size:16px;\"><strong>Adduction: </strong>Forefoot turned inward</span></p></li><li><p style=\"text-align:justify;\"><span style=\"color:black;font-size:16px;\"><strong>Supination: </strong>Sole of the foot turned inward</span></p></li><li><p style=\"text-align:justify;\"><span style=\"color:black;font-size:16px;\"><strong>Equinus: </strong>Plantarflexion<strong> </strong></span></p></li><li><p style=\"text-align:justify;\"><span style=\"color:black;font-size:16px;\"><strong>Varus: </strong>Inversion of the heel</span></p></li></ul></li></ul><p style=\"text-align:justify;\"> </p><p style=\"text-align:justify;\"><span style=\"color:black;font-size:16px;\"><strong>a. 50% cases are in males and are bilateral: </strong></span></p><p style=\"text-align:justify;\"> </p><ul style=\"list-style-type:disc;\"><li><p style=\"text-align:justify;\"><span style=\"color:black;font-size:16px;\">Clubfoot is more common in males than females. The ratio is roughly 2:1. So, more than 50% of cases are in males.</span></p></li><li><p style=\"text-align:justify;\"><span style=\"color:black;font-size:16px;\">Approximately 50% of all clubfoot cases occur in both feet (bilateral).</span></p></li></ul><p style=\"text-align:justify;\"> </p><p style=\"text-align:justify;\"><span style=\"color:black;font-size:16px;\"><strong>b. Forefoot is adducted and supinated:</strong></span></p><p style=\"text-align:justify;\"> </p><ul style=\"list-style-type:disc;\"><li><p style=\"text-align:justify;\"><span style=\"color:black;font-size:16px;\">This statement is correct. </span></p></li><li><p style=\"text-align:justify;\"><span style=\"color:black;font-size:16px;\">As mentioned earlier, forefoot adduction and supination are key components of the clubfoot deformity.</span></p></li></ul><p style=\"text-align:justify;\"> </p><p style=\"text-align:justify;\"><span style=\"color:black;font-size:16px;\"><strong>c. With Ponsetti technique, correction is up to 90%:</strong></span></p><p style=\"text-align:justify;\"> </p><ul style=\"list-style-type:disc;\"><li><p style=\"text-align:justify;\"><span style=\"color:black;font-size:16px;\">This statement is considered correct. </span></p></li><li><p style=\"text-align:justify;\"><span style=\"color:black;font-size:16px;\">The Ponseti method, a non-surgical treatment involving serial casting, has very high success rates, often reported around 90% or even higher when followed properly.</span></p></li></ul><p style=\"text-align:justify;\"> </p><p style=\"text-align:justify;\"><span style=\"color:black;font-size:16px;\"><strong>Other Option:</strong></span></p><p style=\"text-align:justify;\"> </p><p style=\"text-align:justify;\"><span style=\"color:black;font-size:16px;\"><strong>d. Equinus should be corrected first:</strong></span></p><p style=\"text-align:justify;\"> </p><ul style=\"list-style-type:disc;\"><li><p style=\"text-align:justify;\"><span style=\"color:black;font-size:16px;\">This statement is incorrect. </span></p></li><li><p style=\"text-align:justify;\"><span style=\"color:black;font-size:16px;\"><strong>The Ponseti method typically follows a specific sequence of correction:</strong></span></p><ol><li><p style=\"text-align:justify;\"><span style=\"color:black;font-size:16px;\"><strong>Cavus: </strong>Addressing the high arch first.</span></p></li><li><p style=\"text-align:justify;\"><span style=\"color:black;font-size:16px;\"><strong>Adduction and Supination: </strong>Correcting the inward turning of the forefoot.</span></p></li><li><p style=\"text-align:justify;\"><span style=\"color:black;font-size:16px;\"><strong>Varus: </strong>Correcting the inversion of the heel.</span></p></li><li><p style=\"text-align:justify;\"><span style=\"color:black;font-size:16px;\"><strong>Equinus: </strong>Addressing the plantarflexion of the foot, often as the final step.</span></p></li></ol></li></ul><p style=\"margin-left:0cm;text-align:justify;\"> </p><p style=\"margin-left:0cm;text-align:justify;\"><span style=\"color:black;font-size:16px;\"><strong>Educational Objective:</strong></span></p><p style=\"margin-left:0cm;text-align:justify;\"> </p><ul style=\"list-style-type:disc;\"><li><p style=\"text-align:justify;\"><span style=\"color:black;font-size:16px;\">In CTEV, male children are more affected than females. </span></p></li><li><p style=\"text-align:justify;\"><span style=\"color:black;font-size:16px;\">50% of cases of CTEV have bilateral lower limb involvement. </span></p></li><li><p style=\"text-align:justify;\"><span style=\"color:black;font-size:16px;\">There is forefoot adduction and supination in cases of CTEV. </span></p></li><li><p style=\"text-align:justify;\"><span style=\"color:black;font-size:16px;\">Ponseti method of conservative treatment gives correction of up to 90%. </span></p></li></ul><p style=\"text-align:justify;\"> </p><p><span style=\"color:black;font-size:16px;\">Equinus deformity is corrected at last, following the C-A-V-E sequence.</span></p>",
      "correct_choice_id": 200452,
      "solution_audio": null,
      "solution_video": null,
      "audio_explanation_heading": null,
      "video_explanation_heading": null,
      "solution_media_position": "bottom",
      "tags": [],
      "explanation_video": null,
      "question_images": [],
      "explanation_images": []
    },
    {
      "id": 50114,
      "choices": [
        {
          "id": 200456,
          "text": "<p><span style=\"font-size:12pt\"><span style=\"font-family:\"Times New Roman\",serif\"><span style=\"font-family:\"Calibri\",sans-serif\">Conization</span></span></span></p>"
        },
        {
          "id": 200457,
          "text": "<p><span style=\"font-size:12pt\"><span style=\"font-family:\"Times New Roman\",serif\"><span style=\"font-family:\"Calibri\",sans-serif\">Cryotherapy</span></span></span></p>"
        },
        {
          "id": 200458,
          "text": "<p><span style=\"font-size:12pt\"><span style=\"font-family:\"Times New Roman\",serif\"><span style=\"font-family:\"Calibri\",sans-serif\">Targeted biopsy</span></span></span></p>"
        },
        {
          "id": 200459,
          "text": "<p><span style=\"font-size:12pt\"><span style=\"font-family:\"Times New Roman\",serif\"><span style=\"font-family:\"Calibri\",sans-serif\">Pap smear</span></span></span></p>"
        }
      ],
      "text": "<p><span style=\"font-size:12.0pt\"><span style=\"font-family:\"Calibri\",sans-serif\">A 40-year-old woman comes with a history of postcoital bleeding and a visible mass seen in cervix per speculum. The next step to be done? (AIIMS NOV 2019)</span></span></p>",
      "unique_key": "Q3753848",
      "question_audio": null,
      "question_video": null,
      "map_id": 34627210,
      "difficulty_level": "intermediate",
      "subjects_id": [],
      "solution": "<p><span style=\"font-size:12pt\"><span style=\"font-family:\"Times New Roman\",serif\"><strong><span style=\"font-family:\"Calibri\",sans-serif\">Ans. C) Targeted biopsy</span></strong></span></span></p>\r\n\r\n<p> </p>\r\n\r\n<p><span style=\"font-size:12pt\"><span style=\"font-family:\"Times New Roman\",serif\"><strong><span style=\"font-family:\"Calibri\",sans-serif\">Explanation:</span></strong></span></span></p>\r\n\r\n<p> </p>\r\n\r\n<p><span style=\"font-size:12pt\"><span style=\"font-family:\"Times New Roman\",serif\"><span style=\"font-family:\"Calibri\",sans-serif\">A targeted biopsy (punch biopsy) is the next line of management in the above case as the patient is symptomatic (postcoital bleeding) and has a visible lesion. The biopsy will help in diagnosing the nature of the lesion, which is crucial for further management.</span></span></span></p>\r\n\r\n<p> </p>\r\n\r\n<p><span style=\"font-size:12pt\"><span style=\"font-family:\"Times New Roman\",serif\"><strong><span style=\"font-family:\"Calibri\",sans-serif\">Other options:</span></strong></span></span></p>\r\n\r\n<p> </p>\r\n\r\n<p><span style=\"font-size:12pt\"><span style=\"font-family:\"Times New Roman\",serif\"><strong><span style=\"font-family:\"Calibri\",sans-serif\">Option A. Conization:</span></strong><span style=\"font-family:\"Calibri\",sans-serif\"> Conization is an excisional procedure done once biopsy-proven intraepithelial neoplasia (CIN 2 and 3) is diagnosed. It is not the initial step when a visible lesion is present and needs to be assessed.</span></span></span></p>\r\n\r\n<p> </p>\r\n\r\n<p><span style=\"font-size:12pt\"><span style=\"font-family:\"Times New Roman\",serif\"><strong><span style=\"font-family:\"Calibri\",sans-serif\">Option B. Cryotherapy:</span></strong><span style=\"font-family:\"Calibri\",sans-serif\"> Cryotherapy is an ablative procedure done for CIN 1 or 2. It is not suitable for a visible lesion with postcoital bleeding without a prior biopsy.</span></span></span></p>\r\n\r\n<p> </p>\r\n\r\n<p><span style=\"font-size:12pt\"><span style=\"font-family:\"Times New Roman\",serif\"><strong><span style=\"font-family:\"Calibri\",sans-serif\">Option D. Pap smear:</span></strong><span style=\"font-family:\"Calibri\",sans-serif\"> Pap smear is done when there are symptoms with no identifiable lesion. In the presence of a visible mass, a direct biopsy is more appropriate.</span></span></span></p>\r\n\r\n<p> </p>\r\n\r\n<p><span style=\"font-size:12pt\"><span style=\"font-family:\"Times New Roman\",serif\"><strong><span style=\"font-family:\"Calibri\",sans-serif\">Educational Objective:</span></strong></span></span></p>\r\n\r\n<p> </p>\r\n\r\n<p><span style=\"font-size:12pt\"><span style=\"font-family:\"Times New Roman\",serif\"><span style=\"font-family:\"Calibri\",sans-serif\">For a symptomatic patient with postcoital bleeding and a visible lesion on the cervix, the next step is a targeted biopsy to diagnose the nature of the lesion.</span></span></span></p>\r\n\r\n<p> </p>\r\n\r\n<p><span style=\"font-size:12pt\"><span style=\"font-family:\"Times New Roman\",serif\"><strong><span style=\"font-family:\"Calibri\",sans-serif\">Ref: William’s textbook of gynecology 3<sup>rd</sup> edition pg662, Dutta’s textbook of gynecology 6<sup>th</sup> edition pg345</span></strong></span></span></p>",
      "correct_choice_id": 200458,
      "solution_audio": null,
      "solution_video": null,
      "audio_explanation_heading": null,
      "video_explanation_heading": null,
      "solution_media_position": "bottom",
      "tags": [],
      "explanation_video": null,
      "question_images": [],
      "explanation_images": []
    },
    {
      "id": 50115,
      "choices": [
        {
          "id": 200460,
          "text": "<p><span style=\"font-size:12.0pt;\">Coxiella burnetii</span></p>"
        },
        {
          "id": 200461,
          "text": "<p><span style=\"font-size:12.0pt;\">Toxoplasma gondii</span></p>"
        },
        {
          "id": 200462,
          "text": "<p><span style=\"font-size:12.0pt;\">Bartonella henselae</span></p>"
        },
        {
          "id": 200463,
          "text": "<p><span style=\"font-size:12.0pt;\">Ehrlichia chaffeensis</span></p>"
        }
      ],
      "text": "<p><span style=\"font-size:12.0pt;\">A Giemsa stain of a thin peripheral smear is prepared. Which of the following cannot be diagnosed? (INICET NOV 2019)</span></p>",
      "unique_key": "Q4328506",
      "question_audio": null,
      "question_video": null,
      "map_id": 34859986,
      "difficulty_level": "intermediate",
      "subjects_id": [],
      "solution": "<p><span style=\"font-size:12.0pt;\"><strong>Ans. A) Coxiella burnetii</strong></span></p><p> </p><p><span style=\"font-size:12.0pt;\">Coxiella burnetii, the causative agent of Q fever, cannot be diagnosed using a Giemsa stain of a thin peripheral smear. The diagnosis of Coxiella burnetii is typically made through serology for specific antibodies rather than Giemsa staining.</span></p><p> </p><p><span style=\"font-size:12.0pt;\">Giemsa stain is a differential stain which is made up of a combination of reagents (Azure, Methylene blue, and Eosin dye) used widely in cytogenetics and histopathology for the diagnosis of:</span></p><p> </p><ul><li><span style=\"font-size:12.0pt;\">Malaria, spirochetes and other blood parasites</span></li><li><span style=\"font-size:12.0pt;\">Chlamydia trachomatis inclusion bodies</span></li><li><span style=\"font-size:12.0pt;\">Borrelia spp</span></li><li><span style=\"font-size:12.0pt;\">Yersinia pestis</span></li><li><span style=\"font-size:12.0pt;\">Histoplasma spp</span></li><li><span style=\"font-size:12.0pt;\">Pneumocystis jiroveci cysts</span></li><li><span style=\"font-size:12.0pt;\">Bartonella henselae</span></li><li><span style=\"font-size:12.0pt;\">Ehrlichia chaffeensis</span></li><li><span style=\"font-size:12.0pt;\">Klebsiella granulomatis</span></li><li><span style=\"font-size:12.0pt;\">Talaromyces marneffei (formerly called Penicillium marneffei)</span></li></ul><p> </p><p><span style=\"font-size:12.0pt;\">In parasitology to detect intraerythrocytic <strong>(plasmodia, babesiae</strong>) and exoerythrocytic (<strong>trypanosomes, microfilaria</strong>) parasites. It is also used for the detection of <strong>intracellular amastigotes of Leishmania species or Trypanosoma cruzi</strong>. Giemsa stain is also used for the laboratory diagnosis of <strong>Toxoplasmosis.</strong></span></p><p> </p><p><span style=\"font-size:12.0pt;\"><strong>Other Options:</strong></span></p><p> </p><p><span style=\"font-size:12.0pt;\"><strong>Option B. Toxoplasma gondii:</strong> Giemsa stain is used for the laboratory diagnosis of toxoplasmosis, which involves the detection of intracellular organisms.</span></p><p> </p><p><span style=\"font-size:12.0pt;\"><strong>Option C. Bartonella henselae:</strong> Giemsa stain can be used to identify Bartonella henselae, particularly in blood smears.</span></p><p> </p><p><span style=\"font-size:12.0pt;\"><strong>Option D. Ehrlichia chaffeensis:</strong> Giemsa stain is effective in diagnosing infections caused by Ehrlichia chaffeensis by identifying the morulae within white blood cells.</span></p><p> </p><p><span style=\"font-size:12.0pt;\"><strong>Educational Objective:</strong></span></p><p> </p><p><span style=\"font-size:12.0pt;\">Coxiella burnetii cannot be diagnosed using a Giemsa stain of a thin peripheral smear. Serology for specific antibodies is the method used for its diagnosis. Giemsa stain is a versatile stain used to diagnose a variety of blood parasites and intracellular pathogen.</span></p>",
      "correct_choice_id": 200460,
      "solution_audio": null,
      "solution_video": null,
      "audio_explanation_heading": null,
      "video_explanation_heading": null,
      "solution_media_position": "bottom",
      "tags": [],
      "explanation_video": null,
      "question_images": [],
      "explanation_images": []
    },
    {
      "id": 50116,
      "choices": [
        {
          "id": 200464,
          "text": "<p><span style=\"font-size:12.0pt;\">Human Blood Index</span></p>"
        },
        {
          "id": 200465,
          "text": "<p><span style=\"font-size:12.0pt;\">Biting Density</span></p>"
        },
        {
          "id": 200466,
          "text": "<p><span style=\"font-size:12.0pt;\">Slide Positivity Rate</span></p>"
        },
        {
          "id": 200467,
          "text": "<p><span style=\"font-size:12.0pt;\">Inoculation Rate</span></p>"
        }
      ],
      "text": "<p><span style=\"font-size:12.0pt;\">Which of the following is NOT included in Malarial Vector indices?</span></p>",
      "unique_key": "Q4364636",
      "question_audio": null,
      "question_video": null,
      "map_id": 34221028,
      "difficulty_level": "intermediate",
      "subjects_id": [],
      "solution": "<p><span style=\"font-size:16px;\"><strong>Ans. C) Slide Positivity Rate</strong></span></p><p> </p><p><span style=\"font-size:16px;\"><strong>Slide Positivity Rate </strong>is not a malarial vector index. It is a measure of the prevalence of malaria within a population, typically used to identify the percentage of blood samples that test positive for malaria parasites. This measure is more focused on disease prevalence rather than vector behavior or density.</span></p><p> </p><p><span style=\"font-size:16px;\"><strong>Other Options:</strong></span></p><p> </p><p><span style=\"font-size:16px;\">Malarial vector indices are specific measures used to evaluate the malaria transmission potential by assessing mosquito vectors' characteristics and behavior. These indices include:</span></p><p> </p><p><span style=\"font-size:16px;\"><strong>Option A. Human Blood Index:</strong> Measures the proportion of Anopheles mosquitoes that have fed on human blood, indicating how much they prefer human hosts (anthrophilism).</span></p><p> </p><p><span style=\"font-size:16px;\"><strong>Option B. Biting Density (Man Biting Rate):</strong> Reflects the average rate of mosquito bites per person per day, measured through standardized mosquito catches, giving an indication of mosquito exposure.</span></p><p> </p><p><span style=\"font-size:16px;\"><strong>Option D. Inoculation Rate:</strong> This is calculated by multiplying the man-biting rate by the sporozoite rate (percentage of mosquitoes carrying the malaria parasite in their salivary glands), providing an estimate of transmission intensity.</span></p><p> </p><p><span style=\"color:windowtext;font-size:16px;\"><strong>Educational Objective:</strong></span></p><p> </p><p><span style=\"font-size:16px;\">The <strong>Slide Positivity Rate</strong> is a measure of malaria prevalence in humans and is <strong>not a part of malarial vector indices</strong>, which focus on assessing vector behavior and transmission potential.</span></p>",
      "correct_choice_id": 200466,
      "solution_audio": null,
      "solution_video": null,
      "audio_explanation_heading": null,
      "video_explanation_heading": null,
      "solution_media_position": "bottom",
      "tags": [],
      "explanation_video": null,
      "question_images": [],
      "explanation_images": []
    },
    {
      "id": 50117,
      "choices": [
        {
          "id": 200468,
          "text": "<p><span style=\"font-size:12.0pt;\">AAGAAG</span></p>"
        },
        {
          "id": 200469,
          "text": "<p><span style=\"font-size:12.0pt;\">GAGAGG</span></p>"
        },
        {
          "id": 200470,
          "text": "<p><span style=\"font-size:12.0pt;\">AAGCTT</span></p>"
        },
        {
          "id": 200471,
          "text": "<p><span style=\"font-size:12.0pt;\">TACGAG</span></p>"
        }
      ],
      "text": "<p><span style=\"font-size:12.0pt;\">Restriction endonuclease will act on which of the following? (</span>AIIMS Nov 2019)</p>",
      "unique_key": "Q7915868",
      "question_audio": null,
      "question_video": null,
      "map_id": 34192572,
      "difficulty_level": "intermediate",
      "subjects_id": [],
      "solution": "<p><span style=\"font-size:12.0pt;\"><strong>Ans. C) AAGCTT</strong></span></p><p> </p><p><span style=\"font-size:12.0pt;\">Restriction endonucleases have specific recognition sites where they cut the DNA. These enzymes <strong>recognize specific sequence with palindrome arrangement</strong>. These are also <strong>called inverted repeat sequences</strong>, which means the <strong>nucleotide sequence in 5’ to 3’ direction is the same in both strands.</strong></span></p><p> </p><p><span style=\"font-size:12.0pt;\">AAGCTT is a palindromic sequence and other 3 options are not palindromic sequence.</span></p><p> </p><p><span style=\"font-size:12.0pt;\"><strong>Other Options:</strong></span></p><p> </p><p><span style=\"font-size:12.0pt;\"><strong>Option A: AAGAAG</strong></span><br><span style=\"font-size:12.0pt;\">•    Complement: 3′-TTCTTC5’ </span><br><span style=\"font-size:12.0pt;\">•    Not palindromic</span><br><span style=\"font-size:12.0pt;\">•    Not recognized by any common restriction enzyme</span></p><p> </p><p><span style=\"font-size:12.0pt;\"><strong>Option B: GAGAGG</strong></span><br><span style=\"font-size:12.0pt;\">•    Complement: 3′-CTCTCC 5’</span><br><span style=\"font-size:12.0pt;\">•    Not a palindrome</span><br><span style=\"font-size:12.0pt;\">•    Not a restriction site</span></p><p> </p><p><span style=\"font-size:12.0pt;\"><strong>Option D: TACGAG</strong></span><br><span style=\"font-size:12.0pt;\">•    Complement: 3′-ATGCTC 5’</span><br><span style=\"font-size:12.0pt;\">•    Not a palindrome</span><br><span style=\"font-size:12.0pt;\">•    Not recognized by known restriction enzymes</span><br><br> </p><p><span style=\"font-size:12.0pt;\"><strong>Educational Objective:</strong></span></p><p> </p><p><span style=\"font-size:12.0pt;\">Restriction endonucleases act and cleave at the site of a palindromic sequence, such as:</span></p><p> </p><p><span style=\"font-size:12.0pt;\">5' --AAGCTT-- 3'</span></p><p><span style=\"font-size:12.0pt;\">3' --TTCGAA-- 5'</span></p>",
      "correct_choice_id": 200470,
      "solution_audio": null,
      "solution_video": null,
      "audio_explanation_heading": null,
      "video_explanation_heading": null,
      "solution_media_position": "bottom",
      "tags": [],
      "explanation_video": null,
      "question_images": [],
      "explanation_images": []
    },
    {
      "id": 50118,
      "choices": [
        {
          "id": 200472,
          "text": "<p><span style=\"font-size:12.0pt;\">Worm infestation</span></p>"
        },
        {
          "id": 200473,
          "text": "<p><span style=\"font-size:12.0pt;\">Vitamin A deficiency</span></p>"
        },
        {
          "id": 200474,
          "text": "<p><span style=\"font-size:12.0pt;\">Scabies</span></p>"
        },
        {
          "id": 200475,
          "text": "<p><span style=\"font-size:12.0pt;\">Filariasis</span></p>"
        }
      ],
      "text": "<p><span style=\"font-size:12.0pt;\">A 33-year-old public health officer is assigned to lead a healthcare team aiming to address and manage endemic conditions in a remote village with limited healthcare access. As part of the initiative, there's a proposal to start a mass drug administration (MDA) program targeting common health concerns in the area. Which of the following conditions would NOT traditionally be managed through mass drug administration? (AIIMS NOV 2019) </span></p>",
      "unique_key": "Q5455280",
      "question_audio": null,
      "question_video": null,
      "map_id": 34286384,
      "difficulty_level": "intermediate",
      "subjects_id": [],
      "solution": "<p><span style=\"font-size:12.0pt;\"><strong>Ans. B) Vitamin A deficiency </strong></span></p><p> </p><ul><li><span style=\"font-size:12.0pt;\">Mass Drug Administration (MDA) refers to providing a drug to an entire population without considering age and gender.</span></li><li><span style=\"font-size:12.0pt;\">Vitamin A prophylaxis is exclusively administered as per the National Immunization Schedule (NIS) to children up to the age of 5.</span></li><li><span style=\"font-size:12.0pt;\">This prophylactic treatment is not intended as a curative measure but rather as a preventive measure.</span></li><li><span style=\"font-size:12.0pt;\">Treatment with vitamin A is reserved solely for children displaying symptoms of vitamin A deficiency, and such treatment is not widespread throughout the community.</span></li><li><span style=\"font-size:12.0pt;\">As a result, it is not categorized as part of Mass Drug Administration.</span></li></ul><p> </p><p><span style=\"font-size:12.0pt;\"><strong>Other Options:</strong></span></p><p> </p><p><span style=\"font-size:12.0pt;\"><strong>Option A. Worm infestation: </strong>Managed through MDA using albendazole or mebendazole to treat and prevent worm infestations in the population.</span></p><p> </p><p><span style=\"font-size:12.0pt;\"><strong>Option C. Scabies: </strong>Managed through MDA using ivermectin to treat and prevent scabies outbreaks in the community.</span></p><p> </p><p><span style=\"font-size:12.0pt;\"><strong>Option D. Filariasis: </strong>Managed through MDA using DEC (diethylcarbamazine) and albendazole to prevent and control filariasis in endemic areas.</span></p><p> </p><p><span style=\"font-size:12.0pt;\"><strong>Educational Objective:</strong></span></p><p> </p><ul><li><span style=\"font-size:12.0pt;\">Vitamin A deficiency is managed through targeted prophylaxis in children rather than mass drug administration.</span></li><li><span style=\"font-size:12.0pt;\">In contrast, MDA is carried out for conditions like scabies (using ivermectin), worm infestations (using albendazole), and filariasis (using DEC + albendazole).</span></li></ul>",
      "correct_choice_id": 200473,
      "solution_audio": null,
      "solution_video": null,
      "audio_explanation_heading": null,
      "video_explanation_heading": null,
      "solution_media_position": "bottom",
      "tags": [],
      "explanation_video": null,
      "question_images": [],
      "explanation_images": []
    },
    {
      "id": 50119,
      "choices": [
        {
          "id": 200476,
          "text": "<p><span style=\"font-size:12.0pt;\">Central retinal artery occlusion</span></p>"
        },
        {
          "id": 200477,
          "text": "<p><span style=\"font-size:12.0pt;\">Diabetic Macular edema</span></p>"
        },
        {
          "id": 200478,
          "text": "<p><span style=\"font-size:12.0pt;\">Primary open angle glaucoma</span></p>"
        },
        {
          "id": 200479,
          "text": "<p><span style=\"font-size:12.0pt;\">Non-infectious uveitis</span></p>"
        }
      ],
      "text": "<p><span style=\"font-size:12.0pt;\">What was ETDRS study related to? (</span>AIIMS Nov 2019)</p>",
      "unique_key": "Q4367031",
      "question_audio": null,
      "question_video": null,
      "map_id": 34712754,
      "difficulty_level": "intermediate",
      "subjects_id": [],
      "solution": "<p><span style=\"font-size:12.0pt;\"><strong>Ans. B) Diabetic Macular edema</strong></span></p><p> </p><ul><li><span style=\"font-size:12.0pt;\">Early Treatment Diabetic Retinopathy Study (ETDRS) was a clinical trial.</span></li><li><span style=\"font-size:12.0pt;\">The study investigated the effect of photocoagulation on diabetic macular edema.</span></li><li><span style=\"font-size:12.0pt;\">The study demonstrated that focal photocoagulation was beneficial in treating diabetic macular edema.</span></li><li><span style=\"font-size:12.0pt;\">The study recommended that eyes with clinically significant diabetic macular edema should be considered for focal photocoagulation.</span></li></ul><p> </p><p><span style=\"font-size:12.0pt;\"><strong>Other Options:</strong></span></p><p> </p><p><span style=\"font-size:12.0pt;\"><strong>Option A. Central retinal artery occlusion:</strong> Not the focus of the ETDRS; this condition involves sudden, painless vision loss due to an occlusion in the central retinal artery.</span></p><p> </p><p><span style=\"font-size:12.0pt;\"><strong>Option C. Primary open angle glaucoma:</strong> Not related to the ETDRS, which did not address glaucoma treatments or outcomes.</span></p><p> </p><p><span style=\"font-size:12.0pt;\"><strong>Option D. Non-infectious uveitis:</strong> Also unrelated to the ETDRS, as the study was specific to diabetic retinopathy and macular edema, not inflammatory eye diseases.</span></p><p> </p><p><span style=\"font-size:12.0pt;\"><strong>Educational Objective:</strong></span></p><p> </p><p><span style=\"font-size:12.0pt;\">The ETDRS study established the beneficial effects of photocoagulation in treating diabetic macular edema, recommending it as an early treatment option to prevent vision loss in patients with clinically significant macular edema.</span></p>",
      "correct_choice_id": 200477,
      "solution_audio": null,
      "solution_video": null,
      "audio_explanation_heading": null,
      "video_explanation_heading": null,
      "solution_media_position": "bottom",
      "tags": [],
      "explanation_video": null,
      "question_images": [],
      "explanation_images": []
    },
    {
      "id": 50120,
      "choices": [
        {
          "id": 200480,
          "text": "<p><span style=\"font-size:12.0pt;\">No episode of fever for more than 24 hours with paracetamol</span></p>"
        },
        {
          "id": 200481,
          "text": "<p><span style=\"font-size:12.0pt;\">After the return of appetite</span></p>"
        },
        {
          "id": 200482,
          "text": "<p><span style=\"font-size:12.0pt;\">Urine output more than 200ml</span></p>"
        },
        {
          "id": 200483,
          "text": "<p><span style=\"font-size:12.0pt;\">After 24hrs from recovery of shock</span></p>"
        }
      ],
      "text": "<p><span style=\"font-size:12.0pt;\">A 25-year-old woman is admitted with dengue hemorrhagic fever. After several days of management, her condition stabilizes, and the medical team considers discharging her. Which of the following is an appropriate criterion to decide the discharge of a patient recovering from dengue hemorrhagic shock? (AIIMS NOV 2019)</span></p>",
      "unique_key": "Q3175473",
      "question_audio": null,
      "question_video": null,
      "map_id": 34471893,
      "difficulty_level": "intermediate",
      "subjects_id": [],
      "solution": "<p><span style=\"font-size:12.0pt;\"><strong>Ans. B) After the return of appetite</strong></span></p><p> </p><ul><li><span style=\"font-size:12.0pt;\">The appropriate criteria for discharging a patient recovering from dengue hemorrhagic shock include several clinical signs indicating recovery and stability.</span></li><li><span style=\"font-size:12.0pt;\">One crucial criterion is the return of appetite, which signifies a significant clinical improvement and recovery from the acute phase of the illness.</span></li></ul><p> </p><p><span style=\"font-size:12.0pt;\"><strong>SIGNS OF RECOVERY: </strong></span></p><p> </p><ul><li><span style=\"font-size:12.0pt;\">Stable pulse, blood pressure and breathing rate</span></li><li><span style=\"font-size:12.0pt;\">Normal temperature</span></li><li><span style=\"font-size:12.0pt;\">No evidence of external or internal bleeding</span></li><li><span style=\"font-size:12.0pt;\">Return of appetite</span></li><li><span style=\"font-size:12.0pt;\">No vomiting</span></li><li><span style=\"font-size:12.0pt;\">Good urine output </span></li><li><span style=\"font-size:12.0pt;\">Stable haematocrit </span></li><li><span style=\"font-size:12.0pt;\">Convalescent confluent petechiae rash</span></li></ul><p> </p><p><span style=\"font-size:12.0pt;\"><strong>Other Options:</strong></span></p><p> </p><p><span style=\"font-size:12.0pt;\"><strong>Option A. No episode of fever for more than 24 hours with paracetamol: </strong>The absence of fever should be without the use of antipyretics like paracetamol.</span></p><p> </p><p><span style=\"font-size:12.0pt;\"><strong>Option C. Urine output more than 200 ml: </strong>This is not a standard criterion; adequate urine output should be considered, but specific volume thresholds are not typically used.</span></p><p> </p><p><span style=\"font-size:12.0pt;\"><strong>Option D. After 24 hours from recovery of shock: </strong>Recovery from shock should be sustained, and other criteria like appetite and clinical stability are more reliable indicators.</span></p><p> </p><p><span style=\"font-size:12.0pt;\"><strong>Educational Objective:</strong></span></p><p> </p><p><span style=\"font-size:12.0pt;\"><strong>CRITERIA FOR DISCHARGING PATIENTS: </strong></span></p><p> </p><ul><li><span style=\"font-size:12.0pt;\">Absence of fever for at least 24 hours without the use of anti-fever therapy</span></li><li><span style=\"font-size:12.0pt;\">Return of appetite</span></li><li><span style=\"font-size:12.0pt;\">Visible clinical improvement </span></li><li><span style=\"font-size:12.0pt;\">Good urine output </span></li><li><span style=\"font-size:12.0pt;\">Minimum of three days after recovery from shock</span></li><li><span style=\"font-size:12.0pt;\">No respiratory distress from pleural effusion and no ascites</span></li><li><span style=\"font-size:12.0pt;\">Platelet count of more than 50,000/mm</span></li></ul>",
      "correct_choice_id": 200481,
      "solution_audio": null,
      "solution_video": null,
      "audio_explanation_heading": null,
      "video_explanation_heading": null,
      "solution_media_position": "bottom",
      "tags": [],
      "explanation_video": null,
      "question_images": [],
      "explanation_images": []
    },
    {
      "id": 50121,
      "choices": [
        {
          "id": 200484,
          "text": "<p><span style=\"font-size:12.0pt;\">Temperature > 38 degrees Celsius</span></p>"
        },
        {
          "id": 200485,
          "text": "<p><span style=\"font-size:12.0pt;\">Respiratory Rate > 22/minute and PaCO2 <35 mmHg</span></p>"
        },
        {
          "id": 200486,
          "text": "<p><span style=\"font-size:12.0pt;\">Pulse rate > 90/minute</span></p>"
        },
        {
          "id": 200487,
          "text": "<p><span style=\"font-size:12.0pt;\">WBC > 12000/mm3 or < 4000/mm3</span></p>"
        }
      ],
      "text": "<p><span style=\"font-size:12.0pt;\">Which of these is not a feature of Systemic inflammatory response syndrome (SIRS)? (AIIMS NOV 2019)</span></p>",
      "unique_key": "Q9923251",
      "question_audio": null,
      "question_video": null,
      "map_id": 34090790,
      "difficulty_level": "intermediate",
      "subjects_id": [],
      "solution": "<p><span style=\"font-size:12.0pt;\"><strong>Ans. B) Respiratory rate > 22/ minute and PaCO2 <35mmHg</strong></span></p><p> </p><ul><li><span style=\"font-size:12.0pt;\">This statement does not align with the criteria for SIRS. In SIRS, an elevated respiratory rate (tachypnea) is defined as a respiratory rate greater than 20 breaths per minute or an arterial carbon dioxide partial pressure (PaCO2) less than 32 mmHg. Therefore, the option presented combines an elevated respiratory rate with an abnormally low PaCO2, which is not part of the SIRS criteria.</span></li></ul><p> </p><p><span style=\"font-size:12.0pt;\"><strong>Educational Objective:</strong></span></p><p> </p><p><span style=\"font-size:12.0pt;\">Features of Systemic inflammatory response syndrome (SIRS) are:</span></p><p> </p><ul><li><span style=\"font-size:12.0pt;\">Fever (body temperature >38°C) or temperature <36°C.</span></li><li><span style=\"font-size:12.0pt;\">Tachycardia (heart rate >90 beats per minute).</span></li><li><span style=\"font-size:12.0pt;\">Tachypnea (respiratory rate >20 breaths per minute or arterial carbon dioxide tension (PaCO2) < 32 mm Hg).</span></li><li><span style=\"font-size:12.0pt;\">Leukocytosis (white blood cell count >12,000 cells/mm³), leukopenia (white blood cell count <4,000 cells/mm³), or the presence of >10% immature neutrophils (band forms) in the blood.</span></li><li><span style=\"font-size:12.0pt;\">Other signs of systemic inflammation such as elevated levels of C-reactive protein (CRP) or procalcitonin.</span></li></ul>",
      "correct_choice_id": 200485,
      "solution_audio": null,
      "solution_video": null,
      "audio_explanation_heading": null,
      "video_explanation_heading": null,
      "solution_media_position": "bottom",
      "tags": [],
      "explanation_video": null,
      "question_images": [],
      "explanation_images": []
    },
    {
      "id": 50122,
      "choices": [
        {
          "id": 200488,
          "text": "<p><span style=\"font-size:12.0pt;\">K nail</span></p>"
        },
        {
          "id": 200489,
          "text": "<p><span style=\"font-size:12.0pt;\">Rail fixator</span></p>"
        },
        {
          "id": 200490,
          "text": "<p><span style=\"font-size:12.0pt;\">Ilizarov fixator</span></p>"
        },
        {
          "id": 200491,
          "text": "<p><span style=\"font-size:12.0pt;\">Proximal femoral nail</span></p>"
        }
      ],
      "text": "<p style=\"text-align:justify;\"><span style=\"font-size:12.0pt;\">A young patient with RTA sustained an open fracture of femur which was operated and stabilized as shown below. Identify the fixator.(AIIMS NOV 2019)</span></p><p style=\"text-align:justify;\"> </p><p style=\"text-align:justify;\"><span style=\"font-size:12.0pt;\"><img src=\"https://cerebellum-web-static.s3.amazonaws.com/media/public/images/2024/01/17/picture3_Wufh0hr.jpg\" alt=\"\" width=\"300\" height=\"169\"></span></p><p><img src=\"https://cerebellum-web-static.s3.amazonaws.com/media/public/images/2024/01/17/picture3_Wufh0hr.jpg\" alt=\"Question Image\"></p>",
      "unique_key": "Q3737455",
      "question_audio": null,
      "question_video": null,
      "map_id": 34526198,
      "difficulty_level": "intermediate",
      "subjects_id": [],
      "solution": "<p><span style=\"font-size:12.0pt;\"><strong>Ans. B) Rail fixator</strong></span></p><p> </p><p><span style=\"font-size:12.0pt;\"><strong>OPEN FRACTURES</strong></span></p><p> </p><ul><li><span style=\"font-size:12.0pt;\">An open fracture occurs when the <strong>bone breaks through the skin</strong>.</span></li><li><span style=\"font-size:12.0pt;\">These typically result from high-energy injuries and are often associated with <strong>significant damage to the surrounding soft tissues and contamination of the wound</strong>.</span></li><li><span style=\"font-size:12.0pt;\">Phalanges followed by tibia is the most common site.</span></li><li><span style=\"font-size:12.0pt;\">These injuries are <strong>classified into three types according to the</strong> <strong>Gustillo-Anderson</strong></span></li></ul><p> </p><p><span style=\"font-size:12.0pt;\"><strong><img src=\"https://cerebellum-web-static.s3.amazonaws.com/media/public/images/2024/01/17/screenshot-2024-01-17-152913.jpg\" alt=\"\" width=\"1000\" height=\"269\"></strong></span></p><p> </p><ul><li><span style=\"font-size:12.0pt;\">These injuries require immediate administration of antibiotics and irrigation and debridement of the wound.</span></li><li><span style=\"font-size:12.0pt;\">The goal of the treatment is to <strong>achieve fracture healing and to prevent wound infections and osteomyelitis.</strong></span></li><li><span style=\"font-size:12.0pt;\"><strong>When the wound is contaminated, an external fixator is initially used.</strong></span></li><li><span style=\"font-size:12.0pt;\">Early coverage of the wound is important to avoid infection.</span></li><li><span style=\"font-size:12.0pt;\">In general, an increase in Gustillo grade is associated with an increase in infection risk.</span></li><li><span style=\"font-size:12.0pt;\"><strong>External Fixation:</strong></span><ul style=\"list-style-type:circle;\"><li><span style=\"font-size:12.0pt;\"><strong>In external fixation the fixation device is external to skin-external fixator or Ilizarov fixator.</strong></span></li><li><span style=\"font-size:12.0pt;\"><strong>Ilizarov fixator </strong>works on the principles of <strong>distraction osteogenesis</strong> that is an osteotomy is carried out and <strong>distracted at the rate of 1 mm per day</strong> causing distraction at the callus and subsequently lengthening can be done. It can be used for correction of deformities like malunion, shortening, shortening with discharging sinus, gap non-union and also for CTEV.</span></li><li><span style=\"font-size:12.0pt;\">Open fracture is one of the most common cause for segmental loss of bone.</span></li><li><span style=\"font-size:12.0pt;\">For treating bone gap when Ilizarov ring fixator is used, it achieves union, eradicates infection, corrects deformities, reestablishes limb length and at the same time maintains function.</span></li><li><span style=\"font-size:12.0pt;\">The Rail Fixator is designed for bone transport for reconstructing bone loss following open fracture and sequestrectomy following osteomyelitis. It provides correction through bone transport, compression-distraction and bifocal lengthening. </span></li></ul></li></ul><p> </p><p><img src=\"https://cerebellum-web-static.s3.amazonaws.com/media/public/images/2024/01/17/picture4_EBdZbBT.jpg\" alt=\"\" width=\"500\" height=\"247\"></p><p> </p><p><img src=\"https://cerebellum-web-static.s3.amazonaws.com/media/public/images/2024/01/17/screenshot-2024-01-17-154014.jpg\" alt=\"\" width=\"1000\" height=\"1036\"><img src=\"https://cerebellum-web-static.s3.amazonaws.com/media/public/images/2024/01/17/screenshot-2024-01-17-154053.jpg\" alt=\"\" width=\"1000\" height=\"1065\"></p><p> </p><p><span style=\"font-size:12.0pt;\"><strong>Other Options:</strong></span></p><p> </p><p style=\"text-align:justify;\"><span style=\"font-size:12.0pt;\"><strong>Option A. K-nail. </strong>Femoral shaft fractures are one of the commonest high energy fractures, and intramedullary nailing is the gold standard management of these fractures. Intramedullary fixation is considered superior to plate fixation because of lower rates of infection, early weight-bearing, and lesser chances of non-union. Unlocked Kuntscher nail (K-nail) should only be used for isthmic femoral shaft fractures. The main drawback of K-nail for use in other types of femoral shaft fracture was lack of rotational stability. Nowadays, interlocking intramedullary nail is used for almost all types of femoral shaft fractures because of better rotational stability.</span></p><p> </p><p><img src=\"https://cerebellum-web-static.s3.amazonaws.com/media/public/images/2024/01/17/picture5_YcVvWWB.jpg\" alt=\"\" width=\"250\" height=\"412\"></p><p> </p><p style=\"text-align:justify;\"><span style=\"font-size:12.0pt;\"><strong>Option C. Ilizarov fixator. </strong>Ilizarov fixator is an effective treatment modality of open comminuted femur fractures with high union rate, adequate alignment and satisfactory functional outcomes. <strong>Ilizarov fixator</strong> works on the principles of <strong>distraction osteogenesis</strong> that is an osteotomy is carried out and <strong>distracted at the rate of 1 mm per day</strong> causing distraction at the callus and subsequently lengthening can be done. It can be used for correction of deformities like malunion, shortening, shortening with discharging sinus, gap non-union and also for CTEV. For treating bone gap when Ilizarov ring fixator is used, it achieves union, eradicates infection, corrects deformities, reestablishes limb length and at the same time maintains function.</span></p><p> </p><p><span style=\"font-size:12.0pt;\"><img src=\"https://cerebellum-web-static.s3.amazonaws.com/media/public/images/2024/01/17/picture6_jJ1IJcg.jpg\" alt=\"\" width=\"700\" height=\"359\"></span></p><p> </p><p style=\"text-align:justify;\"><span style=\"font-size:12.0pt;\"><strong>Option D. Proximal femoral nail.</strong></span><span style=\"font-size:11pt;\"> </span><span style=\"font-size:12.0pt;\">The <strong>proximal femoral nail (PFN)</strong> is an osteosynthetic implant is used to treat proximal femoral fractures in the trochanter area with a closed intramedullary fixation method. It consists of a funnel-shaped intramedullary nail with slight bending to reflect proximal femoral diaphyseal trochanteric morphology. It has two proximal openings, a larger one distally for a large femoral neck lag screw and a smaller one immediately above for a smaller anti-rotation screw/pin. There are small holes at the distal end of the nail for locking screws.  It can be combined with a wire cerclage with an open reduction for additional stability in complicated subtrochanteric fractures.</span></p><p> </p><p><img src=\"https://cerebellum-web-static.s3.amazonaws.com/media/public/images/2024/01/17/picture7_71GgakL.jpg\" alt=\"\" width=\"300\" height=\"263\"></p><p> </p><p><span style=\"font-size:12.0pt;\"><strong>Educational Objective:</strong></span></p><p> </p><p><span style=\"font-size:12.0pt;\">The fixator shown in the image in the question is a Rail Fixator, used to treat open fractures to fill the bone gap.</span></p><p><img src=\"https://cerebellum-web-static.s3.amazonaws.com/media/public/images/2024/01/17/screenshot-2024-01-17-152913.jpg\" alt=\"Solution Image\"></p>",
      "correct_choice_id": 200489,
      "solution_audio": null,
      "solution_video": null,
      "audio_explanation_heading": null,
      "video_explanation_heading": null,
      "solution_media_position": "bottom",
      "tags": [],
      "explanation_video": null,
      "question_images": [],
      "explanation_images": []
    },
    {
      "id": 50123,
      "choices": [
        {
          "id": 200492,
          "text": "<p><span style=\"font-size:12pt\"><span style=\"font-family:\"Times New Roman\",serif\"><span dir=\"ltr\" lang=\"PT-BR\" style=\"font-family:\"Calibri\",sans-serif\">Malformations</span></span></span></p>"
        },
        {
          "id": 200493,
          "text": "<p><span style=\"font-size:12pt\"><span style=\"font-family:\"Times New Roman\",serif\"><span dir=\"ltr\" lang=\"PT-BR\" style=\"font-family:\"Calibri\",sans-serif\">Polyhydramnios</span></span></span></p>"
        },
        {
          "id": 200494,
          "text": "<p><span style=\"font-size:12pt\"><span style=\"font-family:\"Times New Roman\",serif\"><span dir=\"ltr\" lang=\"PT-BR\" style=\"font-family:\"Calibri\",sans-serif\">Fetal Macrosomia</span></span></span></p>"
        },
        {
          "id": 200495,
          "text": "<p><span style=\"font-size:12pt\"><span style=\"font-family:\"Times New Roman\",serif\"><span style=\"font-family:\"Calibri\",sans-serif\">Neonatal Hypoglycemia</span></span></span></p>"
        }
      ],
      "text": "<p style=\"text-align:left\"><span style=\"font-size:12pt\"><span style=\"font-family:\"Times New Roman\",serif\"><span style=\"font-family:\"Calibri\",sans-serif\">All the followings are seen in Gestational Diabetes Mellitus except: </span></span></span>(INICET NOV 2019)</p>",
      "unique_key": "Q6587645",
      "question_audio": null,
      "question_video": null,
      "map_id": 34991900,
      "difficulty_level": "intermediate",
      "subjects_id": [],
      "solution": "<p><span style=\"font-size:12pt\"><span style=\"font-family:\"Times New Roman\",serif\"><strong><span style=\"font-family:\"Calibri\",sans-serif\">Ans. A) Malformations</span></strong></span></span></p>\r\n\r\n<p> </p>\r\n\r\n<p><span style=\"font-size:12pt\"><span style=\"font-family:\"Times New Roman\",serif\"><span style=\"font-family:\"Calibri\",sans-serif\">Congenital malformations are not typically seen with Gestational Diabetes Mellitus (GDM); they are more associated with pre-existing overt diabetes mellitus. When diabetes is present and uncontrolled in the first trimester, particularly with an HbA1C greater than 10%, there is a higher risk of congenital malformations. The most commonly affected system is cardiac, with Ventricular Septal Defect (VSD) being the most common anomaly. A very rare but characteristic anomaly associated with severe diabetes is Mermaid syndrome (sirenomelia).</span></span></span></p>\r\n\r\n<p> </p>\r\n\r\n<p><span style=\"font-size:12pt\"><span style=\"font-family:\"Times New Roman\",serif\"><strong><span style=\"font-family:\"Calibri\",sans-serif\">Other Options:</span></strong></span></span></p>\r\n\r\n<p> </p>\r\n\r\n<p><span style=\"font-size:12pt\"><span style=\"font-family:\"Times New Roman\",serif\"><strong><span style=\"font-family:\"Calibri\",sans-serif\">Option B. Polyhydramnios:</span></strong><span style=\"font-family:\"Calibri\",sans-serif\"> Polyhydramnios, characterized by an Amniotic Fluid Index (AFI) greater than 25 or a Single Deepest Pocket (SDP) greater than 8, is common in pregnancies complicated by GDM. It results from increased fetal urination due to hyperglycemia.</span></span></span></p>\r\n\r\n<p> </p>\r\n\r\n<p><span style=\"font-size:12pt\"><span style=\"font-family:\"Times New Roman\",serif\"><strong><span style=\"font-family:\"Calibri\",sans-serif\">Option C. Fetal Macrosomia:</span></strong><span style=\"font-family:\"Calibri\",sans-serif\"> Fetal macrosomia, defined as a birth weight greater than 4 kg, is a common complication of GDM. It is associated with excessive fat deposition, particularly around the shoulders, increasing the risk of shoulder dystocia during delivery.</span></span></span></p>\r\n\r\n<p> </p>\r\n\r\n<p><span style=\"font-size:12pt\"><span style=\"font-family:\"Times New Roman\",serif\"><strong><span style=\"font-family:\"Calibri\",sans-serif\">Option D. Neonatal Hypoglycemia:</span></strong><span style=\"font-family:\"Calibri\",sans-serif\"> Neonatal hypoglycemia, with blood glucose levels less than 45 mg/dl, is common in infants of mothers with GDM, especially if maternal blood sugar levels were unstable during labor. This occurs because the fetus produces excess insulin in response to maternal hyperglycemia, leading to low blood sugar levels after birth.</span></span></span></p>\r\n\r\n<p> </p>\r\n\r\n<p><span style=\"font-size:12pt\"><span style=\"font-family:\"Times New Roman\",serif\"><strong><span style=\"font-family:\"Calibri\",sans-serif\">Educational Objective:</span></strong> </span></span></p>\r\n\r\n<p> </p>\r\n\r\n<p><span style=\"font-size:12pt\"><span style=\"font-family:\"Times New Roman\",serif\"><span style=\"font-family:\"Calibri\",sans-serif\">Congenital anomalies are not typically seen with Gestational Diabetes Mellitus (GDM); they are associated with pre-existing overt diabetes mellitus.</span></span></span></p>\r\n\r\n<p> </p>\r\n\r\n<p><span style=\"font-size:12pt\"><span style=\"font-family:\"Times New Roman\",serif\"><strong><span style=\"font-family:\"Calibri\",sans-serif\">Ref: William’s textbook of obstetrics 26<sup>th</sup> edition pg 2787</span></strong></span></span></p>",
      "correct_choice_id": 200492,
      "solution_audio": null,
      "solution_video": null,
      "audio_explanation_heading": null,
      "video_explanation_heading": null,
      "solution_media_position": "bottom",
      "tags": [],
      "explanation_video": null,
      "question_images": [],
      "explanation_images": []
    },
    {
      "id": 50124,
      "choices": [
        {
          "id": 200496,
          "text": "<p><span style=\"font-size:12.0pt;\">Unipolar cautery</span></p>"
        },
        {
          "id": 200497,
          "text": "<p><span style=\"font-size:12.0pt;\">Bipolar cautery</span></p>"
        },
        {
          "id": 200498,
          "text": "<p><span style=\"font-size:12.0pt;\">Harmonic scalpel</span></p>"
        },
        {
          "id": 200499,
          "text": "<p><span style=\"font-size:12.0pt;\">LigaSure</span></p>"
        }
      ],
      "text": "<p><span style=\"font-size:12.0pt;\">Identify the instrument in the image below? (AIIMS NOV 2019)</span></p><p> </p><p><span style=\"font-size:12.0pt;\"><img src=\"https://cerebellum-web-static.s3.amazonaws.com/media/public/images/2023/05/06/untitled-656.jpg\" alt=\"\" width=\"255\" height=\"251\"></span></p><p><img src=\"https://cerebellum-web-static.s3.amazonaws.com/media/public/images/2023/05/06/untitled-656.jpg\" alt=\"Question Image\"></p>",
      "unique_key": "Q3468843",
      "question_audio": null,
      "question_video": null,
      "map_id": 34402134,
      "difficulty_level": "intermediate",
      "subjects_id": [],
      "solution": "<p><span style=\"font-size:12.0pt;\"><strong>Ans. B) Bipolar cautery</strong></span></p><p> </p><p><span style=\"font-size:12.0pt;\">The given instrument is a Bipolar cautery</span></p><p> </p><ul><li><span style=\"font-size:12.0pt;\">Bipolar cautery, like unipolar cautery, is a form of electrosurgery used for tissue coagulation and hemostasis.</span></li><li><span style=\"font-size:12.0pt;\">Unlike unipolar cautery, bipolar cautery uses two electrodes that are very close together on the surgical instrument. The electrical current flows only between these two closely spaced electrodes, which limits the current's path to a small area of tissue.</span></li><li><span style=\"font-size:12.0pt;\">Bipolar cautery is often preferred in delicate surgical procedures where precise tissue coagulation is required, as it has a more localized effect compared to unipolar cautery.</span></li></ul><p> </p><p><span style=\"font-size:12.0pt;\"><strong>Other Options:</strong></span></p><p> </p><p><span style=\"font-size:12.0pt;\"><strong>Option A. Unipolar cautery</strong>: </span></p><p> </p><ul><li><span style=\"font-size:12.0pt;\">Unipolar cautery is a type of electrosurgery that uses a single electrode for cutting or coagulating tissue. It is commonly used for various surgical procedures to cut or coagulate tissues, control bleeding, and achieve hemostasis.</span></li></ul><p> </p><p><span style=\"font-size:12.0pt;\"><strong><img src=\"https://cerebellum-web-static.s3.amazonaws.com/media/public/images/2023/05/06/untitled-657.jpg\" alt=\"\" width=\"306\" height=\"203\"></strong></span></p><p> </p><p><span style=\"font-size:12.0pt;\"><strong>Option C. The harmonic scalpel:</strong></span></p><p> </p><ul><li><span style=\"font-size:12.0pt;\">The harmonic scalpel is known for its precision and minimal thermal spread, making it suitable for various surgical procedures, including laparoscopic and open surgeries.</span></li><li><span style=\"font-size:12.0pt;\">It allows surgeons to dissect tissues and achieve hemostasis with minimal damage to surrounding structures, based on generation of heat from ultrasonic waves.</span></li></ul><p> </p><p><img src=\"https://cerebellum-web-static.s3.amazonaws.com/media/public/images/2023/05/06/untitled-658.jpg\" alt=\"\" width=\"382\" height=\"221\"></p><p> </p><p><span style=\"font-size:12.0pt;\"><strong>Option D. LigaSure vessel sealing system:</strong></span></p><p> </p><ul><li><span style=\"font-size:12.0pt;\">LigaSure is known for its ability to create secure and consistent vessel seals, reducing the risk of bleeding during surgery.</span></li><li><span style=\"font-size:12.0pt;\">It is a type of advanced bipolar vessel sealing device.</span></li><li><span style=\"font-size:12.0pt;\">It is commonly used in a wide range of surgical specialties, including general surgery, gynecology, and urology, among others.</span></li></ul><p> </p><p><span style=\"font-size:12.0pt;\"><strong><img src=\"https://cerebellum-web-static.s3.amazonaws.com/media/public/images/2023/05/06/untitled-659.jpg\" alt=\"\" width=\"326\" height=\"263\"></strong></span></p><p> </p><p><span style=\"font-size:12.0pt;\"><strong>Educational Objective: </strong></span></p><p> </p><p><span style=\"font-size:12.0pt;\">Bipolar cautery is ideal for controlled, precise tissue coagulation in delicate surgeries due to its localized current flow, making it more specific than unipolar cautery.</span></p><p><img src=\"https://cerebellum-web-static.s3.amazonaws.com/media/public/images/2023/05/06/untitled-657.jpg\" alt=\"Solution Image\"></p>",
      "correct_choice_id": 200497,
      "solution_audio": null,
      "solution_video": null,
      "audio_explanation_heading": null,
      "video_explanation_heading": null,
      "solution_media_position": "bottom",
      "tags": [],
      "explanation_video": null,
      "question_images": [],
      "explanation_images": []
    },
    {
      "id": 50125,
      "choices": [
        {
          "id": 200500,
          "text": "<p><span style=\"font-size:12pt;\">4 ml Mgso4 (50% w/v) in 16 ml NS</span></p>"
        },
        {
          "id": 200501,
          "text": "<p><span style=\"font-size:12pt;\">8 ml MgSo4 (50% w/v) in 12 ml NS</span></p>"
        },
        {
          "id": 200502,
          "text": "<p><span style=\"font-size:12pt;\">12 ml MgSo4 (50% w/v) in 8 ml NS</span></p>"
        },
        {
          "id": 200503,
          "text": "<p><span style=\"font-size:12pt;\">10 ml MgSO4 (50% w/v)</span></p>"
        }
      ],
      "text": "<p><span style=\"font-size:12.0pt;\">The loading dose of MgSo4 in pre-eclampsia is? </span>(INICET NOV 2019)</p>",
      "unique_key": "Q7094191",
      "question_audio": null,
      "question_video": null,
      "map_id": 34009118,
      "difficulty_level": "intermediate",
      "subjects_id": [],
      "solution": "<p><span style=\"font-size:12pt;\"><strong>Ans. B) 8 ml MgSo4 (50% w/v) in 12 ml NS</strong></span></p><p> </p><p><span style=\"font-size:12pt;\"><strong>Explanation:</strong></span></p><p> </p><p><span style=\"font-size:12pt;\">The drug of choice for the management of eclampsia is Magnesium Sulfate (MgSO4). The most commonly used regimen in India is the Pritchard regimen, which involves an initial loading dose followed by maintenance doses.</span></p><p> </p><p><span style=\"font-size:12pt;\">For the loading dose, the Pritchard regimen recommends:</span></p><p> </p><ul><li><span style=\"font-size:12pt;\"><strong>Loading dose:</strong> 4 grams of MgSO4 as a 20% solution administered intravenously at 1 gram per minute.</span></li><li><span style=\"font-size:12pt;\">Additionally, 10 grams of 50% MgSO4 is administered intramuscularly, with 5 grams in each buttock.</span></li></ul><p> </p><p><span style=\"font-size:12pt;\">In this question, option B, \"8 ml MgSO4 (50% w/v) in 12 ml NS,\" correctly refers to the preparation required to administer the initial dose of MgSO4.</span></p><p> </p><p><span style=\"font-size:12pt;\">The preparation details:</span></p><p> </p><ul><li><span style=\"font-size:12pt;\">MgSO4 is available in 50% and 20% concentrations.</span></li><li><span style=\"font-size:12pt;\">To make a 50% MgSO4 solution into a 20% solution, a 1.5 times dilution is required.</span></li><li><span style=\"font-size:12pt;\">For a 50% MgSO4 solution, 1 ml of the solution contains 0.5 grams of MgSO4 (1 ampoule = 2 ml).</span></li></ul><p> </p><p><span style=\"font-size:12pt;\"><strong>Educational Objective:</strong></span></p><p> </p><p><span style=\"font-size:12pt;\">The loading dose of MgSO4 in pre-eclampsia, as per the Pritchard regimen, is 4 grams of MgSO4 as a 20% solution administered intravenously, often prepared using 8 ml of 50% MgSO4 diluted in 12 ml normal saline.</span></p><p> </p><p><span style=\"font-size:12pt;\"><strong>Ref: Dutta’s textbook of obstetrics 8<sup>th</sup> edition pg273, Williams textbook of obstetrics 24<sup>th</sup> edition pg 1840</strong></span></p>",
      "correct_choice_id": 200501,
      "solution_audio": null,
      "solution_video": null,
      "audio_explanation_heading": null,
      "video_explanation_heading": null,
      "solution_media_position": "bottom",
      "tags": [],
      "explanation_video": null,
      "question_images": [],
      "explanation_images": []
    },
    {
      "id": 50126,
      "choices": [
        {
          "id": 200504,
          "text": "<p style=\"margin-right:3px\"><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span style=\"font-size:12.0pt\">Histamine</span></span></span></p>"
        },
        {
          "id": 200505,
          "text": "<p style=\"margin-right:3px\"><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span style=\"font-size:12.0pt\">Thromboxane A2</span></span></span></p>"
        },
        {
          "id": 200506,
          "text": "<p style=\"margin-right:3px\"><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span style=\"font-size:12.0pt\">Serotonin</span></span></span></p>"
        },
        {
          "id": 200507,
          "text": "<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span style=\"font-size:12.0pt\">Leukotriene C4</span></span></span></p>"
        }
      ],
      "text": "<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span style=\"font-size:12.0pt\">Which of the following causes vasodilation? </span></span></span><span style=\"font-size:12.0pt\"><span style=\"font-family:\"Calibri\",sans-serif\">(AIIMS NOV 2019)</span></span></p>",
      "unique_key": "Q9772476",
      "question_audio": null,
      "question_video": null,
      "map_id": 34780532,
      "difficulty_level": "intermediate",
      "subjects_id": [],
      "solution": "<p style=\"margin-right:3px\"><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12pt\"><strong>Ans.</strong> </span><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\"><strong>A) Histamine </strong> </span></span></span></p>\r\n\r\n<p style=\"margin-right:3px\"> </p>\r\n\r\n<p style=\"margin-right:3px\"><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\">The most important mast cell–derived amine is histamine. <strong>Histamine causes intense smooth muscle contraction, increased vascular permeability, and increased mucus secretion by nasal, bronchial, and gastric glands.</strong></span></span></span></p>\r\n\r\n<p style=\"margin-right:3px\"> </p>\r\n\r\n<p style=\"margin-right:3px\"><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\">Other Options:</span></strong></span></span></p>\r\n\r\n<p style=\"margin-right:3px\"> </p>\r\n\r\n<p style=\"margin-right:3px\"><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\">Option B. Thromboxane A2</span></strong><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\">: Thromboxane A2 is an activator of platelet aggregation and vasoconstrictor.</span></span></span></p>\r\n\r\n<p style=\"margin-right:3px\"> </p>\r\n\r\n<p style=\"margin-right:3px\"><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\">Option C. Serotonin</span></strong><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\">:<strong> </strong>Serotonin possesses both vasoconstrictor and vasodilator properties.</span></span></span></p>\r\n\r\n<p style=\"margin-right:3px\"> </p>\r\n\r\n<p style=\"margin-right:3px\"><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\">Option D. Leukotrienes</span></strong><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\"> <strong>C4</strong>: <strong>Leukotrienes C4 and D4 are the most potent vasoactive and spasmogenic agents</strong> known. On a molar basis, they are several thousand times more active than histamine in increasing vascular permeability and causing bronchial smooth muscle contraction<strong>. Leukotriene B4 is highly chemotactic for neutrophils, eosinophils, and monocytes.</strong></span></span></span></p>\r\n\r\n<p style=\"margin-right:3px\"> </p>\r\n\r\n<p style=\"margin-right:3px\"><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span style=\"font-size:12.0pt\">Educational Objective: </span></strong></span></span></p>\r\n\r\n<p style=\"margin-right:3px\"> </p>\r\n\r\n<p style=\"margin-right:3px\"><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\">Histamine is the primary mediator responsible for causing vasodilation, playing a critical role in the inflammatory response by increasing blood flow and vascular permeability.</span></span></span></p>",
      "correct_choice_id": 200504,
      "solution_audio": null,
      "solution_video": null,
      "audio_explanation_heading": null,
      "video_explanation_heading": null,
      "solution_media_position": "bottom",
      "tags": [],
      "explanation_video": null,
      "question_images": [],
      "explanation_images": []
    },
    {
      "id": 50127,
      "choices": [
        {
          "id": 200508,
          "text": "<p><span style=\"font-size:11pt\"><span style=\"font-family:Arial,sans-serif\"><span dir=\"ltr\" lang=\"EN\" style=\"font-size:12.0pt\"><span style=\"font-family:\"Calibri\",sans-serif\">IV calcium</span></span></span></span></p>"
        },
        {
          "id": 200509,
          "text": "<p><span style=\"font-size:11pt\"><span style=\"font-family:Arial,sans-serif\"><span dir=\"ltr\" lang=\"EN\" style=\"font-size:12.0pt\"><span style=\"font-family:\"Calibri\",sans-serif\">DC Shock</span></span></span></span></p>"
        },
        {
          "id": 200510,
          "text": "<p><span style=\"font-size:11pt\"><span style=\"font-family:Arial,sans-serif\"><span dir=\"ltr\" lang=\"EN\" style=\"font-size:12.0pt\"><span style=\"font-family:\"Calibri\",sans-serif\">IV MgS04</span></span></span></span></p>"
        },
        {
          "id": 200511,
          "text": "<p><span style=\"font-size:11pt\"><span style=\"font-family:Arial,sans-serif\"><span dir=\"ltr\" lang=\"EN\" style=\"font-size:12.0pt\"><span style=\"font-family:\"Calibri\",sans-serif\">Synchronized cardioversion</span></span></span></span></p>"
        }
      ],
      "text": "<p><span style=\"font-size:11pt\"><span style=\"font-family:Arial,sans-serif\"><span dir=\"ltr\" lang=\"EN\" style=\"font-size:12.0pt\"><span style=\"font-family:\"Calibri\",sans-serif\">The ECG of a pregnant lady having pre-eclampsia is shown below. Her vitals are stable. What is the best step in the management of the condition?</span></span><span dir=\"ltr\" lang=\"EN\" style=\"font-size:12.0pt\"><span style=\"font-family:\"Aptos\",sans-serif\"> (AIIMS NOV 2019)</span></span></span></span></p>\r\n\r\n<p> </p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Arial,sans-serif\"><span dir=\"ltr\" lang=\"EN\" style=\"font-size:12.0pt\"><span style=\"font-family:\"Calibri\",sans-serif\"><img alt=\"\" src=\"https://cerebellum-web-static.s3.amazonaws.com/media/public/images/2023/04/27/nm123.jpg\" style=\"height:337px; width:600px\" /></span></span></span></span></p><p><img src=\"https://cerebellum-web-static.s3.amazonaws.com/media/public/images/2023/04/27/nm123.jpg\" alt=\"Question Image\"></p>",
      "unique_key": "Q2410292",
      "question_audio": null,
      "question_video": null,
      "map_id": 34914660,
      "difficulty_level": "intermediate",
      "subjects_id": [],
      "solution": "<p><span style=\"font-size:11pt\"><span style=\"font-family:Arial,sans-serif\"><strong><span dir=\"ltr\" lang=\"EN\" style=\"font-size:12.0pt\"><span style=\"font-family:\"Calibri\",sans-serif\">Ans. C) </span></span></strong><strong><span dir=\"ltr\" lang=\"EN\" style=\"font-size:12.0pt\"><span style=\"font-family:\"Calibri\",sans-serif\">IV MgSO4</span></span></strong></span></span></p>\r\n\r\n<p> </p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Arial,sans-serif\"><span dir=\"ltr\" lang=\"EN\" style=\"font-size:12.0pt\"><span style=\"font-family:\"Calibri\",sans-serif\">The ECG displays characteristics consistent with Torsades de Pointes (Tdp), which is identified by its distinctive polymorphic ventricular tachycardia and a prolonged QT interval. In the setting of pre-eclampsia, magnesium sulfate (MgSO4) is not only used for seizure prophylaxis but also effectively treats Torsades de Pointes by stabilizing the cardiac membrane and correcting magnesium deficiency, a common trigger for this arrhythmia.</span></span></span></span></p>\r\n\r\n<p> </p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Arial,sans-serif\"><strong><span dir=\"ltr\" lang=\"EN\" style=\"font-size:12.0pt\"><span style=\"font-family:\"Calibri\",sans-serif\">Other Options:</span></span></strong></span></span></p>\r\n\r\n<p> </p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Arial,sans-serif\"><strong><span dir=\"ltr\" lang=\"EN\" style=\"font-size:12.0pt\"><span style=\"font-family:\"Calibri\",sans-serif\">Option A. IV calcium: </span></span></strong><span dir=\"ltr\" lang=\"EN\" style=\"font-size:12.0pt\"><span style=\"font-family:\"Calibri\",sans-serif\">Used for treating hyperkalemia or hypocalcemia-induced cardiac toxicity, not directly effective for Torsades de Pointes.</span></span></span></span></p>\r\n\r\n<p> </p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Arial,sans-serif\"><strong><span dir=\"ltr\" lang=\"EN\" style=\"font-size:12.0pt\"><span style=\"font-family:\"Calibri\",sans-serif\">Option B. DC Shock: </span></span></strong><span dir=\"ltr\" lang=\"EN\" style=\"font-size:12.0pt\"><span style=\"font-family:\"Calibri\",sans-serif\">Indicated for hemodynamically unstable patients with Tdp or other life-threatening arrhythmias, which does not apply here as the patient's vitals are stable.</span></span></span></span></p>\r\n\r\n<p> </p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Arial,sans-serif\"><strong><span dir=\"ltr\" lang=\"EN\" style=\"font-size:12.0pt\"><span style=\"font-family:\"Calibri\",sans-serif\">Option D. Synchronized cardioversion: </span></span></strong><span dir=\"ltr\" lang=\"EN\" style=\"font-size:12.0pt\"><span style=\"font-family:\"Calibri\",sans-serif\">Typically used for managing ventricular tachycardia with a pulse or superventricular tachycardia, but not the first-line for Torsades de Pointes in a stable patient.</span></span></span></span></p>\r\n\r\n<p> </p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Arial,sans-serif\"><strong><span dir=\"ltr\" lang=\"EN\" style=\"font-size:12.0pt\"><span style=\"font-family:\"Calibri\",sans-serif\">Educational Objective</span></span></strong><span dir=\"ltr\" lang=\"EN\" style=\"font-size:12.0pt\"><span style=\"font-family:\"Calibri\",sans-serif\">:</span></span></span></span></p>\r\n\r\n<p> </p>\r\n\r\n<p><span dir=\"ltr\" lang=\"EN\" style=\"font-size:11.0pt\"><span style=\"font-family:\"Calibri\",sans-serif\">In a stable pregnant patient displaying Torsades de Pointes, especially in the context of pre-eclampsia, IV magnesium sulfate is the recommended treatment. It helps in both controlling the arrhythmia and providing prophylaxis against eclamptic seizures.</span></span></p>",
      "correct_choice_id": 200510,
      "solution_audio": null,
      "solution_video": null,
      "audio_explanation_heading": null,
      "video_explanation_heading": null,
      "solution_media_position": "bottom",
      "tags": [],
      "explanation_video": null,
      "question_images": [],
      "explanation_images": []
    },
    {
      "id": 50128,
      "choices": [
        {
          "id": 200512,
          "text": "<p><span style=\"font-size:12.0pt;\">Immediate exploration on both symptomatic and asymptomatic side</span></p>"
        },
        {
          "id": 200513,
          "text": "<p><span style=\"font-size:12.0pt;\">Immediate exploration on symptomatic side only</span></p>"
        },
        {
          "id": 200514,
          "text": "<p><span style=\"font-size:12.0pt;\">Delayed exploration on both symptomatic and asymptomatic side</span></p>"
        },
        {
          "id": 200515,
          "text": "<p><span style=\"font-size:12.0pt;\">Delayed exploration on symptomatic side only</span></p>"
        }
      ],
      "text": "<p><span style=\"font-size:12.0pt;\">A 10-year-old child presents with pain and swelling in the left side of his scrotum. The surgeon suspects testicular torsion based on the clinical presentation. Which is the most appropriate next step in management?</span> <span style=\"font-size:12.0pt;\">(AIIMS NOV 2019)</span></p>",
      "unique_key": "Q8581719",
      "question_audio": null,
      "question_video": null,
      "map_id": 34734656,
      "difficulty_level": "intermediate",
      "subjects_id": [],
      "solution": "<p><span style=\"font-size:12.0pt;\"><strong>Ans. A) Immediate exploration on both symptomatic and asymptomatic side</strong></span></p><p> </p><p><span style=\"font-size:12.0pt;\">In a case of suspected testicular torsion, immediate exploration needs to be done on both the symptomatic as well as the asymptomatic side.</span></p><p> </p><ul><li><span style=\"font-size:12.0pt;\">This is the most appropriate next step in management for suspected testicular torsion. It involves immediate surgical exploration of both the symptomatic (painful) side and the asymptomatic (contralateral) side. Even if only one side appears to be affected, there is a risk of contralateral testicular torsion in future. This occurs as the same anatomical abnormality (high investment of tunica vaginalis/transverse testis are likely to be present on both sides.</span></li><li><span style=\"font-size:12.0pt;\">The surgeon can detorse (untwist) the affected testicle and fixate it to prevent future torsion. Contralateral scrotum is explored and orchidopexy is done to prevent future risk of torsion.</span></li></ul><p> </p><p><span style=\"font-size:12.0pt;\"><strong>Educational Objective:</strong></span></p><p> </p><p><span style=\"font-size:12.0pt;\">Management of testicular torsion: </span></p><p> </p><ul><li><span style=\"font-size:12.0pt;\"><strong>Timely diagnosis: </strong>Testicular torsion is a surgical emergency and requires prompt diagnosis and management to salvage the testis as the blood supply to the testicle is compromised due to the twisting of the spermatic cord within the tunica vaginalis, resulting in ischemia of the epididymis and the testis.</span></li><li><span style=\"font-size:12.0pt;\"><strong>Surgery: </strong>The definitive management of testicular torsion is surgical exploration with detorsion and fixation of the testis to prevent future torsion. The surgery should be performed within 6 hours of the onset of symptoms to maximize the chances of testicular salvage. At the time of surgical exploration contralateral testes also must be explored and fixed as the same anatomic defect can allow torsion on the contralateral side.</span></li></ul>",
      "correct_choice_id": 200512,
      "solution_audio": null,
      "solution_video": null,
      "audio_explanation_heading": null,
      "video_explanation_heading": null,
      "solution_media_position": "bottom",
      "tags": [],
      "explanation_video": null,
      "question_images": [],
      "explanation_images": []
    },
    {
      "id": 50129,
      "choices": [
        {
          "id": 200516,
          "text": "<p><span style=\"font-size:12.0pt;\">Cytomegalovirus</span></p>"
        },
        {
          "id": 200517,
          "text": "<p><span style=\"font-size:12.0pt;\">Epstein-Barr virus</span></p>"
        },
        {
          "id": 200518,
          "text": "<p><span style=\"font-size:12.0pt;\">Varicella zoster virus</span></p>"
        },
        {
          "id": 200519,
          "text": "<p><span style=\"font-size:12.0pt;\">Herpes simplex virus</span></p>"
        }
      ],
      "text": "<p><span style=\"font-size:12.0pt;\">Which of the following is the most common cause of infection post-solid organ transplantation in an Indian setting? (AIIMS NOV 2019)</span></p>",
      "unique_key": "Q2310719",
      "question_audio": null,
      "question_video": null,
      "map_id": 34636578,
      "difficulty_level": "intermediate",
      "subjects_id": [],
      "solution": "<p><span style=\"font-size:12.0pt;\"><strong>Ans. A) Cytomegalovirus</strong></span></p><p> </p><p><span style=\"font-size:12.0pt;\">CMV is most common infection occurring after transplant. Risk depends on induction agent and seropositivity status. Minimal risk for D-/R-(Donor, recipient negative). Highest risk of reactivation in D-/R+ and patients who received anti-lymphocyte therapy. Prophylaxis is given pre-emptively if periodic CMV-DNA PCR are >500 copies/ml with Valgan/ Foscarnet/Cidofovir. Letermovir has no hepato/nephrotoxicity (Safest)</span></p><p> </p><p><span style=\"font-size:12.0pt;\">D-/R- patients should receive leucodepleted blood products to minimise transmission of CMV</span></p><p> </p><p><span style=\"font-size:12.0pt;\"><strong>Other Options:</strong></span></p><p> </p><p><span style=\"font-size:12.0pt;\"><strong>Option B. </strong>EBV infection occurs in 1-2% of post-transplant patients and responds well to acyclovir prophylaxis</span></p><p> </p><p><span style=\"font-size:12.0pt;\"><strong>Option C. </strong>VZV reactivation can occur at any point post-transplant</span></p><p> </p><p><span style=\"font-size:12.0pt;\"><strong>Option D. </strong>HSV occurs within 1-month post-transplant in the absence of acyclovir prophylaxis Nephrology/infectious diseases/post-transplant</span></p><p> </p><p><span style=\"font-size:12.0pt;\"><strong>Educational Objective:</strong></span></p><p> </p><p><span style=\"font-size:12.0pt;\">Cytomegalovirus (CMV) is the most prevalent and clinically significant viral infection in the post-solid organ transplant setting in India, necessitating targeted prophylaxis and monitoring protocols to mitigate its risks.</span></p><p> </p><p><span style=\"font-size:12.0pt;\"><strong>Reference - Critical Care Nephrology /Chapter 95</strong></span></p>",
      "correct_choice_id": 200516,
      "solution_audio": null,
      "solution_video": null,
      "audio_explanation_heading": null,
      "video_explanation_heading": null,
      "solution_media_position": "bottom",
      "tags": [],
      "explanation_video": null,
      "question_images": [],
      "explanation_images": []
    },
    {
      "id": 50130,
      "choices": [
        {
          "id": 200520,
          "text": "<p><span style=\"font-size:12.0pt;\">To hold bone and plate</span></p>"
        },
        {
          "id": 200521,
          "text": "<p><span style=\"font-size:12.0pt;\">To hold bone fragments with traction</span></p>"
        },
        {
          "id": 200522,
          "text": "<p><span style=\"font-size:12.0pt;\">To cut the bone</span></p>"
        },
        {
          "id": 200523,
          "text": "<p><span style=\"font-size:12.0pt;\">For creating a gap in wound</span></p>"
        }
      ],
      "text": "<p><span style=\"font-size:12.0pt;\">What is the use of the given instrument?</span></p><p> </p><p><span style=\"font-size:12.0pt;\"><img src=\"https://cerebellum-web-static.s3.amazonaws.com/media/public/images/2023/08/18/whatsapp-image-2023-06-12-at-190121011010201026_page_68_page_118.jpg\" alt=\"\" width=\"300\" height=\"123\"></span></p><p><img src=\"https://cerebellum-web-static.s3.amazonaws.com/media/public/images/2023/08/18/whatsapp-image-2023-06-12-at-190121011010201026_page_68_page_118.jpg\" alt=\"Question Image\"></p>",
      "unique_key": "Q3933674",
      "question_audio": null,
      "question_video": null,
      "map_id": 34991235,
      "difficulty_level": "intermediate",
      "subjects_id": [],
      "solution": "<p><span style=\"font-size:12.0pt;\"><strong>Ans. B) To hold bone fragments with traction.</strong></span></p><p> </p><p><span style=\"font-size:12.0pt;\"><strong><u>Explanation:</u></strong></span></p><p> </p><p><span style=\"font-size:12.0pt;\"><strong>BONE HOLDING FORCEPS</strong></span></p><p> </p><ul><li><span style=\"font-size:12.0pt;\">Bone holding forceps are used to manipulate bone fragments in place during surgery.</span></li><li><span style=\"font-size:12.0pt;\">They are typically used in orthopedic procedures, such as the repair of fractures or the realignment of bones.</span></li><li><span style=\"font-size:12.0pt;\">These forceps are designed to grip the bone securely without damaging it, and can be adjusted to apply the appropriate amount of force to hold the bone in the desired position.</span></li></ul><p> </p><p><img src=\"https://cerebellum-web-static.s3.amazonaws.com/media/public/images/2024/01/17/picture25.jpg\" alt=\"\" width=\"500\" height=\"333\"></p><p> </p><ul><li><span style=\"font-size:12.0pt;\">They allow for more precise manipulation of the bones during surgery and can help ensure the success of the procedure.</span></li></ul><p> </p><p><span style=\"color:#231f20;font-size:12.0pt;\"><strong><img src=\"https://cerebellum-web-static.s3.amazonaws.com/media/public/images/2023/08/18/page0007.jpg\" alt=\"\" width=\"700\" height=\"1007\"></strong></span></p><p> </p><p> </p><p><span style=\"font-size:12.0pt;\"><strong>Other Options:</strong></span></p><p> </p><p><span style=\"font-size:12.0pt;\"><strong>Option A. To hold bone and plate</strong>. For this purpose, a Bone-Plate Holding Forcep is used. They are designed to aid in the reduction of fractures and can help secure a plate in place during installation<i>. </i>Aid in the reduction of fractures such as spiral, transverse, compound, oblique, or butterfly. The clamp can also be used to secure a plate in place while the screw holes are being drilled and screws inserted. The fracture site can also be manipulated with the clamp being used as a lever. It has teeth in the jaws for a better grip and a ratchet locking handle for use on various bone diameters.</span></p><p> </p><p><img src=\"https://cerebellum-web-static.s3.amazonaws.com/media/public/images/2024/01/17/picture26.jpg\" alt=\"\" width=\"500\" height=\"500\"></p><p> </p><p><span style=\"font-size:12.0pt;\"><strong>Option C. To cut the bone</strong>. For this purpose, a Bone Cutter is used.</span></p><p> </p><p><img src=\"https://cerebellum-web-static.s3.amazonaws.com/media/public/images/2024/01/17/picture27.jpg\" alt=\"\" width=\"500\" height=\"319\"></p><p> </p><p><span style=\"font-size:12pt;\"><strong>Option D.</strong> </span><span style=\"font-size:12.0pt;\"><strong>For creating a gap in wound. Wound Spreader </strong>is a specialized device that is used to grasp, retract and manipulate the edges of wounds and incisions, in order to spread the space between them and localize surgical targets with ease.</span></p><p> </p><p><span style=\"font-size:12.0pt;\"><img src=\"https://cerebellum-web-static.s3.amazonaws.com/media/public/images/2024/01/17/picture28.jpg\" alt=\"\" width=\"500\" height=\"311\"></span></p><p> </p><p> </p><p><span style=\"font-size:12.0pt;\"><strong>Educational Objective:</strong></span></p><p> </p><ul><li><span style=\"font-size:12.0pt;\">To hold the bone with traction during the surgical procedure, a Bone Holding Forcep is used.</span></li></ul><p><img src=\"https://cerebellum-web-static.s3.amazonaws.com/media/public/images/2024/01/17/picture25.jpg\" alt=\"Solution Image\"></p>",
      "correct_choice_id": 200521,
      "solution_audio": null,
      "solution_video": null,
      "audio_explanation_heading": null,
      "video_explanation_heading": null,
      "solution_media_position": "bottom",
      "tags": [],
      "explanation_video": null,
      "question_images": [],
      "explanation_images": []
    },
    {
      "id": 50131,
      "choices": [
        {
          "id": 200524,
          "text": "<p><span style=\"font-size:12.0pt;\">Rabbit ileal loop assay for ETEC</span></p>"
        },
        {
          "id": 200525,
          "text": "<p><span style=\"font-size:12.0pt;\">Injecting Aedes thorax with blood of a patient with suspected dengue</span></p>"
        },
        {
          "id": 200526,
          "text": "<p><span style=\"font-size:12.0pt;\">Injecting a hamster with splenic biopsy for diagnosis of leishmaniasis</span></p>"
        },
        {
          "id": 200527,
          "text": "<p><span style=\"font-size:12.0pt;\">Intradermal test on guinea pigs for toxigenicity of Corynebacterium diphtheria</span></p>"
        }
      ],
      "text": "<p><span style=\"font-size:12.0pt;\">Which of the following is a xenodiagnostic method? (INICET NOV 2019)</span></p>",
      "unique_key": "Q4122952",
      "question_audio": null,
      "question_video": null,
      "map_id": 34472336,
      "difficulty_level": "intermediate",
      "subjects_id": [],
      "solution": "<p><span style=\"font-size:12.0pt;\"><strong>Ans. B) Injecting Aedes thorax with blood of a patient with suspected dengue</strong></span></p><p> </p><p><span style=\"font-size:12.0pt;\">Injecting Aedes thorax with blood of a patient with suspected dengue is the xenodiagnostic method among the given options.</span></p><p> </p><p><span style=\"font-size:12.0pt;\">Xeno-diagnosis is a diagnostic method used to document the presence of infectious disease microorganisms or pathogens by <strong>exposing possibly infected tissue to a vector and then examining the vector for the presence of the microorganisms or pathogens it may have ingested.</strong></span></p><p> </p><p><span style=\"font-size:12.0pt;\"><strong>Uses -</strong></span></p><p> </p><ol style=\"list-style-type:lower-alpha;\"><li><span style=\"font-size:12.0pt;\">Diagnosis of <strong>Chagas disease.</strong> Laboratory bred <strong>Reduviid bugs</strong> (vector/ foreign host) are allowed to feed on the suspected patients (original host). After 4-5 weeks, the feces of the bugs are microscopically examined for amastigote forms of Trypanosoma cruzi (pathogen).</span></li><li><span style=\"font-size:12.0pt;\">Identification of <strong>dengue virus</strong> - Intrathoracic inoculation of the mosquitoes (vector) with viruses (pathogen). The virus multiplies in different organs of the mosquito <strong>(Aedes aegypti</strong>, Aedes albopictus, and Toxorhynchites) and can be easily demonstrated.</span></li><li><span style=\"font-size:12.0pt;\">In <strong>Trichinella spirals </strong>infection, muscle biopsy bits from suspected patients are fed to laboratory <strong>rats (vector) for T. spiralis</strong>. The larvae of T. spiralis can be demonstrated in the muscles of the infected lab rats.</span></li></ol><p> </p><p><span style=\"font-size:12.0pt;\"><strong>Advantage of xeno-diagnosis:</strong> It is useful in cases where a direct microscopic diagnosis is difficult due to the low count of pathogens in the blood of the host/patient.</span></p><p> </p><p><span style=\"font-size:12.0pt;\"><strong>Other Options:</strong></span></p><p> </p><p><span style=\"font-size:12.0pt;\"><strong>Option A. Rabbit ileal loop assay for ETEC:</strong> This is not a xenodiagnostic method but a laboratory assay to test the enterotoxigenicity of ETEC (Enterotoxigenic Escherichia coli).</span></p><p> </p><p><span style=\"font-size:12.0pt;\"><strong>Option C. Injecting a hamster with splenic biopsy for diagnosis of leishmaniasis:</strong> This method is not classified as xenodiagnosis; it is a form of animal inoculation for diagnosing Leishmaniasis.</span></p><p> </p><p><span style=\"font-size:12.0pt;\"><strong>Option D. Intradermal test on guinea pigs for toxigenicity of Corynebacterium diphtheria:</strong> This is the Elek test for diphtheria toxin production and is not a xenodiagnostic method.</span></p><p> </p><p><span style=\"font-size:12.0pt;\"><strong>Educational Objective:</strong></span></p><p> </p><p><span style=\"font-size:12.0pt;\">Xenodiagnosis involves using a vector to detect the presence of pathogens by allowing the vector to feed on or be injected with the patient's tissue, then examining the vector for the pathogen. Injecting Aedes thorax with blood of a patient with suspected dengue is a classic example of this diagnostic method.</span></p>",
      "correct_choice_id": 200525,
      "solution_audio": null,
      "solution_video": null,
      "audio_explanation_heading": null,
      "video_explanation_heading": null,
      "solution_media_position": "bottom",
      "tags": [],
      "explanation_video": null,
      "question_images": [],
      "explanation_images": []
    },
    {
      "id": 50132,
      "choices": [
        {
          "id": 200528,
          "text": "<p><span style=\"font-size:12.0pt;\">1, 2</span></p>"
        },
        {
          "id": 200529,
          "text": "<p><span style=\"font-size:12.0pt;\">2, 3</span></p>"
        },
        {
          "id": 200530,
          "text": "<p><span style=\"font-size:12.0pt;\">1, 4</span></p>"
        },
        {
          "id": 200531,
          "text": "<p><span style=\"font-size:12.0pt;\">3</span></p>"
        }
      ],
      "text": "<p><span style=\"font-size:12.0pt;\">Which of these labeled structures represents a division of the internal carotid artery? (</span>AIIMS Nov 2019)</p><p> </p><p><span style=\"font-size:12.0pt;\"><img src=\"https://cerebellum-web-static.s3.amazonaws.com/media/public/images/2023/03/31/31_sui9nIs.jpg\" alt=\"\" width=\"400\" height=\"329\"></span></p><p><img src=\"https://cerebellum-web-static.s3.amazonaws.com/media/public/images/2023/03/31/31_sui9nIs.jpg\" alt=\"Question Image\"></p>",
      "unique_key": "Q6543508",
      "question_audio": null,
      "question_video": null,
      "map_id": 34756960,
      "difficulty_level": "intermediate",
      "subjects_id": [],
      "solution": "<p><span style=\"font-size:12.0pt;\"><strong>Ans. C) 1, 4</strong></span></p><p> </p><p><span style=\"font-size:12.0pt;\">The structure marked 1 and 4 are the anterior ethmoidal artery and posterior ethmoidal artery, which are branches of the ophthalmic division of the internal carotid artery.</span></p><p> </p><p><span style=\"font-size:12.0pt;\"><strong>Educational Objective:</strong></span></p><p> </p><p><span style=\"font-size:12.0pt;\">Vascular Supply of the Nasal Cavity:</span></p><p> </p><p><span style=\"font-size:12.0pt;\"><img src=\"https://cerebellum-web-static.s3.amazonaws.com/media/public/images/2023/03/31/32_vngPIsW.jpg\" alt=\"\" width=\"700\" height=\"722\"></span></p><p> </p><p><span style=\"font-size:12.0pt;\"><strong>Ref - Dhingra 7<sup>th</sup> edition, Page No. 198</strong></span></p><p><img src=\"https://cerebellum-web-static.s3.amazonaws.com/media/public/images/2023/03/31/32_vngPIsW.jpg\" alt=\"Solution Image\"></p>",
      "correct_choice_id": 200530,
      "solution_audio": null,
      "solution_video": null,
      "audio_explanation_heading": null,
      "video_explanation_heading": null,
      "solution_media_position": "bottom",
      "tags": [],
      "explanation_video": null,
      "question_images": [],
      "explanation_images": []
    },
    {
      "id": 50133,
      "choices": [
        {
          "id": 200532,
          "text": "<p style=\"margin-right:3px\"><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span dir=\"ltr\" lang=\"PT-BR\" style=\"font-size:12.0pt\">Hemangioblastoma</span></span></span></p>"
        },
        {
          "id": 200533,
          "text": "<p style=\"margin-right:3px\"><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span dir=\"ltr\" lang=\"PT-BR\" style=\"font-size:12.0pt\">Ewing's sarcoma</span></span></span></p>"
        },
        {
          "id": 200534,
          "text": "<p style=\"margin-right:3px\"><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span dir=\"ltr\" lang=\"PT-BR\" style=\"font-size:12.0pt\">Retinoblastoma</span></span></span></p>"
        },
        {
          "id": 200535,
          "text": "<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span style=\"font-size:12.0pt\">Neuroblastoma</span></span></span></p>"
        }
      ],
      "text": "<p><span style=\"font-size:12.0pt\"><span style=\"font-family:\"Calibri\",sans-serif\">All are small round blue cell tumors except: (AIIMS NOV 2019)</span></span></p>",
      "unique_key": "Q7132500",
      "question_audio": null,
      "question_video": null,
      "map_id": 34793116,
      "difficulty_level": "intermediate",
      "subjects_id": [],
      "solution": "<p style=\"margin-right:3px\"><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\">Ans. A) Hemangioblastoma</span></strong> </span></span></p>\r\n\r\n<p style=\"margin-right:3px\"> </p>\r\n\r\n<p style=\"margin-right:3px\"><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\">Hemangioblastoma is not a small round blue cell tumor.</span></span></span></p>\r\n\r\n<p style=\"margin-right:3px\"> </p>\r\n\r\n<p style=\"margin-right:3px\"><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\">Many childhood tumors have been collectively referred to as small round blue cell tumors due to their primitive histologic appearance. </span></span></span></p>\r\n\r\n<p style=\"margin-right:3px\"> </p>\r\n\r\n<p style=\"margin-right:3px\"><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\">The differential diagnosis of such tumors includes neuroblastoma, Wilms tumor, lymphoma, rhabdomyosarcoma, Ewing sarcoma/primitive neuroectodermal tumor, medulloblastoma and retinoblastoma.</span></span></span></p>\r\n\r\n<p style=\"margin-right:3px\"> </p>\r\n\r\n<p style=\"margin-right:3px\"><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span style=\"font-size:12.0pt\">Other Options:</span></strong></span></span></p>\r\n\r\n<p style=\"margin-right:3px\"> </p>\r\n\r\n<p style=\"margin-right:3px\"><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\">Option B. Ewing's sarcoma</span></strong><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\">: Ewing's sarcoma is a classic example of a small round blue cell tumor. It is a highly malignant tumor that primarily affects bone and soft tissues, particularly in children and young adults.</span></span></span></p>\r\n\r\n<p style=\"margin-right:3px\"> </p>\r\n\r\n<p style=\"margin-right:3px\"><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\">Option C. Retinoblastoma</span></strong><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\">: Retinoblastoma is a small round blue cell tumor of the eye, commonly seen in children. It is characterized by the presence of small, undifferentiated cells with hyperchromatic nuclei.</span></span></span></p>\r\n\r\n<p style=\"margin-right:3px\"> </p>\r\n\r\n<p style=\"margin-right:3px\"><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\">Option D. Neuroblastoma</span></strong><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\">: Neuroblastoma is another example of a small round blue cell tumor. It arises from neural crest cells and is most commonly found in the adrenal glands or along the sympathetic chain.</span></span></span></p>\r\n\r\n<p style=\"margin-right:3px\"> </p>\r\n\r\n<p style=\"margin-right:3px\"><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span style=\"font-size:12.0pt\">Educational Objective:</span></strong></span></span></p>\r\n\r\n<p style=\"margin-right:3px\"> </p>\r\n\r\n<p style=\"margin-right:3px\"><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\">Hemangioblastoma is <strong>not</strong> classified as a small round blue cell tumor, unlike Ewing's sarcoma, retinoblastoma, and neuroblastoma.</span></span></span></p>\r\n\r\n<p style=\"margin-right:3px\"> </p>\r\n\r\n<p style=\"margin-right:3px\"><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\">Ref: Robbins and cotrans pathologic basis of disease 8<sup>th</sup> edition pg 882</span></strong></span></span></p>",
      "correct_choice_id": 200532,
      "solution_audio": null,
      "solution_video": null,
      "audio_explanation_heading": null,
      "video_explanation_heading": null,
      "solution_media_position": "bottom",
      "tags": [],
      "explanation_video": null,
      "question_images": [],
      "explanation_images": []
    },
    {
      "id": 50134,
      "choices": [
        {
          "id": 200536,
          "text": "<p><span style=\"font-size:12.0pt;\">Acute respiratory infection</span></p>"
        },
        {
          "id": 200537,
          "text": "<p><span style=\"font-size:12.0pt;\">Kartagener syndrome</span></p>"
        },
        {
          "id": 200538,
          "text": "<p><span style=\"font-size:12.0pt;\">Situs inversus</span></p>"
        },
        {
          "id": 200539,
          "text": "<p><span style=\"font-size:12.0pt;\">Cystic fibrosis</span></p>"
        }
      ],
      "text": "<p><span style=\"font-size:12.0pt;\">Ciliocytophthoria is seen in? (AIIMS NOV 2019)</span></p>",
      "unique_key": "Q6735238",
      "question_audio": null,
      "question_video": null,
      "map_id": 34278526,
      "difficulty_level": "intermediate",
      "subjects_id": [],
      "solution": "<p><span style=\"font-size:12.0pt;\"><strong>Ans. A) Acute respiratory infection</strong></span></p><p> </p><p><span style=\"font-size:12.0pt;\">Ciliocytophthoria refers to the degeneration of ciliated cells. It occurs in viral infections, such as acute respiratory infections.</span></p><p> </p><p><span style=\"font-size:12.0pt;\"><strong>Other Options:</strong></span></p><p> </p><p><span style=\"font-size:12.0pt;\"><strong>Options B. Kartagener syndrome and C. Situs inversus</strong>: Kartagener syndrome also known as primary ciliary dyskinesia/ immotile cilia syndrome is due to a <strong>defect in the dynein arm of cilia</strong>. It is characterized by the triad of:</span></p><p> </p><ul><li><span style=\"font-size:12.0pt;\">Sinusitis</span></li><li><span style=\"font-size:12.0pt;\">Situs inversus - Major visceral organs are reversed or mirrored from their normal positions</span></li><li><span style=\"font-size:12.0pt;\">Bronchiectasis</span></li></ul><p> </p><p><span style=\"font-size:12.0pt;\"><strong>Infertility is also seen in Kartagener syndrome but it is not a part of its triad.</strong></span></p><p> </p><p><span style=\"font-size:12.0pt;\"><strong>Option D. Cystic fibrosis</strong>: In cystic fibrosis ciliary ultrastructure remains normal.</span></p><p> </p><p><span style=\"font-size:12.0pt;\"><strong>NOTE</strong>: <strong>Kartagener syndrome and cystic fibrosis are two different genetic disorders that can affect fertility in different ways.</strong></span></p><p> </p><ul><li><span style=\"font-size:12.0pt;\">In men with Kartagener syndrome, the cilia in the sperm cells may be abnormal or immotile, which can result in <strong>reduced sperm count and motility</strong>, leading to male infertility. Women with Kartagener syndrome may have reduced fertility due to impaired ciliary function in the fallopian tubes, which can lead to difficulty in egg transport and fertilization.</span></li><li><span style=\"font-size:12.0pt;\">In the reproductive system, CF can cause thick, <strong>sticky mucus to block the vas deferens</strong> in men, leading to infertility due to the absence of sperm in the ejaculate. Women with CF may have reduced fertility due to <strong>thick cervical mucus that can impede sperm transport</strong> or block the fallopian tubes, preventing fertilization.</span></li></ul><p> </p><p><span style=\"font-size:12.0pt;\">Overall, both Kartagener syndrome and cystic fibrosis can lead to infertility, but the underlying mechanisms and specific impacts on fertility can differ between the two conditions.</span></p><p> </p><p><span style=\"font-size:12.0pt;\"><strong>Educational Objective:</strong></span></p><p><span style=\"font-size:11pt;\"> </span></p><p><span style=\"font-size:12.0pt;\">Ciliocytophthoria, the degeneration of ciliated cells, is typically seen in viral infections, such as acute respiratory infections.</span></p><p> </p><p><span style=\"font-size:12.0pt;\"><strong>Ref: Robbins and Cotrans Pathologic basis of disease 8<sup>th</sup> edition pg 1292</strong></span></p>",
      "correct_choice_id": 200536,
      "solution_audio": null,
      "solution_video": null,
      "audio_explanation_heading": null,
      "video_explanation_heading": null,
      "solution_media_position": "bottom",
      "tags": [],
      "explanation_video": null,
      "question_images": [],
      "explanation_images": []
    },
    {
      "id": 50135,
      "choices": [
        {
          "id": 200540,
          "text": "<p><span style=\"font-size:12.0pt;\">Secretin</span></p>"
        },
        {
          "id": 200541,
          "text": "<p><span style=\"font-size:12.0pt;\">Gastrin</span></p>"
        },
        {
          "id": 200542,
          "text": "<p><span style=\"font-size:12.0pt;\">Cholecystokinin</span></p>"
        },
        {
          "id": 200543,
          "text": "<p><span style=\"font-size:12.0pt;\">GIP</span></p>"
        }
      ],
      "text": "<p><span style=\"font-size:12.0pt;\">Which of the following hormones do not act on the pancreas? (</span>AIIMS Nov 2019)</p>",
      "unique_key": "Q7655684",
      "question_audio": null,
      "question_video": null,
      "map_id": 34533073,
      "difficulty_level": "intermediate",
      "subjects_id": [],
      "solution": "<p><span style=\"font-size:12.0pt;\"><strong>Ans. B) Gastrin</strong></span></p><p> </p><p><span style=\"font-size:12.0pt;\">Gastrin does not act upon the pancreas. Gastrin stimulates gastric acid secretion and gastric mucosal growth.</span></p><p> </p><p><span style=\"font-size:12.0pt;\"><img src=\"https://cerebellum-web-static.s3.amazonaws.com/media/public/images/2023/04/05/aiims-physio-nov-2019-03_yC9p1uA.jpg\" alt=\"\" width=\"600\" height=\"520\"></span></p><p> </p><p><span style=\"font-size:12.0pt;\"><strong>Other Options:  </strong></span></p><p> </p><p><span style=\"font-size:12pt;\"><strong>Option A.</strong> </span><span style=\"font-size:12.0pt;\"><strong>Secretin</strong> is released by the small intestine in response to the presence of acidic chyme. It stimulates the pancreas to secrete bicarbonate-rich pancreatic juice, which helps neutralize the acidity of the chyme entering the small intestine.</span></p><p> </p><p><span style=\"font-size:12pt;\"><strong>Option C.</strong> </span><span style=\"font-size:12.0pt;\"><strong>Cholecystokinin (CCK)</strong> is released by the small intestine in response to the presence of fats and proteins. It stimulates the pancreas to secrete digestive enzymes, including pancreatic amylase, lipase, and proteases, which aid in the digestion of fats, carbohydrates, and proteins.</span></p><p> </p><p><span style=\"font-size:12pt;\"><strong>Option D.</strong> </span><span style=\"font-size:12.0pt;\"><strong>GIP (Glucose-dependent insulinotropic peptide),</strong> also known as gastric inhibitory polypeptide, is released by the small intestine in response to the presence of nutrients, particularly glucose and fat. While its primary role is to stimulate the release of insulin from pancreatic beta cells in response to elevated blood glucose levels, it also indirectly influences the pancreas by enhancing the release of pancreatic enzymes.</span></p><p> </p><p><span style=\"font-size:12.0pt;\"><strong>Educational Objective:</strong></span></p><p> </p><p><span style=\"font-size:12.0pt;\">Gastrin does not act on the pancreas. Instead, it stimulates gastric acid secretion and gastric mucosal growth, while Secretin, CCK, and GIP have direct or indirect actions on the pancreas.</span></p><p><img src=\"https://cerebellum-web-static.s3.amazonaws.com/media/public/images/2023/04/05/aiims-physio-nov-2019-03_yC9p1uA.jpg\" alt=\"Solution Image\"></p>",
      "correct_choice_id": 200541,
      "solution_audio": null,
      "solution_video": null,
      "audio_explanation_heading": null,
      "video_explanation_heading": null,
      "solution_media_position": "bottom",
      "tags": [],
      "explanation_video": null,
      "question_images": [],
      "explanation_images": []
    },
    {
      "id": 50136,
      "choices": [
        {
          "id": 200544,
          "text": "<p><span style=\"font-size:12.0pt;\">Lisfranc fracture</span></p>"
        },
        {
          "id": 200545,
          "text": "<p><span style=\"font-size:12.0pt;\">Jones fracture</span></p>"
        },
        {
          "id": 200546,
          "text": "<p><span style=\"font-size:12.0pt;\">Shin splint</span></p>"
        },
        {
          "id": 200547,
          "text": "<p><span style=\"font-size:12.0pt;\">Nutcracker fracture</span></p>"
        }
      ],
      "text": "<p style=\"text-align:justify;\"><span style=\"font-size:12.0pt;\">A young marathon runner is participating in a marathon competition. After running for 100 m, he develops pain at the anteromedial aspect of tibia which was mild to start with, but increased on further running. X-ray was normal. The doctor ordered a bone scan. What is the likely diagnosis? (AIIMS NOV 2019)</span></p>",
      "unique_key": "Q1899024",
      "question_audio": null,
      "question_video": null,
      "map_id": 34314742,
      "difficulty_level": "intermediate",
      "subjects_id": [],
      "solution": "<p><span style=\"font-size:12.0pt;\"><strong>Ans. C) Shin splint</strong></span></p><p> </p><p><span style=\"font-size:12.0pt;\"><strong>STRESS/FATIGUE FRACTURE</strong></span></p><p> </p><ul><li><span style=\"font-size:12.0pt;\">Stress fracture is due to imbalance between load and resistance of bone.</span></li><li><span style=\"font-size:12.0pt;\"><strong>It is of 2 types:</strong></span><ol><li><span style=\"font-size:12.0pt;\"><strong>Fatigue fracture</strong>: Caused by application of abnormal stress on normal bone.</span></li><li><span style=\"font-size:12.0pt;\"><strong>Insufficiency fracture</strong>: Caused by normal activity on weak bone.</span></li></ol></li><li><span style=\"font-size:12.0pt;\"><strong>Sites of Stress Fractures:</strong></span><ol style=\"list-style-type:decimal;\"><li><span style=\"font-size:12.0pt;\"><strong>Lower Extremity:</strong></span><ul style=\"list-style-type:square;\"><li><span style=\"font-size:12.0pt;\"><strong>March fracture </strong>is a stress fatigue fracture of second metatarsal neck > 3rd metatarsal neck. The most common site is metatarsal neck followed by tibia (proximal third in children, middle third in athlete and lower third in elderly).</span></li><li><span style=\"font-size:12.0pt;\"><strong>Tibia stress fracture </strong>= Shin splints</span></li><li><span style=\"font-size:12.0pt;\"><strong>Femoral neck </strong>(inferomedial compression side in young and superior tension side in older patients).</span></li><li><span style=\"font-size:12.0pt;\">Rarely fibula lower end (<strong>runner’s fracture</strong>).</span></li></ul></li><li><span style=\"font-size:12.0pt;\"><strong>Upper Extremity:</strong></span><ul style=\"list-style-type:square;\"><li><span style=\"font-size:12.0pt;\">Olecranon is most common site of upper limb stress fractures.</span></li></ul></li><li><span style=\"font-size:12.0pt;\"><strong>Pelvis and Spine:</strong></span><ul style=\"list-style-type:square;\"><li><span style=\"font-size:12.0pt;\">Pars interarticularis of 5th lumbar vertebral (causing spondylolysis) is commonest in spine.</span></li></ul></li></ol></li><li><span style=\"font-size:12.0pt;\"><strong>Clinical Presentation:</strong></span><ul style=\"list-style-type:circle;\"><li><span style=\"font-size:12.0pt;\">Load related pain often bilateral</span></li><li><span style=\"font-size:12.0pt;\">The hallmark physical finding is tenderness with palpation and stress.</span></li></ul></li><li><span style=\"font-size:12.0pt;\"><strong>Investigation:</strong></span><ul style=\"list-style-type:circle;\"><li><span style=\"font-size:12.0pt;\"><strong>MRI provides excellent sensitivity and superior specificity </strong>compared to bone scan in differentiating from infections or tumors.</span></li><li><span style=\"font-size:12.0pt;\">Bone scan is preferable for bilateral cases due to feasibility, also bilateral cases go in favour of stress fracture as compared to Infection or tumor and also can scan the whole body.</span></li></ul></li><li><span style=\"font-size:12.0pt;\"><strong>Treatment</strong>: Symptomatic with cast and cessation of activity.</span></li></ul><p> </p><p><span style=\"font-size:12.0pt;\"><strong><u>Explanation:</u></strong></span></p><p> </p><p><span style=\"font-size:12.0pt;\"><strong>Option A. Lisfranc fracture. </strong>A Lisfranc dislocation is a spectrum of injuries involving the tarsometatarsal joints of the foot. The Lisfranc joint is composed of the articulation between the first, second, and third metatarsals bones, and the cuneiform bones. Injury of the joint can range from complete tarsometatarsal displacement with associated fractures and ligamentous tears to partial sprains with no displacement. Lisfranc injuries are uncommon and are often misdiagnosed. Even when recognized and treated promptly, there is still a high risk for chronic disability and complications. There are two main mechanisms of injury: direct, and indirect. A direct mechanism occurs as a crush injury to the joint from motor vehicle collision or industrial accident. An indirect injury is more common and is often associated with sports participation involving a longitudinal force with the foot in plantarflexion with a medial or lateral rotational force. The patient presents with complaint of midfoot pain with weight-bearing, following an acute injury. The pain worsens by forefoot weight bearing, and the patient may describe pain or difficulty with the push-off phases of walking and/or running. There is pain with abduction and eversion of the forefoot. Pain can also commonly be reproduced with passive pronation or supination of the tarsometatarsal joint. Radiographic findings show misalignment of the lateral margin of the first metatarsal base with the lateral edge of the medial cuneiform, misalignment of the medial aspect of the second metatarsal base with the medial edge of the middle cuneiform, and/or small avulsion fragments a one of metatarsal or cuneiform bones. On oblique view, the medial aspect of the cuboid should line up with the medial aspect of the fourth metatarsal base. The dorsal cortex of the first metatarsal and medial cuneiform should be aligned on the lateral radiographs. Lisfranc injuries can be managed operatively. Initial treatment includes reduction, splinting, and elevation. After six weeks, if the patient is non-tender and radiographs are negative, then begin weight-bearing and rehabilitation. If there is any tenderness but no displacement, then the patient should be in a boot or cast for at least another four weeks before starting rehabilitation. Any displacement requires surgical fixation.</span></p><p> </p><p><span style=\"font-size:12.0pt;\"><img src=\"https://cerebellum-web-static.s3.amazonaws.com/media/public/images/2024/01/17/picture1_fqIXgzu.jpg\" alt=\"\" width=\"500\" height=\"292\"></span></p><p> </p><p><span style=\"font-size:12.0pt;\"><strong>Option B. Jones fracture. </strong>A <strong>Jones fracture </strong>is a fracture of the proximal metadiaphyseal junction of the fifth metatarsal bone that involves the 4<sup>th</sup>-5<sup>th</sup> metatarsal articulation. The fracture occurs as a result of significant adduction force to the forefoot with the ankle in plantar flexion. On a plain radiograph, Jones fracture is located at the metadiaphyseal junction, approximately 2 cm (1.5-3 cm) from the tip of the 5<sup>th</sup> metatarsal and has a predominantly horizontal course. It should not extend distally. Jones fractures are particularly prone to non-union due to being in a vascular watershed zone and take longer than two months to heal. Displacement of the fracture can increase with persistent weight-bearing; therefore, immobilization is important, with a non-weight bearing cast for 6-8 weeks. Indications for non-operative management include undisplaced fractures and fractures in patients with limited activity (i.e. recreational athletes). Operative management is indicated in patients that are elite or competitive athletes or when delayed union has occurred. Management includes either intramedullary screw fixation or open reduction and internal fixation. </span></p><p> </p><p><img src=\"https://cerebellum-web-static.s3.amazonaws.com/media/public/images/2024/01/17/picture2_enik85f.jpg\" alt=\"\" width=\"400\" height=\"376\"></p><p> </p><p><span style=\"font-size:12.0pt;\"><strong>Option D. Nutcracker fracture. </strong>A <strong>nutcracker fracture </strong>refers to a cuboid bone fracture with associated navicular avulsion fracture due to compression between the bases of 4<sup>th</sup> and 5<sup>th</sup> metatarsals and calcaneus bone. The injury usually occurs secondary to the traumatic abduction of the forefoot. This results in loss of the normal lateral column support and excess valgus force upon the medial column that commonly causes rupture of tibialis posterior tendon or avulsion fracture of its attachment onto medial aspect of the tarsal navicular bone. Nutcracker fractures are clinically significant because they can interfere with the medchanical alignment of the foot.</span></p><p> </p><p><span style=\"font-size:12.0pt;\"><strong><u>Educational objective:</u></strong></span></p><p> </p><ul><li><span style=\"font-size:12.0pt;\">Shint splint or stress fracture of tibia is the most common injury in runners.</span></li></ul><p><img src=\"https://cerebellum-web-static.s3.amazonaws.com/media/public/images/2024/01/17/picture1_fqIXgzu.jpg\" alt=\"Solution Image\"></p>",
      "correct_choice_id": 200546,
      "solution_audio": null,
      "solution_video": null,
      "audio_explanation_heading": null,
      "video_explanation_heading": null,
      "solution_media_position": "bottom",
      "tags": [],
      "explanation_video": null,
      "question_images": [],
      "explanation_images": []
    },
    {
      "id": 50137,
      "choices": [
        {
          "id": 200548,
          "text": "<p><span style=\"font-size:12.0pt;\">Echinococcus multilocularis</span></p>"
        },
        {
          "id": 200549,
          "text": "<p><span style=\"font-size:12.0pt;\">Echinococcus granulosus</span></p>"
        },
        {
          "id": 200550,
          "text": "<p><span style=\"font-size:12.0pt;\">Entamoeba histolvtica</span></p>"
        },
        {
          "id": 200551,
          "text": "<p><span style=\"font-size:12.0pt;\">Cysticercus cellulose</span></p>"
        }
      ],
      "text": "<p><span style=\"font-size:12.0pt;\">Which of the following organisms cause multiple alveolar-like lesions in the liver? (INICET NOV 2019)</span></p>",
      "unique_key": "Q8999850",
      "question_audio": null,
      "question_video": null,
      "map_id": 34691021,
      "difficulty_level": "intermediate",
      "subjects_id": [],
      "solution": "<p><span style=\"font-size:12.0pt;\"><strong>Ans. A) Echinococcus multilocularis</strong></span></p><p> </p><p><span style=\"font-size:12.0pt;\">E. multilocularis leads to alveolar or multilocular hydatid cyst. The <strong>liver is the most commonly affected organ</strong>. The multilocular infiltrating lesion appears like a grossly invasive growth, without any fluid or free brood capsule or scolices which <u>can be mistaken for a malignant tumor</u>.</span></p><p> </p><p><span style=\"font-size:12.0pt;\">Patients present with upper quadrant and epigastric pain. <u>Liver enlargement and obstructive jaundice may also be present</u>. It <strong>may also metastasize</strong> to the spleen, lungs and brain in 2% cases.</span></p><p> </p><p><span style=\"font-size:12.0pt;\">The prognosis is very grave and if untreated, <strong>70% cases progress to death.</strong></span></p><p> </p><p><span style=\"font-size:12.0pt;\"><strong>Surgical resection, when possible, is the best method of treatment</strong>. <u>Albendazole therapy is recommended for 2 years after curative surgery</u>. In those cases, where surgery is not possible, indefinite treatment with albendazole is recommended.</span></p><p> </p><p><span style=\"font-size:12.0pt;\"><strong>Other Options:</strong></span></p><p> </p><p><span style=\"font-size:12.0pt;\"><strong>Option B. Echinococcus granulosus:</strong> Causes cystic echinococcosis or hydatid disease, which typically involves the formation of fluid-filled cysts rather than alveolar-like lesions.</span></p><p> </p><p><span style=\"font-size:12.0pt;\"><strong>Option C. Entamoeba histolytica:</strong> Causes amoebic liver abscesses, which are different in appearance and pathology from the lesions caused by Echinococcus multilocularis.</span></p><p> </p><p><span style=\"font-size:12.0pt;\"><strong>Option D. Cysticercus cellulose:</strong> The larval stage of Taenia solium, which causes cysticercosis. It can form cysts in various tissues but does not cause alveolar-like lesions in the liver.</span></p><p> </p><p><span style=\"font-size:12.0pt;\"><strong>Educational Objective:</strong></span></p><p> </p><p><span style=\"font-size:12.0pt;\">Echinococcus multilocularis causes multiple alveolar-like lesions in the liver, leading to a serious condition known as alveolar echinococcosis. The prognosis is poor without treatment, emphasizing the importance of early detection and appropriate therapy.</span></p>",
      "correct_choice_id": 200548,
      "solution_audio": null,
      "solution_video": null,
      "audio_explanation_heading": null,
      "video_explanation_heading": null,
      "solution_media_position": "bottom",
      "tags": [],
      "explanation_video": null,
      "question_images": [],
      "explanation_images": []
    },
    {
      "id": 50138,
      "choices": [
        {
          "id": 200552,
          "text": "<p><span style=\"font-size:12.0pt;\">IV Fluids</span></p>"
        },
        {
          "id": 200553,
          "text": "<p><span style=\"font-size:12.0pt;\">Platelets</span></p>"
        },
        {
          "id": 200554,
          "text": "<p><span style=\"font-size:12.0pt;\">Cryoglobulins</span></p>"
        },
        {
          "id": 200555,
          "text": "<p><span style=\"font-size:12.0pt;\">FFP</span></p>"
        }
      ],
      "text": "<p><span style=\"font-size:12.0pt;\">During your clinical rotation in infectious diseases, a patient with dengue fever develops warning signs like abdominal pain, persistent vomiting, clinical fluid accumulation, and an increase in hematocrit with a decrease in platelet count. Which of the following is the cornerstone of management for a patient showing warning signs of dengue? (AIIMS NOV 2019)</span></p>",
      "unique_key": "Q4437348",
      "question_audio": null,
      "question_video": null,
      "map_id": 34563990,
      "difficulty_level": "intermediate",
      "subjects_id": [],
      "solution": "<p><span style=\"font-size:12.0pt;\"><strong>Ans. A) IV Fluids </strong></span></p><p> </p><ul><li><span style=\"font-size:12.0pt;\">The mainstay treatment for patients with dengue showing warning signs is intravenous (IV) fluid therapy.</span></li><li><span style=\"font-size:12.0pt;\">This approach is crucial to prevent progression to severe dengue, including dengue hemorrhagic fever (DHF) and dengue shock syndrome (DSS).</span></li></ul><p> </p><p><span style=\"font-size:12.0pt;\"><strong>Other Options:</strong></span></p><p> </p><p><span style=\"font-size:12.0pt;\"><strong>Option B. Platelets: </strong>Only indicated if there is severe thrombocytopenia (<10,000/mm³) with active bleeding.</span></p><p> </p><p><span style=\"font-size:12.0pt;\"><strong>Option C. Cryoglobulins: </strong>Not relevant for dengue management.</span></p><p> </p><p><span style=\"font-size:12.0pt;\"><strong>Option D. FFP (Fresh Frozen Plasma): </strong>Not a primary treatment for dengue with warning signs.</span></p><p> </p><p><span style=\"font-size:12.0pt;\"><strong>Educational Objective:</strong></span></p><p> </p><p><img src=\"https://cerebellum-web-static.s3.amazonaws.com/media/public/images/2024/09/21/screenshot-2024-09-21-111607.png\" alt=\"\" width=\"1000\" height=\"683\"></p><p><img src=\"https://cerebellum-web-static.s3.amazonaws.com/media/public/images/2024/09/21/screenshot-2024-09-21-111607.png\" alt=\"Solution Image\"></p>",
      "correct_choice_id": 200552,
      "solution_audio": null,
      "solution_video": null,
      "audio_explanation_heading": null,
      "video_explanation_heading": null,
      "solution_media_position": "bottom",
      "tags": [],
      "explanation_video": null,
      "question_images": [],
      "explanation_images": []
    },
    {
      "id": 50139,
      "choices": [
        {
          "id": 200556,
          "text": "<p><span style=\"font-size:12.0pt;\">a, b, c are correct</span></p>"
        },
        {
          "id": 200557,
          "text": "<p><span style=\"font-size:12.0pt;\">a and c are correct</span></p>"
        },
        {
          "id": 200558,
          "text": "<p><span style=\"font-size:12.0pt;\">b and d are correct</span></p>"
        },
        {
          "id": 200559,
          "text": "<p><span style=\"font-size:12.0pt;\">a, b, c, d are correct</span></p>"
        }
      ],
      "text": "<p style=\"text-align:justify;\"><span style=\"font-size:12.0pt;\">Evaluate the following statements with respect to intertrochanteric fracture: (</span>AIIMS Nov 2019)</p><p style=\"text-align:justify;\"> </p><ol style=\"list-style-type:lower-alpha;\"><li><span style=\"font-size:12.0pt;\">More common in males than females.</span></li><li><span style=\"font-size:12.0pt;\">1 year mortality rate is 20-30%.</span></li><li><span style=\"font-size:12.0pt;\">It is more commonly associated with nonunion than fracture neck of femur.</span></li><li><span style=\"font-size:12.0pt;\">1 year mortality can be reduced by operating within 48 hours.</span></li></ol>",
      "unique_key": "Q4621719",
      "question_audio": null,
      "question_video": null,
      "map_id": 34729749,
      "difficulty_level": "intermediate",
      "subjects_id": [],
      "solution": "<p><span style=\"font-size:12.0pt;\"><strong>Ans. C) b and d are correct.</strong></span></p><p> </p><p><span style=\"font-size:12.0pt;\"><strong>Explanation:</strong></span></p><p> </p><p><span style=\"font-size:12.0pt;\"><strong>INTERTROCHANTERIC FRACTURE FEMUR</strong></span></p><p> </p><ul><li><span style=\"font-size:12.0pt;\">Intertrochanteric fractures are extracapsular fractures of the proximal femur that occur between the greater and lesser trochanter.</span></li><li><span style=\"font-size:12.0pt;\">This metaphyseal region has a more abundant blood supply, contributing to a higher union rate and less osteonecrosis compared to femoral neck fractures.</span></li><li><span style=\"font-size:12.0pt;\"><strong>Etiology:</strong></span><ul style=\"list-style-type:circle;\"><li><span style=\"font-size:12.0pt;\">These fractures occur both in the elderly and the young, but they are more common in the elderly population with osteoporosis due to a low energy mechanism. </span></li><li><span style=\"font-size:12.0pt;\">The female to male ration is between 2:1 and 8:1.</span></li><li><span style=\"font-size:12.0pt;\">In the younger population, these fractures typically result from a high-energy mechanism.</span></li></ul></li><li><span style=\"font-size:12.0pt;\">These patients present with a short and externally rotated limb.</span></li><li><span style=\"font-size:12.0pt;\"><strong>Treatment:</strong></span></li></ul><p> </p><p><img src=\"https://cerebellum-web-static.s3.amazonaws.com/media/public/images/2024/01/17/screenshot-2024-01-17-155254_OXXasFn.jpg\" alt=\"\" width=\"700\" height=\"306\"></p><p> </p><ul style=\"list-style-type:circle;\"><li><span style=\"font-size:12.0pt;\"><strong>Treatment of choice: </strong>Dynamic Hip Screw (Undisplaced fracture).</span></li><li><span style=\"font-size:12.0pt;\"><strong>Displaced fracture: </strong>Proximal femoral nail (Cephalomedullary nail).</span></li><li><span style=\"font-size:12.0pt;\">Latest literature claims better results with Proximal Femoral Nail (PFN).</span></li><li><span style=\"font-size:12.0pt;\">Most common complication is malunion.</span></li><li><span style=\"font-size:12.0pt;\">1 year mortality rate is 20-30%.</span></li><li><span style=\"font-size:12.0pt;\">1 year mortality can be reduced by operating within 48 hours.</span></li></ul><p> </p><p><span style=\"font-size:12.0pt;\"><strong>INTERTROCHANTERIC FRACTURE VS NECK OF FEMUR FRACTURE</strong></span></p><p> </p><p><span style=\"font-size:12.0pt;\"><strong><img src=\"https://cerebellum-web-static.s3.amazonaws.com/media/public/images/2024/01/17/screenshot-2024-01-17-155523.jpg\" alt=\"\" width=\"1000\" height=\"688\"></strong></span></p><p> </p><p><span style=\"font-size:12.0pt;\"><strong>Educational Objective:</strong></span></p><p> </p><ul><li><span style=\"font-size:12.0pt;\">Intertrochanteric fracture is more common in females than males.</span></li><li><span style=\"font-size:12.0pt;\">Most common complication is malunion.</span></li><li><span style=\"font-size:12.0pt;\">1 year mortality rate is 20-30%.</span></li><li><span style=\"font-size:12.0pt;\">1 year mortality can be reduced by operating within 48 hours.</span></li></ul><p><img src=\"https://cerebellum-web-static.s3.amazonaws.com/media/public/images/2024/01/17/screenshot-2024-01-17-155254_OXXasFn.jpg\" alt=\"Solution Image\"></p>",
      "correct_choice_id": 200558,
      "solution_audio": null,
      "solution_video": null,
      "audio_explanation_heading": null,
      "video_explanation_heading": null,
      "solution_media_position": "bottom",
      "tags": [],
      "explanation_video": null,
      "question_images": [],
      "explanation_images": []
    },
    {
      "id": 50140,
      "choices": [
        {
          "id": 200560,
          "text": "<p><span style=\"font-size:12.0pt;\">Candidiasis</span></p>"
        },
        {
          "id": 200561,
          "text": "<p><span style=\"font-size:12.0pt;\">Aspergillosis</span></p>"
        },
        {
          "id": 200562,
          "text": "<p><span style=\"font-size:12.0pt;\">Pneumocystis pneumonia</span></p>"
        },
        {
          "id": 200563,
          "text": "<p><span style=\"font-size:12.0pt;\">Mucormycosis</span></p>"
        }
      ],
      "text": "<p><span style=\"font-size:12.0pt;\">β 1-3 glucan assay is used to diagnose all except? (INICET NOV 2019)</span></p>",
      "unique_key": "Q2708639",
      "question_audio": null,
      "question_video": null,
      "map_id": 34071428,
      "difficulty_level": "intermediate",
      "subjects_id": [],
      "solution": "<p><span style=\"font-size:12.0pt;\"><strong>Ans. D) Mucormycosis</strong></span></p><p> </p><p><span style=\"font-size:12.0pt;\">The β 1-3 glucan assay cannot be used to diagnose mucormycosis.</span></p><p> </p><p><span style=\"font-size:12.0pt;\">An abundant cell wall polysaccharide, (1-3)-β-d-glucan (BDG) is found in most fungi, with the notable <strong>exception of the cryptococci, the zygomycetes (Mucor, Rhizopus), and Blastomyces dermatitidis</strong>, which either lack the glucan entirely or produce it at minimal levels.</span></p><p> </p><p><span style=\"font-size:12.0pt;\">This assay is a chromogenic, quantitative enzyme immunoassay (EIA) designed to detect BDG (in ng/ml) by using purified, lysed horseshoe crab (Limulus polyphemus) amebocytes.</span></p><p> </p><p><span style=\"font-size:12.0pt;\"><strong>Level of ≥80 pg/mL is considered a positive</strong> result.</span></p><p> </p><p><span style=\"font-size:12.0pt;\"><strong>Other Options:</strong></span></p><p> </p><p><span style=\"font-size:12.0pt;\"><strong>Option A. Candidiasis:</strong> The β 1-3 glucan assay is used to diagnose candidiasis as Candida species produce BDG.</span></p><p> </p><p><span style=\"font-size:12.0pt;\"><strong>Option B. Aspergillosis:</strong> The assay is also effective for diagnosing aspergillosis since Aspergillus species produce BDG.</span></p><p> </p><p><span style=\"font-size:12.0pt;\"><strong>Option C. Pneumocystis pneumonia:</strong> Pneumocystis jirovecii, the causative agent of Pneumocystis pneumonia, produces BDG, making the assay useful for its diagnosis.</span></p><p> </p><p><span style=\"font-size:12.0pt;\"><strong>Educational Objective:</strong></span></p><p> </p><p><span style=\"font-size:12.0pt;\">The β 1-3 glucan assay is not effective for diagnosing mucormycosis because the fungi causing mucormycosis (Mucor, Rhizopus) either lack (1-3)-β-D-glucan or produce it at minimal levels. This assay is useful for diagnosing fungal infections like candidiasis, aspergillosis, and Pneumocystis pneumonia which involve fungi that produce significant levels of BDG.</span></p>",
      "correct_choice_id": 200563,
      "solution_audio": null,
      "solution_video": null,
      "audio_explanation_heading": null,
      "video_explanation_heading": null,
      "solution_media_position": "bottom",
      "tags": [],
      "explanation_video": null,
      "question_images": [],
      "explanation_images": []
    },
    {
      "id": 50141,
      "choices": [
        {
          "id": 200564,
          "text": "<p style=\"text-align:justify;\"><span style=\"font-size:12.0pt;\">BMI > 30</span></p>"
        },
        {
          "id": 200565,
          "text": "<p><span style=\"font-size:12.0pt;\">Well controlled asthma</span></p>"
        },
        {
          "id": 200566,
          "text": "<p><span style=\"font-size:12.0pt;\">Upper abdominal surgery</span></p>"
        },
        {
          "id": 200567,
          "text": "<p><span style=\"font-size:12.0pt;\">Age > 70 years</span></p>"
        }
      ],
      "text": "<p style=\"text-align:justify;\"><span style=\"font-size:12.0pt;\">Which of the following is not a risk factor for postoperative pulmonary complications? (</span>AIIMS Nov 2019)</p>",
      "unique_key": "Q4365515",
      "question_audio": null,
      "question_video": null,
      "map_id": 34408288,
      "difficulty_level": "intermediate",
      "subjects_id": [],
      "solution": "<p><span style=\"font-size:12pt;\"><strong>Ans. B. Well controlled asthma</strong></span></p><p> </p><p><span style=\"font-size:12pt;\"><strong>Explanation:</strong></span></p><p> </p><p><span style=\"font-size:12pt;\"><strong>Well controlled asthma:</strong> Asthma, when well controlled, should not significantly increase the risk of postoperative pulmonary complications. Uncontrolled or poorly controlled asthma, on the other hand, would be a risk factor due to increased airway hyperreactivity and potential for bronchospasm or other complications in the postoperative period.</span></p><p> </p><p><span style=\"font-size:12.0pt;\"><strong>Other Options:</strong></span></p><p> </p><p><span style=\"font-size:12pt;\"><strong>Option A. BMI > 30:</strong> Obesity can reduce functional residual capacity and total lung volume, which increases the risk of atelectasis after surgery. Additionally, obese patients often have decreased diaphragmatic movement and may have associated conditions like obstructive sleep apnea, which can contribute to postoperative respiratory issues.</span></p><p> </p><p><span style=\"font-size:12pt;\"><strong>Option C. Upper abdominal surgery:</strong> Upper abdominal surgeries are associated with a higher risk of postoperative pulmonary complications. The diaphragmatic movement can be impaired after these surgeries, leading to decreased lung expansion and atelectasis, especially in the bases of the lungs. This can increase the chances of postoperative pneumonia and other respiratory issues.</span></p><p> </p><p><span style=\"font-size:12pt;\"><strong>Option D. Age > 70 years:</strong> Advanced age is a recognized risk factor for postoperative complications, including pulmonary complications. Older patients often have reduced physiological reserve, which means they have less ability to compensate for postoperative stress and changes in lung function. Furthermore, they are more likely to have comorbid conditions that can contribute to respiratory issues.</span></p><p> </p><p><span style=\"font-size:12pt;\"><strong>Educational Objective :</strong></span></p><p> </p><p><span style=\"font-size:12pt;\">Well-controlled asthma is not a significant risk factor for postoperative pulmonary complications, unlike other conditions such as obesity, upper abdominal surgery, and advanced age.</span></p><p> </p><p><span style=\"color:black;font-size:12.0pt;\"><strong>Ref: Miller’s Anesthesia, 9<sup>th</sup> Ed. Pgs</strong></span><span style=\"font-size:12.0pt;\"><strong> 2591-2594</strong></span></p>",
      "correct_choice_id": 200565,
      "solution_audio": null,
      "solution_video": null,
      "audio_explanation_heading": null,
      "video_explanation_heading": null,
      "solution_media_position": "bottom",
      "tags": [],
      "explanation_video": null,
      "question_images": [],
      "explanation_images": []
    },
    {
      "id": 50142,
      "choices": [
        {
          "id": 200568,
          "text": "<p><span style=\"font-size:12.0pt;\">Intubation</span></p>"
        },
        {
          "id": 200569,
          "text": "<p><span style=\"font-size:12.0pt;\">Nasogastric tube insertion</span></p>"
        },
        {
          "id": 200570,
          "text": "<p><span style=\"font-size:12.0pt;\">Orogastric tube Insertion</span></p>"
        },
        {
          "id": 200571,
          "text": "<p><span style=\"font-size:12.0pt;\">Oropharyngeal airway insertion</span></p>"
        }
      ],
      "text": "<p><span style=\"font-size:12.0pt;\">The procedure displayed below is? (AIIMS NOV 2019)</span></p><p> </p><p><img src=\"https://cerebellum-web-static.s3.amazonaws.com/media/public/images/2023/04/13/105_r2ydN0d.jpg\" alt=\"\" width=\"300\" height=\"200\"></p><p><img src=\"https://cerebellum-web-static.s3.amazonaws.com/media/public/images/2023/04/13/105_r2ydN0d.jpg\" alt=\"Question Image\"></p>",
      "unique_key": "Q3981406",
      "question_audio": null,
      "question_video": null,
      "map_id": 34669816,
      "difficulty_level": "intermediate",
      "subjects_id": [],
      "solution": "<p><span style=\"font-size:12.0pt;\"><strong>Ans. C) Orogastric tube insertion.</strong></span></p><p> </p><p><span style=\"font-size:12.0pt;\">The procedure depicted in the image is <strong>orogastric tube insertion</strong>. This involves placing a tube through the mouth (orally) and advancing it down into the stomach. Orogastric tubes are commonly used in pediatric patients for several purposes:</span></p><p> </p><ul><li><span style=\"font-size:12.0pt;\"><strong>Enteral rehydration:</strong> In children with mild-to-moderate dehydration, an orogastric tube can be used to facilitate enteral rehydration, allowing for fluid administration directly into the stomach.</span></li><li><span style=\"font-size:12.0pt;\"><strong>Nutritional support:</strong> For children who are severely ill or have significant dehydration, orogastric tubes can also be used for nutritional support by delivering necessary nutrients and medications directly to the stomach.</span></li></ul><p> </p><p><span style=\"font-size:12.0pt;\"><strong>Other Options:</strong></span></p><p> </p><p><span style=\"font-size:12.0pt;\"><strong>Option A. Intubation:</strong> Intubation involves placing a tube into the trachea to maintain an open airway and is primarily used in situations where airway protection or mechanical ventilation is required. This is not the procedure shown in the image.</span></p><p> </p><p><span style=\"font-size:12.0pt;\"><strong>Option B. Nasogastric tube insertion:</strong> Nasogastric tube insertion is similar to orogastric tube insertion, but the tube is inserted through the nose instead of the mouth. While both procedures aim to reach the stomach, the entry point distinguishes them.</span></p><p> </p><p><span style=\"font-size:12.0pt;\"><strong>Option D. Oropharyngeal airway insertion:</strong> Oropharyngeal airways are devices inserted into the mouth to prevent the tongue from obstructing the airway, usually during anesthesia or in unconscious patients. This is not the procedure shown in the image.</span></p><p> </p><p><span style=\"font-size:12.0pt;\"><strong>Educational Objective:</strong></span></p><p> </p><p><span style=\"font-size:12.0pt;\">Orogastric tube insertion involves placing a tube through the mouth into the stomach and is used for rehydration and nutritional support in pediatric patients, particularly those with dehydration or severe illness.</span></p>",
      "correct_choice_id": 200570,
      "solution_audio": null,
      "solution_video": null,
      "audio_explanation_heading": null,
      "video_explanation_heading": null,
      "solution_media_position": "bottom",
      "tags": [],
      "explanation_video": null,
      "question_images": [],
      "explanation_images": []
    },
    {
      "id": 50143,
      "choices": [
        {
          "id": 200572,
          "text": "<p><span style=\"font-size:12.0pt;\">Mineralocorticoids</span></p>"
        },
        {
          "id": 200573,
          "text": "<p><span style=\"font-size:12.0pt;\">Glucocorticoids</span></p>"
        },
        {
          "id": 200574,
          "text": "<p><span style=\"font-size:12.0pt;\">Thyroid hormones</span></p>"
        },
        {
          "id": 200575,
          "text": "<p><span style=\"font-size:12.0pt;\">Estradiol</span></p>"
        }
      ],
      "text": "<p style=\"text-align:justify;\"><span style=\"font-size:12.0pt;\">A 56-year-old woman presented with a gradually diminishing visual field. She was found to have a pituitary mass and underwent trans-sphenoidal hypophysectomy. Now she has low levels of ACTH, TSH, FSH, and LH. Which of the following hormone supplements is not needed in the patient postoperatively? (AIIMS NOV 2019)</span></p>",
      "unique_key": "Q6355225",
      "question_audio": null,
      "question_video": null,
      "map_id": 34077909,
      "difficulty_level": "intermediate",
      "subjects_id": [],
      "solution": "<p><span style=\"font-size:12.0pt;\"><strong>Ans. A) Mineralocorticoids</strong></span></p><p> </p><p><span style=\"font-size:12.0pt;\">After a trans-sphenoidal hypophysectomy, the pituitary gland's ability to produce several hormones including ACTH, TSH, FSH, and LH can be impaired. The lack of ACTH typically necessitates glucocorticoid replacement, but not mineralocorticoid supplementation. This is because the regulation of mineralocorticoids (primarily aldosterone) is mainly via the renin-angiotensin-aldosterone system (RAAS), which operates independently of the pituitary gland. Aldosterone secretion is primarily controlled by plasma potassium levels and the RAAS, not ACTH, although ACTH can have a stimulatory effect.</span></p><p> </p><p><span style=\"font-size:12.0pt;\"><strong>Other Options:</strong></span></p><p> </p><p><span style=\"font-size:12.0pt;\"><strong>Option B. Glucocorticoids: </strong>Low dose steroid supplementation is required as they are ACTH dependent.</span></p><p> </p><p><span style=\"font-size:12.0pt;\"><strong>Option C. Thyroid hormones:</strong> Necessary due to diminished TSH, which is essential for thyroid hormone synthesis and secretion. LT4 supplementation targeting T4 levels is required.</span></p><p> </p><p><span style=\"font-size:12.0pt;\"><strong>Option D. Estradiol: </strong>While gonadotropin supplementation post-pituitary surgery can be complex, replacement might be necessary due to the absence of FSH and LH, affecting estrogen levels.</span></p><p> </p><p><span style=\"font-size:12.0pt;\"><strong>Educational Objective:</strong></span></p><p><br><span style=\"font-size:12.0pt;\">Post-hypophysectomy, patients often require supplementation of several hormones, including glucocorticoids and thyroid hormones, due to impaired pituitary function. However, mineralocorticoid supplementation is typically not needed as aldosterone secretion is primarily regulated by the RAAS system, independent of pituitary control.</span></p><p> </p><p><span style=\"font-size:12.0pt;\"><strong>Reference - Harrison 21E/ Chapter 379/</strong></span></p>",
      "correct_choice_id": 200572,
      "solution_audio": null,
      "solution_video": null,
      "audio_explanation_heading": null,
      "video_explanation_heading": null,
      "solution_media_position": "bottom",
      "tags": [],
      "explanation_video": null,
      "question_images": [],
      "explanation_images": []
    },
    {
      "id": 50144,
      "choices": [
        {
          "id": 200576,
          "text": "<p><span style=\"font-size:12.0pt;\">Minimum volume</span></p>"
        },
        {
          "id": 200577,
          "text": "<p><span style=\"font-size:12.0pt;\">Zero</span></p>"
        },
        {
          "id": 200578,
          "text": "<p><span style=\"font-size:12.0pt;\">﻿﻿﻿Functional residual capacity</span></p>"
        },
        {
          "id": 200579,
          "text": "<p><span style=\"font-size:12.0pt;\">Residual volume</span></p>"
        }
      ],
      "text": "<p><span style=\"font-size:12.0pt;\">If the lung is allowed to undergo elastic recoil without the chest wall, the resultant volume of the lung would be? (</span>AIIMS Nov 2019)</p>",
      "unique_key": "Q5586626",
      "question_audio": null,
      "question_video": null,
      "map_id": 34021859,
      "difficulty_level": "intermediate",
      "subjects_id": [],
      "solution": "<p><span style=\"font-size:12.0pt;\"><strong>Ans. A) Minimum volume</strong></span></p><p> </p><p><span style=\"font-size:12.0pt;\">If lung is allowed to undergo elastic recoil without the chest wall, the resultant volume of the lung would be minimum volume. This is due to the inherent elastic properties of the lung tissue, which tend to make the lungs contract inward when not counteracted by the outward elastic recoil of the chest wall.</span></p><p> </p><p><span style=\"font-size:12.0pt;\"><strong>Other Options:</strong></span></p><p> </p><p><span style=\"font-size:12pt;\"><strong>Option</strong> </span><span style=\"font-size:12.0pt;\"><strong>B. Zero:</strong> Incorrect. The lung cannot have zero volume due to the presence of air in the alveoli and residual airways even at its minimal state.</span></p><p> </p><p><span style=\"font-size:12pt;\"><strong>Option</strong> </span><span style=\"font-size:12.0pt;\"><strong>C. Functional residual capacity:</strong> Incorrect. Functional residual capacity (FRC) is the volume of air present in the lungs at the end of passive expiration, which includes the balance between the inward recoil of the lungs and the outward recoil of the chest wall.</span></p><p> </p><p><span style=\"font-size:12pt;\"><strong>Option</strong> </span><span style=\"font-size:12.0pt;\"><strong>D. Residual volume:</strong> Incorrect. Residual volume (RV) is the volume of air remaining in the lungs after a maximal exhalation. The minimum volume after elastic recoil without the chest wall support would be less than the residual volume.</span></p><p> </p><p><span style=\"font-size:12.0pt;\"><strong>Educational Objective:</strong></span></p><p> </p><p><span style=\"font-size:12.0pt;\">If the lung undergoes elastic recoil without the chest wall, it would collapse to its minimum volume due to the lung's inherent elastic properties.</span></p>",
      "correct_choice_id": 200576,
      "solution_audio": null,
      "solution_video": null,
      "audio_explanation_heading": null,
      "video_explanation_heading": null,
      "solution_media_position": "bottom",
      "tags": [],
      "explanation_video": null,
      "question_images": [],
      "explanation_images": []
    },
    {
      "id": 50145,
      "choices": [
        {
          "id": 200580,
          "text": "<p style=\"margin-right:3px\"><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span style=\"font-size:12.0pt\">Bare lymphocytes</span></span></span></p>"
        },
        {
          "id": 200581,
          "text": "<p style=\"margin-right:3px\"><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span style=\"font-size:12.0pt\">Chronic granulocyte deficiency</span></span></span></p>"
        },
        {
          "id": 200582,
          "text": "<p style=\"margin-right:3px\"><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span style=\"font-size:12.0pt\">Hyper IgM syndrome</span></span></span></p>"
        },
        {
          "id": 200583,
          "text": "<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span style=\"font-size:12.0pt\">DiGeorge syndrome</span></span></span></p>"
        }
      ],
      "text": "<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\">A 3-year-old boy presents with recurrent bacterial infections and Pneumocystis jiroveci pneumonia. The flowcytometry analysis of the boy (Boxes c & d) is shown below (Boxes a & b are normal). What is the most likely diagnosis?</span> </span></span><span style=\"font-size:12.0pt\"><span style=\"font-family:\"Calibri\",sans-serif\">(AIIMS NOV 2019)</span></span></p>\r\n\r\n<p> </p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\"><img alt=\"\" src=\"https://cerebellum-web-static.s3.amazonaws.com/media/public/images/2023/04/12/953.jpg\" style=\"height:507px; width:500px\" /></span></span></span></p><p><img src=\"https://cerebellum-web-static.s3.amazonaws.com/media/public/images/2023/04/12/953.jpg\" alt=\"Question Image\"></p>",
      "unique_key": "Q2537569",
      "question_audio": null,
      "question_video": null,
      "map_id": 34695744,
      "difficulty_level": "intermediate",
      "subjects_id": [],
      "solution": "<p style=\"margin-right:3px\"><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\">Ans. C) Hyper IgM syndrome</span></strong> </span></span></p>\r\n\r\n<p style=\"margin-right:3px\"> </p>\r\n\r\n<p style=\"margin-right:3px\"><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\">The given clinical scenario and the flow cytometry is suggestive of <strong>Hyper IgM syndrome</strong>. The flow cytometry shows the following findings:</span></span></span></p>\r\n\r\n<p style=\"margin-right:3px\"> </p>\r\n\r\n<ul>\r\n\t<li><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\">B-cell gating (images a and c)</span></span></span></li>\r\n\t<li><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\">Side scatter (images b and d)</span></span></span></li>\r\n\t<li><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\">Decrease in the number of CD40 (image d)</span></strong></span></span></li>\r\n</ul>\r\n\r\n<p style=\"margin-right:3px\"> </p>\r\n\r\n<p style=\"margin-right:3px\"><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\">In hyper-IgM syndrome the affected patients make IgM antibodies but are deficient in their ability to produce IgG, IgA, and IgE antibodies<strong>. The ability of helper T cells to deliver activating signals to B cells and macrophages is affected.</strong> Many of the functions of CD4+ helper T cells require the engagement of CD40 on B cells, macrophages and dendritic cells by CD40L (also called CD154) expressed on antigen-activated T cells<strong>. This interaction triggers Ig class switching</strong> and affinity maturation in B cells, and stimulates the microbicidal functions of macrophages.</span></span></span></p>\r\n\r\n<p style=\"margin-right:3px\"> </p>\r\n\r\n<p style=\"margin-right:3px\"><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\">Most of these patients have mutations in the gene encoding CD40 or the enzyme called activation-induced deaminase, a DNA-editing cytosine deaminase that is required for class switching and affinity maturation.</span></span></span></p>\r\n\r\n<p style=\"margin-right:3px\"> </p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\"><img alt=\"\" src=\"https://cerebellum-web-static.s3.amazonaws.com/media/public/images/2023/04/12/954.jpg\" style=\"height:418px; width:500px\" /></span></span></span></p>\r\n\r\n<p> </p>\r\n\r\n<p> </p>\r\n\r\n<p style=\"margin-right:3px\"><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span style=\"font-size:12.0pt\">Other Options:</span></strong></span></span></p>\r\n\r\n<p style=\"margin-right:3px\"> </p>\r\n\r\n<p style=\"margin-right:3px\"><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\">Option A. Bare lymphocytes</span></strong><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\">: This refers to a rare genetic condition where major histocompatibility complex (MHC) molecules are not expressed on the surface of cells, leading to immune deficiency. This condition is unrelated to the findings presented in the question.</span></span></span></p>\r\n\r\n<p style=\"margin-right:3px\"> </p>\r\n\r\n<p style=\"margin-right:3px\"><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\">Option B. Chronic granulocyte deficiency</span></strong><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\">: This refers to Chronic Granulomatous Disease (CGD), a condition where phagocytes cannot effectively kill certain bacteria and fungi. It does not fit the flow cytometry or clinical presentation described in the question.</span></span></span></p>\r\n\r\n<p style=\"margin-right:3px\"> </p>\r\n\r\n<p style=\"margin-right:3px\"><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\">Option D. DiGeorge syndrome</span></strong><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\">: DiGeorge syndrome is a congenital immunodeficiency due to the deletion of chromosome 22q11.2, leading to thymic hypoplasia and T cell deficiency. The clinical and flow cytometry findings in this question do not match those typically seen in DiGeorge syndrome.</span></span></span></p>\r\n\r\n<p style=\"margin-right:3px\"> </p>\r\n\r\n<p style=\"margin-right:3px\"><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span style=\"font-size:12.0pt\">Educational Objective:</span></strong></span></span></p>\r\n\r\n<p style=\"margin-right:3px\"> </p>\r\n\r\n<p style=\"margin-right:3px\"><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\">Hyper IgM syndrome is characterized by a deficiency in class switching due to defective CD40-CD40L interactions, leading to elevated levels of IgM and a lack of other immunoglobulin isotypes.</span></span></span></p><p><img src=\"https://cerebellum-web-static.s3.amazonaws.com/media/public/images/2023/04/12/954.jpg\" alt=\"Solution Image\"></p>",
      "correct_choice_id": 200582,
      "solution_audio": null,
      "solution_video": null,
      "audio_explanation_heading": null,
      "video_explanation_heading": null,
      "solution_media_position": "bottom",
      "tags": [],
      "explanation_video": null,
      "question_images": [],
      "explanation_images": []
    },
    {
      "id": 50146,
      "choices": [
        {
          "id": 200584,
          "text": "<p><span style=\"font-size:12.0pt;\">Seashore sign</span></p>"
        },
        {
          "id": 200585,
          "text": "<p><span style=\"font-size:12.0pt;\">Stratosphere sign</span></p>"
        },
        {
          "id": 200586,
          "text": "<p><span style=\"font-size:12.0pt;\">Lung point sign</span></p>"
        },
        {
          "id": 200587,
          "text": "<p><span style=\"font-size:12.0pt;\">Sinusoidal sign</span></p>"
        }
      ],
      "text": "<p><span style=\"font-size:12.0pt;\">Identify this sign on USG: (AIIMS NOV 2019)  </span></p><p> </p><p><img src=\"https://cerebellum-web-static.s3.amazonaws.com/media/public/images/2024/05/27/screenshot-2024-05-27-092554.jpg\" alt=\"\" width=\"300\" height=\"273\"></p><p><img src=\"https://cerebellum-web-static.s3.amazonaws.com/media/public/images/2024/05/27/screenshot-2024-05-27-092554.jpg\" alt=\"Question Image\"></p>",
      "unique_key": "Q9474906",
      "question_audio": null,
      "question_video": null,
      "map_id": 34130547,
      "difficulty_level": "intermediate",
      "subjects_id": [],
      "solution": "<p><span style=\"font-size:12.0pt;\"><strong>Ans. A. Seashore sign</strong></span></p><p> </p><p><span style=\"font-size:12.0pt;\"><strong>Explanation:</strong></span></p><p><br><span style=\"font-size:12.0pt;\">The image shows the \"Seashore sign\" on M-mode ultrasound, which is used primarily to evaluate for lung sliding. The seashore sign is characterized by a sandy or granular pattern in the lower half of the M-mode display, beneath the pleural line. This pattern is caused by the motion of the lung relative to the pleura during breathing. It is a normal finding, indicating that the lung is sliding smoothly against the parietal pleura, which helps rule out conditions like pneumothorax in the area scanned.</span></p><p> </p><p><span style=\"font-size:12.0pt;\"><strong>Other Options:</strong></span></p><p> </p><p><span style=\"font-size:12.0pt;\"><strong>Option B. Stratosphere sign:</strong> Also known as the \"barcode sign,\" it appears as parallel lines in M-mode and is associated with the absence of lung sliding, often seen in cases of pneumothorax.</span></p><p> </p><p><span style=\"font-size:12.0pt;\"><strong>Option C. Lung point sign:</strong> This is seen in lung ultrasound as the point at which the normal seashore sign of lung sliding transitions to the stratosphere sign in cases of pneumothorax. It is specific for pneumothorax but not depicted in this ultrasound image.</span></p><p> </p><p><span style=\"font-size:12.0pt;\"><strong>Option D. Sinusoidal sign:</strong> Typically refers to a waveform pattern seen in various types of medical imaging and monitoring, not relevant to the depiction of lung sliding on ultrasound.</span></p><p> </p><p><span style=\"font-size:12.0pt;\"><strong>Educational Objective:</strong></span></p><p> </p><p><span style=\"font-size:12.0pt;\">Lung sliding- seen at the pleural lining due to relative motion between pleural layer. Seashore sign- M mode counterpart of lung sliding. Motion of the lung deep to the pleura causes grainy appearance in M-mode, stimulating sand in a seashore.</span></p><p> </p><p><img src=\"https://cerebellum-web-static.s3.amazonaws.com/media/public/images/2024/05/27/screenshot-2024-05-27-102120.jpg\" alt=\"\" width=\"500\" height=\"322\"></p><p><img src=\"https://cerebellum-web-static.s3.amazonaws.com/media/public/images/2024/05/27/screenshot-2024-05-27-102120.jpg\" alt=\"Solution Image\"></p>",
      "correct_choice_id": 200584,
      "solution_audio": null,
      "solution_video": null,
      "audio_explanation_heading": null,
      "video_explanation_heading": null,
      "solution_media_position": "bottom",
      "tags": [],
      "explanation_video": null,
      "question_images": [],
      "explanation_images": []
    },
    {
      "id": 50147,
      "choices": [
        {
          "id": 200588,
          "text": "<p><span style=\"font-size:12.0pt;\">Normal pH can't rule out acid base disorder</span></p>"
        },
        {
          "id": 200589,
          "text": "<p><span style=\"font-size:12.0pt;\">Add 0.5 ml Heparin to the syringe before taking blood</span></p>"
        },
        {
          "id": 200590,
          "text": "<p><span style=\"font-size:12.0pt;\">If modified Allen’s test is negative, alternate site is chosen</span></p>"
        },
        {
          "id": 200591,
          "text": "<p style=\"text-align:justify;\"><span style=\"font-size:12.0pt;\">Radial artery is the preferred site</span></p>"
        }
      ],
      "text": "<p><span style=\"font-size:12pt;\">You are an intern posted in the ICU. While taking a blood sample for ABG, which of the following steps would you not do? (</span>AIIMS Nov 2019)</p>",
      "unique_key": "Q4451611",
      "question_audio": null,
      "question_video": null,
      "map_id": 34268749,
      "difficulty_level": "intermediate",
      "subjects_id": [],
      "solution": "<p><span style=\"font-size:12pt;\"><strong>Ans. B. Add 0.5 ml Heparin to the syringe before taking blood</strong></span></p><p> </p><p><span style=\"font-size:12pt;\"><strong>Explanation:</strong></span></p><p> </p><p><span style=\"font-size:12pt;\"><strong>Add 0.5 ml Heparin to the syringe before taking blood:</strong> Traditionally, to prevent blood from clotting inside the syringe when obtaining an ABG, a small amount of heparin was added to the syringe. However, in contemporary practice, syringes used for ABG are pre-heparinized, which means they already contain a coating of dry heparin that will mix with the blood sample and prevent clotting. Adding additional heparin to such a syringe is unnecessary and can dilute the sample, potentially altering the results.</span></p><p> </p><p><span style=\"font-size:12pt;\"><strong>Other Options:</strong></span></p><p> </p><p><span style=\"font-size:12pt;\"><strong>Option A. Normal pH can't rule out acid base disorder:</strong> This statement is accurate. A patient can have a mixed acid-base disorder where two primary disorders (e.g., metabolic acidosis and respiratory alkalosis) coexist and \"cancel\" each other out, leading to a seemingly \"normal\" pH. However, when the components of the arterial blood gas (ABG) like PaCO2 and HCO3- are evaluated, abnormalities can be detected.</span></p><p> </p><p><span style=\"font-size:12pt;\"><strong>Option C. If modified Allen’s test is negative, alternate site is chosen:</strong> The modified Allen's test is a simple way to evaluate the collateral blood flow to the hand via the ulnar artery. Before taking a sample or placing an arterial line in the radial artery, it's a recommended step to ensure that if the radial artery becomes occluded, the hand will still receive adequate blood flow. If the test is negative (indicative of inadequate collateral flow), it's safer to choose an alternate site for arterial puncture.</span></p><p> </p><p><span style=\"font-size:12pt;\"><strong>Option D. Radial artery is the preferred site:</strong> The radial artery is commonly chosen for ABG sampling and arterial line placement due to its accessibility, the presence of collateral blood flow (via the ulnar artery), and its relatively superficial location which makes puncture technically easier. Furthermore, complications like hematoma or injury are less problematic at this location when compared to other potential sites, such as the femoral artery.</span></p><p> </p><p><span style=\"font-size:12pt;\"><strong>Educational Objective :</strong></span></p><p> </p><p><span style=\"font-size:12pt;\">Adding extra heparin to pre-heparinized ABG syringes is unnecessary and can alter the blood sample.</span></p>",
      "correct_choice_id": 200589,
      "solution_audio": null,
      "solution_video": null,
      "audio_explanation_heading": null,
      "video_explanation_heading": null,
      "solution_media_position": "bottom",
      "tags": [],
      "explanation_video": null,
      "question_images": [],
      "explanation_images": []
    },
    {
      "id": 50148,
      "choices": [
        {
          "id": 200592,
          "text": "<p><span style=\"font-size:12pt\"><span style=\"font-family:\"Times New Roman\",serif\"><span dir=\"ltr\" lang=\"PT-BR\" style=\"font-family:\"Calibri\",sans-serif\">MgSO4</span></span></span></p>"
        },
        {
          "id": 200593,
          "text": "<p><span style=\"font-size:12pt\"><span style=\"font-family:\"Times New Roman\",serif\"><span dir=\"ltr\" lang=\"PT-BR\" style=\"font-family:\"Calibri\",sans-serif\">Nifedipine</span></span></span></p>"
        },
        {
          "id": 200594,
          "text": "<p><span style=\"font-size:12pt\"><span style=\"font-family:\"Times New Roman\",serif\"><span dir=\"ltr\" lang=\"PT-BR\" style=\"font-family:\"Calibri\",sans-serif\">Ritoridine</span></span></span></p>"
        },
        {
          "id": 200595,
          "text": "<p><span style=\"font-size:12pt\"><span style=\"font-family:\"Times New Roman\",serif\"><span style=\"font-family:\"Calibri\",sans-serif\">Isoxsuprine</span></span></span></p>"
        }
      ],
      "text": "<p><span style=\"font-size:12.0pt\"><span style=\"font-family:\"Calibri\",sans-serif\">In preterm labor which drug has a neuro-protective role? (AIIMS NOV 2019)</span></span></p>",
      "unique_key": "Q4994271",
      "question_audio": null,
      "question_video": null,
      "map_id": 34659394,
      "difficulty_level": "intermediate",
      "subjects_id": [],
      "solution": "<p><span style=\"font-size:12pt\"><span style=\"font-family:\"Times New Roman\",serif\"><strong><span style=\"font-family:\"Calibri\",sans-serif\">Ans. A) MgSO4</span></strong></span></span></p>\r\n\r\n<p> </p>\r\n\r\n<p><span style=\"font-size:12pt\"><span style=\"font-family:\"Times New Roman\",serif\"><strong><span style=\"font-family:\"Calibri\",sans-serif\">Explanation:</span></strong></span></span></p>\r\n\r\n<p> </p>\r\n\r\n<p><span style=\"font-size:12pt\"><span style=\"font-family:\"Times New Roman\",serif\"><strong><span style=\"font-family:\"Calibri\",sans-serif\">Neuroprotection in preterm labor:</span></strong></span></span></p>\r\n\r\n<p> </p>\r\n\r\n<ul>\r\n\t<li><span style=\"font-size:12pt\"><span style=\"font-family:\"Times New Roman\",serif\"><span style=\"font-family:\"Calibri\",sans-serif\">The drug given is MgSO4.</span></span></span></li>\r\n\t<li><span style=\"font-size:12pt\"><span style=\"font-family:\"Times New Roman\",serif\"><span style=\"font-family:\"Calibri\",sans-serif\">It reduces the incidence of cerebral palsy and neurodevelopmental delay.</span></span></span></li>\r\n\t<li><span style=\"font-size:12pt\"><span style=\"font-family:\"Times New Roman\",serif\"><span style=\"font-family:\"Calibri\",sans-serif\">IV MgSO4 should be offered for neuroprotection of the baby to all women between 24+0 and 29+6 weeks who are:</span></span></span>\r\n\t<ul style=\"list-style-type:circle\">\r\n\t\t<li><span style=\"font-size:12pt\"><span style=\"font-family:\"Times New Roman\",serif\"><span style=\"font-family:\"Calibri\",sans-serif\">In established preterm labor or</span></span></span></li>\r\n\t\t<li><span style=\"font-size:12pt\"><span style=\"font-family:\"Times New Roman\",serif\"><span style=\"font-family:\"Calibri\",sans-serif\">Having a planned preterm birth within 24 hours.</span></span></span></li>\r\n\t</ul>\r\n\t</li>\r\n\t<li><span style=\"font-size:12pt\"><span style=\"font-family:\"Times New Roman\",serif\"><span style=\"font-family:\"Calibri\",sans-serif\">It can be considered for neuroprotection of the baby for women between 30+0 and 33+6 weeks.</span></span></span></li>\r\n\t<li><span style=\"font-size:12pt\"><span style=\"font-family:\"Times New Roman\",serif\"><strong><span style=\"font-family:\"Calibri\",sans-serif\">Dose:</span></strong><span style=\"font-family:\"Calibri\",sans-serif\"> 4 g intravenous bolus of magnesium sulfate over 15 minutes, followed by an intravenous infusion of 1 g per hour until the birth or for 24 hours (whichever is sooner).</span></span></span></li>\r\n</ul>\r\n\r\n<p> </p>\r\n\r\n<p><span style=\"font-size:12pt\"><span style=\"font-family:\"Times New Roman\",serif\"><strong><span style=\"font-family:\"Calibri\",sans-serif\">Uses of MgSO4 in Obstetrics:</span></strong></span></span></p>\r\n\r\n<p> </p>\r\n\r\n<ol>\r\n\t<li><span style=\"font-size:12pt\"><span style=\"font-family:\"Times New Roman\",serif\"><span style=\"font-family:\"Calibri\",sans-serif\">Treatment of Eclampsia (Anti-seizure)</span></span></span></li>\r\n\t<li><span style=\"font-size:12pt\"><span style=\"font-family:\"Times New Roman\",serif\"><span style=\"font-family:\"Calibri\",sans-serif\">Prophylaxis in severe pre-eclampsia (to prevent eclampsia)</span></span></span></li>\r\n\t<li><span style=\"font-size:12pt\"><span style=\"font-family:\"Times New Roman\",serif\"><span style=\"font-family:\"Calibri\",sans-serif\">As a tocolytic in preterm labor</span></span></span></li>\r\n\t<li><span style=\"font-size:12pt\"><span style=\"font-family:\"Times New Roman\",serif\"><span style=\"font-family:\"Calibri\",sans-serif\">As a neuroprotective drug in preterm labor (especially < 30 weeks)</span></span></span></li>\r\n</ol>\r\n\r\n<p> </p>\r\n\r\n<p><span style=\"font-size:12pt\"><span style=\"font-family:\"Times New Roman\",serif\"><strong><span style=\"font-family:\"Calibri\",sans-serif\">Other Options:</span></strong></span></span></p>\r\n\r\n<p> </p>\r\n\r\n<p><span style=\"font-size:12pt\"><span style=\"font-family:\"Times New Roman\",serif\"><strong><span style=\"font-family:\"Calibri\",sans-serif\">Option B. Nifedipine:</span></strong><span style=\"font-family:\"Calibri\",sans-serif\"> A calcium channel blocker used as a tocolytic and antihypertensive but has no role in neuroprotection.</span></span></span></p>\r\n\r\n<p> </p>\r\n\r\n<p><span style=\"font-size:12pt\"><span style=\"font-family:\"Times New Roman\",serif\"><strong><span style=\"font-family:\"Calibri\",sans-serif\">Option C. Ritodrine:</span></strong><span style=\"font-family:\"Calibri\",sans-serif\"> A beta-sympathomimetic used as a tocolytic but has no neuroprotective role.</span></span></span></p>\r\n\r\n<p> </p>\r\n\r\n<p><span style=\"font-size:12pt\"><span style=\"font-family:\"Times New Roman\",serif\"><strong><span style=\"font-family:\"Calibri\",sans-serif\">Option D. Isoxsuprine:</span></strong><span style=\"font-family:\"Calibri\",sans-serif\"> Another beta-sympathomimetic used as a tocolytic without neuroprotective properties.</span></span></span></p>\r\n\r\n<p> </p>\r\n\r\n<p><span style=\"font-size:12pt\"><span style=\"font-family:\"Times New Roman\",serif\"><strong><span style=\"font-family:\"Calibri\",sans-serif\">Educational Objective:</span></strong></span></span></p>\r\n\r\n<p> </p>\r\n\r\n<p><span style=\"font-size:12pt\"><span style=\"font-family:\"Times New Roman\",serif\"><span style=\"font-family:\"Calibri\",sans-serif\">In preterm labor, MgSO4 is used for neuroprotection, reducing the incidence of cerebral palsy and neurodevelopmental delay in preterm infants.</span></span></span></p>\r\n\r\n<p> </p>\r\n\r\n<p><span style=\"font-size:12pt\"><span style=\"font-family:\"Times New Roman\",serif\"><strong><span style=\"font-family:\"Calibri\",sans-serif\">Ref: William’s textbook of obstetrics 26<sup>th</sup> edition, Dutta’s textbook of obstetrics 8<sup>th</sup> edition pg 538</span></strong></span></span></p>",
      "correct_choice_id": 200592,
      "solution_audio": null,
      "solution_video": null,
      "audio_explanation_heading": null,
      "video_explanation_heading": null,
      "solution_media_position": "bottom",
      "tags": [],
      "explanation_video": null,
      "question_images": [],
      "explanation_images": []
    },
    {
      "id": 50149,
      "choices": [
        {
          "id": 200596,
          "text": "<p><span style=\"font-size:12.0pt;\">3</span></p>"
        },
        {
          "id": 200597,
          "text": "<p><span style=\"font-size:12.0pt;\">4</span></p>"
        },
        {
          "id": 200598,
          "text": "<p><span style=\"font-size:12.0pt;\">5</span></p>"
        },
        {
          "id": 200599,
          "text": "<p><span style=\"font-size:12.0pt;\">6</span></p>"
        }
      ],
      "text": "<p style=\"text-align:justify;\"><span style=\"font-size:12.0pt;\">A study on 100 urban women evaluates potential risk factors for breast cancer using odds ratios (OR) and 95% confidence intervals (CI). An OR > 1 with a CI not including 1 suggests a significant association. How many risk factors show a statistically significant association with breast cancer? (AIIMS NOV 2019)</span></p><p> </p><p><img src=\"https://cerebellum-web-static.s3.amazonaws.com/media/public/images/2023/04/23/ip40.jpg\" alt=\"\" width=\"636\" height=\"329\"></p><p><img src=\"https://cerebellum-web-static.s3.amazonaws.com/media/public/images/2023/04/23/ip40.jpg\" alt=\"Question Image\"></p>",
      "unique_key": "Q5030926",
      "question_audio": null,
      "question_video": null,
      "map_id": 34859345,
      "difficulty_level": "intermediate",
      "subjects_id": [],
      "solution": "<p><span style=\"background-color:hsl(0, 0%, 100%);font-size:12.0pt;\"><strong>Ans. A. 3</strong></span></p><p> </p><p><span style=\"background-color:hsl(0, 0%, 100%);font-size:12.0pt;\">In the above statistical group, the odds ratio of early menarche, BRCA mutation, and obesity show positive association and are statistically significant.</span></p><p> </p><p><span style=\"background-color:hsl(0, 0%, 100%);font-size:12.0pt;\">A high socioeconomic status does not pose a risk factor. Despite observing a positive correlation, the statistical significance is absent. Any correlation with a 95% confidence interval with the value of 1.0 is deemed as statistically insignificant. A value of 1.0 within this range implies that both factors can coexist without one being the cause of the other.</span></p><p><span style=\"background-color:hsl(0, 0%, 100%);font-size:12.0pt;\">Odds ratio (OR) is the key parameter in case-control studies to assess the strength of association between the exposure and outcome. The interpretation of the odds ratio can be done as below:</span></p><p> </p><ul style=\"list-style-type:disc;\"><li><span style=\"background-color:hsl(0, 0%, 100%);font-size:12.0pt;\">OR > 1 indicates a positive association.</span></li><li><span style=\"background-color:hsl(0, 0%, 100%);font-size:12.0pt;\">OR = 1 indicates no association.</span></li><li><span style=\"background-color:hsl(0, 0%, 100%);font-size:12.0pt;\">OR < 1 indicates a negative (protective) association.</span></li></ul><p> </p><p><span style=\"background-color:hsl(0, 0%, 100%);font-size:12.0pt;\">Interpretation of the individual factors given in the question:</span></p><p> </p><p><span style=\"background-color:hsl(0, 0%, 100%);\"><img src=\"https://cerebellum-web-static.s3.amazonaws.com/media/public/image_IjtklbT.png\" width=\"914\" height=\"737\"></span></p><p> </p><p><span style=\"background-color:hsl(0, 0%, 100%);font-size:12.0pt;\"><strong>Educational Objective: </strong></span></p><p> </p><p><span style=\"background-color:hsl(0, 0%, 100%);font-size:12.0pt;\">There are three factors (early menarche, BRCA mutation, obesity), that have statistically significant associations with breast cancer according to the odds ratios and their 95% confidence intervals provided.</span></p><p><img src=\"https://cerebellum-web-static.s3.amazonaws.com/media/public/image_IjtklbT.png\" alt=\"Solution Image\"></p>",
      "correct_choice_id": 200596,
      "solution_audio": null,
      "solution_video": null,
      "audio_explanation_heading": null,
      "video_explanation_heading": null,
      "solution_media_position": "bottom",
      "tags": [],
      "explanation_video": null,
      "question_images": [],
      "explanation_images": []
    },
    {
      "id": 50150,
      "choices": [
        {
          "id": 200600,
          "text": "<p><span style=\"font-size:12.0pt;\">Digastric muscle</span></p>"
        },
        {
          "id": 200601,
          "text": "<p><span style=\"font-size:12.0pt;\">Sternocleidomastoid muscle</span></p>"
        },
        {
          "id": 200602,
          "text": "<p><span style=\"font-size:12.0pt;\">Spinal accessory nerve</span></p>"
        },
        {
          "id": 200603,
          "text": "<p><span style=\"font-size:12.0pt;\">Ipsilateral cervical lymph nodes</span></p>"
        }
      ],
      "text": "<p><span style=\"font-size:12.0pt;\">A 60-year-old male patient with squamous cell carcinoma of the neck undergoes radical neck dissection. Which of the following structures is typically spared during this procedure?</span> <span style=\"font-size:12.0pt;\">(AIIMS NOV 2019)</span></p>",
      "unique_key": "Q6359448",
      "question_audio": null,
      "question_video": null,
      "map_id": 34675986,
      "difficulty_level": "intermediate",
      "subjects_id": [],
      "solution": "<p><span style=\"font-size:12.0pt;\"><strong>Ans. A) Digastric muscle</strong></span></p><p> </p><p><span style=\"font-size:12.0pt;\">Radical neck dissection spares the digastric muscle.</span></p><p> </p><ul><li><span style=\"font-size:12.0pt;\">The digastric muscle is typically spared during a radical neck dissection. This muscle is important for several functions, including swallowing and jaw movement.</span></li><li><span style=\"font-size:12.0pt;\">Preservation of the digastric muscle helps maintain normal swallowing and chewing abilities, which is essential for a patient's quality of life postoperatively.</span></li></ul><p> </p><p><span style=\"font-size:12.0pt;\"><strong>Educational Objective:</strong></span></p><p> </p><p><span style=\"font-size:12.0pt;\">A radical neck dissection is a surgical procedure that involves the removal of lymph nodes level 1 to 5, ipsilateral submandibular gland and tail of parotid, as well as other structures in the neck such as the sternocleidomastoid muscle, internal jugular vein, and spinal accessory nerve.</span></p><p> </p><p><span style=\"font-size:12.0pt;\">In modified radical neck dissections, some structures may be spared, such as the internal jugular vein, sternocleidomastoid muscle or the spinal accessory nerve.</span></p>",
      "correct_choice_id": 200600,
      "solution_audio": null,
      "solution_video": null,
      "audio_explanation_heading": null,
      "video_explanation_heading": null,
      "solution_media_position": "bottom",
      "tags": [],
      "explanation_video": null,
      "question_images": [],
      "explanation_images": []
    },
    {
      "id": 50151,
      "choices": [
        {
          "id": 200604,
          "text": "<p><span style=\"font-size:12.0pt;\">POAG</span></p>"
        },
        {
          "id": 200605,
          "text": "<p><span style=\"font-size:12.0pt;\">Hypoplasia of optic disc</span></p>"
        },
        {
          "id": 200606,
          "text": "<p><span style=\"font-size:12.0pt;\">Papilledema</span></p>"
        },
        {
          "id": 200607,
          "text": "<p><span style=\"font-size:12.0pt;\">Medullated nerve fibres</span></p>"
        }
      ],
      "text": "<p><span style=\"font-size:12.0pt;\">All are causes for expanding blind spot, except? (</span><span style=\"background-color:rgb(255,255,255);color:rgb(111,126,149);font-size:14px;\">AIIMS Nov 2019)</span></p>",
      "unique_key": "Q5538749",
      "question_audio": null,
      "question_video": null,
      "map_id": 34064952,
      "difficulty_level": "intermediate",
      "subjects_id": [],
      "solution": "<p><span style=\"font-size:12.0pt;\"><strong>Ans. B) Hypoplasia of optic disc</strong></span></p><p> </p><p><span style=\"font-size:12.0pt;\">Expansion of blind spot is not seen in optic disc hypoplasia. Optic nerve hypoplasia is the most common congenital optic disc anomaly that presents due to the underdevelopment of the optic nerve. The optic disc is surrounded by a yellowish pigmented ring known as a <strong>\"double-ring\" sign. </strong>This condition does not typically lead to changes in the size of the blind spot, as it primarily affects the development of the optic nerve rather than its function related to the blind spot's expansion.</span></p><p> </p><p><span style=\"font-size:12.0pt;\"><strong><img src=\"https://cerebellum-web-static.s3.amazonaws.com/media/public/images/2023/04/29/asdcadas.jpg\" alt=\"\" width=\"400\" height=\"378\"></strong></span></p><p> </p><ul><li><span style=\"font-size:12.0pt;\">Physiological blind spot is an area of absolute scotoma caused by the absence of photoreceptors in the region occupied by the optic disc.</span></li><li><span style=\"font-size:12.0pt;\">Lesions affecting the optic disc region can expand the blind spot.</span></li></ul><p> </p><p><span style=\"font-size:12.0pt;\"><strong>Other Options:</strong></span></p><p> </p><p><span style=\"font-size:12.0pt;\"><strong>Option A. POAG:</strong></span><span style=\"font-size:10.5pt;\"> </span><span style=\"font-size:12.0pt;\">The rise in IOP in primary open-angle glaucoma causes pressure on the optic nerve head and consequent atrophy leading to expansion of the blindspot.</span></p><p> </p><p><span style=\"font-size:12.0pt;\"><strong>Option C. Papilledema:</strong></span><span style=\"font-size:10.5pt;\"> </span><span style=\"font-size:12.0pt;\">Papilledema is a passive disc swelling associated with raised intracranial pressure, and the edematous optic disc is swollen beyond its usual margins, causing the blind spot to enlarge.</span></p><p> </p><p><span style=\"font-size:12.0pt;\"><strong>Option D. Medullated nerve fibres:</strong></span><span style=\"font-size:10.5pt;\"> </span><span style=\"font-size:12.0pt;\">Medullated nerve fibers (optic disc medullation) is a condition of abnormal myelination of the nerve fibers of the retina, where myelination continues beyond lamina cribrosa and spreads into the retina beyond the optic disc. This leads to the expansion of the blind spot.</span></p><p> </p><p><span style=\"font-size:12.0pt;\"><strong>Educational Objective:</strong></span></p><p> </p><p><span style=\"font-size:12.0pt;\">Optic disc hypoplasia, a congenital underdevelopment of the optic nerve, does not typically result in an expanding blind spot, unlike conditions like POAG, papilledema, and the presence of medullated nerve fibers, which can directly affect the structure or function of the area surrounding the optic disc.</span></p><p><img src=\"https://cerebellum-web-static.s3.amazonaws.com/media/public/images/2023/04/29/asdcadas.jpg\" alt=\"Solution Image\"></p>",
      "correct_choice_id": 200605,
      "solution_audio": null,
      "solution_video": null,
      "audio_explanation_heading": null,
      "video_explanation_heading": null,
      "solution_media_position": "bottom",
      "tags": [],
      "explanation_video": null,
      "question_images": [],
      "explanation_images": []
    },
    {
      "id": 50152,
      "choices": [
        {
          "id": 200608,
          "text": "<p><span style=\"font-size:12pt\"><span style=\"font-family:\"Times New Roman\",serif\"><span style=\"font-family:\"Calibri\",sans-serif\">Minute volume decreases by 50%</span></span></span></p>"
        },
        {
          "id": 200609,
          "text": "<p><span style=\"font-size:12pt\"><span style=\"font-family:\"Times New Roman\",serif\"><span style=\"font-family:\"Calibri\",sans-serif\">Residual volume increases</span></span></span></p>"
        },
        {
          "id": 200610,
          "text": "<p><span style=\"font-size:12pt\"><span style=\"font-family:\"Times New Roman\",serif\"><span style=\"font-family:\"Calibri\",sans-serif\">FRC decreases</span></span></span></p>"
        },
        {
          "id": 200611,
          "text": "<p><span style=\"font-size:12pt\"><span style=\"font-family:\"Times New Roman\",serif\"><span style=\"font-family:\"Calibri\",sans-serif\">Total lung capacity increases</span></span></span></p>"
        }
      ],
      "text": "<p><span style=\"font-size:12.0pt\"><span style=\"font-family:\"Calibri\",sans-serif\">The correct statement regarding the physiological changes in the respiratory system in pregnancy? </span></span>(INICET NOV 2019)</p>",
      "unique_key": "Q3695364",
      "question_audio": null,
      "question_video": null,
      "map_id": 34155968,
      "difficulty_level": "intermediate",
      "subjects_id": [],
      "solution": "<p style=\"text-align:left\"><span style=\"font-size:12pt\"><span style=\"font-family:\"Times New Roman\",serif\"><strong><span style=\"font-family:\"Calibri\",sans-serif\">Ans. C) FRC decreases</span></strong></span></span></p>\r\n\r\n<p style=\"text-align:left\"> </p>\r\n\r\n<p><span style=\"font-size:12pt\"><span style=\"font-family:\"Times New Roman\",serif\"><strong><span style=\"font-family:\"Calibri\",sans-serif\">Explanation: </span></strong></span></span></p>\r\n\r\n<p> </p>\r\n\r\n<p style=\"text-align:left\"><span style=\"font-size:10.5pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\"><img alt=\"\" src=\"https://cerebellum-web-static.s3.amazonaws.com/media/public/images/2023/09/30/untitled-277.jpg\" style=\"height:644px; width:900px\" /></span></strong></span></span></p>\r\n\r\n<p style=\"text-align:left\"> </p>\r\n\r\n<p><span style=\"font-size:12pt\"><span style=\"font-family:\"Times New Roman\",serif\"><strong><span style=\"font-family:\"Calibri\",sans-serif\">Other options:</span></strong></span></span></p>\r\n\r\n<p> </p>\r\n\r\n<p><span style=\"font-size:12pt\"><span style=\"font-family:\"Times New Roman\",serif\"><strong><span style=\"font-family:\"Calibri\",sans-serif\">Option A. Minute volume decreases by 50%:</span></strong><span style=\"font-family:\"Calibri\",sans-serif\"> This statement is incorrect. In fact, minute ventilation, which is the total volume of air inspired in a minute, increases by 40% during pregnancy due to an increase in tidal volume.</span></span></span></p>\r\n\r\n<p> </p>\r\n\r\n<p><span style=\"font-size:12pt\"><span style=\"font-family:\"Times New Roman\",serif\"><strong><span style=\"font-family:\"Calibri\",sans-serif\">Option B. Residual volume increases:</span></strong><span style=\"font-family:\"Calibri\",sans-serif\"> This statement is incorrect. Residual volume, which is the volume of air remaining in the lungs after maximal expiration, decreases by 20-25% during pregnancy.</span></span></span></p>\r\n\r\n<p> </p>\r\n\r\n<p><span style=\"font-size:12pt\"><span style=\"font-family:\"Times New Roman\",serif\"><strong><span style=\"font-family:\"Calibri\",sans-serif\">Option D. Total lung capacity increases:</span></strong><span style=\"font-family:\"Calibri\",sans-serif\"> This statement is incorrect. Total lung capacity, which is the maximum amount of air the lungs can hold, is either unaffected or slightly decreased (by about 5%) during pregnancy.</span></span></span></p>\r\n\r\n<p> </p>\r\n\r\n<p><span style=\"font-size:12pt\"><span style=\"font-family:\"Times New Roman\",serif\"><strong><span style=\"font-family:\"Calibri\",sans-serif\">Educational Objective:</span></strong> </span></span></p>\r\n\r\n<p> </p>\r\n\r\n<p><span style=\"font-size:12pt\"><span style=\"font-family:\"Times New Roman\",serif\"><span style=\"font-family:\"Calibri\",sans-serif\">Functional Residual Capacity (FRC) decreases by approximately 22% during pregnancy due to the upward displacement of the diaphragm by the enlarging uterus.</span></span></span></p>\r\n\r\n<p> </p>\r\n\r\n<p><span style=\"font-size:12pt\"><span style=\"font-family:\"Times New Roman\",serif\"><strong><span style=\"font-family:\"Calibri\",sans-serif\">Ref: William’s textbook of obstetrics 26<sup>th</sup> edition pg189, Dutta’s textbook of obstetrics 8<sup>th</sup> edition pg 6</span></strong></span></span></p><p><img src=\"https://cerebellum-web-static.s3.amazonaws.com/media/public/images/2023/09/30/untitled-277.jpg\" alt=\"Solution Image\"></p>",
      "correct_choice_id": 200610,
      "solution_audio": null,
      "solution_video": null,
      "audio_explanation_heading": null,
      "video_explanation_heading": null,
      "solution_media_position": "bottom",
      "tags": [],
      "explanation_video": null,
      "question_images": [],
      "explanation_images": []
    },
    {
      "id": 50153,
      "choices": [
        {
          "id": 200612,
          "text": "<p><span style=\"font-size:12pt\"><span style=\"font-family:\"Times New Roman\",serif\"><span style=\"font-family:\"Calibri\",sans-serif\">APLA syndrome</span></span></span></p>"
        },
        {
          "id": 200613,
          "text": "<p><span style=\"font-size:12pt\"><span style=\"font-family:\"Times New Roman\",serif\"><span style=\"font-family:\"Calibri\",sans-serif\">Congenital heart defects</span></span></span></p>"
        },
        {
          "id": 200614,
          "text": "<p><span style=\"font-size:12pt\"><span style=\"font-family:\"Times New Roman\",serif\"><span style=\"font-family:\"Calibri\",sans-serif\">SLE</span></span></span></p>"
        },
        {
          "id": 200615,
          "text": "<p><span style=\"font-size:12pt\"><span style=\"font-family:\"Times New Roman\",serif\"><span style=\"font-family:\"Calibri\",sans-serif\">Hemolytic anemia</span></span></span></p>"
        }
      ],
      "text": "<p style=\"text-align:left\"><span style=\"font-size:12.0pt\"><span style=\"font-family:\"Calibri\",sans-serif\">On finding a congenital heart block in a fetus which of the following conditions would you evaluate for in the mother? </span></span>(INICET NOV 2019)</p>",
      "unique_key": "Q4394846",
      "question_audio": null,
      "question_video": null,
      "map_id": 34405216,
      "difficulty_level": "intermediate",
      "subjects_id": [],
      "solution": "<p><span style=\"font-size:12pt\"><span style=\"font-family:\"Times New Roman\",serif\"><strong><span style=\"font-family:\"Calibri\",sans-serif\">Ans. C) SLE</span></strong></span></span></p>\r\n\r\n<p> </p>\r\n\r\n<p><span style=\"font-size:12pt\"><span style=\"font-family:\"Times New Roman\",serif\"><span style=\"font-family:\"Calibri\",sans-serif\">Congenital heart block (CHB) in a fetus is often associated with maternal autoimmune conditions, particularly Systemic Lupus Erythematosus (SLE). This condition is related to the presence of maternal antibodies against the SS-A (Ro) or SS-B (La) antigens. These antibodies can cross the placenta and affect the fetal heart, leading to congenital heart block. Therefore, if a congenital heart block is detected in a fetus, it is essential to evaluate the mother for SLE.</span></span></span></p>\r\n\r\n<p> </p>\r\n\r\n<p><span style=\"font-size:12pt\"><span style=\"font-family:\"Times New Roman\",serif\"><span style=\"font-family:\"Calibri\",sans-serif\">Neonatal lupus erythematosus, a subtype of lupus erythematosus, is caused by the transplacental passage of these maternal antibodies. The most frequent clinical manifestations in the neonate include congenital heart block and cutaneous lesions. Fetal echocardiography is recommended between 18 and 26 weeks of gestation in pregnancies where these antibodies are present to monitor for congenital heart block.</span></span></span></p>\r\n\r\n<p> </p>\r\n\r\n<p><span style=\"font-size:12pt\"><span style=\"font-family:\"Times New Roman\",serif\"><strong><span style=\"font-family:\"Calibri\",sans-serif\">Other Options:</span></strong></span></span></p>\r\n\r\n<p> </p>\r\n\r\n<p><span style=\"font-size:12pt\"><span style=\"font-family:\"Times New Roman\",serif\"><strong><span style=\"font-family:\"Calibri\",sans-serif\">Option A. APLA syndrome:</span></strong><span style=\"font-family:\"Calibri\",sans-serif\"> Antiphospholipid antibody syndrome (APLA) is associated with increased risks of miscarriages, intrauterine fetal demise (IUFD), and preterm births. However, it is not specifically associated with congenital heart block in the fetus.</span></span></span></p>\r\n\r\n<p> </p>\r\n\r\n<p><span style=\"font-size:12pt\"><span style=\"font-family:\"Times New Roman\",serif\"><strong><span style=\"font-family:\"Calibri\",sans-serif\">Option B. Congenital heart defects:</span></strong><span style=\"font-family:\"Calibri\",sans-serif\"> Women with certain congenital cardiac defects may have an increased chance of giving birth to children with similar defects, such as Marfan syndrome, aortic stenosis, ventricular septal defect (VSD), atrial septal defect (ASD), and coarctation of the aorta. However, these conditions are not directly linked to congenital heart block caused by maternal antibodies.</span></span></span></p>\r\n\r\n<p> </p>\r\n\r\n<p><span style=\"font-size:12pt\"><span style=\"font-family:\"Times New Roman\",serif\"><strong><span style=\"font-family:\"Calibri\",sans-serif\">Option D. Hemolytic anemia:</span></strong><span style=\"font-family:\"Calibri\",sans-serif\"> Hemolytic anemias, such as thalassemia, sickle cell anemia, and hereditary spherocytosis, are inherited conditions but are not associated with congenital heart block in the fetus.</span></span></span></p>\r\n\r\n<p> </p>\r\n\r\n<p><span style=\"font-size:12pt\"><span style=\"font-family:\"Times New Roman\",serif\"><strong><span style=\"font-family:\"Calibri\",sans-serif\">Educational Objective:</span></strong> </span></span></p>\r\n\r\n<p> </p>\r\n\r\n<p><span style=\"font-size:12pt\"><span style=\"font-family:\"Times New Roman\",serif\"><span style=\"font-family:\"Calibri\",sans-serif\">Congenital heart block (CHB) in a fetus is associated with maternal antibodies to SS-A (Ro) or SS-B (La), commonly seen in Systemic Lupus Erythematosus (SLE).</span></span></span></p>\r\n\r\n<p> </p>\r\n\r\n<p><span style=\"font-size:12pt\"><span style=\"font-family:\"Times New Roman\",serif\"><strong><span style=\"font-family:\"Calibri\",sans-serif\">Ref: Dutta’s textbook of obstetrics 8<sup>th</sup> edition pg 722</span></strong></span></span></p>",
      "correct_choice_id": 200614,
      "solution_audio": null,
      "solution_video": null,
      "audio_explanation_heading": null,
      "video_explanation_heading": null,
      "solution_media_position": "bottom",
      "tags": [],
      "explanation_video": null,
      "question_images": [],
      "explanation_images": []
    },
    {
      "id": 50154,
      "choices": [
        {
          "id": 200616,
          "text": "<p><span style=\"font-size:12.0pt;\">Inner nuclear layer</span></p>"
        },
        {
          "id": 200617,
          "text": "<p><span style=\"font-size:12.0pt;\">﻿﻿﻿Inner plexiform layer</span></p>"
        },
        {
          "id": 200618,
          "text": "<p><span style=\"font-size:12.0pt;\">﻿﻿﻿Outer plexiform layer</span></p>"
        },
        {
          "id": 200619,
          "text": "<p><span style=\"font-size:12.0pt;\">﻿﻿﻿Outer nuclear layer</span></p>"
        }
      ],
      "text": "<p><span style=\"font-size:12.0pt;\">Identify the structure marked with a yellow question mark ? (</span>AIIMS Nov 2019)</p><p> </p><p><img src=\"https://cerebellum-web-static.s3.amazonaws.com/media/public/images/2023/10/10/screenshot-2023-10-10-103037.jpg\" alt=\"\" width=\"300\" height=\"360\"></p><p><img src=\"https://cerebellum-web-static.s3.amazonaws.com/media/public/images/2023/10/10/screenshot-2023-10-10-103037.jpg\" alt=\"Question Image\"></p>",
      "unique_key": "Q6175597",
      "question_audio": null,
      "question_video": null,
      "map_id": 34943009,
      "difficulty_level": "intermediate",
      "subjects_id": [],
      "solution": "<p><span style=\"font-size:12.0pt;\"><strong>Ans. A) Inner nuclear layer</strong></span></p><p> </p><p><span style=\"font-size:12.0pt;\">The marked structure in the slide is the inner nuclear layer of the retina</span></p><p> </p><ul><li><span style=\"font-size:12.0pt;\">Present between the outer plexiform layer and the inner plexiform layer.</span></li><li><span style=\"font-size:12.0pt;\">Contains the <strong>cell</strong> <strong>bodies</strong> of bipolar cells, horizontal cells, and amacrine cells.</span></li><li><span style=\"font-size:12.0pt;\">Dark stain.</span></li></ul><p> </p><p><span style=\"font-size:12.0pt;\"><img src=\"https://cerebellum-web-static.s3.amazonaws.com/media/public/images/2023/04/29/wefcs.jpg\" alt=\"\" width=\"500\" height=\"388\"></span></p><p> </p><p><span style=\"font-size:12.0pt;\"><strong>Educational Objective:</strong></span></p><p> </p><p><img src=\"https://cerebellum-web-static.s3.amazonaws.com/media/public/images/2024/07/05/screenshot-2024-07-05-114547.png\" alt=\"\" width=\"1000\" height=\"552\"></p><p><img src=\"https://cerebellum-web-static.s3.amazonaws.com/media/public/images/2023/04/29/wefcs.jpg\" alt=\"Solution Image\"></p>",
      "correct_choice_id": 200616,
      "solution_audio": null,
      "solution_video": null,
      "audio_explanation_heading": null,
      "video_explanation_heading": null,
      "solution_media_position": "bottom",
      "tags": [],
      "explanation_video": null,
      "question_images": [],
      "explanation_images": []
    },
    {
      "id": 50155,
      "choices": [
        {
          "id": 200620,
          "text": "<p><span style=\"font-size:12.0pt;\">Auriculotemporal nerve</span></p>"
        },
        {
          "id": 200621,
          "text": "<p><span style=\"font-size:12.0pt;\">Great auricular nerve</span></p>"
        },
        {
          "id": 200622,
          "text": "<p><span style=\"font-size:12.0pt;\">Facial nerve</span></p>"
        },
        {
          "id": 200623,
          "text": "<p><span style=\"font-size:12.0pt;\">Marginal mandibular nerve</span></p>"
        }
      ],
      "text": "<p><span style=\"font-size:12.0pt;\">A 50-year-old male patient undergoes parotidectomy surgery to remove a tumor. During the postoperative period, the patient complains of loss of sensation while shaving. Which nerve is most likely affected in this patient?</span> <span style=\"font-size:12.0pt;\">(AIIMS NOV 2019)</span></p>",
      "unique_key": "Q4693074",
      "question_audio": null,
      "question_video": null,
      "map_id": 34529197,
      "difficulty_level": "intermediate",
      "subjects_id": [],
      "solution": "<p><span style=\"font-size:12.0pt;\"><strong>Ans. B) Great auricular nerve</strong></span></p><p> </p><p><span style=\"font-size:12.0pt;\">The great auricular nerve is a branch of the cervical plexus (specifically, the cervical spinal nerves C2 and C3). It provides sensory innervation to the skin of the earlobe and the skin over the parotid gland. Damage to this nerve during parotidectomy surgery can lead to loss of sensation in the earlobe area, which could affect the patient's sensation while shaving.</span></p><p> </p><p><span style=\"font-size:12.0pt;\"><strong>Other Options:</strong></span></p><p> </p><p><span style=\"font-size:12pt;\"><strong>Option A.</strong> </span><span style=\"font-size:12.0pt;\"><strong>Auriculotemporal nerve</strong>: The auriculotemporal nerve is a branch of the mandibular nerve (a branch of the trigeminal nerve). It provides sensory innervation to the skin of the external ear and the temporal region, which if injured gives rise to gustatory sweating or Frey’s syndrome.</span></p><p> </p><p><span style=\"font-size:12pt;\"><strong>Option</strong> </span><span style=\"font-size:12.0pt;\"><strong>C. Facial nerve</strong>: The facial nerve is responsible for motor control of the muscles of facial expression, not sensation. Damage to the facial nerve during parotidectomy surgery can result in facial weakness or paralysis rather than altered sensation.</span></p><p> </p><p><span style=\"font-size:12pt;\"><strong>Option</strong> </span><span style=\"font-size:12.0pt;\"><strong>D. Marginal mandibular nerve</strong>: The marginal mandibular nerve is a branch of the facial nerve and primarily provides innervation to the lower lip. It is not typically involved in sensation during shaving.</span></p><p> </p><p><span style=\"font-size:12.0pt;\"><strong>Educational Objective:</strong></span></p><p> </p><p><span style=\"font-size:12.0pt;\">Nerves that can be injured in parotidectomy and its significance:</span></p><p> </p><p><span style=\"font-size:12.0pt;\">A) Auriculotemporal nerve injury – Frey’s syndrome</span></p><p> </p><p><span style=\"font-size:12.0pt;\">B) Great auricular nerve- loss of sensation in area of shaving</span></p><p> </p><p><span style=\"font-size:12.0pt;\">C) Facial nerve- facial palsy</span></p>",
      "correct_choice_id": 200621,
      "solution_audio": null,
      "solution_video": null,
      "audio_explanation_heading": null,
      "video_explanation_heading": null,
      "solution_media_position": "bottom",
      "tags": [],
      "explanation_video": null,
      "question_images": [],
      "explanation_images": []
    },
    {
      "id": 50156,
      "choices": [
        {
          "id": 200624,
          "text": "<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\">Metoprolol</span></span></span></p>"
        },
        {
          "id": 200625,
          "text": "<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\">Trimetazidine</span></span></span></p>"
        },
        {
          "id": 200626,
          "text": "<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\">Sacubitril</span></span></span></p>"
        },
        {
          "id": 200627,
          "text": "<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\">Nesiritide</span></span></span></p>"
        }
      ],
      "text": "<p style=\"text-align:justify\"><span style=\"font-size:12pt\"><span style=\"font-family:\"Liberation Serif\",serif\"><span dir=\"ltr\" lang=\"EN-US\" style=\"font-family:\"Calibri\",sans-serif\"><span style=\"color:#333333\">Which</span></span><span dir=\"ltr\" lang=\"EN-US\" style=\"font-family:\"Calibri\",sans-serif\"><span style=\"color:#333333\"> of the following drugs is not used in heart failure?</span></span></span></span>(AIIMS NOV 2019)</p>",
      "unique_key": "Q1182396",
      "question_audio": null,
      "question_video": null,
      "map_id": 34967565,
      "difficulty_level": "intermediate",
      "subjects_id": [],
      "solution": "<p><span style=\"font-size:12pt\"><span style=\"font-family:\"Liberation Serif\",serif\"><strong><span dir=\"ltr\" lang=\"EN-US\" style=\"font-family:\"Calibri\",sans-serif\"><span style=\"color:#333333\">Ans. B. Trimetazidine</span></span></strong></span></span></p>\r\n\r\n<p> </p>\r\n\r\n<p style=\"text-align:left\"><span style=\"font-size:10.5pt\"><span style=\"font-family:Calibri,sans-serif\"><span style=\"font-size:12.0pt\">Trimetazidine is not used in heart failure because it is primarily a metabolic modulator. It partially inhibits the beta-oxidation of fatty acids, which results in shifting the metabolism of heart muscles from fatty acids to glucose. This shift requires less oxygen, making trimetazidine beneficial for patients with angina pectoris. However, it does not have a role in the management of heart failure.</span></span></span></p>\r\n\r\n<p style=\"text-align:left\"> </p>\r\n\r\n<p style=\"text-align:left\"><span style=\"font-size:10.5pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span style=\"font-size:12.0pt\">Other Options:</span></strong></span></span></p>\r\n\r\n<p style=\"text-align:left\"> </p>\r\n\r\n<p style=\"text-align:left\"><span style=\"font-size:10.5pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span style=\"font-size:12.0pt\">Option A. Metoprolol: </span></strong><span style=\"font-size:12.0pt\">Metoprolol is a beta-blocker that is used in the management of chronic heart failure. Beta-blockers are contraindicated in acute heart failure but can be beneficial in chronic heart failure when started at a low dose and gradually increased to avoid decompensation. The beta-blockers commonly used in heart failure include carvedilol, metoprolol, and bisoprolol.</span></span></span></p>\r\n\r\n<p style=\"text-align:left\"> </p>\r\n\r\n<p style=\"text-align:left\"><span style=\"font-size:10.5pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span style=\"font-size:12.0pt\">Option C. Sacubitril: </span></strong><span style=\"font-size:12.0pt\">Sacubitril is an NEP (neutral endopeptidase) inhibitor, which prevents the breakdown of brain natriuretic peptide (BNP). By inhibiting NEP, sacubitril increases BNP levels, leading to natriuresis and vasodilation, which are beneficial effects in chronic heart failure (CHF). Therefore, sacubitril is used in the treatment of CHF.</span></span></span></p>\r\n\r\n<p style=\"text-align:left\"> </p>\r\n\r\n<p style=\"text-align:left\"><span style=\"font-size:10.5pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span style=\"font-size:12.0pt\">Option D. Nesiritide: </span></strong><span style=\"font-size:12.0pt\">Nesiritide is a recombinant form of BNP and is administered through the subcutaneous route. It helps to induce natriuresis and vasodilation, thus can be used in the treatment of heart failure.</span></span></span></p>\r\n\r\n<p style=\"text-align:left\"> </p>\r\n\r\n<p style=\"text-align:left\"><span style=\"font-size:10.5pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span style=\"font-size:12.0pt\">Educational objective:</span></strong></span></span></p>\r\n\r\n<p style=\"text-align:left\"> </p>\r\n\r\n<p style=\"text-align:left\"><span style=\"font-size:10.5pt\"><span style=\"font-family:Calibri,sans-serif\"><span style=\"font-size:12.0pt\">Trimetazidine, although beneficial for angina pectoris due to its metabolic modulation properties, is not used in the treatment of heart failure.</span></span></span></p>\r\n\r\n<p> </p>\r\n\r\n<p><span style=\"font-size:12pt\"><span style=\"font-family:\"Liberation Serif\",serif\"><strong><span dir=\"ltr\" lang=\"EN-US\" style=\"font-family:\"Calibri\",sans-serif\"><span style=\"color:#333333\">Note - </span></span></strong><span dir=\"ltr\" lang=\"EN-US\" style=\"font-family:\"Calibri\",sans-serif\"><span style=\"color:#333333\">Beta blockers are contraindicated in acute heart failure, but they can be used in chronic heart failure. Beta blockers should be started at low dose, dose should be increased gradually to prevent decompensation. </span></span></span></span></p>\r\n\r\n<p> </p>\r\n\r\n<p><span style=\"font-size:12pt\"><span style=\"font-family:\"Liberation Serif\",serif\"><strong><span dir=\"ltr\" lang=\"EN-US\" style=\"font-family:\"Calibri\",sans-serif\"><span style=\"color:#333333\">Beta blockers used are</span></span></strong><span dir=\"ltr\" lang=\"EN-US\" style=\"font-family:\"Calibri\",sans-serif\"><span style=\"color:#333333\"> – Carvedilol, metoprolol and bisoprolol.</span></span></span></span></p>\r\n\r\n<p> </p>\r\n\r\n<p><span style=\"font-size:12pt\"><span style=\"font-family:\"Liberation Serif\",serif\"><strong><span dir=\"ltr\" lang=\"EN-US\" style=\"font-family:\"Calibri\",sans-serif\"><span style=\"color:#333333\">Reference: KDT 8th/ 599, 600</span></span></strong></span></span></p>",
      "correct_choice_id": 200625,
      "solution_audio": null,
      "solution_video": null,
      "audio_explanation_heading": null,
      "video_explanation_heading": null,
      "solution_media_position": "bottom",
      "tags": [],
      "explanation_video": null,
      "question_images": [],
      "explanation_images": []
    },
    {
      "id": 50157,
      "choices": [
        {
          "id": 200628,
          "text": "<p style=\"text-align:left\"><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\">0.5 ml of 1:1000 adrenaline by intramuscular route</span></span></span></p>"
        },
        {
          "id": 200629,
          "text": "<p style=\"text-align:left\"><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\">0.5 ml of 1:1000 adrenaline by intravenous route</span></span></span></p>"
        },
        {
          "id": 200630,
          "text": "<p style=\"text-align:left\"><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\">0.5 ml of 1:10000 adrenaline by intramuscular route</span></span></span></p>"
        },
        {
          "id": 200631,
          "text": "<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\">0.5 ml of 1:10000 adrenaline by intravenous route</span></span></span></p>"
        }
      ],
      "text": "<p style=\"text-align:justify\"><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\"><span style=\"font-family:\"Calibri\",sans-serif\">A patient was given ampicillin 2 g intravenously. After that, the person developed rash on skin, hypotension and difficulty in breathing. The patient should be managed by? (</span></span>AIIMS Nov 2019)</p>",
      "unique_key": "Q3097017",
      "question_audio": null,
      "question_video": null,
      "map_id": 34548069,
      "difficulty_level": "intermediate",
      "subjects_id": [],
      "solution": "<p><span style=\"font-size:12pt\"><span style=\"font-family:\"Liberation Serif\",serif\"><strong><span dir=\"ltr\" lang=\"EN-US\" style=\"font-family:\"Calibri\",sans-serif\"><span style=\"color:#333333\">Ans. A. 0.5 ml of 1:1000 adrenaline by intramuscular route</span></span></strong></span></span></p>\r\n\r\n<p> </p>\r\n\r\n<p><span style=\"font-size:12pt\"><span style=\"font-family:\"Liberation Serif\",serif\"><span dir=\"ltr\" lang=\"EN-US\" style=\"font-family:\"Calibri\",sans-serif\"><span style=\"color:#333333\">Penicillin’s are prone to cause allergic reactions. Features like rash on skin, hypotension, and difficulty in breathing are suggestive of anaphylactic shock.</span></span></span></span></p>\r\n\r\n<p> </p>\r\n\r\n<p><span style=\"font-size:12pt\"><span style=\"font-family:\"Liberation Serif\",serif\"><span dir=\"ltr\" lang=\"EN-US\" style=\"font-family:\"Calibri\",sans-serif\"><span style=\"color:#333333\">In case of anaphylactic shock the resuscitation council of UK has recommended the following measures:</span></span></span></span></p>\r\n\r\n<p> </p>\r\n\r\n<ul>\r\n\t<li><span style=\"font-size:12pt\"><span style=\"font-family:\"Liberation Serif\",serif\"><span dir=\"ltr\" lang=\"EN-US\" style=\"font-family:\"Calibri\",sans-serif\"><span style=\"color:#333333\">Put the patient in reclining position, administer oxygen at high flow rate and perform cardiopulmonary resuscitation if required.</span></span></span></span></li>\r\n\t<li><span style=\"font-size:12pt\"><span style=\"font-family:\"Liberation Serif\",serif\"><span dir=\"ltr\" lang=\"EN-US\" style=\"font-family:\"Calibri\",sans-serif\"><span style=\"color:#333333\">Inject adrenaline 0.5 mg (0.5 ml of 1 in 1000 for adult, 0.3 ml for child 6-12 years and 0.15 ml for child upto 6 years) i.m.; repeat every 5-10 min in case patient does not improve or improvement is transient. This is the only life saving measure. Adrenaline should not be injected i.v. (can itself be fatal) unless shock is immediately life threatening. If adrenaline is to be injected i. v., it should be diluted to 1:10,000 and infused slowly with constant monitoring.</span></span></span></span></li>\r\n\t<li><span style=\"font-size:12pt\"><span style=\"font-family:\"Liberation Serif\",serif\"><span dir=\"ltr\" lang=\"EN-US\" style=\"font-family:\"Calibri\",sans-serif\"><span style=\"color:#333333\">Administer a H1 antihistaminic (pheniramine 20-40 mg or chlorpheniramine 10-20 mg) i.m./slow i.v. It may have adjuvant value.</span></span></span></span></li>\r\n\t<li><span style=\"font-size:12pt\"><span style=\"font-family:\"Liberation Serif\",serif\"><span dir=\"ltr\" lang=\"EN-US\" style=\"font-family:\"Calibri\",sans-serif\"><span style=\"color:#333333\">Intravenous glucocorticoid (hydrocortisone sod. succinate 200 mg) should be added in severe/recurrent cases. It acts slowly but is especially valuable for prolonged reactions and in asthmatics. It may be followed by oral prednisolone for 3 days.</span></span></span></span></li>\r\n</ul>\r\n\r\n<p> </p>\r\n\r\n<p><span style=\"font-size:12pt\"><span style=\"font-family:\"Liberation Serif\",serif\"><strong><span dir=\"ltr\" lang=\"EN-US\" style=\"font-family:\"Calibri\",sans-serif\"><span style=\"color:#333333\">Educational objective:</span></span></strong></span></span></p>\r\n\r\n<p> </p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\"><img alt=\"\" src=\"https://cerebellum-web-static.s3.amazonaws.com/media/public/images/2023/12/19/screenshot-2023-12-19-185948.jpg\" style=\"height:331px; width:1000px\" /></span></span></span></p>\r\n\r\n<p> </p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\">Reference: KDT 8<sup>th</sup>/ 97</span></strong></span></span></p><p><img src=\"https://cerebellum-web-static.s3.amazonaws.com/media/public/images/2023/12/19/screenshot-2023-12-19-185948.jpg\" alt=\"Solution Image\"></p>",
      "correct_choice_id": 200628,
      "solution_audio": null,
      "solution_video": null,
      "audio_explanation_heading": null,
      "video_explanation_heading": null,
      "solution_media_position": "bottom",
      "tags": [],
      "explanation_video": null,
      "question_images": [],
      "explanation_images": []
    },
    {
      "id": 50158,
      "choices": [
        {
          "id": 200632,
          "text": "<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\">To allay anxiety</span></span></span></p>"
        },
        {
          "id": 200633,
          "text": "<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\">To decrease secretions</span></span></span></p>"
        },
        {
          "id": 200634,
          "text": "<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span style=\"font-size:12.0pt\">As inducing agent</span></span></span></p>"
        },
        {
          "id": 200635,
          "text": "<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\">For muscle relaxation</span></span></span></p>"
        }
      ],
      "text": "<p style=\"text-align:justify\"><span style=\"font-size:12pt\"><span style=\"font-family:\"Liberation Serif\",serif\"><span dir=\"ltr\" lang=\"EN-US\" style=\"font-family:\"Calibri\",sans-serif\"><span style=\"color:#333333\">A patient was schedule for surgery. Before giving anaesthesia, he was administered glycopyrrolate. What is rationale of giving glycopyrrolate before anaesthesia?</span></span></span></span>(AIIMS NOV 2019)</p>",
      "unique_key": "Q8895002",
      "question_audio": null,
      "question_video": null,
      "map_id": 34206907,
      "difficulty_level": "intermediate",
      "subjects_id": [],
      "solution": "<p><span style=\"font-size:12pt\"><span style=\"font-family:\"Liberation Serif\",serif\"><strong><span dir=\"ltr\" lang=\"EN-US\" style=\"font-family:\"Calibri\",sans-serif\"><span style=\"color:#333333\">Ans. B. To decrease secretions</span></span></strong></span></span></p>\r\n\r\n<p> </p>\r\n\r\n<ul>\r\n\t<li><span style=\"font-size:12pt\"><span style=\"font-family:\"Liberation Serif\",serif\"><span dir=\"ltr\" lang=\"EN-US\" style=\"font-family:\"Calibri\",sans-serif\"><span style=\"color:#333333\">Preanesthetic medication refers to the use of drugs before anaesthesia to make it safe and less unpleasant.</span></span></span></span></li>\r\n\t<li><span style=\"font-size:12pt\"><span style=\"font-family:\"Liberation Serif\",serif\"><span dir=\"ltr\" lang=\"EN-US\" style=\"font-family:\"Calibri\",sans-serif\"><span style=\"color:#333333\">When inhalation anaesthetic agents are given, they inhibit the ciliary function resulting in accumulation of secretions in the respiratory pathway. Therefore anti-cholinergic drugs like atropine or glycopyrrolate are used as pre-anaesthetic medication for their anti-secretory action.</span></span></span></span></li>\r\n\t<li><span style=\"font-size:12pt\"><span style=\"font-family:\"Liberation Serif\",serif\"><span dir=\"ltr\" lang=\"EN-US\" style=\"font-family:\"Calibri\",sans-serif\"><span style=\"color:#333333\">Glycopyrrolate is twice as potent and longer acting quaternary anti-muscarinic which does not produce central effects. Anti-secretory action is more marked than atropine and tachycardia is less marked. It acts rapidly when given i.v. and is the preferred anti-muscarinic in anaesthetic practice.</span></span></span></span></li>\r\n</ul>\r\n\r\n<p> </p>\r\n\r\n<p style=\"text-align:left\"><span style=\"font-size:10.5pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span style=\"font-size:12.0pt\">Other Options:</span></strong></span></span></p>\r\n\r\n<p style=\"text-align:left\"> </p>\r\n\r\n<p style=\"text-align:left\"><span style=\"font-size:10.5pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span style=\"font-size:12.0pt\">Option A. To allay anxiety: </span></strong><span style=\"font-size:12.0pt\">Glycopyrrolate is not used to allay anxiety. Anxiolytics such as benzodiazepines are typically used for this purpose.</span></span></span></p>\r\n\r\n<p style=\"text-align:left\"> </p>\r\n\r\n<p style=\"text-align:left\"><span style=\"font-size:10.5pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span style=\"font-size:12.0pt\">Option C. As inducing agent: </span></strong><span style=\"font-size:12.0pt\">Glycopyrrolate is not an inducing agent. Inducing agents are drugs like propofol or thiopental used to induce anaesthesia.</span></span></span></p>\r\n\r\n<p style=\"text-align:left\"> </p>\r\n\r\n<p style=\"text-align:left\"><span style=\"font-size:10.5pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span style=\"font-size:12.0pt\">Option D. For muscle relaxation: </span></strong><span style=\"font-size:12.0pt\">Glycopyrrolate is not used for muscle relaxation. Muscle relaxants like vecuronium or succinylcholine are used for this purpose during surgical procedures.</span></span></span></p>\r\n\r\n<p style=\"text-align:left\"> </p>\r\n\r\n<p style=\"text-align:left\"><span style=\"font-size:10.5pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span style=\"font-size:12.0pt\">Educational objective:</span></strong></span></span></p>\r\n\r\n<p style=\"text-align:left\"> </p>\r\n\r\n<p style=\"text-align:left\"><span style=\"font-size:10.5pt\"><span style=\"font-family:Calibri,sans-serif\"><span style=\"font-size:12.0pt\">Glycopyrrolate is administered before anaesthesia to decrease respiratory secretions, making the anaesthetic procedure safer and more efficient by preventing the accumulation of secretions that can interfere with the airway during surgery.</span></span></span></p>\r\n\r\n<p> </p>\r\n\r\n<p><span style=\"font-size:12pt\"><span style=\"font-family:\"Liberation Serif\",serif\"><strong><span dir=\"ltr\" lang=\"EN-US\" style=\"font-family:\"Calibri\",sans-serif\"><span style=\"color:#333333\">Reference: KDT 8th/. 413,414</span></span></strong></span></span></p>",
      "correct_choice_id": 200633,
      "solution_audio": null,
      "solution_video": null,
      "audio_explanation_heading": null,
      "video_explanation_heading": null,
      "solution_media_position": "bottom",
      "tags": [],
      "explanation_video": null,
      "question_images": [],
      "explanation_images": []
    },
    {
      "id": 50159,
      "choices": [
        {
          "id": 200636,
          "text": "<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\">Chronic gout</span></span></span></p>"
        },
        {
          "id": 200637,
          "text": "<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\">Paralytic ileus</span></span></span></p>"
        },
        {
          "id": 200638,
          "text": "<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\">Psoriatic arthritis</span></span></span></p>"
        },
        {
          "id": 200639,
          "text": "<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\">Rheumatoid arthritis</span></span></span></p>"
        }
      ],
      "text": "<p><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\"><span style=\"font-family:\"Calibri\",sans-serif\"><span style=\"color:#333333\">Pegloticase is used in the treatment of </span></span></span>(AIIMS NOV 2019)</p>",
      "unique_key": "Q7691329",
      "question_audio": null,
      "question_video": null,
      "map_id": 34398052,
      "difficulty_level": "intermediate",
      "subjects_id": [],
      "solution": "<p><span style=\"font-size:12pt\"><span style=\"font-family:\"Liberation Serif\",serif\"><strong><span dir=\"ltr\" lang=\"EN-US\" style=\"font-family:\"Calibri\",sans-serif\"><span style=\"color:#333333\">Ans. A. Chronic gout</span></span></strong></span></span></p>\r\n\r\n<p> </p>\r\n\r\n<p><span style=\"font-size:12pt\"><span style=\"font-family:\"Times New Roman\",serif\"><span style=\"font-family:\"Calibri\",sans-serif\">Pegloticase is a recombinant form of uricase, an enzyme that converts uric acid into allantoin, a more water-soluble substance that is easily excreted by the kidneys. Humans naturally lack this enzyme, and pegloticase is specifically designed to address the accumulation of uric acid in patients with gout.</span></span></span></p>\r\n\r\n<p> </p>\r\n\r\n<p><span style=\"font-size:12pt\"><span style=\"font-family:\"Times New Roman\",serif\"><span style=\"font-family:\"Calibri\",sans-serif\">Pegloticase is particularly indicated for the treatment of chronic gout in patients who have not responded to conventional therapies. Due to its potential immunogenicity, which can lead to infusion reactions including anaphylaxis, pegloticase is reserved for rare cases of refractory symptomatic chronic gout.</span></span></span></p>\r\n\r\n<p> </p>\r\n\r\n<h3><span style=\"font-size:13.5pt\"><span style=\"font-family:\"Times New Roman\",serif\"><strong><span style=\"font-size:12.0pt\"><span style=\"font-family:\"Calibri\",sans-serif\">Other Options:</span></span></strong></span></span></h3>\r\n\r\n<p> </p>\r\n\r\n<p><span style=\"font-size:12pt\"><span style=\"font-family:\"Times New Roman\",serif\"><strong><span style=\"font-family:\"Calibri\",sans-serif\">Option <strong><span style=\"font-family:\"Calibri\",sans-serif\">B. Paralytic ileus: </span></strong></span></strong><span style=\"font-family:\"Calibri\",sans-serif\">Paralytic ileus is a condition of impaired bowel motility. Pegloticase has no role in the treatment of paralytic ileus.</span></span></span></p>\r\n\r\n<p> </p>\r\n\r\n<p><span style=\"font-size:12pt\"><span style=\"font-family:\"Times New Roman\",serif\"><strong><span style=\"font-family:\"Calibri\",sans-serif\">Option <strong><span style=\"font-family:\"Calibri\",sans-serif\">C. Psoriatic arthritis: </span></strong></span></strong><span style=\"font-family:\"Calibri\",sans-serif\">Psoriatic arthritis is an inflammatory arthritis associated with psoriasis. Treatments typically include NSAIDs, DMARDs, and biologics, but not pegloticase.</span></span></span></p>\r\n\r\n<p> </p>\r\n\r\n<p><span style=\"font-size:12pt\"><span style=\"font-family:\"Times New Roman\",serif\"><strong><span style=\"font-family:\"Calibri\",sans-serif\">Option <strong><span style=\"font-family:\"Calibri\",sans-serif\">D. Rheumatoid arthritis: </span></strong></span></strong><span style=\"font-family:\"Calibri\",sans-serif\">Rheumatoid arthritis is an autoimmune disorder treated with NSAIDs, corticosteroids, DMARDs, and biologic agents. Pegloticase is not used in the management of rheumatoid arthritis.</span></span></span></p>\r\n\r\n<p> </p>\r\n\r\n<p><span style=\"font-size:12pt\"><span style=\"font-family:\"Times New Roman\",serif\"><strong><span style=\"font-family:\"Calibri\",sans-serif\">Educational objective:</span></strong></span></span></p>\r\n\r\n<p> </p>\r\n\r\n<p><span style=\"font-size:12pt\"><span style=\"font-family:\"Times New Roman\",serif\"><span style=\"font-family:\"Calibri\",sans-serif\">Pegloticase is used in the treatment of chronic gout, particularly in patients who have not responded to other therapies, due to its ability to lower uric acid levels by converting it to allantoin.</span></span></span></p>\r\n\r\n<p> </p>\r\n\r\n<p><span style=\"font-size:12pt\"><span style=\"font-family:\"Liberation Serif\",serif\"><strong><span dir=\"ltr\" lang=\"EN-US\" style=\"font-family:\"Calibri\",sans-serif\"><span style=\"color:#333333\">Reference: KDT 8th/. 235</span></span></strong></span></span></p>",
      "correct_choice_id": 200636,
      "solution_audio": null,
      "solution_video": null,
      "audio_explanation_heading": null,
      "video_explanation_heading": null,
      "solution_media_position": "bottom",
      "tags": [],
      "explanation_video": null,
      "question_images": [],
      "explanation_images": []
    },
    {
      "id": 50160,
      "choices": [
        {
          "id": 200640,
          "text": "<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\">Muscarinic M2 receptor</span></span></span></p>"
        },
        {
          "id": 200641,
          "text": "<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\">Dopamine D2 receptor</span></span></span></p>"
        },
        {
          "id": 200642,
          "text": "<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\">Serotonin 5 HT 1 receptor</span></span></span></p>"
        },
        {
          "id": 200643,
          "text": "<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\">Angiotensin 1 receptor</span></span></span></p>"
        }
      ],
      "text": "<p style=\"text-align:justify\"><span style=\"font-size:12pt\"><span style=\"font-family:\"Liberation Serif\",serif\"><span dir=\"ltr\" lang=\"EN-US\" style=\"font-family:\"Calibri\",sans-serif\"><span style=\"color:#333333\">G-protein</span></span><span dir=\"ltr\" lang=\"EN-US\" style=\"font-family:\"Calibri\",sans-serif\"><span style=\"color:#333333\"> coupled receptor that does not act through opening of potassium channels is</span></span></span></span>(AIIMS NOV 2019)</p>",
      "unique_key": "Q9576431",
      "question_audio": null,
      "question_video": null,
      "map_id": 34285848,
      "difficulty_level": "intermediate",
      "subjects_id": [],
      "solution": "<p><span style=\"font-size:12pt\"><span style=\"font-family:\"Liberation Serif\",serif\"><strong><span dir=\"ltr\" lang=\"EN-US\" style=\"font-family:\"Calibri\",sans-serif\"><span style=\"color:#333333\">Ans. D. Angiotensin 1 receptor </span></span></strong></span></span></p>\r\n\r\n<p> </p>\r\n\r\n<p style=\"text-align:left\"><span style=\"font-size:10.5pt\"><span style=\"font-family:Calibri,sans-serif\"><span style=\"font-size:12.0pt\">G-protein coupled receptors (GPCRs) can have various mechanisms of action, including the opening of potassium channels or increasing intracellular calcium levels. Opening potassium channels typically results in hyperpolarization and inhibition, whereas increasing calcium levels generally leads to excitation.</span></span></span></p>\r\n\r\n<p style=\"text-align:left\"> </p>\r\n\r\n<ul>\r\n\t<li style=\"text-align:left\"><span style=\"font-size:10.5pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span style=\"font-size:12.0pt\">Muscarinic M2 receptor</span></strong><span style=\"font-size:12.0pt\">: This receptor is coupled to G-proteins that open potassium channels, leading to hyperpolarization and inhibition, particularly in cardiac tissue where it slows the heart rate.</span></span></span></li>\r\n\t<li style=\"text-align:left\"><span style=\"font-size:10.5pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span style=\"font-size:12.0pt\">Dopamine D2 receptor</span></strong><span style=\"font-size:12.0pt\">: This receptor is also coupled to G-proteins that open potassium channels, resulting in hyperpolarization and inhibition. It is involved in regulating neurotransmitter release and motor control.</span></span></span></li>\r\n\t<li style=\"text-align:left\"><span style=\"font-size:10.5pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span style=\"font-size:12.0pt\">Serotonin 5 HT 1 receptor</span></strong><span style=\"font-size:12.0pt\">: This receptor acts similarly by opening potassium channels, leading to hyperpolarization and inhibition. It plays a role in mood regulation and other central nervous system functions.</span></span></span></li>\r\n</ul>\r\n\r\n<p style=\"text-align:left\"> </p>\r\n\r\n<p style=\"text-align:left\"><span style=\"font-size:10.5pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span style=\"font-size:12.0pt\">Angiotensin 1 receptor</span></strong><span style=\"font-size:12.0pt\">: Unlike the others, the Angiotensin 1 receptor does not act through the opening of potassium channels. Instead, it is coupled to G-proteins that activate the phospholipase C pathway, leading to an increase in intracellular calcium levels. This results in vasoconstriction and increased blood pressure.</span></span></span></p>\r\n\r\n<p style=\"text-align:left\"> </p>\r\n\r\n<p style=\"text-align:left\"><span style=\"font-size:10.5pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span style=\"font-size:12.0pt\">Other Options:</span></strong></span></span></p>\r\n\r\n<p style=\"text-align:left\"> </p>\r\n\r\n<p style=\"text-align:left\"><span style=\"font-size:10.5pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span style=\"font-size:12.0pt\">Option A. Muscarinic M2 receptor: </span></strong><span style=\"font-size:12.0pt\">This receptor opens potassium channels, leading to hyperpolarization and inhibition, particularly in the heart, where it decreases heart rate.</span></span></span></p>\r\n\r\n<p style=\"text-align:left\"> </p>\r\n\r\n<p style=\"text-align:left\"><span style=\"font-size:10.5pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span style=\"font-size:12.0pt\">Option B. Dopamine D2 receptor: </span></strong><span style=\"font-size:12.0pt\">This receptor also opens potassium channels, resulting in hyperpolarization and inhibition, affecting neurotransmitter release and motor control.</span></span></span></p>\r\n\r\n<p style=\"text-align:left\"> </p>\r\n\r\n<p style=\"text-align:left\"><span style=\"font-size:10.5pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span style=\"font-size:12.0pt\">Option C. Serotonin 5 HT 1 receptor: </span></strong><span style=\"font-size:12.0pt\">This receptor acts through the opening of potassium channels, leading to hyperpolarization and inhibition, influencing mood and other central nervous system activities.</span></span></span></p>\r\n\r\n<p> </p>\r\n\r\n<p><span style=\"font-size:12pt\"><span style=\"font-family:\"Liberation Serif\",serif\"><strong><span dir=\"ltr\" lang=\"EN-US\" style=\"font-family:\"Calibri\",sans-serif\"><span style=\"color:#333333\">Educational Objective:</span></span></strong></span></span></p>\r\n\r\n<p> </p>\r\n\r\n<p><span style=\"font-size:12pt\"><span style=\"font-family:\"Liberation Serif\",serif\"><span dir=\"ltr\" lang=\"EN-US\" style=\"font-family:\"Calibri\",sans-serif\"><span style=\"color:#333333\">GPCR that acts through opening of K<sup>+</sup> channels can result in hyper-polarization, thus leading to inhibition. So, receptor which causes stimulation cannot act through opening of K<sup>+</sup> channels.</span></span></span></span></p>\r\n\r\n<p> </p>\r\n\r\n<ul style=\"list-style-type:circle\">\r\n\t<li><span style=\"font-size:12pt\"><span style=\"font-family:\"Liberation Serif\",serif\"><span dir=\"ltr\" lang=\"EN-US\" style=\"font-family:\"Calibri\",sans-serif\"><span style=\"color:#333333\">Muscarinic M2 receptor, Dopamine D2 receptor and serotonin 5HT1 receptor act through opening of K<sup>+</sup> channels.</span></span></span></span></li>\r\n\t<li><span style=\"font-size:12pt\"><span style=\"font-family:\"Liberation Serif\",serif\"><span dir=\"ltr\" lang=\"EN-US\" style=\"font-family:\"Calibri\",sans-serif\"><span style=\"color:#333333\">Whereas Angiotensin 1 receptor act by increasing Ca<sup>2+</sup>.</span></span></span></span></li>\r\n</ul>\r\n\r\n<p> </p>\r\n\r\n<p><span style=\"font-size:12pt\"><span style=\"font-family:\"Liberation Serif\",serif\"><strong><span dir=\"ltr\" lang=\"EN-US\" style=\"font-family:\"Calibri\",sans-serif\"><span style=\"color:#333333\">Reference: <strong>KDT 8<sup>th</sup>/56</strong></span></span></strong></span></span></p>",
      "correct_choice_id": 200643,
      "solution_audio": null,
      "solution_video": null,
      "audio_explanation_heading": null,
      "video_explanation_heading": null,
      "solution_media_position": "bottom",
      "tags": [],
      "explanation_video": null,
      "question_images": [],
      "explanation_images": []
    },
    {
      "id": 50161,
      "choices": [
        {
          "id": 200644,
          "text": "<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\">Zidovudine is used as monotherapy for post-exposure prophylaxis</span></span></span></p>"
        },
        {
          "id": 200645,
          "text": "<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\">Washing hands with soap and water is advised</span></span></span></p>"
        },
        {
          "id": 200646,
          "text": "<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\">Baseline viral markers of health care personnel should be done at the time of prick</span></span></span></p>"
        },
        {
          "id": 200647,
          "text": "<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\">Follow up viral markers of health care personnel should be measured at 6 weeks</span></span></span></p>"
        }
      ],
      "text": "<p style=\"text-align:justify\"><span style=\"font-size:12pt\"><span style=\"font-family:\"Liberation Serif\",serif\"><span dir=\"ltr\" lang=\"EN-US\" style=\"font-family:\"Calibri\",sans-serif\"><span style=\"color:#333333\">A nurse </span></span><span dir=\"ltr\" lang=\"EN-US\" style=\"font-family:\"Calibri\",sans-serif\"><span style=\"color:#333333\">got accidental prick from the HIV infected needle. Which of the following statements is false regarding the management of this nurse? </span></span></span></span>(AIIMS NOV 2019)</p>",
      "unique_key": "Q9738874",
      "question_audio": null,
      "question_video": null,
      "map_id": 34875450,
      "difficulty_level": "intermediate",
      "subjects_id": [],
      "solution": "<p><span style=\"font-size:12pt\"><span style=\"font-family:\"Liberation Serif\",serif\"><strong><span dir=\"ltr\" lang=\"EN-US\" style=\"font-family:\"Calibri\",sans-serif\"><span style=\"color:#333333\">Ans. A. Zidovudine is used as monotherapy for post-exposure prophylaxis</span></span></strong></span></span></p>\r\n\r\n<p> </p>\r\n\r\n<p style=\"text-align:left\"><span style=\"font-size:10.5pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span style=\"font-size:12.0pt\">Post-Exposure Prophylaxis (PEP)</span></strong><span style=\"font-size:12.0pt\"> involves a series of steps to reduce the risk of HIV infection after potential exposure, such as a needlestick injury.</span></span></span></p>\r\n\r\n<p style=\"text-align:left\"> </p>\r\n\r\n<ol>\r\n\t<li style=\"text-align:left\"><span style=\"font-size:10.5pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span style=\"font-size:12.0pt\">Washing the Wound</span></strong><span style=\"font-size:12.0pt\">: Immediately after exposure, the wound should be washed thoroughly with soap and water. This helps to reduce the risk of infection.</span></span></span></li>\r\n\t<li style=\"text-align:left\"><span style=\"font-size:10.5pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span style=\"font-size:12.0pt\">Baseline Viral Markers</span></strong><span style=\"font-size:12.0pt\">: Blood samples should be taken from the exposed individual to measure baseline viral markers. This provides a reference point to determine if the infection was acquired.</span></span></span></li>\r\n\t<li style=\"text-align:left\"><span style=\"font-size:10.5pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span style=\"font-size:12.0pt\">Triple Drug Therapy</span></strong><span style=\"font-size:12.0pt\">: PEP should be initiated within 72 hours of exposure, preferably as soon as possible. The recommended regimen includes a combination of three antiretroviral drugs:</span></span></span>\r\n\t<ul>\r\n\t\t<li style=\"text-align:left\"><span style=\"font-size:10.5pt\"><span style=\"font-family:Calibri,sans-serif\"><span style=\"font-size:12.0pt\">Tenofovir</span></span></span></li>\r\n\t\t<li style=\"text-align:left\"><span style=\"font-size:10.5pt\"><span style=\"font-family:Calibri,sans-serif\"><span style=\"font-size:12.0pt\">Lamivudine (or Emtricitabine)</span></span></span></li>\r\n\t\t<li style=\"text-align:left\"><span style=\"font-size:10.5pt\"><span style=\"font-family:Calibri,sans-serif\"><span style=\"font-size:12.0pt\">A boosted protease inhibitor (such as lopinavir/ritonavir)</span></span></span></li>\r\n\t</ul>\r\n\t</li>\r\n</ol>\r\n\r\n<p style=\"margin-left:48px; text-align:left\"> </p>\r\n\r\n<p style=\"margin-left:48px; text-align:left\"><span style=\"font-size:10.5pt\"><span style=\"font-family:Calibri,sans-serif\"><span style=\"font-size:12.0pt\">Zidovudine monotherapy is not recommended. Combination therapy is more effective in preventing seroconversion.</span></span></span></p>\r\n\r\n<p style=\"margin-left:48px; text-align:left\"> </p>\r\n\r\n<ol start=\"4\">\r\n\t<li style=\"text-align:left\"><span style=\"font-size:10.5pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span style=\"font-size:12.0pt\">Follow-Up Testing</span></strong><span style=\"font-size:12.0pt\">: Follow-up viral markers should be measured at 6 weeks post-exposure to check for HIV infection. Additional testing may also be done at 3 months and 6 months.</span></span></span></li>\r\n</ol>\r\n\r\n<p style=\"text-align:left\"> </p>\r\n\r\n<p style=\"text-align:left\"><span style=\"font-size:10.5pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span style=\"font-size:12.0pt\">Other Options:</span></strong></span></span></p>\r\n\r\n<p style=\"text-align:left\"> </p>\r\n\r\n<p style=\"text-align:left\"><span style=\"font-size:10.5pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span style=\"font-size:12.0pt\">Option B. Washing hands with soap and water is advised: </span></strong><span style=\"font-size:12.0pt\">This is correct. Washing the wound with soap and water immediately after exposure is a crucial first step.</span></span></span></p>\r\n\r\n<p style=\"text-align:left\"> </p>\r\n\r\n<p style=\"text-align:left\"><span style=\"font-size:10.5pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span style=\"font-size:12.0pt\">Option C. Baseline viral markers of health care personnel should be done at the time of prick: </span></strong><span style=\"font-size:12.0pt\">This is correct. Establishing baseline viral markers at the time of exposure is essential for monitoring potential seroconversion.</span></span></span></p>\r\n\r\n<p style=\"text-align:left\"> </p>\r\n\r\n<p style=\"text-align:left\"><span style=\"font-size:10.5pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span style=\"font-size:12.0pt\">Option D. Follow up viral markers of health care personnel should be measured at 6 weeks: </span></strong><span style=\"font-size:12.0pt\">This is correct. Follow-up testing at 6 weeks is recommended to detect any early seroconversion.</span></span></span></p>\r\n\r\n<p> </p>\r\n\r\n<p><span style=\"font-size:12pt\"><span style=\"font-family:\"Liberation Serif\",serif\"><strong><span dir=\"ltr\" lang=\"EN-US\" style=\"font-family:\"Calibri\",sans-serif\"><span style=\"color:#333333\">Educational Objective:</span></span></strong></span></span></p>\r\n\r\n<p> </p>\r\n\r\n<p><span style=\"font-size:12pt\"><span style=\"font-family:\"Liberation Serif\",serif\"><strong><span dir=\"ltr\" lang=\"EN-US\" style=\"font-family:\"Calibri\",sans-serif\"><span style=\"color:#333333\">POST EXPOSURE PROPHYLAXIS</span></span></strong></span></span></p>\r\n\r\n<p> </p>\r\n\r\n<ul>\r\n\t<li><span style=\"font-size:12pt\"><span style=\"font-family:\"Liberation Serif\",serif\"><span dir=\"ltr\" lang=\"EN-US\" style=\"font-family:\"Calibri\",sans-serif\"><span style=\"color:#333333\">Treatment should be started within 72 hours of exposure, preferably as early as possible</span></span></span></span></li>\r\n\t<li><span style=\"font-size:12pt\"><span style=\"font-family:\"Liberation Serif\",serif\"><span dir=\"ltr\" lang=\"EN-US\" style=\"font-family:\"Calibri\",sans-serif\"><span style=\"color:#333333\">At first the wound is washed with soap and water.</span></span></span></span></li>\r\n\t<li><span style=\"font-size:12pt\"><span style=\"font-family:\"Liberation Serif\",serif\"><span dir=\"ltr\" lang=\"EN-US\" style=\"font-family:\"Calibri\",sans-serif\"><span style=\"color:#333333\">Secondly before initiating drug therapy blood samples are taken to measure the baseline viral markers</span></span></span></span></li>\r\n\t<li><span style=\"font-size:12pt\"><span style=\"font-family:\"Liberation Serif\",serif\"><span dir=\"ltr\" lang=\"EN-US\" style=\"font-family:\"Calibri\",sans-serif\"><span style=\"color:#333333\">Then, triple drug therapy is given which includes Tenofovir, Lamivudine and a boosted protease inhibitor for 28 days.</span></span></span></span></li>\r\n\t<li><span style=\"font-size:12pt\"><span style=\"font-family:\"Liberation Serif\",serif\"><span dir=\"ltr\" lang=\"EN-US\" style=\"font-family:\"Calibri\",sans-serif\"><span style=\"color:#333333\">After 6 weeks again viral markers are measured to check for the infection.</span></span></span></span></li>\r\n</ul>\r\n\r\n<p> </p>\r\n\r\n<p><span style=\"font-size:12pt\"><span style=\"font-family:\"Liberation Serif\",serif\"><strong><span dir=\"ltr\" lang=\"EN-US\" style=\"font-family:\"Calibri\",sans-serif\"><span style=\"color:#333333\">Reference: KDT 8<sup>th</sup>/872</span></span></strong></span></span></p>",
      "correct_choice_id": 200644,
      "solution_audio": null,
      "solution_video": null,
      "audio_explanation_heading": null,
      "video_explanation_heading": null,
      "solution_media_position": "bottom",
      "tags": [],
      "explanation_video": null,
      "question_images": [],
      "explanation_images": []
    },
    {
      "id": 50162,
      "choices": [
        {
          "id": 200648,
          "text": "<p style=\"text-align:left\"><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\">5HT4 agonist</span></span></span></p>"
        },
        {
          "id": 200649,
          "text": "<p style=\"text-align:left\"><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\">5HT2b agonist</span></span></span></p>"
        },
        {
          "id": 200650,
          "text": "<p style=\"text-align:left\"><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\">5HT2b antagonist</span></span></span></p>"
        },
        {
          "id": 200651,
          "text": "<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\">5HT1a partial agonist</span></span></span></p>"
        }
      ],
      "text": "<p style=\"text-align:left\"><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\"><span style=\"font-family:\"Calibri\",sans-serif\"><span style=\"color:#333333\">Prucalopride</span></span></span><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\"><span style=\"font-family:\"Calibri\",sans-serif\"><span style=\"color:#333333\"> is a (AIIMS NOVEMBER 2019)</span></span></span></p>",
      "unique_key": "Q4700687",
      "question_audio": null,
      "question_video": null,
      "map_id": 34917881,
      "difficulty_level": "intermediate",
      "subjects_id": [],
      "solution": "<p><span style=\"font-size:12pt\"><span style=\"font-family:\"Liberation Serif\",serif\"><strong><span dir=\"ltr\" lang=\"EN-US\" style=\"font-family:\"Calibri\",sans-serif\"><span style=\"color:#333333\">Ans. A. 5HT4 agonist</span></span></strong></span></span></p>\r\n\r\n<p> </p>\r\n\r\n<p><span style=\"font-size:12pt\"><span style=\"font-family:\"Liberation Serif\",serif\"><strong><span dir=\"ltr\" lang=\"EN-US\" style=\"font-family:\"Calibri\",sans-serif\"><span style=\"color:#333333\">PRUCALOPRIDE</span></span></strong></span></span></p>\r\n\r\n<p> </p>\r\n\r\n<ul>\r\n\t<li><span style=\"font-size:12pt\"><span style=\"font-family:\"Liberation Serif\",serif\"><span dir=\"ltr\" lang=\"EN-US\" style=\"font-family:\"Calibri\",sans-serif\"><span style=\"color:#333333\">It is a selective <strong>5-HT4 receptor agonist</strong> approved recently for the treatment of chronic constipation, when other laxatives fail to provide adequate relief.</span></span></span></span></li>\r\n\t<li><span style=\"font-size:12pt\"><span style=\"font-family:\"Liberation Serif\",serif\"><span dir=\"ltr\" lang=\"EN-US\" style=\"font-family:\"Calibri\",sans-serif\"><span style=\"color:#333333\">It activates pre-junctional 5-HT4 receptors on intrinsic enteric neurons to enhance release of the excitatory transmitter ACh. It, thereby promotes the propulsive contractions in ileum and more prominently in colon.</span></span></span></span></li>\r\n\t<li><span style=\"font-size:12pt\"><span style=\"font-family:\"Liberation Serif\",serif\"><span dir=\"ltr\" lang=\"EN-US\" style=\"font-family:\"Calibri\",sans-serif\"><span style=\"color:#333333\">Prucalopride is shown to have negligible affinity for cardiac K<sup>+</sup> channels. It is therefore, believed to be free of cardiovascular risk. No Q-T prolongation has been noted during clinical trial. </span></span></span></span></li>\r\n</ul>\r\n\r\n<p><br />\r\n<span style=\"font-size:12pt\"><span style=\"font-family:\"Liberation Serif\",serif\"><strong><span dir=\"ltr\" lang=\"EN-US\" style=\"font-family:\"Calibri\",sans-serif\">Educational objective:</span></strong></span></span></p>\r\n\r\n<p> </p>\r\n\r\n<p><span style=\"font-size:12pt\"><span style=\"font-family:\"Times New Roman\",serif\"><span style=\"font-family:\"Calibri\",sans-serif\">Prucalopride is a selective 5-HT4 receptor agonist used for the treatment of chronic constipation, working by enhancing acetylcholine release to promote intestinal motility without significant cardiovascular risks.</span></span></span></p>\r\n\r\n<p> </p>\r\n\r\n<p><span style=\"font-size:12pt\"><span style=\"font-family:\"Liberation Serif\",serif\"><strong><span dir=\"ltr\" lang=\"EN-US\" style=\"font-family:\"Calibri\",sans-serif\"><span style=\"color:#333333\">Reference: KDT 8<sup>th</sup>/724</span></span></strong></span></span></p>",
      "correct_choice_id": 200648,
      "solution_audio": null,
      "solution_video": null,
      "audio_explanation_heading": null,
      "video_explanation_heading": null,
      "solution_media_position": "bottom",
      "tags": [],
      "explanation_video": null,
      "question_images": [],
      "explanation_images": []
    },
    {
      "id": 50163,
      "choices": [
        {
          "id": 200652,
          "text": "<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\">Both A and R are correct and R is correct explanation of A</span></span></span></p>"
        },
        {
          "id": 200653,
          "text": "<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\">Both A and R are correct and R is not correct explanation of A</span></span></span></p>"
        },
        {
          "id": 200654,
          "text": "<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\">A is true and R is false</span></span></span></p>"
        },
        {
          "id": 200655,
          "text": "<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\">A is false and R is true</span></span></span></p>"
        }
      ],
      "text": "<p><span style=\"font-size:12pt\"><span style=\"font-family:\"Liberation Serif\",serif\"><strong><span dir=\"ltr\" lang=\"EN-US\" style=\"font-family:\"Calibri\",sans-serif\"><span style=\"color:#333333\">Assertion:</span></span></strong><span dir=\"ltr\" lang=\"EN-US\" style=\"font-family:\"Calibri\",sans-serif\"><span style=\"color:#333333\"> In a patient</span></span><span dir=\"ltr\" lang=\"EN-US\" style=\"font-family:\"Calibri\",sans-serif\"><span style=\"color:#333333\"> admitted in hospital for community acquired pneumonia, combination therapy of beta lactams and azithromycin is given.</span></span></span></span></p>\r\n\r\n<p> </p>\r\n\r\n<p><span style=\"font-size:12pt\"><span style=\"font-family:\"Liberation Serif\",serif\"><strong><span dir=\"ltr\" lang=\"EN-US\" style=\"font-family:\"Calibri\",sans-serif\"><span style=\"color:#333333\">Reason:</span></span></strong><span dir=\"ltr\" lang=\"EN-US\" style=\"font-family:\"Calibri\",sans-serif\"><span style=\"color:#333333\"> The combination covers gram positive organisms as well as anaerobes.</span></span></span></span></p>",
      "unique_key": "Q9350454",
      "question_audio": null,
      "question_video": null,
      "map_id": 34702198,
      "difficulty_level": "intermediate",
      "subjects_id": [],
      "solution": "<p><span style=\"font-size:12pt\"><span style=\"font-family:\"Liberation Serif\",serif\"><strong><span dir=\"ltr\" lang=\"EN-US\" style=\"font-family:\"Calibri\",sans-serif\"><span style=\"color:#333333\">Ans. C</span></span></strong><span dir=\"ltr\" lang=\"EN-US\" style=\"font-family:\"Calibri\",sans-serif\"><span style=\"color:#333333\">. <strong>A is true and R is false</strong></span></span></span></span></p>\r\n\r\n<p> </p>\r\n\r\n<ul>\r\n\t<li><span style=\"font-size:12pt\"><span style=\"font-family:\"Liberation Serif\",serif\"><span dir=\"ltr\" lang=\"EN-US\" style=\"font-family:\"Calibri\",sans-serif\"><span style=\"color:#333333\">In patients admitted in hospital for community acquired pneumonia, combination therapy of beta lactams and azithromycin is given. Beta lactams covers the gram positive and gram negative organisms whereas azithromycin covers the atypical mycobacteria like mycoplasma and chlamydia.</span></span></span></span></li>\r\n\t<li><span style=\"font-size:12pt\"><span style=\"font-family:\"Liberation Serif\",serif\"><span dir=\"ltr\" lang=\"EN-US\" style=\"font-family:\"Calibri\",sans-serif\"><span style=\"color:#333333\">Alternative to this therapy is fluoroquinolones.</span></span></span></span></li>\r\n\t<li><span style=\"font-size:12pt\"><span style=\"font-family:\"Liberation Serif\",serif\"><span dir=\"ltr\" lang=\"EN-US\" style=\"font-family:\"Calibri\",sans-serif\"><span style=\"color:#333333\">If a patient is not admitted, then either beta lactams alone or macrolides is prescribed.</span></span></span></span></li>\r\n</ul>\r\n\r\n<p> </p>\r\n\r\n<p><span style=\"font-size:6pt\"><span style=\"font-family:\"Liberation Serif\",serif\"><strong><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\"><span style=\"font-family:\"Calibri\",sans-serif\">Educational objective:</span></span></strong></span></span></p>\r\n\r\n<p> </p>\r\n\r\n<p><span style=\"font-size:12pt\"><span style=\"font-family:\"Liberation Serif\",serif\"><span dir=\"ltr\" lang=\"EN-US\" style=\"font-family:\"Calibri\",sans-serif\">In hospitalized patients with community-acquired pneumonia, combination therapy of beta-lactams and azithromycin is used to cover typical and atypical bacterial pathogens, not anaerobes.</span></span></span></p>\r\n\r\n<p> </p>\r\n\r\n<p><span style=\"font-size:12pt\"><span style=\"font-family:\"Liberation Serif\",serif\"><strong><span dir=\"ltr\" lang=\"EN-US\" style=\"font-family:\"Calibri\",sans-serif\"><span style=\"color:#333333\">Reference: Katzung 13<sup>th</sup>/878</span></span></strong></span></span></p>",
      "correct_choice_id": 200654,
      "solution_audio": null,
      "solution_video": null,
      "audio_explanation_heading": null,
      "video_explanation_heading": null,
      "solution_media_position": "bottom",
      "tags": [],
      "explanation_video": null,
      "question_images": [],
      "explanation_images": []
    },
    {
      "id": 50164,
      "choices": [
        {
          "id": 200656,
          "text": "<p><span style=\"font-size:12.0pt;\">Clindamycin</span></p>"
        },
        {
          "id": 200657,
          "text": "<p><span style=\"font-size:12.0pt;\">Metronidazole</span></p>"
        },
        {
          "id": 200658,
          "text": "<p><span style=\"font-size:12.0pt;\">Erythromycin</span></p>"
        },
        {
          "id": 200659,
          "text": "<p><span style=\"font-size:12.0pt;\">Rovamycin</span></p>"
        }
      ],
      "text": "<p style=\"text-align:justify;\"><span style=\"color:#333333;font-size:12.0pt;\">Drug of choice for treatment of bacterial vaginosis in pregnancy is</span></p>",
      "unique_key": "Q7593127",
      "question_audio": null,
      "question_video": null,
      "map_id": 34761858,
      "difficulty_level": "intermediate",
      "subjects_id": [],
      "solution": "<p><span style=\"color:#333333;font-size:12pt;\"><strong>Ans. B. Metronidazole</strong></span></p><p> </p><p><span style=\"font-size:12.0pt;\"><strong>Metronidazole</strong> is the drug of choice for the treatment of bacterial vaginosis, including in pregnancy. Bacterial vaginosis is a common vaginal infection caused by an imbalance of the normal bacterial flora.</span></p><p> </p><ul><li><span style=\"font-size:12.0pt;\"><strong>Effectiveness</strong>: Metronidazole is highly effective against the anaerobic bacteria that are commonly implicated in bacterial vaginosis.</span></li><li><span style=\"font-size:12.0pt;\"><strong>Safety</strong>: It is considered safe for use during pregnancy, making it the preferred treatment option.</span></li></ul><p> </p><p><span style=\"font-size:12.0pt;\"><strong>Other Options:</strong></span></p><p> </p><p><span style=\"font-size:12.0pt;\"><strong>Option A. Clindamycin: </strong>Clindamycin is an alternative treatment for bacterial vaginosis and can be used if metronidazole is contraindicated or not tolerated. However, it is not the first-line treatment.</span></p><p> </p><p><span style=\"font-size:12.0pt;\"><strong>Option C. Erythromycin: </strong>Erythromycin is not commonly used for bacterial vaginosis. It is more commonly used for infections caused by gram-positive bacteria and atypical pathogens.</span></p><p> </p><p><span style=\"font-size:12.0pt;\"><strong>Option D. Rovamycin: </strong>Rovamycin (spiramycin) is a macrolide antibiotic used primarily for the treatment of toxoplasmosis in pregnancy. It is not used for bacterial vaginosis.</span></p><p> </p><p><span style=\"font-size:12.0pt;\"><strong>Educational Objective:</strong></span></p><p> </p><p><span style=\"font-size:12.0pt;\">Metronidazole is the drug of choice for treating bacterial vaginosis in pregnancy due to its effectiveness against anaerobic bacteria and its safety profile during pregnancy.</span></p><p> </p><p><span style=\"color:#333333;font-size:12pt;\">Rovamycin i.e. spiramycin (which is a macrolide) is drug of choice for toxoplasmosis in pregnancy.</span></p><p> </p><p><span style=\"color:#333333;font-size:12pt;\"><strong>Reference: KDT 8<sup>th</sup>/894-896.</strong></span></p>",
      "correct_choice_id": 200657,
      "solution_audio": null,
      "solution_video": null,
      "audio_explanation_heading": null,
      "video_explanation_heading": null,
      "solution_media_position": "bottom",
      "tags": [],
      "explanation_video": null,
      "question_images": [],
      "explanation_images": []
    },
    {
      "id": 50165,
      "choices": [
        {
          "id": 200660,
          "text": "<p style=\"text-align:left\"><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\">Peripheral neuropathy is a common adverse effect</span></span></span></p>"
        },
        {
          "id": 200661,
          "text": "<p style=\"text-align:left\"><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\">It is active against gram positive organisms</span></span></span></p>"
        },
        {
          "id": 200662,
          "text": "<p style=\"text-align:left\"><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\">It has poor oral bioavailability</span></span></span></p>"
        },
        {
          "id": 200663,
          "text": "<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\">Major mode of elimination is renal excretion</span></span></span></p>"
        }
      ],
      "text": "<p style=\"text-align:left\"><span style=\"font-size:12pt\"><span style=\"font-family:\"Liberation Serif\",serif\"><span dir=\"ltr\" lang=\"EN-US\" style=\"font-family:\"Calibri\",sans-serif\"><span style=\"color:#333333\">W</span></span><span dir=\"ltr\" lang=\"EN-US\" style=\"font-family:\"Calibri\",sans-serif\"><span style=\"color:#333333\">hich of the following statements about tedizolid is true? (</span></span></span></span>AIIMS Nov 2019)</p>",
      "unique_key": "Q4442518",
      "question_audio": null,
      "question_video": null,
      "map_id": 34251745,
      "difficulty_level": "intermediate",
      "subjects_id": [],
      "solution": "<p><span style=\"font-size:12pt\"><span style=\"font-family:\"Liberation Serif\",serif\"><strong><span dir=\"ltr\" lang=\"EN-US\" style=\"font-family:\"Calibri\",sans-serif\"><span style=\"color:#333333\">Ans. B. It is active against gram positive organisms</span></span></strong></span></span></p>\r\n\r\n<p> </p>\r\n\r\n<p style=\"text-align:left\"><span style=\"font-size:10.5pt\"><span style=\"font-family:Calibri,sans-serif\"><span style=\"font-size:12.0pt\">Tedizolid is an oxazolidinone-class antibiotic, similar to linezolid, and is primarily used to treat infections caused by gram-positive bacteria.</span></span></span></p>\r\n\r\n<p style=\"text-align:left\"> </p>\r\n\r\n<p style=\"text-align:left\"><span style=\"font-size:10.5pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span style=\"font-size:12.0pt\">Activity Against Gram-Positive Organisms</span></strong><span style=\"font-size:12.0pt\">: Tedizolid is particularly effective against gram-positive pathogens, including methicillin-resistant Staphylococcus aureus (MRSA) and vancomycin-resistant Staphylococcus aureus (VRSA). It works by inhibiting protein synthesis through binding to the 50S ribosomal subunit.</span></span></span></p>\r\n\r\n<p style=\"text-align:left\"> </p>\r\n\r\n<p style=\"text-align:left\"><span style=\"font-size:10.5pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span style=\"font-size:12.0pt\">Other Options:</span></strong></span></span></p>\r\n\r\n<p style=\"text-align:left\"> </p>\r\n\r\n<p style=\"text-align:left\"><span style=\"font-size:10.5pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span style=\"font-size:12.0pt\">Option A. Peripheral neuropathy is a common adverse effect: </span></strong><span style=\"font-size:12.0pt\">Peripheral neuropathy and lactic acidosis are potential adverse effects of tedizolid, but they are not common.</span></span></span></p>\r\n\r\n<p style=\"text-align:left\"> </p>\r\n\r\n<p style=\"text-align:left\"><span style=\"font-size:10.5pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span style=\"font-size:12.0pt\">Option C. It has poor oral bioavailability: </span></strong><span style=\"font-size:12.0pt\">This is incorrect. Tedizolid has very good oral bioavailability, nearly 90%, making it effective when administered orally.</span></span></span></p>\r\n\r\n<p style=\"text-align:left\"> </p>\r\n\r\n<p style=\"text-align:left\"><span style=\"font-size:10.5pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span style=\"font-size:12.0pt\">Option D. Major mode of elimination is renal excretion: </span></strong><span style=\"font-size:12.0pt\">This is incorrect. Tedizolid is primarily metabolized in the liver, and renal excretion is not the major route of elimination.</span></span></span></p>\r\n\r\n<p style=\"text-align:left\"> </p>\r\n\r\n<p style=\"text-align:left\"><span style=\"font-size:10.5pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span style=\"font-size:12.0pt\">Educational objective:</span></strong></span></span></p>\r\n\r\n<p style=\"text-align:left\"> </p>\r\n\r\n<p style=\"text-align:left\"><span style=\"font-size:10.5pt\"><span style=\"font-family:Calibri,sans-serif\"><span style=\"font-size:12.0pt\">Tedizolid is a protein synthesis inhibitor that is primarily active against gram-positive organisms, including resistant strains like MRSA and VRSA. It has good oral bioavailability and is primarily metabolized in the liver.</span></span></span></p>\r\n\r\n<p style=\"text-align:left\"> </p>\r\n\r\n<p><span style=\"font-size:12pt\"><span style=\"font-family:\"Liberation Serif\",serif\"><strong><span dir=\"ltr\" lang=\"EN-US\" style=\"font-family:\"Calibri\",sans-serif\"><span style=\"color:#333333\">Reference: KDT 8<sup>th</sup>/808</span></span></strong></span></span></p>",
      "correct_choice_id": 200661,
      "solution_audio": null,
      "solution_video": null,
      "audio_explanation_heading": null,
      "video_explanation_heading": null,
      "solution_media_position": "bottom",
      "tags": [],
      "explanation_video": null,
      "question_images": [],
      "explanation_images": []
    },
    {
      "id": 50166,
      "choices": [
        {
          "id": 200664,
          "text": "<p style=\"text-align:left\"><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\">Monitoring of lithium therapy</span></span></span></p>"
        },
        {
          "id": 200665,
          "text": "<p style=\"text-align:left\"><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\">Monitoring of carbamazepine therapy</span></span></span></p>"
        },
        {
          "id": 200666,
          "text": "<p style=\"text-align:left\"><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\">Administration of long acting depot antipsychotics</span></span></span></p>"
        },
        {
          "id": 200667,
          "text": "<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\">Administration of nicotine patches</span></span></span></p>"
        }
      ],
      "text": "<p style=\"text-align:left\"><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\"><span style=\"font-family:\"Calibri\",sans-serif\"><span style=\"color:#333333\">Z track technique is used for (</span></span></span>AIIMS Nov 2019)</p>",
      "unique_key": "Q3848940",
      "question_audio": null,
      "question_video": null,
      "map_id": 34619259,
      "difficulty_level": "intermediate",
      "subjects_id": [],
      "solution": "<p><span style=\"font-size:12pt\"><span style=\"font-family:\"Liberation Serif\",serif\"><strong><span dir=\"ltr\" lang=\"EN-US\" style=\"font-family:\"Calibri\",sans-serif\"><span style=\"color:#333333\">Ans. C. Administration of long acting depot antipsychotics</span></span></strong></span></span></p>\r\n\r\n<p> </p>\r\n\r\n<p><span style=\"font-size:12pt\"><span style=\"font-family:\"Liberation Serif\",serif\"><span dir=\"ltr\" lang=\"EN-US\" style=\"font-family:\"Calibri\",sans-serif\"><span style=\"color:#333333\">Z track technique is a technique used for intramuscular injection.</span></span></span></span></p>\r\n\r\n<p><br />\r\n<span style=\"font-size:12pt\"><span style=\"font-family:\"Liberation Serif\",serif\"><span dir=\"ltr\" lang=\"EN-US\" style=\"font-family:\"Calibri\",sans-serif\"><span style=\"color:#333333\">During Z track technique, skin is stretched to one side before injecting the needle so that the point of injection and point of deposition of drug are not in straight line. This decreases the risk of efflux back of drug.</span></span></span></span></p>\r\n\r\n<p> </p>\r\n\r\n<p><span style=\"font-size:12pt\"><span style=\"font-family:\"Liberation Serif\",serif\"><strong><span dir=\"ltr\" lang=\"EN-US\" style=\"font-family:\"Calibri\",sans-serif\"><span style=\"color:#333333\">Advantages of Z track technique –</span></span></strong></span></span></p>\r\n\r\n<p> </p>\r\n\r\n<ul>\r\n\t<li><span style=\"font-size:12pt\"><span style=\"font-family:\"Liberation Serif\",serif\"><span dir=\"ltr\" lang=\"EN-US\" style=\"font-family:\"Calibri\",sans-serif\"><span style=\"color:#333333\">It will not cause any pigmentation</span></span></span></span></li>\r\n</ul>\r\n\r\n<ul>\r\n\t<li><span style=\"font-size:12pt\"><span style=\"font-family:\"Liberation Serif\",serif\"><span dir=\"ltr\" lang=\"EN-US\" style=\"font-family:\"Calibri\",sans-serif\"><span style=\"color:#333333\">Lithium and carbamazepine are oral drugs and monitoring is done by taking blood through intravenous route.</span></span></span></span></li>\r\n\t<li><span style=\"font-size:12pt\"><span style=\"font-family:\"Liberation Serif\",serif\"><span dir=\"ltr\" lang=\"EN-US\" style=\"font-family:\"Calibri\",sans-serif\"><span style=\"color:#333333\">Long acting depot antipsychotics are given by intramuscular route via z-track technique.</span></span></span></span></li>\r\n\t<li><span style=\"font-size:12pt\"><span style=\"font-family:\"Liberation Serif\",serif\"><span dir=\"ltr\" lang=\"EN-US\" style=\"font-family:\"Calibri\",sans-serif\"><span style=\"color:#333333\">Nicotine patches are applied on the skin.</span></span></span></span></li>\r\n</ul>\r\n\r\n<p> </p>\r\n\r\n<p><span style=\"font-size:12pt\"><span style=\"font-family:\"Times New Roman\",serif\"><strong><span style=\"font-family:\"Calibri\",sans-serif\">Other Options:</span></strong></span></span></p>\r\n\r\n<p> </p>\r\n\r\n<p><span style=\"font-size:12pt\"><span style=\"font-family:\"Times New Roman\",serif\"><strong><span style=\"font-family:\"Calibri\",sans-serif\">Option <strong><span style=\"font-family:\"Calibri\",sans-serif\">A. Monitoring of lithium therapy: </span></strong></span></strong></span></span><span style=\"font-size:12pt\"><span style=\"font-family:\"Times New Roman\",serif\"><span style=\"font-family:\"Calibri\",sans-serif\">Lithium therapy is monitored through blood tests, not intramuscular injections. Blood samples are taken intravenously to measure lithium levels.</span></span></span></p>\r\n\r\n<p> </p>\r\n\r\n<p><span style=\"font-size:12pt\"><span style=\"font-family:\"Times New Roman\",serif\"><strong><span style=\"font-family:\"Calibri\",sans-serif\">Option <strong><span style=\"font-family:\"Calibri\",sans-serif\">B. Monitoring of carbamazepine therapy: </span></strong></span></strong></span></span><span style=\"font-size:12pt\"><span style=\"font-family:\"Times New Roman\",serif\"><span style=\"font-family:\"Calibri\",sans-serif\">Carbamazepine therapy is also monitored through blood tests. Blood samples are taken intravenously to measure carbamazepine levels, and the medication is usually taken orally.</span></span></span></p>\r\n\r\n<p> </p>\r\n\r\n<p><span style=\"font-size:12pt\"><span style=\"font-family:\"Times New Roman\",serif\"><strong><span style=\"font-family:\"Calibri\",sans-serif\">Option <strong><span style=\"font-family:\"Calibri\",sans-serif\">D. Administration of nicotine patches: </span></strong></span></strong></span></span><span style=\"font-size:12pt\"><span style=\"font-family:\"Times New Roman\",serif\"><span style=\"font-family:\"Calibri\",sans-serif\">Nicotine patches are applied transdermally to the skin. The Z track technique is not relevant for this method of administration.</span></span></span></p>\r\n\r\n<p> </p>\r\n\r\n<p><span style=\"font-size:12pt\"><span style=\"font-family:\"Times New Roman\",serif\"><strong><span style=\"font-family:\"Calibri\",sans-serif\">Educational objective:</span></strong></span></span></p>\r\n\r\n<p> </p>\r\n\r\n<p><span style=\"font-size:12pt\"><span style=\"font-family:\"Times New Roman\",serif\"><span style=\"font-family:\"Calibri\",sans-serif\">The Z track technique is used for intramuscular injections, particularly for long-acting depot antipsychotics, to ensure proper deposition of the medication and prevent leakage back through the injection path.</span></span></span></p>",
      "correct_choice_id": 200666,
      "solution_audio": null,
      "solution_video": null,
      "audio_explanation_heading": null,
      "video_explanation_heading": null,
      "solution_media_position": "bottom",
      "tags": [],
      "explanation_video": null,
      "question_images": [],
      "explanation_images": []
    },
    {
      "id": 50167,
      "choices": [
        {
          "id": 200668,
          "text": "<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\">Thalidomide</span></span></span></p>"
        },
        {
          "id": 200669,
          "text": "<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\">Colistin</span></span></span></p>"
        },
        {
          "id": 200670,
          "text": "<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\">Ketamine</span></span></span></p>"
        },
        {
          "id": 200671,
          "text": "<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\">Halothane</span></span></span></p>"
        }
      ],
      "text": "<p><span style=\"font-size:12pt\"><span style=\"font-family:\"Liberation Serif\",serif\"><span dir=\"ltr\" lang=\"EN-US\" style=\"font-family:\"Calibri\",sans-serif\"><span style=\"color:#333333\">W</span></span><span dir=\"ltr\" lang=\"EN-US\" style=\"font-family:\"Calibri\",sans-serif\"><span style=\"color:#333333\">hich of the following is a schedule X-drug?</span></span></span></span></p>",
      "unique_key": "Q3690230",
      "question_audio": null,
      "question_video": null,
      "map_id": 34067218,
      "difficulty_level": "intermediate",
      "subjects_id": [],
      "solution": "<p><span style=\"font-size:12pt\"><span style=\"font-family:\"Liberation Serif\",serif\"><strong><span dir=\"ltr\" lang=\"EN-US\" style=\"font-family:\"Calibri\",sans-serif\"><span style=\"color:#333333\">Ans. C. Ketamine</span></span></strong></span></span></p>\r\n\r\n<p> </p>\r\n\r\n<p><span style=\"font-size:12pt\"><span style=\"font-family:\"Liberation Serif\",serif\"><span dir=\"ltr\" lang=\"EN-US\" style=\"font-family:\"Calibri\",sans-serif\"><span style=\"color:#333333\">Schedule X is for the psychotropic drugs i.e. addictive drugs.  </span></span></span></span></p>\r\n\r\n<p> </p>\r\n\r\n<p><span style=\"font-size:12pt\"><span style=\"font-family:\"Liberation Serif\",serif\"><span dir=\"ltr\" lang=\"EN-US\" style=\"font-family:\"Calibri\",sans-serif\"><span style=\"color:#333333\">Among given options, drug that comes under schedule X is KETAMINE. </span></span><span dir=\"ltr\" lang=\"EN-US\" style=\"font-family:\"Calibri\",sans-serif\">It is used medically for anesthesia but is also known for its misuse as a recreational drug.</span></span></span></p>\r\n\r\n<p> </p>\r\n\r\n<p><span style=\"font-size:12pt\"><span style=\"font-family:\"Times New Roman\",serif\"><strong><span style=\"font-family:\"Calibri\",sans-serif\">Other Options:</span></strong></span></span></p>\r\n\r\n<p> </p>\r\n\r\n<p><span style=\"font-size:12pt\"><span style=\"font-family:\"Times New Roman\",serif\"><strong><span style=\"font-family:\"Calibri\",sans-serif\">Option <strong><span style=\"font-family:\"Calibri\",sans-serif\">A. Thalidomide: </span></strong></span></strong><span style=\"font-family:\"Calibri\",sans-serif\">Thalidomide is not classified as a Schedule X drug. It is used for specific medical conditions like multiple myeloma and complications of leprosy, but it is not a psychotropic substance.</span></span></span></p>\r\n\r\n<p> </p>\r\n\r\n<p><span style=\"font-size:12pt\"><span style=\"font-family:\"Times New Roman\",serif\"><strong><span style=\"font-family:\"Calibri\",sans-serif\">Option <strong><span style=\"font-family:\"Calibri\",sans-serif\">B. Colistin: </span></strong></span></strong><span style=\"font-family:\"Calibri\",sans-serif\">Colistin is an antibiotic used for treating multi-drug-resistant bacterial infections. It is not classified as a Schedule X drug.</span></span></span></p>\r\n\r\n<p> </p>\r\n\r\n<p><span style=\"font-size:12pt\"><span style=\"font-family:\"Times New Roman\",serif\"><strong><span style=\"font-family:\"Calibri\",sans-serif\">Option <strong><span style=\"font-family:\"Calibri\",sans-serif\">D. Halothane: </span></strong></span></strong><span style=\"font-family:\"Calibri\",sans-serif\">Halothane is an inhalational anesthetic agent. It is not a Schedule X drug as it does not have psychotropic properties.</span></span></span></p>\r\n\r\n<p> </p>\r\n\r\n<p><span style=\"font-size:12pt\"><span style=\"font-family:\"Liberation Serif\",serif\"><strong><span dir=\"ltr\" lang=\"EN-US\" style=\"font-family:\"Calibri\",sans-serif\"><span style=\"color:#333333\">Educational objective:</span></span></strong></span></span></p>\r\n\r\n<p> </p>\r\n\r\n<p><span style=\"font-size:12pt\"><span style=\"font-family:\"Liberation Serif\",serif\"><strong><span dir=\"ltr\" lang=\"EN-US\" style=\"font-family:\"Calibri\",sans-serif\"><span style=\"color:#333333\">IMPORTANT DRUG SCHEDULES</span></span></strong></span></span></p>\r\n\r\n<p> </p>\r\n\r\n<ul>\r\n\t<li><span style=\"font-size:12pt\"><span style=\"font-family:\"Liberation Serif\",serif\"><strong><span dir=\"ltr\" lang=\"EN-US\" style=\"font-family:\"Calibri\",sans-serif\"><span style=\"color:#333333\">Schedule G:</span></span></strong><span dir=\"ltr\" lang=\"EN-US\" style=\"font-family:\"Calibri\",sans-serif\"><span style=\"color:#333333\"> Deals with details of drugs to be labeled 'CAUTION-it is dangerous to take this medicine except under medical supervision'.</span></span></span></span></li>\r\n\t<li><span style=\"font-size:12pt\"><span style=\"font-family:\"Liberation Serif\",serif\"><strong><span dir=\"ltr\" lang=\"EN-US\" style=\"font-family:\"Calibri\",sans-serif\"><span style=\"color:#333333\">Schedule H:</span></span></strong><span dir=\"ltr\" lang=\"EN-US\" style=\"font-family:\"Calibri\",sans-serif\"><span style=\"color:#333333\"> Deals with drugs and medicine to be sold on prescription-only.</span></span></span></span></li>\r\n\t<li><span style=\"font-size:12pt\"><span style=\"font-family:\"Liberation Serif\",serif\"><strong><span dir=\"ltr\" lang=\"EN-US\" style=\"font-family:\"Calibri\",sans-serif\"><span style=\"color:#333333\">Schedule R:</span></span></strong><span dir=\"ltr\" lang=\"EN-US\" style=\"font-family:\"Calibri\",sans-serif\"><span style=\"color:#333333\"> Deals with standards for contraceptives.</span></span></span></span></li>\r\n</ul>\r\n\r\n<ul>\r\n\t<li><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\"><strong><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\"><span style=\"font-family:\"Calibri\",sans-serif\"><span style=\"color:#333333\">Schedule X:</span></span></span></strong><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\"><span style=\"font-family:\"Calibri\",sans-serif\"><span style=\"color:#333333\"> Deals with psychotropic drugs which require special license for manufacturing and sale.</span></span></span></span></span></span></li>\r\n</ul>",
      "correct_choice_id": 200670,
      "solution_audio": null,
      "solution_video": null,
      "audio_explanation_heading": null,
      "video_explanation_heading": null,
      "solution_media_position": "bottom",
      "tags": [],
      "explanation_video": null,
      "question_images": [],
      "explanation_images": []
    },
    {
      "id": 50168,
      "choices": [
        {
          "id": 200672,
          "text": "<p style=\"margin-right:3px\"><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span style=\"font-size:12.0pt\">Friedrich's ataxia</span></span></span></p>"
        },
        {
          "id": 200673,
          "text": "<p style=\"margin-right:3px\"><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span style=\"font-size:12.0pt\">Felty syndrome</span></span></span></p>"
        },
        {
          "id": 200674,
          "text": "<p style=\"margin-right:3px\"><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span dir=\"ltr\" lang=\"PT-BR\" style=\"font-size:12.0pt\">Fanconi anemia</span></span></span></p>"
        },
        {
          "id": 200675,
          "text": "<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span dir=\"ltr\" lang=\"PT-BR\" style=\"font-size:12.0pt\">Fabry's disease</span></span></span></p>"
        }
      ],
      "text": "<p><span style=\"font-size:12.0pt\"><span style=\"font-family:\"Calibri\",sans-serif\">Maltese cross crystals in the urine are seen in which of the following diseases other than nephrotic syndrome? (AIIMS NOV 2019)</span></span></p>",
      "unique_key": "Q8663762",
      "question_audio": null,
      "question_video": null,
      "map_id": 34996205,
      "difficulty_level": "intermediate",
      "subjects_id": [],
      "solution": "<p style=\"margin-right:3px\"><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span style=\"font-size:12.0pt\">Ans. D) Fabry's disease</span></strong></span></span></p>\r\n\r\n<p style=\"margin-right:3px\"> </p>\r\n\r\n<p style=\"margin-right:3px\"><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span style=\"font-size:12.0pt\">Maltese cross crystals in the urine are seen in Fabry's disease.</span></span></span></p>\r\n\r\n<p style=\"margin-right:3px\"> </p>\r\n\r\n<p style=\"margin-right:3px\"><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span style=\"font-size:12.0pt\">Maltese cross birefringence is caused by a radially birefringent substance such as a lipid droplet.</span></span></span></p>\r\n\r\n<p style=\"margin-right:3px\"> </p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\"><img alt=\"\" src=\"https://cerebellum-web-static.s3.amazonaws.com/media/public/images/2023/04/12/958.jpg\" style=\"height:316px; width:475px\" /></span></span></span></p>\r\n\r\n<p> </p>\r\n\r\n<p style=\"margin-right:3px\"><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span style=\"font-size:12.0pt\">Fabry disease is a genetic disorder caused by deficiency of lysosomal alpha-galactosidase A leading to accumulation of metabolic intermediates like glycosphingolipids etc.</span></span></span></p>\r\n\r\n<p style=\"margin-right:3px\"> </p>\r\n\r\n<p style=\"margin-right:3px\"><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span style=\"font-size:12.0pt\">Urine analysis in Fabry's disease shows oval fat bodies and birefringent glycolipid globules under polarized light showing a Maltese cross appearance. It can also be seen in nephrotic syndrome.</span></span></span></p>\r\n\r\n<p style=\"margin-right:3px\"> </p>\r\n\r\n<p style=\"margin-right:3px\"><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span style=\"font-size:12.0pt\">Other Options:</span></strong></span></span></p>\r\n\r\n<p style=\"margin-right:3px\"> </p>\r\n\r\n<p style=\"margin-right:3px\"><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span style=\"font-size:12.0pt\">Option </span></strong><strong><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\">A. Friedrich's ataxia</span></strong><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\">: This is a genetic disorder that affects the nervous system and does not involve the formation of Maltese cross crystals in the urine.</span></span></span></p>\r\n\r\n<p style=\"margin-right:3px\"> </p>\r\n\r\n<p style=\"margin-right:3px\"><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span style=\"font-size:12.0pt\">Option </span></strong><strong><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\">B. Felty syndrome</span></strong><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\">: This syndrome is a complication of long-standing rheumatoid arthritis, characterized by splenomegaly and neutropenia. It does not cause the formation of Maltese cross crystals in the urine.</span></span></span></p>\r\n\r\n<p style=\"margin-right:3px\"> </p>\r\n\r\n<p style=\"margin-right:3px\"><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span style=\"font-size:12.0pt\">Option </span></strong><strong><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\">C. Fanconi anemia</span></strong><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\">: A genetic disorder that primarily affects the bone marrow, leading to aplastic anemia and increased cancer risk, but it is not associated with the presence of Maltese cross crystals in the urine.</span></span></span></p>\r\n\r\n<p style=\"margin-right:3px\"> </p>\r\n\r\n<p style=\"margin-right:3px\"><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\">Educational Objective:</span></strong></span></span></p>\r\n\r\n<p style=\"margin-right:3px\"> </p>\r\n\r\n<p style=\"margin-right:3px\"><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\">Maltese cross crystals in the urine are seen in Fabry's disease, indicating the presence of lipid-laden cells.</span></span></span></p><p><img src=\"https://cerebellum-web-static.s3.amazonaws.com/media/public/images/2023/04/12/958.jpg\" alt=\"Solution Image\"></p>",
      "correct_choice_id": 200675,
      "solution_audio": null,
      "solution_video": null,
      "audio_explanation_heading": null,
      "video_explanation_heading": null,
      "solution_media_position": "bottom",
      "tags": [],
      "explanation_video": null,
      "question_images": [],
      "explanation_images": []
    },
    {
      "id": 50169,
      "choices": [
        {
          "id": 200676,
          "text": "<p><span style=\"font-size:12.0pt;\">IL-5</span></p>"
        },
        {
          "id": 200677,
          "text": "<p><span style=\"font-size:12.0pt;\">INF-gamma</span></p>"
        },
        {
          "id": 200678,
          "text": "<p><span style=\"font-size:12.0pt;\">TNF-alpha</span></p>"
        },
        {
          "id": 200679,
          "text": "<p><span style=\"font-size:12.0pt;\">IL-2</span></p>"
        }
      ],
      "text": "<p><span style=\"font-size:12.0pt;\">Basophils are activated by? (AIIMS NOV 2019)</span></p>",
      "unique_key": "Q1472041",
      "question_audio": null,
      "question_video": null,
      "map_id": 34283692,
      "difficulty_level": "intermediate",
      "subjects_id": [],
      "solution": "<p><span style=\"font-size:12.0pt;\"><strong>Ans. A) IL-5</strong></span></p><p> </p><p><span style=\"font-size:12.0pt;\">The best answer for basophil differentiation of basophil is <strong>IL3 h</strong>owever considering the options given for this particular question in INICET exam the appropriate answer shall be IL-5</span></p><p> </p><p><span style=\"font-size:12.0pt;\">Interleukin-5 (IL-5) is a cytokine that specifically acts on eosinophils and basophils. It plays a crucial role in their growth, differentiation, activation, and survival. In the case of basophils, IL-5 stimulates their activation, leading to the release of histamine and other mediators that are involved in allergic responses and inflammation.</span></p><p> </p><p><span style=\"font-size:12.0pt;\">IL-5: Primarily activates eosinophilia but also involved in basophil growth and differentiation.</span></p><p> </p><p><span style=\"font-size:12.0pt;\"><strong>Other Options:</strong></span></p><p> </p><p><span style=\"font-size:12.0pt;\"><strong>Option B. INF-gamma</strong>: Interferon-gamma is primarily involved in the activation of macrophages and is a key cytokine in the Th1 immune response, but it does not specifically activate basophils.</span></p><p> </p><p><span style=\"font-size:12.0pt;\"><strong>Option C. TNF-alpha</strong>: Tumor Necrosis Factor-alpha is a pro-inflammatory cytokine involved in systemic inflammation and is a major mediator in the acute phase reaction, but it does not specifically activate basophils.</span></p><p> </p><p><span style=\"font-size:12.0pt;\"><strong>Option D. IL-2</strong>: Interleukin-2 is crucial for the growth, proliferation, and differentiation of T cells and natural killer (NK) cells, but it does not play a significant role in the activation of basophils.</span></p><p> </p><p><span style=\"font-size:12.0pt;\"><strong>Educational Objective</strong>:</span></p><p> </p><p><span style=\"font-size:12.0pt;\">Interleukins are a type of cytokine, which are small proteins produced by immune cells that play a crucial role in regulating the immune response.</span></p><p> </p><p><span style=\"font-size:12.0pt;\">A brief overview of some of the key interleukins and their functions:</span></p><p> </p><ol><li><span style=\"font-size:12.0pt;\"><strong>Interleukin-1 (IL-1):</strong> This interleukin is involved in the regulation of inflammation and immune responses, as well as activation of immune cells such as T cells and B cells.</span></li><li><span style=\"font-size:12.0pt;\"><strong>Interleukin-2 (IL-2):</strong> This cytokine is primarily produced by T cells and plays a key role in the activation and proliferation of T cells and natural killer (NK) cells. It is also involved in the differentiation of immune cells, such as the development of memory T cells.</span></li><li><span style=\"font-size:12.0pt;\"><strong>Interleukin-4 (IL-4):</strong> Plays a key role in the development of Th2 cells, which are involved in the immune response to parasites and allergies. IL-4 also stimulates the production of antibodies by B cells.</span></li><li><span style=\"font-size:12.0pt;\"><strong>Interleukin-5 (IL-5): </strong>Primarily activates eosinophils but also involved in basophil growth and differentiation, contributing to their role in allergic responses and inflammation.</span></li><li><span style=\"font-size:12.0pt;\"><strong>Interleukin-6 (IL-6):</strong> Plays a key role in the regulation of inflammation and immune responses. It can stimulate the production of acute-phase proteins, such as C-reactive protein, as well as the activation of immune cells like plasma cells.</span></li><li><span style=\"font-size:12.0pt;\"><strong>Interleukin-10 (IL-10)</strong>: Plays a key role in regulating the immune response and limiting inflammation. It can suppress the production of pro-inflammatory cytokines, as well as the activation of immune cells.</span></li><li><span style=\"font-size:12.0pt;\"><strong>Interleukin-12 (IL-12</strong>): IL-12<strong> </strong>is involved in the activation of T cells and NK cells. It can stimulate the differentiation of Th1 cells, which are involved in the immune response to intracellular pathogens.</span></li></ol><p> </p><p><span style=\"font-size:12.0pt;\"><strong>Ref: Wintrobe’s Clinical hematology, 14th edition</strong></span></p>",
      "correct_choice_id": 200676,
      "solution_audio": null,
      "solution_video": null,
      "audio_explanation_heading": null,
      "video_explanation_heading": null,
      "solution_media_position": "bottom",
      "tags": [],
      "explanation_video": null,
      "question_images": [],
      "explanation_images": []
    },
    {
      "id": 50170,
      "choices": [
        {
          "id": 200680,
          "text": "<p style=\"margin-right:3px\"><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span style=\"font-size:12.0pt\">Transferrin</span></span></span></p>"
        },
        {
          "id": 200681,
          "text": "<p style=\"margin-right:3px\"><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span style=\"font-size:12.0pt\">Ferroportin</span></span></span></p>"
        },
        {
          "id": 200682,
          "text": "<p style=\"margin-right:3px\"><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span style=\"font-size:12.0pt\">Ferritin</span></span></span></p>"
        },
        {
          "id": 200683,
          "text": "<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span style=\"font-size:12.0pt\">Divalent metal transporter 1</span></span></span></p>"
        }
      ],
      "text": "<p><span style=\"font-size:12.0pt\"><span style=\"font-family:\"Calibri\",sans-serif\">Hepcidin inhibits iron transfer from the enterocyte to the plasma by binding to? (AIIMS NOV 2019)</span></span></p>",
      "unique_key": "Q8700974",
      "question_audio": null,
      "question_video": null,
      "map_id": 34065169,
      "difficulty_level": "intermediate",
      "subjects_id": [],
      "solution": "<p style=\"margin-right:3px\"><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\">Ans. B) Ferroportin</span></strong></span></span></p>\r\n\r\n<p style=\"margin-right:3px\"> </p>\r\n\r\n<p style=\"margin-right:3px\"><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\">Iron absorption is regulated by hepcidin, a small circulating peptide that is synthesized and released from the liver in response to increases in intrahepatic iron levels.</span></span></span></p>\r\n\r\n<p style=\"margin-right:3px\"> </p>\r\n\r\n<p style=\"margin-right:3px\"><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\">Hepcidin inhibits iron transfer from the enterocyte to plasma by binding to ferroportin and causing it to be endocytosed and degraded. As a result, as hepcidin levels rise, iron becomes trapped within duodenal cells in the form of mucosal ferritin and is lost as these cells are sloughed. Thus, when the body is replete with iron, high hepcidin levels inhibit its absorption into the blood.</span></span></span></p>\r\n\r\n<p style=\"margin-right:3px\"> </p>\r\n\r\n<p style=\"margin-right:3px\"><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\">Conversely, with low body stores of iron, hepcidin synthesis falls and this in turn facilitates iron absorption. By inhibiting ferroportin, hepcidin not only reduces iron uptake from enterocytes but also suppresses iron release from macrophages, which are an important source of the iron that is used by erythroid precursors to make hemoglobin.</span></span></span></p>\r\n\r\n<p style=\"margin-right:3px\"> </p>\r\n\r\n<p style=\"margin-right:3px\"><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span style=\"font-size:12.0pt\">Other Options:</span></strong></span></span></p>\r\n\r\n<p style=\"margin-right:3px\"> </p>\r\n\r\n<p style=\"margin-right:3px\"><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span style=\"font-size:12.0pt\">Option </span></strong><strong><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\">A. Transferrin</span></strong><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\">: Transferrin is a plasma protein that binds iron in the bloodstream and transports it to various tissues. It is not directly involved in the inhibition of iron transfer by hepcidin.</span></span></span></p>\r\n\r\n<p style=\"margin-right:3px\"> </p>\r\n\r\n<p style=\"margin-right:3px\"><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span style=\"font-size:12.0pt\">Option </span></strong><strong><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\">C. Ferritin</span></strong><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\">: Ferritin is a protein that stores iron within cells, particularly in the liver, spleen, and bone marrow. It does not play a direct role in the transfer of iron from enterocytes to the plasma.</span></span></span></p>\r\n\r\n<p style=\"margin-right:3px\"> </p>\r\n\r\n<p style=\"margin-right:3px\"><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span style=\"font-size:12.0pt\">Option </span></strong><strong><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\">D. Divalent metal transporter 1 (DMT1)</span></strong><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\">: DMT1 is responsible for transporting iron across the apical membrane of enterocytes into the cell. It is not the target of hepcidin's inhibitory action.</span></span></span></p>\r\n\r\n<p style=\"margin-right:3px\"> </p>\r\n\r\n<p style=\"margin-right:3px\"><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span style=\"font-size:12.0pt\">Educational objective:</span></strong></span></span></p>\r\n\r\n<p style=\"margin-right:3px\"> </p>\r\n\r\n<p style=\"margin-right:3px\"><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\">Hepcidin inhibits iron transfer from enterocytes to the plasma by binding to <strong>ferroportin</strong>, leading to its internalization and degradation.</span></span></span></p>\r\n\r\n<p style=\"margin-right:3px\"> </p>\r\n\r\n<p style=\"margin-right:3px\"><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\">Ref: Robbin and Cotran pathologic basis of disease, 8th edition, Pg no. 1231</span></strong></span></span></p>",
      "correct_choice_id": 200681,
      "solution_audio": null,
      "solution_video": null,
      "audio_explanation_heading": null,
      "video_explanation_heading": null,
      "solution_media_position": "bottom",
      "tags": [],
      "explanation_video": null,
      "question_images": [],
      "explanation_images": []
    },
    {
      "id": 50171,
      "choices": [
        {
          "id": 200684,
          "text": "<p><span style=\"font-size:18px;\">Dermal atrophy</span></p>"
        },
        {
          "id": 200685,
          "text": "<p><span style=\"font-size:18px;\">Eczematous dermatitis</span></p>"
        },
        {
          "id": 200686,
          "text": "<p><span style=\"font-size:18px;\">Vesicular lesions due to Herpes simplex infection</span></p>"
        },
        {
          "id": 200687,
          "text": "<p><span style=\"font-size:18px;\">Rosacea</span></p>"
        }
      ],
      "text": "<p><span style=\"font-size:18px;\">Topical steroids are most effective in: (AIIMS Nov 2019</span></p>",
      "unique_key": "Q8098852",
      "question_audio": null,
      "question_video": null,
      "map_id": 34646093,
      "difficulty_level": "intermediate",
      "subjects_id": [],
      "solution": "<p><span style=\"font-size:18px;\"><strong>Ans. B) Eczematous dermatitis.</strong></span></p><p> </p><p><span style=\"font-size:18px;\"><strong>Topical steroids </strong>are the <strong>drug of choice</strong> in the treatment of <strong>eczematous dermatitis</strong>.</span></p><p> </p><ul><li><span style=\"font-size:18px;\"><strong>Topical steroids </strong>are <strong>anti-inflammatory</strong> medications that are highly effective in treating <strong>eczematous dermatitis</strong>, which is characterized by <strong>inflammation, redness, and itching</strong> of the skin.</span></li><li><span style=\"font-size:18px;\">They work by <strong>reducing inflammation</strong> and <strong>suppressing</strong> the <strong>immune response</strong> in the skin.</span></li></ul><p> </p><p><span style=\"font-size:18px;\"><strong>Other Options:</strong></span></p><p> </p><p><span style=\"font-size:18px;\"><strong>Option A. Dermal atrophy: </strong>Dermal atrophy is actually a <strong>side effect </strong>of <strong>prolonged or inappropriate </strong>use of topical <strong>steroids</strong>, not a condition that is treated with them. It is <strong>thinning</strong> of the skin which can lead to <strong>transparency</strong>, easy <strong>bruising</strong>, and other skin changes as shown below.</span></p><p> </p><p><span style=\"font-size:18px;\"><img src=\"https://cerebellum-web-static.s3.amazonaws.com/media/public/images/2023/11/27/picture16.jpg\" alt=\"\" width=\"200\" height=\"267\"></span></p><p> </p><p><span style=\"font-size:18px;\"><strong>Option C. Vesicular lesions due to Herpes simplex infection: </strong>Topical steroids are <strong>contraindicated in herpes simplex</strong> infections because they can <strong>exacerbate</strong> the condition by suppressing the <strong>local immune</strong> response, which is necessary to control viral infections.</span></p><p> </p><p><span style=\"font-size:18px;\"><img src=\"https://cerebellum-web-static.s3.amazonaws.com/media/public/images/2023/12/01/picture565.jpg\" alt=\"\" width=\"300\" height=\"246\"></span></p><p> </p><p><span style=\"font-size:18px;\"><strong>Herpes labialis: </strong>Vesicular lesions due to Herpes simplex</span></p><p> </p><p><span style=\"font-size:18px;\"><strong>Option D. Rosacea: </strong>Topical steroids may <strong>temporarily reduce inflammation</strong> associated with rosacea, but their use is generally <strong>avoided</strong> as they can lead to a <strong>worsening</strong> of the condition over time, particularly by <strong>exacerbating flushing</strong> and potentially leading to a condition known as <strong>steroid-induced rosacea.</strong></span></p><p> </p><p><span style=\"font-size:18px;\"><i><strong><img src=\"https://cerebellum-web-static.s3.amazonaws.com/media/public/images/2023/11/27/picture18.jpg\" alt=\"\" width=\"600\" height=\"180\"></strong></i></span></p><p> </p><p><span style=\"font-size:18px;\"><strong>Educational Objective:</strong></span></p><p> </p><p><span style=\"font-size:18px;\">Topical steroids are effective in treating <strong>eczematous dermatitis</strong> due to their <strong>anti-inflammatory properties,</strong> but they should not be used for conditions like <strong>herpes simplex infections or rosacea</strong>, and can cause <strong>dermal atrophy</strong> if used inappropriately.</span></p><p> </p><p><span style=\"font-size:18px;\"><strong>Ref - Fitzpatrick’s Dermatology, 9<sup>th</sup> edition page number 377</strong></span></p><p><img src=\"https://cerebellum-web-static.s3.amazonaws.com/media/public/images/2023/11/27/picture16.jpg\" alt=\"Solution Image\"></p>",
      "correct_choice_id": 200685,
      "solution_audio": null,
      "solution_video": null,
      "audio_explanation_heading": null,
      "video_explanation_heading": null,
      "solution_media_position": "bottom",
      "tags": [],
      "explanation_video": null,
      "question_images": [],
      "explanation_images": []
    },
    {
      "id": 50172,
      "choices": [
        {
          "id": 200688,
          "text": "<p style=\"margin-right:3px\"><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span style=\"font-size:12.0pt\">Endothelial injury of vessel due to HTN</span></span></span></p>"
        },
        {
          "id": 200689,
          "text": "<p style=\"margin-right:3px\"><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span dir=\"ltr\" lang=\"PT-BR\" style=\"font-size:12.0pt\">Arterial internal elastic lamina defect</span></span></span></p>"
        },
        {
          "id": 200690,
          "text": "<p style=\"margin-right:3px\"><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span style=\"font-size:12.0pt\">Endothelial layer defect</span></span></span></p>"
        },
        {
          "id": 200691,
          "text": "<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span style=\"font-size:12.0pt\">Adventitia defect</span></span></span></p>"
        }
      ],
      "text": "<p><span style=\"font-size:12.0pt\"><span style=\"font-family:\"Calibri\",sans-serif\">Berry aneurysm occurs due to? (AIIMS NOV 2019)</span></span></p>",
      "unique_key": "Q6425500",
      "question_audio": null,
      "question_video": null,
      "map_id": 34986031,
      "difficulty_level": "intermediate",
      "subjects_id": [],
      "solution": "<p style=\"margin-right:3px\"><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span dir=\"ltr\" lang=\"PT-BR\" style=\"font-size:12.0pt\">Ans. B) Arterial internal elastic lamina defect</span></strong> </span></span></p>\r\n\r\n<p style=\"margin-right:3px\"> </p>\r\n\r\n<p style=\"margin-right:3px\"><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\">Berry aneurysm occurs due an <strong>arterial internal elastic lamina defect</strong>.</span></span></span></p>\r\n\r\n<p style=\"margin-right:3px\"> </p>\r\n\r\n<p style=\"margin-right:3px\"><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\">Berry (Saccular) aneurysms occur when <strong>there is collagen deficiency in the internal elastic lamina and breakdown of the tunica media.</strong> An outpouching, consisting of only tunica intima and adventitia, protrudes through the defect in the internal elastic lamina and tunica media to produce the aneurismal sac</span></span></span></p>\r\n\r\n<p style=\"margin-right:3px\"> </p>\r\n\r\n<p style=\"margin-right:3px\"><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\">As an aneurysm develops, it typically forms a neck with a dome and the arterial internal elastic lamina disappears at the base of the neck. The media thins and connective tissue replaces the smooth-muscle cells. The site of rupture is most often the dome. Here the wall thins, and the tear that allows bleeding is usually ≤0.5 mm long.</span></span></span></p>\r\n\r\n<p style=\"margin-right:3px\"> </p>\r\n\r\n<p style=\"margin-right:3px\"><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\">The most frequent cause of clinically significant subarachnoid hemorrhage is rupture of a saccular (berry) aneurysm.</span></span></span></p>\r\n\r\n<p style=\"margin-right:3px\"> </p>\r\n\r\n<p style=\"margin-right:3px\"><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\">Saccular/ Berry aneurysm is the most common type of intracranial aneurysm. About 90% of saccular aneurysms are found near major arterial branch points in the <strong>anterior circulation.</strong></span></span></span></p>\r\n\r\n<p style=\"margin-right:3px\"> </p>\r\n\r\n<p style=\"margin-right:3px\"><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span style=\"font-size:12.0pt\">Other Options:</span></strong></span></span></p>\r\n\r\n<p style=\"margin-right:3px\"> </p>\r\n\r\n<p style=\"margin-right:3px\"><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span style=\"font-size:12.0pt\">Option </span></strong><strong><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\">A. Endothelial injury of vessel due to HTN:</span></strong><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\"> While hypertension (HTN) is a risk factor that can exacerbate the progression of an aneurysm, it is not the primary cause of Berry aneurysm formation. The initial defect occurs in the internal elastic lamina.</span></span></span></p>\r\n\r\n<p style=\"margin-right:3px\"> </p>\r\n\r\n<p style=\"margin-right:3px\"><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span style=\"font-size:12.0pt\">Option </span></strong><strong><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\">C. Endothelial layer defect:</span></strong><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\"> The endothelial layer is the innermost lining of blood vessels, but defects in this layer alone do not cause Berry aneurysms. The structural weakness in Berry aneurysms is primarily related to the internal elastic lamina and the underlying media.</span></span></span></p>\r\n\r\n<p style=\"margin-right:3px\"> </p>\r\n\r\n<p style=\"margin-right:3px\"><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span style=\"font-size:12.0pt\">Option </span></strong><strong><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\">D. Adventitia defect:</span></strong><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\"> The adventitia is the outermost layer of the blood vessel, but defects in the adventitia alone are not responsible for the formation of Berry aneurysms. The crucial defect is in the internal elastic lamina.</span></span></span></p>\r\n\r\n<p style=\"margin-right:3px\"> </p>\r\n\r\n<p style=\"margin-right:3px\"><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span style=\"font-size:12.0pt\">Educational Objective:</span></strong></span></span></p>\r\n\r\n<p style=\"margin-right:3px\"> </p>\r\n\r\n<p style=\"margin-right:3px\"><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\">Berry aneurysms </span></strong><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\">occur due to a defect in the <strong>arterial internal elastic lamina</strong>, leading to a weakened vessel wall and the potential for aneurysmal outpouching and rupture.</span></span></span></p>",
      "correct_choice_id": 200689,
      "solution_audio": null,
      "solution_video": null,
      "audio_explanation_heading": null,
      "video_explanation_heading": null,
      "solution_media_position": "bottom",
      "tags": [],
      "explanation_video": null,
      "question_images": [],
      "explanation_images": []
    },
    {
      "id": 50173,
      "choices": [
        {
          "id": 200692,
          "text": "<p><span style=\"font-size:12.0pt;\">1-3-2-4</span></p>"
        },
        {
          "id": 200693,
          "text": "<p><span style=\"font-size:12.0pt;\">2-3-1-4</span></p>"
        },
        {
          "id": 200694,
          "text": "<p><span style=\"font-size:12.0pt;\">2-1-3-4</span></p>"
        },
        {
          "id": 200695,
          "text": "<p><span style=\"font-size:12.0pt;\">2-4-1-3</span></p>"
        }
      ],
      "text": "<p><span style=\"font-size:16px;\">Arrange the following steps in the correct order for delivering bad news to a patient, according to the accepted standard protocol:</span></p><p> </p><ol><li><span style=\"font-size:16px;\">Giving information and knowledge to the patient</span></li><li><span style=\"font-size:16px;\">Setting up the interview</span></li><li><span style=\"font-size:16px;\">Addressing the patient’s emotions with empathetic responses</span></li><li><span style=\"font-size:16px;\">Assessing the patient’s understanding of the situation</span></li></ol>",
      "unique_key": "Q1470106",
      "question_audio": null,
      "question_video": null,
      "map_id": 34782886,
      "difficulty_level": "intermediate",
      "subjects_id": [],
      "solution": "<p><span style=\"font-size:16px;\"><strong>Ans. D) 2-4-1-3</strong></span></p><p> </p><p><span style=\"font-size:16px;\">According to the SPIKES protocol, which is a structured and widely used approach for delivering difficult news in healthcare, the correct sequence of steps is:</span></p><p> </p><ol><li><span style=\"font-size:16px;\"><strong>Setting Up the Interview (B):</strong> Start by arranging a suitable environment and private setting for the discussion to ensure the patient feels safe and supported.</span></li><li><span style=\"font-size:16px;\"><strong>Assessing the Patient’s Understanding (D):</strong> Next, assess the patient’s current understanding of their condition. This step ensures that the information is tailored to the patient's level of knowledge and readiness.</span></li><li><span style=\"font-size:16px;\"><strong>Providing Knowledge and Information (A):</strong> After understanding the patient’s perception, give them the necessary medical information in a clear, gradual manner to avoid overwhelming them.</span></li><li><span style=\"font-size:16px;\"><strong>Addressing the Patient’s Emotions with Empathy (C):</strong> Finally, respond empathetically to any emotional reactions, acknowledging their feelings and offering support.</span></li></ol><p> </p><p><span style=\"font-size:16px;\">Each of these steps is essential to ensure that the news is delivered thoughtfully, with respect for the patient’s emotional state and comprehension.</span></p><p> </p><p><span style=\"color:windowtext;font-size:16px;\"><strong>Educational Objective:</strong></span></p><p> </p><p><span style=\"font-size:16px;\">The SPIKES protocol emphasizes the importance of a structured approach to delivering difficult news: setting up the interview, assessing understanding, giving information, and addressing emotional responses empathetically.</span></p>",
      "correct_choice_id": 200695,
      "solution_audio": null,
      "solution_video": null,
      "audio_explanation_heading": null,
      "video_explanation_heading": null,
      "solution_media_position": "bottom",
      "tags": [],
      "explanation_video": null,
      "question_images": [],
      "explanation_images": []
    },
    {
      "id": 50174,
      "choices": [
        {
          "id": 200696,
          "text": "<p><span style=\"font-size:12.0pt;\">1, 3, 4</span></p>"
        },
        {
          "id": 200697,
          "text": "<p><span style=\"font-size:12.0pt;\">1, 4</span></p>"
        },
        {
          "id": 200698,
          "text": "<p><span style=\"font-size:12.0pt;\">2, 3</span></p>"
        },
        {
          "id": 200699,
          "text": "<p><span style=\"font-size:12.0pt;\">1, 2, 3, 4</span></p>"
        }
      ],
      "text": "<p><span style=\"font-size:16px;\">Which of the following methods are used to record the cause of death in India?</span></p><p> </p><ol><li><span style=\"font-size:16px;\">Sample registration system</span></li><li><span style=\"font-size:16px;\">Census</span></li><li><span style=\"font-size:16px;\">Death declaration and medical certificate</span></li><li><span style=\"font-size:16px;\">Lay reporting</span></li></ol>",
      "unique_key": "Q7046677",
      "question_audio": null,
      "question_video": null,
      "map_id": 34040836,
      "difficulty_level": "intermediate",
      "subjects_id": [],
      "solution": "<p><span style=\"font-size:16px;\"><strong>Ans. A) 1, 3, 4</strong></span></p><p> </p><p><span style=\"font-size:16px;\">The cause of death in India is typically recorded using the following methods:</span></p><p> </p><ul style=\"list-style-type:disc;\"><li><span style=\"font-size:16px;\"><strong>Sample Registration System (SRS):</strong> Initiated in the 1960s, SRS provides reliable estimates of birth and death rates at the national and state levels. This system helps in tracking the cause of death through surveys and statistical records.</span></li><li><span style=\"font-size:16px;\"><strong>Death Certificate/Medical Certification:</strong> Medical professionals document the cause of death on death certificates, which provides official data for mortality statistics.</span></li><li><span style=\"font-size:16px;\"><strong>Lay Reporting:</strong> Lay reporting involves non-professional health workers collecting and transmitting health information, including death causes, to higher levels in the health system.</span></li></ul><p> </p><p><span style=\"font-size:16px;\">The <strong>Census</strong> does not record the cause of death directly; it provides demographic data but does not focus on specific mortality causes.</span></p><p> </p><p><span style=\"font-size:16px;\"><strong>Educational Objective:</strong></span></p><p> </p><p><span style=\"font-size:16px;\">In India, the cause of death is primarily recorded through the Sample Registration System, death certification, and lay reporting, not through the Census.</span></p>",
      "correct_choice_id": 200696,
      "solution_audio": null,
      "solution_video": null,
      "audio_explanation_heading": null,
      "video_explanation_heading": null,
      "solution_media_position": "bottom",
      "tags": [],
      "explanation_video": null,
      "question_images": [],
      "explanation_images": []
    },
    {
      "id": 50175,
      "choices": [
        {
          "id": 200700,
          "text": "<p><span style=\"font-size:16px;\">Both the statement and the reason are true, and the reason explains the statement correctly.</span></p>"
        },
        {
          "id": 200701,
          "text": "<p><span style=\"font-size:16px;\">Both the statement and the reason are true, but the reason does not explain the statement.</span></p>"
        },
        {
          "id": 200702,
          "text": "<p><span style=\"font-size:16px;\">The statement is false, but the reason is true.</span></p>"
        },
        {
          "id": 200703,
          "text": "<p><span style=\"font-size:16px;\">Both the statement and the reason are false.</span></p>"
        }
      ],
      "text": "<p><span style=\"font-size:16px;\">Which of the following is true regarding the given statements: </span></p><p> </p><p><span style=\"font-size:16px;\"><strong>Assertion:</strong> WHO recommends Typhoid Vaccine for disaster management in endemic areas.</span></p><p><br><span style=\"font-size:16px;\"><strong>Reason:</strong> Vaccination is a cost-effective method of disaster control.</span></p>",
      "unique_key": "Q7134394",
      "question_audio": null,
      "question_video": null,
      "map_id": 34677485,
      "difficulty_level": "intermediate",
      "subjects_id": [],
      "solution": "<p><span style=\"font-size:16px;\"><strong>Ans.</strong> <strong>D) Both the statement and the reason are false.</strong></span></p><p> </p><p><span style=\"font-size:16px;\">The WHO does not recommend vaccines such as typhoid, cholera, or tetanus for the general population after a disaster. These vaccinations are, however, advised for healthcare workers who are at a higher risk due to their roles in managing post-disaster health scenarios.</span></p><p> </p><p><span style=\"font-size:16px;\">In the context of post-disaster management, the most effective approach to preventing disease spread includes the provision of safe drinking water and the proper disposal of excreta, rather than vaccination for the general population. These measures address the root causes of potential outbreaks and are more practical and effective under post-disaster conditions.</span></p><p> </p><p><span style=\"font-size:16px;\"><strong>Educational Objective:</strong></span></p><p> </p><p><span style=\"font-size:16px;\">WHO does not recommend widespread typhoid vaccination after a disaster. Instead, providing safe water and sanitation is essential for preventing disease in affected areas.</span></p>",
      "correct_choice_id": 200703,
      "solution_audio": null,
      "solution_video": null,
      "audio_explanation_heading": null,
      "video_explanation_heading": null,
      "solution_media_position": "bottom",
      "tags": [],
      "explanation_video": null,
      "question_images": [],
      "explanation_images": []
    },
    {
      "id": 50176,
      "choices": [
        {
          "id": 200704,
          "text": "<p><span style=\"font-size:12.0pt;\">1, 3, 4, 2</span></p>"
        },
        {
          "id": 200705,
          "text": "<p><span style=\"font-size:12.0pt;\">1, 2, 4, 3</span></p>"
        },
        {
          "id": 200706,
          "text": "<p><span style=\"font-size:12.0pt;\">2, 3, 1, 4</span></p>"
        },
        {
          "id": 200707,
          "text": "<p><span style=\"font-size:12.0pt;\">1, 2, 3, 4</span></p>"
        }
      ],
      "text": "<p><span style=\"font-size:16px;\">Sequentially arrange the following renal injuries from least severe to most severe. </span></p><p> </p><ol><li><span style=\"font-size:16px;\">Subcapsular hematoma</span></li><li><span style=\"font-size:16px;\">Injury confined to Gerota’s fascia</span></li><li><span style=\"font-size:16px;\">Avulsion of Pelvi-ureteric junction</span></li><li><span style=\"font-size:16px;\">Shattered kidney</span></li></ol>",
      "unique_key": "Q4852787",
      "question_audio": null,
      "question_video": null,
      "map_id": 34918057,
      "difficulty_level": "intermediate",
      "subjects_id": [],
      "solution": "<p><span style=\"font-size:16px;\"><strong>Ans. D) 1, 2, 3, 4</strong></span></p><p><br><span style=\"font-size:16px;\">The correct sequence from least to most severe renal injuries is as follows:</span></p><p> </p><ol><li><span style=\"font-size:16px;\"><strong>Subcapsular hematoma</strong> (Grade I): A non-expanding hematoma under the capsule without parenchymal laceration.</span></li><li><span style=\"font-size:16px;\"><strong>Injury confined to Gerota’s fascia</strong> (Grade II): Hematoma confined within the renal fascia without significant renal tissue damage.</span></li><li><span style=\"font-size:16px;\"><strong>Avulsion of Pelvi-ureteric junction</strong> (Grade IV): Injury involving avulsion of the renal pelvis or ureter, often associated with significant bleeding.</span></li><li><span style=\"font-size:16px;\"><strong>Shattered kidney</strong> (Grade V): Represents a severe renal injury with extensive fragmentation or laceration of the renal tissue.</span></li></ol><p> </p><p><span style=\"font-size:16px;\"><strong>Educational Objective:</strong></span></p><p> </p><p><span style=\"font-size:16px;\">The American Association for the Surgery of Trauma (AAST) grading helps assess the severity of renal injuries, and CT scans are typically used for evaluating these injuries in trauma cases. </span></p><p> </p><p><span style=\"font-size:16px;\"><img src=\"https://cerebellum-web-static.s3.amazonaws.com/media/public/Screenshot%202024-11-12%20123144.jpg\" width=\"544\" height=\"789\"></span></p><p><img src=\"https://cerebellum-web-static.s3.amazonaws.com/media/public/Screenshot%202024-11-12%20123144.jpg\" alt=\"Solution Image\"></p>",
      "correct_choice_id": 200707,
      "solution_audio": null,
      "solution_video": null,
      "audio_explanation_heading": null,
      "video_explanation_heading": null,
      "solution_media_position": "bottom",
      "tags": [],
      "explanation_video": null,
      "question_images": [],
      "explanation_images": []
    },
    {
      "id": 50177,
      "choices": [
        {
          "id": 200708,
          "text": "<p><span style=\"font-size:12.0pt;\">Cock-up splint</span></p>"
        },
        {
          "id": 200709,
          "text": "<p><span style=\"font-size:12.0pt;\">Colles' cast</span></p>"
        },
        {
          "id": 200710,
          "text": "<p><span style=\"font-size:12.0pt;\">Knuckle bender splint</span></p>"
        },
        {
          "id": 200711,
          "text": "<p><span style=\"font-size:12.0pt;\">Dynamic finger splint</span></p>"
        }
      ],
      "text": "<p><span style=\"font-size:12.0pt;\">Identify the device shown in the image. </span></p><p> </p><p><span style=\"font-size:12.0pt;\"><img src=\"https://cerebellum-web-static.s3.amazonaws.com/media/public/Screenshot%202024-11-12%20123154.jpg\" width=\"465\" height=\"468\"></span></p><p><img src=\"https://cerebellum-web-static.s3.amazonaws.com/media/public/Screenshot%202024-11-12%20123154.jpg\" alt=\"Question Image\"></p>",
      "unique_key": "Q1473452",
      "question_audio": null,
      "question_video": null,
      "map_id": 34450044,
      "difficulty_level": "intermediate",
      "subjects_id": [],
      "solution": "<p><span style=\"font-size:16px;\"><strong>Ans. A) Cock-up splint</strong></span></p><p><br><span style=\"font-size:16px;\">The device shown is a <strong>cock-up splint</strong>, commonly used for managing radial nerve palsy. Radial nerve palsy leads to an inability to dorsiflex the wrist and fingers, resulting in a condition known as wrist drop and finger drop. This splint holds the wrist in a neutral or slightly extended position, preventing contracture and improving functional hand use by compensating for the wrist drop.</span></p><p> </p><p><span style=\"font-size:16px;\"><strong>Other Options:</strong></span></p><p> </p><p><span style=\"font-size:16px;\"><strong>Option B. Colles' cast: </strong>Used in managing an undisplaced Colles' fracture by immobilizing the wrist in a cast for around six weeks. In cases of displaced Colles' fracture, reduction is followed by immobilization with the wrist in palmar flexion, pronation, and ulnar deviation.</span></p><p> </p><p><span style=\"font-size:16px;\"><img src=\"https://cerebellum-web-static.s3.amazonaws.com/media/public/Screenshot%202024-11-12%20123205.jpg\" width=\"611\" height=\"412\"></span></p><p> </p><p><span style=\"font-size:16px;\"><strong>Option C. Knuckle bender splint: </strong>Applied for ulnar claw hand, particularly when ulnar nerve recovery is anticipated. This splint maintains flexion at the metacarpophalangeal joints to prevent hyperextension.</span></p><p> </p><p><span style=\"font-size:16px;\"><img src=\"https://cerebellum-web-static.s3.amazonaws.com/media/public/Screenshot%202024-11-12%20123216.jpg\" width=\"455\" height=\"412\"></span></p><p> </p><p><span style=\"font-size:16px;\"><strong>Option D. Dynamic finger splint: </strong>This splint is used for immobilization after fractures of the proximal phalanx, extensor tendon injuries, deformity prevention in rheumatoid arthritis, and postoperative immobilization.</span></p><p> </p><p><span style=\"font-size:16px;\"><img src=\"https://cerebellum-web-static.s3.amazonaws.com/media/public/Screenshot%202024-11-12%20123226.jpg\" width=\"284\" height=\"247\"></span></p><p> </p><p><span style=\"font-size:16px;\"><strong>Educational Objective:</strong></span></p><p> </p><p><span style=\"font-size:16px;\">The cock-up splint is effective for managing radial nerve palsy by positioning the wrist to counteract wrist drop and support hand functionality.</span></p><p><img src=\"https://cerebellum-web-static.s3.amazonaws.com/media/public/Screenshot%202024-11-12%20123205.jpg\" alt=\"Solution Image\"></p>",
      "correct_choice_id": 200708,
      "solution_audio": null,
      "solution_video": null,
      "audio_explanation_heading": null,
      "video_explanation_heading": null,
      "solution_media_position": "bottom",
      "tags": [],
      "explanation_video": null,
      "question_images": [],
      "explanation_images": []
    },
    {
      "id": 50178,
      "choices": [
        {
          "id": 200712,
          "text": "<p><span style=\"font-size:12.0pt;\">1-B, 2-C, 3-A, 4-D</span></p>"
        },
        {
          "id": 200713,
          "text": "<p><span style=\"font-size:12.0pt;\">1-A, 2-B, 3-D, 4-C</span></p>"
        },
        {
          "id": 200714,
          "text": "<p><span style=\"font-size:12.0pt;\">1-B, 2-C, 3-D, 4-A</span></p>"
        },
        {
          "id": 200715,
          "text": "<p><span style=\"font-size:12.0pt;\">1-B, 2-A, 3-C, 4-D</span></p>"
        }
      ],
      "text": "<p><span style=\"font-size:12.0pt;\">Match the following organisms with their characteristic inclusion bodies:</span></p><p> </p><p><strong>Column A:</strong></p><p><span style=\"font-size:12.0pt;\">1. Molluscum contagiosum</span></p><p><span style=\"font-size:12.0pt;\">2. BK Polyomavirus</span></p><p><span style=\"font-size:12.0pt;\">3. Rabies</span></p><p><span style=\"font-size:12.0pt;\">4. CMV</span></p><p> </p><p><strong>Column B:</strong><br>A. Negri Bodies<br>B. Henderson Patterson Body<br>C. Decoy cells<br>D. Owl’s eye cells</p>",
      "unique_key": "Q8608435",
      "question_audio": null,
      "question_video": null,
      "map_id": 34275275,
      "difficulty_level": "intermediate",
      "subjects_id": [],
      "solution": "<p><span style=\"font-size:16px;\"><strong>Ans. A) 1-B, 2-C, 3-A, 4-D</strong></span></p><p> </p><ol><li><span style=\"font-size:16px;\"><strong>Molluscum contagiosum</strong> - Associated with <strong>Henderson Patterson Bodies</strong>: These are eosinophilic intracytoplasmic inclusion bodies found within keratinocytes infected by the Molluscum contagiosum virus, characteristic of this viral infection.</span></li><li><span style=\"font-size:16px;\"><strong>BK Polyomavirus</strong> - Associated with <strong>Decoy Cells</strong>: Decoy cells are infected urothelial cells with enlarged, altered nuclei, often observed in the urine of immunocompromised patients, particularly those with kidney transplants.</span></li><li><span style=\"font-size:16px;\"><strong>Rabies</strong> - Associated with <strong>Negri Bodies</strong>: Negri bodies are classic intracytoplasmic inclusions found in neurons infected by the Rabies virus, especially in the hippocampus and cerebellum.</span></li><li><span style=\"font-size:16px;\"><strong>CMV (Cytomegalovirus)</strong> - Associated with <strong>Owl’s Eye Cells</strong>: These are large cells with prominent intranuclear inclusions that resemble an \"owl's eye,\" characteristic of CMV infections, commonly observed in immunocompromised individuals.</span></li></ol><p> </p><p><span style=\"color:windowtext;font-size:16px;\"><strong>Educational Objective:</strong></span></p><p> </p><p><span style=\"font-size:16px;\">Viral infections and their unique inclusion bodies:</span></p><p> </p><ul style=\"list-style-type:disc;\"><li><span style=\"font-size:16px;\"><strong>Molluscum contagiosum</strong> - Henderson Patterson Bodies</span></li><li><span style=\"font-size:16px;\"><strong>BK Polyomavirus</strong> - Decoy Cells</span></li><li><span style=\"font-size:16px;\"><strong>Rabies</strong> - Negri Bodies</span></li><li><span style=\"font-size:16px;\"><strong>CMV</strong> - Owl’s Eye Cells</span></li></ul>",
      "correct_choice_id": 200712,
      "solution_audio": null,
      "solution_video": null,
      "audio_explanation_heading": null,
      "video_explanation_heading": null,
      "solution_media_position": "bottom",
      "tags": [],
      "explanation_video": null,
      "question_images": [],
      "explanation_images": []
    },
    {
      "id": 50179,
      "choices": [
        {
          "id": 200716,
          "text": "<p><span style=\"font-size:12.0pt;\">1-B, 2-A, 3-C, 4-D</span></p>"
        },
        {
          "id": 200717,
          "text": "<p><span style=\"font-size:12.0pt;\">1-A, 2-B, 3-D, 4-C</span></p>"
        },
        {
          "id": 200718,
          "text": "<p><span style=\"font-size:12.0pt;\">1-D, 2-C, 3-B, 4-A</span></p>"
        },
        {
          "id": 200719,
          "text": "<p><span style=\"font-size:12.0pt;\">1-C, 2-D, 3-A, 4-B</span></p>"
        }
      ],
      "text": "<p><span style=\"font-size:16px;\">Match the following:</span></p><p> </p><p style=\"margin-left:0cm;\"><span style=\"font-size:16px;\"><strong>Column A:</strong></span></p><p><span style=\"font-size:16px;\">1. Box car Nuclei</span></p><p><span style=\"font-size:16px;\">2. Myocyte disarray</span></p><p><span style=\"font-size:16px;\">3. Vacuolation in myocyte</span></p><p><span style=\"font-size:16px;\">4. Myocyte hypertrophy</span></p><p> </p><p><span style=\"font-size:16px;\"><strong>Column B:</strong></span><br><span style=\"font-size:16px;\">A. Hypertrophic cardiomyopathy</span><br><span style=\"font-size:16px;\">B. Hypertension</span><br><span style=\"font-size:16px;\">C. Subendocardial ischemia</span><br><span style=\"font-size:16px;\">D. Dilated Cardiomyopathy</span></p>",
      "unique_key": "Q4600889",
      "question_audio": null,
      "question_video": null,
      "map_id": 34336236,
      "difficulty_level": "intermediate",
      "subjects_id": [],
      "solution": "<p><span style=\"font-size:16px;\"><strong>Ans. A) 1-B, 2-A, 3-C, 4-D</strong></span></p><p> </p><ol><li><span style=\"font-size:16px;\"><strong>Box Car Nuclei - B. Hypertension</strong>: In hypertensive heart disease, individual myocytes become enlarged and exhibit nucleomegaly. This enlargement of the myocyte nuclei in response to the increased workload is referred to as \"Box Car Nuclei.\" It is characteristic of hypertensive cardiomyopathy, where myocardial cells adapt to increased resistance.</span></li><li><span style=\"font-size:16px;\"><strong>Myocyte Disarray - A. Hypertrophic Cardiomyopathy</strong>: The hallmark of hypertrophic cardiomyopathy (HOCM) is myocyte disarray. In this condition, there is a haphazard arrangement of myocardial fibers and sarcomeres. This structural disarray, along with extensive interstitial and replacement fibrosis, contributes to the abnormal function of the myocardium.</span></li><li><span style=\"font-size:16px;\"><strong>Vacuolation in Myocyte - C. Subendocardial Ischemia</strong>: Vacuolation in myocytes, also known as myocytolysis, occurs due to ischemia, especially in the subendocardial region. This type of cellular change is seen when there is an inadequate supply of oxygen, resulting in cellular damage and vacuolation within myocardial cells.</span></li><li><span style=\"font-size:16px;\"><strong>Myocyte Hypertrophy - D. Dilated Cardiomyopathy</strong>: Myocyte hypertrophy can be observed in both hypertrophic and dilated cardiomyopathies. However, in the context of dilated cardiomyopathy (DCM), myocyte hypertrophy occurs as a compensatory mechanism to manage increased chamber size and workload. Myocyte hypertrophy in DCM is associated with dilation of the ventricles and decreased contractile function.</span></li></ol><p> </p><p><span style=\"font-size:16px;\"><strong>Educational Objective:</strong></span></p><p> </p><ul><li><span style=\"font-size:16px;\">Hypertension → Box car nuclei</span></li><li><span style=\"font-size:16px;\">Hypertrophic cardiomyopathy → Myocyte disarray</span></li><li><span style=\"font-size:16px;\">Subendocardial ischemia → Myocyte vacuolation</span></li><li><span style=\"font-size:16px;\">Dilated cardiomyopathy → Myocyte hypertrophy</span></li></ul>",
      "correct_choice_id": 200716,
      "solution_audio": null,
      "solution_video": null,
      "audio_explanation_heading": null,
      "video_explanation_heading": null,
      "solution_media_position": "bottom",
      "tags": [],
      "explanation_video": null,
      "question_images": [],
      "explanation_images": []
    },
    {
      "id": 50180,
      "choices": [
        {
          "id": 200720,
          "text": "<p><span style=\"font-size:12.0pt;\">Statements 1, 3 and 4 are True; Statements 2 and 5 are False.</span></p>"
        },
        {
          "id": 200721,
          "text": "<p><span style=\"font-size:12.0pt;\">Statements 1, 2 and 4 are True; Statements 3 and 5 are False.</span></p>"
        },
        {
          "id": 200722,
          "text": "<p><span style=\"font-size:12.0pt;\">Statements 1, 2 and 3 are True; Statements 4 and 5 are False.</span></p>"
        },
        {
          "id": 200723,
          "text": "<p><span style=\"font-size:12.0pt;\">Statements 2, 4 and 5 are True; Statements 1 and 3 are False.</span></p>"
        }
      ],
      "text": "<p><span style=\"font-size:16px;\">Regarding CPR, identify which statements are True and which are False:</span></p><p> </p><ol><li><span style=\"font-size:16px;\">CPR can be administered regardless of rib fractures.</span></li><li><span style=\"font-size:16px;\">Chest compressions should be at a rate of 100-120/min for adults and 90/min for infants.</span></li><li><span style=\"font-size:16px;\">In adult CPR, even with two rescuers, the compression-to-ventilation ratio remains 30:2.</span></li><li><span style=\"font-size:16px;\">In infant CPR, the compression-to-ventilation ratio changes to 15:2 if a second rescuer is available.</span></li><li><span style=\"font-size:16px;\">If an AED is available, alternate defibrillation and chest compressions every 3 minutes.</span></li></ol>",
      "unique_key": "Q3388507",
      "question_audio": null,
      "question_video": null,
      "map_id": 34858197,
      "difficulty_level": "intermediate",
      "subjects_id": [],
      "solution": "<p><span style=\"font-size:16px;\"><strong>Ans. A) Statements 1, 3 and 4 are True; Statements 2 and 5 are False</strong></span></p><p> </p><ol><li><span style=\"font-size:16px;\"><strong>CPR can be administered regardless of rib fractures - True</strong></span><br><span style=\"font-size:16px;\">Administering CPR is prioritized over concerns of rib fractures, as immediate chest compressions can be life-saving even if ribs are at risk of injury.</span></li><li><span style=\"font-size:16px;\"><strong>Chest compressions should be at a rate of 100-120/min for adults and 90/min for infants - False</strong></span><br><span style=\"font-size:16px;\">The recommended compression rate is consistently 100-120/min for both adults and infants. This rate maximizes blood flow during CPR.</span></li><li><span style=\"font-size:16px;\"><strong>In adult CPR, even with two rescuers, the compression-to-ventilation ratio remains 30:2 - True</strong></span><br><span style=\"font-size:16px;\">For adults, the 30:2 compression-to-ventilation ratio applies regardless of the number of rescuers to maintain consistent oxygenation and circulation.</span></li><li><span style=\"font-size:16px;\"><strong>In infant CPR, the compression-to-ventilation ratio changes to 15:2 if a second rescuer is available - True</strong></span><br><span style=\"font-size:16px;\">For infants, adding a second rescuer changes the ratio to 15:2 to increase the frequency of breaths, as infants require more frequent ventilation.</span></li><li><span style=\"font-size:16px;\"><strong>If an AED is available, alternate defibrillation and chest compressions every 3 minutes - False</strong></span><br><span style=\"font-size:16px;\">AED guidelines recommend alternating defibrillation and chest compressions every 2 minutes, ensuring timely reassessment and potential shock delivery.</span></li></ol><p> </p><p><span style=\"font-size:16px;\"><strong>Educational Objective:</strong></span></p><p> </p><p><span style=\"font-size:16px;\">For effective CPR, use a consistent chest compression rate of 100-120/min across all age groups, and alternate defibrillation with chest compressions every 2 minutes if an AED is available.</span></p>",
      "correct_choice_id": 200720,
      "solution_audio": null,
      "solution_video": null,
      "audio_explanation_heading": null,
      "video_explanation_heading": null,
      "solution_media_position": "bottom",
      "tags": [],
      "explanation_video": null,
      "question_images": [],
      "explanation_images": []
    },
    {
      "id": 50181,
      "choices": [
        {
          "id": 200724,
          "text": "<p><span style=\"font-size:12.0pt;\">It occurs as a sequela following infection with Varicella Zoster Virus (VZV)</span></p>"
        },
        {
          "id": 200725,
          "text": "<p><span style=\"font-size:12.0pt;\">Seizures, personality changes, and myoclonus are common clinical features</span></p>"
        },
        {
          "id": 200726,
          "text": "<p><span style=\"font-size:12.0pt;\">EEG shows a characteristic periodic sharp wave pattern</span></p>"
        },
        {
          "id": 200727,
          "text": "<p><span style=\"font-size:12.0pt;\">Symptoms typically present 8 - 10 years after the initial infection</span></p>"
        }
      ],
      "text": "<p><span style=\"font-size:16px;\">Identify the statement that is false regarding Subacute Sclerosing Pan Encephalitis (SSPE).</span></p>",
      "unique_key": "Q7203279",
      "question_audio": null,
      "question_video": null,
      "map_id": 34466976,
      "difficulty_level": "intermediate",
      "subjects_id": [],
      "solution": "<p><span style=\"font-size:16px;\"><strong>Ans. A) It occurs as a sequela following infection with Varicella Zoster Virus (VZV)</strong></span></p><p> </p><p><span style=\"font-size:16px;\"><strong>It occurs as a sequela following infection with Varicella Zoster Virus (VZV) - False</strong></span><br><span style=\"font-size:16px;\">This statement is false. Subacute Sclerosing Pan Encephalitis (SSPE) is a rare, progressive, and fatal complication that occurs as a delayed consequence of measles (Rubeola) virus infection, not Varicella Zoster Virus (VZV). SSPE typically manifests years after the initial measles infection, often in childhood or adolescence.</span></p><p> </p><p><span style=\"font-size:16px;\"><strong>Other Options:</strong></span></p><p> </p><p><span style=\"font-size:16px;\"><strong>Option B. Seizures, personality changes, and myoclonus are common clinical features – True: </strong>SSPE often presents with symptoms including personality changes, intellectual decline, seizures, and myoclonus (involuntary muscle jerks). These progressive neurological symptoms are characteristic of SSPE.</span></p><p> </p><p><span style=\"font-size:16px;\"><strong>Option C. EEG shows a characteristic periodic sharp wave pattern – True:  </strong>The EEG in SSPE is distinctive, often showing a periodic pattern with bursts of high-voltage, sharp waves or slow waves occurring every 3-8 seconds. This pattern is a hallmark of SSPE.</span></p><p> </p><p><span style=\"font-size:16px;\"><strong>Option D. Symptoms typically present 8 - 10 years after the initial infection – True:  </strong>SSPE generally appears as a late complication, emerging about 5-15 years after the initial measles infection, with an average onset around 8-10 years. This delayed onset is typical of the disease.</span></p><p> </p><p><span style=\"font-size:16px;\"><strong>Educational Objective:</strong></span></p><p> </p><p><span style=\"font-size:16px;\">SSPE is a late-onset, progressive, and fatal neurological disorder resulting from a previous measles infection, not VZV. It commonly presents years after the initial infection with specific clinical and EEG findings.</span></p>",
      "correct_choice_id": 200724,
      "solution_audio": null,
      "solution_video": null,
      "audio_explanation_heading": null,
      "video_explanation_heading": null,
      "solution_media_position": "bottom",
      "tags": [],
      "explanation_video": null,
      "question_images": [],
      "explanation_images": []
    },
    {
      "id": 50182,
      "choices": [
        {
          "id": 200728,
          "text": "<p><span style=\"font-size:12.0pt;\">Polygenic inheritance</span></p>"
        },
        {
          "id": 200729,
          "text": "<p><span style=\"font-size:12.0pt;\">Lamotrigine helps control myoclonic jerks</span></p>"
        },
        {
          "id": 200730,
          "text": "<p><span style=\"font-size:12.0pt;\">Benzodiazepines can be used as monotherapy for myoclonic jerks</span></p>"
        },
        {
          "id": 200731,
          "text": "<p><span style=\"font-size:12.0pt;\">Valproate is not useful for the treatment</span></p>"
        }
      ],
      "text": "<p><span style=\"font-size:16px;\">Which of the following is not true regarding Juvenile myoclonic epilepsy?</span></p>",
      "unique_key": "Q7331604",
      "question_audio": null,
      "question_video": null,
      "map_id": 34807677,
      "difficulty_level": "intermediate",
      "subjects_id": [],
      "solution": "<p><span style=\"font-size:16px;\"><strong>Ans. D) Valproate is not useful for the treatment</strong></span></p><p> </p><p><span style=\"font-size:16px;\"><strong>Valproate is not useful for the treatment</strong> - This statement is incorrect, as Valproate is actually the first-line and most effective treatment for juvenile myoclonic epilepsy (JME). It effectively controls the characteristic myoclonic jerks, generalized tonic-clonic seizures, and absence seizures seen in JME. Thus, the correct answer is that it <i>is</i> useful for treatment, making this option \"not true.\"</span></p><p> </p><p><span style=\"font-size:16px;\"><strong>Other Options:</strong></span></p><p> </p><p><span style=\"font-size:16px;\"><strong>Option A. Polygenic inheritance</strong>:  This statement is true. Juvenile myoclonic epilepsy is thought to have a polygenic inheritance pattern, meaning that multiple genetic factors contribute to the condition. Genes such as CACNB4 and GABRA1 have been associated with JME.</span></p><p> </p><p><span style=\"font-size:16px;\"><strong>Option B. Lamotrigine helps control myoclonic jerks:</strong> This is also true. Lamotrigine can help in managing myoclonic jerks, although it is generally considered a secondary option compared to valproate, which is more commonly prescribed for JME.</span></p><p> </p><p><span style=\"font-size:16px;\"><strong>Option C. Benzodiazepines can be used as monotherapy for myoclonic jerks: </strong> This statement is true. Benzodiazepines, particularly clonazepam, can be used as monotherapy or adjunct therapy for controlling myoclonic jerks in JME, especially if other drugs are not effective or not tolerated.</span></p><p> </p><p><span style=\"font-size:16px;\"><strong>Educational Objective:</strong></span></p><p><br><span style=\"font-size:16px;\">Valproate is the primary drug of choice for juvenile myoclonic epilepsy, effectively controlling all seizure types associated with this condition.</span></p>",
      "correct_choice_id": 200731,
      "solution_audio": null,
      "solution_video": null,
      "audio_explanation_heading": null,
      "video_explanation_heading": null,
      "solution_media_position": "bottom",
      "tags": [],
      "explanation_video": null,
      "question_images": [],
      "explanation_images": []
    },
    {
      "id": 50183,
      "choices": [
        {
          "id": 200732,
          "text": "<p><span style=\"font-size:12.0pt;\">Both Assertion and Reason are true, and the Reason explains the Assertion.</span></p>"
        },
        {
          "id": 200733,
          "text": "<p><span style=\"font-size:12.0pt;\">Both Assertion and Reason are true, but the Reason does not explain the Assertion.</span></p>"
        },
        {
          "id": 200734,
          "text": "<p><span style=\"font-size:12.0pt;\">The Assertion is true, but the Reason is false.</span></p>"
        },
        {
          "id": 200735,
          "text": "<p><span style=\"font-size:12.0pt;\">The Assertion is false, but the Reason is true.</span></p>"
        }
      ],
      "text": "<p><span style=\"font-size:16px;\"><strong>Assertion:</strong> Topical Steroids are contraindicated in a viral corneal ulcer.</span></p><p><br><span style=\"font-size:16px;\"><strong>Reason:</strong> Topical steroids can increase intraocular pressure.</span></p>",
      "unique_key": "Q8404589",
      "question_audio": null,
      "question_video": null,
      "map_id": 34781569,
      "difficulty_level": "intermediate",
      "subjects_id": [],
      "solution": "<p><span style=\"font-size:16px;\"><strong>Ans. B) Both Assertion and Reason are true, but the Reason does not explain the Assertion.</strong></span></p><p> </p><p><span style=\"font-size:16px;\">Topical steroids are avoided in viral corneal ulcers because they can worsen the infection by suppressing the immune response in the cornea. This can lead to a recurrence of the infection when the steroid is stopped.</span></p><p> </p><p><span style=\"font-size:16px;\">While it is true that steroids can increase intraocular pressure, this is not the reason why they are avoided in viral corneal ulcers. The main concern with steroid use in these cases is the risk of worsening the viral infection, not the increase in eye pressure.</span></p><p> </p><p><span style=\"font-size:16px;\"><strong>Educational Objective: </strong></span></p><p> </p><p><span style=\"font-size:16px;\">Topical steroids should not be used in viral corneal ulcers primarily due to the risk of aggravating the infection, not because of increased eye pressure.</span></p>",
      "correct_choice_id": 200733,
      "solution_audio": null,
      "solution_video": null,
      "audio_explanation_heading": null,
      "video_explanation_heading": null,
      "solution_media_position": "bottom",
      "tags": [],
      "explanation_video": null,
      "question_images": [],
      "explanation_images": []
    },
    {
      "id": 50184,
      "choices": [
        {
          "id": 200736,
          "text": "<p><span style=\"font-size:12.0pt;\">Intravenous</span></p>"
        },
        {
          "id": 200737,
          "text": "<p><span style=\"font-size:12.0pt;\">Subcutaneous</span></p>"
        },
        {
          "id": 200738,
          "text": "<p><span style=\"font-size:12.0pt;\">Intramuscular</span></p>"
        },
        {
          "id": 200739,
          "text": "<p><span style=\"font-size:12.0pt;\">Intradermal</span></p>"
        }
      ],
      "text": "<p><span style=\"font-size:16px;\">Which route is used to administer LMWH?</span></p>",
      "unique_key": "Q4879803",
      "question_audio": null,
      "question_video": null,
      "map_id": 34261876,
      "difficulty_level": "intermediate",
      "subjects_id": [],
      "solution": "<p><span style=\"font-size:16px;\"><strong>Ans. B) Subcutaneous</strong></span></p><p><br><span style=\"font-size:16px;\">Low Molecular Weight Heparin (LMWH) is typically administered via the subcutaneous route, which allows for steady and gradual absorption. LMWH, along with heparin and fondaparinux, cannot be absorbed through the gastrointestinal tract, so it requires parenteral administration. The subcutaneous route is preferred for LMWH to achieve a sustained anticoagulant effect.</span></p><p> </p><p><span style=\"font-size:16px;\"><strong>Other Options:</strong></span></p><p> </p><p><span style=\"font-size:16px;\"><strong>Option A. Intravenous:</strong> While heparin can be given intravenously, LMWH is usually administered subcutaneously due to its unique pharmacokinetic properties that provide prolonged action when given this way.</span></p><p> </p><p><span style=\"font-size:16px;\"><strong>Option C. Intramuscular:</strong> The intramuscular route is avoided for LMWH as it can increase the risk of bleeding and does not provide optimal absorption for anticoagulation.</span></p><p> </p><p><span style=\"font-size:16px;\"><strong>Option D. Intradermal: </strong>Intradermal administration is not used for LMWH, as it would not allow for adequate systemic absorption necessary for its anticoagulant effects.</span></p><p> </p><p><span style=\"font-size:16px;\"><strong>Educational Objective:</strong></span></p><p> </p><p><span style=\"font-size:16px;\">LMWH is best administered through the subcutaneous route to ensure effective and sustained anticoagulation.</span></p>",
      "correct_choice_id": 200737,
      "solution_audio": null,
      "solution_video": null,
      "audio_explanation_heading": null,
      "video_explanation_heading": null,
      "solution_media_position": "bottom",
      "tags": [],
      "explanation_video": null,
      "question_images": [],
      "explanation_images": []
    },
    {
      "id": 50185,
      "choices": [
        {
          "id": 200740,
          "text": "<p><span style=\"font-size:12.0pt;\">Zinc</span></p>"
        },
        {
          "id": 200741,
          "text": "<p><span style=\"font-size:12.0pt;\">Penicillamine</span></p>"
        },
        {
          "id": 200742,
          "text": "<p><span style=\"font-size:12.0pt;\">Calcium citrate</span></p>"
        },
        {
          "id": 200743,
          "text": "<p><span style=\"font-size:12.0pt;\">Trientine</span></p>"
        }
      ],
      "text": "<p><span style=\"font-size:16px;\">Which of the following is not given in Wilson's disease? </span></p>",
      "unique_key": "Q9889877",
      "question_audio": null,
      "question_video": null,
      "map_id": 34565862,
      "difficulty_level": "intermediate",
      "subjects_id": [],
      "solution": "<p><span style=\"font-size:16px;\"><strong>Ans. C) Calcium citrate</strong></span></p><p><br><span style=\"font-size:16px;\">Calcium citrate is not part of the treatment regimen for Wilson's disease, as it does not have any role in reducing copper levels in the body.</span></p><p> </p><p><span style=\"font-size:16px;\">The primary treatment approach for Wilson's disease involves medications that help reduce copper accumulation in the body. These include:</span></p><p> </p><ol><li><span style=\"font-size:16px;\"><strong>Chelating Agents</strong>:</span><ul style=\"list-style-type:circle;\"><li><span style=\"font-size:16px;\"><strong>D-Penicillamine</strong>: It binds to copper, forming a complex that can be excreted through urine. It is the commonly used treatment due to its availability and cost-effectiveness. However, it has side effects such as aplastic anemia, myasthenia gravis, membranous nephropathy, and can worsen neurological symptoms. Supplementation with pyridoxine is recommended since D-penicillamine is a pyridoxine antagonist.</span></li><li><span style=\"font-size:16px;\"><strong>Trientine</strong>: Another chelating agent used in patients who cannot tolerate D-penicillamine.</span></li><li><span style=\"font-size:16px;\"><strong>Tetrathiomolybdate</strong>: This medication is effective in patients with neuropsychiatric symptoms of Wilson's disease.</span><br> </li></ul></li><li><span style=\"font-size:16px;\"><strong>Zinc</strong>:</span><ul style=\"list-style-type:circle;\"><li><span style=\"font-size:16px;\">Zinc is used as it blocks the absorption of copper in the intestine by inducing metallothionein in enterocytes. It is commonly used as maintenance therapy or as a first-line treatment in pregnant women with Wilson's disease.</span></li></ul></li></ol><p> </p><p><span style=\"font-size:16px;\"><strong>Educational Objective:</strong></span></p><p> </p><p><span style=\"font-size:16px;\">Calcium citrate is not used in Wilson's disease. Treatment primarily involves chelating agents (like D-penicillamine and trientine) and zinc to manage copper accumulation.</span></p>",
      "correct_choice_id": 200742,
      "solution_audio": null,
      "solution_video": null,
      "audio_explanation_heading": null,
      "video_explanation_heading": null,
      "solution_media_position": "bottom",
      "tags": [],
      "explanation_video": null,
      "question_images": [],
      "explanation_images": []
    },
    {
      "id": 50186,
      "choices": [
        {
          "id": 200744,
          "text": "<p><span style=\"font-size:12.0pt;\">1234</span></p>"
        },
        {
          "id": 200745,
          "text": "<p><span style=\"font-size:12.0pt;\">4213</span></p>"
        },
        {
          "id": 200746,
          "text": "<p><span style=\"font-size:12.0pt;\">3124</span></p>"
        },
        {
          "id": 200747,
          "text": "<p><span style=\"font-size:12.0pt;\">3142</span></p>"
        }
      ],
      "text": "<p><span style=\"font-size:16px;\">Arrange the steps of intubation in the correct order, starting from the initial preparation to confirmation of placement: </span></p><p> </p><p><span style=\"font-size:16px;\"><strong>1.</strong> Introduction of laryngoscope</span><br><span style=\"font-size:16px;\"><strong>2.</strong> Check breath sounds with a stethoscope</span><br><span style=\"font-size:16px;\"><strong>3.</strong> Position the neck with extension and flexion</span><br><span style=\"font-size:16px;\"><strong>4.</strong> Inflate the tube cuff</span></p>",
      "unique_key": "Q7945825",
      "question_audio": null,
      "question_video": null,
      "map_id": 34047134,
      "difficulty_level": "intermediate",
      "subjects_id": [],
      "solution": "<p><span style=\"font-size:16px;\"><strong>Ans. D) 3142</strong></span></p><p> </p><p><span style=\"font-size:16px;\">The proper sequence for intubation is as follows:</span></p><p> </p><p><span style=\"font-size:16px;\"><strong>3. Position the neck with extension and flexion</strong> - This positioning provides a clear view of the vocal cords by aligning the oral, pharyngeal, and laryngeal axes.</span></p><p> </p><p><span style=\"font-size:16px;\"><strong>1. Introduction of laryngoscope</strong> - After positioning, the laryngoscope is introduced to visualize the vocal cords and facilitate tube placement.</span></p><p> </p><p><span style=\"font-size:16px;\"><strong>4. Inflate the tube cuff</strong> - Once the endotracheal tube is correctly placed, the cuff is inflated to secure the airway.</span></p><p> </p><p><span style=\"font-size:16px;\"><strong>2. Check breath sounds with a stethoscope</strong> - Auscultation ensures correct placement by verifying that both lungs are being ventilated equally.</span></p><p> </p><p><span style=\"font-size:16px;\"><strong>Educational Objective: </strong></span></p><p> </p><p><span style=\"font-size:16px;\">The correct sequence for intubation is <strong>Positioning the neck → Introducing the laryngoscope → Inflating the tube cuff → Confirming with breath sounds</strong>.</span></p>",
      "correct_choice_id": 200747,
      "solution_audio": null,
      "solution_video": null,
      "audio_explanation_heading": null,
      "video_explanation_heading": null,
      "solution_media_position": "bottom",
      "tags": [],
      "explanation_video": null,
      "question_images": [],
      "explanation_images": []
    },
    {
      "id": 50187,
      "choices": [
        {
          "id": 200748,
          "text": "<p><span style=\"font-size:16px;\">The surfactant should be gently warmed before administration.</span></p>"
        },
        {
          "id": 200749,
          "text": "<p><span style=\"font-size:16px;\">Shaking the surfactant vial vigorously ensures thorough mixing.</span></p>"
        },
        {
          "id": 200750,
          "text": "<p><span style=\"font-size:16px;\">It is mandatory to change the ET tube position between each surfactant dose.</span></p>"
        },
        {
          "id": 200751,
          "text": "<p><span style=\"font-size:16px;\">ET tube suctioning should occur every 30 minutes for the first two hours after surfactant administration.</span></p>"
        }
      ],
      "text": "<p><span style=\"font-size:16px;\">Which statement is correct regarding the procedures for administering surfactant replacement therapy?</span></p>",
      "unique_key": "Q3379764",
      "question_audio": null,
      "question_video": null,
      "map_id": 34893818,
      "difficulty_level": "intermediate",
      "subjects_id": [],
      "solution": "<p><span style=\"font-size:16px;\"><strong>Ans. A) The surfactant should be gently warmed before administration.</strong></span></p><p> </p><p><span style=\"font-size:16px;\"><strong>The surfactant should be gently warmed before administration – Correct</strong> Prior to administering surfactant, it should be gently warmed by holding it in the hands or allowing it to reach room temperature. This gentle warming lowers viscosity, which facilitates smoother administration. However, overheating should be avoided as it may degrade the surfactant’s properties.</span></p><p> </p><p><span style=\"color:windowtext;font-size:16px;\"><strong>Other Options: </strong></span></p><p> </p><p><span style=\"font-size:16px;\"><strong>Option B. Shaking the surfactant vial vigorously ensures thorough mixing – Incorrect: </strong>Vigorous shaking of the surfactant vial is not recommended because it can introduce bubbles and affect the surfactant's stability. Instead, the vial may be gently rolled or swirled to ensure proper mixing without disrupting its structural integrity.</span></p><p> </p><p><span style=\"font-size:16px;\"><strong>Option C. It is mandatory to change the ET tube position between each surfactant dose – Incorrect: </strong>There is no requirement to change the ET tube position between doses of surfactant. The surfactant is administered in multiple aliquots through a stable ET tube position to ensure consistent delivery.</span></p><p> </p><p><span style=\"font-size:16px;\"><strong>Option D. ET tube suctioning should occur every 30 minutes for the first two hours after surfactant administration – Incorrect: </strong>Routine suctioning after surfactant administration is discouraged for at least 2 hours to allow the surfactant to remain effective. Frequent suctioning can disrupt the surfactant and reduce its therapeutic benefit. Suctioning is performed only when absolutely necessary to maintain airway patency.</span></p><p> </p><p><span style=\"color:windowtext;font-size:16px;\"><strong>Educational Objective:</strong></span></p><p> </p><p><span style=\"font-size:16px;\">The surfactant should be gently warmed before administration, but it should not be shaken or subjected to frequent suctioning afterward.</span></p>",
      "correct_choice_id": 200748,
      "solution_audio": null,
      "solution_video": null,
      "audio_explanation_heading": null,
      "video_explanation_heading": null,
      "solution_media_position": "bottom",
      "tags": [],
      "explanation_video": null,
      "question_images": [],
      "explanation_images": []
    },
    {
      "id": 50188,
      "choices": [
        {
          "id": 200752,
          "text": "<p><span style=\"font-size:12.0pt;\">Both Assertion and Reasons are correct statements, and the Reason is the correct explanation for the Assertion.</span></p>"
        },
        {
          "id": 200753,
          "text": "<p><span style=\"font-size:12.0pt;\">Both Assertion and Reasons are correct statements, but the Reason is not the correct explanation for the Assertion.</span></p>"
        },
        {
          "id": 200754,
          "text": "<p><span style=\"font-size:12.0pt;\">The assertion is correct statement, but the Reason is incorrect statement.</span></p>"
        },
        {
          "id": 200755,
          "text": "<p><span style=\"font-size:12.0pt;\">The assertion is incorrect statement, but the Reason is correct statement.</span></p>"
        }
      ],
      "text": "<p><span style=\"font-size:16px;\"><strong>Assertion:</strong> In pregnancy, anemia has a different cutoff point.</span></p><p><br><span style=\"font-size:16px;\"><strong>Reason:</strong> Physiological hemodilution takes place during pregnancy.</span></p>",
      "unique_key": "Q6996963",
      "question_audio": null,
      "question_video": null,
      "map_id": 34097374,
      "difficulty_level": "intermediate",
      "subjects_id": [],
      "solution": "<p><span style=\"font-size:16px;\"><strong>Ans.</strong> <strong>A) Both Assertion and Reasons are correct statements, and the Reason is the correct explanation for the Assertion.</strong></span></p><p> </p><p><span style=\"font-size:16px;\">In pregnancy, anemia is assessed differently than in non-pregnant individuals due to the process of physiological hemodilution. Hemodilution occurs as plasma volume increases significantly more than red cell mass, leading to a natural dilution effect on hemoglobin concentration, which can create a lower hemoglobin value. This adjustment is necessary to accommodate the increased blood flow requirements of the fetus and the placenta, making it a critical part of maternal adaptation during pregnancy.</span></p><p> </p><p><span style=\"font-size:16px;\">The Reason provided, \"Physiological hemodilution takes place during pregnancy,\" is indeed accurate and directly explains why anemia cutoff points differ in pregnant individuals. Physiological hemodilution is essential for supporting fetal development and helps to prevent maternal blood from becoming too viscous, thus promoting better blood flow.</span></p><p> </p><p><span style=\"color:windowtext;font-size:16px;\"><strong>Educational Objective:</strong></span></p><p> </p><p><span style=\"font-size:16px;\">In pregnancy, physiological hemodilution necessitates a different cutoff for diagnosing anemia due to the increase in plasma volume relative to red cell mass.</span></p>",
      "correct_choice_id": 200752,
      "solution_audio": null,
      "solution_video": null,
      "audio_explanation_heading": null,
      "video_explanation_heading": null,
      "solution_media_position": "bottom",
      "tags": [],
      "explanation_video": null,
      "question_images": [],
      "explanation_images": []
    },
    {
      "id": 50189,
      "choices": [
        {
          "id": 200756,
          "text": "<p><span style=\"font-size:12.0pt;\">iii, ii, i, iv, v, vi, vii</span></p>"
        },
        {
          "id": 200757,
          "text": "<p><span style=\"font-size:12.0pt;\">i, v, ii, iii, iv, vii, vi</span></p>"
        },
        {
          "id": 200758,
          "text": "<p><span style=\"font-size:12.0pt;\">vii, ii, v, i, vi, iii, iv</span></p>"
        },
        {
          "id": 200759,
          "text": "<p><span style=\"font-size:12.0pt;\">ii, i, iv, v, vi, iii, vii</span></p>"
        }
      ],
      "text": "<p><span style=\"font-size:16px;\">Arrange the following steps in the correct sequence for performing the Ziehl-Neelsen staining technique:</span></p><p> </p><ol style=\"list-style-type:lower-roman;\"><li><span style=\"font-size:16px;\">Apply carbol fuchsin to cover the smear.</span></li><li><span style=\"font-size:16px;\"> Rinse with distilled water.</span></li><li><span style=\"font-size:16px;\">Decolorize by flooding with 3% acid-alcohol.</span></li><li><span style=\"font-size:16px;\">Let the slide sit for 2-3 minutes.</span></li><li><span style=\"font-size:16px;\">Heat the slide with a flame to allow stain penetration.</span></li><li><span style=\"font-size:16px;\">Air dry the slide.</span></li><li><span style=\"font-size:16px;\">Apply methylene blue as a counterstain.</span></li></ol><p> </p><p><span style=\"font-size:16px;\">The correct sequence is:</span></p>",
      "unique_key": "Q8856133",
      "question_audio": null,
      "question_video": null,
      "map_id": 34666480,
      "difficulty_level": "intermediate",
      "subjects_id": [],
      "solution": "<p><span style=\"font-size:16px;\"><strong>Ans. B) i, v, ii, iii, iv, vii, vi</strong></span></p><p> </p><p><span style=\"font-size:16px;\">The Ziehl-Neelsen (ZN) staining process is designed to identify acid-fast bacteria, particularly Mycobacterium species, by distinguishing acid-fast from non-acid-fast bacteria. Each step is essential for preparing the sample, applying the stain, decolorizing, and counterstaining, so the acid-fast organisms are clearly visible under a microscope. The correct steps in sequence are as follows:</span></p><p> </p><ol><li><span style=\"font-size:16px;\"><strong>Apply Carbol Fuchsin (Step i):</strong> This primary stain binds to acid-fast bacteria.</span></li><li><span style=\"font-size:16px;\"><strong>Heat the Slide (Step v):</strong> Gentle heating helps the stain penetrate the waxy cell walls of acid-fast bacteria.</span></li><li><span style=\"font-size:16px;\"><strong>Rinse with Distilled Water (Step ii):</strong> Washing removes excess carbol fuchsin.</span></li><li><span style=\"font-size:16px;\"><strong>Decolorize with Acid-Alcohol (Step iii):</strong> Acid-alcohol removes the stain from non-acid-fast bacteria, while acid-fast bacteria retain it.</span></li><li><span style=\"font-size:16px;\"><strong>Let Stand for 2-3 Minutes (Step iv):</strong> Allowing time ensures thorough decolorization.</span></li><li><span style=\"font-size:16px;\"><strong>Apply Methylene Blue (Step vii):</strong> This counterstain provides contrast by staining non-acid-fast bacteria.</span></li><li><span style=\"font-size:16px;\"><strong>Air Dry the Slide (Step vi):</strong> The slide is allowed to dry before examination under a microscope.</span></li></ol><p> </p><p><span style=\"color:windowtext;font-size:16px;\"><strong>Educational Objective:</strong></span></p><p> </p><p><span style=\"font-size:16px;\">For effective Ziehl-Neelsen staining, the sequence involves applying carbol fuchsin with heat, followed by decolorization with acid-alcohol, counterstaining with methylene blue, and drying.</span></p>",
      "correct_choice_id": 200757,
      "solution_audio": null,
      "solution_video": null,
      "audio_explanation_heading": null,
      "video_explanation_heading": null,
      "solution_media_position": "bottom",
      "tags": [],
      "explanation_video": null,
      "question_images": [],
      "explanation_images": []
    },
    {
      "id": 50190,
      "choices": [
        {
          "id": 200760,
          "text": "<p><span style=\"font-size:12.0pt;\">1 & 2 are correct</span></p>"
        },
        {
          "id": 200761,
          "text": "<p><span style=\"font-size:12.0pt;\">1, 2 & 4 are correct</span></p>"
        },
        {
          "id": 200762,
          "text": "<p><span style=\"font-size:12.0pt;\">3 & 4 are correct</span></p>"
        },
        {
          "id": 200763,
          "text": "<p><span style=\"font-size:12.0pt;\">2 & 4 are correct</span></p>"
        }
      ],
      "text": "<p><span style=\"font-size:16px;\">Which of the following statements are correct regarding Haab's Striae?</span></p><p> </p><ol><li><span style=\"font-size:16px;\">Not seen in juvenile glaucoma</span></li><li><span style=\"font-size:16px;\">Usually horizontal or concentric to the limbus</span></li><li><span style=\"font-size:16px;\">Are usually indistinguishable from birth trauma striae</span></li><li><span style=\"font-size:16px;\">Persist even after control of glaucoma</span></li></ol>",
      "unique_key": "Q2976282",
      "question_audio": null,
      "question_video": null,
      "map_id": 34279948,
      "difficulty_level": "intermediate",
      "subjects_id": [],
      "solution": "<p><span style=\"font-size:16px;\"><strong>Ans. B) 1, 2 & 4 are correct</strong></span></p><p> </p><p><span style=\"font-size:16px;\">Haab's striae are characterized by breaks in Descemet's membrane, often presenting as double \"tram-track\" lines that are concentric to the limbus. These are typically associated with congenital glaucoma (Buphthalmos) and are not commonly seen in juvenile glaucoma. Haab's striae tend to be horizontal or concentric around the limbus, making them distinct from birth trauma striae, which are often oblique or vertical. Additionally, Haab's striae usually remain visible even after glaucoma has been managed or controlled.</span></p><p> </p><p><span style=\"font-size:16px;\"><img src=\"https://cerebellum-web-static.s3.amazonaws.com/media/public/Screenshot%202024-11-12%20123459.jpg\" width=\"444\" height=\"327\"></span></p><p> </p><p><span style=\"color:windowtext;font-size:16px;\"><strong>Other Option:</strong></span></p><p> </p><p><span style=\"font-size:16px;\"><strong>Option 3:</strong> Incorrect because Haab's striae are distinguishable from birth trauma striae due to their characteristic concentric pattern.</span></p><p> </p><p><span style=\"color:windowtext;font-size:16px;\"><strong>Educational Objective:</strong></span></p><p> </p><p><span style=\"font-size:16px;\">Haab's striae are breaks in Descemet's membrane commonly seen in congenital glaucoma, characterized by horizontal or concentric lines around the limbus, and persist even after glaucoma management.</span></p><p><img src=\"https://cerebellum-web-static.s3.amazonaws.com/media/public/Screenshot%202024-11-12%20123459.jpg\" alt=\"Solution Image\"></p>",
      "correct_choice_id": 200761,
      "solution_audio": null,
      "solution_video": null,
      "audio_explanation_heading": null,
      "video_explanation_heading": null,
      "solution_media_position": "bottom",
      "tags": [],
      "explanation_video": null,
      "question_images": [],
      "explanation_images": []
    },
    {
      "id": 50191,
      "choices": [
        {
          "id": 200764,
          "text": "<p><span style=\"font-size:12.0pt;\">Both assertion and reason are true and the reason is the correct explanation of the assertion.</span></p>"
        },
        {
          "id": 200765,
          "text": "<p><span style=\"font-size:12.0pt;\">Both the assertion and reason are true but the reason is not the correct explanation of the assertion.</span></p>"
        },
        {
          "id": 200766,
          "text": "<p><span style=\"font-size:12.0pt;\">Assertion is true but the reason is false.</span></p>"
        },
        {
          "id": 200767,
          "text": "<p><span style=\"font-size:12.0pt;\">Assertion is false but the reason is true.</span></p>"
        }
      ],
      "text": "<p><span style=\"font-size:16px;\"><strong>Assertion:</strong> Amphotericin B is given as 5% Dextrose infusion.</span></p><p><br><span style=\"font-size:16px;\"><strong>Reason:</strong> Coadministration of Dextrose reduces the nephrotoxicity. </span></p>",
      "unique_key": "Q7324688",
      "question_audio": null,
      "question_video": null,
      "map_id": 34559863,
      "difficulty_level": "intermediate",
      "subjects_id": [],
      "solution": "<p><span style=\"font-size:16px;\"><strong>Ans. C) Assertion is true but the reason is false.</strong></span></p><p> </p><p><span style=\"font-size:16px;\">Amphotericin B is administered with 5% Dextrose because dextrose serves as a suitable carrier for the drug, ensuring it is properly dissolved and infused. The use of 5% Dextrose does not have a role in reducing nephrotoxicity, which is a known side effect of Amphotericin B.</span></p><p> </p><p><span style=\"font-size:16px;\">To manage and reduce the risk of nephrotoxicity associated with Amphotericin B, normal saline (0.9%) is administered before and/or after the infusion. Sodium repletion has been shown to mitigate nephrotoxicity, as sodium depletion is linked with an increased risk. Therefore, 500 mL of 0.9% saline is commonly infused to reduce the nephrotoxic effects rather than using 5% Dextrose for this purpose.</span></p><p> </p><p><span style=\"color:windowtext;font-size:16px;\"><strong>Educational Objective:</strong></span></p><p> </p><p><span style=\"font-size:16px;\">Amphotericin B is administered with 5% Dextrose as a carrier solution, while 0.9% saline is used to reduce nephrotoxicity risks.</span></p>",
      "correct_choice_id": 200766,
      "solution_audio": null,
      "solution_video": null,
      "audio_explanation_heading": null,
      "video_explanation_heading": null,
      "solution_media_position": "bottom",
      "tags": [],
      "explanation_video": null,
      "question_images": [],
      "explanation_images": []
    },
    {
      "id": 50192,
      "choices": [
        {
          "id": 200768,
          "text": "<p><span style=\"font-size:12.0pt;\">Both Assertion and Reasons are correct statements and the Reason is the correct explanation for the Assertion.</span></p>"
        },
        {
          "id": 200769,
          "text": "<p><span style=\"font-size:12.0pt;\">Both Assertion and Reasons are correct statements, but the Reason is not the correct explanation for the Assertion.</span></p>"
        },
        {
          "id": 200770,
          "text": "<p><span style=\"font-size:12.0pt;\">The assertion is correct statement, but the Reasons is incorrect statement.</span></p>"
        },
        {
          "id": 200771,
          "text": "<p><span style=\"font-size:12.0pt;\">The assertion is independently an incorrect statement, but the Reasons is a correct statement.</span></p>"
        }
      ],
      "text": "<p><span style=\"font-size:16px;\"><strong>Assertion:</strong> The most common hematological finding in a case of lead poisoning is eosinophilia.</span></p><p><br><span style=\"font-size:16px;\"><strong>Reason:</strong> Lead causes inhibition of ALA Dehydratase.</span></p>",
      "unique_key": "Q1081096",
      "question_audio": null,
      "question_video": null,
      "map_id": 34720237,
      "difficulty_level": "intermediate",
      "subjects_id": [],
      "solution": "<p><span style=\"font-size:16px;\"><strong>Ans.</strong> <strong>D) The assertion is independently an incorrect statement, but the Reasons is a correct statement.</strong></span></p><p> </p><p><span style=\"font-size:16px;\">The assertion that \"the most common hematological finding in lead poisoning is eosinophilia\" is incorrect. The typical hematological findings in lead poisoning include anemia, basophilic stippling of red blood cells, and the presence of ringed sideroblasts. Eosinophilia is not a characteristic finding in cases of lead toxicity.</span></p><p> </p><p><span style=\"font-size:16px;\">The reason provided, \"Lead causes inhibition of ALA Dehydratase,\" is true. Lead toxicity interferes with heme synthesis by inhibiting enzymes such as ALA Dehydratase and Ferrochelatase. This inhibition contributes to the accumulation of intermediates and results in anemia with basophilic stippling of RBCs.</span></p><p> </p><p><span style=\"color:windowtext;font-size:16px;\"><strong>Educational Objective:</strong></span></p><p> </p><p><span style=\"font-size:16px;\">In lead poisoning, typical hematological findings include anemia and basophilic stippling, not eosinophilia. Lead toxicity inhibits enzymes critical for heme synthesis, such as ALA Dehydratase.</span></p>",
      "correct_choice_id": 200771,
      "solution_audio": null,
      "solution_video": null,
      "audio_explanation_heading": null,
      "video_explanation_heading": null,
      "solution_media_position": "bottom",
      "tags": [],
      "explanation_video": null,
      "question_images": [],
      "explanation_images": []
    },
    {
      "id": 50193,
      "choices": [
        {
          "id": 200772,
          "text": "<p><span style=\"font-size:12.0pt;\">A-1, B-2, C-3, D-4</span></p>"
        },
        {
          "id": 200773,
          "text": "<p><span style=\"font-size:12.0pt;\">A-4, B-2, C-1, D-3</span></p>"
        },
        {
          "id": 200774,
          "text": "<p><span style=\"font-size:12.0pt;\">A-2, B-3, C-4, D-1</span></p>"
        },
        {
          "id": 200775,
          "text": "<p><span style=\"font-size:12.0pt;\">A-3, B-1, C-2, D-4</span></p>"
        }
      ],
      "text": "<p><span style=\"font-size:16px;\">Match the following autoimmune diseases with their respective antibodies: (PATHO)</span></p><p> </p><p><span style=\"font-size:16px;\"><strong>Column A:</strong></span></p><ol><li><span style=\"font-size:16px;\">Systemic Sclerosis</span></li><li><span style=\"font-size:16px;\">SLE (Systemic Lupus Erythematosus)</span></li><li><span style=\"font-size:16px;\">Dermatomyositis</span></li><li><span style=\"font-size:16px;\">Mixed Connective Tissue Disease</span><br><br> </li></ol><p><span style=\"font-size:16px;\"><strong>Column B:</strong></span></p><ol style=\"list-style-type:upper-alpha;\"><li><span style=\"font-size:16px;\">Anti-U1RNP</span></li><li><span style=\"font-size:16px;\">Anti-Sm</span></li><li><span style=\"font-size:16px;\">Anti-topoisomerase</span></li><li><span style=\"font-size:16px;\">Anti-Jo</span></li></ol>",
      "unique_key": "Q2158481",
      "question_audio": null,
      "question_video": null,
      "map_id": 34232738,
      "difficulty_level": "intermediate",
      "subjects_id": [],
      "solution": "<p><span style=\"font-size:16px;\"><strong>Ans. B) A-4, B-2, C-1, D-3</strong></span></p><p> </p><ul style=\"list-style-type:disc;\"><li><span style=\"font-size:16px;\"><strong>Systemic Sclerosis:</strong> Associated with <strong>Anti-topoisomerase</strong> antibodies, also known as Anti-Scl-70. These antibodies are specific for systemic sclerosis and are primarily found in diffuse cutaneous systemic sclerosis, indicating a higher risk for severe organ involvement.</span></li><li><span style=\"font-size:16px;\"><strong>SLE (Systemic Lupus Erythematosus):</strong> Associated with <strong>Anti-Sm</strong> antibodies. Anti-Sm antibodies are specific markers for SLE and are part of the diagnostic criteria for lupus. They are considered highly specific but not very sensitive.</span></li><li><span style=\"font-size:16px;\"><strong>Dermatomyositis:</strong> Associated with <strong>Anti-Jo</strong> antibodies. These antibodies are linked to the inflammatory myopathies, particularly polymyositis and dermatomyositis, and are often associated with interstitial lung disease.</span></li><li><span style=\"font-size:16px;\"><strong>Mixed Connective Tissue Disease (MCTD):</strong> Associated with <strong>Anti-U1RNP</strong> antibodies. High titers of Anti-U1RNP are characteristic of MCTD, a condition with overlapping features of systemic sclerosis, lupus, and polymyositis.</span></li></ul><p> </p><p><span style=\"font-size:16px;\"><strong>Educational Objective:</strong></span></p><p> </p><p><span style=\"font-size:16px;\">Each autoimmune disease has a specific antibody association which aids in diagnosis: Systemic Sclerosis with Anti-topoisomerase, SLE with Anti-Sm, Dermatomyositis with Anti-Jo, and Mixed Connective Tissue Disease with Anti-U1RNP.</span></p>",
      "correct_choice_id": 200773,
      "solution_audio": null,
      "solution_video": null,
      "audio_explanation_heading": null,
      "video_explanation_heading": null,
      "solution_media_position": "bottom",
      "tags": [],
      "explanation_video": null,
      "question_images": [],
      "explanation_images": []
    },
    {
      "id": 50194,
      "choices": [
        {
          "id": 200776,
          "text": "<p><span style=\"font-size:12.0pt;\">1, 2</span></p>"
        },
        {
          "id": 200777,
          "text": "<p><span style=\"font-size:12.0pt;\">2, 4</span></p>"
        },
        {
          "id": 200778,
          "text": "<p><span style=\"font-size:12.0pt;\">1, 4</span></p>"
        },
        {
          "id": 200779,
          "text": "<p><span style=\"font-size:12.0pt;\">3, 4</span></p>"
        }
      ],
      "text": "<p><span style=\"font-size:16px;\">Which of the following pairs correctly match the techniques of organ removal in autopsy?</span></p><p> </p><ol><li><span style=\"font-size:16px;\">Letulle - one by one</span></li><li><span style=\"font-size:16px;\">Virchow - en masse</span></li><li><span style=\"font-size:16px;\">Ghon's - En bloc</span></li><li><span style=\"font-size:16px;\">Rokitansky - in situ</span></li></ol>",
      "unique_key": "Q3529440",
      "question_audio": null,
      "question_video": null,
      "map_id": 34851379,
      "difficulty_level": "intermediate",
      "subjects_id": [],
      "solution": "<p><span style=\"font-size:16px;\"><strong>Ans. D) 3, 4</strong></span></p><p> </p><ul style=\"list-style-type:disc;\"><li><span style=\"font-size:16px;\"><strong>Ghon's technique</strong>: In this method, organs are removed \"en bloc,\" meaning groups of organs (e.g., thoracic, cervical, pelvic, and abdominal organs) are taken out as blocks. This method allows for systematic dissection of interconnected organs as single units.</span></li><li><span style=\"font-size:16px;\"><strong>Rokitansky's technique</strong>: Characterized by \"in situ\" dissection, where organs are examined and dissected within the body before partial removal. It combines some aspects of en bloc removal for thorough examination, often starting from the neck and moving downwards.</span></li></ul><p> </p><p><span style=\"font-size:16px;\"><strong>Other Options:</strong></span></p><p> </p><p><span style=\"font-size:16px;\"><strong>Option A. Letulle - one by one</strong>: This is incorrect because Letulle's technique involves the removal of organs \"en masse\" or as one large organ block, not individually.</span></p><p> </p><p><span style=\"font-size:16px;\"><strong>Option B. Virchow - en masse</strong>: Incorrect as Virchow’s technique involves removing organs one by one rather than en masse, allowing for a separate and thorough examination of each organ.</span></p><p> </p><p><span style=\"font-size:16px;\"><strong>Educational Objective:</strong></span></p><p> </p><p><span style=\"font-size:16px;\">Ghon's technique involves en bloc organ removal, and Rokitansky's technique is an in situ dissection approach in autopsy procedures.</span></p>",
      "correct_choice_id": 200779,
      "solution_audio": null,
      "solution_video": null,
      "audio_explanation_heading": null,
      "video_explanation_heading": null,
      "solution_media_position": "bottom",
      "tags": [],
      "explanation_video": null,
      "question_images": [],
      "explanation_images": []
    },
    {
      "id": 50195,
      "choices": [
        {
          "id": 200780,
          "text": "<p><span style=\"font-size:12.0pt;\">Lahey's method</span></p>"
        },
        {
          "id": 200781,
          "text": "<p><span style=\"font-size:12.0pt;\">Crile's method</span></p>"
        },
        {
          "id": 200782,
          "text": "<p><span style=\"font-size:12.0pt;\">Kocher's method</span></p>"
        },
        {
          "id": 200783,
          "text": "<p><span style=\"font-size:12.0pt;\">Pemberton's method</span></p>"
        }
      ],
      "text": "<p><span style=\"font-size:16px;\">A patient with a neck nodule presents to the surgery outpatient department. The junior resident employs a specific technique to palpate the nodule as demonstrated. Identify the method being used in this examination.</span></p><p> </p><p><span style=\"font-size:16px;\"><img src=\"https://cerebellum-web-static.s3.amazonaws.com/media/public/Screenshot%202024-11-12%20123658.jpg\" width=\"418\" height=\"341\"></span></p><p><img src=\"https://cerebellum-web-static.s3.amazonaws.com/media/public/Screenshot%202024-11-12%20123658.jpg\" alt=\"Question Image\"></p>",
      "unique_key": "Q2951419",
      "question_audio": null,
      "question_video": null,
      "map_id": 34949012,
      "difficulty_level": "intermediate",
      "subjects_id": [],
      "solution": "<p><span style=\"font-size:16px;\"><strong>Ans. A) Lahey's method</strong></span></p><p><br><span style=\"font-size:16px;\">The image depicts <strong>Lahey's method</strong> for palpating the thyroid gland. In this method, to examine the left lobe of the thyroid, the examiner uses their left hand to push the right lobe medially. This stabilizes the gland and allows palpation of the left lobe’s borders and consistency with the right hand, providing a thorough assessment of the gland's characteristics.</span></p><p> </p><p><span style=\"font-size:16px;\"><strong>Other Options:</strong></span></p><p> </p><p><span style=\"font-size:16px;\"><strong>Option B. Crile's method:</strong> In Crile’s method, the patient is asked to swallow while the examiner palpates the thyroid with their thumb. This technique helps in detecting slight gland enlargement or small nodules by assessing their movement during swallowing.</span></p><p> </p><p><span style=\"font-size:16px;\"><strong>Option C. Kocher's method:</strong> This method demonstrates the pressure effect of the thyroid on the trachea or larynx. Applying lateral compression can induce stridor if there is significant gland enlargement pressing on the airway.</span></p><p> </p><p><span style=\"font-size:16px;\"><strong>Option D. Pemberton's method:</strong> Technically known as <strong>Pemberton's sign</strong>, this is not a palpation method but rather a clinical sign. When the patient raises their arms until they touch the sides of their head, engorgement of the neck veins can indicate a retrosternal goiter.</span></p><p> </p><p><span style=\"font-size:16px;\"><strong>Educational Objective:</strong></span></p><p> </p><p><span style=\"font-size:16px;\"><strong>Lahey's method </strong>is used for thyroid gland palpation by medial displacement of one lobe to assess the other, offering detailed information on the gland's borders and consistency.</span></p>",
      "correct_choice_id": 200780,
      "solution_audio": null,
      "solution_video": null,
      "audio_explanation_heading": null,
      "video_explanation_heading": null,
      "solution_media_position": "bottom",
      "tags": [],
      "explanation_video": null,
      "question_images": [],
      "explanation_images": []
    },
    {
      "id": 50196,
      "choices": [
        {
          "id": 200784,
          "text": "<p><span style=\"font-size:12.0pt;\">1</span></p>"
        },
        {
          "id": 200785,
          "text": "<p><span style=\"font-size:12.0pt;\">1, 4</span></p>"
        },
        {
          "id": 200786,
          "text": "<p><span style=\"font-size:12.0pt;\">1, 3, 4</span></p>"
        },
        {
          "id": 200787,
          "text": "<p><span style=\"font-size:12.0pt;\">1, 2, 3, 4</span></p>"
        }
      ],
      "text": "<p><span style=\"font-size:16px;\">Which of the following can cause Pulmonary-Renal Syndrome? </span></p><p> </p><ol><li><span style=\"font-size:16px;\">Goodpasture Syndrome</span></li><li><span style=\"font-size:16px;\">Leptospirosis</span></li><li><span style=\"font-size:16px;\">Hantavirus</span></li><li><span style=\"font-size:16px;\">Wegener’s Granulomatosis</span></li></ol>",
      "unique_key": "Q5919555",
      "question_audio": null,
      "question_video": null,
      "map_id": 34918884,
      "difficulty_level": "intermediate",
      "subjects_id": [],
      "solution": "<p><span style=\"font-size:16px;\"><strong>Ans. D) 1, 2, 3, 4</strong></span></p><p> </p><p><span style=\"font-size:16px;\">Pulmonary-Renal Syndrome is a clinical condition characterized by concurrent lung and kidney involvement. Various diseases, including both autoimmune and infectious conditions, can lead to this syndrome.</span></p><p> </p><ol><li><span style=\"font-size:16px;\"><strong>Goodpasture Syndrome</strong> - An autoimmune condition in which anti-glomerular basement membrane antibodies attack the basement membrane in both the lungs and kidneys, causing hemorrhage and glomerulonephritis.</span></li><li><span style=\"font-size:16px;\"><strong>Leptospirosis</strong> - An infectious bacterial disease that can affect multiple organs, including the kidneys and lungs, leading to pulmonary-renal syndrome.</span></li><li><span style=\"font-size:16px;\"><strong>Hantavirus</strong> - A viral infection that can cause hantavirus pulmonary syndrome, which sometimes includes kidney involvement, contributing to pulmonary-renal syndrome.</span></li><li><span style=\"font-size:16px;\"><strong>Wegener’s Granulomatosis (now known as Granulomatosis with Polyangiitis)</strong> - An autoimmune condition associated with ANCA antibodies that commonly affects small blood vessels in both the lungs and kidneys.</span></li></ol><p> </p><p><span style=\"font-size:16px;\">All four conditions listed can cause Pulmonary-Renal Syndrome.</span></p><p> </p><p><span style=\"font-size:16px;\"><strong>Educational Objective:</strong></span></p><p> </p><p><span style=\"font-size:16px;\">Pulmonary-Renal Syndrome can be caused by autoimmune conditions like Goodpasture Syndrome and Wegener’s Granulomatosis, as well as by infections such as Leptospirosis and Hantavirus.</span></p>",
      "correct_choice_id": 200787,
      "solution_audio": null,
      "solution_video": null,
      "audio_explanation_heading": null,
      "video_explanation_heading": null,
      "solution_media_position": "bottom",
      "tags": [],
      "explanation_video": null,
      "question_images": [],
      "explanation_images": []
    },
    {
      "id": 50197,
      "choices": [
        {
          "id": 200788,
          "text": "<p><span style=\"font-size:12.0pt;\">1, 2, 3, 4, 5</span></p>"
        },
        {
          "id": 200789,
          "text": "<p><span style=\"font-size:12.0pt;\">1, 2, 4</span></p>"
        },
        {
          "id": 200790,
          "text": "<p><span style=\"font-size:12.0pt;\">2, 4</span></p>"
        },
        {
          "id": 200791,
          "text": "<p><span style=\"font-size:12.0pt;\">4, 5</span></p>"
        }
      ],
      "text": "<p><span style=\"font-size:16px;\">Which of the following statements are true regarding chalazion? </span></p><p> </p><ol><li><span style=\"font-size:16px;\">Always Painful</span></li><li><span style=\"font-size:16px;\">Can occur in the upper or lower eyelid</span></li><li><span style=\"font-size:16px;\">Hair follicle inflammation</span></li><li><span style=\"font-size:16px;\">Meibomian Gland Inflammation</span></li><li><span style=\"font-size:16px;\">Always treated with antibiotics</span></li></ol>",
      "unique_key": "Q8477595",
      "question_audio": null,
      "question_video": null,
      "map_id": 34707866,
      "difficulty_level": "intermediate",
      "subjects_id": [],
      "solution": "<p><span style=\"font-size:16px;\"><strong>Ans. C)  2, 4</strong></span></p><p> </p><p><span style=\"font-size:16px;\">A chalazion is a chronic lipogranulomatous inflammation of the Meibomian gland. It presents as a painless swelling in the eyelid and can occur in both the upper and lower eyelids due to blockage and inflammation of the Meibomian glands, not hair follicles.</span></p><p> </p><ul style=\"list-style-type:disc;\"><li><span style=\"font-size:16px;\"><strong>Statement 2 (Can occur in the upper or lower eyelid):</strong> True. A chalazion can develop in either the upper or lower eyelid.</span></li><li><span style=\"font-size:16px;\"><strong>Statement 4 (Meibomian Gland Inflammation):</strong> True. Chalazion is specifically an inflammation of the Meibomian glands, which are responsible for secreting oils into the tears.</span></li></ul><p> </p><p><span style=\"font-size:16px;\"><img src=\"https://cerebellum-web-static.s3.amazonaws.com/media/public/Screenshot%202024-11-12%20123753.jpg\" width=\"448\" height=\"358\"></span></p><p> </p><p><span style=\"font-size:16px;\"><strong>Other Options:</strong></span></p><p> </p><p><span style=\"font-size:16px;\"><strong>Statement 1. Always Painful:</strong> Incorrect. A chalazion is generally painless, unlike a stye which is often painful.</span></p><p> </p><p><span style=\"font-size:16px;\"><strong>Statement 3. Hair follicle inflammation:</strong> Incorrect. Hair follicle inflammation pertains to a stye, not a chalazion.</span></p><p> </p><p><span style=\"font-size:16px;\"><strong>Statement 5. Always treated with antibiotics:</strong> Incorrect. Chalazion treatment typically involves incision and curettage or steroid injection rather than antibiotics, as it is not usually due to an infection.</span></p><p> </p><p><span style=\"font-size:16px;\"><strong>Educational Objective:</strong></span></p><p> </p><p><span style=\"font-size:16px;\">A chalazion is a painless inflammation of the Meibomian gland and can appear on either the upper or lower eyelid.</span></p><p><img src=\"https://cerebellum-web-static.s3.amazonaws.com/media/public/Screenshot%202024-11-12%20123753.jpg\" alt=\"Solution Image\"></p>",
      "correct_choice_id": 200790,
      "solution_audio": null,
      "solution_video": null,
      "audio_explanation_heading": null,
      "video_explanation_heading": null,
      "solution_media_position": "bottom",
      "tags": [],
      "explanation_video": null,
      "question_images": [],
      "explanation_images": []
    },
    {
      "id": 50198,
      "choices": [
        {
          "id": 200792,
          "text": "<p><span style=\"font-size:12.0pt;\">A transverse lie is associated with placenta previa</span></p>"
        },
        {
          "id": 200793,
          "text": "<p><span style=\"font-size:12.0pt;\">Admission is indicated at 35 weeks (immediately)</span></p>"
        },
        {
          "id": 200794,
          "text": "<p><span style=\"font-size:12.0pt;\">An external cephalic version can be tried in patients beyond 34 weeks</span></p>"
        },
        {
          "id": 200795,
          "text": "<p><span style=\"font-size:12.0pt;\">LSCS is to be done only at the onset of labor</span></p>"
        }
      ],
      "text": "<p><span style=\"font-size:16px;\">A Primigravida presents with a transverse lie at 35 weeks and 0 days of pregnancy. Mark the following statements true regarding this condition. </span></p>",
      "unique_key": "Q1552376",
      "question_audio": null,
      "question_video": null,
      "map_id": 34564047,
      "difficulty_level": "intermediate",
      "subjects_id": [],
      "solution": "<p><span style=\"font-size:16px;\"><strong>Ans. A) A transverse lie is associated with placenta previa</strong></span></p><p> </p><p><span style=\"font-size:16px;\"><strong>A transverse lie is associated with placenta previa:</strong> True. A transverse lie can often be associated with various factors, one of which is placenta previa. Other contributing factors include:</span></p><p> </p><ol><li><span style=\"font-size:16px;\">Multiparity (due to a lax abdominal wall and weaker uterine tone).</span></li><li><span style=\"font-size:16px;\">Prematurity, which affects the center of gravity of the fetus.</span></li><li><span style=\"font-size:16px;\">The presence of a second twin in multiple gestations.</span></li><li><span style=\"font-size:16px;\">Hydramnios (excess amniotic fluid).</span></li><li><span style=\"font-size:16px;\">A contracted pelvis that limits fetal engagement in a longitudinal position.</span></li><li><span style=\"font-size:16px;\">Pelvic tumors that alter the uterine space.</span></li><li><span style=\"font-size:16px;\">Congenital uterine malformations, such as arcuate or subseptate uterus.</span></li><li><span style=\"font-size:16px;\">Intrauterine fetal demise, which may affect the fetus's orientation.</span></li></ol><p> </p><p><span style=\"font-size:16px;\"><strong>Other Options:</strong></span></p><p> </p><p><span style=\"font-size:16px;\"><strong>Option B. Admission is indicated at 35 weeks immediately:</strong> False. Admission is generally recommended around 37 weeks for cases of transverse lie, as there is an increased risk of membrane rupture and complications such as cord or hand prolapse. Immediate admission at 35 weeks is typically not required unless other risk factors are present.</span></p><p> </p><p><span style=\"font-size:16px;\"><strong>Option C. An external cephalic version can be tried in patients beyond 34 weeks:</strong> False. External cephalic version (ECV) is generally recommended at or after 35 weeks if there are no contraindications. Attempting it too early (such as at 34 weeks) may not be effective, as the fetus could revert to a non-longitudinal position. ECV is contraindicated in cases like placenta previa.</span></p><p> </p><p><span style=\"font-size:16px;\"><strong>Option D. LSCS is to be done only at the onset of labor:</strong> False. Elective lower segment cesarean section (LSCS) is the preferred method of delivery in cases of transverse lie with associated risks. If a patient with a transverse lie presents at the onset of labor, an ECV may be attempted if there are no contraindications. If ECV is unsuccessful or contraindicated, immediate LSCS is recommended.</span></p><p> </p><p><span style=\"font-size:16px;\"><strong>Educational Objective:</strong></span></p><p> </p><p><span style=\"font-size:16px;\">In cases of transverse lie at 36 weeks, transverse lie can be associated with conditions such as placenta previa. Monitoring, admission at 37 weeks, and elective LSCS are recommended to minimize risks associated with labor in this fetal position.</span></p>",
      "correct_choice_id": 200792,
      "solution_audio": null,
      "solution_video": null,
      "audio_explanation_heading": null,
      "video_explanation_heading": null,
      "solution_media_position": "bottom",
      "tags": [],
      "explanation_video": null,
      "question_images": [],
      "explanation_images": []
    }
  ]
}